Academic Press is an imprint of Elsevier 32 Jamestown Road, London NW1 7BY, UK 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA 525 B Street, Suite 1900, San Diego, CA 92101-4495, USA First edition 2009 Copyright © 2009 Elsevier Inc. All rights reserved except chapter 44 which is in the Public Domain No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (44) (0) 1865 843830; fax (44) (0) 1865 853333; email:
[email protected]. Alternatively visit the Science and Technology Books website at www.elsevierdirect.com/rights for further information Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Library of Congress Cataloging in Publication Data A catalog record for this book is available from the Library of Congress ISBN: 978-0-12-374546-0 For information on all Academic Press publications visit our website at www.elsevierdirect.com Typeset by Macmillan Publishing Solutions www.macmillansolutions.com Printed and bound in United States of America 09 10 11 12 13 10 9 8 7 6 5 4 3 2 1
To all those who contributed, knowingly or unknowingly, to this endeavour.
List of Contributors
Nawaf Al-Maharik College of Life Sciences, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, UK Heidi Annuk School of Natural Sciences, National University of Ireland, Galway, Ireland
De Groote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
Ivo G. Boneca Group Biology and Genetics of the Bacterial Cell Wall, Institut Pasteur, Paris, France
Marguerite Clyne Health Science Centre, School of Medicine and Medical Science, University College Dublin, Belfield, Dublin, Ireland
Stephen D. Carrington Veterinary Science Centre, University College Dublin, Belfield, Dublin, Ireland Michael A. Apicella Department of Micro‑ biology, University of Iowa, Iowa City, Iowa, Paola Cescutti Dipartimento di Scienze della USA Vita, Università di Trieste, Trieste, Italy Ben J. Appelmelk Department of Medical Delphi Chatterjee Department of Microbiology, Microbiology and Infection Control, VU Immunology and Pathology, College of University Medical Center, Amsterdam, The Veterinary and Biomedical Sciences, Colorado Netherlands State University, Fort Collins, Colorado, USA
Petra Born Institute for Cell and Molecular Biosciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
Richard M. Cooper Department of Biology and Biochemistry, University of Bath, Bath, UK Anthony P. Corfield Mucin Research Group, University of Bristol, Bristol, UK
Klaus Brandenburg Division of Biophysics, Department of Immunochemistry and Bio chemical Microbiology, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel, Germany
Monica M. Cunneen School of Molecular and Microbial Biosciences, University of Sydney, New South Wales, Australia Piet W. J. de Groot Swammerdam Institute of Life Sciences, University of Amsterdam, Amsterdam, The Netherlands
Patrick J. Brennan Department of Microbiology, Immunology and Pathology, College of Veteri nary and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA
Gennaro De Libero Experimental Immunology, Department of Research, University Hospital, University of Basel, Basel, Switzerland
Volker Briken Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA Eric D. Brown Department of Biochemistry and Biomedical Sciences and the Michael G.
xi
Clara G. de los Reyes-Gavilán Departamento de Microbiología y Bioquímica de Productos Lácteos, Instituto de Productos Lácteos de
xii
List of Contributors
Asturias, Consejo Superior de Investigaciones Científicas, Villaviciosa, Asturias, Spain Tamara L. Doering Washington University School of Medicine, St. Louis, Missouri, USA Max Dow BIOMERIT Research Centre, Depart ment of Microbiology, University College Cork, Cork, Ireland Nicole N. Driessen Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands Jeffrey C. Dyason Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland, Australia Eva Maria Egelseer Zentrum für NanoBiotech nologie, Universität für Bodenkultur Wien, Vienna, Austria Alan D. Elbein Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA Mario F. Feldman Alberta Ingenuity Centre for Carbohydrate Science, Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada Eamonn Fitz Patrick Veterinary Science Centre, University College Dublin, Belfield, Dublin, Ireland Yukari Fujimoto Department of Chemistry, Graduate School of Science, Osaka University, Osaka, Japan Koichi Fukase Department of Chemistry, Graduate School of Science, Osaka University, Osaka, Japan
Marlyn Gonzalez Department of Biology, Brooklyn College of City University of New York, Brooklyn, New York, USA I. Darren Grice Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland, Australia Patricia Guerry Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland, USA Thomas Gutsmann Division of Biophysics, Department of Immunochemistry and Biochemical Microbiology, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel, Germany Holger Heine Division of Innate Immunity, Department of Immunology and Cell Biology, Borstel Research Center, LeibnizCenter for Medicine and Biosciences, Borstel, Germany Joanne Heng Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia Otto Holst Division of Structural Biochemistry, Department of Immunochemistry and Biochemical Microbiology, Borstel Research Center, Leibniz-Center for Medicine and Biosciences, Borstel, Germany Harold J. Jennings Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada Michael P. Jennings School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Queensland, Australia
Patrick Garidel Institut für Physikalische Chemie, Martin-Luther-Universität HalleWittenberg, Halle/Saale, Germany
Margaret I. Kanipes Department of Chemistry, North Carolina Agricultural and Technical State University, Greensboro, North Carolina, USA
Jeroen Geurtsen Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands
Dennis L. Kasper Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
List of Contributors
Wafa Khamri Department of Nephrology and Transplantation, King’s College London School of Medicine, Guy’s Hospital Campus, London, UK Milton J. Kiefel Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland, Australia Dionne C. G. Klein Biophysics and Medical Technology, Department of Physics, The Norwegian University of Science and Technology, Trondheim; Department of Cancer Research and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway Frans M. Klis Swammerdam Institute of Life Sciences, University of Amsterdam, Amsterdam, The Netherlands Yuriy A. Knirel N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia
xiii
Peter N. Lipke Department of Biology, Brooklyn College of City University of New York, Brooklyn, New York, USA Susan M. Logan Institute for Biological Sciences, National Research Council, Ottawa, Ontario, Canada Radia Mahfoud The Hospital for Sick Children, Molecular Structure & Function Programme, Toronto, Ontario, Canada Malcolm J. McConville Department of Bio chemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia Rachel M. McLoughlin Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA Paul Messner Zentrum für NanoBiotechnologie, Universität für Bodenkultur Wien, Vienna, Austria Antonio Molinaro Dipartimento di Chimica Organica e Biochimica, Università di Napoli Federico II, Napoli, Italy
Thomas Kohler Cellular and Molecular Microbiology Section, Medical Microbiology Department, University of Tübingen, Tübingen, Anthony P. Moran School of Natural Sciences, National University of Ireland, Galway, Germany Ireland; Institute for Glycomics, Gold Coast Paul Kosma Department of Chemistry, Campus, Griffith University, Queensland, University of Natural Resources and Applied Australia Life Sciences Vienna, Vienna, Austria Thomas Naderer Department of Biochemistry Emir Kulauzovic Cellular and Molecular and Molecular Biology, University of Melbourne, Microbiology Section, Medical Microbiology Parkville, Victoria, Australia Department, University of Tübingen, Tübingen, Thomas R. Neu Department of River Ecology, Germany Helmholtz Centre for Environmental Research – Shoichi Kusumoto Suntory Institute for Bio organic Research, Osaka, Japan John R. Lawrence Aquatic Ecosystem Protection Research Division, Science and Technology Branch, Environment Canada, Saskatoon, Saskatchewan, Canada Clifford A. Lingwood The Hospital for Sick Children, Molecular Structure & Function Programme, Toronto, Ontario, Canada
UFZ, Magdeburg, Germany
Mari-Anne Newman Department of Plant Biology, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark Andrei V. Nikolaev College of Life Sciences, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, UK Christian M. Pedersen Fachbereich Chemie, Universität Konstanz, Konstanz, Germany
xiv
List of Contributors
Mark P. Pereira Department of Biochemistry and Biomedical Sciences and the Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada Andreas Peschel Cellular and Molecular Microbiology Section, Medical Microbiology Department, University of Tübingen, Tübingen, Germany Stefan Pöhlmann Institute of Virology, Han nover Medical School, Hannover, Germany Robert A. Pon Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada Stuart A. Ralph Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia Peter R. Reeves School of Molecular and Microbial Biosciences, University of Sydney, New South Wales, Australia Anne N. Reid Microbiology Research Division, Bureau of Microbial Hazards, Food Directorate, Health Products and Food Branch, Health Canada, Ottawa, Ontario, Canada Colm J. Reid Veterinary Science Centre, University College Dublin, Belfield, Dublin, Ireland Morgann C. Reilly Washington University School of Medicine, St Louis, Missouri, USA Sabine Riekenberg Division of Innate Immunity, Department of Immunology and Cell Biology, Research Center Borstel, LeibnizCenter for Medicine and Biosciences, Borstel, Germany Patricia Ruas-Madiedo Departamento de Microbiología y Bioquímica de Productos Lácteos, Instituto de Productos Lácteos de Asturias, Consejo Superior de Investigaciones Científicas, Villaviciosa, Asturias, Spain
Nuria Salazar Departamento de Microbiología y Bioquímica de Productos Lácteos, Instituto de Productos Lácteos de Asturias, Consejo Superior de Investigaciones Científicas, Villaviciosa, Asturias, Spain Christina Schäffer Zentrum für Nano Biotechnologie, Universität für Bodenkultur Wien, Vienna, Austria Richard R. Schmidt Fachbereich Chemie, Universität Konstanz, Konstanz, Germany Ian C. Schoenhofen Institute for Biological Sciences, National Research Council, Ottawa, Ontario, Canada Marit Sletmoen Biophysics and Medical Technology, Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway Uwe B. Sleytr Zentrum für NanoBiotechnologie, Universität für Bodenkultur Wien, Vienna, Austria Evelyn C. Soo Institute for Marine Biosciences, National Research Council, Halifax, Nova Scotia, Canada Imke Steffen Institute of Virology, Hannover Medical School, Hannover, Germany Daniel C. Stein Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA Bjørn T. Stokke Biophysics and Medical Technology, Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway Christine M. Szymanski Department of Bio- logical Sciences, University of Alberta, Edmonton, Alberta, Canada Joe Tiralongo Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland, Australia Jennifer A. Tee College of Life Sciences, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, UK
List of Contributors
Mark R. Thursz Gastroenterology and Hepato logy Research, Faculty of Medicine, Imperial College, St Mary’s Campus, London, UK M. Stephen Trent Section of Molecular Genetics and Microbiology, University of Texas, Austin, Texas, USA Theodros S. Tsegaye Institute of Virology, Hannover Medical School, Hannover, Germany Jean van Heijenoort Institut de Biochimie et Biophysique Moléculaire et Cellulaire, Université Paris-Sud, Orsay, France Waldemar Vollmer Institute for Cell and Mole cular Biosciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
xv
Mark von Itzstein Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland, Australia Jennifer C. Wilson Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland, Australia Guoqing Xia Cellular and Molecular Micro biology Section, Medical Microbiology Depart ment, University of Tübingen, Tübingen, Germany
Preface
Glycobiology can be said to be sweet biology. The full appreciation of the role of sugars, glycomolecules and glycosylated structures and their biological functions has been a more recent one compared to that of nucleic acids and proteins, particularly in the specialization of microbiology and related fields. Understanding has grown that monosaccharides represent an alphabet of biological information similar to amino acids and nucleic acids, but with a greater, and potentially unsurpassed, coding capacity. Though it has been predicted that microorganisms can synthesize more sugar building blocks than their eukaryotic counterparts, e.g. for bacteria it is considered to be six-fold greater, this extensive coding capacity impacts the biological functioning of microbial molecules and also influences the interaction of microbes with their environment, including host structures. The concept behind this book is to present, in an easy-to-read format, reviews of the important central aspects of microbial glycobiology, i.e. the study of carbohydrates as related to the biology of microorganisms. The importance of substitution of proteins by sugars (glycosylation) and the role played by glycosylated structures (glycoproteins, glycopeptides, glycolipids, lipoglycans, glycoconjugates, etc.) in disease development, immune recognition, and environmental processes have become well-established. Moreover, from the viewpoint of biotechnology industry, glycobiology, microbial glycobiology and microbial glycomics are important components. Microbial, especially bacterial, glycomes represent an excellent toolbox for glycobiologists
to understand the fundamentals of glycosylation pathways, to develop new techniques for glycobiology, and to exploit glycosylation pathways for development of novel diagnostics and therapeutics. Despite the relevance of glycobiology in medical and environmental microbiology, and the potential to exploit this knowledge for industrial and medical processes, this field has only begun to be fully appreciated. In particular, glycomics – the applied biology and chemistry of the structures and functions of carbohydrates – and microbial glycomics – glycomics as related to microbial components – have become recognized as areas of emerging technological development. For instance, this area has been highlighted in the Massachusetts Institute of Technology Review as one of ten emerging technologies that will have a significant influence in the near future. Furthermore, it has been commented that the field of microbial glycobiology could fuel a revolution in biology and industry and aid biomedical development and drug discovery. Indeed, the number of publications in this field has risen dramatically in recent years, making it extremely difficult for even the most diligent reader to stay abreast of progress. Additionally, in many areas of microbial glycobiology well-based and extensive reviews are lacking. Thus, we considered there was a major need to provide a book reviewing the range of topics relevant to microbial glycobiology since no such book has previously been available. It is our hope that this text distills the most important cutting-edge findings in the field to
xvii
xviii
Preface
produce a timely and definitive overview, providing a useful introduction to the subject for new researchers, as well as an invaluable reference for experienced ones. Our goal has been to create a state-of-the-art compendium and to delineate the knowns and unknowns in the field. Since microbial glycobiology represents a multidisciplinary and emerging area with implications for a range of basic and applied research fields, as well as having industrial, medical and biotechnological implications, care has been taken in the choice of topics to be covered. This volume cannot attempt to be completely comprehensive, but we believe, the central concepts and areas of intensive investigation have been covered as have aspects of the glycobiology of bacteria, viruses, fungi and protozoa. The approach has been to cover and link knowledge among microbiologists, synthetic and analytical chemists, biomedical and biopharmaceutical scientists and biotechnologists. The first section of the book introduces readers to the nature, structures and functions of glycomolecules and glycosylated components of microorganisms and infectious agents. This includes not only such components of bacteria but also those from viruses, fungi and protozoa. In the next section, the genetics and biosynthesis of these components, as well as the ability to chemically synthesize a number of these molecules are reviewed.
The interaction with and recognition by the host of these molecules is considered subsequently, as are both the environmental and medical relevance of microbial glycosylated structures and glycomolecules. Finally, the biotechnological and medical applications of microbial glycosylation and glycosylated molecules is explored. Collectively, the chapters present basic science understanding of these molecules through to the applied science of exploitation and applications of microbial glycosylation, both industrially and biomedically. We have been fortunate to have been joined by our colleagues, leaders in the field, who have contributed their ideas, experiences and insights in a free and open manner to yield what we believe are insightful, concise and stimulating chapters in a review format. The editors sincerely thank the numerous contributors of these chapters. Furthermore, special thanks is deserved by Mari Moran and Sharon Ackerman for their expert secretarial assistance during manuscript preparation at different stages of this project. Finally, and by no means least, we thank Lisa Tickner and Christine Minihane for their unwavering support in making this text a reality, Kristi Anderson for her editorial skills, and Claire Hutchins, Caroline Jones and their team for their efforts during the production phase. On behalf of the editors, Anthony P. Moran
P a r t
I
Microbial glycolipids, glycoproteins and glycopolymers
c h a p t e r
1 Overview of the glycosylated components of the bacterial cell envelope Otto Holst, Anthony P. Moran and Patrick J. Brennan
1. Introduction – the bacterial cell envelope encountering environmental challenges
Summary Within this chapter, the various types of bacterial cell envelope and their carbohydrate-related mole cules, as well as the glycoprotein S-layers that can be found in all bacteria except mycobacteria, are introduced. Whereas each of the Gram-positive, Gramnegative and mycobacterial cell envelopes possess a general and typical architecture, the archaeal cell envelope shows a broader variety of constructions and may be comprised of only a membrane. Apart from S-layers, carbohydrate-containing macromolecules like lipopolysaccharides, peptidoglycan, lipoteichoic acids, teichoic acids, capsule polysaccharides, lipoarabinomannan and others are briefly described. This chapter refers to other, more detailed, subsequent chapters that summarize the chemistry and biological function of the cell envelope macromolecules.
Bacteria of various species populate most of the environments encountered on Earth. As a group, these microorganisms cope with very low, even down to 4°C, temperatures (psycrophilic bacteria), medium range temperatures (mesophilic bacteria), warm to hot temperatures (thermophilic bactera) or very hot, up to 115°C, temperatures (hyperthermophilic bacteria). Also, they exhibit an ability to survive and withstand an impressive range of pH, between pH 0.7 and 9 (acido- and alkaliphilic bacteria), to survive high pressures (deep sea, barophilic bacteria), or they may need or have to survive high or higher salt concentrations (halotolerant and halophilic bacteria) in their environments. Moreover, they may need to live and proliferate in eukaryotic hosts (symbiotic or pathogenic bacteria). In
Keywords: Bacterial cell envelope; Lipopolysaccharide; Lipoteichoic acid; Teichoic acid; Lipoarabinomannan; Arabinogalactan; Peptidoglycan; Polysaccharide; Glycolipid; Glycoprotein
Microbial Glycobiology
© 2009 2010, Elsevier Inc.
1. Cell wall glycosylated components
addition, bacterial species have developed the means to overcome longer periods of dryness and/or starvation or exposure to strong UV radiation. In order to survive in a particular niche, bacteria have developed a large variety of intracellular physiological adaptations; also, most possess an outer cellular barrier, the cell envelope, by which they communicate with and protect themselves from the environment they inhabit (Seltmann and Holst, 2001). In nearly all genera of the domain Bacteria and in several of those of the domain archaeal, this layer is present which, by definition, consists of the cytoplasmic membrane (CM), the cell wall and, if present, outer layers such as capsules or sheaths. The outer barrier of other genera of the domain archaeal is formed by a particular membrane structure which contains ether-linked lipids that span the whole membrane and are highly resistant to temperature and pH (Seltmann and Holst, 2001). When considering the broad variety of environments inhabited and encountered by bacteria, it is quite astonishing that only a few general architectural forms of cell envelope have evolved to cope with these varied conditions. The common architectural principle of the CM and cell wall is present in all bacterial envelopes in the four great variations of the envelope, i.e. Gram-negative bacterial, Gram-positive bacterial, mycobacterial and archaeal, and which may possess further adaptation even at the species level. Importantly, all cell envelopes possess a significant proportion of carbohydratecontaining constituents. This chapter serves to introduce the various types of cell envelope and their carbohydrate-related molecules and the glycoprotein S-layers that can be found in all bacteria except mycobacteria. As subsequent chapters will present more detailed reviews of the cell envelope-related macromolecules, their synthesis and applications, extensive literature will not be cited here, merely the relevant chapters will be indicated.
2. The gram-negative cell envelope The Gram-negative bacterial world contains a broad variety of genera that may comprise only harmless species (e.g. phototrophic bacteria of genera like Rhodobacter or Rhodomicrobium) or both harmless and human- or animal-pathogenic species (e.g. Escherichia coli or Acinetobacter spp.) or plant-pathogenic species (e.g. Erwinia and Xanthomonas spp.). Independent of this, all Gram-negative bacteria possess a cell envelope of the same general architecture which is schematically depicted in Figure 1.1. The periplasmic “space” is present on top of the CM and contains peptidoglycan (PG), also known as murein, as a major constituent. This macromolecular sacculus is composed of sugar chains built from alternating 2-acetamido-2-deoxy-d-glucopyranose (GlcpNAc) and 2-acetamido-3-O-[(R)-1-carboxyethyl]-2-deoxy-d-glucopyranose, also termed N-acetylmuramic acid (MurNAc), residues which carry, and can be cross-linked by, smaller peptides – the amino acid composition of which varies in different species. The PG sacculus represents a rigid layer that determines the form of the bacterial cell and is important for osmotic stability and acts as a protective barrier. However, the PG sacculus is not a completely closed wall that inhibits transport of small molecules (e.g. nutrients) or their excretion. Although very stable, the PG matrix represents a mesh with holes large enough to guarantee the flow of molecules, including those that have to be transported to the outer membrane (OM). The three-dimensional architecture of PG has been an issue of discussion for a long time. The first model, which many scientists consider represents the correct one, is built from sugar chains that run in a parallel direction to the CM and which are interlinked by short peptide stems that are oriented perpendicular to this membrane. About ten years ago, an alternative, called the scaffold model, was proposed
I. MICROBIAL GLYCOLIPIDS, GLYOPROTEINS AND GLYCOPOLYMERS
2. The gram-negative cell envelope
Lipopolysaccharide Porin
Outer membrane
Outer membrane protein
Periplasmic space
Braun’s lipoprotein Peptidoglycan
Cytoplasmic membrane Cytosol Membrane(-attached) proteins
Figure 1.1 A schematic model of the Gram-negative cell envelope as present in E. coli. The cell envelope comprises the cytoplasmic membrane, which is a symmetric membrane consisting mainly of phospholipids in both leaflets, the periplasmic space and the outer membrane. Embedded in the cytoplasmic membrane, i.e. membrane-attached at the cytosolic leaflet or integrated into the membrane, are a number of proteins including those important for lipopolysaccharide or capsular polysaccharide biosynthesis and transport to the periplasmic space. The thin peptidoglycan layer represents the major constituent of the periplasmic space, but which also contains proteins including transport-proteins (indicated by the ovoid shapes in the periplasm). In E. coli, Braun’s lipoprotein is present which is covalently bound to the peptidoglycan and anchored by its lipid moiety in the inner leaflet of the outer membrane. In contrast to the cytoplasmic membrane, the outer membrane represents an asymmetric membrane, i.e. comprising phospholipids in the inner and lipopolysaccharides in the outer leaflet. It contains a number of outer membrane proteins, including the porins that are water-filled channels important for the import of small molecules, like sugars or ions. Not shown are capsular polysaccharides and the enterobacterial common antigen which may also be anchored in the outer leaflet by a lipid structure. In addition, S-layer glycoproteins may be present in certain Gram-negative bacterial species (not shown).
with perpendicular sugar chains connected by peptides that run parallel to the CM. It should be noted that there is no clear proof for either model to date. Importantly, the Gram-negative PG is a rather thin construction making its examination difficult. A detailed review of PG is given in Chapter 2 and of its biosynthesis in Chapter 16. Apart from PG, the periplasmic space contains various smaller molecules like mono- and oligosaccharides, amino acids and peptides, as well as the biosynthetic precursors and degradation products of PG. The concentration of all these substances is rather high, thus the periplasmic space represents a highly viscous solution that can be considered a gel-like matrix.
Outside the periplasmic space is located a second membrane, the OM, which had been considered unique to Gram-negative bacteria for a long time. Nevertheless, the presence of an analogous structure in mycobacteria has been postulated for quite some time and whose presence has finally been verified recently (see below) (Hoffmann et al., 2008). Both leaflets of the OM represent lipid bilayers that are organized asymmetrically, i.e. the inner leaflet is composed of different molecules compared to the outer one. In the case of the OM of Gram-negative bacteria, the inner leaflet is comprised of phospholipids, whereas the outer leaflet is mainly constructed from lipopolysaccharides (LPSs)
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
1. Cell wall glycosylated components
(Holst and Müller-Loennies, 2007). In some cases, polysaccharide capsules are present that may be anchored by a lipid into the OM and this is also true for the enterobacterial common antigen (ECA) of enterobacteria. In addition, the OM contains various proteins (outer membrane proteins, OMPs), constituting up to 50% of the membrane and which often interact with LPS molecules, thereby yielding particular lipid– protein structural units. Several of the OMPs are channel-formers and are involved in diffusion of ions (e.g. diffusion of phosphate through PhoE channels in E. coli) and transport of mono- and small oligosaccharides (e.g. specific-channel forming proteins, like LamB that is involved in transport of maltose and maltodextrins) and, thus, they play important roles in the uptake of nutrients. Other OMPs represent structural proteins like OmpA and related proteins in various enterobacterial species and Braun’s lipoprotein, also known as PG-associated lipoprotein, in E. coli and related species. The latter is covalently linked to PG and has its lipid moiety embedded in the inner leaflet of the OM, thus interconnecting PG and OM and providing structural stability. Molecules of LPS are of high relevance not only for Gram-negative bacteria but also for an infected, eukaryotic host. In bacteria, these molecules are part of the protective barrier shielding the microbes from dangerous environmental compounds, like bile salts in the gut or antibiotics in sensu latu. In contrast, domains within LPS, specifically the core region and the O-specific polysaccharide, can also act as receptors for bacteriophages, thereby contributing indirectly to the destruction of the bacterial cell in such cases. In pathogenic bacteria that infect either humans or animals or plants, LPSs represent very important virulence factors. Moreover, this family of molecules is also called the endotoxins of Gram-negative bacteria; however, their toxicity is highly dependent on their structural properties, and it should be noted that not all LPSs are toxic molecules, not even those from
pathogens. Importantly, in many chronically infecting bacterial species (e.g. Helicobacter pylori, Porphyromonas gingivalis, etc.), LPSs are of low toxic and immunological activity and this attribute is considered to aid the development of chronicity (Moran, 2007). Chemically, LPSs, as exemplified by those of the Enterobacteriaceae, are lipoglycans. Three regions within LPS can be distinguished, according to their chemical structure, biosynthesis, genetics and function, i.e. the lipid A component (that anchors the whole molecule in the OM and which represents the endotoxically active moiety of toxic LPS), the core region which is covalently linked to lipid A and which may modulate lipid A toxicity and, finally, the O-specific polysaccharide which is covalently linked to the core region and represents a highly antigenic structure which is also called the O-antigen. Whereas the core region is comprised of an oligosaccharide of up to 15 sugars, the O-antigen is a polysaccharide mostly composed of repeating units containing 2–8 monosaccharide residues. In general, between one and about 40 repeating units are found, but this glycan may also be much longer. When all three regions are present in LPS, the resulting high-molecular-mass molecule is referred to as smooth- (S-) form LPS and is normally encountered in wildtype enterobacterial strains. A low-molecularmass, rough- (R-) form LPS that lacks the O-antigen, thus consisting only of the lipid A and core regions, occurs in many laboratory-derived enterobacterial strains. Resembling this phenotype, but still a member of the LPS family of molecules, are the so-called lipo-oligosaccharide (LOS) molecules encountered in the wild-type strains of certain mucosal pathogens in particular (e.g. Bordetella pertussis, Haemophilus influenzae and Campylobacter jejuni). These molecules, composed of core and lipid A regions, exhibit greater structural variability in the core oligosaccharide than encountered in enterobacterial R-form LPS. Chemical and structural details of LPSs are discussed in Chapters 3 and 4, their biosyntheses in Chapters 17 and 18, chemical
I. MICROBIAL GLYCOLIPIDS, GLYOPROTEINS AND GLYCOPOLYMERS
2. The gram-negative cell envelope
syntheses in Chapters 24 and 25 and functional aspects in Chapter 31. As mentioned earlier, capsules composed of capsular polysaccharides (CPSs) may be anchored to the OM. Generally, it is considered that this is achieved by a glycerolipid structure, however, such a structure has only been identified in a few cases (e.g. E. coli, C. jejuni) (Schmidt and Jann, 1982; Corcoran et al., 2006). In other cases, CPSs have been found linked to the core region of R-form LPS, yielding an “S-form-like LPS” structure which is referred to as KLPS. Thus, probably all CPSs represent or are analogous to lipoglycans that, in many cases, contain repeating units like O-antigens. Consequently, both structures can only be distinguished by their genetics. Rather than considering capsules of CPS as amorphous structures, since they are composed of 90% water they provide a gel-like hydrated mesh that protects the bacteria from dehydration. Polysaccharide capsules are present in many pathogenic bacteria (e.g. E. coli, Klebsiella pneumoniae, C. jejuni, etc.), in which CPSs function as important virluence factors, including aiding bacterial evasion of the host’s defence system. The CPSs often represent antigenic structures called K-antigens and they are also involved in biofilm production and/or influence bacterial colonization. In plant–bacterial interactions, CPSs play also an important role, independent of whether the process is pathogenic or symbiotic. A special case of CPS is that of ECA where the structure comprises the repeating unit → 3)--d-FucpNAc-(1→4)--d-ManpNAcA-(1→4)-d-GlcpNAc-(1→ (where d-FucpNAc, 2-acetamido-2-deoxy-d-fucopyranose; d-ManpNAcA, pyranosidic 2-acetamido-2-deoxy-d-mannuronic acid; d-GlcpNAc, 2-acetamido-2-deoxy-dglucoyranose). Other polysaccharide structures belong to the so-called exocellular polymeric structures, also termed exopolysaccharides. Such molecules are often found in the surrounding milieu of bacteria (e.g. in the culture supernatant) and have importance in biofilm formation or in a variety of bacteria–host interactions. Mostly,
exopolysaccharides are composed of repeating units of oligosaccharides. Chapter 6 provides an overview of CPS and these related molecules. Importantly, all bacterial (lipo)glycans represent structures that are located in or on the outer bacterial surface and are synthesized in the cytosol and at the inner leaflet of the CM. Thus, bacteria have to deal with the great challenge of transport of hydro- or amphiphilic macromolecules through their lipid-like cell walls. In the biosynthesis of LPS, which is best understood in E. coli, the syntheses of lipid A and the core oligosaccharide are genetically and biochemically connected. Beginning with uridine diphosphate- (UDP-) GlcpNAc, the tetra-acylated and bisphosphorylated lipid A precursor lipid IVa is synthesized in a series of six steps. Prior to the addition of the fifth and sixth fatty acid, two residues of 3-deoxy-d-manno-oct-2-ulopyranosonic acid (Kdo) are transferred by one Kdo-transferase and yield the disaccharide -Kdo-(2→4)--Kdo which is linked to position C-6’ of -d-GlcpNAcyl3-O-Acyl-4-P-(1→6)--d-GlcpNAcyl-3-O-Acyl-1P. Subsequently, the core region is completed by a series of glycosyltransferases that transfer activated monosaccharide precursors. This all occurs at the inner leaflet of the CM. Such completed Rform LPS is then transported (or “flipped”) from the inner to the outer leaflet of the CM, a process which is achieved by the adenosine triphosphate(ATP-) binding cassette (ABC)-transporter, MsbA. There, on the periplasmic side, the completed Oantigen is transferred to the core oligosaccharide and the completed LPS is then transferred to the OM. The molecular basis for this translocation process still remains an enigma (for more details see Chapter 17). The biosynthesis of heteropolymeric O-antigen and of many such CPSs (e.g. E. coli capsule groups 1 and 4) follow the same general principle (see Chapter 18). The repeating units, built by the sequential action of glycosyltransferases, are linked to an undecaprenyl-phosphate carrier lipid. Lipid-linked repeats are then flipped across the CM and polymerized on the periplasmic side.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
1. Cell wall glycosylated components
The O-antigen (and some CPS) are attached to lipid A-core molecules by a ligase. With regard to the further transport of CPS to the surface, a number of participating components involved in the translocation of group 1 capsules and their interaction have been elucidated recently, confirming the earlier concept of zones of adhesion, or Bayer’s fusion sites, published in the early 1980s (Bayer, 1981). These CPS molecules are transported to the surface via a complex of the two proteins Wzc and Wza, the latter of which is a channel-forming protein. Biosynthesis and export of E. coli group 2 and 3 capsules proceeds differently. Briefly, the polysaccharides are completely synthesized at the cytosolic surface of the CM, transferred to a diacylglycerophosphate anchor and the whole lipoglycan is translocated through the CM, by the ABC-transporter called KpsM, and through S-Layer glycoprotein
Teichoid acid
the periplasm and OM, by the protein complex of KpsE and KpsD. A review of the biosynthesis and assembly of CPSs is presented in Chapter 20.
3. The gram-positive cell envelope As in Gram-negative bacteria, the Grampositive group of bacteria comprise many harmless species and several important pathogenic ones, e.g. Streptococcus pneumoniae, Staphylococcus aureus, Enterococcus faecalis and Clostridium tetani. The Gram-positive cell envelope (Figure 1.2) is organized more simply than that of Gramnegative bacteria, but is as effective. The cell wall, layered on top of the CM, is mainly composed Lipoteichoic acid Cell wall polysaccharide
Peptidoglycan
Cytoplasmic Membrane
Membrane(-attached) proteins
Cytosol
Figure 1.2 A schematic model of the Gram-positive cell envelope. This cell envelope comprises the cytoplasmic membrane, which is a symmetric membrane consisting mainly of phospholipids in both leaflets and the thick peptidoglycan layer. Embedded in the cytoplasmic membrane are a number of proteins, probably including those important for (lipo-)glycan and polysaccharide biosynthesis and transport to exterior regions. Peptidoglycan represents a major macromolecule outside the cytoplasmic membrane, however, also proteins, including transport-proteins and lipoproteins are present (not shown). Additionally, capsular polysaccharides (not depicted) and S-layer glycoproteins may be present in certain species. Various carbohydrate-based structures are present in the cell envelope, namely the lipoteichoic acids, which are anchored by a lipid in the cytoplasmic membrane, and the teichoic acids and transpose cell wall polysaccharides that are covalently linked to peptidoglycan. The latter polysaccharides may be neutral but often represent teichuronic acids which are mainly synthesized when phosphate is lacking in the environment and thus may replace teichoic acids.
I. MICROBIAL GLYCOLIPIDS, GLYOPROTEINS AND GLYCOPOLYMERS
3. The gram-positive cell envelope
of a thick layer of PG, generally 20–80 nm thick, compared to a 7 nm PG in Gram-negative bacteria. The general chemical structure of this PG is similar to that of Gram-negative bacteria. In addition, the overall conformation, i.e. 3dimensional architecture of this PG, is discussed using the same bases of the two models mentioned above for Gram-negative PG. The Gram-positive cell envelope does not contain a second membrane, i.e. the outer membrane as seen in Gram-negative bacteria. However, CPSs are often present in Gram-positive bacteria and represent, in many cases of pathogenic species, important virulence factors with similar functions as those mentioned for Gramnegative species. Moreover, the structures of CPSs of Gram-positive and -negative bacteria are generally similar. Again, in the former bacterial group, polysaccharide capsules are layered over the PG, but it remains unclear whether they are connected to the cell wall and, if so, how this is achieved. As far as has been investigated, Gram-positive CPSs are synthesized in a similar manner as E. coli group 1 capsules. Moreover, Gram-positive bacteria also produce exopolysaccharides which often are components of biofilms. Three major carbohydrate structures are present in the Gram-positive cell envelope, namely the lipoteichoic acids (LTAs), wall teichoic acids (WTAs) and wall polysaccharides (WPSs). Several LTAs and WTAs are structurally very similar in their polymeric chain, which does not represent a classical polysaccharide but is, instead, produced from phosphodiesterbridged alditol units (of glycerol or ribitol) that are often substituted by sugars. Both macromolecules may contain d-alanine (d-Ala) which, in LTA, may substitute both the sugar(s) (as in E. faecalis) and the alditol residues. In LTA, this polymeric chain is linked to a short oligosaccharide which serves as a “linker” and binds the chain to a diacylglycerophosphate lipid anchor that is embedded in the CM. Thus, LTA molecules protrude through the PG matrix and reach the outer surface. The LTAs are considered
immunomodulatory constituents of Grampositive bacteria that react with cells of the innate immune system via Toll-like receptor (TLR-) 2 and induce cytokine expression. However, this view is heavily debated (Zähringer et al., 2008). In WTA, the polymeric chain is also bound to a “linker”, which is a disaccharide composed of 2-acetamido-2-deoxy-mannopyranose (ManpNAc) and GlcpNAc that is covalently linked by a phosphodiester bridge to C-6 of MurNAc of PG. Both WTAs and LTAs play important roles in interactions with host receptors, maintaining cation homeostasis and providing physicochemical surface properties. The biosyntheses of WTAs and LTAs occur in cyclic processes. In the case of WTA of Bacillus subtilis, the binding unit is synthesized first, linked to a lipid carrier. Subsequently, the glycerophosphate units are attached by a polymerase and part of this chain is subsequently substituted with glucopyranose (d-Glcp). The polymer is transported from the inner to the outer leaflet of the CM by means of a two-stage ABC-transporter. Then, other free hydroxylgroups of the glycerol are substituted by d-Ala. Finally, the completed molecule is linked to MurNAc of PG. On the other hand, the biosynthesis of LTA begins with that of the lipid anchor, i.e. 1,2-diacylglycerol (e.g. in S. aureus), which is substituted with two residues of d-Glcp. To this linker, glycerophosphate units are attached up to the required chain length. Any further substituents can be incorporated during or after chain elongation. Chapters 5, 19 and 25 describe the structures and syntheses, both biological and chemical, of WTA and LTA in detail. Another class of polysaccharides, WPS, namely the teichuronic acids, are usually synthesized in greater amounts under phosphate starvation. They are polysaccharides composed of at least one residue of uronic acid, the negative charge of which helps to overcome the lack of phosphate charges, e.g. in metal cation binding. Teichuronic acids are also linked by a phosphodiester bridge to MurNAc of PG via a linker structure. Their
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
10
1. Cell wall glycosylated components
biosynthesis occurs in a cyclic process which involves a lipid carrier to which the linker is synthesized first, followed by transfer of the monosaccharide units and then polymerization.
4. The mycobacterial cell envelope Many mycobacteria live in soil and water and are harmless members of the genus, but three species are well known as human and animal pathogens, i.e. Mycobacterium tuberculosis, Mycobacterium leprae and the Mycobacterium avium–Mycobacterium intracellulare complex. In the host, these species live intracellularly, in particular in the phagosome of the most-feared defensive cell of the innate immune system, the macrophage. Such intracellular mycobacteria inhibit phagosome–lysosome fusion of macrophages and may survive for an
extended period intracellularly. For this lifestyle, mycobacteria need a well-constructed protection barrier that renders them resistant to the various defence activities of eukaryotic hosts. Although mycobacteria yield slightly positive reactions in the Gram stain, the mycobacterial cell envelope (Figure 1.3) possesses more Gram-negative than -positive features, i.e. a less extensive PG matrix and an outer lipid bilayer which has been identified as like an outer membrane, the mycobacterial outer membrane (MOM) (Hoffmann et al., 2008). Apart from such general similarities, the mycobacterial cell envelope represents a unique barrier that should be clearly distinguishable from other bacterial membrane barriers. The PG matrix is located on top of the CM and is organized similarly to those of Gram-positive and -negative bacteria. As in other cell envelopes, the mycobacterial barrier contains several important glycan structures, namely; lipoarabinomannan (LAM)
Free glycolipids
Mycolic acids
Arabinogalactan
Peptidoglycan
Plasma membrane
Figure 1.3 Schematic representation of the generic structure of the mycobacterial cell wall. Phosphatidylinositol mannosides and lipomannan are shown to be embedded and attached to the plasma membrane although their location is not known. The surface layer is covered with non-covalently associated free glycolipids.
I. MICROBIAL GLYCOLIPIDS, GLYOPROTEINS AND GLYCOPOLYMERS
4. The mycobacterial cell envelope
and its biosynthetic precursors [the lipomannan (LM) and the phosphatidylinositol-mannosides (PIM)], the mycoloyl-arabinogalactan (MAG) complex and a capsular structure which comprises the polysaccharide arabinomannan (AM) (Daffé and Draper, 1998; Wittkowski et al., 2007) and glucan (with proteins). Detailed overviews of the structures and functions of these components and their biosynthesis are presented in Chapters 9 and 21. The LAM is a lipoglycan which is anchored in the CM by a phosphoinositol moiety that carries as characteristic fatty acids 9-hexadecenoic acid (16:1, palmitoleic acid) and 10-methyl-octadecanoic acid (tuberculostearic acid). In particular, bound to the inositol residue is an -(1→6)-linked d-mannan main chain with -(1→2)-linked mannopyranose (Manp) branches that are substituted by a longer branched arabinan composed of arabinofuranose (Araf) residues at the second last Manp residue. The whole molecule is anchored in the CM by its lipid moiety and protrudes through the PG to the outside of the cell wall, similar to the LTA of Gram-positive bacteria. Here, at its nonreducing end, it may carry Man residues that substitute the terminal Ara sugars in monosaccharidic and disaccharidic substitutions. There is evidence also that part of the LAM is anchored in the MOM, probably in the outer leaflet, but proof to date is lacking. Mycobacterial LAM has been reported to possess important functions in the pathogenesis of mycobacteria, e.g. induction of phagocytosis of these microbes, phagosome–lysosome fusion or activation of innate immune responses. Nevertheless, some of the reports in these areas are conflicting. The biosynthesis of LAM has not yet been completely elucidated. As a general pathway, it is believed that biosynthesis starts with PIM and that chain elongation to obtain the mannan chain proceeds from the Manp residue at O-6 of the inositol that builds up to yield LM. The molecule known as PIM4, PIM containing Manp residues, is the likely precursor here. In the last step, the arabinan, a main chain of -(1→5)-linked
11
d-Araf residues that may be branched at the nonreducing end, is produced and linked to LM. The MAG is, as are the TA of Gram-positive bacteria, covalently linked via a disaccharide linker composed of l-rhamnopyranose (l-Rhap) and d-GlcpNAc and a phosphodiester bridge to C-6 of MurNAc of PG. The linker is substituted by a galactan chain, which is furnished exclusively from d-galactofuranose (d-Galf ) residues in alternating -(1→5) and -(1→6)-linkages, a polysaccharide feature that is rarely found in nature. Quite early in this chain, branches of arabinan chains, i.e. -(1→5)-linked d-Araf residues, are present that protrude to the outer surface of the cell wall. At their reducing ends, a so-called hexa-arabinosyl motif is present as a branched structure, the terminal arabinose residues of which are substituted at C-5 by very long chain (up to 90 C-atoms) -alkyl-b-hydroxy-fatty acids, the so-called mycolic acids that occur in a broad range of structural varieties (Barry et al., 1998). These mycolic acids form the inner leaflet of the MOM, whereas the outer leaflet is believed to be composed of various lipids, including glycolipids, different types of which are present in different mycobacterial species (e.g. mycobacterial LOSs and glycopeptidolipids). The MAG complex, together with the MOM, represents cell envelope structures of mycobacteria that are highly important for cell wall architecture and rigidity, as well as protection. Thus, MAG (and LAM) biosynthesis represent potentially important drug targets. The biosynthesis of the arabinogalactan proceeds stepwise, beginning with the linker and followed by the galactan chain which are linked to a decaprenylphosphoryl (C50-P) lipid. The arabinan chains are attached by the sequential addition of Araf residues that are transported as C50-P-Araf units. The mycobacterial capsule has a different composition to those of Gram-negative and -positive bacteria; namely, it is not a purely polysaccharide capsule, but contains proteins, including glycoproteins, and mainly two polysaccharides, an arabinomannan and a glucan. The arabinomannan
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
12
1. Cell wall glycosylated components
possesses a similar structure to the polysaccharide of LAM. So far, it remains unclear how this glycan is synthesized and transported to the outer surface. Although it has been reported several times to the contrary, a recent investigation shows that this molecule has no immunomodulatory properties. Instead, it has been shown to activate natural killer cells that then destroy tumour cells. Thus, the AM possesses cytotoxic properties. The glucan is structurally similar to glycogen, but no particular biological functions have been described so far.
5. The Archaeal cell envelopes and S-Layers As mentioned above, the archaeal cell envelope structures cannot be classified as a common architectural type as is the case with the other envelope types described thus far. Instead, the cell envelope shows a number of structural variants which are adapted to the particular or extreme living conditions. Archaea can be subdivided into the kingdoms Euryarchaeota and Crenarchaeota, any further classification of which occurs according to the physiological properties of the organism in question. All members possess a membrane which, in several cases, consists of a tetra-ether lipid that spans the whole width of the membrane, i.e. no bilayer is present. Here, this membrane represents the whole “cell envelope”. A so-called pseudomurein represents the cell-stabilizing component in Gram-positive archaea. In other genera, a relatively thick layer of acidic polysaccharides constitute the cell wall. Finally, nearly all archaea, and also many Gram-negative and -positive Eubacteria, contain cell surface layers (Slayers) which thus represent common structures of the prokaryotic cell envelope. S-layers appear in lattice-like arrangements that are formed by a self-assembly process and are attached to the bacterial cell wall by certain cell wall polymers.
Also, the outer region of quite many S-layer proteins is often substituted by covalently linked glycan chains and, thus, glycoproteins are formed. The understanding of the mode of interaction between S-layer (glyco)proteins and secondary cell wall polymers is believed will pave the way towards the production of novel nanopatterned “biomaterials” for various applications in the fields of biomedicine and nanobiotechnology. Chapter 7 details the structure, function and applications of S-layer structures.
6. Conclusions The cell envelope represents the outermost layer of the bacterial cell which has as general functions the protection of the cell, communication with the environment, maintenance of cellular shape, stability and rigidity of the cell, as well as allowing appropriate metabolism, growth and division of the cell. Important components of the cell envelope are carbohydrate-based and carbohydrate-containing macromolecules that contribute significantly to all of these functions, independent of which variation of the cell envelope occurs, i.e. Gram-positive, -negative, mycobacterial or archaeal. The structures, syntheses and functions of all these macromolecules are described in detail in subsequent chapters.
Acknowledgements The authors thank Delphi Chatterjee for help with preparation of Figure 1.3.
References Barry III, C.E., Lee, R.E., Mdluli, K., et al., 1998. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37, 143–179. Bayer, M.E., 1981. Structural and functional evidence of coopeartivity between membranes and cell wall in bacteria. Int. Rev. Cytol. Suppl. 12, 39–70.
I. MICROBIAL GLYCOLIPIDS, GLYOPROTEINS AND GLYCOPOLYMERS
rEFERENCES
Corcoran, A.T., Annuk, H., Moran, A.P., 2006. The structure of the lipid anchor of Campylobacter jejuni polysaccharide. FEMS Microbiol. Lett. 257, 228–235. Daffé, M., Draper, P., 1998. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39, 131–203. Hoffmann, C., Leis, A., Niederweis, M., Plitzko, J.M., Engelhardt, H., 2008. Disclosure of the mycobacterial outer membrane: cry-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc. Natl. Acad. Sci. USA 105, 3963–3967. Holst, O., Müller-Loennies, S., 2007. Microbial polysaccharides structures. In: Kamerling, J.P., Boons, G.-J., Lee, Y.C., Suzuki, A., Taniguchi, N., Voragen, A.G.J. (Eds.) Comprehensive Glycoscience. From Chemistry to Systems Biology, vol. 1. Elsevier Inc., Amsterdam, pp. 123–179.
13
Moran, A.P., 2007. Lipopolysaccharide in bacterial chronic infection: insights from Helicobacter pylori lipopolysaccharide and lipid A. Int. J. Med. Microbiol. 297, 307–319. Schmidt, M.A., Jann, K., 1982. Phospholipid substitution of capsular (K) polysaccharide antigens from Escherichia coli causing extraintestinal infections. FEMS Microbiol. Lett. 14, 69–74. Seltmann, G., Holst, O., 2001. The Bacterial Cell Wall. Springer, Heidelberg. Wittkowski, M., Mittelstädt, J., Brandau, S., et al., 2007. Capsular arabinomannans from Mycobacterium avium with morphotype-specific structural differences but identical biological activity. J. Biol. Chem. 282, 19103–19112. Zähringer, U., Lindner, B., Inamura, S., Heine, H., Alexander, C., 2008. TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213, 205–224.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
2 Bacterial cell envelope peptidoglycan Waldemar Vollmer and Petra Born
Summary
1. Introduction
Peptidoglycan (murein) forms a bag-shaped sacculus in the cell envelope of most bacteria. It is essential for osmotic stability and determines the shape of a bacterial cell. Peptidoglycan is a heteropolymer consisting of glycan strands that carry short peptides. Peptides of neighbouring glycans may be connected by amide bonds resulting in a net-like architecture of the sacculus. Although there are some common structural features of peptidoglycan, there is great variation in the chemical composition of peptidoglycan isolated from different bacteria. The glycans are synthesized as oligo(N-acetylglucosamine-N-acetylmuramic acid) strands of variable length and become modified shortly after their synthesis in many species. The peptides contain l- and d-amino acids and have a species-specific amino acid composition, sequence and type of cross-linkage. Maturation of peptidoglycan involves cleavage of amide bonds in the peptides resulting in a nonhomogeneous structure of the polymer. Introduction of secondary modifications and maturation are the reasons for the complex composition of mature peptidoglycan often manifesting in a species-specific fine structure.
The bacterial peptidoglycan (murein) s acculus is a bag-shaped macromolecule which completely surrounds the cytoplasmic membrane and thereby protects the integrity of the cell against the turgor (Weidel and Pelzer, 1964; Vollmer et al., 2008a). Peptidoglycan consists of glycan strands of alternating -(1→4)-linked Nacetyl-d-glucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) residues cross-linked by peptide side chains, thus forming a rigid, net-like structure. The peptide subunit contains l- as well as d-amino acids and has the general structure l-Ala-d-iGlu-l-Lys (or mesoA2pm)-d-Ala-d-Ala (where l- and d-Ala, l- and d-alanine; d-iGlu, d-iso-glutamic acid; l-Lys; l-lysine; meso-A2pm, meso-2,6-diaminopimelic acid). However, the analysis of the peptidoglycan of different species has revealed a high degree of structural variation due to the presence of other amino acids, namely N g-acetyl-l2,4-diaminobutyric acid, amidated meso-A2pm, d-asparagine (d-Asn), d-aspartic acid (d-Asp), l- and d-2,4-diaminobutyric acid (l- and dDab); 2,6-diamino-3-hydroxypimelic acid; d-isoglutamine (d-iGln); glycine (Gly); l-homoserine
Keywords: Peptidoglycan; Murein; Sacculus; Bacterial cell wall; Peptide cross-links; de-N-acetylation; O-acetylation; N-acetylmuramic acid
Microbial Glycobiology
15
© 2009 2010, Elsevier Inc.
16
2. Peptidoglycan
(l-Hsr), threo-3-hydroxyglutamic acid (3-Hyg), meso-lanthionine, l-5-hydroxylysine, d-lysine (d-Lys); l- and d-ornithine (l- and d-Orn), l- and dserine (l- and d-Ser); l-threonine (l-Thr) or d-lactic acid (d-Lac) and the frequent occurrence of modifications of the sugar residues. Besides its function as a stress-bearing layer, the sacculus serves as an anchor for other cell wall polymers such as surface proteins (Dramsi et al., 2008), wall teichoic acids and capsular polysaccharides (Neuhaus and Baddiley, 2003; Vollmer, 2008). Peptidoglycan is present in almost all eubacteria with the exception of Chlamydia spp., Mycoplasma spp. and Orientia tsutsugamushi (Moulder, 1993). Interestingly, although Chlamydia spp. lack detectable peptidoglycan, they possess a nearly complete set of peptidoglycan biosynthesis genes (Moulder, 1993; Chopra et al., 1998; Bavoil et al., 2000). Peptidoglycan is also present in the cyanelles of glaucophytes (Aitken and Stanier, 1979). Several peptidoglycan biosynthesis genes have been identified in Arabidopsis thaliana and the moss Physcomitrella patens. These genes are essential for chloroplast division, although peptidoglycan has not been detected in chloroplasts (Machida et al., 2006). This chapter provides an overview on the diversity and variability of the peptidoglycan structures found in different bacteria. We also summarize biophysical properties of peptidoglycan and discuss its architecture.
2. Structural variation in bacterial peptidoglycan 2.1. The glycan strands in peptidoglycan Polymerization of the peptidoglycan precursor lipid II [GlcNAc-MurNAc(peptide)-pyrophosphoryl-undecaprenol] by peptidoglycan glycosyltransferases results in oligo--(1→4)[GlcNAc--(1→4)-MurNAc(peptide)] glycan strands. Because MurNAc is a 3-d-lactylGlcNAc, the backbone of these glycan strands
is an oligomer of -(1→4)-linked GlcNAc residues and thus identical to the polysaccharide chains in chitin. Cleavage by muramidases or glucosaminidases in peptidoglycan may result in strands with an odd number of monosaccharides or with MurNAc and GlcNAc residing at the “wrong” end of the strand. In Gram-negative species, the glycan strands do not end with MurNAc but with a 1,6-anhydroMurNAc residue. In many species, these glycan strands become structurally modified shortly after their synthesis and they serve as sites for the attachment of other cell wall polymers such as teichoic acids and capsular polysaccharides (Vollmer, 2008). 2.1.1. Length distribution of the glycan strands Depending on the species and growth conditions, the average length of the glycan strands in peptidoglycan varies between 10 and several hundred disaccharide units. Glycan strand length does not correlate with the thickness of the cell wall, as seen from the following examples from Gram-positive and Gram-negative species with thick and thin cell walls, respectively. Gram-positive Bacillus spp. (Bacillus subtilis, Bacillus licheniformis and Bacillus cereus) have an average chain length of 50–250 disaccharide units (Hughes, 1971; Warth and Strominger, 1971; Ward, 1973). In contrast, the glycan strands of Staphylococcus aureus are much shorter with an average chain length of about 18 disaccharide units (Tipper et al., 1967; Ward, 1973). A major fraction of the glycan material from S. aureus has strands 3–10 disaccharide units in length. Longer glycan strands with more than 26 disaccharide units represent only 10–15% of the total glycan material (Boneca et al., 2000). The l-ornithine-containing peptidoglycan of the Gram-positive Deinococcus radiodurans Sark has glycan strands with an average chain length of about 20 disaccharide units (Quintela et al., 1999). In Gram-negative species, there is some variation in the average glycan strand
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. Structural variation in bacterial peptidoglycan
length but the normal range lies between 20 and 40 disaccharide units (Glauner et al., 1988; Tuomanen et al., 1989; Harz et al., 1990; Quintela et al., 1995a,b). Helicobacter pylori has exceptionally short glycan strands with an average chain length of less than 10 disaccharide units (Costa et al., 1999). These glycan strands become even shorter during transition from a spiral to coccoid cell shape in the stationary growth phase (Costa et al., 1999; Chaput et al., 2007). 2.1.2. Modifications in the glycan structure Different types of glycan strand modifications have been found in a number of species (Figure 2.1). Many Gram-positive pathogens modify their glycan strands by N-glycolylation, de-N-acetylation and/or O-acetylation. These modifications, as well as the attachment of other cell wall polymers, contribute to higher levels of resistance to lysozyme, which is a glycan strand-cleaving enzyme and an important defence factor of the innate immune system. The presence of a glycolyl residue (instead of acetate) at the 2-amino group of muramic acid is the hallmark of some closely related genera within the Actinomycetales (Uchida and Aida, 1979). In fact, glycolylated muramic acid- (MurNGlyc-) containing peptidoglycan is present in most genera with mycolic acids (the mycolata) including Mycobacterium, Rhodococcus, Tsukamurella, Gordonia, Nocardia, Skermania and Dietzia (Azuma et al., 1970; Sutcliffe, 1998), but with the exception of the genus Corynebacterium, members of which contain “normal” acetylated muramic acid in their peptidoglycan (Azuma et al., 1970; Uchida and Aida, 1979). In addition, there are several closely related genera within the Actinomycetales which contain MurNGlyc in their peptidoglycan but do not have mycolic acids (Evtushenko et al., 2002; Matsumoto et al., 2003; Li et al., 2005 and references therein). In Mycobacterium tuberculosis, both the precursor pool and the peptidoglycan contained a mixture of MurNGlyc and MurNAc residues (Mahapatra et al., 2005a,b).
17
The presence of de-N-acetylated amino sugars in the peptidoglycan has been detected, for example, in different Bacillus spp., Streptococcus pneumoniae and Listeria monocytogenes (Araki et al., 1971; Vollmer and Tomasz, 2000; Boneca et al., 2007). Either GlcNAc or MurNAc or both are de-N-acetylated to a variable extent by the activity of peptidoglycan deacetylases. The first gene encoding a peptidoglycan GlcNAc deacetylase, pgdA, was identified in S. pneumoniae (Vollmer and Tomasz, 2000). A pgdA mutant strain lacks de-N-acetylated amino sugars in its peptidoglycan. It shows no growth defect but higher sensitivity towards lysozyme and a significantly reduced virulence in the intraperitoneal mouse model of infection (Vollmer and Tomasz, 2002). Spore peptidoglycan of Bacillus spp. and Clostridium sporogenes contains the spore-specific muramic acid -lactam structure, which is generated by intramolecular amide bond formation between the carboxyl group of the lactyl group at position 3 of de-N-acetylated MurN and the amino group at position 2. In B. subtilis about 50% of the MurNAc residues in the spore peptidoglycan are modified to the muramic acid -lactam and these residues appear to be distributed regularly at every second muramic acid position along the glycan strands (Atrih et al., 1996; Popham et al., 1996). O-acetylated peptidoglycan contains variable amounts of 2,6-N,O-diacetyl muramic acid which is MurNAc with an extra acetyl group linked to the O-6 position. This modification has been detected in a high number of species, for example in the Gram-positive Micrococcus luteus (Brumfitt et al., 1958), Enterococcus faecium (Abrams, 1958), S. pneumoniae (Crisostomo et al., 2006) and S. aureus (Ghuysen and Strominger, 1963) and in the Gram-negative Neisseria meningitidis (Antignac et al., 2003), H. pylori (Weadge and Clarke, 2006) and Proteus mirabilis (Martin and Gmeiner, 1979). The extent of O-acetylation varies between less than 20% and 70% in different species and strains (Vollmer, 2008). The process of peptidoglycan O-acetylation is not well understood. Only more
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
18 2. Peptidoglycan
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
Figure 2.1 Modifications in the glycan strands. On the left side the unmodified disaccharide is shown. The names of species containing the modifications in their peptidoglycan are indicated. Pep, peptide at MurNAc; LU, linkage unit; SP, surface polymer.
2. Structural variation in bacterial peptidoglycan
recently, two genes, oatA and adr, encoding peptidoglycan O-acetyltransferases in S. aureus and S. pneumoniae, respectively, have been identified (Bera et al., 2005; Crisostomo et al., 2006). The glycan strands in Gram-negative bacteria have a 1,6-anhydroMurNAc residue (instead of MurNAc) at their end. A low fraction of 1,6anhydroMurNAc residues are also present in the Gram-positive B. subtilis (Atrih et al., 1999), but are absent in S. aureus (Boneca et al., 2000). The 1,6-anhydroMurNAc residues are generated by cleavage of glycan strands by lytic transglycosylases (Vollmer et al., 2008b) and eventually also by synthetic glycosyltransferases when terminating the polymerization reaction (Höltje, 1998). All Gram-positive species covalently attach cell wall polymers (e.g. teichoic acid, teichuronic acid, capsular polysaccharides and/or arabinogalactan) to the glycan strands of peptidoglycan. Attachment occurs most often via a linkage unit and a phosphodiester bond to O-6 of MurNAc residues (Vollmer, 2008).
2.2. The peptides in peptidoglycan 2.2.1. Variation in the peptide structure Structural variations in the stem peptide may be introduced at different steps of peptidoglycan
19
biosynthesis, either on the level of the nucleotide activated precursors or on the level of the lipid intermediates (Barreteau et al., 2008; Bouhss et al., 2008) (Figure 2.2). The amino acid residue in the first position of the peptide moiety is predominantly l-Ala and it is linked with its amino group to the lactyl group of the MurNAc residue. Only in a few species, as with glycine (Gly) in Microbacterium lacticum, Mycobacterium leprae, Corynebacterium or l-serine (l-Ser) in Butyribacterium rettgeri has another amino acid been found to occur instead of l-Ala (Schleifer and Kandler, 1972; Draper et al., 1987). A d-isoglutamic acid (d-iGlu) residue is linked in all species via its -carboxylic group to the amino group of the first amino acid. It often undergoes secondary modifications mainly on the lipid II level. For example, hydroxylation of d-iGlu results in the occurrence of threo-3-hydroxyglutamic acid in M. lacticum. Hydroxylation depends on the availability of oxygen during growth; cells grown in a microaerobic environment contain mainly nonhydroxylated d-iGlu (Schleifer et al., 1967). The more abundant modifications affect the free carboxyl group of the d-iGlu residue; it can be amidated resulting in d-isoglutamine (d-iGln) that is common for Gram-positive species, or it can be substituted either by Gly (e.g. in Thermus
Figure 2.2 Variation in the structure of the stem peptide. The most common amino acids for each position are indicated in bold. Amino acids with a star (*) are formed by secondary modification during peptidoglycan biosynthesis. Abbreviations: G, GlcNAc; M, MurNAc; d-iGlu, d-iso-glutamic acid; d-iGln, d-isoglutamine; l-Orn, l-ornithine; meso-A2pm, meso-2,6-diaminopimelic acid.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
20
2. Peptidoglycan
thermophilus and Eubacterium nodatum), glycine amide (in Arthrobacter athrocyaneus), d-alanine amide (in Renibacterium salmoninarum), or by polyamines like cadaverine (in Selenomonas ruminantium), putrescine (in Veillonella alcalescens), N-acetylputrescine (in the cyanelles of Cyanophora paradoxa) or spermidine (in Anaerovibrio lipolytica) (Schleifer and Kandler, 1972; Kamio et al., 1981a,b; Fiedler and Draxl, 1986; Pittenauer et al., 1993; Pfanzagl et al., 1996a,b; Hirao et al., 2000). Interestingly, in T. thermophilus, the Gly residue attached to d-iGlu can be modified itself by the addition of a phenylacetic acid residue (Quintela et al., 1995b). The greatest variation occurs at the third position of the peptide unit (see Figure 2.2). Usually, it is a diamino acid attached with its -amino group to the -carboxyl group of the d-iGlu residue at position-2. The most widespread amino acids at this position are meso-A2pm (in almost all Gram-negative species and species of Bacillus, Lactobacilli and Mycobacterium) or l-Lys (mainly in Gram-positive species). Other diamino acids (l-ornithine, d-Lys, mesolanthionine, ll-A2pm and l-2,4-diaminobutyric acid) or monoamino acids (l-homoserine, l-Ala, l-Glu) have been identified (Schleifer and Kandler, 1972). Like d-iGlu in position-2, mesoA2pm and l-Lys can be further modified. Thus, the hydroxylated forms (2,6-diamino-3-hydroxypimelate and l-hydroxylysine) or amidated meso-A2pm have been found in a few species (Shockman et al., 1965; Perkins, 1969; Mahapatra et al., 2005b). The amino acids of position 4 and 5 are represented in most bacteria by d-Ala-d-Ala and are added during synthesis of the cytoplasmic precursor as a dipeptide. In contrast to the conserved d-Ala residue in position 4, the d-Ala in position 5 can be replaced in some species by either d-lactate (d-Lac) or d-Ser. The presence of these alternative residues correlates with a natural or acquired resistance to vancomycin of the related species, e.g. in Enterococcus hirae or Lactobacillus plantarum (Allen et al., 1992; Arthur
et al., 1992; Ferain et al., 1996). Under certain growth conditions, Gly can be incorporated in the peptide moiety instead of one of the terminal d-Ala residues (Glauner et al., 1988). In Escherichia coli, the percentage of peptides with a Gly residue is relatively low (about 1%), but it can reach up to 19% in Caulobacter crescentus (Markiewicz et al., 1983; Glauner et al., 1988). The peptide moiety functions as an anchor for covalent linkage of surface proteins (Dramsi et al., 2008). In E. coli and related species, Braun’s lipoprotein (Lpp) is linked by the -amino group of its C-terminal lysine residue to the -amino group of the meso-A2pm residue of the tripeptide unit in the peptidoglycan (Braun, 1975; Magnet et al., 2007b). In Gram-positive bacteria, many proteins are found to be covalently attached to the peptidoglycan (e.g. protein A and adhesins). The protein precursor carries a C-terminal signal peptide containing the general sequence l-Leul-Pro-X-l-Thr-Gly (where l-Leu, l-leucine; l-Pro, l-proline; X, any l-amino acid). The membranebound protein sortase A cleaves between the Thr and Gly residues and links the protein with the -carboxylic group of Thr to the amino group in the side chain of the diamino acid (position 3) of a lipid II molecule (Ton-That et al., 2004). 2.2.2. Structures of peptide cross-links Variations are found in the mode of crosslinkage and the composition of the interpeptide bridge (Figure 2.3). Two main types of peptide cross-links can be distinguished (Schleifer and Kandler, 1972). First, in 3–4 cross-links, the carboxyl group of the d-Ala on position-4 of one peptide (the acyl donor) is linked to the amino group of the side chain of the diamino acid in position-3 of another peptide (the acyl acceptor). This represents the main type of cross-linkage. The 3–4 cross-links are formed by dd-transpeptidases, the penicillin-binding proteins (PBPs), and can be either direct (mainly in Gram-negative species) or indirect via an interpeptide bridge (mainly in Gram-positive species). In some species, the
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. Structural variation in bacterial peptidoglycan
21
Figure 2.3 Types of peptide cross-linking. 3–4 cross-link between the diamino acid in position 3 and the d-Ala residue in position 4 can be either direct (A) or indirect via an interpeptide bridge (B). A direct 3–3 cross-bridge is shown in (C) and an indirect 2–4 cross-link is depicted in (D). G, GlcNAc; M, MurNAc.
peptidoglycan contains a mixture of different cross-links. For example, in S. pneumoniae there are direct 3–4 cross-links as well as indirect crosslinks via l-Ala-l-Ala or l-Ala-l-Ser interpeptide bridges and the percentage of each type of crosslink varies with the strain and growth condition (Garcia-Bustos et al., 1988). The second type of cross-link (termed 2–4) is only found in coryneform bacteria, especially in plant pathogenic species. Here the -carboxyl group of the d-iGlu in position 2 of one peptide unit and the carboxyl group of d-Ala in position 4 of another unit are indirectly connected via an interpeptide bridge containing a diamino acid. The size of the interpeptide bridge varies between one to seven amino acids (Table 2.1). Only a few enzymes (so-called “branching enzymes”) that are involved in the formation of the interpeptide bridge are characterized so far. The tRNA-dependent aminoacyl transferases, like the FmhB, FemA, FemB proteins of S. aureus, FemX of Weissella viridescens, the MurM and MurN proteins of S. pneumoniae or the BppA1 and BppA1 proteins of Enterococcus faecalis transfer the l-amino acids and Gly (activated as amino-acylated tRNAs) to the peptidoglycan precursors (Bouhss et al., 2002; Fiser et al., 2003; Biarrotte-Sorin et al., 2004; Schneider et al., 2004).
Aspartate ligases belonging to the ATP-grasp superfamily activate a d-aspartate (d-Asp) residue as -d-aspartyl-phosphate in an ATP-dependent reaction and, subsequently, link d-Asp to the -amino group of l-Lys at position-3 of a cytoplasmic precursor molecule. Some of the d-Asp residues are later amidated by an unknown enzyme (Bellais et al., 2006). Besides the two main types of cross-linking described above, also 3–3 cross-links can occur at a lesser frequency in species which normally exhibit 3–4 cross-links. The 3–3 cross-links were first described in mycobacteria (Wietzerbin et al., 1974) and are formed by the more recently identified ld-transpeptidases (Mainardi et al., 2005; Magnet et al., 2007a). In Mycobacterium smegmatis, the 3–3 cross-links constitute about one-third of the total cross-links (Mainardi et al., 2000). The 3–3 cross-links are present in small amounts in exponentially growing E. coli cells, but their abundance increases to about 16% of the total cross-links in stationary cells (Pisabarro et al., 1985; Glauner et al., 1988). Interestingly, in M. luteus (formerly Micrococcus lysodeikticus), the stem peptide itself is utilized as the interpeptide bridge. The peptide unit l-Ala-d-iGlu(Gly)-l-Lys-d-Ala is removed from
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
22
2. Peptidoglycan
Table 2.1 Examples of interpeptide bridgesa Cross-link 3–4
2–4
Interpeptide bridge(s)
Species
(Gly)5
Staphylococcus aureus
l-Ala-l-Ala
Enterococcus faecalis
l-Ala-l-Ser; l-Ala-l-Ser-l-Ala
Weissella viridescens
none; l-Ala-l-Ala; l-Ala-l-Ser
Streptococcus pneumoniae
Gly-l-Thr
Streptococcus salivarius
l-Ala-l-Thr-l-Ser
Arthrobacter polychromogenes
d-Asp; d-Asn
Enterococcus hirae, Lactococcus lactis
d-Glu()-l-Ser
Micrococcus cyaneus
d-Glu()-d-Glu
Micrococcus conglomeratus
(d-Ala-l-Lys-d-iGlu(Gly)-l-Ala)n
Micrococcus luteus
l-Orn
Corynebacterium poinsettiae
d-Lys; d-Orn
Butyribacterium rettgeri
d-diaminobutyrate
Corynebacterium insidiosum
Gly-l-Lys
Microbacterium lacticum
a
See text for references and Schleifer and Kandler (1972).
the MurNAc residue by an amidase activity and becomes incorporated between position 3 and 4 of two other peptide moieties. Up to four stem peptides can be linked in a “head-to-tail” arrangement to form a long interpeptide bridge (Ghuysen et al., 1968).
2.3. Species- and strain-specific fine structure Peptidoglycan is a dynamic structure which is enlarged during cell growth and division and which is subject to maturation and turnover caused by hydrolytic enzymes (Vollmer et al., 2008b). This causes a high degree of structural diversity in the sacculus and is reflected by the great number of structurally different muropeptides released by a muramidase (like lysozme) from peptidoglycan of all species studied to date. For example, the peptidoglycan of E. coli is composed of more than 50 different muropeptide subunits that differ in the length of the peptide
chain (i.e. di-, tri-, tetra- or pentapeptide), the presence of either d-Ala or Gly at positions-4 or -5, the state of oligomerization (i.e. monomer, dimer, trimer or tetramer), the type of cross-linkage (i.e. 3–4 or 3–3 links), the presence of 1,6anhydroMurNAc residues (i.e. from the glycan strand termini) and the presence of a l-Lys-l-Arg dipeptide (i.e. linked to position-3) which remains after proteolytic digestion of Braun’s lipoprotein (Glauner, 1988). The major muropeptides present in the murein of E. coli are the disaccharide tetrapeptide monomer (30% of the total material) and the 3–4-cross-linked bis-disaccharide tetratetrapeptide dimer (20% of the total material). The fine structure of the peptidoglycan varies with strain, growth phase and growth condition. New material incorporated into the sacculus has different muropeptide composition as compared to old peptidoglycan (Glauner et al., 1988). In the Gram-positive S. pneumoniae, even greater structural diversity of the muropeptides exists due to the presence or absence of O-acetylated or de-N-acetylated MurNAc
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. The molecular architecture of peptidoglycan
residues and the different possible types of crosslinks (i.e. direct or indirect) mentioned above. Interestingly, the indirect type of cross-link is the hallmark of penicillin-resistant isolates of S. pneumoniae, whereas penicillin-sensitive strains contain mainly direct cross-links in their peptidoglycan (Garcia-Bustos and Tomasz, 1990). Thus, the muropeptide profile can dramatically vary within a species and is a useful parameter for the characterization of different strains and mutants.
3. Biophysical properties of peptidoglycan The bag-shaped peptidoglycan sacculi have unique biophysical properties which have been mainly studied for the Gram-negative model bacterium E. coli (Vollmer and Höltje, 2004). Sacculi from E. coli are extremely thin as compared to their length and diameter, but which are comparable to the dimensions of a bacterial cell. Hydrated sacculi from the Gram-negative E. coli are 2.5–7 nm thick, as determined by small-angle neutron scattering and atomic force microscopy (Labischinski et al., 1991; Yao et al., 1999). Yet, they have the strength to withstand the cell’s turgor of several atmospheres. Sacculi are by no means rigid walls but are elastic and stretchable, allowing reversible expansion and shrinkage of cells upon osmolarity changes in the environment. Isolated E. coli sacculi are significantly more deformable in the direction of the long axis of the cell than in the direction perpendicular to the long axis (Yao et al., 1999) which is consistent with the observation that volume changes of osmotically shocked E. coli cells are mainly due to changes in the cell length, whereas the cell diameter is virtually constant (van den Bogaart et al., 2007). It has been suggested that the anisotropy in elasticity is the consequence of the predominant alignment of the (more flexible) peptides in the direction of the long axis of the cell and of the (more
23
rigid) glycan strands perpendicular to the direction of the long axis. Such a network has been modelled and the theoretical calculations of the elastic moduli are in good agreement with the measured values (Boulbitch et al., 2000). The pores (or holes) present in peptidoglycan sacculi from E. coli or B. subtilis are similar in size and relatively uniform with a mean radius of about 2.1 nm (Demchick and Koch, 1996). These authors calculated that globular, uncharged proteins with molecular masses of 22 000–24 000 should be able to penetrate the isolated, relaxed peptidoglycan. Stretched peptidoglycan, as it would occur in the cell, might allow diffusion of globular proteins of a molecular mass of up to 50 000 or more. Thus, peptidoglycan from both Gram-positive and -negative bacteria has relatively wide pores enabling diffusion of large molecules such as proteins.
4. The molecular architecture of peptidoglycan Peptidoglycan has a heterogeneous, flexible structure and is not crystalline, making it impossible to determine its three-dimensional structure at high resolution with the presently available techniques. Molecular modelling has suggested that the glycan strands are rather rigid structures, whereas the peptides are flexible and are able to adopt a bent or a more straight conformation (Barnickel et al., 1979). Presumably, this flexibility of the peptides causes the observed elasticity of peptidoglycan. The anisotropy in elasticity observed in isolated sacculi could indicate that the flexible peptides run predominantly in the direction of the long axis of the rod-shaped E. coli cell, whereas the glycan strands run predominantly perpendicular to the long axis (Yao et al., 1999). According to a model of peptidoglycan architecture, successive peptides protrude in a helical manner from the glycan strands, with
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
24
2. Peptidoglycan
about four disaccharide units being required for one complete turn (Barnickel et al., 1979, 1983; Labischinski et al., 1985). Monolayered, net-like structures can be modelled by cross-linking peptides from adjacent glycan strands. According to a model by Koch, the glycan strands are not straight but follow a zigzag line to form a layer with hexagonal “tessera” as the smallest pores (Koch, 1995, 1998). Recently, other “scaffold” models have been proposed in which the glycan strands have a vertical arrangement relative to the cytoplasmic membrane (Dmitriev et al., 1999, 2003, 2004; Meroueh et al., 2006). However, the majority of the glycan strands in the peptidoglycan are too long for a vertical arrangement in E. coli and other species (Vollmer and Höltje, 2004). To determine the molecular architecture of peptidoglycan will be a major task for future research.
by unusual peptides. There is large variability in the structure of bacterial peptidoglycan due to differences in the amino acid sequence, types of cross-links and the presence or absence of secondary modifications in both the glycan strands and peptides. High-resolution techniques have revealed high complexity in the fine structure of peptidoglycan, as well as compositional changes that occur when newly synthesized material matures. Sacculi from E. coli are highly elastic and have remarkably large pores allowing free diffusion of medium-sized proteins. The architecture of peptidoglycan cannot be determined by the available methods. Biophysical data support a model of a layered architecture in which the glycan strands are arranged in parallel to the cytoplasmic membrane. Further questions to be explored are detailed in the Research Focus Box.
5. Conclusions
Acknowledgements
Peptidoglycan is responsible for the osmotic stability by encasing the cytoplasmic membrane of most bacteria. It is a unique, net-like polymer made of glycan strands which are cross-linked
This work was supported by the European Commission through the EUR-INTAFAR project (LSHM-CT-2004-512138) and the BBSRC (BB/F001231/1).
Research Focus Box The following major questions and tasks in peptidoglycan research remain to be solved: • What is the molecular architecture of peptidoglycan? Is there a preferred direction of the glycan strands and peptides relative to the cell’s axis? Is the architecture similar in Gram-positive and Gram-negative species? • How are other cell surface polymers like teichoic acids interlaced in the peptidoglycan network in Gram-positive species?
• What is the function of modifications in the peptidoglycan structure? Are there other modifications in yet uncharacterized peptidoglycan structures? The fine structure of peptidoglycan is only known in a few model bacteria but is unknown in most species. • Many enzymes responsible for peptidoglycan synthesis, hydrolysis and modification are poorly characterized. • What is the molecular growth mechanism of the peptidoglycan sacculus?
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
References Abrams, A., 1958. O-acetyl groups in the cell wall of Streptococcus faecalis. J. Biol. Chem. 230, 949–959. Aitken, A., Stanier, R.Y., 1979. Characetrization of peptidoglycan from cyanelles of Cyanophora paradoxa. J. Gen. Microbiol. 112, 219–223. Allen, N.E., Hobbs, J.N., Richardson, J.M., Riggin, R.M., 1992. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. FEMS Microbiol. Lett. 77, 109–115. Antignac, A., Rousselle, J.C., Namane, A., Labigne, A., Taha, M.K., Boneca, I.G., 2003. Detailed structural analysis of the peptidoglycan of the human pathogen Neisseria meningitidis. J. Biol. Chem. 278, 31521–31528. Araki, Y., Nakatani, T., Hayashi, H., Ito, E., 1971. Occurrence of non-N-substituted glucosamine residues in lysozymeresistant peptidoglycan from Bacillus cereus cell walls. Biochem. Biophys. Res. Commun. 42, 691–697. Arthur, M., Molinas, C., Bugg, T.D., Wright, G.D., Walsh, C.T., Courvalin, P., 1992. Evidence for in vivo incorporation of d-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 36, 867–869. Atrih, A., Zollner, P., Allmaier, G., Foster, S.J., 1996. Structural analysis of Bacillus subtilis 168 endospore peptidoglycan and its role during differentiation. J. Bacteriol. 178, 6173–6183. Atrih, A., Bacher, G., Allmaier, G., Williamson, M.P., Foster, S.J., 1999. Analysis of peptidoglycan structure from vegetative cells of Bacillus subtilis 168 and role of PBP 5 in peptidoglycan maturation. J. Bacteriol. 181, 3956–3966. Azuma, I., Thomas, D.W., Adam, A., et al., 1970. Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim. Biophys. Acta 208, 444–451. Barnickel, G., Labischinski, H., Bradaczek, H., Giesbrecht, P., 1979. Conformational energy calculation on the peptide part of murein. Eur. J. Biochem. 95, 157–165. Barnickel, G., Naumann, D., Bradaczek, H., Labischinski, H., Giesbrecht, P., 1983. Computer aided molecular modelling of the three-dimensional structure of bacterial peptidoglycan. In: Hakenbeck, R., Höltje, J.-V., Labischinski, H. (Eds.), The Target of Penicillin: The Murein Sacculus of Bacterial Cell Walls. de Gruyter, Berlin/New York, pp. 61–66. Barreteau, H., Kovač, A., Boniface, A., Sova, M., Gobec, S., Blanot, D., 2008. Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 168–207. Bavoil, P.M., Hsia, R., Ojcius, D.M., 2000. Closing in on Chlamydia and its intracellular bag of tricks. Microbiology 146, 2723–2731. Bellais, S., Arthur, M., Dubost, L., et al., 2006. Aslfm, the daspartate ligase responsible for the addition of d-aspartic
25
acid onto the peptidoglycan precursor of Enterococcus faecium. J. Biol. Chem. 281, 11586–11594. Bera, A., Herbert, S., Jakob, A., Vollmer, W., Götz, F., 2005. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol. Microbiol. 55, 778–787. Biarrotte-Sorin, S., Maillard, A.P., Delettre, J., Sougakoff, W., Arthur, M., Mayer, C., 2004. Crystal structures of Weissella viridescens FemX and its complex with UDPMurNAc-pentapeptide: insights into FemABX family substrates recognition. Structure 12, 257–267. Boneca, I.G., Huang, Z.H., Gage, D.A., Tomasz, A., 2000. Characterization of Staphylococcus aureus cell wall glycan strands, evidence for a new b-N-acetylglucosaminidase activity. J. Biol. Chem. 275, 9910–9918. Boneca, I.G., Dussurget, O., Cabanes, D., et al., 2007. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. USA 104, 997–1002. Bouhss, A., Josseaume, N., Severin, A., et al., 2002. Synthesis of the l-alanyl-l-alanine cross-bridge of Enterococcus faecalis peptidoglycan. J. Biol. Chem. 277, 45935–45941. Bouhss, A., Trunkfield, A.E., Bugg, T.D.H., Mengin-Lecreulx, D., 2008. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol. Rev. 32, 208–233. Boulbitch, A., Quinn, B., Pink, D., 2000. Elasticity of the rod-shaped gram-negative eubacteria. Phys. Rev. Lett. 85, 5246–5249. Braun, V., 1975. Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim. Biophys. Acta 415, 335–377. Brumfitt, W., Wardlaw, A.C., Park, J.T., 1958. Development of lysozyme-resistance in Micrococcus lysodiekticus and its association with an increased O-acetyl content of the cell wall. Nature 181, 1783–1784. Chaput, C., Labigne, A., Boneca, I.G., 2007. Characterization of Helicobacter pylori lytic transglycosylases Slt and MltD. J. Bacteriol. 189, 422–429. Chopra, I., Storey, C., Falla, T.J., Pearce, J.H., 1998. Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited. Microbiology 144, 2673–2678. Costa, K., Bacher, G., Allmaier, G., et al., 1999. The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. J. Bacteriol. 181, 3710–3715. Crisostomo, M.I., Vollmer, W., Kharat, A.S., et al., 2006. Attenuation of penicillin resistance in a peptidoglycan O-acetyl transferase mutant of Streptococcus pneumoniae. Mol. Microbiol. 61, 1497–1509. Demchick, P., Koch, A.L., 1996. The permeability of the wall fabric of Escherichia coli and Bacillus subtilis. J. Bacteriol. 178, 768–773.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
26
2. Peptidoglycan
Dmitriev, B.A., Ehlers, S., Rietschel, E.T., 1999. Layered murein revisited: a fundamentally new concept of bacterial cell wall structure, biogenesis and function. Med. Microbiol. Immunol. (Berlin) 187, 173–181. Dmitriev, B.A., Toukach, F.V., Schaper, K.J., Holst, O., Rietschel, E.T., Ehlers, S., 2003. Tertiary structure of bacterial murein: the scaffold model. J. Bacteriol. 185, 3458–3468. Dmitriev, B.A., Toukach, F.V., Holst, O., Rietschel, E.T., Ehlers, S., 2004. Tertiary structure of Staphylococcus aureus cell wall murein. J. Bacteriol. 186, 7141–7148. Dramsi, S., Davison, S., Magnet, S., Arthur, M., 2008. Surface proteins covalently attached to peptidoglycan: examples from both Gram-positive and Gram-negative bacteria. FEMS Microbiol. Rev. 32, 307–320. Draper, P., Kandler, O., Darbre, A., 1987. Peptidoglycan and arabinogalactan of Mycobacterium leprae. J. Gen. Microbiol. 133, 1187–1194. Evtushenko, L.I., Dorofeeva, L.V., Krausova, V.I., Gavrish, E.Y., Yashina, S.G., Takeuchi, M., 2002. Okibacterium fritillariae gen. nov., sp. nov., a novel genus of the family Microbacteriaceae. Int. J. Syst. Evol. Microbiol. 52, 987–993. Ferain, T., Hobbs, J.N., Richardson, J., et al., 1996. Knockout of the two ldh genes has a major impact on peptidoglycan precursor synthesis in Lactobacillus plantarum. J. Bacteriol. 178, 5431–5437. Fiedler, F., Draxl, R., 1986. Biochemical and immunochemical properties of the cell surface of Renibacterium salmoninarum. J. Bacteriol. 168, 799–804. Fiser, A., Filipe, S.R., Tomasz, A., 2003. Cell wall branches, penicillin resistance and the secrets of the MurM protein. Trends Microbiol 11, 547–553. Garcia-Bustos, J., Tomasz, A., 1990. A biological price of antibiotic resistance: major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proc. Natl. Acad. Sci. USA 87, 5415–5419. Garcia-Bustos, J.F., Chait, B.T., Tomasz, A., 1988. Altered peptidoglycan structure in a pneumococcal transformant resistant to penicillin. J. Bacteriol. 170, 2143–2147. Ghuysen, J.M., Strominger, J.L., 1963. Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. Ii. Separation and structure of disaccharides. Biochemistry 2, 1119–1125. Ghuysen, J.M., Bricas, E., Lache, M., Leyh-Bouille, M., 1968. Structure of the cell walls of Micrococcus lysodeikticus. 3. Isolation of a new peptide dimer, N-alpha-[l-alanyl-gamma-(alpha-d-glutamylglycine)]l-lysyl-d-alanyl-N-alpha-[l-alanyl-gamma-(alpha-dglutamylglycine)]-l-lysyl-d-alanine. Bi. Biochemistry 7, 1450–1460. Glauner, B., 1988. Separation and quantification of muropeptides with high-performance liquid chromatography. Anal. Biochem. 172, 451–464.
Glauner, B., Höltje, J.-V., Schwarz, U., 1988. The composition of the murein of Escherichia coli. J. Biol. Chem. 263, 10088–10095. Harz, H., Burgdorf, K., Höltje, J.-V., 1990. Isolation and separation of the glycan strands from murein of Escherichia coli by reversed-phase high-performance liquid chromatography. Anal. Biochem. 190, 120–128. Hirao, T., Sato, M., Shirahata, A., Kamio, Y., 2000. Covalent linkage of polyamines to peptidoglycan in Anaerovibrio lipolytica. J. Bacteriol. 182, 1154–1157. Höltje, J.-V., 1998. Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli. Microbiol. Mol. Biol. Rev. 62, 181–203. Hughes, R.C., 1971. Autolysis of Bacillus cereus cell walls and isolation of structural components. Biochem. J. 121, 791–802. Kamio, Y., Itoh, Y., Terawaki, Y., 1981a. Chemical structure of peptidoglycan in Selenomonas ruminantium: cadaverine links covalently to the d-glutamic acid residue of peptidoglycan. J. Bacteriol. 146, 49–53. Kamio, Y., Itoh, Y., Terawaki, Y., Kusano, T., 1981b. Cadaverine is covalently linked to peptidoglycan in Selenomonas ruminantium. J. Bacteriol. 145, 122–128. Koch, A.L., 1995. Bacterial Growth and Form. Chapman & Hall, New York. Koch, A.L., 1998. Orientation of the peptidoglycan chains in the sacculus of Escherichia coli. Res. Microbiol. 149, 689–701. Labischinski, H., Barnickel, G., Naumann, D., Keller, P., 1985. Conformational and topological aspects of the three-dimensional architecture of bacterial peptidoglycan. Ann. Inst. Pasteur Microbiol. 136A, 45–50. Labischinski, H., Goodell, E.W., Goodell, A., Hochberg, M.L., 1991. Direct proof of a ‘more-than-single-layered’ peptidoglycan architecture of Escherichia coli W7: a neutron small-angle scattering study. J. Bacteriol. 173, 751–756. Li, W.J., Chen, H.H., Kim, C.J., et al., 2005. Microbacterium halotolerans sp. nov., isolated from a saline soil in the west of China. Int. J. Syst. Evol. Microbiol. 55, 67–70. Machida, M., Takechi, K., Sato, H., et al., 2006. Genes for the peptidoglycan synthesis pathway are essential for chloroplast division in moss. Proc. Natl. Acad. Sci. USA 103, 6753–6758. Magnet, S., Arbeloa, A., Mainardi, J.L., et al., 2007a. Specificity of l,d-transpeptidases from Gram-positive bacteria producing different peptidoglycan chemotypes. J. Biol. Chem. 282, 13151–13159. Magnet, S., Bellais, S., Dubost, L., et al., 2007b. Identification of the l,d-transpeptidases responsible for attachment of the Braun lipoprotein to Escherichia coli peptidoglycan. J. Bacteriol. 189, 3927–3931. Mahapatra, S., Scherman, H., Brennan, P.J., Crick, D.C., 2005a. N-Glycolylation of the nucleotide precursors of
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment. J. Bacteriol. 187, 2341–2347. Mahapatra, S., Yagi, T., Belisle, J.T., et al., 2005b. Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate. J. Bacteriol. 187, 2747–2757. Mainardi, J.L., Legrand, R., Arthur, M., Schoot, B., van Heijenoort, J., Gutmann, L., 2000. Novel mechanism of beta-lactam resistance due to bypass of dd-transpeptidation in Enterococcus faecium. J. Biol. Chem. 275, 16490–16496. Mainardi, J.L., Fourgeaud, M., Hugonnet, J.E., et al., 2005. A novel peptidoglycan cross-linking enzyme for a beta-lactam-resistant transpeptidation pathway. J. Biol. Chem. 280, 38146–38152. Markiewicz, Z., Glauner, B., Schwarz, U., 1983. Murein structure and lack of dd- and ld-carboxypeptidase activities in Caulobacter crescentus. J. Bacteriol. 156, 649–655. Martin, H.H., Gmeiner, J., 1979. Modification of peptidoglycan structure by penicillin action in cell walls of Proteus mirabilis. Eur. J. Biochem. 95, 487–495. Matsumoto, A., Takahashi, Y., Shinose, M., Seino, A., Iwai, Y., Omura, S., 2003. Longispora albida gen. nov., sp. nov., a novel genus of the family Micromonosporaceae. Int. J. Syst. Evol. Microbiol. 53, 1553–1559. Meroueh, S.O., Bencze, K.Z., Hesek, D., et al., 2006. Threedimensional structure of the bacterial cell wall peptidoglycan. Proc. Natl. Acad. Sci. USA 103, 4404–4409. Moulder, J.W., 1993. Why is Chlamydia sensitive to penicillin in the absence of peptidoglycan? Infect. Agents Dis. 2, 87–99. Neuhaus, F.C., Baddiley, J., 2003. A continuum of anionic charge: structures and functions of d-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67, 686–723. Perkins, H.R., 1969. The configuration of 2,6-diamino-3hydroxypimelic acid in microbial cell walls. Biochem. J. 115, 797–805. Pfanzagl, B., Zenker, A., Pittenauer, E., et al., 1996a. Primary structure of cyanelle peptidoglycan of Cyanophora paradoxa: a prokaryotic cell wall as part of an organelle envelope. J. Bacteriol. 178, 332–339. Pfanzagl, B., Allmaier, G., Schmid, E.R., de Pedro, M.A., Loffelhardt, W., 1996b. N-acetylputrescine as a characteristic constituent of cyanelle peptidoglycan in glaucocystophyte algae. J. Bacteriol. 178, 6994–6997. Pisabarro, A.G., de Pedro, M.A., Vazquez, D., 1985. Structural modifications in the peptidoglycan of Escherichia coli associated with changes in the state of growth of the culture. J. Bacteriol. 161, 238–242. Pittenauer, E., Schmid, E.R., Allmaier, G., et al., 1993. Structural characterization of the cyanelle peptidoglycan of Cyanophora paradoxa by 252Cf plasma desorption mass
27
spectrometry and fast atom bombardment/tandem mass spectrometry. Biol. Mass Spectrom. 22, 524–536. Popham, D.L., Helin, J., Costello, C.E., Setlow, P., 1996. Muramic lactam in peptidoglycan of Bacillus subtilis spores is required for spore outgrowth but not for spore dehydration or heat resistance. Proc. Natl. Acad. Sci. USA 93, 15405–15410. Quintela, J.C., Caparros, M., de Pedro, M.A., 1995a. Variability of peptidoglycan structural parameters in Gram-negative bacteria. FEMS Microbiol. Lett. 125, 95–100. Quintela, J.C., Pittenauer, E., Allmaier, G., Aran, V., de Pedro, M.A., 1995b. Structure of peptidoglycan from Thermus thermophilus HB8. J. Bacteriol 177, 4947–4962. Quintela, J.C., Garcia-del Portillo, F., Pittenauer, E., Allmaier, G., de Pedro, M.A., 1999. Peptidoglycan fine structure of the radiotolerant bacterium Deinococcus radiodurans Sark. J. Bacteriol. 181, 334–337. Schleifer, K.H., Kandler, O., 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36, 407–477. Schleifer, K.H., Plapp, R., Kandler, O., 1967. Identification of threo-3-hydroxyglutamic acid in the cell wall of Microbacterium lacticum. Biochem. Biophys. Res. Commun. 28, 566–570. Schneider, T., Senn, M.M., Berger-Bachi, B., Tossi, A., Sahl, H.G., Wiedemann, I., 2004. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol. Microbiol. 53, 675–685. Shockman, G.D., Thompson, J.S., Conover, M.J., 1965. Replacement of lysine by hydroxylysine and its effects on cell lysis in Streptococcus faecalis. J. Bacteriol. 90, 575–588. Sutcliffe, I.C., 1998. Cell envelope composition and organisation in the genus Rhodococcus. Antonie van Leeuwenhoek 74, 49–58. Tipper, D.J., Strominger, J.L., Ensign, J.C., 1967. Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. VII. Mode of action of the bacteriolytic peptidase from Myxobacter and the isolation of intact cell wall polysaccharides. Biochemistry 6, 906–920. Ton-That, H., Marraffini, L.A., Schneewind, O., 2004. Protein sorting to the cell wall envelope of Gram-positive bacteria. Biochim. Biophys. Acta 1694, 269–278. Tuomanen, E., Schwartz, J., Sande, S., Light, K., Gage, D., 1989. Unusual composition of peptidoglycan in Bordetella pertussis. J. Biol. Chem. 264, 11093–11098. Uchida, E., Aida, K., 1979. Taxonomic significance of cell-wall acyl type in Corynebacterium-MycobacteriumNocardia group by a glycolate test. J. Gen. Appl. Microbiol. 25, 169–183. van den Bogaart, G., Hermans, N., Krasnikov, V., Poolman, B., 2007. Protein mobility and diffusive barriers in
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
28
2. Peptidoglycan
Escherichia coli: consequences of osmotic stress. Mol. Microbiol. 64, 858–871. Vollmer, W., 2008. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol. Rev. 32, 287–306. Vollmer, W., Höltje, J.-V., 2004. The architecture of the murein (peptidoglycan) in Gram-negative bacteria: Vertical scaffold or horizontal layer(s)? J. Bacteriol. 186, 5978–5987. Vollmer, W., Tomasz, A., 2000. The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae. J. Biol. Chem. 275, 20496–20501. Vollmer, W., Tomasz, A., 2002. Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae. Infect. Immun. 70, 7176–7178. Vollmer, W., Blanot, D., de Pedro, M.A., 2008a. Peptidoglycan structure and architecture. FEMS Microbiol. Rev. 32, 149–167. Vollmer, W., Joris, B., Charlier, P., Foster, S., 2008b. Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol. Rev. 32, 259–286.
Ward, J.B., 1973. The chain length of the glycans in bacterial cell walls. Biochem. J. 133, 395–398. Warth, A.D., Strominger, J.L., 1971. Structure of the peptidoglycan from vegetative cell walls of Bacillus subtilis. Biochemistry 10, 4349–4358. Weadge, J.T., Clarke, A.J., 2006. Identification and characterization of O-acetylpeptidoglycan esterase: a novel enzyme discovered in Neisseria gonorrhoeae. Biochemistry 45, 839–851. Weidel, W., Pelzer, H., 1964. Bagshaped macromolecules – a new outlook on bacterial cell walls. Adv. Enzymol. 26, 193–232. Wietzerbin, J., Das, B.C., Petit, J.F., Lederer, E., Leyh-Bouille, M., Ghuysen, J.M., 1974. Occurrence of d-alanyl-(d)meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of mycobacteria. Biochemistry 13, 3471–3476. Yao, X., Jericho, M., Pink, D., Beveridge, T., 1999. Thickness and elasticity of Gram-negative murein sacculi measured by atomic force microscopy. J. Bacteriol. 181, 6865–6875.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
3 Core region and lipid A components of lipopolysaccharides Otto Holst and Antonio Molinaro
Summary One of the major virulence factors of Gram-negative bacteria are lipopolysaccharides (LPSs), also known as endotoxins, intensive research on which has been performed for more than 50 years leading to an indepth characterization of LPS structures and their functions, including immunological, pharmacological and pathophysiological effects displayed in eukaryotic hosts. Lipopolysaccharides represent amphiphilic molecules generally comprising three defined regions which are distinguished by their genetics, structures, function and biosynthesis. The first moiety, lipid A, is substituted by the second, the core region, which in turn carries a polysaccharide which may be the Ospecific polysaccharide, a capsular polysaccharide, or the enterobacterial common antigen (only in Enterobacteriaceae). With regard to the structure– function relationships of LPSs, lipid A has been identified as the toxic principle of endotoxically active LPS. This toxicity depends mostly on lipid A chemical structure which defines the overall molecular conformation, but is also influenced by the core region. Thus, a complete structural analysis of lipid A and core region represent the prerequisite for the understanding of LPS functions. To date, quite a number of lipid A and core structures from LPSs of various Gram-negative bacteria have been published
Microbial Glycobiology
and summarized in several overviews. This chapter adds to this knowledge, however, due to space limitations, the collection of structures reviewed has to be incomplete. Keywords: Lipopolysaccharide; Lipid A; Core region; Structural analysis; Burkholderia cepacia, Plant pathogenic bacteria; Pathogenesis; Enterobacteriaceae; Pseudomonadaceae
1. Introduction Endotoxin was discovered and named by Richard Pfeiffer in the year 1892. Pfeiffer was working on cell lysates of Vibrio cholerae from which he identified this heat-resistant toxin that appeared to be attached to the bacteria unlike the exotoxins that were secreted. The term lipopolysaccharide (LPS) was introduced by Murray Shear in 1943 (Shear and Turner, 1943) characterizing a bacterial toxin which was constituted of polysaccharide and lipoidic material and used for the treatment of malignant tumours. Afterwards, this term was adopted by Otto Westphal and Otto Lüderitz, the two most important pioneer scientists of modern endotoxin research, to indicate
29
© 2009 2010, Elsevier Inc.
30
3. Core region and lipid A of LPS
Figure 3.1 General chemical structure of an LPS from Gram-negative bacteria. All forms of LPS known to date consist of a lipid A domain and a covalently linked saccharide moiety composed of the core region (oligosaccharide) plus polysaccharide or oligosaccharide portion only (S- form LPS or R- form LPS/LOS, respectively). The polysaccharide region is termed the O-antigen, O-specific polysaccharide, O-side chain. According to preferential carbohydrate compositions in the core structure, an inner and an outer core region are commonly distinguished.
the pyrogenic fractions arising from enterobacteria, mainly Escherichia coli and Salmonella enterica, which they had isolated in sufficiently pure amounts for structural studies (Westphal et al., 1952). They showed that the pyrogenic activity mainly resided in the lipopolysaccharide by testing all the bacterial components. From that era on the study of chemical and biological features of endotoxin has quickly developed and is nowadays in the molecular era in which the full chemical and biological characterization of endotoxin from various Gram-negative microorganisms can be achieved. The interested reader will find detailed and fascinating historical perspectives in two other publications (Rietschel and Westphal, 1999; Beutler and Rietschel, 2003). The lipopolysaccharides are amphiphilic components present in the cell wall of almost all Gram-negative bacteria, where in particular they are localized in the external leaflet of the outer membrane (OM) in which they represent approximately 75% of the material. The OM is responsible for the minor permeability of Gram-negative surface compared to that of Gram-positive bacteria
which do not possess a second membrane in their cell wall. In general, the OM protects the bacteria against hydrophobic and higher molecular mass hydrophilic compounds owing to the very low fluidity of the highly ordered structure of the LPS monolayer. Furthermore, due to their external location, LPSs are involved in interactions with the external environment, in particular concerning host–bacterium interactions like recognition, adhesion and colonization. Lipopolysaccharides represent very important virulence factors of pathogenic Gram-negative bacteria, are major players in symbiosis and tolerance of commensal bacteria and, in the case of extremophile bacteria, are important for the survival under harsh conditions. With regard to their structure, all LPSs possess the same general chemical architecture independent to the bacterial activity (pathogenic, symbiontic, commensal) or ecological niches: (human, animal, soil, plant, water) or growth conditions (Raetz and Whitfield, 2002; Holst and Müller-Loennies, 2007). Three different regions are usually identified in LPS (Figure 3.1), namely a polysaccharide, which may be the O-specific polysaccharide (OPS, known also as O-side
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. General structural features of the lipid A molecule
31
chain or O-antigen), a capsular polysaccharide or, only in Enterobacteriaceae, the enterobacterial common antigen. The polysaccharide is covalently linked to an oligosaccharide named the core region, which in turn is linked to the lipid A. The lipid A anchors LPS in the outer leaflet of the OM, whereas the sugar moiety is oriented outwards (Raetz and Whitfield, 2002; Holst and Müller-Loennies, 2007). Complete LPS comprising all three regions is termed smooth- (S)-form LPS, whereas mutants lacking the OPS are called rough- (R)-form LPS (lipo-oligosaccharide, LOS). This chapter will deal with the structural aspects of lipid A and the core region. The chemical features of OPS are illustrated in the following chapter.
2. General structural features of the lipid A molecule The first lipid A structures, early investigated in the Enterobacteriaceae by Westphal and Lüderitz in the year 1954 (Westphal and Lüderitz, 1954), were finally established in 1983 (Takayama et al., 1983; Imoto et al., 1983) and consisted of a -(1→ 6)-linked 2-amino-2-deoxy-d-glucopyranose (d-GlcpN, glucosamine) disaccharide that bore (R)-3-hydroxy fatty acid residues, two of which were ester-linked to the 3- and 3’-positions, and another two were amide-linked at the 2- and 2’-positions (primary fatty acid residues, e.g. 3-OH(14:0) in E. coli). The 3-hydroxy fatty acids were in turn further esterified by secondary fatty acids, e.g. tetradecanoic acid (14:0) and dodecanoic acid (12:0) in LPS of E. coli. The hydroxyl groups at position-4’ of the non-reducing GlcN II residue (distal unit) and that of the -anomeric position of the reducing GlcN I residue (proximal unit) were both substituted by phosphate groups (Figure 3.2). Apart from such a general chemical architecture conserved in many bacterial LPSs, a number of subtle chemical differences have been
Figure 3.2 The chemical structure of lipid A from Escherichia coli LPS. The -(1→6)-linked 2-amino-2-deoxyd-glucopyranose (GlcpN) disaccharide bears primary (R)3-OH(14:0) residues either ester- (at the 3- and 3’-positions) or amide-linked (at 2- and 2’-positions). Both fatty acid residues on the GlcN II are further esterified by a dodecanoic (12:0) and a tetradecanoic (14:0) acid residue. The hydroxyl at position-4’ of the non-reducing GlcN II residue (distal unit) and that of the -anomeric position of the reducing GlcN I residue (proximal unit) are both phosphorylated.
identified in the past that are responsible for lipid A variation among bacterial LPSs. Furthermore, in both, mammalian and plant pathogen bacterial LPSs, chemical variations are responsible for the agonist/antagonist effect of lipid A in host innate immune response processes. The structures of lipid A residues shown in Table 3.1 are either those published after 2002, when the most recent review specifically addressing the chemical structure of lipid A appeared (Alexander and Zähringer, 2002), or those which had not been published in reviews of the years 2002–2008 (Munford and Varley, 2006; De Castro et al., 2008; Munford, 2008).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
32
Table 3.1 Substitution pattern on the two GlcN residues on different bacterial lipid A GlcN II substitution Bacteria Acinetobacter radioresistens
O-4’
N-2’
12:0(3-OH) 12:0
12:0
P
14:0(3-OH)c
14:0 (3-OH)
16:1c
12:0
14:0(3-OH)
16:0(3-OH)
P
12:0(3-OH)
O-3
N-2
O-1
12:0(3-OH)
12:0/14:0 (3-OH)
P
14:0(3-OH)c
14:0(3-OH)
-
14:0(3-OH)
16:0(3-OH)
P
12:0(3-OH)c
12:0(3-OH)c
P
14:0(3-OH)
16:0(3-OH)
GalA
12:0(3-OH)
16:0(3-OH)
P
13:0(3-OH)
13:0(3,4-OH)
Man
10:0(3-OH)
14:0(3-OH)
P-GalN
14:0(3-OH)e
16:0(3-OH)
Ara4N-Pe
18:0(3-OH)
18:0(3-OH)
P-GalN
12:0(3-OH)
12:0(3-OH)
Pe
12:0(3-OH)
16:0(3-OH)
P-Methyl
12:0(3-OH)
12:0(3-OH)
P
12:0
28:0(27-OH) 14:0 (3-OH)e Alteromonas macleodi
f
P
12:0(3-OH)
c
12:0(3-OH)c 12:0
Azospirillum lipoferum g
-
14:0(3-OH)
16:0(3-OH) 18:1/18:0
Bartonella henselae h,j
P
12:0(3-OH)
16:0(3-OH) 28:0(27-OH)
Bdellovibrio bacteriovorus i,j Bordetella pertussis k
Man GalN-P
13:0(3-OH)
13:1(3-OH)
13:0(3-OH)
13:0(3-OH)
14:0(3-OH)
14:0(3-OH) 14:0
Burkholderia cepacia complex l
Ara4N-Pe
14:0(3-OH)e
16:0 (3-O)
Francisella tularensis m
Man-P
-
18:0 (3-OH)
14:0 16:0 Halomonas magadiensis n
P
12:0(3-OH)e e
Leptospira interrogans o,j Marinomonas vaga p
-
12:0(3-OH)e e
18:1/16:0
14:0
12:0(3-OH)
16:0(3-OH)
12:1/14:1
12:1/14:1
-
12:0(3-OH) 12:0(3-OH)
10:0
10:0/12:0 (Continues)
3. Core region and lipid A of LPS
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
Agrobacterium tumefaciens d
O-3’
P a
Aeromonas salmonicida b
GlcN I substitution
Photorabdus luminescens q
P
14:0/15:0 (3-OH) 14:0
Pseudoalteromonas nigrifaciens r
P
a
10:0 (3-OH)b
14:0/15:0(3-OH)
14:0/15:0(3-OH)
14:0/15:0(3-OH)
P
10:0(3-OH)b
12:0 (3-OH)
P
a
14:0
12:0(3-OH)
12:0 P
Xanthomonas campestris t
P-P-EtNa
13:0 (3-OH)b
12:0(3-OH)b
13:0
13:0
12:0 (3-OH)b 10:0
b
12:0(3-OH)b
13:0(3-OH)b
13:0 (3-OH)b
P
12:0(3-OH)b
12:0 (3-OH)b
P-P-EtNa
b
10:0
Ara4N-P, 4-amino-4-deoxy-l-arabinopyranose-phosphate; GalA, galacturonic acid-phosphate; GalN, 2-amino-2-deoxy-d-galactose-phosphate; Man, mannose; P, phosphate; P-P-EtN, 2-aminoethanol diphosphate. a Leone et al., 2006. b Wang et al., 2006b. c High structural heterogeneity in fatty acids. d Silipo et al., 2004a. e Present in non-stoichiometric amount. f Liparoti et al., 2006. g Choma and Komniecka, 2008. h Zähringer et al., 2004. i Schwudke et al., 2003. j Both GlcN are replaced by GlcN3N. k Marr et al., 2008. l Silipo et al., 2005a. m Kay et al., 2006. n Silipo et al., 2004b. o Raetz et al., 2007. p Krasikova et al., 2004. q Molinaro, personal communication. r Krasikova et al., 2001. s Leone et al., 2007. t Silipo et al., 2005d.
2. General structural features of the lipid A molecule
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
Shewanella pacifica s
33
34
3. Core region and lipid A of LPS
With regard to the lipid A carbohydrate backbone, a -(1→6)-linked disaccharide has been always identified to date, in which a rather common variation is the replacement of one or both d-GlcpN residues by a residue of 2,3-diamino2,3-dideoxy-d-glucopyranose (d-GlcpN3N) to which both primary fatty acids are linked as amide residues. In Rhizobium etli CE3, the proximal glucosamine unit is exceptionally replaced by its aldonic acid derivative, the 2-amino-2deoxy-d-gluconate residue (Bhat et al., 1994; Raetz et al., 2007; De Castro et al., 2008). As for the polar heads of lipid A, these are largely represented by a phosphate group, to which in turn another phosphate group or 2aminoethanol (EtN) can be further attached. A remarkable difference is observed when the phosphate group is substituted by a further carbohydrate moiety, i.e. 4-amino-4-deoxy-l-arabinopyranose (Arap4N, arabinosamine) which has been found in a number of bacterial LPSs in recent years, in particular in all LPSs from the Burkholderia cepacia complex (see Table 3.1). Analogously, the 2-amino-2-deoxy-d-galactopyranose (GalpN) has been found very recently to substitute phosphate in Bordetella LPS (Marr et al., 2008). In a few cases, a phosphate group can be replaced by acidic monosaccharides like d-galactopyranosuronic acid (d-GalpA) in the lipid A of Aquifex pyrophylus (Plötz et al., 2000) and Rhizobium (Bhat et al., 1994), or by neutral monosaccharide residues, e.g. d-mannopyranose (d-Manp) in the lipid A of Bdellovibrio bacteriovorus (Schwudke et al., 2003). Acyl residues may vary in number, type and distribution (see Table 3.1). The most frequent primary fatty acid residues found in lipid A are 3-OH(10:0), 3-OH(12:0), 3-OH(14:0), 3-OH(16:0) and 3-OH(18:0) and, as secondary fatty acids, the corresponding 3-deoxy acyl chains, some of which may be present as (S)-2-OH derivatives (Zähringer et al., 1994; Raetz and Whitfield, 2002; Raetz et al., 2007). Less frequently present are odd numbered, methyl branched and unsaturated fatty acids and long chain and (-1)-hydroxy
fatty acids, the 27-OH(28:0) in Rhizobiaceae LPSs (Bhat et al., 1994; Basu et al., 2002; Vedam et al., 2003; De Castro et al., 2008), or in Legionella and Brucella LPSs (Zähringer et al., 1994; Raetz and Whitfield, 2002; Raetz et al., 2007). The grade of acylation and the fatty acid distribution between the GlcpN units determines the three-dimensional structure, i.e. the conical or cylindrical molecular shape, of lipid A (Seydel et al., 1993, 2000; Brandenburg et al., 1996) which is correlated to its biological activity, i.e. the binding to proteins of the innate immune system of both animals and plants (Medzhitov, 2001; Akira et al., 2006).
3. Lipopolysaccharides of mammalian pathogenic bacteria: the case of B. cepacia complex Among the lipid A from LPSs of pathogenic bacteria, that from B. cepacia complex (Bcc) deserves an own paragraph. Although a body of publications related to the biology and biochemistry of LPS/lipid A from Bcc has appeared in recent years, only scanty data are available on the molecular structure. The Bcc comprises ten closely related Gram-negative bacterial species, all of which appear to be capable of causing disease in humans. These organisms appear to be of particular relevance to patients with cystic fibrosis. Lipopolysaccharide is an important virulence determinant in these pathogens. An indisputable first step toward the understanding of the complex phenomenon of pathogenesis of Bcc is a complete characterization of the LPS structures of all ten species, followed by comprehensive studies of signal transduction and cytokine induction. The in vivo controls of Bcc lipid A acylation also require further investigations to define if mechanisms such as the magnesium responsive kinase system PhoP/Q as seen in enteric pathogens and Pseudomonas has a similar role in Bcc pathogenesis and affects TLR4 signalling.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Plant pathogenic agrobacterium and xanthomonas LPS
Thus far, the established lipid A structures of Bcc LPSs possess a general architecture in which the following elements are always present: the d-GlcpN disaccharide carbohydrate backbone plus l-Arap4N; the phosphate groups, 3-OH(14:0) and 3-OH(16:0) as primary and 14:0 as secondary fatty acids. However, these elements are very often present in nonstoichiometric amounts giving rise to a wide array of lipid A primary structures that varies within the same and among the strains and depends on the environment from which the bacteria have been isolated. To date, the isolated structures of Bcc lipid A are penta- or tetraacylated, but no hexa-acylated structures have been identified so far (De Soyza et al., 2008). The Bcc lipid A chemical structures possess strong similarities with other non-Bcc Burkholderia spp. lipid A, as for example the lipid A from the LPS of the plant pathogen Burkholderia caryophylli which possesses a nearly identical structure to that of B. cepacia LPS (Molinaro et al., 2003a) (see Table 3.1). Collectively, these data suggest that the biosynthetic pathways for lipid A may not be unique to a particular genomovar but differential lipid A acylation and glycosylation by Arap4N may depend on environmental pressures. Both lipid A acylation and substitution by l-Arap4N are pivotal for the survival of Gramnegative bacteria against host response. l-Arap4N substitution in lipid A and the LPS inner core (see below) contributes to the overall net charge of the OM and plays a key role in pathogenesis. In fact, LPS from Burkholderia are frequently positively charged or in an isoelectric state. This is closely related to the abundance of l-Arap4N residues present in the lipid A-inner core and confers resistance to antibiotic compounds and host cationic antimicrobial peptides. Under physiological conditions, l-Arap4N moieties are positively charged and reduce the negative net charge on the OM, weakening the ionic attraction for respiratory tract antimicrobial defensins. The inherent resistance of these microorganisms to polymyxin B (PmB), a cyclic polycationic
35
antibiotic peptide that possesses high affinity for negatively charged bacterial LPSs, is thought to depend on the l-Arap4N content which prevents an increased permeability in the OM produced by PmB. Interestingly, other frequently occurring cationic substituents (e.g. EtN) have not been reported as substituents of lipid A from B. cepacia, suggesting a unique role for l-Arap4N. Hence, the transferase which attaches l-Arap4N residues to lipid A and earlier enzymatic steps involved in l-Arap4N biosynthesis may be novel targets for future developments of drugs against B. cepacia. The gene cluster encoding lArap4N biosynthesis enzymes has been mapped and shown to be essential for the viability of Burkholderia cenocepacia. Using a conditional mutation strategy with rhamnose supplementation in growth media, the group of M. Valvano demonstrated dramatic changes in bacterial cell morphology and ultrastructure and bacterial permeability and osmotic sensitivity, suggesting a fundamental cell membrane defect in the absence of l-Arap4N (Ortega et al., 2007).
4. Plant pathogenic agrobacterium and xanthomonas LPS and the activation of innate immune response in plants In animal and insect cells, innate immune defences are triggered by the perception of pathogen-associated molecular patterns (PAMPs), conserved and generally indispensable microbial structures including LPSs. The recognition of PAMPs by these cells is often mediated by LRR (leucine-rich repeat) proteins such as Toll in Drosophila and the Toll-like receptors (TLR) in mammals (see Chapter 31). Recognition of LPS occurs through the lipid A moiety which is responsible for most of the biological effects of LPSs in animals. Lipid A toxicity in animals strongly depends on its structure and is also
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
36
3. Core region and lipid A of LPS
influenced by the covalently linked core region, which possesses immunogenic properties. Lipopolysaccharides apparently play diverse roles in bacterial pathogenesis of plants. It can be recognized by plants to elicit or potentiate plant defence-related responses as part of a group of general elicitors that include flagellin and other pathogen surface effectors such as peptidoglycan. In comparison with animal and human cells, little is known about the mechanisms of LPS perception by plants and cognate signal transduction pathway. The receptor for LPS in plant cells is not identified and cloning and characterization of LPS receptors in plants is currently a major goal in this area. Despite the wealth of information on the structures of LPS and lipid A from Rhizobiaceae (Raetz et al., 2007), no complete information was present until recently on Agrobacterium LPS and lipid A. The latter is composed of two main lipid A species (see Table 3.1), the first one of which is bearing two unsubstituted 3-OH(14:0) in ester linkage, two 3-OH(16:0) or one 3-OH(16:0) and one 3-OH(18:1) in amide linkage, one 27-OH(28:0) linked to 3-OH(16:0) on GlcN II, and one 3-OH(4:0) linked to 27-OH(28:0). The second species, present in minor amounts, is missing a 3-OH(14:0) on GlcN I. Other species are deriving from these two and lack phosphate or 3-OH(14:0). Recently, the lipid A isolated from LPS of Xanthomonas campestris was identified. It consists of a bis-phosphorylated -(1’→6)-linked d-GlcpN disaccharide backbone and, in the main hexa-acyl species, two unsubstituted 3-OH(12:0) and/or 3-OH(13:0) were linked to the disaccharide backbone in amide linkage and two primary fatty acids with different chain length [3-OH(10:0), 3-OH(11:0), 3-OH(12:0), or 3-OH(13:0)] were present in ester-linkage at C3 and C3’ of the GlcpN residues. These acyl chains were further substituted at their 3-hydroxy groups by 10:0 and 11:0 (see Table 3.1). The importance of LPSs in plant pathogenesis has been recognized in past years, but
the mechanisms involved are far from being fully understood, although there are interesting parallels with animals (Zipfel and Felix, 2005; Jones and Dangl, 2006; Newman et al., 2007). Plants have evolved and maintained competence to recognize several general elicitors which are pathogen surface molecules and can thus be considered PAMPs. They bind to plant pattern recognition receptors and trigger the expression of immune response genes and the production of antimicrobial compounds. Lipopolysaccharides belong to such surface compounds that act as general elicitors of plant innate immunity (Dow et al., 2000; Newman et al., 2002, 2007; see also Chapter 40). The activation of plant innate immunity responses upon recognition of PAMPs resembles the activation mechanisms in mammals and insects (Medzhitov, 2001). The invasion of a bacterium activates a signal transduction pathway which may lead to the hypersensitive response (HR). The HR is a programmed cell death response, triggered by live bacteria and associated with plant host resistance. It is associated with a decline of the number of viable bacteria recovered in the tissue and follows a rapid necrosis of plant tissue representing the final stage of resistance, when stress signals induce strong defensive responses. One of the most widely studied effects of LPSs on plant cells is their ability to retard or completely block HR induced by avirulent bacteria. Pre-inoculation of leaves with heat-killed bacterial cells delays or prevents the disease symptoms expected with the subsequent inoculation with living bacteria (Dow et al., 2000; Newman et al., 2002). Recent findings have shed light on the molecular aspect of these biological events. The lipid A moiety may be at least partially responsible for LPS perception by Arabidopsis thaliana leading to a rapid burst of nitric oxide, a hallmark of innate immunity in animals (Zeidler et al., 2004). The minimal structural requirements for the elicitor activity can be different from a mammalian host. In the case of LOS,
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
6 General structural features of the core region
both lipid A and core oligosaccharide from a pathogenic bacterium can be recognized by plant receptors (Silipo et al., 2005d) and are potent inducers of immune responses. Consequently, a single pathogen-associated compound can cause multiple signals indicating the existence of multiple receptors of several general elicitors. Intact LOS, the lipid A and core oligosaccharide derived from X. campestris pv. campestris are all able to induce the defencerelated genes PR1 and PR2 in Arabidopsis and to prevent HR caused by avirulent bacteria. Furthermore, these defensive cellular responses occur via a distinctive recognition event that occurs in different temporal phases (Silipo et al., 2005d). As in the case of mammalian pathogenic bacteria, the structural variation in the lipid A region can strongly influence the ability of LPS to induce defence-related genes and to be recognized as PAMPs (Silipo et al., 2008). The alteration of the acylation pattern and the modification of the polar heads seem to play a crucial role.
5. Structural elucidation of lipid A The complete structural elucidation of lipid A is of pivotal importance toward the full understanding of its biological properties, i.e. an (ant)agonistic action in the elicitation of the host innate immune response. The lipid fraction obtained by precipitation after mild acid treatment of LPS (or LOS) is constituted of a mixture of intrinsically heterogeneous lipid A molecules. Any structural approach applies intensively mass spectrometric analyses by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-) and electrospray ionization (ESI-) mass spectrometry (MS) techniques on both the native and the selectively degraded lipid A fractions (see Chapter 13). The MALDI-TOF- and ESI-MS data give insight into the number of lipid A species
37
present in the isolate, the presence of polar head groups and the distribution of acyl residues on each GlcpN units of the disaccharide backbone (Que et al., 2000). This latter issue is of particular importance given that fatty acid composition and distribution strongly affect the endotoxic activity. Through the chemical and spectroscopical study of several lipids A and LPSs in our institutions, novel general approaches to gain structural insight in such molecules have been developed. In particular, combining MALDITOF- or ESI-MS and selective chemical degradation by ammonium hydroxide hydrolysis, we have developed a general and easy methodology to obtain the secondary fatty acid distribution, which is one of the most demanding issues in the structural determination of lipid A (Silipo et al., 2002; Sforza et al., 2004; Sturiale et al., 2005). These approaches must be supported by classical chemical analysis of lipid A which implies the removal of ester-linked fatty acids by mild alkaline treatment or the complete removal of fatty acids by strong alkaline treatment (Holst, 2000) and gas-liquid chromatography-mass spectrometry (GLC-MS) analyses of fatty acids as methyl ester derivatives (Rietschel, 1976; Zähringer et al., 1994) NMR spectroscopy is still less applied but equally important (Ribeiro et al., 1999; Brecker, 2003; Silipo et al., 2004a). The amphiphilic nature of lipid A entails a very poor solubility of the sample in many solvent systems, however, when possible, it allows obtaining diagnostic information mainly about the saccharide backbone, i.e. the anomeric configuration of the carbohydrate residues and their sequence and the occurrence and position of the polar head groups.
6. General structural features of the core region The structures of the core regions of LPSs have been reviewed in a number of overviews in
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
38
3. Core region and lipid A of LPS
the past 15 years (Holst and Brade, 1992; Knirel and Kochetkov, 1993; Holst, 1999, 2002, 2007; Bystrova et al., 2006; Knirel et al., 2006; De Soyza et al., 2008). Owing to this and to space limitations, principles of core structures are given in this chapter, illustrated by structures published after the year 2002 and not yet included in the earlier reviews. Chemical variation in core region structures occurs in a more limited range than in O-specific polysaccharides. Only one structural element is present in all core regions, which is the particular -linked 3-deoxy-d-manno-oct-2-ulopyranosonic acid (Kdo) (Unger, 1983) residue that binds the core region to the lipid A. Several core regions possess in addition l-glycero-d-manno-heptopyranose (l,d-Hep) and the oligosaccharide l-ad-Hep-(1→7)-l-a-d-Hep-(1→3)-l--d-Hep-(1→ 5)-[-Kdo-(2→4)]--Kdo (Hep III, Hep II, Hep I, Kdo II and Kdo I, respectively), substitutions of which furnish structural variability. Other substituents may be sugars or phosphate residues and acetyl and amino acid residues may be present also. In addition to or instead of l,d-Hep, LPSs may contain d-glycero-d-manno-heptopyranose (d,d-Hep) which is the biosynthetic precursor of l,d-Hep. Several LPSs lack heptose residues at all. Both, Kdo I and II can be replaced by the stereochemical similar sugar d-glycero-d-talo-oct2-ulopyranosonic acid (Ko) (Gass et al., 1993), of which neither the biosynthesis nor the regulation of its exchange with Kdo have been elucidated to date. Other LPSs possess only Kdo I which may then be phosphorylated at O-4.
7. Core structures of various bacteria 7.1. Enterobacterial core structures Presently, there are two types of enterobacterial core regions known, i.e. the S. enterica core regions and the core regions different to the Salmonella type. In the first, the common structural
element l-a-d-Hep-(1→7)-l-a-d-Hep-(1→3)l-a-d-Hep-(1→5)-a-Kdo is present which is substituted at O-3 of the second heptose by glucopyranose (Glcp). Heptose residues I and II are phosphorylated and O-4 of Hep I is not substituted by a saccharide. In the other core type, the common partial structure l-a-d-Hep-(1→ 7)-l-a-d-Hep-(1→3)-l-a-d-Hep-(1→5)-a-Kdo is present which is not substituted at O-3 of Hep II by Glc and in which heptose residues are not generally phosphorylated. Position O-4 of Hep I is substituted by a hexose residue or oligosaccharide. As examples for each type, the core regions of LPSs from E. coli R4 (in LPS from E. coli, five core regions of the S. enterica core type are known) and Yersinia pestis are shown in Figure 3.3. A detailed review on enterobacterial LPS core regions has been published recently (Holst, 2007).
7.2. Core structures of LPS from Pasteurellaceae Of the family Pasteurellaceae (-proteobacteria), a good number of core structures have been published since the year 2002 from LPSs of the genera Haemophilus, Histophilus and Pasteurella and Haemophilus somnus (Cox et al., 2002b, 2003a; Inzana et al., 2002; Månsson et al., 2002, 2003; Müller-Loennies et al., 2002a; Bouchet et al., 2003; Schweda et al., 2003; Harper et al., 2004; St Michael et al., 2004a, 2005a,b,c,d, 2006; Tinnert et al., 2005; Yildrim et al., 2005; Lundström et al., 2007). In Haemophilus influenzae, the core region possesses as common partial structure the saccharide l--d-Hepp-(1→2)-[PEtn→6]-l--dHepp-(1→3)-[-d-Glcp-(1→4)]-l--d-Hepp-(1→ 5)-[PP-Etn→4)]--Kdo (Figure 3.4). Generally, only this one Kdo residue is present that links the core region to lipid A. Further substitutions occur mainly at the -d-Glcp and Hep III residues. In particular, core regions of non-typeable H. influenzae strains have been investigated
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
7. Core structures of various bacteria
39
Figure 3.3 Two examples of core region structures of enterobacterial LPS. Where not stated otherwise, sugars are -d-pyranosides. a Müller-Loennies et al. (2002b). b Product obtained after de-O-acylation. Further substituents are not known. c This residue was identified to link the core region to GlcN II of lipid A. d Knirel et al. (2005). e Non-stoichiometric substitution.
in the past 5 years which are excellently summarized in a very recent review (Schweda et al., 2008). Additionally, the functions of several biosynthetic genes (Griffin et al., 2003; Fox et al., 2005) and of the glycosyltransferase LpsA (Deadman et al., 2006) have been elucidated. The core region of Histophilus somni (Haemophilus somnus) strains possesses instead an -Kdo-(2→4)--Kdo disaccharide and the common structure L--d-Hepp-(1→3)-[-d-Glcp(1→4)]-l--d-Hepp-(1→5)--Kdo. The -d-Glcp is further substituted and Hep II carries either -d-GlcpNAc or d-Galp at O-2. Phosphocholine is not present, but Hep II may be substituted by one or two PEtn residues (see Figure 3.4). N-acetylneuraminic acid may be incorporated, leading to serum resistance and reduction of antibody binding (Inzana et al., 2002). The common partial structure of the core region of LPS from Pasteurella multocida may be described as l--d-Hepp-(1→2)-l--dHepp-(1→3)-[-d-Glcp-(1→4)]-[-d-Glcp-(1→ 6)]-l--d-Hepp-(1→5)--Kdo. Interestingly, an
-Kdo-(2→4)--Kdo disaccharide and Kdo-4→ PP-Etn were present in the core region of strain VP161. Due to this variability, two acceptorspecific heptosyl I transferases are required in order to link Hep I either to the -Kdo-(2→4)-Kdo-containing core or to the Kdo-4→PP-Etn one (Harper et al., 2007). Core extensions which include a fourth l,d-Hep residue occur at the (1→4)-linked -d-Glcp residue (Figure 3.5).
7.3. Core structures of LPSs from Pseudomonadaceae 7.3.1. Pseudomonas The core regions of LPSs of Pseudomonas aeruginosa possess a GalpN residue that is mostly amidated by alanine (in a few cases, it is present as GalpNAc) and which substitutes (O-3 of) Hep II of the trisaccharide l,d-Hep-(1→3)-l,d-Hep(1→5)-Kdo and two Kdo residues are present in the inner core region. The Hep II residue is further substituted at O-7 by a carbamoyl residue.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
40
3. Core region and lipid A of LPS
Most strikingly is the fact that the core regions are highly phosphorylated. Figure 3.6 presents some examples of these structures. Publications of the last six years (Bystrova et al., 2003, 2004; Kooistra et al., 2003; Choudhury et al., 2005, 2008) and two recently published overviews (Bystrova et al., 2006; Knirel et al., 2006) expatiate on this field. Similar structures were identified in the core region of Pseudomonas stutzeri OX1 (Leone et al., 2004a,b), however, no alanine was present. As a novel feature of a core region, two residue of pyruvic acid were identified (see Figure 3.6). Another core structure which possesses features very similar to Ps. aeruginosa cores was identified in the LPS of Pseudomonas syringae pv. phaseolicola (Zdorovenko et al., 2004). A completely unusual core structure lacking heptose and
phosphate residues was identified in Pseudomonas cichorii which belongs to the RNA group I of Pseudomonadaceae, as do Ps. aeruginosa, Ps. stutzeri and Ps. syringae (De Castro et al., 2004).
7.3.2. Burkholderia The genus Burkholderia represents the RNA group II of Pseudomonadaceae and possesses other and significant structural features in its LPS core regions which are of chemotaxonomic value (Isshiki et al., 2003; De Castro et al., 2005). First of all, all core regions that have been identified so far possess in various amounts both the disaccharides -Ko-(2→4)--Kdo (which has not yet been found in other genera of Pseudomonadaceae
(Continues)
Figure 3.4 The structures of core regions of LPS from Haemophilus. Where not stated otherwise, sugars are -d-pyranosides. Abbreviations: PCho, 2-trimethylaminoethanol phosphate, PEtn, 2-aminoethanol phosphate, PPEtn, 2-aminoethanol diphosphate. a O-acetylated at position 3 in strain 723. b O-acetylated at position 2 in strain 723. c This residue was identified to link the core region to GlcN II of lipid A. d O-acetylated at unknown position in strain 723. e Månsson et al. (2002a). f Cox et al. (2002b). g Schweda et al. (2003). h Tinnert et al. (2005). Månsson et al. (2002b). i Yildrim et al. (2005). j Lundsträm et al. (2007). k Cox et al. (2003a). l St Michael et al. (2004a). m St Michael et al. (2005b). n St Michael et al. (2006).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
7. Core structures of various bacteria
41
Figure 3.4 Continued
but in some enterobacteria, i.e. Y. pestis and Serratia marcescens) and -Kdo-(2→4)--Kdo (see Figure 3.6). The common partial structure is l-d-Hepp-(1→7)-l--d-Hepp-(1→3)-[-d-Glcp-(1→
4)]-l--d-Hepp-(1→5)--Kdo. In B. caryophylli, O-3 of Hep II is substituted by a branched glycan to which one of the O-specific polysaccharides is linked (the caryan) (De Castro et al., 2005).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
42
3. Core region and lipid A of LPS
Figure 3.5 The structures of core regions of LPS from Pasteurella multocida. Where not stated otherwise, sugars are -dpyranosides. a St Michael et al. (2005a). b Harper et al. (2007). c This residue was identified to link the core region to GlcN II of lipid A. d St Michael et al. (2005c). e St Michael et al. (2005d). I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
43
7. Core structures of various bacteria
This core region possessed as a novel feature two l--d-Hepp-(1→5)--Kdo moieties. The core region of the rough-type LPS of Burkholderia pyrrocinia possessed a complex oligosaccharide in which the Kdo unit was substituted at O-5 by the pentasaccharide -Hep-(1→7)-[-Rha-(1→ 2)]--Hep-(1→3)-[-Glc-(1→4)]--Hep-(1→, a saccharide common in LPS of B. cepacia (Silipo et al., 2006). The last heptose residue of this moiety was further substituted by a heptose trisaccharide, giving rise to a heptan pentasaccharide representing the remote region of the outer core. An excellent review on structural and biological features of LPS from Burkholderia has been published recently (De Soyza et al., 2008). 7.3.3. Xanthomonas It was shown that the oxidative burst in tobacco plants initiated by LOS from X. campestris pv. campestris was provoked by the inner
core region (Braun et al., 2005). The complete structure of the LOS was characterized (Silipo et al., 2005d) (see Figure 3.6) and it was shown that plant cells recognize both core region and lipid A, however, these moieties induced defence-related gene transcription at different times. Later, even smaller core oligosaccharides from this LOS were shown to induce an oxidative burst in tobacco cells (Kaczynski et al., 2007).
7.4. Core structures of LPSs from Neisseria Additional information on the core structures from LPS of Neisseria meningitidis strain BZ157 galE (two PEtn residues at Hep I) and various immunotypes (the presence of glycine on O-7 of Hep II) have been published (Cox et al., 2002a,c). A novel core structure was identified in strain 1000 (Cox et al., 2003b) (Figure 3.7).
(Continues)
Figure 3.6 The structures of core regions of LPS from Pseudomonadaceae. a Structure published after 2006. b Choudhury
et al. (2008). c The amino function is either acetylated or alanylated. d Zdorovenko et al. (2004). e Non-stoichiometric substitution. f This residue was identified to link the core region to GlcN II of lipid A. g Leone et al. (2004a). h De Castro et al. (2004). i Silipo et al. (2006). j Isshiki et al. (2003). k Silipo et al. (2005d). l Kaczyski et al. (2007). m R, phosphoramide or galacturonic acid-phosphate-1 (GalA-1P).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
44
3. Core region and lipid A of LPS
Figure 3.6 Continued
7.5. Core structures of LPSs from Acinetobacter The core region of the LPS from Acinetobacter radioresistens S13 belonged to the Ko-lacking cores of Acinetobacter (Leone et al., 2006) and possessed the branched trisaccharide -Kdo(2→4)-[-Kdo-(2→5)-]-Kdo, as found earlier in Acinetobacter baumannii strain ATCC
19606 (Vinogradov et al., 2002a) and a Glcprich outer core region. In the core region of Acinetobacter lwoffii F78, the Chlamydia-specific epitope Kdo-(2→8)-Kdo was identified by chemical and serological methods, suggesting an explanation for the cross-reactivity between Chlamydia and Acinetobacter that had been described earlier (Brade and Brunner, 1979) (Figure 3.8).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
7. Core structures of various bacteria
45
Figure 3.7 The structure of core regions of LPS from Neisseriaceae. a Cox et al. (2003b). b This residue was identified to link the core region to GlcN II of lipid A.
Figure 3.8 The structures of core regions of LPS from Acinetobacter. a Leone et al. (2006). b This residue was identified to link the core region to GlcN II of lipid A. c Non-stoichiometric substitution. d Hanuszkiewicz et al. (2008).
7.6. Core structures of LPSs from various families 7.6.1. Shewanella This genus is of particular interest since it has the ability to take up various metals which are then excreted in an altered state. Thus, Shewanella bacteria are important for the cleaning of contaminated areas. Several core structures of LPSs from different Shewanella spp. have been published (Figure 3.9), two of which possessed the novel sugar 8-amino-Kdo4P which linked the core to the lipid A (Vinogradov et al., 2003, 2004a), however, in Shewanella putrefaciens CN 32, an “ordinary” Kdo4P was identified (Vinogradov et al., 2002b). The absolute
configuration of 8-amino-Kdo has been identified recently (Leone et al., 2007). To either residue a d,d-Hepp was linked at O-5. Further core elongations proceeded from various positions of this residue. 7.6.2. Alteromonadaceae Two core structures from the LPSs of Alteromonas macleodii and Pseudoalteromonas carrageenovora have been elucidated (Silipo et al., 2005b; Liparoti et al., 2006). Both were of the deeper (3 and 4 sugar residues, respectively) rough type. The most prominent feature was the presence of a (terminal) -linked Kdo residue which has been identified in LPS for the first time (see Figure 3.9).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
46
3. Core region and lipid A of LPS
(Continues)
Figure 3.9 The structures of core regions of LPS from various species.
a
Vinogradov et al. (2002b). b This residue was identified to link the core region to GlcN II of lipid A. c Vinogradov et al. (2003). d Non-stoichiometric substitution by ethanolamine-phosphate. e Vinogradov et al. (2004a). f Non-stoichiometric substitution by Ac. g Silipo et al. (2005b). h Liparoti et al. (2006). i St Michael et al. (2004b). k Wang et al. (2006b). l Hashii et al. (2003). m 5-acetamido-7-(N-acetyld-alonyl) amino-3,5,7,9-tetradeoxy-d-galacto-non-zulosonic acid (Non5Ac7Ala), n Kay et al. (2006). o Molinaro et al. (2003b). p De Castro et al. (2006a). q De Castro et al. (2006a). r Zähringer et al. (2004). s Silipo et al. (2005c). t Nonstoichiometric substitution. u Pieretti et al. (2008). v Vinogradov et al. (2004b).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
7. Core structures of various bacteria
Figure 3.9 Continued
47
(Continues)
7.6.3. Actinobacillus Four structures have been published in the past 6 years, namely those of the LPSs from Actinobacillus pleuropneumoniae serotypes 1, 2, 5a and 5b (St Michael et al., 2004b). Their common
feature is the oligosaccharide l--d-Hepp-(1→ 2)-l--d-Hepp-(1→3)-[d--d-Hepp-(1→6)--dGlcp-(1→4)]-[-d-Glcp-(1→6)]-l--d-Hepp-(1→ 5)--Kdo which is differently substituted at the d,d-Hepp residue (see Figure 3.9).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
48
3. Core region and lipid A of LPS
Figure 3.9 Continued
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
8. Conclusions
7.6.4. Vibrionaceae The core region of Aeromonas salmonicida ssp. salmonicida (Wang et al., 2006a) possesses a cluster of four l,d-Hepp residues, Hepp I of which is -(1→5)-linked to Kdo4P and in turn carries the disaccharide l--d-Hepp-(1→6)--d-Glcp at O4. The heptose residue of this unit is differently substituted at O-4, leading to heterogeneity (see Figure 3.9). Another but incomplete structure was identified in the LPS from Vibrio parahaemolyticus isolated from a patient, containing alanylated nonulosonic acid (Hashii et al., 2003) (see Figure 3.9).
7.7. Various genera The core structures of the LPSs from the fish pathogen Francisella victoria (Kay et al., 2006), the plant pathogens Agrobacterium larrymoorei (Molinaro et al., 2003b) and Agrobacterium tumefaciens A1 and TT111 (De Castro et al., 2006a,b), the zoonotic pathogen Bartonella henselae (Zähringer et al., 2004), the marine bacterium Arenibacter certesii (Silipo et al., 2005c), all of which possessed no heptose residues, and the heptose-containing core structures of the LPSs from the haloalkaliphilic bacterium Halomonas pantellerensis (Pieretti et al., 2008) and the ironand sulfur-reducing species Geobacter sulfurreducens (Vinogradov et al., 2004b) are summarized in Figure 3.9.
8. Conclusions From the chemical point of view, the lipid A structure still remains a rather conserved architectural principle within the LPSs of Gramnegative bacteria with only a low number of variants. Thus far, a -(1→6)-linked amino sugar disaccharide has been found with no exception and the core oligosaccharide is linked to O-6 of the second (non-reducing) residue.
49
As for polar head groups, the principle of a charged lipid A is still valid, since phosphate residues are present in a good number of structures and may further be esterified (or replaced) by GalpA. In some examples, these negative charges are counterbalanced through the esterification of the phosphate residue with positively charged groups as EtN, Arap4N or GalpN. An important but single exception of the dogma of a charged lipid A has been recently described in the LPS of B. bacteriovorus in which a totally neutral lipid A has been identified, containing -dmannose residues that stoichiometrically replace phosphate groups (Schwudke et al., 2003). With regard to the fatty acids, there is considerable variability either in length or in their number, to which is also correlated the biological activity of the lipid A. Both primary and secondary fatty acids between 10 and 16 carbon atoms represent the major species. From the biological point of view, lipid A represents the endotoxic principle of the LPS and, thus, is responsible for LPS perception and biological activity in any system, i.e. vegetal or animal. Since 2002, a good number of core structures from LPS of various bacterial species, including several which live under rather extreme environmental conditions, have been elucidated. The general principle of a negatively charged core region contributing to the rigidity of the Gram-negative cell wall through intermolecular cationic cross-links is still valid. Many core regions comprise as partial structure a tetrasaccharide l,d-Hep-(1→7)/(1→2)-l,d-Hep-(1→ 3)-l,d-Hep-(1→5)-Kdo and a common structural theme is often identified within a genus or strains of a species, varying by different substituents. Apart from the finding that a mutant of E. coli K-12 has been identified that is viable possessing only lipid IVA as a minimal “LPS” structure, the common principle of LPS may still be seen as the core oligosaccharide and the lipid A, as identified in all other LPSs investigated so far. The expression of a (O-specific)
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
50
3. Core region and lipid A of LPS
polysaccharide in LPSs is not a prerequisite for bacterial survival, however, the finding that the polysaccharide portion in S-form LPS may be furnished either by the O-chain or a capsule or ECA indicates that such an LPS form is highly advantageous in many bacteria. The binding of the core region to lipid A occurs always via a Kdo residue (except in Acinetobacter, where this Kdo may be replaced in non-stoichiometric amounts by Ko). A further general feature of LPS is that the core region is always negatively charged (provided by phosphoryl substituents and/or sugar acids like Kdo and uronic acids) which is believed to contribute to the rigidity of the Gram-negative cell wall through intermolecular cationic cross-links. There are two types of core structures: those containing and those without heptoses. In the first type, l,d-Hep or d,d-Hep alone, or both may be present in a particular core structure. If present, d,d-Hep either decorates the inner core region (e.g. in Y. enterocolitica) or is attached to more remote parts of the carbohydrate chain. Still, the regulation of the distribution of l,dHep and d,d-Hep in the core region is not understood and it is not known whether l,dHep and d,d-Hep are transferred by different transferases. Further areas for future investigation are listed in the Research Focus Box.
Acknowledgements The research of O.H. is supported by the Deutsche Forschungsgemeinschaft (grants SFBTR 22 A1 and A2) and the European Union (GABRIEL, GALTRAIN, GA2LEN). A.M. thanks M. Parrilli and R. Lanzetta for the useful discussions and help through these years.
References Akira, S., Uematsu, S., Osamu, T., 2006. Pathogen recognition and innate immunity. Cell 124, 783–801. Alexander, C., Zähringer, U., 2002. Chemical structure of lipid A – the primary immunomodulatory center of bacterial lipopolysaccharides. Trends Glycosci. Glycotech. 14, 69–86. Basu, S.S., Karbarz, M.J., Raetz, C.H.R., 2002. Expression cloning and characterization of the c28 acyltransferase of lipid A biosynthesis in Rhizobium leguminosarum. J. Biol. Chem. 277, 28959–28971. Beutler, B., Rietschel, E.Th., 2003. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3, 169–176. Bhat, U.R., Forsberg, L.S., Carlson, R.W., 1994. Structure of lipid A component of Rhizobium leguminosarum bv. phaseoli lipopolysaccharide. Unique nonphosphorylated lipid A containing 2-amino-2-deoxygluconate, galacturonate, and glucosamine. J. Biol. Chem. 269, 14402–14410. Bouchet, V., Hood, D.W., Li, J., et al., 2003. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc. Natl. Acad. Sci. USA 100, 8898–8903.
Research Focus Box • Determination of the complete analysis of highly phosphorylated LPS. • Identification of additional non-toxic and antagonistic lipid A structures would be advantageous. • Investigative studies of the use of non-toxic/ detoxified lipid A as a vaccine adjuvant.
• Genetic studies on LPS from non-enteric bacteria would aid the field. • Additional molecular studies on the interaction of LPS with receptor molecules are required. • Futher investigation of the interaction of LPS with the plant innate immune system.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Brade, H., Brunner, H., 1979. Serological cross-reactions between Acinetobacter calcoaceticus and chlamydiae. J. Clin. Microbiol. 10, 819–822. Brandenburg, K., Seydel, U., Schromm, A.B., Loppnow, H., Koch, M.H.J., Rietschel, E.Th., 1996. Conformation of lipid A, the endotoxic center of bacterial lipopolysaccharides. J. Endotoxin Res. 3, 173–178. Braun, S.G., Meyer, A., Holst, O., Pühler, A., Niehaus, K., 2005. Characterization of the Xanthomonas campestris pv. campestris lipopolysaccharide substructures essential for elicitation of an oxidative burst in tobacco cells. Mol. Plant Microbe Interact. 18, 674–681. Brecker, L., 2003. Nuclear magnetic resonance of lipid A: the influence of solvents on spin relaxation and spectral quality. Chem. Phys. Lipids 125, 27–39. Bystrova, O.V., Lindner, B., Moll, H., et al., 2003. Structure of the lipopolysaccharide of Pseudomonas aeruginosa O-12 with a randomly O-acetylated core region. Carbohydr. Res. 338, 1895–1905. Bystrova, O.V., Lindner, B., Moll, H., et al., 2004. Full structure of the lipopolysaccahride of Pseudomonas aeruginosa immunotype 5. Biochemistry (Moscow) 69, 170–175. Bystrova, O.V., Knirel, Y.A., Lindner, B., et al., 2006. Struc tures of the core oligosaccharides and O-units in the Rand SR-type lipopolysaccharides of reference strains of Pseudomonas aeruginosa O-serogroups. FEMS Immunol. Med. Microbiol. 46, 85–99. Choma, A., Komaniecka, I., 2008. Characterization of a novel lipid A structure isolated from Azospirillum lipoferum lipopolysaccharide. Carbohydr. Res. 343, 799–804. Choudhury, B., Carlson, R.W., Goldberg, J.B., 2005. The structure of the lipopolysaccharide from a galU mutant of Pseudomonas aeruginosa serogroup-O11. Carbohydr. Res. 343, 2761–2772. Choudhury, B., Carlson, R.W., Goldberg, J.B., 2008. Characterization of the lipopolysaccharide from a wbjE mutant of the serogroup O11 Pseudomonas aeruginosa strain, PA103. Carbohydr. Res. 343, 238–248. Cox, A.D., Li, J., Brisson, J.-R., Moxon, E.R., Richards, J.C., 2002a. Structural analysis of the lipopolysaccharide from Neisseria meningitides strain BZ157 galE: localization of two phosphoethanolamine residues in the inner core oligosaccharide. Carbohydr. Res. 337, 1435–1444. Cox, A.D., Hodd, D.W., Martin, A., et al., 2002b. Identi fication and structural characterization of a sialylated lacto-N-neotetraose structure in the lipopolysaccharide of Haemophilus influenzae. Eur. J. Biochem. 269, 4009–4019. Cox, A.D., Li, J., Richards, J.C., 2002c. Identification and localization of glycine in the inner core lipopolysaccharide of Neisseria meningitidis. Eur. J. Biochem. 269, 4169–4175. Cox, A.D., Howard, M.D., Inzana, T.J., 2003a. Structural analysis of the lipooligosaccharide from the commensal
51
Haemophilus somnus strain 1P. Carbohydr. Res. 338, 1223–1228. Cox, A.D., Wright, J.C., Gidney, M.A.J., et al., 2003b. Identi fication of a novel inner-core oligosaccharide structure in Neisseria meningitidis lipopolysaccharide. Eur. J. Biochem. 270, 1759–1766. Deadman, M.E., Lundström, S.L., Schweda, E.K.H., Moxon, E.R., Hood, D.W., 2006. Specific amino acids of the glycosyltransferase LpsA direct the addition of glucose or galactose to the terminal inner core heptose of Haemophilus influenzae lipopolysaccharide via alternative linkages. J. Biol. Chem. 281, 29455–29467. De Castro, C., Molinaro, A., Nunziata, R., Lanzetta, R., Parrilli, M., Holst, O., 2004. A novel core region, lacking heptose and phosphate, of the lipopolysaccharide from the Gram-negative bacterium Pseudomonas cichorii (Pseudomonadaceae RNA group I). Eur. J. Org. Chem., 2427–2435. De Castro, C., Molinaro, A., Lanzetta, R., Holst, O., Parrilli, M., 2005. The linkage between O-specific caryan and core region in the lipopolysaccharide of Burkholderia caryophylli is furnished by a primer monosaccharide. Carbohydr. Res. 340, 1802–1807. De Castro, C., Carannante, A., Lanzetta, R., Liparoti, V., Molinaro, A., Parrilli, M., 2006a. Core oligosaccharide structure from the highly pathogenic Agrobacterium tumefaciens TT111 and conformational analysis of the putative rhamnan epitope. Glycobiology 16, 1272–1280. De Castro, C., Carannante, A., Lanzetta, R., et al., 2006b. Structural characterisation of the core oligosaccharides isolated from the lipooligosaccharide fraction of Agrobacterium tumefaciens A1. Chem. Eur. J. 12, 4668–4674. De Castro, C., Molinaro, A., Lanzetta, R., Silipo, A., Parrilli, M., 2008. Lipopolysaccharide structures from Agrobacterium and other Rhizobiaceae species. Carbohydr. Res. 343, 1924–1933. De Soyza, A., Silipo, A., Lanzetta, R., Govan, J.R., Molinaro, A., 2008. The chemical and biological features of Burkholderia cepacia complex lipopolysaccharides. Innate Immun. 14, 127–144. Dow, J.M., Newman, M.-A., von Roepenack, E., 2000. The induction and modulation of plant defence responses by bacterial lipopolysaccharides. Annu. Rev. Phytopathol. 38, 241–261. Fox, K.L., Yildrim, H.H., Deadman, M.E., Schweda, E.K.H., Moxon, E.R., Hood, D.W., 2005. Novel lipopolysaccharide biosynthetic genes containing tetranucleotide repeats in Haemophilus influenzae, identification of a gene for adding O-acetyl groups. Mol. Microbiol. 58, 207–216. Gass, J., Strobl, M., Loibner, A., Zähringer, U., 1993. Synthesis of allyl O-[sodium (-d-glycero-d-talo2-octulopyranosyl)onate]-(2→6)-2-acetamido-2deoxy--d-glucopyranoside, a core constituent of the
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
52
3. Core region and lipid A of LPS
lipopolysaccharide from Acinetobacter calcoaceticus NCTC 10305. Carbohydr. Res. 244, 69–84. Griffin, R., Cox, A.D., Makepeace, K., Richards, J.C., Moxon, E.R., Hood, D.W., 2003. The role of lex2 in lipopolysaccharide biosynthesis in Haemophilus influenzae strains RM7004 and RM153. Microbiology 149, 3165–3175. Hanuszkiewicz, A., Hübner, G., Vinogradov, E., et al., 2008. Structural and immunochemical analysis of the lipopolysaccharide from Acinetobacter lwoffii F78 located outside Chlamydiaceae with a Chlamydia-specific lipopolysaccharide epitope. Chem. Eur. J. 14, 10251–10258. Harper, M., Cox, A.D., St Michael, F., Wilkie, I.W., Boyce, J.D., Adler, B., 2004. A heptosayltransferase mutant of Pasteurella multocida produces a truncated lipopolysaccharide structure and is attenuated in virulence. Infect. Immun. 72, 3436–3443. Harper, M., Boyce, J.D., Cox, A.D., et al., 2007. Pasteurella multocida espresses two lipopolysaccharide glycoforms simultaneously, but only a single form is required for virulence: identification of two acceptor-specific heptosyl I transferases. Infect. Immun. 75, 3885–3893. Hashii, N., Isshiki, Y., Iguchi, T., Kondo, S., 2003. Structural characterization of the carbohydrate backbone of the lipopolysaccharide of Vibrio parahaemolyticus O-untypeable strain KX-V212 isolated from a patient. Carbohydr. Res. 338, 2711–2719. Holst, O., 1999. Chemical structure of the core region of lipopolysaccharides. In: Brade, H., Opal, S.M., Vogel, S.N., Morrison, D.C. (Eds.), Endotoxin in Health and Disease. Marcel Dekker, New York, pp. 115–154. Holst, O., 2000. Deacylation of lipopolysaccharides and isolation of oligosaccharide phosphates. In: Holst, O. (Ed.), Methods in Molecular Biology: Bacterial Toxins. Humana Press, Totowa, pp. 345–353. Holst, O., 2002. Chemical structure of the core region of lipopolysaccharides – an update. Trends. Glycosci. Glycotech. 14, 87–103. Holst, O., 2007. The structures of core regions from enterobacterial lipopolysaccharides – an update. FEMS Microbiol. Lett. 271, 3–11. Holst, O., Brade, H., 1992. Chemical structure of the core region of lipopolysaccharides. In: Morrison, D.C., Ryan, J.L. (Eds.), Bacterial Endotoxic Lipopolysaccharides, Vol. I. Boca Raton, CRC Press, pp. 135–170. Holst, O., Müller-Loennies, S., 2007. Microbial polysaccharide structures. In: Kamerling, J.P., Boons, G.-J., Lee, Y.C., Suzuki, A., Taniguchi, N., Voragen, A.G.J. (Eds.), Comprehensive Glycoscience. From Chemistry to Systems Biology, Vol. 1. Elsevier Ltd, Oxford, pp. 123–179. Imoto, M., Shiba, T., Naoki, H., et al., 1983. Chemical structure of E. coli lipid A: linkage site of acyl groups in the disaccharide backbone. Tetrahedron Lett. 24, 4017–4020. Inzana, T.J., Glindemann, G., Cox, A.D., Wakarchuk, W., Howard, M.D., 2002. Incorporation of N-acetylneuraminic
acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding. Infect. Immun. 70, 4870–4879. Isshiki, Y., Zähringer, U., Kawahara, K., 2003. Structure of the core oligosaccharide with a characteristic d-glycero--d-talo-oct-2-ulosonate-(2→4)-3-deoxy-d-mannooct-2-ulosonate [-Ko-(2→4)-Kdo] disaccharide in the lipopolysaccharide of Burkholderia cepacia. Carbohydr. Res. 338, 2659–2666. Jones, J.D.G., Dangl, J.L., 2006. The plant immune system. Nature 444, 323–329. Kaczyski, Z., Braun, S., Lindner, B., Niehaus, K., Holst, O., 2007. Investigation of the chemical structure and biological activity of oligosaccharides isolated from rough-type Xanthomonas campestris pv. campestris B100 lipopolysaccharides. J. Endotoxin Res. 13, 101–108. Kay, W., Petersen, B.O., Duus, J.Ø., Perry, M.B., Vinogradov, E., 2006. Characterization of the lipopolysaccharide and glucan of the fish pathogen Francisella victoria. FEBS J. 273, 3002–3013. Knirel, Y.A., Kochetkov, N.K., 1993. The structure of lipopolysaccharides of gram-negative bacteria. II. The structure of the core region: a review. Biokhimya 58, 182–201. Knirel, Y.A., Lindner, B., Vinogradov, E., et al., 2005. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis. Biochemistry 44, 1731–1743. Knirel, Y.A., Bystrova, O.V., Kocharova, N.A., Zähringer, U., Pier, G.B., 2006. Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa. J. Endotoxin Res. 12, 324–336. Kooistra, O., Bedoux, G., Brecker, L., et al., 2003. Structure of a highly phosphorylated core in the algC mutant derived from Pseudomonas aeruginosa wild-type strains PAO1 (serogroup O5) and PAC1R (serogroup O3). Carbohydr. Res. 338, 2667–2677. Krasikova, I.N., Kapustina, N.V., Svetashev, V.I., et al., 2001. Chemical characterization of lipid A from some marine proteobacteria. Biochemistry (Moscow) 66, 1047–1054. Krasikova, I.N., Kapustina, N.V., Isakov, V.V., et al., 2004. Detailed structure of lipid A isolated from lipopolysaccharide from the marine proteobacterium Marinomonas vaga ATCC 27119. Eur. J. Biochem. 271, 2895–2904. Leone, S., Izzo, V., Silipo, A., et al., 2004a. A novel type of highly negatively charged lipooligosaccharide from Pseudomonas stutzeri OX1 possessing two 4,6-O-(1-carboxy)-ethylidene residues in the outer core region. Eur. J. Biochem. 271, 2691–2704. Leone, S., Izzo, V., Sturiale, L., et al., 2004b. Structure of minor oligosaccharides from the lipopolysaccharide fraction of Pseudomonas stutzeri OX1. Carbohydr. Res. 339, 2657–2665. Leone, S., Molinaro, A., Pessione, E., et al., 2006. Structural elucidation of the core-lipid A backbone from the
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
lipopolysaccharide of Acinetobacter radioresistens S13, an organic solvent tolerating Gram-negative bacterium. Carbohydr. Res. 341, 582–590. Leone, S., Molinaro, A., De Castro, C., et al., 2007. Absolute configuration of 8-amino-3,8-dideoxyoct-2-ulosonic acid, the chemical hallmark of lipopolysaccharides of the genus Shewanella. J. Nat. Prod. 70, 1624–1627. Liparoti, V., Molinaro, A., Sturiale, L., et al., 2006. Structural analysis of the deep rough lipopolysaccharide from Gram negative bacterium Alteromonas macleodii ATCC 27126: the first finding of -Kdo in the inner core of lipopolysaccharides. Eur. J. Org. Chem. 2006, 4710–4716. Lundström, S.L., Twelkmeyer, B., Sagemark, M.K., et al., 2007. Novel globoside-like oligosaccharide expression patterns in non-typeable Haemophilus influenzae lipopolysaccharide. FEBS J. 274, 4886–4903. Månsson, M., Hood, D.W., Li, J., Richards, J.C., Moxon, E.R., Schweda, E.K.H., 2002a. Structural analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae strain 1003. Eur. J. Biochem. 269, 808–818. Månsson, M., Hood, D.W., Moxon, E.R., Schweda, E.K.H., 2003. Structural characterization of a novel branching pattern in the lipopolysaccharide from nontypeable Haemophilus influenzae. Eur. J. Biochem. 270, 2979–2991. Marr, N., Tirsoaga, A., Blanot, D., Fernandez, R., Caroff, M., 2008. Glucosamine found as a substituent of both phosphate groups in Bordetellae lipid A backbones: role of a BvgAS-activated ArnT ortholog. J. Bacteriol. 190, 4281–4290. Medzhitov, R., 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135–145. Molinaro, A., Lindner, B., De Castro, C., et al., 2003a. The structure of the lipid A of the lipopolysaccharide from Burkholderia caryophylli possessing a 4-amino-4-deoxyl-arabinopyranose-1-phosphate residue exclusively in glycosidic linkage. Chem. Eur. J. 9, 1542–1548. Molinaro, A., De Castro, C., Lanzetta, R., Parrilli, M., Raio, A., Zoina, A., 2003b. Structural elucidation of a novel core oligosaccharide backbone of the lipopolysaccharide from the new bacterial species Agrobacterium larrymoorei. Carbohydr. Res. 338, 2721–2730. Müller-Loennies, S., Brade, L., Brade, H., 2002a. Chemical structure and immunoreactivity of the lipopolysaccharide of the deep rough mutant I-69 Rd-/b of Haemophilus influenzae. Eur. J. Biochem. 269, 1237–1242. Müller-Loennies, S., Lindner, B., Brade, H., 2002b. Structural analysis of deacylated lipopolysaccharide of Escherichia coli strains 2513 (R4 core-type) and F653 (R3 core-type). Eur. J. Biochem. 269, 5982–5991. Munford, S.R., 2008. Sensing Gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect. Immun. 76, 454–465. Munford, S.R., Varley, A.W., 2006. Shield as signal: lipopolysaccharides and the evolution of immunity to Gramnegative bacteria. PLoS Pathog. 2, 467–471.
53
Newman, M.-A., von Roepenack-Lahaye, E., Parr, A., Daniels, M.J., Dow, J.M., 2002. Prior exposure to lipopolysaccharide potentiates expression of plant defences in response to bacteria. Plant J. 29, 485–497. Newman, M.-A., Dow, J.M., Molinaro, A., Parrilli, M., 2007. Priming, induction and modulation of plant defence responses by bacterial lipopolysaccharides. J. Endotox. Res. 13, 69–84. Ortega, X.P., Cardona, S.T., Brown, A.R., et al., 2007. A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability. J. Bacteriol. 189, 3639–3644. Pieretti, G., Corsaro, M.M., Lanzetta, R., et al., 2008. Structural characterization of the core region of the lipopolysaccharide from the haloalkaliphilic Halomonas pantellerensis: identification of the biological O-antigen repeating unit. Eur. J. Org. Chem. 2008, 721–728. Plötz, B.M., Lindner, B., Stetter, K.O., Holst, O., 2000. Characterization of a novel lipid A containing d-galacturonic acid that replaces phosphate residues. The structure of the lipid A of the lipopolysaccharide from the hyperthermophilic bacterium Aquifex pyrophilus. J. Biol. Chem. 275, 11222–11228. Que, N.L.S., Lin, S.H., Cotter, R.J., Raetz, C.H.R., 2000. Purification and mass spectrometry of six lipid a species from the bacterial endosymbiont Rhizobium etli. J. Biol. Chem. 275, 28006–28016. Raetz, C.R.H., Whitfield, C., 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635–700. Raetz, C.R.H., Reynolds, C.M., Trent, M.S., Bishop, R.E., 2007. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 76, 295–329. Ribeiro, A.A., Zhou, Z., Raetz, C.R.H., 1999. Multidimensional NMR structural analyses of purified Lipid X and Lipid A (endotoxin). Magn. Reson. Chem. 37, 620–630. Rietschel, E.Th., 1976. Absolute configuration of 3-hydroxy fatty acids present in lipopolysaccharides from various bacterial groups. Eur. J. Biochem. 64, 423–428. Rietschel, E.Th., Westphal, O., 1999. Endotoxins: historical perspectives. In: Brade, H., Morrison, D.C., Opal, S., Vogel, S. (Eds.), Endotoxin in Health and Disease. Marcel Dekker Inc, New York, pp. 1–30. Schweda, E.K.H., Landerholm, M.K., Li, J., Moxon, E.R., Richards, J.C., 2003. Structural profiling of lipopolysaccharide glycoforms expressed by non-typeable Haemophilus influenzae: phenotypic similarities between NTHi strain 162 and the genome strain Rd. Carbohydr. Res. 338, 2731–2744. Schweda, E.K.H., Twelkmeyer, B., Li, J., 2008. Profiling structural elements of short-chain lipopolysaccharide of non-typeable Haemophilus influenzae. Innate Immun. 14, 199–211. Schwudke, D., Linscheid, M., Strauch, E., et al., 2003. The obligate predatory Bdellovibrio bacteriovorus possesses
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
54
3. Core region and lipid A of LPS
a neutral lipid A containing -d-mannoses that replace phosphate residues: similarities and differences between the lipid As and the lipopolysaccharides of the wild type strain B. bacteriovorus HD100 and its host-independent derivative HI100. J. Biol. Chem. 278, 27502–27512. Seydel, U., Labischinski, H., Kastowsky, M., Brandenburg, K., 1993. Phase behaviour, supramolecular structure, and molecular conformation of lipopolysaccharide. Immunobiology 187, 191–211. Seydel, U., Oikawa, M., Fukase, K., Kusumoto, S., Brandenburg, K., 2000. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur. J. Biochem. 267, 3032–3039. Sforza, S., Silipo, A., Molinaro, A., Marchelli, R., Parrilli, M., Lanzetta, R., 2004. Determination of fatty acid positions in native lipid A by positive and negative electrospray ionization mass spectrometry. J. Mass Spectrom. 39, 378–383. Shear, M.J., Turner, F.C., 1943. Chemical treatment of tumors. VII. Nature of hemorrhage-producing fraction from Serrati marcescens (Bacillus prodigiosus) culture filtrates. J. Natl. Cancer Inst. 4, 107–122. Silipo, A., Lanzetta, R., Amoresano, A., Parrilli, M., Molinaro, A., 2002. Ammonium hydroxide hydrolysis: a valuable support in the MALDI-TOF mass spectrometry analysis of lipid A fatty acid distribution. J. Lipid Res. 43, 2188–2195. Silipo, A., De Castro, C., Lanzetta, R., Molinaro, A., Parrilli, M., 2004a. Full structural characterization of the lipid A components from the Agrobacterium tumefaciens strain C58 lipopolysaccharide fraction. Glycobiology 14, 805–815. Silipo, A., Sturiale, L., Garozzo, D., et al., 2004b. Structure elucidation of the highly heterogeneous lipid A from the lipopolysaccharide of the Gram-negative extremophile bacterium Halomonas magadiensis strain 21 M1. Eur. J. Org. Chem 2004, 2263–2271. Silipo, A., Molinaro, A., Cescutti, P., et al., 2005a. Complete structural characterization of the lipid A fraction of a clinical strain of Burkholderia cepacia genomovar I lipopolysaccharide. Glycobiology 15, 561–570. Silipo, A., Lanzetta, R., Parrilli, M., et al., 2005b. The complete structure of the core carbohydrate backbone from the LPS of marine halophilic bacterium Pseudoalteromonas carrageenovora type strain IAM 12662. Carbohydr. Res. 340, 1475–1482. Silipo, A., Molinaro, A., Nazarenko, E.L., et al., 2005c. Structural characterization of the carbohydrate backbone of the lipooligosaccharide of the marine bacterium Arenibacter certesii strain KMM 3941. Carbohydr. Res. 340, 2540–2549. Silipo, A., Molinaro, A., Sturiale, L., et al., 2005d. The elicitation of plant innate immunity by lipooligosaccharide of Xanthomonas campestris. J. Biol. Chem. 280, 33660–33668.
Silipo, A., Molinaro, A., Comegna, D., et al., 2006. Full structural characterization of the lipooligosaccharide of a Burkholderia pyrrocina clinical isolate. Eur. J. Org. Chem. 2006, 4874–4883. Silipo, A., Sturiale, L., Garozzo, D., et al., 2008. The acylation and phosphorylation pattern of lipid A strongly influence its ability to trigger the innate immune response in Arabidopsis: Xanthomonas campestris pv. campestris mutant strain 8530 synthesizes a chemically different LPS that it is not recognized by innate immunity in plants. Chembiochem 9, 896–904. St Michael, F., Howard, M.D., Li, J., Duncan, A.J., Inzana, T.J., Cox, A.D., 2004a. Structural analysis of the lipooligosaccharide from the commensal Haemophilus somnus genome strain 129Pt. Carbohydr. Res. 339, 529–535. St Michael, F., Brisson, J.-R., Larocque, S., et al., 2004b. Structural analysis of the lipoopolysaccharide derived core oligosaccharides of Actinobacillus pleuropneumoniae serotypes 1, 2, 5a and the genome strain 5b. Carbohydr. Res. 339, 1973–1984. St Michael, F., Li, J., Vinogradov, E., Larocque, S., Harper, M., Cox, A.D., 2005a. Structural analysis of the lipooligosaccharide of Pasteurella multocida strain VP161: identification of both Kdo-P and Kdo-Kdo species in the lipopolysaccharide. Carbohydr. Res. 340, 59–68. St Michael, F., Li, J., Howard, M.D., Duncan, A.J., Inzana, T.J., Cox, A.D., 2005b. Structural analysis of the oligosaccharide of Histophilus somni (Haemophilus somnus) strain 2336 and identification of several lipooligosaccharide biosynthesis gene homologues. Carbohydr. Res. 340, 665–672. St Michael, F., Li, J., Cox, A.D., 2005c. Structural analysis of the core oligosaccharide of Pasteurella multocida strain X73. Carbohydr. Res. 340, 1253–1257. St Michael, F., Vinogradov, E., Li, J., Cox, A.D., 2005d. Structural analysis of the lipopolysaccharide of Pasteurella multocida strain Pm70 and identification of the putative lipopolysaccharide glycosyltransferases. Glycobiology 15, 323–333. St Michael, F., Inzana, T.J., Cox, A.D., 2006. Structural analysis of the lipooligosaccharide-derived oligosaccharide of Histophilus somni (Haemophilus somnus) strain 8025. Carbohydr. Res. 341, 281–284. Sturiale, L., Garozzo, D., Silipo, A., Lanzetta, R., Parrilli, M., Molinaro, A., 2005. MALDI mass spectrometry of native bacterial lipooligosaccharides. Rapid Commun. Mass Spectrom. 19, 1829–1834. Takayama, K., Qureshi, N., Mascagni, P., 1983. Complete structures of lipid A obtained from the lipopolysaccharide of the heptoseless mutant of Salmonella typhimurium. J. Biol. Chem. 258, 12801–12803. Tinnert, A.-S., Månsson, M., Yildrim, H.H., Hood, D.W., Schweda, E.K.H., 2005. Structural investigation of lipooli gosaccharides from non-typeable Haemophilus influenzae:
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
investigation of inner-core phosphoethanolamine addition in NTHi strain 981. Carbohydr. Res. 340, 1900–1907. Unger, F.M., 1983. The chemistry and biological significance of 3-deoxy-d-manno-2-octulosonic acid (Kdo). Adv. Carbohydr. Chem. Biochem. 348, 323–387. Vedam, V., Kannenberg, E.L., Haynes, J.G., Sherrier, D., Datta., Carlson, R.W., 2003. A Rhizobium leguminosarum AcpXL mutant produces lipopolysaccharide lacking 27-hydroxyoctacosanoic acid. J. Bacteriol. 185, 1841–1850. Vinogradov, E., Duus, J.Ø., Brade, H., Holst, O., 2002a. The structure of the carbohydrate backbone of the lipopolysaccharide from Acinetobacter baumannii strain ATCC 19606. Eur. J. Biochem 269, 422–430. Vinogradov, E., Korenevsky, A., Beveridge, T.J., 2002b. The structure of the carbohydrate backbone of the LPS from Shewanella putrefaciens CN32. Carbohydr. Res. 337, 1285–1289. Vinogradov, E., Korenevsky, A., Beveridge, T.J., 2003. The structure of the rough-type lipooligosaccharide from Shewanella oneidensis MR-1, containing 8-amino-8-deoxyKdo and an open-chain form of 2-acetamido-2-deoxy-dgalactose. Carbohydr. Res. 338, 1991–1997. Vinogradov, E., Korenevsky, A., Beveridge, T.J., 2004a. The structure of the core region of the lipopolyosaccharide from Shewanella algae BrY, containing 8-amino-3,8dideoxy-d-manno-oct-2-ulosonic acid. Carbohydr. Res. 339, 737–740. Vinogradov, E., Korenevsky, A., Lovley, D.R., Beveridge, T.J., 2004b. The structure of the core region of the lipopol yosaccharide from Geobacter sulfurreducens. Carbohydr. Res. 339, 2901–2904. Wang, Z., Li, J., Vinogradov, E., Altman, E., 2006a. Structural studies of the core region of Aeromonas salmonicida subsp. salmonicida lipopolysaccharide. Carbohydr. Res. 341, 109–117.
55
Wang, Z., Li, J., Altman, E., 2006b. Structural characterization of the lipid A region of Aeromonas salmonicida subsp. salmonicida lipopolysaccharide. Carbohydr. Res. 341, 2816–2825. Westphal, O., Lüderitz, O., 1954. Chemische Erforschung von Lipopolysacchariden gram-negativer Bakterien. Angew. Chem. 66, 407–417. Westphal, O., Lüderitz, O., Bister, F., 1952. Uber die Extraktion von Bakterien mit Phenol/Wasser. Z. Naturforsch. 7, 148–155. Yildrim, H.H., Li, J., Richards, J.C., Hood, D.W., Moxon, E.R., Schweda, E.K.H., 2005. Complex O-acetylation in nontypeable Haemophilus influenzae lipopolysaccharide: evidence for a novel site of O-acetylation. Carbohydr. Res. 340, 2598–2611. Zähringer, U., Lindner, B., Rietschel, E.Th., 1994. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv. Carbohydr. Chem. Biochem. 50, 211–276. Zähringer, U., Lindner, B., Knirel, Y.A., et al., 2004. Structure and biological activity of the short-chain lipopolysaccharide from Bartonella henselae ATCC 49882. J. Biol. Chem. 279, 21046–21054. Zdorovenko, E.L., Vinogradov, E., Zdorovenko, G.M., et al., 2004. Structure of the core oligosaccharide of a roughtype lipopolysaccharide of Pseudomonas syringae pv. phaseolica. Eur. J. Biochem. 271, 4968–4977. Zeidler, D., Zähringer, U., Gerber, I., et al., 2004. Innate immunity in Arabidopsis thaliana: lipopolysaccharides activate nitric oxide synthase (NOS) and induce defense genes. Proc. Natl. Acad. Sci. USA 101, 15811–15816. Zipfel, C., Felix, G., 2005. Plants and animals: a different taste for microbes? Curr. Opin. Plant Pathol. 8, 353–360.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
4 O-Specific polysaccharides of Gram-negative bacteria Yuriy a. knirel Summary The present chapter examines the composition and structure of the O-specific polysaccharides (O-antigens) of the lipopolysaccharides of Gram-negative bacteria. The occurrence of both monosaccharides and noncarbohydrate groups as O-specific polysaccharide components is surveyed. Various types of these structures are considered, including homopolymers of a monosaccharide, homo- and hetero-polysaccharides built up of oligosaccharide repeats (O-units) and block co-polymers. Structural features of regular O-specific polysaccharides and factors that mask their regularity are described. Emphasis is placed on the occurrence and the role of non-repetitive domains that are present at the reducing and non-reducing ends of some O-chains. Key words: O-Specific polysaccharide; O-antigen; O-Chain; O-unit; Repeating unit; Lipopolysaccharide; Bacterial polysaccharide structure; Monosaccharide composition; Acyl group
1. Introduction The O-specific polysaccharide (O-PS) or O-antigen represents the polymer chain of lipo polysaccharide (LPS), the major constituent of
Microbial Glycobiology
the outer membrane of Gram-negative bacteria (see Chapter 1). Composition and structure of O-PSs are highly diverse. Based on the O-antigens, serologically distinct strains of the same bacterial species are classified into O-serogroups or O-serotypes (e.g. Liu et al., 1983; Nielsen, 1986; Ewing, 1986; Shimada et al., 1994). The O-PS plays important roles in protection of the bacteria and their virulence in animals and humans (Iredell et al., 1998; Erridge et al., 2002; Skurnik and Bengoechea, 2003; Morona et al., 2003; Lugo et al., 2007; Kintz and Goldberg, 2008; Bravo et al., 2008) as well as in microbe–plant interactions (Newman et al., 2007). In recent decades the chemistry of O-PSs has made significant progress and the data obtained have helped a better understanding of the mechanisms of pathogenesis of infectious diseases and the development of improved vaccines (Cryz et al., 1995; Favre et al., 1996; Conlan et al., 2002; Taylor et al., 2004; Kubler-Kielb et al., 2008; Döring and Pier, 2008) and diagnostic agents (Kawasaki et al., 1995; Trautmann et al., 1996; Jauho et al., 2000; Thirumalapura et al., 2005; Amano et al., 2007; Blixt et al., 2008). Composition and structures of bacterial polysaccharides, including O-PSs, have been repeatedly surveyed (Kenne and Lindberg, 1983;
57
© 2009 2010, Elsevier Inc.
58
4. O-Polysaccharides
Jann and Jann, 1984; Lindberg, 1990, 1998; Knirel and Kochetkov, 1994; Wilkinson, 1996; Jansson, 1999; Corsaro et al., 2001) and a number of reviews have been published that are devoted to O-PSs of particular bacterial species, including Escherichia coli (Stenutz et al., 2006), Shigella spp. (Liu et al., 2008), Citrobacter spp. (Knirel et al., 2002a), Proteus spp. (Knirel et al., 1999), Hafnia alvei (Romanowska, 2000), Serratia marcescens (Aucken et al., 1998), Yersinia spp. (Ovodov and Gorshkova, 1988; Ovodov et al., 1992; Bruneteau and Minka, 2003), Pseudomonas aeruginosa (Knirel, 1990; Knirel et al., 2006), Burkholderia cepacia (Vinion-Dubiela and Goldberg, 2003); Agrobacterium and Rhizobiaceae spp. (De Castro et al., 2008). Since 2005, an annually updated Bacterial Carbohydrate Structure Database is available via the Internet (http://www.glyco. ac.ru/bsdb). The present review updates data on the composition of O-PSs and considers selected topics related to their structural features. To avoid extensive citation, for topics already mentioned, the reviews cited above are referenced rather than original publications.
2. Composition of O-PSs 2.1. Monosaccharides d-Glucose and d-galactose are the most abundant neutral sugars in O-PSs and d-mannose is fairly common too. All three are present as pyranosides and d-galactofuranoside is not uncommon. Pentoses occur less often, d-ribose being the most common of them. d-Ribose and d-arabinose are known only as furanosides, d-xylose occurs in both forms and l-xylose always as a pyranoside. Other pentoses and hexoses have not been found in O-PSs. d-glycero-d-manno- and l-glycero-d-manno-heptoses have been identified in various bacteria and d-glycero-d-altro-heptose has been reported in Campylobacter jejuni (Aspinall
et al., 1992). There are only a few examples of ketoses, including d-threo-pent-2-ulose (d-xylulose) (Yersinia enterocolitica O5,27 and E. coli O97), d-fructose (Yersinia intermedia) (Ovodov et al., 1992; and Stenutz et al., 2006). A variety of 6-deoxy sugars occur in O-PSs, the most abundant being l-rhamnose and l-fucose; their d isomers as well as 6-deoxy-d- and -ltalose occur fairly often too. Less common are 6-deoxy-l-glucose (l-quinovose) (Providencia stuartii O44), 6-deoxy-l-altrose (Y. enterocolitica, Pectinatus frisingensis) and 6-deoxy-d-gulose (d-dantiorose) (Y. enterocolitica) (Ovodov et al., 1992; Jansson, 1999; Kocharova et al., 2005). dFucose and 6-deoxy-l-altrose are known as both pyranosides and furanosides, whereas the other 6-deoxyhexoses are always pyranosidic. From other deoxyhexoses, only 4-deoxy-d-arabino-hexopyranose has been reported as a component of several Citrobacter O-PSs (Knirel et al., 2002a). A group of 3,6-dideoxyhexoses has been identified, mainly in Salmonella (Jann and Jann, 1984) and Yersinia pseudotuberculosis (Ovodov and Gorshkova, 1988; Ovodov et al., 1992). Most often occurring is the l-xylo isomer (colitose), which always exists as a pyranoside, just like the d- and l-arabino, d-xylo and d-ribo isomers (tyvelose, ascarylose, abequose and paratose, respectively). In Y. pseudotuberculosis, paratose has been found also as a furanoside. There are several examples of the occurrence of 6-deoxy-d-manno-heptopyranose, e.g. in Y. pseudotuberculosis (Ovodov and Gorshkova, 1988) and 6-deoxy-d-altro-heptopyranose is present in C. jejuni (Aspinall et al., 1992). d-Glucosamine and d-galactosamine are widespread in O-PSs as the majority of Gramnegative bacteria employ either of them as the first monosaccharide of the O-unit (or repeating unit) whose transfer to a lipid carrier initiates biosynthesis of the O-antigen by the O-antigen polymerase (Wzy)-dependent pathway (Raetz and Whitfield, 2002) (see Chapter 18). Some 2-amino-2,6-dideoxy-d-hexoses(d-quinovosamine
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. composition of o-pss
and d-fucosamine), as well as 2,4-diamino-2,4, 6-trideoxy-d-glucose and -d-galactose, may play this role too. d-Mannosamine, 3-amino-3,6dideoxy-d-glucose and -d-galactose as well as 4-amino-4,6-dideoxy-d-hexoses (the gluco, manno and galacto isomers) occur fairly often. l-Quinovosamine and l-fucosamine are components of numerous O-PSs, whereas some other l isomers have been identified only in a few bacteria, namely l-glucosamine in B. cepacia O1 (Vinion-Dubiel and Goldberg, 2003), l-rhamnosamine in Proteus vulgaris O55 (Kondakova et al., 2003) and E. coli O3 (Stenutz et al., 2006), 3-amino-3,6-dideoxy-l-glucose in Vibrio anguillarum (Knirel and Kochetkov, 1994) and 4-amino4,6-dideoxy-l-mannose in Vibrio cholerae O76 and O144 (Jansson, 1999). The sugar 2,3diamino-2,3,6-trideoxy-l-mannose has been found in Proteus penneri O66 (Knirel et al., 1999) and its d enantiomer in E. coli O119 (Anderson et al., 1992), but the latter finding requires additional confirmation. A biosynthetic precursor of 2-amino-2,6dideoxy-d-hexoses, 2-amino-2,6-dideoxy-d-xylohex-4-ulose, has been identified in several O-PSs, e.g. in Flavobacterium columnare (MacLean et al., 2003) and Pseudoalteromonas rubra (Kilcoyne et al., 2005). All amino sugars occurring in O-chains are known exclusively as pyranosides, except for d-galactosamine, which is known also as a furanoside, e.g. in P. penneri O63 (Knirel et al., 1999). d-Glucuronic and d-galacturonic acids are common and their C-5 epimers have been reported, e.g. l-iduronic acid in Pseudo alteromonas haloplanktis (Hanniffy et al., 1998) and E. coli (Perepelov et al., 2008) and l-altruronic acid in Proteus mirabilis O10 (Knirel et al., 1999). From 2-amino-2-deoxyhexuronic acids, the d-galacto, d-manno and l-gulo isomers occur rather often in O-chains, whereas the l-galacto and l-altro isomers have been found in P. aeruginosa (Knirel, 1990) and Shigella sonnei (Kenne et al., 1980), respectively. In particular, 2-amino2-deoxy-d-mannuronic acid is also a constituent
59
of the enterobacterial common antigen (Kuhn et al., 1988). A group of 2,3-diamino-2,3-dideoxyhexuronic acids has been identified, three of them, the d-gluco, d-manno and l-gulo isomers, as components of various P. aeruginosa O-PSs (Knirel, 1990). However, 2,3-diamino-2,3-dideoxy-dgalacturonic acid has only been found in the genus Bordetella (Vinogradov, 2002; Preston et al., 2006) and the l-galacto isomer originally reported in Vibrio ordalii and V. anguillarum has been revised later to the l-gulo isomer (Kilcoyne et al., 2005). A 2,4-diamino-2,4-dideoxyglucuronic acid has been found in a Thiobacillus spp. (Jansson., 1999), though its absolute configuration remains unknown to date. All glycuronic acids that have been reported in O-PSs are pyranosidic. Additionally, all glyculosonic acids found in O-PSs are 3-deoxy sugars; 3-deoxy-d-mannooct-2-ulosonic acid (Kdo) is a component of the O-PS of Providencia alcalifaciens O36 (Kocharova et al., 2007) and neuraminic acid has been identified, e.g. in some other enteric bacteria (Gamian and Kenne, 1993). The 5,7-diamino-3,5,7,9tetradeoxy-non-2-ulosonic acids are unique to bacteria (Knirel et al., 2003) and four stereoisomers thereof are known. These are the l-glycero-l-manno (pseudaminic acid), d-glycerod-galacto (legionaminic acid), l-glycero-d-galacto (8-epilegionaminic acid) and d-glycero-d-talo (4-epilegionaminic acid) isomers, the originally reported configurations of the last three being subsequently revised (Knirel et al., 2003). Also, a 5,7,8-triamino-3,5,7,8,9-pentadeoxy-l- or -dglycero-l-manno-non-2-ulosonic acid has been found in Flexibacter maritimus (Vinogradov et al., 2003d), but the configuration at C-8 remains to be determined. Monosaccharides with a branched skeleton occur rarely. The simplest of these is 3-Cmethyl-d-mannose found in Helicobacter pylori (Kocharova et al., 2000). Structures of the other representative sugars are shown in Figure 4.1;
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
60
4. O-Polysaccharides
their names are derived from the bacteria in which they were found. Two branched isomeric monosaccharides, yersiniose A 1 and yersiniose B 2 occur mainly in Yersinia spp. (Ovodov and Gorshkova, 1988; Ovodov et al., 1992); their structures have been confirmed by chemical synthesis of the authentic sugars (Zubkov et al., 1992). The highest branched sugars, 10-carbon erwiniose 3 and 12-carbon caryophyllose 4, have been found in Erwinia carotovora (Senchenkova et al., 2005) and Burkholderia caryophylli (Adinolfi et al., 1996b), respectively. A branched 9-carbon ketoamino glycuronamide 5, called shewanellose, has been identified in two distantly related bacteria Shewanella putrefaciens (Shashkov et al., 2002) and Morganella morganii (Kilcoyne et al., 2002). In the former, shewanellose exists as a pyranoside, whereas in the latter, shewanellose occurs as both pyranoside and furanoside. The most unusual of the known O-PS components
appears to be a carbocyclic sugar caryose 6, which as caryophyllose 4, is present in B. caryophylli (Adinolfi et al., 1996a).
2.2. Non-carbohydrate components O-PSs include a great variety of non-sugar constituents, which can be linked to sugars in various manners: by the ether linkage (as in partially methylated monosaccharides and ethers with lactic acids), acetal linkage (acetals with pyruvic acid), ester linkage (O-acylated and phosphorylated monosaccharides) or amidic linkage (N-acylated amino sugars and amides of uronic acids). O-acetyl groups are very common and an O-linked propanoyl group has been found in V. anguillarum (Knirel and Kochetkov, 1994). The occurrence of various O-methylated
Figure 4.1 Structures of branched and carbocyclic monosaccharide components of various O-PSs: yersiniose A 1; yersiniose B 2; erwiniose 3; caryophyllose 4; shewanellose 5; and caryose 6.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. composition of o-pss
monosaccharides in LPSs has been deduced (Lindberg, 1990), but it is not always clear if the methylated sugar definitely occurs in the O-PS. However, in several cases this has been unambiguously established (Wilkinson, 1996). Ethers with (R)- and (S)-lactic acids called glycolactilic acids are components of several O-PSs. The parent sugars are hexoses, 6-deoxyhexoses or hexosamines. For example, 4-O-[(R)-1-carboxyethyl]-d-glucose and 3-O-[(R)-1-carboxyethyl]-l-rhamnose occur in Shigella dysenteriae (Liu et al., 2008) and 2-amino3-O-[(R)-1-carboxyethyl]-2-deoxy-d-glucose (muramic acid), its (S)-stereoisomer (isomuramic acid) and their regioisomers with an ether group at position-4 have been identified in Proteus (Knirel et al., 1999; Perepelov et al., 2002) and Providencia (Kocharova et al., 2002). Cyclic (R)- or (S)-acetals of pyruvic acid are common in exopolysaccharides (Kenne and Lindberg, 1983), but occur less often in O-PSs as the only non-sugar carbonyl components. Usually, pyruvic acid is linked to O-4 and O-6 of various monosaccharides but, in a few cases, it has been found on O-3 and O-4 of d-galactose, e.g. in P. mirabilis O24 (Shashkov et al., 2000) and S. dysenteriae type 9 (Zhao et al., 2007). Amino sugars with a free amino group are uncommon; among the few exceptions are 4-amino-4,6-dideoxy-d-glucose and 2-amino2-deoxy-l-guluronic acid in Idiomarina zobellii (Kilcoyne et al., 2004). Moreover, 2,4-diamino2,4,6-trideoxy-d-galactose occurs always with the free amino group at position-4, e.g. in S. sonnei where it was found for the first time (Kenne et al., 1980). The 2-amino group of amino sugars is usually acetylated but formyl and acetimidoyl (Knirel, 1990), (R)-3-hydroxybutanoyl (Romanowska, 2000) and l-alanyl (Knirel et al., 1999) groups have been found in P. aeruginosa, H. alvei 1187 and P. penneri 25 (O69), respectively. Amino groups in other positions of 6-deoxyamino and diamino sugars are acylated with various functionalized carboxylic acids much more often.
61
Of the hydroxy derivatives, (R)- and (S)-3hydroxybutanoic acids are the most abundant, but the others are: (R)- and (S)-2-hydroxypropanoic in V. cholerae O76 and O144 (Jansson, 1999); 3-hydroxypropanoic in V. cholerae 1875, 4-hydroxybutanoic in Yersinia ruckeri O1, l-glyceric in Citrobacter O32, (S)-2,4dihydroxybutanoic in V. cholerae O1 (Kenne and Lindberg, 1983) and (S,S)-3,5-dihydroxyhexanoic in Flavobacterium psychrophilum (MacLean et al., 2001). There are also examples of N-linked dicarboxylic acids occurring, such as malonic and succinic in P. mirabilis (Kondakova et al., 2004), l-malic in Shewanella algae (Vinogradov et al., 2003a) and (S)-2-hydroxyglutaric in F. maritimus (Vinogradov et al., 2003d). A number of N-linked amino acids have been identified and, among them, glycine in S. dysenteriae O7 (Liu et al., 2008), d- and l-alanine in Proteus spp. (Knirel et al., 1999), l-serine in E. coli O114 (Stenutz et al., 2006), d- and laspartic acids in Providencia and Proteus spp. (Kocharova et al., 2004) and a group of 5-oxoproline derivatives: (R,R)-3-hydroxy-3-methyl in V. cholerae O5), 3-hydroxy-2,3-dimethyl in Pseudomonas fluorescens), 2,4-dihydroxy-3,3,4-trimethyl in V. anguillarum (Knirel and Kochetkov, 1994; Wilkinson, 1996) or 4-amino-3-hydroxy-3methyl in Francisella victoria (Kay et al., 2006). A hydroxyl group of N-linked hydroxy acids may be O-acetylated (Kilcoyne et al., 2005), O-methylated (Preston et al., 2006) or glycosylated with a neighbouring monosaccharide (Knirel, 1990; Vinogradov et al., 2003d), in the latter case, monomers in the polysaccharide are linked by both glycosidic and amidic linkages. Amino groups of N-linked amino acids are usually N-acetylated or substituted with another acyl group, such as a formyl (Preston et al., 2006), (R)-3-hydroxybutanoyl (Perepelov et al., 2001) or 3-aminobutanoyl (Kay et al., 2006) group. Uronic acids may occur as amides with 2-aminopropane-1,3-diol, e.g. in Shigella boydii type 8 (Lindberg, 1990) or with various amino
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
62
4. O-Polysaccharides
acids, including glycine in E. coli O91 (Stenutz et al., 2006), l-alanine, l-serine, l-threonine and l-lysine all in Proteus spp. (Knirel et al., 1999) and d-allothreonine in H. alvei 1206 (Romanowska, 2000). Derivatives of l-lysine belonging to the class of opines, N-[(R)- and (S)-1-carboxyethyl]-l-lysine, have been identified in Proteus and Providencia spp. (Knirel et al., 1999; Kocharova et al., 2003). Phosphoric esters occur fairly often. Phosphate may interlink Ounits in the polysaccharide chain. Alternatively, it may attach as a substituent or incorporate an alcohol or amino alcohol into the main chain. Most common phosphate-linked non-sugar constituents are glycerol, ribitol and 2-aminoethanol, i.e. ethanolamine (Lindberg, 1990), but there are other examples, such as arabinitol in H. alvei 1191 (Romanowska, 2000), 2-[(R)-1-carboxyethy lamino]ethanol (Knirel et al., 1999) and choline (Fudala et al., 2003) in P. mirabilis O14 and O18, respectively, or the more complex compound, 2-amino-3,4,5-trihydroxy-2-methylpentanoic acid in Fusobacterium necrophorum (Knirel and Kochetkov, 1994). Unsubstituted phosphate is uncommon in O-PSs but a cyclic phosphate has been found in V. cholerae O139 (Jansson, 1999).
3. Repetitive O-PS structures 3.1. Homopolysaccharides Long known homopolysaccharides are linear mannans having tri- to penta-saccharide O-units that are characteristic for some enterobacteria. The O-PS of E. coli O9, Klebsiella pneumoniae O3 and H. alvei PCM 1223 is d-mannan 7 with alternating -(1→2)- and -(1→3)linkages in the pentasaccharide repeating unit (Katzenellenbogen et al., 2001; Stenutz et al., 2006) as shown in Figure 4.2. Mannan 8 with a truncated tetrasaccharide O-unit has been found in E. coli O9a and mannan 9 having a trisaccharide repeating unit with both - and -linked mannose residues is shared by E. coli O8 and K. pneumoniae O5 (Stenutz et al., 2006). The LPSs of the phytopathogenic bacterium Pseudomonas syringae possess various linear d- and l-rhamnans 10–13, including a pair of enantiomeric homopolysaccharides 11 and 12 (Ovod et al., 1999, 2004) (see Figure 4.2). The l-rhamnans 12 and 13 differ in the number of -(1→2)- and -(1→3)-linkages in the tetrasaccharide O-units that are present together in the same strain (Ovod et al., 2004). In addition,
Figure 4.2 Structures of d-mannan- 7–9, d-rhamnan- 10, 11 and l-rhamnan- 12–14 containing O-PSs of various bacteria.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. repetitive o-ps structures
d-rhamnan 10 represents the common polysaccharide antigen of P. aeruginosa which, as the O-antigen chain, is linked to the core-lipid A moiety (Rocchetta et al., 1998). Finally, the l-rhamnan 14 that is enantiomeric to d-rhamnan 10 has been reported as the O-PS of Rhizobium sp. NGR234 (Reuhs et al., 2005). In some bacterial species, all strains produce only one or several related homopolysaccharides and, accordingly, are characterized by a limited sero-variation. For instance, strains of Legionella pneumophila possess homopolymers of -(1→4)-interlinked 5-acetamidino-7acetamido-3,5,7,9-tetradeoxy-non-2-ulosonic acid residues, either 8-O-acetylated or not, which have the d-glycero-d-galacto configuration in serogroup 1 or the d-glycero-d-talo configuration in all other serogroups (Knirel et al., 2003). Also in Brucella, two homopolymers have been found, one an -(1→2)-interlinked poly(4,6-dideoxy-4-formamido-d-mannopyranose), whereas the other includes both -(1→2)and -(1→3)-linkages. They are characteristic for antigenically different A-dominant and M-dominant Brucella strains, respectively and may coexist in one strain (Meikle et al., 1989). The former polysaccharide is characteristic also for Y. enterocolitica Hy 128 (O9) (Wilkinson, 1996) that accounts for false-positive serological reactions in the serodiagnostics of these diseases. Homopolymers of 4-amino-4,6-dideoxy-dmannopyranose (d-Rhap4N) with other N-acyl groups are known too, e.g. (S)-2,4-dihydroxybutanoyl in V. cholerae O1 (Kenne and Lindberg, 1983) and acetyl in V. cholerae 1875 (Wilkinson, 1996). The O-PSs of V. cholerae O76 and O144 possess -(1→2)-linked homopolymers of the enantiomer sugar l-Rhap4N, which bears an N-linked (S)- or (R)-2-hydroxypropanoyl group, respectively (Jansson, 1999). More examples of homopolysaccharides with a monosaccharide O-unit are presented in the review by Wilkinson (1996).
63
3.2. Heteropolysaccharides In many cases, e.g. in S. dysenteriae and S. boydii (Liu et al., 2008), the O-PSs of serologically distinct strains have quite different structures but, in some bacterial species, they are related to a various extent. A classical example is Salmonella enterica serogroups A–D (Jann and Jann, 1984). Their O-PSs share the main chain, which is either unsubstituted (serogroup E) or decorated with paratose, abequose and tyvelose in serogroups A, B and D, respectively. Being exposed on the surface, the 3,6-dideoxyhexoses define the serospecificity of these Salmonella strains. The O-PSs of P. aeruginosa O1-O13 (Figure 4.3) also share some peculiar features (Knirel, 1990; Knirel et al., 2006). In all O-serogroups, the first monosaccharide of the O-unit is a 6-deoxy-dhexosamine, 2-acetamido-2,6-dideoxy-d-glucose (d-QuiNAc), 2-acetamido-2,6-dideoxy-d-galactose (d-FucNAc) or 2,4-diacetamido-2,4,6trideoxy-d-glucose (d-QuiNAc4Ac), which are synthesized in a combined pathway. The O-units are linear tri- or tetrasaccharides that are enriched in l-rhamnose, deoxyhexosamines, amino- and diamino-hexuronic and diaminononulosonic acids. Simple O-serogroups include strains having the same O-PS structure, whereas complex O-serogroups are divided into subgroups with different, but more closely related, O-PSs than between O-serogroups. For example, the O-PSs of all O6 subgroups have the same O-unit but differ in the mode of their connection to each other, i.e. by -(1→2)-, -(1→3)- or -(1→3)linkage. In serogroup O2, each of the two 2,3diamino-2,3-dideoxyhexuronic acids may have either the d-manno or l-gulo configuration. The repeating units in O4 serogroup differ in the first monosaccharide, which is either d-QuiNAc or d-FucNAc. The O7 polysaccharides have the same carbohydrate structure but different 5-Nacyl groups on pseudaminic acid, either acetyl or (R)-3-hydroxybutanoyl groups. Further
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
64
4. O-Polysaccharides
Figure 4.3 Structures of the O-polysaccharides of selected P. aeruginosa O-serogroups and subgroups. All monosaccharides are in the pyranose form. Amidation of hexuronic acids and O-acetylation are not shown. Abbreviations: GalNA, 2-amino-2-deoxygalacturonic acid; GlcN3NA, GulN3NA, ManN3NA, 2,3-diamino-2,3-dideoxygluc-, gul- and mann-uronic acids, respectively; Pse, 5,7-diamino-3,5,7,9-tetradeoxy-l-glycero-l-manno-non-2-ulosonic (pseudaminic) acid; 8eLeg, 5,7diamino-3,5,7,9-tetradeoxy-l-glycero-d-galacto-non-2-ulosonic (8-epilegionaminic) acid; Am, acetimidoyl; Fo, formyl; RHb, (R)-3-hydroxybutanoyl.
differences are added by O-acetylation and amidation (see next section). As with homopolysaccharides, some heteropolysaccharides are shared by different bacteria. Thus, more than half of the 34 Shigella O-PSs have been found in various E. coli clones which is explained by the recent origin of the former
bacterium from the latter (Liu et al., 2008). Close relatedness of the O-PSs between various other enterobacterial genera are known as well and could be due to the origin of these strains from a common ancestor. Nevertheless, sometimes similar or even identical O-chains are found in taxonomically
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. repetitive o-ps structures
distant bacteria, even in those belonging to different families (Knirel and Kochetkov, 1994; Wilkinson, 1996). For instance, the O-PSs of Francisella tularensis, V. anguillarum, S. dysenteriae type 7 and P. aeruginosa O6 possess a common trisaccharide fragment of linear tetrasaccharide units, either -d-GalNA-(1→4)--d-GalNA-(1→ 3)-d-QuiN, -d-QuiN-(1→4)--d-GalNA-(1→ 4)--d-GalNA or both (Knirel and Kochetkov, 1994). A likely reason for this phenomenon is a horizontal transfer of polysaccharide gene clusters or their parts. An O-PS may have the same structure as a capsular or extracellular polysaccharide produced by the same bacterium (Wilkinson, 1996) or, sometimes, by different bacteria. For example, as shown in Figure 4.4, an identical structure 15 has been established for the pyruvic acid (R)-acetal-containing O-PS of S. dysenteriae type 9 and the capsular polysaccharide of E. coli K47 (Zhao et al., 2007). In addition, in members of the Enterobacteriaceae, a specific O-PS may be replaced or coexist with the enterobacterial common antigen, a heteropolysaccharide having a trisaccharide repeating
65
unit, which is known in several forms, including a core-lipid A-linked form (Kuhn et al., 1988). O-PSs may be synthesized by a combined pathway with other glycoconjugates. For instance, in P. aeruginosa O7, a single pseudaminic acid-containing trisaccharide O-unit is either polymerized to give the O7a,b,c polysaccharides (see Figure 4.3) or O-linked to a serine residue of pilin, a glycoprotein of the somatic pili (Castric et al., 2001).
3.3. Block copolysaccharides O-PSs may consist of blocks of O-units having different structures. In K. pneumoniae O1, two homopolysaccharide domains called galactan I and II are connected to afford a copolymer 16 (Vinogradov et al., 2002) (Figure 4.5). Galactan II is necessary for serum resistance and O1 strains are most prevalent in clinical isolates. The O-PS of K. pneumoniae O2a,c 17 includes a galactan I domain associated with a heteropolysaccharide domain. The O-PS of S. marcescens O19 18 (see Figure 4.5) consists of two blocks built of similar disaccharide repeating units that differ in the
Figure 4.4 The identical structure of the (R)-acetal-pyruvic acid (Rpyr) containing O-PS of S. dysenteriae type 9 and the capsular polysaccharide of E. coli K47 15.
Figure 4.5 Structures of the block copolymer-type O-PSs of K. pneumoniae 16, 17 and S. marcescens 18.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
66
4. O-Polysaccharides
position of glycosylation of the rhamnose residue (Vinogradov et al., 2003c). It was suggested that domains of the same repeating units occur also in serotypes O1 and O17 and serological differences between strains of these O-serotypes may be due to variations in the lengths and position of the blocks.
4. Non-repetitive motifs 4.1. Irregular carbohydrate structures The O-PS of Xanthomonas campestris bv. vitians shows a rare example of the lack of regularity in the main chain, which is due to a random distribution of - and -linked l-rhamnopyranose residues (Molinaro et al., 2002). Two O-PSs have been isolated, one linear 19 and the other branched 20 (Figure 4.6), in which some -l-rhamnose residues are glycosylated with residues of 3-acetamido-3,6dideoxy--d-galactose (-d-Fuc3NAc). In both O-PSs, the majority of -l-rhamnose blocks include two sugar residues, but can include just a single residue and blocks of three residues occur as well. The irregular structure of the main chain may result from a relaxed specificity of rhamnosyltransferases involved. Similarly, caryophyllan, the major O-PS of B. caryophylli, consists of -(1→7)- and -(1→ 7)-linked caryopyllose 4 residues in a 8:1 ratio, respectively (De Castro et al., 1998), but no data of their sequence in the O-chain have been obtained to date.
4.2. Non-stoichiometric O-unit modifications A common reason for masking the repetitive O-PS structure is a non-stoichiometric modification of the O-unit by glycosylation, acetylation, methylation, amidation or phosphorylation that is added in the course of or after polymerization. Most often glycosylation is d-glucosylation but substitution by other monosaccharides, such as l-xylose, d-galactose, d- and l-fucose, d- and l-rhamnose, are known to occur as well. A repeating unit may possess more than one site of post-polymerization modification. For instance, both the main chain and the side chain of the O-PS are non-stoichiometrically d-glucosylated in H. alvei PCM 1189 (Katzenellenbogen et al., 2005). In addition, three sites of l-xylosylation have been reported in the main chain of the O-unit of X. campestrus pv. pruni (Molinaro et al., 2003). Multiple O-acetylation of repeating units occurs often. This is usually site-specific but may be random within one monosaccharide residue, e.g. within 6-deoxy-l-talose in Aeromonas hydrophila O34 (Knirel et al., 2002b) or caryophyllose in B. caryophylli (De Castro et al., 2001). O-methylation and phosphorylation are site-specific in all known cases. For example, only one of four -d-rhamnose residues is replaced with 3-O-methyl--d-rhamnose (dacofriose) in 30% of repeating units of P. syringae pv. phaseolicola (Zdorovenko et al., 2001). Multiple phosphorylation has been reported with up to three phosphate groups linking
Figure 4.6 Irregular structure motifs of the O-PS of Xanthomonas campestris bv. vitians 19, 20. Abbreviations: Fuc3NAc, 3-acetamido-3,6-dideoxygalactose.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. non-repetitive motifs
one ribitol and two ethanolamine residues in the tetrasaccharide O-unit of P. mirabilis O41 (Senchenkova et al., 2004). Amidation of the carboxyl group occurs usually when several amino- and diamino- hexuronic acids are present in the repeating unit (Knirel, 1990; Vinogradov, 2002) and is believed to help to adjust the optimal charge of the cell surface. Another reason of structural heterogeneity in O-PSs is a non-stoichiomteric epimerization at C-5 of hexuronic acids, which is well known to occur in bacterial alginate. An example is provided by P. aeruginosa O(2a),2d,2f that possess comparable amounts of trisaccharide O-units of two types which differ in the occurrence of either 2,3-diamino-2,3-dideoxy-d-mannuronic acid or 2,3-diamino-2,3-dideoxy-l-guluronic acid (Knirel, 1990). Finally, incorporation to the O-PS of amino sugars with different N-acyl substituents has been reported, e.g. in Acinetobacter baumannii strain 24 the amino group at C-4 of 2,4-diamino2,4,6-trideoxy-d-glucose is acetylated in about two-thirds of repeating units of the O-PS and bears an (S)-3-hydroxybutanoyl group in the rest (Vinogradov et al., 2003b). Non-stoichiometric modifications may not be distributed evenly within the polysaccharide chain. Mainly blockwise O-acetylation has been reported in caryan, a minor O-PS of B. caryophylli (Molinaro et al., 2000). The O-units of P. syringae pv. phaseolicola that contain 3-Omethyl-d-rhamnose are linked to each other nearby the non-reducing end of the O-PS (Zdorovenko et al., 2001). The occurrence of two populations of d-glucosylated and non-glucosylated O-PSs has been reported in Salmonella enterica sv. Thompson (Lindberg et al., 1988).
4.3. Non-repetitive terminal domains In homopolysaccharides, the non-reducing terminus is often occupied by an O-methylated monosaccharide, which is usually one of the
67
O-unit components. Examples are d-acofriose and l-acofriose in the corresponding rhamnans or 3-O-methyl-d-mannose in d-mannans (Wilkinson, 1996). In V. cholerae O1, a loss of the O-methyl group from the terminal 2-O-methylated 4-amino-4,6-dideoxy-d-mannopyranose residue results in seroconversion from Inaba to Ogawa (Stroeher et al., 1992). Terminal Omethylation may occur also in heteropolysaccharides, e.g. in the O-PS of Bordetella hinzii that consists of derivatives of 2,3-diamino-2,3dideoxy-d-glucuronic and -galacturonic acids (Vinogradov, 2002). In some other cases, the O-PSs are terminated with a monosaccharide that is different from the repeating unit components. Thus, various Nacyl derivatives of 2,3,4-triamino-2,3,4-trideoxyd-galacturonamide occupy the non-reducing end of the O-PS of Bordetella bronchiseptica and Bordetella parapertussis which is a homopolymer of 2,3-diacetamido-2,3-dideoxy-d-galacturonamide (Vinogradov et al., 2000; Preston et al., 2006). The O-PSs of S. marcescens O19 (Vinogradov et al., 2002) and K. pneumoniae O12 (Vinogradov et al., 2002) are terminated with a -linked Kdo residue and that of K. pneumoniae O4 (Vinogradov et al., 2002) has a terminal linked Kdo; all these O-PSs have disaccharide repeating units. The non-reducing end of the O-PS may be the subject of phase variation, e.g. in the variable O-PS of the gastric bacterium H. pylori, which is composed of occasionally glycosylated N-acetyl-lactosamine units (Moran, 2008). The terminal non-reducing O-unit often carries one or two -l-fucose residues giving rise to Lewis x and Lewis y antigen determinants. Although less often, sialyl-Lewis x is observed too. Moreover, the -(1→4)-linkage of the terminal non-reducing N-acetyllactosamine unit may be replaced with an isomeric disaccharide, in which d-galactose and d-N-acetylglucosamine are -(1→3)interlinked and whose -l-fucosylation affords Lewis a, Lewis b or H type I blood group antigens (Moran, 2008).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
68
4. O-Polysaccharides
Figure 4.7 Structure of the pentasaccharide domain between the O-PS and the core in the LPS of B. parapertussis and B. hinzii 21. Abbreviations: GlcNAc3NAcAN, ManNAc3NAcAN, 2,3-diacetamido-2,3-dideoxygluc-, mann-uronamides, respectively; FucNAc4N, 2-acetamido-4-amino-2,4,6-trideoxygalactose.
A different monosaccharide, a so-called primer, occurs at the reducing end of homopolysaccharides. The most common primer is -d-GlcpNAc, which is present, e.g. in all K. pneumoniae O-serotypes (Vinogradov et al., 2002) and the common polysaccharide antigen of P. aeruginosa (Rocchetta et al., 1998). Other sugars can be involved as a primer, e.g. 2-acetamido-2,6dideoxy--d-glucose in caryan of B. caryophylli (De Castro et al., 2005). In some bacteria, a more complex non-repetitive domain occurs between the O-PS and the core. In K. pneumoniae O5 and O3, the O-unit is not linked directly to the primer but, instead, the O-PS includes a bridging (→3)--d-Manp(1→3)--d-Manp-(1→3)- disaccharide called an adaptor, which is located between the primer and the first O-unit (Vinogradov et al., 2002). The O-PSs of B. parapertussis and B. hinzii are linked to the core through a specific pentasaccharide 21 (Preston et al., 2006; Vinogradov, 2007) (Figure 4.7). This domain is not present in natural LPS variants without a repetitive O-PS.
5. Conclusions O-PSs are extraordinarily diverse in composition and structure giving rise to a high degree of antigenic heterogeneity both between and within Gram-negative bacterial species. Numerous monosaccharides and non-sugar constituents have been identified as their components; some of them are widespread in nature, others are less common and some occur in O-PSs only. The structures of most unusual monosaccharides have been established unambiguously using modern analytical methods but the stereochemistry of
some requires confirmation, especially when they cannot be isolated in the free state as, e.g. as in the case of higher sugars. Many OPS structures established by older methods should be confirmed, which can result in significant revision, e.g. as has happened when S. dysenteriae and S. boydii O-antigen structures have been reinvestigated (Liu et al., 2008). Heteropolysaccharides are more widespread in bacteria than homopolysaccharides and their topology is more diverse. About half of the known heteropolysaccharides are branched, the whole O-repeating unit varying from di- to octa-saccharide, the number of side chains varying from 1 to 3 and the side chain length from a mono- to a tetra-saccharide. Homopolysaccharides are usually linear and either represent a polymerized monosaccharide or have an oligosaccharide (up to a pentasaccharide) repeating unit. Many, if not all, homopolysaccharides and linear heteropolysaccharides with disaccharide O-units are synthesized by an ATP-binding cassette (ABC) transporter-dependent pathway including a sequential transfer of single monosaccharides to the growing chain (see Chapter 18). Other heteropolysaccharides are products of polymerization of pre-assembled O-units by the O-antigen polymerase (Wzy)-dependent pathway (Raetz and Whitfield, 2002) (see Chapter 18). An intriguing question is how bacteria regulate the O-PS chain length, which is modal and appears to be fine-tuned giving bacteria advantages in particular econiches. Several O-PSs consisting of two repetitive homo- or hetero-polysaccharide domains have been discovered. One can expect that more structures of these exist but, in most cases, when more than one O-PS is found, their connection
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
to each other is neither proved nor disproved. Alternatively, one of the multiple isolated polysaccharides may not be related to the LPS as has happened with one of the “O-PSs” of Burkholderia pseudomallei (Isshiki et al., 2001). A common theme in the field is the occurrence of the same or closely related O-PSs in different bacteria. In some particular cases, this phenomenon may complicate reliable serodiagnosis of infectious disease. As a result of long coevolution with the host, some bacteria, e.g. H. pylori (Moran, 2008), have acquired an ability to express on the O-PS various domains that are similar to host carbohydrates. Such molecular mimicry helps the bacterium to escape adaptive immune response and may be a reason of autoimmune diseases (see Chapters 42 and 43). Although many O-PSs are regular polymers, non-repetitive motifs are rather common, which result either from post-polymerization modifications or, in the case of ABC transporterdependent synthesis pathway, from different initiation and termination steps of biosynthesis. For instance, an addition of an O-methylated sugar or a different monosaccharide to the non-reducing end appears to be a signal for the cessation of the O-PS chain, which allows termination of the O-chain at a specific sugar residue rather than at any residue. Another non-repetitive domain that is derived from the O-antigen biosynthesis pathway occurs between the O-PS and the core. It usually includes a primer (a 2-N-acetylamino sugar) whose transfer to a lipid carrier initiates the O-antigen synthesis. In O-PSs that are synthesized by the Wzy-dependent pathway, the first sugar of the O-unit plays the role of the primer. More complex reducing-end domains (so-called adaptors) have been found to be present in a few O-PSs but may be much more common. A biological role for this domain remains to be determined. These findings point to a higher complexity of LPSs than had been expected based on the impressive progress in
69
structure elucidation of their isolated components at the end of the 20th century.
References Adinolfi, M., Corsaro, M.M., De Castro, C., et al., 1996a. Caryose: a carbocyclic monosaccharide from Pseudomonas caryophylli. Carbohydr. Res. 284, 111–118. Adinolfi, M., Corsaro, M.M., De Castro, C., et al., 1996b. Analysis of the polysaccharide components of the lipopolysaccharide fraction of Pseudomonas caryophylli. Carbohydr. Res. 284, 119–133. Amano, K., Yatsuyanagi, J., Saito, S., 2007. Development of O-serogroup serodiagnosis for patients with hemolytic uremic syndrome by Ec-LPS array. Kansenshogaku Zasshi. 81, 26–32. Anderson, A.N., Richards, J.C., Perry, M.B., 1992. Structure of the O-antigen of Escherichia coli O119 lipopolysaccharide. Carbohydr. Res. 237, 249–262. Aspinall, G.O., McDonald, A.G., Pang, H., 1992. Structures of the O chains from lipopolysaccharides of Campylobacter jejuni serotypes O:23 and O:36. Carbohydr. Res. 231, 13–30. Aucken, H.M., Wilkinson, S.G., Pitt, T.L., 1998. Re-evaluation of the serotypes of Serratia marcescens and separation into two schemes based on lipopolysaccharide (O) and capsular polysaccharide (K) antigens. Microbiology 144, 639–653. Blixt, O., Hoffmann, J., Svenson, S., Norberg, T., 2008. Pathogen specific carbohydrate antigen microarrays: a chip for detection of Salmonella O-antigen specific antibodies. Glycoconj. J. 25, 27–36. Bravo, D., Silva, C., Carter, J.A., et al., 2008. Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella. J. Med. Microbiol. 57, 938–946. Bruneteau, M., Minka, S., 2003. Lipopolysaccharides of bacterial pathogens from the genus Yersinia: a minireview. Biochimie 85, 145–152. Castric, P., Cassels, F.J., Carlson, R.W., 2001. Structural characterization of the Pseudomonas aeruginosa 1244 pilin glycan. J. Biol. Chem. 276, 26479–26485. Conlan, J.W., Shen, H., Webb, A., Perry, M.B., 2002. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 20, 3465–3471. Corsaro, M.M., De Castro, C., Molinaro, A., Parrilli, M., 2001. Structure of lipopolysaccharides from phytopathogenic Gram-negative bacteria. Recent Res. Devel. Phytochem. 5, 119–138.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
70
4. O-Polysaccharides
Cryz Jr, S.J., Que, J.O., Cross, A.S., Fürer, E., 1995. Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine. Vaccine 13, 449–453. De Castro, C., Evidente, A., Lanzetta, R., et al., 1998. Presence of -glycosyl linkages in caryophyllan: the main polysaccharide from the Pseudomonas caryophylli LPS fraction. Carbohydr. Res. 307, 167–172. De Castro, C., Lanzetta, R., Molinaro, A., Parrilli, M., Piscopo, V., 2001. Acetyl substitution of the O-specific polysaccharide caryophyllan from the phenol phase of Pseudomonas (Burkholderia) caryophylli. Carbohydr. Res. 335, 205–211. De Castro, C., Molinaro, A., Lanzetta, R., Holst, O., Parrilli, M., 2005. The linkage between O-specific caryan and core region in the lipopolysaccharide of Burkholderia caryophylli is furnished by a primer monosaccharide. Carbohydr. Res. 340, 1802–1807. De Castro, C., Molinaro, A., Lanzetta, R., Silipo, A., Parrilli, M., 2008. Lipopolysaccharide structures from Agrobacterium and Rhizobiaceae species. Carbohydr. Res. 343, 1924–1933. Döring, G., Pier, G.B., 2008. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine 26, 1011–1024. Erridge, C., Bennett-Guerrero, E., Poxton, I.R., 2002. Structure and function of lipopolysaccharides. Microbes Infect. 4, 837–851. Ewing, W.H., 1986. Edwards and Ewing’s Identification of Enterobacteriaceae. Elsevier, New York. Favre Jr, D., Cryz, S.J., Viret, J.F., 1996. Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibro cholerae expressing the Shigella serotype D O polysaccharide. Infect. Immun. 64, 576–584. Fudala, R., Kondakova, A.N., Bednarska, K., et al., 2003. Structure and serological characterization of the O-antigen of Proteus mirabilis O18 with a phosphocholine-containing oligosaccharide phosphate repeating unit. Carbohydr. Res. 338, 1835–1842. Gamian, A., Kenne, L., 1993. Analysis of 7-substituted sialic acid in some enterobacterial lipopolysaccharides. J. Bacteriol. 175, 1508–1513. Hanniffy, O.M., Shashkov, A.S., Senchenkova, S.N., et al., 1998. Structure of a highly acidic O-specific polysaccharide from Pseudoalteromonas haloplanktis KMM 223 (44-1) containing l-iduronic acid. Carbohydr. Res 307, 291–298. Iredell, J.R., Stroeher, U.H., Ward, H.M., Manning, P.A., 1998. Lipopolysaccharide O-antigen expression and the effect of its absence on virulence in rfb mutants of Vibrio cholerae O1. FEMS Immunol. Med. Microbiol. 20, 45–54. Isshiki, Y., Matsuura, M., Dejsirilert, S., Ezaki, T., Kawahara, K., 2001. Separation of 6-deoxy-heptane from a smooth-
type lipopolysaccharide preparation of Burkholderia pseudomallei. FEMS Microbiol. Rev. 199, 21–25. Jann, K., Jann, B., 1984. Structure and biosynthesis of O-antigens. In: Rietschel, E.T. (Ed.), Handbook of Endotoxin, Vol. 1. Chemistry of Endotoxin. Elsevier, Amsterdam, pp. 138–186. Jansson, P.-E., 1999. The chemistry of O-polysaccharide chains in bacterial lipopolysaccharides. In: Brade, H., Opal, S.M., Vogel, S.N., Morrison, D.C. (Eds.). Endotoxin in Health and Disease. Marcel Dekker, New York, pp. 155–178. Jauho, E.S., Boas, U., Wiuff, C., et al., 2000. New technology for regiospecific covalent coupling of polysaccharide antigens in ELISA for serological detection. J. Immunol. Methods. 242, 133–143. Katzenellenbogen, E., Kocharova, N.A., Zatonsky, G.V., et al., 2001. Structural and serological studies on Hafnia alvei O-specific polysaccharide of -d-mannan type isolated from the lipopolysaccharide of strain PCM 1223. FEMS Immunol. Med. Microbiol. 30, 223–227. Katzenellenbogen, E., Kocharova, N.A., Zatonsky, G.V., et al., 2005. Structure of the O-polysaccharide of Hafnia alvei strain PCM 1189 that has hexa- to octa-saccharide repeating units owing to incomplete glucosylation. Carbohydr. Res. 340, 263–270. Kawasaki, M., Takamatsu, N., Ansai, T., Yamashita, Y., Takehara, T., Koga, T., 1995. An enzyme-linked immunosorbent assay for measuring antibodies to serotypespecific polysaccharide antigens of Actinobacillus actinomycetemcomitans. J. Microbiol. Methods 21, 181–192. Kay, W., Petersen, B.O., Duus, J., Perry, M.B., Vinogradov, E., 2006. Characterization of the lipopolysaccharide and -glucan of the fish pathogen Francisella victoria. FEBS J. 273, 3002–3013. Kenne, L., Lindberg, B., 1983. Bactertial polysaccharides. In: Aspinall, G.O. (Ed.), The Polysaccharides, Vol. 2. Academic Press, New York, pp. 287–363. Kenne, L., Lindberg, B., Petersson, K., Katzenellenbogen, E., Romanowska, E., 1980. Structural studies of the O-specific side-chains of the Shigella sonnei phase I lipopolysaccharide. Carbohydr. Res. 78, 119–126. Kilcoyne, M., Shashkov, A.S., Senchenkova, S.N., et al., 2002. Structural investigation of the O-specific polysaccharides of Morganella morganii consisting of two higher sugars. Carbohydr. Res. 337, 1697–1702. Kilcoyne, M., Perepelov, A.V., Tomshich, S.V., et al., 2004. Structure of the O-polysaccharide of Idiomarina zobellii KMM 231T containing two unusual amino sugars with the free amino group, 4-amino-4,6-dideoxy-d-glucose and 2-amino-2-deoxy-l-guluronic acid. Carbohydr. Res. 339, 477–482. Kilcoyne, M., Shashkov, A.S., Knirel, Y.A., et al., 2005. The structure of the O-polysaccharide of the Pseudoalteromonas rubra ATCC 29570T lipopolysaccharide containing a keto sugar. Carbohydr. Res. 340, 2369–2375.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
Kintz, E., Goldberg, J.B., 2008. Regulation of lipopolysaccharide O antigen expression in Pseudomonas aeruginosa. Future Microbiol. 3, 191–203. Knirel, Y.A., 1990. Polysaccharide antigens of Pseudomonas aeruginosa. CRC Crit. Rev. Microbiol. 17, 273–304. Knirel, Y.A., Kochetkov, N.K., 1994. The structure of lipopolysaccharides of Gram-negative bacteria. III. The structure of O-antigens. Biochemistry (Moscow) 59, 1325–1383. Knirel, Y.A., Kaca, W., Rozalski, A., Sidorczyk, Z., 1999. Structure of the O-antigenic polysaccharides of Proteus bacteria. Polish J. Chem. 73, 895–907. Knirel, Y.A., Kocharova, N.A., Bystrova, O.V., Katzenellenbogen, E., Gamian, A., 2002a. Structures and serology of the O-specific polysaccharides of bacteria of the genus Citrobacter. Arch. Immunol. Ther. Exp. 50, 379–391. Knirel, Y.A., Shashkov, A.S., Senchenkova, S.N., Merino, S., Tomas, J.M., 2002b. Structure of the O-polysaccharide of Aeromonas hydrophila O:34; a case of random O-acetylation of 6 deoxy-l-talose. Carbohydr. Res. 337, 1381–1386. Knirel, Y.A., Shashkov, A.S., Tsvetkov, Y.E., Jansson, P.-E., Zähringer, U., 2003. 5,7 Diamino-3,5,7,9-tetradeoxynon2-ulosonic acids in bacterial glycopolymers: chemistry and biochemistry. Adv. Carbohydr. Chem. Biochem. 58, 371–417. Knirel, Y.A., Bystrova, O.V., Kocharova, N.A., Zähringer, U., Pier, G.B., 2006. Conserved and variable structural features of the Pseudomonas aeruginosa lipopolysaccharide. J. Endotoxin Res. 12, 324–336. Kocharova, N.A., Knirel, Y.A., Widmalm, G., Jansson, P.-E., Moran, A.P., 2000. Structure of an atypical O-antigen polysaccharide of Helicobacter pylori containing a novel monosaccharide 3-C-methyl-d-mannose. Biochemistry 39, 4755–4760. Kocharova, N.A., Zatonsky, G.V., Bystrova, O.V., et al., 2002. Structure of the O-specific polysaccharide of Providencia alcalifaciens O16 containing N-acetylmuramic acid. Carbohydr. Res. 337, 1667–1671. Kocharova, N.A., Zatonsky, G.V., Torzewska, A., et al., 2003. Structure of the O-specific polysaccharide of Providencia rustigianii O14 containing N-[(S)-1-carboxyethyl]-N-(dgalacturonoyl)-l-lysine. Carbohydr. Res. 338, 1009–1016. Kocharova, N.A., Senchenkova, S.N., Kondakova, A.N., et al., 2004. d- and l-Aspartic acids: new non-sugar components of bacterial polysaccharides. Biochemistry (Moscow) 69, 103–107. Kocharova, N.A., Bushmarinov, I.S., Ovchinnikova, O.G., et al., 2005. The structure of the O-polysaccharide from the lipopolysaccharide of Providencia stuartii O44 containing l-quinovose, a 6-deoxy sugar rarely occurring in bacterial polysaccharides. Carbohydr. Res. 340, 1419–1423.
71
Kocharova, N.A., Ovchinnikova, O.G., Torzewska, A., Shashkov, A.S., Knirel, Y.A., Rozalski, A., 2007. The structure of the O-polysaccharide from the lipopolysaccharide of Providencia alcalifaciens O36 containing 3-deoxy-d-manno-oct-2-ulosonic acid. Carbohydr. Res. 342, 665–670. Kondakova, A.N., Zych, K., Senchenkova, S.N., Sidorczyk, Z., Shashkov, A.S., Knirel, Y.A., 2003. Structure of the N-acetyl-l-rhamnosamine-containing O-polysaccharide of Proteus vulgaris TG 155 from a new Proteus serogroup, O55. Carbohydr. Res. 338, 1999–2004. Kondakova, A.N., Lindner, B., Fudala, R., et al., 2004. New stuctures of the O-specific polysaccharides of Proteus. Part 4. Polysaccharides containing unusual acidic N-acyl derivatives of 4-amino-4,6-dideoxy-d-glucose. Biochemistry (Moscow) 69, 1034–1043. Kubler-Kielb, J., Vinogradov, E., Ben Menachem, G., Pozsgay, V., Robbins, J.B., Schneerson, R., 2008. Saccharide/protein conjugate vaccines for Bordetella species: Preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates. Vaccine 26, 3587–3593. Kuhn, H.-M., Meier-Dieter, U., Mayer, H., 1988. ECA, the enterobacterial common antigen. FEMS Microbiol. Lett. 54, 195–222. Lindberg, B., 1990. Components of bacterial polysaccharides. Adv. Carbohydr. Chem. Biochem. 48, 279–318. Lindberg, B., 1998. Bacterial polysaccharides: components. In: Dumitriu, S. (Ed.), Polysaccharides: Structural Diversity and Functional Versatility. Marcel Dekker, New York, pp. 237–273. Lindberg, B., Leontein, K., Lindquist, U., et al., 1988. Structural studies of the O-antigen polysaccharide of Salmonella thompson, serogroup C1 (6,7). Carbohydr. Res. 174, 313–322. Liu, B., Knirel, Y.A., Feng, L., et al., 2008. Structure and genetics of Shigella O antigens. FEMS Microbiol. Rev. 32, 627–653. Liu, P.V., Matsumoto, H., Kusama, H., Bergan, T., 1983. Survey of heat-stable major somatic antigens of Pseudomonas aeruginosa. Int. J. Syst. Bacteriol. 33, 256–264. Lugo, J.Z., Price, S., Miller, J.E., et al., 2007. Lipopolysaccharide O-antigen promotes persistent murine bacteremia. Shock 27, 186–191. MacLean, L.L., Vinogradov, E., Crump, E.M., Perry, M.B., Kay, W.W., 2001. The structure of the lipopolysaccharide O-antigen produced by Flavobacterium psychrophilum (259-93). Eur. J. Biochem. 268, 2710–2716. MacLean, L.L., Perry, M.B., Crump, E.M., Kay, W.W., 2003. Structural characterization of the lipopolysaccharide O-polysaccharide antigen produced by Flavobacterium columnare ATCC 43622. Eur. J. Biochem. 270, 3440–3446.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
72
4. O-Polysaccharides
Meikle, P.J., Perry, M.B., Cherwonogrodzky, J.W., Bundle, D.R., 1989. Fine structure of A and M antigens from Brucella biovars. Infect. Immun. 57, 2820–2828. Molinaro, A., De Castro, C., Petersen, B.O., Duus, J.O., Parrilli, M., Holst, O., 2000. Acetyl substitution of the O-specific caryan from the lipopolysaccharide of Pseudomonas (Burkholderia) caryophylli leads to a block pattern. Angew. Chem. Int. Ed. Engl. 39, 156–160. Molinaro, A., De Castro, C., Lanzetta, R., et al., 2002. NMR and MS evidences for a random assembled O-specific chain structure in the LPS of the bacterium Xanthomonas campestris pv. vitians. Eur. J. Biochem. 269, 4185–4193. Molinaro, A., Evidente, A., Lo Cantore, P., et al., 2003. Structural determination of a novel O-chain polysaccharide of the lipopolysaccharide from the bacterium Xanthomonas campestris pv. Pruni. Eur. J. Org. Chem. 2254–2259. Moran, A.P., 2008. Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr. Res. 343, 1952–1965. Morona, R., Daniels, C., Van den Bosch, L., 2003. Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence. Microbiology 149, 925–939. Newman, M.A., Dow, J.M., Molinaro, A., Parrilli, M., 2007. Priming, induction and modulation of plant defence responses by bacterial lipopolysaccharides. J. Endotoxin Res. 13, 69–84. Nielsen, R., 1986. Serological characterization of Actinobacillus pleuropneumoniae strains and proposal of a new serotype: serotype 12. Acta Vet. Scand. 27, 453–455. Ovod, V., Knirel, Y.A., Samson, R., Krohn, K., 1999. Immunochemical characterization and taxonomic evaluation of the O polysaccharides of the lipopolysaccharides of Pseudomonas syringae serogroup O1 strains. J. Bacteriol. 181, 6937–6947. Ovod, V., Zdorovenko, E.L., Shashkov, A.S., Kocharova, N.A., Knirel, Y.A., 2004. Structural diversity of O-polysaccharides and serological classification of Pseudomonas syringae pv. garcae and other strains of genomospecies 4. Mikrobiologiya 73, 666–677. Ovodov, Y.S., Gorshkova, R.P., 1988. Lipopolysaccharides of Yersinia pseudotuberculosis. Khim. Prirod. Soed., 163–171. Ovodov, Y.S., Gorshkova, R.P., Tomshich, S.V., et al., 1992. Chemical and immunochemical studies on lipopolysaccharides of some Yersinia species. A review of some recent investigations. J. Carbohydr. Chem. 11, 21–35. Perepelov, A.V., Babicka, D., Senchenkova, S.N., et al., 2001. Structure of the O-specific polysaccharide of Proteus vulgaris O4 containing a new component of bacterial polysaccharides, 4,6-dideoxy-4-{N-[(R)-3-hydroxybu-
tyryl]-l-alanyl}amino-d-glucose. Carbohydr. Res. 331, 195–202. Perepelov, A.V., Senchenkova, S.N., Shashkov, A.S., Rozalski, A., Knirel, Y.A., 2002. Structure of the O-specific polysaccharide of the bacterium Proteus vulgaris O15 containing a novel regioisomer of N-acetylmuramic acid. Carbohydr. Res. 337, 2463–2468. Perepelov, A.V., Liu, B., Senchenkova, S.N., et al., 2008. Structure of the O-polysaccharide of Escherichia coli O112ab containing l-iduronic acid. Carbohydr. Res. 343, 571–575. Preston, A., Petersen, B.O., Duus, J.Ø., et al., 2006. Complete structure of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharides. J. Biol. Chem. 281, 18135–18144. Raetz, C.R.H., Whitfield, C., 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635–700. Reuhs, B.L., Relic, B., Forsberg, L.S., et al., 2005. Structural characterization of a flavonoid-inducible Pseudomonas aeruginosa A-band-like O antigen of Rhizobium sp. strain NGR234, required for the formation of nitrogen-fixing nodules. J. Bacteriol. 187, 6479–6487. Rocchetta, H.L., Burrows, L.L., Pacan, J.C., Lam, J.S., 1998. Three rhamnosyltransferases responsible for assembly of the A-band d-rhamnan polysaccharide in Pseudomonas aeruginosa: a fourth transferase, WbpL, is required for the initiation of both A-band and B-band lipopolysaccharide synthesis. Mol. Microbiol. 28, 1103–1119. Romanowska, E., 2000. Immunochemical aspects of Hafnia alvei O antigens. FEMS Immunol. Med. Microbiol. 27, 219–225. Senchenkova, S.N., Perepelov, A.V., Cedzynski, M., et al., 2004. Structure of a highly phosphorylated O-polysaccharide of Proteus mirabilis O41. Carbohydr. Res. 339, 1347–1352. Senchenkova, S.N., Shashkov, A.S., Knirel, Y.A., Ahmed, M., Mavridis, A., Rudolph, K., 2005. Structure of the O-polysaccharide of Erwinia carotovora ssp. atroseptica GSPB 9205, containing a new higher branched monosaccharide. Russ. Chem. Bull. 1276–1281. Shashkov, A.S., Senchenkova, S.N., Vinogradov, E.V., et al., 2000. Full structure of the O-specific polysaccharide of Proteus mirabilis O24 containing 3,4-O-[(S)-1carboxyethylidene]-d-galactose. Carbohydr. Res. 329, 453–457. Shashkov, A.S., Torgov, V.I., Nazarenko, E.L., et al., 2002. Structure of the phenol-soluble polysaccharide from Shewanella putrefaciens strain A6. Carbohydr. Res. 337, 1119–1127. Shimada, T., Arakawa, E., Itoh, K., et al., 1994. Expanded serotyping scheme for Vibrio cholerae. Curr. Microbiol. 28, 175–178. Skurnik, M., Bengoechea, J.A., 2003. The biosynthesis and biological role of lipopolysaccharide O-antigens of pathogenic Yersiniae. Carbohydr. Res. 338, 2521–2529.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
Stenutz, R., Weintraub, A., Widmalm, G., 2006. The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol. Rev. 30, 382–403. Stroeher, U.H., Karageorgos, L.E., Morona, R., Manning, P.A., 1992. Serotype conversion in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 89, 2566–2570. Taylor, R.K., Kirn, T.J., Bose, N., et al., 2004. Progress towards development of a cholera subunit vaccine. Chem. Biodivers. 1, 1036–1057. Thirumalapura, N.R., Morton, R.J., Ramachandran, A., Malayer, J.R., 2005. Lipopolysaccharide microarrays for the detection of antibodies. J. Immunol. Methods 298, 73–81. Trautmann, M., Cross, A.S., Reich, G., Held, H., Podschun, R., Marre, R., 1996. Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens. J. Med. Microbiol. 44, 44–51. Vinion-Dubiel, A.D., Goldberg, J.B., 2003. Lipopolysaccharide of Burkholderia cepacia complex. J. Endotoxin Res. 9, 201–213. Vinogradov, E., 2002. Structure of the O-specific polysaccharide chain of the lipopolysaccharide of Bordetella hinzii. Carbohydr. Res. 337, 961–963. Vinogradov, E., 2007. The structure of the core-O-chain linkage region of the lipopolysaccharide from Bordetella hinzii. Carbohydr. Res. 342, 638–642. Vinogradov, E., Peppler, M.S., Perry, M.B., 2000. The structure of the nonreducing terminal groups in the O-specific polysaccharides from two strains of Bordetella bronchiseptica. Eur. J. Biochem. 267, 7230–7236. Vinogradov, E., Frirdich, E., MacLean, L.L., et al., 2002. Structures of lipopolysaccharides from Klebsiella
73
pneumoniae. Eluicidation of the structure of the linkage region between core and polysaccharide O chain and identification of the residues at the non-reducing termini of the O chains. J. Biol. Chem. 277, 25070–25081. Vinogradov, E., Korenevsky, A., Beveridge, T.J., 2003a. The structure of the O-specific polysaccharide chain of the Shewanella algae BrY lipopolysaccharide. Carbohydr. Res. 338, 385–388. Vinogradov, E.V., Brade, L., Brade, H., Holst, O., 2003b. Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter baumannii strain 24. Carbohydr. Res. 338, 2751–2756. Vinogradov, E., Petersen, B.O., Duus, J.Ø., RadziejewskaLebrecht, J., 2003c. The structure of the polysaccharide part of the LPS from Serratia marcescens serotype O19, including linkage region to the core and the residue at the non-reducing end. Carbohydr. Res. 338, 2757–2761. Vinogradov, E., MacLean, L.L., Crump, E.M., Perry, M.B., Kay, W.W., 2003d. Structure of the polysaccharide chain of the lipopolysaccharide from Flexibacter maritimus. Eur. J. Biochem. 270, 1810–1815. Wilkinson, S.G., 1996. Bacterial lipopolysaccharides. Themes and variations. Prog. Lipid Res. 35, 283–343. Zdorovenko, E.L., Ovod, V., Zatonsky, G.V., Shashkov, A.S., Kocharova, N.A., Knirel, Y.A., 2001. Location of the O-methyl groups in the O polysaccharide of Pseudomonas syringae pv. phaseolicola. Carbohydr. Res. 330, 505–510. Zhao, G., Perepelov, A.V., Senchenkova, S.N., et al., 2007. Structural relation of the antigenic polysaccharides of Escherichia coli O40, Shigella dysenteriae type 9, and E. coli K47. Carbohydr. Res. 342, 1275–1279. Zubkov, V.A., Gorshkova, R.P., Ovodov, Y.S., Sviridov, A.F., Shashkov, A.S., 1992. Synthesis of 3,6-dideoxy-4-C-(41hydroxyethyl)hexopyranoses (yersinioses) from 1,6anhydro--d-glycopyranose. Carbohydr. Res. 225, 189–207.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
5 Teichoic acids, lipoteichoic acids and related cell wall glycopolymers of Gram-positive bacteria Thomas Kohler, Guoqing Xia, Emir Kulauzovic and Andreas Peschel
Summary Most Gram-positive bacteria contain characteristic membrane- or peptidoglycan-attached carbohydratebased polymers in their cell wall whose structure, function and biosynthesis are only superficially understood. The composition of these cell wall glycopolymers (CWGs) is highly variable and often species and strain specific. Recent studies have yielded a growing picture of the biosynthetic pathways for the cell wall-anchored wall teichoic acid (WTA) and the membrane-anchored lipoteichoic acid (LTA) in Bacillus subtilis and Staphylococcus aureus. Besides zwitterionic LTA and WTA, further CWG types such as anionic teichuronic acids or uncharged lipoglycans occur in certain Gram-positive bacteria. The CWGs play important roles in bacterial physiology and various potential functions, such as control of autolytic enzymes, regulation of divalent cations, attachment of surface proteins or protection against antibacterial molecules, have been described. In those bacteria who colonize or infect animal hosts, CWGs have been implicated in adherence to host cells and activation of immune responses, e.g. via the toll-like receptors. In addition, CWGs are very
Microbial Glycobiology
important targets for antimicrobials, vaccines and diagnostics. Accordingly, CWGs represent a very important topic for research. Keywords: Teichoic acid; Cell wall glycopolymers; Lipoteichoic acid; Teichuronic acid; Lipoarabino mannan; Pathogen-associated molecular pattern; Glycobiology; Staphylococcus aureus; Bacillus subtilis; Innate immunity; Vaccines; Antibiotics; Diagnostics
1. Introduction Most Gram-positive bacterial cell walls are composed of two types of structural components, the peptidoglycan (PG) with highly conserved composition and additional cell wall glycopolymers (CWGs), which vary extensively between species and even between individual strains (Figure 5.1). While the functions of PG in maintaining the mechanical stability of the bacterial cells are well studied, the roles of CWGs are still far from clear. Most Gram-positive bacteria
75
© 2009 2010, Elsevier Inc.
76
5. Teichoic and lipoteichoic acids
have two types of CWG, one a PG-anchored polymer (P-CWG) and one a membrane-anchored polymer (M-CWG) (Fischer, 1988; Neuhaus and Baddiley, 2003; Weidenmaier and Peschel, 2008). Some bacteria even have three or four types of CWGs. The CWG polymers are composed of repeating units containing one or more sugar building blocks plus non-sugar residues such as phosphate, alanine, succinate, pyruvate, choline or mycolic acids to name a few. Those CWGs containing phosphate in the polymer backbone are traditionally referred to as teichoic acids (TAs) according to James Baddiley’s nomenclature from the 1950s (Armstrong et al., 1959). Most TAs have zwitterionic properties since, in addition to the negatively charged phosphate groups, the repeating units contain d-alanine residues with free, positively charged amino groups (Fischer, 1988; Neuhaus and Baddiley, 2003). Many Gram-positive bacteria produce CWGs without phosphate groups in repeating units. Such polymers are either uncharged, e.g. in many actinobacteria and certain bacilli, or are anionic because of the presence of uronic acid, pyruvyl or succinyl groups (Powell et al., 1975; Ward, 1981; Greenberg et al., 1996; Delmas et al., 1997; Soldo et al., 1999; Schäffer and Messner, 2005). This review will mainly focus on TAs, their structures, biosynthetic pathways and functions while other types of CWGs will be mentioned only briefly.
2. teichoic acid structures 2.1. Wall teichoic acids and other P-CWGs Most P-CWGs are attached to PG via linkage units with more or less conserved structures (Figure 5.2). These units often start with Nacetylglucosamine (GlcNAc) residues, which are linked to the N-acetylmuramic acid of PG
via a phosphodiester bond and are connected to further sugars of the linkage unit or directly connected to the CWG polymer (Araki and Ito, 1989; Naumova and Shashkov, 1997). The TAs of the P-CWG type are referred to as wall teichoic acids (WTAs), which can account for up to 50% of the entire cell wall mass. The linkage unit of Staphylococcus aureus WTA, which is particularly well studied, is composed of one GlcNAc residue, one N-acetylmannosamine and two glycerolphosphate (Gro-P) residues. The WTA repeating units contain sugars of various sizes ranging from trioses to hexoses, which are frequently reduced to corresponding polyols such as glycerol or ribitol. The WTA structures are particularly diverse and differ profoundly between species or even strains (Endl et al., 1983; Potekhina et al., 1993; Fischer et al., 1993; Naumova and Shashkov, 1997). The WTA polymer of most S. aureus strains is formed by up to 40 repeating units of ribitolphosphate (Endl et al., 1983). Simpler WTA structures occur, e.g. in Staphylococcus epidermidis, where Gro-P units are not only found in the linkage unit but form the entire polymer. More complex structures occur, e.g. in Staphylococcus hyicus, whose repeating units are composed of glycerolphosphateglycosylphosphate (Endl et al., 1983). The most complicated WTA-like molecule among the known molecules is probably found in Streptococcus agalactiae. This polymer is extensively branched and is composed of different types of repeating units forming individual branches of the molecule (Sutcliffe et al., 2008). Of note, this polymer represents the speciesspecific antigen used for serological differentiation of streptococci according to Rebecca Lancefield (Lancefield and Freimer, 1966). In most but not all WTA molecules, the repeating units are further substituted with a diverse set of additional sugars and with d-alanine (Neuhaus and Baddiley, 2003), other amino acids such as glutamate or lysine (in certain actinobacteria) (Potekhina et al., 1993; Shashkov et al., 2006) or
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
Wall teichoic acid
Capsular polysaccharide
L-Ala D-Glu L-Lys D-Ala
Lipoteichoic acid
N-Acetylglucosamine N-Acetylmuramic acid Pentaglycine cross-link
2. teichoic acid structures
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
Surface protein
Phospholipid Cytoplasmic Glucose membrane N-Acetylmanosamine Glycerolphosphate
Membrane protein
Ribitolphosphate
Figure 5.1 Molecular structure of the cell wall of S. aureus, composed of peptidoglycan, teichoic acid, proteins and capsular polysaccharide.
77
78
5. Teichoic and lipoteichoic acids
Peptidoglycan anchored cell-wall glycopolymers (CWGs) MurNAc
+ − MurNAc
+
Ala
GlcNAc
P
Ala
− GlcNAc ManNAc
− Gro
P
P
GlcNAc
Wall teichoic acid from Staphylococcus aureus
Gro
N
Glc
3
MurNAc
+
+ Ala
GlcNAc
− MurNAc
P
Ala
− GlcNAc ManNAc
P
− Gro
GlcNAc
GlcNAc
Wall teichoic acid from Bacillus subtilis
Rto
P
3
Membrane anchored CWGs (M-CWGs)
N
+ Ala
Gro
− Glc
Glc
P
Lipoteichoic acid from Staphylococcus aureus
Gro
N + C
Gro
Glc
AATGal
AI a
− Glc
P
Rto
Gal
P
−
+ C P
− +
GalNAc AATGal
Lipoteichoic acid from Streptococcus pneumoniae
Glc
GlcNAc
N
Figure 5.2 Selected WTA and LTA structures. Trioses, pentoses and hexoses are shown as triangles, pentagons and hexagons, respectively. Fatty acids are shown as zigzag lines. Non-glycosyl residues: Ala, d-alanine; C, choline; P, phosphate. Glycosyl-residues: AATGal, 2-acetamido-4-amino-2,4,6-trideoxy-d-galactose; Gal, galactose; GalNAc, N-acetylgalactosamine; Glc, glucose; GlcNAc, N-acetylglucosamine; Gro, glycerol; ManNAc, N-acetylmannosamine; Rto, ribitol.
phosphocholine (S. pneumoniae) (Fischer, 2000). The incorporation of d-alanine leads to a reduction or compensation of the negative charge derived from the phosphate groups (Neuhaus and Baddiley, 2003).
Anionic P-CWG lacking phosphate represent a less well-studied group of so-called “secondary cell wall polymers”. They include the teichuronic acids (TUA), which are distinguished by the presence of uronic acid residues
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. Biosynthesis of WTAs and LTA
in repeating units (e.g. in many bacilli and micrococci) (Ward, 1981; Soldo et al., 1999) and pyruvylated polymers (e.g. in Bacillus anthracis and Bacillus cereus) (Schäffer and Messner, 2005; Choudhury et al., 2006; Leoff et al., 2007). Bacillus subtilis expresses TUA when grown under phosphate limitation instead of WTA. The B. subtilis TUA has a similar linkage unit as WTAs and its linkage units consist of GlcNAc and glucuronic acid (Soldo et al., 1999). The pyruvylated B. anthracis P-CWG has only recently been characterized and found to consist of repeating units formed by several hexoses (Choudhury et al., 2006). Uncharged, often branched P-CWGs are produced by many actinobacteria, particularly in those with an outer membrane-like mycolic acid layer. Mycobacterium tuberculosis, for instance, has a branched arabinogalactan polymer, which is covalently bound to mycolic acid thereby connecting PG and the mycolic acid membrane (Brennan, 2003; Takayama et al., 2005).
2.2. Lipoteichoic acid (LTA) and other M-CWGs The M-CWGs, such as LTA, are attached to cytoplasmic membranes by linking the polymer to glycolipids. In S. aureus, the lipid anchor consists of a diglycosylated diacylglycerol (Fischer, 1988). The backbone is formed by Gro-P repeating units in S. aureus and many other Gram-positive bacteria. In contrast to WTAs, LTA is usually less diverse, which is probably due to the particular biosynthetic pathway (see below) (Fischer, 1994) (see Figure 5.2). However, a very complicated LTA structure is found, e.g. in Streptococcus pneumoniae, the repeating units of which are identical to those of pneumococcal WTAs and contain phosphocholine (Fischer et al., 1993). As in WTAs, most LTA polymers are substituted with d-alanine at the 2-hydroxy group of the glycerol and with additional sugars.
79
Of note, M-CWGs without phosphate in the repeating units are produced by many actinobacteria. Such polymers are often anionic because of substitution with succinyl groups (Powell et al., 1975; Greenberg et al., 1996; Delmas et al., 1997). Uncharged, branched lipoarabinomannans (LAM) are found in many mycolic acid-producing bacteria (Briken et al., 2004; Sutcliffe, 2005).
3. Biosynthesis of WTAs and LTA Despite their structural similarity, WTAs and LTA usually use profoundly different precursor molecules and biosynthetic pathways. Because of the enormous structural diversity of P-CWGs, which implies that most bacterial species need different sets of genes, it has been difficult to identify biosynthetic genes and pathways by comparative genomics. The rather simple Gro-P WTA of B. subtilis 168 requires only ca. 13 genes (Qian et al., 2006) while synthesis of the extremely complex WTA-like polymer of S. agalactiae is proposed to depend on more than 120 genes (Sutcliffe et al., 2008). Anyway, certain principles are widely conserved among P-CWGproducing bacteria, such as the enzymes mediating the first steps of linkage unit biosynthesis, the use of a C55 lipid carrier during the assembly process and the allocation of biosynthetic genes in clusters. Most knowledge on genetics and biosynthesis has been gathered in B. subtilis and S. aureus as outlined in the chapters below (Bhavsar and Brown, 2006; Xia and Peschel, 2008).
3.1. WTA biosynthesis in B. subtilis and S. aureus Pioneering in vitro reconstitution studies of certain WTA-biosynthetic steps demonstrated the involvement of nucleotide-activated precursor molecules such as cytidine diphosphate-(CDP-)
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
80
5. Teichoic and lipoteichoic acids
glycerol, CDP-ribitol and uridine diphosphate(UDP)-GlcNAc in WTA biosynthesis (Nathenson et al., 1966; Brooks et al., 1971; Bracha et al., 1978; Baddiley, 1989). They also demonstrated that biosynthesis occurs initially at the inside of the cytoplasmic membrane on the universal undecaprenyl pyrophosphate lipid carrier (C55), which is also used for peptidoglycan or capsular polysaccharide biosynthesis (Anderson et al., 1972). The first gene cluster involved in biosynthesis of WTA, tagABDEFGH, has been identified in B. subtilis 168 by analysis of temperature-sensitive mutants by the laboratory of Dimitri Karamata (Pooley and Karamata, 1994). Further genes such as tagO and the more complex WTA gene clusters of B. subtils W23 and S. aureus, both of which produce ribitolphosphate (Rbo-P) WTA, were identified by large-scale sequencing projects and comparative genomics in the last couple of years (Qian et al., 2006). Biochemical studies with crude enzymatic preparations derived from temperature-sensitive mutant strains, or with recombinant enzymes produced in Escherichia coli, led to functional predictions for most of the WTA-biosynthetic gene products as outlined below. The CWG-biosynthetic steps are shown in Figure 5.3. They can be divided into four groups: (i) The first group of WTA-biosynthetic enzymes encompasses those that mediate synthesis of linkage units that usually have conserved structures and connect the polymers with peptidoglycan or membrane (Araki and Ito, 1989). Accordingly, involved genes such as tagO and tagA are well conserved among Gram-positive bacteria and allow an easy identification of CWG gene clusters (Weidenmaier et al., 2004; Ginsberg et al., 2006). The protein TagO transfers GlcNAc phosphate to C55 phosphate (Soldo et al., 2002a) and TagA adds a ManNAc unit using UDP-GlcNAc and UDP-ManNAc precursors, respectively (Ginsberg et al., 2006).
(ii) The second group of enzymes includes enzymes involved in generation of special nucleotide-activated precursor molecules such as UDP-ManNAc (MnaA) (Soldo et al., 2002b), CDP-glycerol (TagD) (Park et al., 1993) or CDP-ribitol (TarI, TarJ) (Pereira and Brown, 2004). Many of these genes share conserved domains because of interaction with the nucleotides. (iii) The products of the third group of genes incorporate the preformed repeating units into CWG and encompass both priming and polymerizing enzymes. The Gro-P WTA polymer of B. subtilis 168 depends on the primase TagB, which adds the first repeating unit to the C55-bound linkage unit and the polymerase TagF adding the further Gro-P units (Ginsberg et al., 2006). The situation is more complicated in S. aureus Rbo-P WTA biosynthesis. Here, the TagB reaction is followed by addition of only a second Gro-P unit by the TarF enzyme (Brown et al., 2008). The RboP polymer is subsequently synthesized by the TarL polymerase (Brown et al., 2008; Pereira et al., 2008). While no Rbo-P primase seems to be involved in S. aureus, such an enzyme has been implicated in Rbo-P WTA biosynthesis in B. subtilis W23 (TarK) (Bhavsar and Brown, 2006). Three genes involved in Rbo-P generation and incorporation seem to be duplicated in S. aureus (Qian et al., 2006), which has been a major obstacle in studying enzyme functions. It appears now that the two TarL enzymes mediate the same types of reaction albeit leading to WTA of different chain length and electrophoretic migration. One of the tarL genes (also been named tarK) is regulated by the agr quorum sensing system indicating that S. aureus can control WTA structure according to bacterial density and environmental changes (Brown et al., 2008).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. Biosynthesis of WTAs and LTA
81
Figure 5.3 Pathways of S. aureus wall teichoic acid (WTA) biosynthesis (A), lipoteichoic acid (LTA) biosynthesis (B) and d-alanine incorporation into LTA and WTA (C). CDP-Gro, cytidyldiphosphate-glycerol; CDP-Rbo, cytidyldiphosphate-ribitol; Glc, glucose; GlcNAc, N-acetylglucosamine; Gro, glycerol; Gro-P, glycerolphosphate; ManNAc, N-acetylmannosamine; MurNAc, N-acetylmuramic acid; Rbo-P, ribitol-phosphate; Rib-P, ribulose-5-phosphate; UDP-Glc, undecaprenylphoshateglucose; UDP-GlcNAc, uridine-5-diphosphate-glucose; UDP-GlcNAc, uridine-5-n-acetylglucosamine; UDP-ManNAc, uridine-5-N-acetylmannosamine. (See colour plates section.)
(iv) Proteins mediating the transfer of the WTA polymers to the outer membrane leaflet (TagG, TagH, forming an ABC transporter) (Lazarevic and Karamata, 1995) and from C55 to the acceptor molecules (responsible proteins still unknown) are allocated into group iv.
Further proteins involved in decoration of WTA/LTA repeating units with sugars, d-alanine, cholin, pyruvate or other residues constitute a further group (v). Different biosynthetic pathways only sharing the tagO and (in many cases) tagA genes with the above described ones have been proposed for WTA with more complex,
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
82
5. Teichoic and lipoteichoic acids
hexose-containing repeating units such as the minor WTA of B. subtilis (Freymond et al., 2006) or the branched WTA-like polymer of S. agalactiae (Sutcliffe et al., 2008).
3.2. LTA biosynthesis in S. aureus The Gro-P repeating units of LTA are not derived from a nucleotide-activated precursor but from the phospholipid phosphatidylglycerol, a major constituent of bacterial membranes (Glaser and Lindsay, 1974). A second difference between LTA and WTA biosynthesis is the fact that LTA is not polymerized on C55 but directly on the glycolipid that serves as the LTA membrane anchor (Koch et al., 1984; Fischer, 1988). As the glycolipids differ between species, different genes have been implicated in glycolipid biosynthesis of S. aureus and S. agalactiae (Kiriukhin et al., 2001; Doran et al., 2005). S. aureus LTA is linked to diglucosyldiacylglycerol. The YpfP enzyme generates this lipid by adding two glucose residues from UDP-glucose to diacylglycerol (Jorasch et al., 1998, 2000; Kiriukhin et al., 2001). Efficient LTA biosynthesis depends on the ltaA gene which encodes a membrane protein that is thought to be a flippase that translocates the glycolipid from the inner leaflet of the membrane to the outer leaflet (Grundling and Schneewind, 2007b). The LTA polymerase LtaS, recently discovered by Angelika Grundling and Olaf Schneewind, utilizes Gro-P units from phosphatidylglycerol to synthesize the LTA polymer at the outer surface of the cytoplasmic membrane (Grundling and Schneewind, 2007a). One or several ltaS-related genes are found in most bacteria known to produce LTA indicating that LTA biosynthesis is a rather conserved process. Amazingly, deletion of ypfP does not lead to a halt of LTA biosynthesis but to synthesis of LTA whose polymer is attached to diacylglygcerol (Kiriukhin et al., 2001; Fedtke et al., 2007). Another unexpected finding is the fact that, depending on the S. aureus strain background, ypfP mutants produce
strongly reduced or unaltered amounts of the altered LTA, compared to wild-type strains for unknown reasons (Fedtke et al., 2007). In conclusion, LTA biosynthesis requires far less genes and is less complex compared to WTA biosynthesis. The limited diversity of LTA molecules reflects the use of the universal lipid phosphatidylglycerol as repeating unit donor. In any case, bacteria such as S. pneumoniae produce highly complex LTA polymers (Fischer et al., 1993; Draing et al., 2006), which are most probably synthesized in a C55-dependent fashion.
3.3. Incorporation of d-alanine into WTAs and LTA While most other constituents of WTAs and LTA are variable, the modification with d-alanine is a very constant trait of most TA polymers. Only those TA molecules without polyol constituents in repeating units, such as the minor WTA of B. subtilis, seem to lack these substituents (Freymond et al., 2006). In accord with the high prevalence of d-alanylation, the dltABCD genes responsible for d-alanine activation and incorporation into WTA and LTA are highly conserved and seem always to form an operon (Neuhaus et al., 1996; Neuhaus and Baddiley, 2003). d-Alanine has a profound impact on TA net charge with crucial consequences for resistance to antimicrobial peptides, adhesion to host cell receptors and biofilm formation (Weidenmaier and Peschel, 2008). Interestingly, the dlt operons of S. aureus and S. epidermidis are controlled in response to antimicrobial peptide challenge via the ApsXRS (also named GraXRS) regulatory system and in response to cell wall stress (Li et al., 2007; Herbert et al., 2007; Kraus et al., 2008). d-Alanine is incorporated after biosynthesis of the TA polymers is completed and, since the d-alanine esters are rather labile and get easily lost, d-alanine can be repeatedly incorporated into a given molecule (Koch et al., 1985). The transfer of d-alanine into teichoic acids requires four proteins (DltA, -B, -C, -D) forming
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Roles of WTAs and LTA in bacterial physiology
a pathway that involves activation of d-alanine in the cytoplasm, linkage to a d-alanine carrier protein (DltC), translocation and incorporation of d-alanine into teichoic acids (Neuhaus and Baddiley, 2003). The first step requires hydrolysis of ATP. It is catalysed by the DltA protein, which is homologous to the activating domains of peptide synthetases (Heaton and Neuhaus, 1992; Neuhaus et al., 1996). In fact, d-alanine activation and transfer to a carrier protein resembles the biosynthesis of non-ribosomally synthesized peptides or fatty acids. All these pathways involve intermediates linked to the phosphopantetheine prosthetic groups of dedicated carrier proteins by energy-rich thioester bonds. The last steps of d-alanine transfer into teichoic acids are less well understood. They seem to require DltC, DltB, an integral membrane protein, and DltD, a membrane-tethered hydrophilic protein (Debabov et al., 2000). The Dlt proteins represent interesting targets for inhibitory compounds that block d-alanylation. Accordingly, specific inhibitors of DltA have recently been described to render bacteria more susceptible to cationic antimicrobial molecules (May et al., 2005) and to be very efficient in clearing bacterial infections in vivo (Escaich et al., 2007).
4. Roles of WTAs and LTA in bacterial physiology The universal presence of CWGs in Grampositive bacteria and the fact that the bacterial cells commit considerable amounts of energy and genetic information into their biosynthesis indicates very important roles of WTAs and LTAlike polymers for bacterial integrity and fitness. Only recently, defined mutants lacking CWGs (Weidenmaier et al., 2004; D’Elia et al., 2006) or with altered CWG structures (Peschel et al., 1999; Doran et al., 2005; Kristian et al., 2005) have become available that allow a thorough characterization of CWG functions. Recently, WTA
83
has been shown to be dispensable for viability of S. aureus and B. subtilis (Weidenmaier et al., 2004; D’Elia et al., 2006). These mutants seemed to have only minor phenotypic defects when grown in the laboratory. In contrast, LTA is indispensable in S. aureus (Grundling and Schneewind, 2007a) but the LTA content in the cell envelope can be strongly reduced without affecting the in vitro growth behaviour (Fedtke et al., 2007). Accordingly, many of the functions assigned to CWGs seem to be non-essential and may be critical only in certain instances, such as exposure to environmental stresses or to host defence factors (Weidenmaier and Peschel, 2008). In fact, many reports point toward a function of WTAs and LTA in protecting the cell envelope from penetration of harmful molecules such as host defence molecules, bacteriocins and antibiotics. This protective function may be direct by clogging pores and cavities between peptidoglycan layers or indirect by attachment of outer protection layers such as S-layer proteins (e.g. B. anthracis) (Mesnage et al., 2000) or mycolic acids (e.g. M. tuberculosis) (Brennan, 2003). Accordingly, S. aureus WTA contributes to lysozyme resistance (Bera et al., 2007) and mutants lacking d-alanine in WTA and LTA are more susceptible to cationic antimicrobial peptides (Peschel et al., 1999, 2000; Peschel and Sahl, 2006). In certain cases, however, WTA increases the susceptibility for harmful molecules such as phages that use WTA as a receptor (Park et al., 1974; Lopez et al., 1982; Wendlinger et al., 1996) or human antimicrobial defensin hBD3 and secretory group IIA phospholipase A2 (Koprivnjak et al., 2008). Certain bacterial proteins are non-covalently anchored to the cell wall by CWGs. S. pneumoniae anchors many of its virulence factors to the phosphocholine residues of its CWGs (Bergmann and Hammerschmidt, 2006). B. anthracis and relatives use pyruvylated CWGs to attach S-layer proteins to the bacterial surface (Mesnage et al., 2000). The autolysins of S. aureus and other bacteria have high affinities for WTA and LTA (Giudicelli and Tomasz, 1984; Bierbaum and Sahl, 1987) but S. aureus mutants with reduced LTA had no
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
84
5. Teichoic and lipoteichoic acids
reduced amounts of autolysins (Fedtke et al., 2007) suggesting that autolysins bind to the cell wall independently of CWGs. However, WTA and LTA play a profound role in controlling autolysin activity by interactions that are only partially understood and may involve CWG-bound bivalent cations. Depleting S. aureus from LTA leads to bacterial cells with distorted shapes and division sites (Grundling and Schneewind, 2007a) suggesting that LTA interacts with components of the membrane-bound cell division machinery and contributes to its proper placement or regulation. The zwitterionic and anionic CWG types have ion-exchanger-like properties that have been proposed to have important roles in shaping the ionic milieu in the cell wall. The TAs have particularly high affinities for magnesium ions and are regarded as magnesium ion storage molecules (Heptinstall et al., 1970). The hydrophilic nature of surface-exposed CWGs has a strong impact on the physicochemical properties of bacterial cell surfaces. Accordingly, S. aureus and Enterococcus faecalis mutants with altered CWGs are strongly affected in biofilm formation on biomaterials and virulence attenuated in animal models of foreign body infections (Fabretti et al., 2006; Fedtke et al., 2007; Gross et al., 2001; Kristian et al., 2003). The CWGs can play a second role in biofilm formation when they are released to form part of the biofilm matrix that protects and glues bacterial cells together (Sadovskaya et al., 2004; Vinogradov et al., 2006). How CWGs are shed from their cell wall or membrane anchors has remained unknown.
5. teichoic acids and host cell receptor interaction The CWGs seem to play crucial roles in microbe/host interaction in bacteria colonizing or infecting animal hosts (Figure 5.4). Such roles have been studied thoroughly in S. aureus whose WTAs and LTA appear to shape the entire
infection process from initial colonization to activation of innate immunity and to recognition by the adaptive immune system (Weidenmaier and Peschel, 2008). S. aureus mutants lacking WTA are abrogated in binding to epithelial and endothelial cells and lose the ability to colonize the nose in animal models (Weidenmaier et al., 2004, 2008) or to leave the bloodstream and infect subendothelial tissues in endovascular infections (Weidenmaier et al., 2005a). Altering TA structure by disrupting the d-alanylation pathway in S. aureus (Weidenmaier et al., 2004, 2005b), Streptococcus pyogenes (Kristian et al., 2005), or Listeria monocytogenes (Abachin et al., 2002) or altering LTA membrane anchoring in S. agalactiae (Doran et al., 2005) has similar impacts on bacterial host cell binding. Several lines of evidence point toward a direct binding of WTA to yet-to-be identified receptors on epithelial and endothelial cells. Of note, these interactions seem to contribute to S. aureus host cell attachment to a similar extent as the staphylococcal adhesion proteins (Weidenmaier et al., 2008), which bind, for example, keratin, fibronectin or fibrinogen (Foster and Hook, 1998; Navarre and Schneewind, 1999; Mongodin et al., 2002). The WTA-binding host receptors are still unknown but the fact that WTA-mediated binding can be inhibited by polyinosinic acid, an established inhibitor of scavenger receptors (SR) indicates that SR-like receptors play a major role in this type of interaction (Weidenmaier et al., 2008). Several members of the SR family have been identified on mammalian cells and some of them have been shown to bind purified CWGs and intact S. aureus cells. The SCARA5 and LOX1 are expressed by airway epithelial and endothelial cells, respectively, and represent candidate receptors for WTA-mediated binding (Shimaoka et al., 2001; Jiang et al., 2006). While SRs appear to mediate bacterial attachment, other host receptors have been shown to stimulate inflammatory processes upon CWG binding. In fact, LTA, mycobacterial LAM and other M-CWGs have been identified as
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
5. teichoic acids and host cell receptor interaction
Adherence, ingestion
Opsonization
Scavenger receptors
Innate host defences, inflamation
Complement activation
MBL, Ficolin
TLR 2
MHC Class II
85
T-cell activation
Antibodies
Teichoic acids
Cytoplasmic membrane
Phospholipid Membrane protein
Figure 5.4 Interaction of LTA and WTA with host molecules. Scavenger receptors, mannose-binding lectin and ficolins interact with different CWGs, this leads to binding and internalization by host cells or complement activation. Some MCWGs seem to elicit proinflammatory responses through TLR-2. MBL, Mannose-binding lectin; TLR2, Toll-like receptor 2; MHC, Major histocompatibility complex.
athogen-associated molecular pattern (PAMP) p molecules that activate the innate immune system via the Toll-like receptor-2 (TLR-2) (Hermann et al., 2002; Sugawara et al., 2003; Tapping and Tobias, 2003; Hoebe et al., 2005). The co-receptors TLR-6, CD14, LBP and CD36 seem to contribute to LTA-mediated TLR-2 activation (Chavakis et al., 2002; Han et al., 2003; Hoebe et al., 2005; Henneke et al., 2005). The proinflammatory potency of M-CWGs is still a matter of debate since many of the commonly used preprations have been shown to be contaminated with lipopeptides, which account for a large percentage of the activity (Hashimoto
et al., 2006, 2007). Nevertheless, synthetic LTA analogues have been shown to stimulate TLR-2 (Deininger et al., 2003). Soluble C-type lectins such as the mannose-binding lectin (MBL), l-ficolin and the lung surfactant proteins A and D also bind LTA or LAM (Polotsky et al., 1996, 1997; Ferguson et al., 1999; Sidobre et al., 2000; van de Wetering et al., 2001; Lynch et al., 2004). MBL and l-ficolin activate the lectin-initiated complement pathway upon binding to CWGs on the bacterial surface leading to bacterial opsonization and release of chemotactic complement split products (Endo et al., 2007; Takahashi et al., 2007).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
86
5. Teichoic and lipoteichoic acids
The CWGs, such as S. aureus LTA, have been known to be a major target for antibodies for many decades (Verbrugh et al., 1981; Verhoef et al., 1983; Kumar et al., 2005). Accordingly, CWGs have been proposed as vaccination targets and promising results have been obtained with active vaccination directed against enterococcal LTA (Theilacker et al., 2006) or passive vaccination with a humanized monoclonal antibody specific for staphylococcal LTA (Weisman, 2007). While glycopolymers have traditionally been regarded only as T-cell-independent antigens, there is increasing evidence that zwitterionic glycopolymers can activate T-cells upon processing and presentation via MHC class II by antigen-presenting cells (Kalka-Moll et al., 2002; Mazmanian and Kasper, 2006). Most detailed studies concerning this new pathway are available for Bacteroides fragilis capsular polysaccharides, but recent studies with S. aureus WTA, which is equally zwitterionic, suggest that WTA may serve as a T-cell-independent antigen (Tzianabos et al., 2001; McLoughlin et al., 2006). Such studies are still in their infancy but, if the concept is confirmed, CWGs should be regarded increasingly as vaccine candidates with the capacity to elicit immunological memory. Another way how CWGs might stimulate specific T-cells comes from mycobacterial LAM which has been shown to stimulate T-cells restricted to the MHC-like molecule CD1, which is known to present certain lipid antigens (Prigozy et al., 1997). Thus, it is tempting to propose that M-CWGs could prove to be the general subjects of CD1 presentation than had been previously thought.
6. Conclusions and perspectives The TAs and other CWGs have represented a field of active research following their discovery in the 1960s, but only a small group of scientists has studied the chemical, biochemical and genetic basis of CWG biosynthesis later on. Only in recent years, after certain CWGs turned out to
be of pivotal importance in microbe–host interaction, did these polymers receive increasing attention in the scientific community. Moreover, the desperate need for new antimicrobial target structures has put CWG chemistry and biology on the list of major scientific challenges. In fact, several promising studies have recently demonstrated the suitability of CWGs as targets for new vaccines or antibiotics (Mikusova et al., 1995; Theilacker et al., 2004; May et al., 2005). With improved glycochemical methodology it should be possible to obtain a broader view on the diversity and variability of CWG structures. The availability of genomic and metagenomic databases represents a valuable basis for predicting CWG biosynthetic pathways by bioinformatic methods. Moreover, recent progress in the in vitro reconstitution of biosynthetic steps will help to confirm predicted enzyme functions and to use the reactions in high-throughput screening programmes in the search for new antibiotics. The WTA biosynthetic enzymes seem to form a membrane-associated complex in B. subtilis indicating that CWG biosynthesis is a highly organized process (Formstone et al., 2008). It can be assumed that the CWGs and PG biosynthetic machineries are coordinated in sophisticated ways, maybe in cooperation with cytoskeletal elements and with the cell division apparatus. With the increasing availability of defined mutants it should be possible to correlate structural features of CWGs with certain functions in cell wall physiology or host interaction. Major open questions needing to be answered concern the proinflammatory capacity of M-CWGs and the potential of CWGs to activate specific T-cells upon processing and presentation in MHC class II or CD1 molecules. Many host receptors recognizing and binding CWGs remain to be identified. It is tempting to speculate that the vast diversity of CWG structures play a role in bacterial cell and host tropism according to cell- and species-specific differences in expression of CWG-binding molecules. Thus, a number of areas for further investigation remain (Research Focus Box).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
87
Research Focus Box
Complete clarification of the biosynthetic pathways of the different types of CWGs is required. l In vitro reconstitution of biosynthetic steps to confirm predicted enzyme functions could prove useful. l CWGs could act as a target for new vaccines or antibiotics and are worthy of examination. l
Acknowledgements Our research is supported by grants from the German Research Foundation (TR34, FOR449, GRK685, SFB685, SFB766), the European Union (LSHM-CT-2004-512093), the German Ministry of Education and Research (NGFN2, SkinStaph) and the IZKF programme of the Medical Faculty, University of Tübingen, to AP.
References Abachin, E., Poyart, C., Pellegrini, E., et al., 2002. Formation of d-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 43, 1–14. Anderson, R.G., Hussey, H., Baddiley, J., 1972. The mechanism of wall synthesis in bacteria. The organization of enzymes and isoprenoid phosphates in the membrane. Biochem. J. 127, 11–25. Araki, Y., Ito, E., 1989. Linkage units in cell walls of Grampositive bacteria. Crit. Rev. Microbiol. 17, 121–135. Armstrong, J.J., Baddiley, J., Buchanan, J.G., Davision, A.L., Kelemen, M.V., Neuhaus, F.C., 1959. Composition of teichoic acids from a number of bacterial walls. Nature 184, 247–248. Baddiley, J., 1989. Bacterial cell walls and membranes. Discovery of the teichoic acids. Bioessays 10, 207–210.
The role of M-CWG and P-CWG as proinflammatory stimuli of the immune system requires further intense investigation. l A deeper understanding of the role of CWGs in bacterial physiology and host interaction could prove beneficial. l
Bera, A., Biswas, R., Herbert, S., et al., 2007. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J. Bacteriol. 189, 280–283. Bergmann, S., Hammerschmidt, S., 2006. Versatility of pneumococcal surface proteins. Microbiology 152, 295–303. Bhavsar, A.P., Brown, E.D., 2006. Cell wall assembly in Bacillus subtilis: how spirals and spaces challenge paradigms. Mol. Micrbiol. 60, 1077–1090. Bierbaum, G., Sahl, H.G., 1987. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-l-alanine amidase. J. Bacteriol. 169, 5452–5458. Bracha, R., Chang, M., Fiedler, F., Glaser, L., 1978. Biosynthesis of teichoic acids. Methods Enzymol. 50, 387–402. Brennan, P.J., 2003. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinburgh) 83, 91–97. Briken, V., Porcelli, S.A., Besra, G.S., Kremer, L., 2004. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53, 391–403. Brooks, D., Mays, L.L., Hatefi, Y., Young, F.E., 1971. Glucosylation of teichoic acid: solubilization and partial characterization of the uridine diphosphoglucose: polyglycerolteichoic acid glucosyl transferase from membranes of Bacillus subtilis. J. Bacteriol. 107, 223–229. Brown, S., Zhang, Y.H., Walker, S., 2008. A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps. Chem. Biol. 15, 12–21.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
88
5. Teichoic and lipoteichoic acids
Chavakis, T., Hussain, M., Kanse, S.M., et al., 2002. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat. Med. 8, 687–693. Choudhury, B., Leoff, C., Saile, E., et al., 2006. The structure of the major cell wall polysaccharide of Bacillus anthracis is species-specific. J. Biol. Chem. 281, 27932–27941. D’Elia, M.A., Millar, K.E., Beveridge, T.J., Brown, E.D., 2006. Wall teichoic acid polymers are dispensable for cell viability in Bacillus subtilis. J. Bacteriol. 188, 8313–8316. Debabov, D.V., Kiriukhin, M.Y., Neuhaus, F.C., 2000. Biosynthesis of lipoteichoic acid in Lactobacillus rhamnosus: role of DltD in d-alanylation. J. Bacteriol. 182, 2855–2864. Deininger, S., Stadelmaier, A., von Aulock, S., Morath, S., Schmidt, R.R., Hartung, T., 2003. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 170, 4134–4138. Delmas, C., Gilleron, M., Brando, T., et al., 1997. Comparative structural study of the mannosylatedlipoarabinomannans from Mycobacterium bovis BCG vaccine strains: characterization and localization of succinates. Glycobiology 7, 811–817. Doran, K.S., Engelson, E.J., Khosravi, A.M.H., et al., 2005. Group B Streptococcus blood-brain barrier invasion depends upon proper cell surface anchoring of lipoteichoic acid. J. Clin. Invest. 115, 2499–2507. Draing, C., Pfitzenmaier, M., Zummo, S., et al., 2006. Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae. J. Biol. Chem. 281, 33849–33859. Endl, J., Seidl, H.P., Fiedler, F., Schleifer, K.H., 1983. Chemical composition and structure of the cell wall teichoic acids of staphylococci. Arch. Microbiol. 135, 215–223. Endo, Y., Matsushita, M., Fujita, T., 2007. Role of ficolin in innate immunity and its molecular basis. Immunobiology 212, 371–379. Escaich, S., Moreau, F., Vongsouthi, V.S.C., et al., 2007. Discovery of new Gram-positive antivirulence drugs: the first antivirulence molecule active in vivo. ICAAC Conference, abstract F2-958. Fabretti, F., Theilacker, C., Baldassarri, L., et al., 2006. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 74, 4164–4171. Fedtke, I., Mader, D., Kohler, T., et al., 2007. A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol. Microbiol. 65, 1078–1091. Ferguson, J.S., Voelker, D.R., McCormack, F.X., Schlesinger, L.S., 1999. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydratelectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J. Immunol. 163, 312–321.
Fischer, W., 1988. Physiology of lipoteichoic acids in bacteria. Adv. Microbiol. Physiol. 29, 233–302. Fischer, W., 1994. Lipoteichoic acids and lipoglycans. In: Ghuysen, J.-M., Hakenbeck, R. (eds.), Bacterial Cell Wall. Elsevier Science B.V., Amsterdam, pp. 199–215. Fischer, W., 2000. Phosphocholine of pneumococcal teichoic acids: role in bacterial physiology and pneumococcal infection. Res. Microbiol. 151, 421–427. Fischer, W., Behr, T., Hartmann, R., Peter-Katalinic, J., Egge, H., 1993. Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoic acid (C polysaccharide). Eur. J. Biochem. 215, 851–857. Formstone, A., Carballido-Lopez, R., Noirot, P., Errington, J., Scheffers, D.J., 2008. Localization and interactions of teichoic acid synthetic enzymes in Bacillus subtilis. J. Bacteriol. 190, 1812–1821. Foster, T.J., Hook, M., 1998. Surface protein adhesions of Staphylococcus aureus. Trends Microbiol. 6, 484–488. Freymond, P.P., Lazarevic, V., Soldo, B., Karamata, D., 2006. Poly(glucosyl-N-acetylgalactosamine 1-phosphate), a wall teichoic acid of Bacillus subtilis 168: its biosynthetic pathway and mode of attachment to peptidoglycan. Microbiology 152, 1709–1718. Ginsberg, C., Zhang, Y.H., Yuan, Y., Walker, S., 2006. In vitro reconstitution of two essential steps in wall teichoic acid biosynthesis. ACS Chem. Biol. 1, 25–28. Giudicelli, S., Tomasz, A., 1984. Attachment of pneumococcal autolysin to wall teichoic acids, an essential step in enzymatic wall degradation. J. Bacteriol. 158, 1188–1190. Glaser, L., Lindsay, B., 1974. The synthesis of lipoteichoic acid carrier. Biochem. Biophys. Res. Commun. 59, 1131–1136. Greenberg, J.W., Fischer, W., Joiner, K.A., 1996. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect. Immun. 64, 3318–3325. Gross, M., Cramton, S., Götz, F., Peschel, A., 2001. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect. Immun. 69, 3423–3426. Grundling, A., Schneewind, O., 2007a. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA. 104, 8478–8483. Grundling, A., Schneewind, O., 2007b. Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus. J. Bacteriol. 189, 2521–2530. Han, S.H., Kim, J.H., Martin, M., Michalek, S.M., Nahm, M.H., 2003. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect. Immun. 71, 5541–5548. Hashimoto, M., Tawaratsumida, K., Kariya, H., et al., 2006. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 177, 3162–3169.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Hashimoto, M., Furuyashiki, M., Kaseya, R., et al., 2007. Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction. Infect. Immun. 75, 1926–1932. Heaton, M.P., Neuhaus, F.C., 1992. Biosynthesis of d-alanyllipoteichoc acid: cloning, nucleotide sequence, and expression of the Lactobacillus casei gene for the d-alanineactivating enzyme. J. Bacteriol. 174, 4707–4717. Henneke, P., Morath, S., Uematsu, S., et al., 2005. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J. Immunol. 174, 6449–6455. Heptinstall, S., Archibald, A.R., Baddiley, J., 1970. Teichoic acids and membrane function in bacteria. Nature 225, 519–521. Herbert, S., Bera, A., Nerz, C., et al., 2007. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 3, 981–994. Hermann, C., Spreitzer, I., Schroder, N.W., et al., 2002. Cytokine induction by purified lipoteichoic acids from various bacterial species – role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur. J. Immunol. 32, 541–551. Hoebe, K., Georgel, P., Rutschmann, S., et al., 2005. CD36 is a sensor of diacylglycerides. Nature 433, 523–527. Jiang, Y., Oliver, P., Davies, K.E., Platt, N., 2006. Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells. J. Biol. Chem. 281, 11834–11845. Jorasch, P., Warnecke, D.C., Lindner, B., Zähringer, U., Heinz, E., 2000. Novel processive and nonprocessive glycosyltransferases from Staphylococcus aureus and Arabidopsis thaliana synthesize glycoglycerolipids, glycophospholipids, glycosphingolipids and glycosylsterols. Eur. J. Biochem. 267, 3770–3783. Kalka-Moll, W.M., Tzianabos, A.O., Bryant, P.W., Niemeyer, M., Ploegh, H.L., Kasper, D.L., 2002. Zwitterionic polysaccharides stimulate T cells by MHC class IIdependent interactions. J. Immunol. 169, 6149–6153. Kiriukhin, M.Y., Debabov, D.V., Shinabarger, D.L., Neuhaus, F.C., 2001. Biosynthesis of the glycolipid anchor in lipoteichoic acid of Staphylococcus aureus RN4220: role of YpfP, the diglucosyldiacylglycerol synthase. J. Bacteriol. 183, 3506–3514. Koch, H.U., Haas, R., Fischer, W., 1984. The role of lipoteichoic acid biosynthesis in membrane lipid metabolism of growing Staphylococcus aureus. Eur. J. Biochem. 138, 357–363. Koch, H.U., Doker, R., Fischer, W., 1985. Maintenance of d-alanine ester substitution of lipoteichoic acid by reesterification in Staphylococcus aureus. J. Bacteriol. 164, 1211–1217. Koprivnjak, T., Weidenmaier, C., Peschel, A., Weiss, J.P., 2008. Wall teichoic acid deficiency in Staphylococcus
89
aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3. Infect. Immun. 76, 2169–2176. Kraus, D., Herbert, S., Kristian, S.A., et al., 2008. The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol. 8, 85. Kristian, S.A., Lauth, X., Nizet, V., et al., 2003. Alanylation of teichoic acids protects Staphylococcus aureus against Tolllike receptor 2-dependent host defense in a mouse tissue cage infection model. J. Infect. Dis. 188, 414–423. Kristian, S.A., Datta, V., Weidenmaier, C., et al., 2005. dalanylation of teichoic acid promotes group A Streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 187, 6719–6725. Kumar, A., Ray, P., Kanwar, M., Sharma, M., Varma, S., 2005. A comparative analysis of antibody repertoire against Staphylococcus aureus antigens in patients with deepseated versus superficial staphylococcal infections. Int. J. Med. Sci. 2, 129–136. Lancefield, R.C., Freimer, E.H., 1966. Type-specific polysaccharide antigens of group B streptococci. J. Hyg. (London) 64, 191–203. Lazarevic, V., Karamata, D., 1995. The tagGH operon of Bacillus subtilis 168 encodes a two-component ABC transporter involved in the metabolism of two wall teichoic acids. Mol. Microbiol. 16, 345–355. Leoff, C., Saile, E., Sue, D., et al., 2007. Cell wall carbohydrate compositions of strains from the B. cereus group of species correlate with phylogenetic relatedness. J. Bacteriol. 190, 112–121. Li, M., Lai, Y., Villaruz, A.E., Cha, D.J., Sturdevant, D.E., Otto, M., 2007. Gram-positive three-component antimicrobial peptide-sensing system. Proc. Natl. Acad. Sci. USA 104, 9469–9474. Lopez, R., Garcia, E., Garcia, P., Ronda, C., Tomasz, A., 1982. Choline-containing bacteriophage receptors in Streptococcus pneumoniae. J. Bacteriol. 151, 1581–1590. Lynch, N.J., Roscher, S., Hartung, T., et al., 2004. l-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J. Immunol. 172, 1198–1202. May, J.J., Finking, R., Wiegeshoff, F., et al., 2005. Inhibition of the d-alanine:d-alanyl carrier protein ligase from Bacillus subtilis increases the bacterium’s susceptibility to antibiotics that target the cell wall. FEBS J. 272, 2993–3003. Mazmanian, S.K., Kasper, D.L., 2006. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 6, 849–858. McLoughlin, R.M., Solinga, R.M., Rich, J., et al., 2006. CD4 T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc. Natl. Acad. Sci. USA. 103, 10408–10413. Mesnage, S., Fontaine, T., Mignot, T., Delepierre, M., Mock, M., Fouet, A., 2000. Bacterial SLH domain proteins are
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
90
5. Teichoic and lipoteichoic acids
non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation. EMBO J. 19, 4473–4484. Mikusova, K., Slayden, R.A., Besra, G.S., Brennan, P.J., 1995. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob. Agents Chemother. 39, 2484–2489. Mongodin, E., Bajolet, O., Cutrona, J., et al., 2002. Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway epithelium. Infect. Immun. 70, 620–630. Nathenson, S.G., Ishimoto, N., Anderson, J.S., Strominger, J.L., 1966. Enzymatic synthesis and immunochemistry of a- and b-N-acetylglucosaminylribitol linkages in teichoic acids from several strains of Staphylococcus aureus. J. Biol. Chem. 241, 651–658. Naumova, I.B., Shashkov, A.S., 1997. Anionic polymers in cell walls of Gram-positive bacteria. Biochemistry (Moscow) 62, 809–840. Navarre, W.W., Schneewind, O., 1999. Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63, 174–229. Neuhaus, F.C., Baddiley, J., 2003. A continuum of anionic charge: structures and functions of d-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol Rev. 67, 686–723. Neuhaus, F.C., Heaton, M.P., Debabov, D.V., Zhang, Q., 1996. The dlt operon in the biosynthesis of d-alanyllipoteichoic acid in Lactobacillus casei. Microb. Drug Resist. 2, 77–84. Park, J.T., Shaw, D.R., Chatterjee, A.N., Mirelman, D., Wu, T., 1974. Mutants of staphylococci with altered cell walls. Ann. NY Acad. Sci. 236, 54–62. Park, Y.S., Sweitzer, T.D., Dixon, J.E., Kent, C., 1993. Expression, purification, and characterization of CTP: glycerol-3-phosphate cytidylyltransferase from Bacillus subtilis. J. Biol. Chem. 268, 16648–16654. Pereira, M.P., Brown, E.D., 2004. Bifunctional catalysis by CDP-ribitol synthase: convergent recruitment of reductase and cytidylyltransferase activities in Haemophilus influenzae and Staphylococcus aureus. Biochemistry 43, 11802–11812. Pereira, M.P., Delia, M.A., Troczynska, J., Brown, E.D., 2008. Duplication of teichoic acid biosynthetic genes in Staphylococcus aureus leads to functionally redundant poly(ribitol phosphate) polymerases. J. Bacteriol. 190 (16), 5642–5649. Peschel, A., Sahl, H.G., 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4, 529–536. Peschel, A., Otto, M., Jack, R.W., Kalbacher, H., Jung, G., Götz, F., 1999. Inactivation of the dlt operon in
Staphylococcus aureus confers sensitivity to defensins, protegrins and other antimicrobial peptides. J. Biol. Chem. 274, 8405–8410. Peschel, A., Vuong, C., Otto, M., Götz, F., 2000. The d-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolysins. Antimicrob. Agents Chemother. 44, 2845–2847. Polotsky, V.Y., Fischer, W., Ezekowitz, A.B., Joiner, K.A., 1996. Interactions of human mannose-binding protein with lipoteichoic acids. Infect. Immun. 64, 380–383. Polotsky, V.Y., Belisle, J.T., Mikusova, K., Ezekowitz, R.A., Joiner, K.A., 1997. Interaction of human mannose-binding protein with Mycobacterium avium. J. Infect. Dis. 175, 1159–1168. Pooley, H.M., Karamata, D., 1994. Teichoic acid synthesis in Bacillus subtilis: genetic organization and biological roles. In: Ghuysen, J.-M., Hakenbeck, R. (eds.) Bacterial Cell Wall. Elsevier Science B.V., Amsterdam, pp. 187–197. Potekhina, N.V., Tul’skaya, E.M., Naumova, I.B., Shashkov, A.S., Evtushenko, L.I., 1993. Erythritolteichoic acid in the cell wall of Glycomyces tenuis VKM Ac-1250. Eur. J. Biochem. 218, 371–375. Powell, D.A., Duckworth, M., Baddiley, J., 1975. A membrane-associated lipomannan in micrococci. Biochem. J. 151, 387–397. Prigozy, T.I., Sieling, P.A., Clemens, D., et al., 1997. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6, 187–197. Qian, Z., Yin, Y., Zhang, Y., Lu, L., Li, Y., Jiang, Y., 2006. Genomic characterization of ribitol teichoic acid synthesis in Staphylococcus aureus: genes, genomic organization and gene duplication. BMC Genomics 7, 74. Sadovskaya, I., Vinogradov, E., Li, J., Jabbouri, S., 2004. Structural elucidation of the extracellular and cell-wall teichoic acids of Staphylococcus epidermidis RP62A, a reference biofilm-positive strain. Carbohydr. Res. 339, 1467–1473. Schäffer, C., Messner, P., 2005. The structure of secondary cell wall polymers: how Gram-positive bacteria stick their cell walls together. Microbiology 151, 643–651. Shashkov, A.S., Streshinskaya, G.M., Senchenkova, S.N., et al., 2006. Cell wall teichoic acids of streptomycetes of the phenetic cluster ‘Streptomyces fulvissimus’. Carbohydr. Res. 341, 796–802. Shimaoka, T., Kume, N., Minami, M., et al., 2001. LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. J. Immunol. 166, 5108–5114. Sidobre, S., Nigou, J., Puzo, G., Riviere, M., 2000. Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to mycobacteria. Critical role of the lipids for lectin-carbohydrate recognition. J. Biol. Chem. 275, 2415–2422.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Soldo, B., Lazarevic, V., Pagni, M., Karamata, D., 1999. Teichuronic acid operon of Bacillus subtilis 168. Mol. Microbiol. 31, 795–805. Soldo, B., Lazarevic, V., Karamata, D., 2002a. tagO is involved in the synthesis of all anionic cell-wall polymers in Bacillus subtilis 168. Microbiology 148, 2079–2087. Soldo, B., Lazarevic, V., Pooley, H.M., Karamata, D., 2002b. Characterization of a Bacillus subtilis thermosensitive teichoic acid-deficient mutant: gene mnaA (yvyH) encodes the UDP-N-acetylglucosamine 2-epimerase. J. Bacteriol. 184, 4316–4320. Sugawara, I., Yamada, H., Li, C., Mizuno, S., Takeuchi, O., Akira, S., 2003. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol. 47, 327–336. Sutcliffe, I., 2005. Lipoarabinomannans--structurally diverse and functionally enigmatic macroamphiphiles of mycobacteria and related actinomycetes. Tuberculosis (Edinburgh) 85, 205–206. Sutcliffe, I.C., Black, G.W., Harrington, D.J., 2008. Bioinformatic insights into the biosynthesis of the Group B carbohydrate in Streptococcus agalactiae. Microbiology 154, 1354–1363. Takahashi, M., Mori, S., Shigeta, S., Fujita, T., 2007. Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway. Adv. Exp. Med. Biol. 598, 93–104. Takayama, K., Wang, C., Besra, G.S., 2005. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18, 81–101. Tapping, R.I., Tobias, P.S., 2003. Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J. Endotoxin. Res. 9, 264–268. Theilacker, C., Krueger, W.A., Kropec, A., Huebner, J., 2004. Rationale for the development of immunotherapy regimens against enterococcal infections. Vaccine 22 (Suppl. 1), S31–S38. Theilacker, C., Kaczynski, Z., Kropec, A., et al., 2006. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid. Infect. Immun. 74, 5703–5712. Tzianabos, A.O., Wang, J.Y., Lee, J.C., 2001. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc. Nat. Acad. Sci. USA 98, 9365–9370. van de Wetering, J.K., van, E.M., van Golde, L.M., Hartung, T., Van Strijp, J.A., Batenburg, J.J., 2001. Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell
91
wall components of Gram-positive bacteria. J. Infect. Dis. 184, 1143–1151. Verbrugh, H.A., Peters, R., Rozenberg-Arska, M., Peterson, P.K., Verhoef, J., 1981. Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections. J. Infect. Dis. 144, 1–9. Verhoef, J., Musher, D.M., Spika, J.S., Verbrugh, H.A., Jaspers, F.C., 1983. The effect of staphylococcal peptidoglycan on polymorphonuclear leukocytes in vitro and in vivo. Scand. J. Infect. Dis. (Suppl. 41), 79–86. Vinogradov, E., Sadovskaya, I., Li, J., Jabbouri, S., 2006. Structural elucidation of the extracellular and cell-wall teichoic acids of Staphylococcus aureus MN8 m, a biofilm forming strain. Carbohydr. Res. 341, 738–743. Ward, J.B., 1981. Teichoic and teichuronic acids: biosynthesis, assembly and location. Microbiol. Rev. 45, 211–243. Weidenmaier, C., Peschel, A., 2008. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 6, 276–287. Weidenmaier, C., Kokai-Kun, J.F., Kristian, S.A., et al., 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosokomial infections. Nat. Med. 10, 243–245. Weidenmaier, C., Peschel, A., Xiong, Y.Q., et al., 2005a. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J. Infect. Dis 191, 1771–1777. Weidenmaier, C., Peschel, A., Kempf, V.A., Lucindo, N., Yeaman, M.R., Bayer, A.S., 2005b. DltABCD- and MprFmediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect. Immun. 73, 8033–8038. Weidenmaier, C., Kokai-Kun, J.F., Kulauzovic, E., et al., 2008. Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int. J. Med. Microbiol. 298, 505–513. Weisman, L.E., 2007. Antibody for the prevention of neonatal nosocomial staphylococcal infection: a review of the literature. Arch. Pediatr. 14 (Suppl. 1), S31–S34. Wendlinger, G., Loessner, M.J., Scherer, S., 1996. Bacteriophage receptors on Listeria monocytogenes cells are the Nacetylglucosamine and rhamnose substituents of teichoic acids or the peptidoglycan itself. Microbiology 142, 985–992. Xia, G., Peschel, A., 2008. Toward the pathway of S. aureus WTA biosynthesis. Chem. Biol. 15, 95–96.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
6 Bacterial capsular polysaccharides and exopolysaccharides Paola Cescutti
Summary Bacteria often produce an external layer of polysaccharides, characterized by a definite primary structure, which in turn is responsible for sometimes remarkable physicochemical properties. Although the number of monosaccharides which constitute the polymers is rather low, the great number of different polysaccharides defined up to now shows the capacity of the microbes to exploit the possible isomers and linkage types of the building blocks. Furthermore, variability is often introduced by the presence of non-carbohydrate groups linked to hydroxyl, carboxyl or amine functions. In this chapter, examples of polysaccharides produced by Gramnegative and Gram-positive pathogenic bacteria are given, together with a description of those polymers that are interesting for industrial and biotechnological purposes. Some discussion is also devoted to the general features of shapes that polysaccharides may adopt in solution. The biological functions of these biomolecules are discussed particularly in relation to their role in human infection processes. The structures of the polysaccharides produced by species of the Burkholderia cepacia complex is reported
Microbial Glycobiology
as an example of a current investigation devoted to the understanding of the role of these biopolymers in lung infections. Keywords: Capsular polysaccharides; Exopoly saccharides; Primary structure; Biological properties; Burkholderia cepacia complex
1. Introduction Bacterial cells are often surrounded by a polysaccharidic layer which constitutes the interface with the environment. Sometimes this structure is referred to as the “glycocalyx”. Bacterial polysaccharides are classified into two different types: capsular polysaccharides (Kantigens) (CPS) and exopolysaccharides (EPS). Thus, CPS are defined as polymers linked to the cell surface via covalent bond to phospholipid or lipid A molecules, while EPS appear to be released on the cell surface with no attachment to the cell and they are often sloughed off to form slime. However, there is no clear cut
93
© 2009 2010, Elsevier Inc.
94
6. Capsular polysaccharides and exopolysaccharides
efinition for CPS and EPS, because the former d can also be released into the growth medium and the latter may be closely associated with the cell surface (Taylor and Roberts, 2005). Despite this ambiguity, these are the most common definitions found in the literature and they will be used as such in this context. It is worth mentioning that Costerton et al. (1981) gave a more detailed definition of capsule, distinguishing four different types of CPS: (i) rigid, which excludes particles, like India ink; (ii) flexible, sufficiently deformable that it does not exclude particles; (iii) integral, intimately associated with the cell; and (iv) peripheral, may remain associated with the cell and may be shed into the medium. In this view, EPS probably would be defined as capsule type (iv). Structurally, CPS and EPS can be homopolysaccharides, like dextran and cellulose, or heteropolysaccharides, and can have a linear or branched structure. They are constituted of oligomers, ranging in size from 2 to 10 sugar residues, which repeat regularly a given number of times to yield a polymer of generally high molecular mass (105–106). These macromolecules may be neutral or charged and the polyanionic ones prevail. Cyanobacteria are an exception in this context because they usually have very complicated repeating units which may not have a strictly repeating regular structure (De Philippis and Vincenzini, 1998). In general, CPS and EPS are rather widespread and are synthesized by plant, animal and human pathogen bacteria, by soil, fresh water and seawater microbes and by cyanobacteria. Being the interface with the “outer” world for microbes, their biological role must be related to the interaction with the environment. Furthermore, it was demonstrated that most bacteria, except those found in deep groundwater and abyssal oceans, live associated with surfaces in the form of multicellular aggregates
commonly referred to as biofilm and that CPS and EPS are involved in the biofilm architecture (see Chapters 37 and 39). Sometimes bacterial polysaccharides exhibit extremely interesting solution and gelling properties, characteristics strictly related to their primary structure and conformation. Therefore, some of them are used in several industrial applications or are exploited as potential new biomaterials (Kumar et al., 2007). Their commercial use is linked to their origin; in general those already on the market are environmental species, while CPS and EPS from human pathogenic bacterial are used to prepare conjugated vaccine (see Chapter 48). The availability of powerful techniques, like nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry, has led to an enormous increase in the amount of available polysaccharide structures in the last 20 years. Therefore, a choice on the content of this chapter was inevitable and it was concluded that a description of only some CPS and EPS related to human disease and to industrial exploitation was possible. A number of references, especially reviews, are provided and the reader is encouraged to refer to them for more detailed data.
2. Carbohydrate components of capsular and exo-polysaccharides The most common components of CPS and EPS are: (i) pentoses: ribose and arabinose, the latter found especially in Mycobacterium species; (ii) hexoses: glucose, mannose, galactose and fructose; (iii) deoxysugars: fucose and rhamnose; (iv) uronic acids: glucuronic and galacturonic acids; and (v) aminosugar: glucosamine and galactosamine, often N-acetylated.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Structure overview of bacterial polysaccharides
Occasionally, other sugars are detected: 2-acetamido-2,6-dideoxygalactose, 3-deoxy-dmanno-oct-2-ulosonic acid (Kdo), N-acetyl neuraminic acid, 2-acetamido-2-deoxy-guluronic acid, 2-acetamido-2-deoxy-mannuronic acid, guluronic acid and mannuronic acid. OMethylated sugars are also common. Apart from ribose, fructose and galactose, which sometimes adopt the furanosidic ring structure, the other monosaccharides are usually in the pyranosidic form. Although the number of monosaccharides used by microbes to synthesize polysaccharides is relatively small, the great variety of CPS and EPS structures is achieved through the versatility of the glycosidic linkages, where variation occurs in terms of both configuration at the anomeric carbon atom ( or ) and choice of the carbon atom engaged in the linkage. CPS and EPS usually are negatively charged due to the presence of uronic acids or to ionic non-carbohydrate substituents (see below). In the past years, excellent reviews (Kenne and Lindberg 1983; Lindberg, 1990; Griffiths and Davies 1991a,b) have listed with great detail the carbohydrate components of bacterial polysaccharides.
3. Non-carbohydrate substituents of capsular and exopolysaccharides The most common non-carbohydrate groups are: N- and O-acetyl, pyruvic acid ketal and phosphoric acid linked with diester linkages. Less common are succinic acid, amino acids, glycerol, ribitol, lactic acid, to name a few (Kenne and Lindberg, 1983). N-acetyl groups are linked through an amide bond and are thus much more resistant to hydrolysis than the Oacetyl substituents. Substitution with N- or O-acetyl groups changes the hydrophilic character of sugars which normally is dominated by hydroxyl groups. Moreover, O-acetyl groups on a sugar may migrate, unless they are impeded
95
by other substituents. Therefore, if O-acetyl groups are found in two positions in a sugar residue, O-acetylation may have occurred in a single position during biosynthesis. Pyruvic acid is most often linked to the 4- and 6-position of a hexopyranose ring and its absolute configuration can be determined by 13C-NMR spectroscopy (Garegg et al., 1980). In addition, pyruvic acid can also be linked to vicinal hydroxyl functions, for example 3- and 4-position in galactopyranosyl residues (Lindberg, 1990). Some non-carbohydrate substituents are present in an even ratio with the repeating unit (e.g. pyruvate), while others may exist in stoichiometric as well as non-stoichiometric amounts (e.g. O-acetyl). When charged, the substituents turn a neutral polymer into a polyelectrolyte, with important consequences on its macromolecular properties; alternatively, they might increase the charge density on an already anionic polysaccharide.
4. Structure overview of bacterial polysaccharides 4.1. Capsular polysaccharides of Gram-negative bacteria The cell envelope of Gram-negative bacteria is made of an inner membrane, separated from the peptidoglycan by a periplasmic space and, finally, an outer membrane containing the LPS. Some bacteria also possess an extracellular envelope called a capsule, or K-antigen (Kapselantigene) which, being the most external layer, imparts its dominant immunological properties to the whole cell. Some pathogenic bacteria are capsulated and their virulence is closely related with the structure of the polysaccharide. The knowledge of the polymer primary structure is important in the definition of its immunological activity, a first step towards the preparation of efficacious vaccines.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
96
6. Capsular polysaccharides and exopolysaccharides
The Enterobacteriaceae is a family of Gramnegative bacteria that normally live in the intestines of humans and other animals, while others are found in water or soil, or are parasites on a variety of different animals and plants. Some species can cause infections of the digestive tract or of other organs of the body. In this family, Escherichia coli and Klebsiella pneumoniae are remarkable for the copious number of different CPS they produce. E. coli is an opportunistic human pathogen because certain strains can cause intestinal or urinary tract infections and neonatal septicaemia and meningitis. This species is divided into more than 80 serotypes, according to the number of different capsular antigens synthesized. These CPS were characterized and classified in group I and group II according to their structure (Jann and Jann, 1990). Group I is rather homogeneous and is further subdivided according to the presence or absence of amino sugars. Group II contains polymers that differ widely in composition and in general structural features and this group can be subdivided depending on the acidic component. The biosynthesis and regulation of the CPS in E. coli has been extensively investigated (Whitfield, 2006). K. pneumoniae is the most important clinical species of its genus, because it is an opportunistic human pathogen responsible of nosocomial infection outbreaks, like pneumonia, bacteraemia and infections of the urinary tract, wound, soft tissue and respiratory tract. This species also synthesizes more than 80 different K-antigens which have been fully characterized (Kenne and Lindberg, 1983; Dutton, 1984; Griffiths and Davies, 1991a; Ovodov, 2006). The structure of the repeating units of K. pneumoniae CPS shows great variability. They contain from three to seven sugars, arranged in linear or branched oligomers, with negative charges carried by uronic acids and/or pyruvate groups, and may be acetylated. Some examples are shown in Figure 6.1. Another Gram-negative bacterium interesting as a human pathogen is Haemophilus influenzae. It is present in the nasopharynx of about
75% of healthy children and adults in the form of encapsulated strains. This species is divided into six types (a–f) which express six different K-antigens (Griffiths and Davies, 1991b; Ovodov, 2006). The repeating units of these CPS are constituted of two or three sugar residues, some of which are amino sugars, and may contain phosphate esters and N- and O-acetyl groups. The importance of this species resides in the dangerousness of H. influenzae type b (Hib) infection, which can result in meningitis and other severe infections (e.g. pneumonia, bacteraemia, cellulitis, septic arthritis and epiglottitis) primarily among infants and children 5 years of age. In the early 1990s, the introduction of carbohydrate-based Hib conjugate vaccines was followed by a dramatic decrease of meningitis in children (Weintraub, 2003). The success of vaccination was also ascribed to a reduction of Hib carriage, which probably decreased the transmission rates to children devoid of protective antibodies. Neisseria meningitidis are Gram-negative aerobic bacteria, commonly known as meningococci and are exclusively human pathogens causing meningitis. The major virulence factor is the Kantigen: on the basis of its structure, twelve different K-types were identified (A, B, C, H, I, K, L, X, Y, Z, 29E and W135) (Griffiths and Davies, 1991b). The different repeating units contain from one to three sugar residues, often amino sugars and neuraminic acid; acetyl groups and phosphate esters are also present as non-carbohydrate substituents. More than 90% of meningitis cases are caused by serotypes A, B, C, W135 and Y. As with Hib vaccine, A and C glycoconjugate vaccines showed to be efficacious and are available for disease prevention.
4.2. Capsular polysaccharides of Gram-positive bacteria Gram-positive bacteria are characterized by an inner membrane surrounded by a thick layer
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Structure overview of bacterial polysaccharides
97
[3)-α-D-Galp-(1→2)-[3,4-O-(1-carboxyethylidene)]-α-L-Rhap-(1→ →3)-β-L-Rhap-(1→4)-α-L-Rhap-(1→]n K32a
[3)-α-L-Rhap-(1→2)-α-L-Rhap-(1→4)-α-D-GlcpA-(1→ →2)-α-D-Manp-(1→2)-α-D-Manp-(1→3)-α-D-Galp-(1→]n K40b
[3)-β-D-Glcp-(1→3)-β-D-GlcpA-(1→)-α-D-Galp-(1→3)-α-D-Manp-(1→]n 4 2 2 ↑ ↑ ↑ 1 1 1 α-D-Glcp β-D-Glcp β-D-Glcp K60c
[3)-α-L-Rhap-(1→3)-β-D-Glcp-(1→2)-α-L-Rhap-(1→2)-α-L-Rhap-(1→]n 3 ↑ 1 β-D-GlcAp-(1→3)-α-L-Rhap 2 ↑ 1 β-D-Glcp K71d
Figure 6.1 Examples of Klebsiella pneumoniae CPS repeating units. O-Acetyl substituents are not considered in the structures: a Bebault et al. (1978); b Cescutti et al. (1993); c Dutton and Di Fabio (1980); d Jackson et al. (1990).
of peptidoglycan, which in turn may be covered with a polysaccharidic capsule. Also, these microorganisms present a large variability of the CPS structure. Among the Streptococcus genus there are several species which are human opportunistic pathogens. Streptococcus pneumoniae often causes severe infections, especially in infants, elderly persons and patients with debilitating conditions. The most common types of infections include middle ear infections,
pneumonia, bacteraemia, sinus infections and meningitis. The pneumococcal capsule is indispensable for virulence (Llull et al., 2001). More than 90 different CPS are known (Weintraub, 2003), but only 23, those considered the most virulent, are used for the formulation of a polysaccharide vaccine (van Dam et al., 1990). The structure of their CPS is very diverse ranging from a simple disaccharidic repeating unit (type 3) to more complex ones containing higher
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
98
6. Capsular polysaccharides and exopolysaccharides
number of monomers in the repeating unit and non-carbohydrate substituents, like phosphate, pyruvate, glycerol, ribitol and acetyl (van Dam et al., 1990; Ovodov, 2006). Contrary to the Gram-negative bacteria, the CPS of streptococci, and most probably of other Gram-positive bacteria, is covalently attached to the bacterial cell wall and detailed data are available for serotype III of group B streptococci (Llull et al., 2001). Staphylococcus aureus is another capsulated opportunistic pathogen of humans and animals. It plays an important role in nosocomial and community acquired infections. Control of S. aureus infections is becoming more difficult due to the prevalence of antibiotic resistant strains and to the emergence of vancomycin resistant clinical isolates. CPS is listed among the virulence factors of this species. At least 18 different CPS were described and all contain hexosaminuronic acids, but only four were completely characterized. Besides the acidic component, they contain N-acetylated amino sugars and sometimes O-acetyl or alanyl groups (O’Riordan and Lee, 2004). Mycobacterium tuberculosis is the aetiologic agent of tuberculosis, an old disease that is still a threat for humans. The envelope which surrounds bacterial cells is really unique; it is constituted of long chain fatty acids (mycolic acids), glycolipids, lipoglycans and polysaccharides. Such an envelope contributes to bacterial survival in the infected host; the lipoglycan was shown to modulate the host immune response and, in particular, to have a powerful antiinflammatory activity. Lipoglycans are known as lipoarabinomannans (LAM) and they are composed of three domains: a polysaccharide backbone, the mannosyl-phosphatidyl-myo-inositol (MPI) anchor and the capping motifs. These are ubiquitous structural features which are then subjected to strain dependent structural variation. The polysaccharide part is constituted of two homopolysaccharides, a d-mannan and a d-arabinan; the MPI is linked to the mannan polymer and is acylated; the capping motifs are
essentially two: a manno-oligosaccharide and a phosphoinositol. According to the cap structure, LAM are classified into ManLAM and PILAM, the former being present in the slow growing microbes (e.g. M. tuberculosis) and the latter in the fast growing ones (Nigou et al., 2003; Ovodov, 2006).
4.3. Exopolysaccharides Exopolysaccharides are produced by a great variety of microorganisms, opportunistic human pathogens as well as environmental microbes. Among the pathogens, the case of Pseudomonas aeruginosa, a Gram-negative free-living bacterium, commonly found in soil and water, is very well known, because it constitutes a life threat for cystic fibrosis patients, causing infections characterized by high morbidity and mortality. In fact, it colonizes the respiratory tract of cystic fibrosis (CF) patients and switches from a non-mucoid to a mucoid phenotype, producing copious amounts of alginate, as extracellular polymer. Alginate is a linear copolymer of -d-mannuronic acid (ManA) and its epimer, -l-guluronic acid (GulA), linked via (1→4)-glycosidic linkages. An important characteristic of alginate is that it does not possess a regular repeating unit, it is highly negatively charged and it is O-acetylated on the mannuronic acid residues (Gacesa and Russell, 1990). In general, alginate from the Pseudomonas genus is characterized by the lack of contiguous sequences of the two uronic acids, and by a mannuronic and guluronic acid (ManA:GulA) ratio between 2 and 5. Azotobacter vinelandi, a Gramnegative soil microbe, is another species which produces alginate: in this case the polymer is more similar to the algal product because it contains contiguous sequences of both mannuronic and guluronic acids as well as mixed random sequences (Sutherland, 1994; Remminghorst and Rehm, 2006). Exopolysaccharides also surround bacterial cells which live in seawater; they constitute
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Structure overview of bacterial polysaccharides
part of the reduced carbon reservoir in the ocean and directly protect marine bacteria by creating a controlled physicochemical environment around the cells. Moreover, EPS are abundant in harsh environments, like the Antarctic Ocean, where they may contribute to bacterial survival in extreme temperatures, salinity and scarce-nutrient niches. The EPS from marine bacteria are usually heteropolysaccharides containing hexoses, pentoses and uronic acids and are formed by repeating units of 10 or less residues: they may be linear or branched and also comprise non-sugar substituents, like acetyl, phosphate, sulfate and pyruvate (Mancuso Nichols et al., 2005). For their physicochemical and gelling properties, some EPS from environmental species are used for technological applications, including the biotechnology industry. Curdlan is a linear -(1→3)-glucan, produced by several different Gram-negative bacteria, including strains of Agrobacterium spp. and Rhizobium spp. It is used as a gelling agent to improve the textural quality, water-holding capacity and thermal stability of various foods (Sutherland, 1999). Xanthan is synthesized by Xanthomonas campestris and also by other Xanthomonas species. This polysaccharide is composed of a pentasaccharide repeating unit (Figure 6.2) and, depending on the bacterial strain, it may be O-acetylated and pyruvylated (Sutherland, 1994). It produces high viscosity water solutions characterized by high pseudoplasticity, properties that render it amenable for many industrial applications. Xanthan is used in crude-oil recovery, in paints, pesticide and detergent formulations, cosmetics, pharmaceuticals and in food often in combination with guar gum. Gellan is produced by strains of Sphingomonas paucimobilis and has a linear tetrasaccharide repeating unit (see Figure 6.2). Removal of l-glyceryl and acetyl groups gives a strong and clear gel, comparable to that formed by agarose and, therefore, modified gellan is used in bacterial culture media. Dextran is a homopolymer of -(1→6)-linked
99
glucose with a varying degree of branching at C-3. The main applications for dextran are in the pharmaceutical and medical areas, as a blood plasma substitute and as a substitute for heparin, after being modified through the introduction of sulfate groups. Cross-linked dextrans are widely used in chromatographic media, while the use of dextrans in the field of bakery is less exploited (Kumar et al., 2007; Lacaze et al., 2007). Hyaluronan is constituted of a disaccharidic repeating unit (see Figure 6.2) and is widely used in the cosmetic and pharmaceutical industries (e.g. in skin moisturizers, for osteoarthritis treatment, in ophthalmic surgery, in adhesion prevention after abdominal surgery and wound healing). It is obtained commercially from rooster combs and some attenuated strains of group C Streptococcus. However, the polysaccharide from rooster combs can cause side effects in persons allergic to avian products, while that from Streptococcus spp. can contain potentially dangerous toxins. Recently, to overcome these undesirable effects, hyaluronan was produced by expressing the hasA gene, which encodes the enzyme hyaluronan synthase in Streptococcus equisimilis, in Bacillus subtilis, as many of its products were awarded a GRAS (generall recognized as safe) definition (Widner et al., 2005). Cellulose is a linear homopolysaccharide constituted of -(1→4)-glucopyranosyl residues. Acetobacter xylinum is the most prolific celluloseproducing bacterial species. Microbial cellulose is currently used in food and wound care products, paper and paper products (patent JP 63295793). Even audio speaker diaphragms were made using microbial cellulose (US Patent 4,742,164). The exopolysaccharide named succinoglycan (see Figure 6.2) was first isolated from Alcaligenes faecalis var. myxogenes. It was then discovered that succinoglycans are also synthesized by strains of Agrobacterium tumefaciens, Agrobacterium radiobacter and Rhizobium meliloti and by many strains of Pseudomonas spp.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
100
6. Capsular polysaccharides and exopolysaccharides [4)-β-D-Glcp-(1→4)-β-D-Glcp-(1→]n 3 ↑ 1 α-D-Manp6Ac 2 ↑ 1 β-D-GlcpA 4 ↑ 1 4,6-O-(1-carboxyethylidene)]-β-D-Manp
xanthana
[4)-α-L-Rhap-(1→3)-β-D-Glcp-(1→4)-β-D-GlcAp-(1→4)-β-D-Glcp-(1→]n gellanb
[3)-β-D-GlcNAcp-(1→4)-β-D-GlcAp-(1→]n hyaluronic acid
[4)-β-D-Glcp-(1→4)-β-D-Glcp-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1→]n 6 ↑ 1 [4,6-O-(1-carboxyethylidene)]-β-D-Glcp-(1→3)-β-D-Glcp-(1→3)-β-D-Glcp-(1→6)-β-D-Glcp succinoglycanc
Figure 6.2 Structures of the repeating units of EPS (mentioned in this chapter) and used in industrial applications.
a The EPS produced by Xanthomonas campestris: usually the internal -mannosyl residue is fully acetylated, while the pyruvil group, in the S absolute configuration, is present on about 30% of the terminal -mannosyl residues. b The 3-linked glucose residue is substituted on O-2 with l-glyceryl and on O-6 with acetyl groups. c Succinoglycan contains also acetyl and succinyl substituents depending on the bacterial strain (Zevenhuizen, 1997); pyruvyl groups are in the S absolute configuration.
i solated from activated sludge and from other sources. Succinoglycans produced by diverse species differ for the content of pyruvate, succinate and acetyl groups (Zevenhuizen, 1997). Succinoglycan is used in agrochemical formulations, oil and gas field chemicals and products for personal and home care.
5. Polysaccharide shapes The biological function and the properties of polysaccharide are closely related to their primary structure and conformation, which in turn depends stringently on the former. The
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
6. Biological functions of capsular and exopolysaccharides
overall chain conformation of the carbohydrate polymers depends on the conformation of their building blocks. In fact, the size (penta-, hexa-, heptasaccharide), the type of ring (pyranose or furanose), the anomeric configuration ( or ) greatly influence the conformation of the monosaccharide (boat, skew boat or chair) and, consequently, that of the polysaccharide. Furthermore, the multiplicity of possible glycosidic linkages between sugar residues introduces further variability in the conformation of the final macromolecules. Glycosidic linkages involve C-1 of one residue and one of the hydroxyls on the other residues, originating several possibilities: (1→2)-, (1→3)-, (1→4)-, and (1→6)linkages. The glycosidic bond can also have two possible orientations, axial or equatorial, thus originating four possibilities for each linkage type. For example, in the case of a pyranose ring in the 4C1(D) conformation, the four possibilities for a (1→4)-linkage are: 1e→4e, 1a→4e, 1e→4a, 1a→4a, where 1a is the anomer and 1e is the one. Each of these possibilities has consequences on the conformation of the whole macromolecule. For example, there are eleven known disaccharides constituted only of glucose residues, but differing in the anomeric configuration and in the carbon atoms involved in the glycosidic bond. In contrast, from one type of amino acid only one dipeptide can be formed. It is straightforward that conformational complexity and variability increases by increasing the number of residues linked together. Without entering into details about the overall shapes of carbohydrate molecules, it can be generally stated that the rather high rigidity of the glycosidic ring, its steric hindrance and the limitation of the rotation degree of freedom around the glycosidic bonds [except for (1→6)-linkages which exhibit three rotational degrees of freedom, one of them having low rotational energy barriers] confer to these macromolecules rather elongated shapes. Therefore, their hydrodynamic volume is definitely larger than that of a globular protein with the same molar mass. Generally,
101
olysaccharides do not exhibit a tertiary strucp ture, as globular protein do, but their overall conformation dynamically changes according to the shape of the conformational-energy surface of local conformers. The concept of secondary structure for saccharides is also rather far from that applied to proteins. Although some structure regularity may exist, it usually dynamically involves stretches of the polymer and it is not restricted to specific sequences. Often, the presence of secondary structures is related to particular chemical constraints, like junction zones between different chains in gel phase (Morris et al., 1978), or interaction with specific agents (e.g. amylose-I2 complexes or specific cations interactions with polyelectrolytes (Chandrasekaran and Thailambal, 1990)). Several experimental methodologies are used in structure analysis: fibre X-ray diffraction, NMR spectroscopy and computational methods (Rao et al., 1998). In recent years, atomic force microscopy has given a notable contribution to the investigation of polysaccharide shapes (see Chapter 14).
6. Biological functions of capsular and exopolysaccharides The functions of the exopolymers can be distinguished in general and specific ways. With general functions, those related to the physico chemical characteristic of the polysaccharide molecules are intended and therefore they may apply to all bacteria with an exosaccharide layer. Polysaccharides are highly hydrated molecules and, therefore, they can provide an anti-dessication milieu. Thus, CPS and EPS, having quite a high molecular mass and a large number of possible hydrogen bond-forming groups, easily give rise to a very viscous aqueous solution, eventually leading to the formation of an interconnected polymeric matrix.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
102
6. Capsular polysaccharides and exopolysaccharides
These structures constitute a physical barrier towards potential enemies (e.g. macromolecules, bacteriophages and cell components of the host immune system), preventing the recognition and attachment to epitopes exposed on the underneath layer (outer membrane or peptidoglycan). When polyanionic, a further charge effect adds to the simple barrier, capturing positively charged species and repulsing negatively charged molecules, like serum components and cells with similar surface charge. For example, encapsulated bacteria pathogens show resistance to non-specific host immunity, like complement-mediated killing. In the absence of specific antibodies, the CPS barrier masks the underlying cell surface components that are usually potent activators of the complement alternative pathway (Taylor and Roberts, 2005). Another example is related to cationic antimicrobial peptides which are components of the humoral innate host defences and are produced by neutrophils; they can interact with bacterial membranes causing ultimately cell lysis. It was shown that alginate formed complexes with some antimicrobial peptides, keeping them distant from the bacterial membrane and thus protecting P. aeruginosa from lysis (Herasimenka et al., 2005). In addition, CPS and EPS can promote the adherence of bacteria to surfaces as well as to each other, facilitating the formation of a biofilm and the colonization of different ecological niches (fresh and seawater surfaces, dental surfaces, medical devices, industrial pipes and vessels) (Donlan and Costerton, 2002; Taylor and Roberts, 2005). Specific functions are those related to particular chemical and stereochemical motifs of the CPS and EPS. Hence, CPS that contain N-acetylneuraminic acid (Neu5Ac) are poor activators of the alternative pathway of the complement cascade because Neu5Ac binds a complement factor, resulting in breaking the amplification cascade and failure of the membrane attack complex formation (Michalek et al., 1988). Moreover,
CPS that have a primary structure identical to components of the host are not recognized as non-self and therefore they elicit no or a poor immune response. E. coli K1 and N. meningitidis serogroup B synthesize a homopolymer of -(2→8) sialic acid. Its low immunogenicity is attributable to immunologic tolerance induced by fetal exposure to polysialylated glycoproteins (Weintraub, 2003). Other examples are E. coli K5 CPS [4)--d-GlcAp-(1→4)--d-GlcNAcp(1→]n, which has a structure identical to an intermediate in the biosynthesis of heparin and Streptococcus pyogenes, one of the most pathogenic streptococci, with a capsule of hyaluronan, identical to the polysaccharide produced in higher animals. Alginate produced by P. aeruginosa has been extensively investigated to elucidate its biological function in the context of CF. It has been reported that alginate scavenges reactive oxygen species produced by macrophages as well as by cell free systems (Learn et al., 1987; Simpson et al., 1989). Most importantly, it was found that the conversion of non-mucoid to mucoid phenotype was the response of the bacteria to the release of H2O2 by activated polymorphonuclear leukocytes, as a defence mechanism towards this toxic chemical (Mathee et al., 1999). A role for the O-acetyl groups was also postulated; their presence was associated with dampening of the complement activation, with a consequent resistance to antibody-independent phagocytic killing (Pier et al., 2001). A further interesting example of a specific effect exerted by a CPS is that related to the Salmonella genus. Salmonella strains are responsible for typhoid fever (S. enterica sv. Typhi) and gastroenteritis (S. enterica serovars Typhimurium and Enteritidis) worldwide. It was demonstrated that neutrophil infiltration, observed in typhoid fever and not in gastroenteritis, was associated with the Vi capsular antigen, which was expressed by S. enterica sv. Typhi and not by serovar Typhimurium. (Raffatellu et al., 2006).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
7. Exopolysaccharides of the BURKHOLDERIA CEPACIA COMPLEX: A CASE STUDY
7. Exopolysaccharides of the Burkholderia cepacia complex: a case study B. cepacia was first described as Pseudomonas cepacia by Walter Burkholder in 1950 (Burkholder, 1950) and recognized as the phytopathogen responsible for the bacterial rot of onions. Before the early 1980s, B. cepacia was reported to cause infections only in hospitalized patients but, by the beginning of the 1980s, a rising incidence of pulmonary infection in CF patients was observed. Since then, B. cepacia was recognized as one of the bacterial species which can cause serious pulmonary infections in CF patients reducing their survival and sometimes leading to the “cepacia syndrome”, a rapidly fatal necrotizing pneumonia (Govan and Deretic, 1996). Detailed typing of microorganisms classified as B. cepacia revealed enough diversity to divide them in 16 different species B. cepacia, B. multivorans, B. cenocepacia, B. stabilis, B.vietnamensis, B. dolosa, B. ambifaria, B. anthina, B. pyrrocinia, B. latens, B. diffusa, B. arboris, B. seminalis, B. metallica B. contaminans and B. lata, that altogether constitute the B. cepacia complex (BCC), which includes environmental bacteria, as well as opportunistic pathogens. Most of the BCC species are mucoid due to the presence of exopolysaccharides when cultivated on mannitol-yeast extract solid medium (Sage et al., 1990), while this character is not always evident on other media. The presence of EPS as an indispensable requirement to express virulence is under debate. An investigation carried out on all species of the BCC showed that they express the mucoid phenotype, although among clinical isolates, B. cenocepacia was most frequently nonmucoid. Interestingly, isolates from patients with chronic infections were shown to convert from mucoid to non-mucoid (Zlosnik et al., 2008). Structural studies of several species revealed that members of the BCC can produce at least five different EPS (Figure 6.3) and that sometimes
103
the type produced depends on the medium used. Moreover, very often these microorganisms produce mixtures of up to three of the EPS indicated. Most of the strains examined produced the EPS named cepacian (see Figure 6.3), which has a rather unusual structure. The heptasaccharidic repeating unit has three residues in the main chain, two single and one double unit side chains, the rhamnose is in the d absolute configuration and the glucuronic acid is completely substituted on its hydroxyl functions (Cérantola et al., 1999). A three-dimensional sketch of three repeating units of cepacian is shown in Figure 6.4 as an example of polymeric chain complexity of EPS. Cepacian bears also from 1 to 3 acetyl substituents per repeating unit, depending on the strain examined. Regarding the remaining four known EPS, the one named PS-I (Cérantola et al., 1996) was reported to be produced only by two strains, while the one constituted of galactose and Kdo (Cescutti et al., 2003) is identical to the EPS produced by B. pseudomallei, the causative agent of mieloidosis. Levan was reported to be synthesized only by one strain of the BCC when mannitol was used instead of glycerol as a carbon source (Cescutti et al., 2003); interestingly, the bacteria did not need sucrose to produce it, as reported in the literature for other species. Dextran was demonstrated to be produced together with cepacian and PS-I only by B. cenocepacia strain C9343 (Conway et al., 2004). Molecular modelling calculations indicated a large intramolecular network of hydrogen bonds, especially between the main chain and the side chains. Overall, the chain showed a rather elongated shape, with bends characterized by a large bending radius (Sampaio Nogueira et al., 2005). In water, cepacian is also capable of forming double stranded stretches, which can be disentangled by addition of dimethylsulphoxide, as evidenced by viscometry and atomic force microscopy (AFM) studies (Figure 6.5). These double-chain segments do not give perfect matches between the two different chains, thus leading a single chain to interact
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
104
6. Capsular polysaccharides and exopolysaccharides β-D-Galp-(1→2)-α-D-Rhap 1 ↓ 4 [3)-β-D-Glcp-(1→3)-α-D-GlcpA-(1→3)-α-D-Manp-(1→]n 2 6 ↑ ↑ 1 1 β-D-Galp α-D-Galp cepaciana
[3)-β-D-Glcp-(1→3)-[4,6-O-(1-carboxyethylidene)]-α-D-Galp-(1→]n PS-Ib [5)-β-D-Kdop-(2→3)-β-D-Galp2Ac-(1→4)-α-D-Galp-(1→3)-β-D-Galp-(1→]n EPS containing Gal and Kdoc [6)-β-D-Fruf-(2→]n levanc [6)-α-D-Glcp-(1→]n Dextrand
Figure 6.3 Structures of the EPS repeating units produced by Burkholderia cepacia complex bacteria. Cepacian contains from 1 to 3 O-acetyl groups per repeating unit, depending on the strain: Cescutti et al. (2003); d Conway et al. (2004).
c
with more than one chain, with the consequent formation of a polymer network (Herasimenka et al., 2008). In particular, the chain rigidity and the tendency to aggregate makes cepacian a good candidate in establishing biofilm architecture. Although the primary structure of cepacian is very different from that of alginate, these two EPS share some similarities in their macromolecular properties: they give rise to a rather viscous aqueous solution and can form polymeric network, as visualized by AFM. The biological functions of EPS of BCC have just begun to be explored. Bylund et al. (2006) demonstrated that a mixture of cepacian, PS-I and dextran scavenged reactive oxygen species,
a
Cérantola et al. (1999);
b
Cérantola et al. (1996);
with a potency similar to alginate, and inhibited neutrophil chemotaxis. Recent experiments also indicated a protective effect of cepacian towards hypochlorite, another reactive oxygen species produced by neutrophils to kill microbes. In fact it was shown that hypochlorite caused an abrupt reduction of the molecular mass, a reaction which occurs mainly in the first two hours of incubation, by cleaving mainly the main chain of the polymer; alginate behaves in a very similar manner (P. Cescutti, unpublished results). Further definition of the biological properties of the EPS produced by strains of the BCC will lead to a better understanding of the interaction between bacterial pathogens and
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
8. Conclusion
105
Figure 6.4 Snapshot of three repeating units of cepacian taken during molecular dynamic simulation. Reprinted with permission, from Sampaio Nogueira et al. (2005).
Figure 6.5 AFM image of native cepacian recorded in non-contact mode after spray-drying onto a mica surface. The polymer concentration was 30 g/ml in water. The network of intertwined polysaccharidic chains is visible as white strings on a dark background.
host, a fundamental knowledge to fight and defeat microbial infections.
8. Conclusion In the last thirty years, there has been an enormous increase in the amount of polysaccharides
structures determined, mainly due to the advancement in the field of NMR and mass spectrometry. These studies on one hand evidenced the striking variability of the synthesized polymers, making one think that their number might be very large. On the other hand, the availability of these two very powerful techniques changed the way the primary structure of polysaccharides is determined. In fact, even if it is far from being automated, as it is for proteins, the full determination of the primary structure nowadays is achieved with small amounts of samples, because little chemical derivatization is necessary, and more NMR spectroscopy and mass spectrometry experiments, compared to some decades ago. It is worth emphasizing that the knowledge of the primary structure is fundamental to understand the biological functions of polysaccharides and their physicochemical properties. Future work should focus on understanding what are the general characteristics of EPS and CPS that render bacteria more resistant within their environmental niches and thus allowing their survival. The association of mucoid phenotype with pathogenicity has been proven for several bacteria, e.g. P. aeruginosa, S. aureus and
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
106
6. Capsular polysaccharides and exopolysaccharides
K. pneumoniae. However, in the case of bacteria belonging to the BCC, this association is still controversial. An important issue is the biological role of non-carbohydrate substituents. Certainly their presence is reflected on the shape the polysaccharide assumes, thus influencing the interaction with other molecules. A possible consequence of acetate binding to hydroxyl functions on the polysaccharide is the subtraction of linkage sites to complement opsonins (Pier et al., 2001). Another example is associated with enzymatic activity: it was reported that a lyase specific for cepacian was much more active on the deacetylated polysaccharide than on the native one. Considering that both bacteria, those producing cepacian and those synthesising the enzyme, were environmental, one
could suppose that the O-acetyl groups conferred some kind of protection to the former, impeding degradation of the EPS by the latter which, in turn, metabolized the enzymatic products (Cescutti et al., 2006). A characteristic that recently emerged and needs scientific investigation is the ability of some bacterial strains to synthesize more than one polysaccharide simultaneously; one example is given by some strains of the BCC. This capacity may confer a biological advantage to the microbes, like a wider range of responses, leading to the hypothesis that polysaccharide biosynthesis can be modulated depending on the type of molecular interactions. Further open questions for investigations on CPS and EPS are indicated in the Research Focus Box.
Research Focus Box
Is primary structure the key to understanding the biological properties? l Are there yet unknown general properties of CPS and EPS which are beneficial to microbes? l What is the importance of bacterial polysaccharides in biofilm structure? l
Acknowledgements I wish to thank Professor R. Rizzo for useful discussion throughout this work. The research on BCC polysaccharides was supported by the Italian Cystic Fibrosis Foundation (grant FFC # 11/2006) and by a grant of the Friuli Venezia Giulia Regional Government (LR11/2003, project n. 200502027001).
What are the roles of non-carbohydrate substituents? l What advantage is conferred to the microbe by the production of a polysaccharide mixture? l
References Bebault, G.M., Dutton, G.G.S., Funnell, N.A., Mackie, K.L., 1978. Structural investigation of Klebsiella serotype K32 polysaccharide. Carbohydr. Res. 63, 183–192. Burkholder, W.H., 1950. Sour skin, a bacterial rot of onion bulbs. Phytopathology 40, 115–117. Bylund, J., Burgess, L.A., Cescutti, P., Ernst, R.K., Speert, D.P., 2006. Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species. J. Biol. Chem. 281, 2526–2532.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
rEFERENCES
Cérantola, S., Marty, N., Montrozier, H., 1996. Structural studies of the acidic exopolysaccharide produced by a mucoid strain of Burkholderia cepacia, isolated from cystic fibrosis. Carbohydr. Res. 285, 59–67. Cérantola, S., Lemassu-Jacquier, A., Montrozier, H., 1999. Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Characterization of a trisubstituted glucuronic acid residue in a heptasaccharide repeating unit. Eur. J. Biochem. 260, 373–383. Cescutti, P., Toffanin, R., Kvam, B.J, Paoletti, S., Dutton, G.G.S., 1993. Structural determination of the capsular polysaccharide produced by Klebsiella pneumoniae serotype K40. NMR studies of the oligosaccharide obtained upon depolymerisation of the polysaccharide with a bacteriophage-associated endoglycanase. Eur. J. Biochem. 213, 445–453. Cescutti, P., Impallomeni, G., Garozzo, D., et al., 2003. Novel exopolysaccharides produced by a clinical strain of Burkholderia cepacia isolated from a cystic fibrosis patient. Carbohydr. Res. 338, 2687–2695. Cescutti, P., Scussolin, S., Herasimenka, Y., Impallomeni, G., Bicego, M., Rizzo, R., 2006. First report of a lyase for cepacian, the polysaccharide produced by Burkholderia cepacia complex bacteria. Biochem. Biophys. Res. Commun. 339, 821–826. Chandrasekaran, R., Thailambal, V.G., 1990. The influence of calcium ions, acetate and l-glycerate groups on the gellan double-helix. Carbohydr. Polym. 12, 431–442. Conway, B.D., Chu, K.K., Bylund, J., Altman, E., Speert, D.P., 2004. Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. J. Infect. Dis. 190, 957–966. Costerton, J.W., Irwin, R.T., Cheng, K.-J., 1981. The bacterial glycocalix in nature and disease. Annu. Rev. Microbiol. 35, 299–324. De Philippis, R., Vincenzini, M., 1998. Exocellular polysaccharides from cyanobacteria and their possible applications. FEMS Microbiol. Rev. 22, 151–175. Donlan, R.M., Costerton, J.W., 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167–193. Dutton, G.G.S., 1984. Capsular polysaccharides of Gram negative bacteria. In: Crescenzi, V., Dea, I.C.M., Stivala, S.S. (Eds.), New Developments in Industrial Polysaccharides. Gordon and Breach Science Publishers, Amsterdam, pp. 7–26. Dutton, G.G.S., Di Fabio, J., 1980. The capsular polysaccharide of Klebsiella serotype K60; a novel structural pattern. Carbohydr. Res. 87, 129–139.
107
Gacesa, P., Russell, N.J., 1990. Pseudomonas Infection and Alginates: Biochemistry, Genetics and Pathology. Chapman and Hall, London. Garegg, P.J., Jansson, P.-E., Lindberg, B., et al., 1980. Configuration of the acetal carbon atom of pyruvic acid acetals in some bacterial polysaccharides. Carbohydr. Res. 78, 127–132. Govan, J.R.W., Deretic, V., 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60, 539–574. Griffiths, A.J., Davies, D.B., 1991a. Type specific carbohydrate antigens of pathogenic bacteria. Part 1: Enterobacteriaceae. Carbohydr. Polym. 14, 241–279. Griffiths, A.J., Davies, D.B., 1991b. Type specific carbohydrate antigens of pathogenic bacteria. Part 2. Carbohydr. Polym. 14, 339–365. Herasimenka, Y., Benincasa, M., Mattiuzzo, M., Cescutti, P., Gennaro, R., Rizzo, R., 2005. Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 26, 1127–1132. Herasimenka, Y., Cescutti, P., Sampaio Noguera, C.E., et al., 2008. Macromolecular properties of cepacian in water and in dimethylsulfoxide. Carbohydr. Res. 343, 81–89. Jackson, G.E., Ravenscroft, N., Stephen, A.M., 1990. The use of bacteriophage-mediated depolymerisation in investigations of the structure of the capsular polysaccharide from Klebsiella serotype K71. Carbohydr. Res. 200, 409–428. Jann, B., Jann, K., 1990. Structure and biosynthesis of the capsular antigens of Escherichia coli. Curr. Top. Microbiol. 150, 19–42. Kenne, L., Lindberg, B., 1983. Bacterial polysaccharides. In: Aspinall, G. (ed.), The Polysaccharides, Vol. 2. Academic Press Inc, New York, pp. 287–363. Kumar, A.S., Mody, K., Jha, B., 2007. Bacterial exopolysaccharides – a perception. J. Basic Microb. 47, 103–117. Lacaze, G., Wick, M., Cappelle, S., 2007. Emerging fermentation technologies: development of novel sourdoughs. Food Microbiol. 24, 155–160. Learn, D.B., Brestel, E.P., Seetharama, S., 1987. Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect. Immun. 55, 1813–1818. Lindberg, B., 1990. Components of bacterial polysaccharides. Adv. Carbohydr. Chem. Biochem. 48, 279–318. Llull, D., López, R., García, E., 2001. Genetic bases and medical relevance of capsular polysaccharide biosynthesis in pathogenic streptococci. Curr. Mol. Med. 1, 475–491. Mancuso Nichols, C.A., Guezennec, J., Bowman, J.P., 2005. Bacterial exopolysaccharides from extreme marine environments with special consideration on the Southern ocean, sea ice, and deep-sea hydrothermal vents: a review. Mar. Biotechnol. 7, 253–271.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
108
6. Capsular polysaccharides and exopolysaccharides
Mathee, K., Ciofu, O., Sternberg, C., et al., 1999. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145, 1349–1357. Michalek, M.T., Mold, C., Bremer, E.G., 1988. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid. J. Immunol. 140, 1588–1594. Morris, E.R., Rees, D.A., Thom, D., Boyd, J., 1978. Chiroptical and stoichiometric evidence of a specific, primary dimerisation process in alginate gelation. Carbohydr. Res. 66, 145–154. Nigou, J., Gilleron, M., Puzo, G., 2003. Lipoarabinomannans: from structure to biosynthesis. Biochimie 85, 153–166. O’Riordan, K., Lee, J.C., 2004. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17, 218–234. Ovodov, Y.S., 2006. Bacterial capsular antigens. Structural patterns of capsular antigens. Biochemistry (Moscow) 71, 937–954. Pier, G.B., Coleman, F., Grout, M., Franklin, M., Ohman, D.E., 2001. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect. Immun. 69, 1895–1901. Raffatellu, M., Chessa, D., Wilson, R.P., Tükel, Ç., Akçelik, M., Bäumler, A.J., 2006. Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect. Immun. 74, 19–27. Rao, V.S.R., Qasba, P.K., Balaji, P.V., Chandrasekaran, R., 1998. Conformation of Carbohydrates. Harwood Academic Publishers, Amsterdam. Remminghorst, U., Rehm, B.H.A., 2006. Bacterial alginates: from biosynthesis to applications. Biotechnol. Lett. 28, 1701–1712. Sage, A., Linker, A., Evans, L.R., Lessie, T.G., 1990. Hexose phosphate metabolism and exopolysaccharide formation in Pseudomonas cepacia. Curr. Microbiol. 20, 191–198.
Sampaio Nogueira, C.E., Ruggiero, J.R., Sist, P., Cescutti, P., Urbani, R., Rizzo, R., 2005. Conformational features of cepacian: the exopolysaccharides produced by clinical strains of Burkholderia cepacia. Carbohydr. Res. 340, 1025–1037. Simpson, J.A., Smith, S.E., Dean, R.T., 1989. Scavenging by alginate of free radicals released by macrophages. Free Radical Bio. Med. 6, 347–353. Sutherland, I.W., 1994. Structure-function relationships in microbial exopolysaccharides. Biotechnol. Adv. 12, 393–448. Sutherland, I.W., 1999. Microbial polysaccharide products. Biotechnol. Genet. Eng. 16, 217–229. Taylor, C.M., Roberts, I.S., 2005. Capsular polysaccharides and their role in virulence. Contrib. Microbiol. 12, 55–66. van Dam, J.E.G., Fleer, A., Snippe, H., 1990. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie van Leeuwenhoek 58, 1–47. Weintraub, A., 2003. Immunology of bacterial polysaccharide antigens. Carbohydr. Res. 338, 2539–2547. Whitfield, C., 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75, 39–68. Widner, B., Behr, R., Von Dollen, S., et al., 2005. Hyaluronic acid production in Bacillus subtilis. Appl. Environ. Microb. 71, 3747–3752. Zevenhuizen, L.P.T.M., 1997. Succinoglycan and galactoglucan. Carbohydr. Polym. 33, 139–144. Zlosnik, J.E., Hird, T.J., Fraenkel, M.C., Moreira, L.M., Henry, D.A., Speert, D.P., 2008. Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J. Clin. Microbiol. 46, 1470–1473.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
7 Bacterial surface layer glycoproteins and “non-classical” secondary cell wall polymers Paul Messner, Eva Maria Egelseer, Uwe B. Sleytr and Christina Schäffer
Summary Cell surface layers, S-layers, are common structures of the prokaryotic cell envelope with a lattice-like appearance. They are formed by a selfassembly process and are attached to the bacterial cell via a special class of secondary cell wall polymers. Frequently, the constituting S-layer proteins are modified with covalently linked glycan chains facing the extracellular environment. S-layer glycoproteins by far exceed the display found with eukaryal or viral glycoproteins, making them ideal targets for studying the molecular basis of bacterial protein glycosylation. While in the past, research was focused on the elucidation of S-layer glycan structures and on their biochemistry, now, a molecular picture of the S-layer glycosylation process is evolving.
Microbial Glycobiology
This is the basis for the envisaged combination of S-layers with heterologous glycosylation systems to produce functional S-layer neoglycoproteins that, according to their intrinsic property to selfassemble into crystalline arrays, allow controlled and oriented display of glycan motifs with nanometerscale periodicity. Together with the developing understanding of the mode of interaction between S-layer (glyco)proteins and secondary cell wall polymers this will pave the way towards the production of novel nanopatterned “biomaterials” for various applications in the fields of biomedicine and nanobiotechnology, using carbohydrate recognition. Keywords: Cell wall component; Crystalline array; Glycoprotein; Molecular basis; Nanobiotechnology; Nanopatterning; Prokaryotic glycosylation; Secondary cell wall polymer; S-layer
109
© 2009 2010, Elsevier Inc.
110
7. S-layer glycoproteins and secondary wall polymers
1. Introduction A major issue for the survival of bacteria in a competitive habitat was the development of highly specific cell envelope structures as the primary site of interaction with the environment. These were even more diversified through incorporation and attachment of saccharide structures. This chapter focuses on unique, (glyco)protein self-assembly structures, forming two-dimensional crystalline arrays on bacterial cell surfaces (S-layers) (Sleytr and Beveridge, 1999; Sleytr et al., 2007) and on their cell wallanchoring polysaccharides (Mesnage et al., 2000; Sára, 2001; Schäffer and Messner, 2005).
2. Bacterial and archaeal S-layers S-layers are recognized as one of the most common cell surface structures in bacteria and represent an almost universal feature of archaea. In most archaea, the S-layer is either integrated into or penetrating the plasma membrane (Baumeister and Lembke, 1992). In Grampositive bacteria and archaea, the S-layer lattice assembles on the surface of the rigid peptidoglycan or the pseudomurein, respectively (Sleytr et al., 1999). In Gram-negative bacteria, a specific fraction of “smooth” lipopolysaccharide (LPS) is required for attachment of the S-layer to the outer membrane (Awram and Smit, 2001). S-layer synthesis and assembly resemble a very efficient system since, at a generation time of 20 minutes, at least 500 copies of a single (glyco)protein species have to be synthesized per second, translocated to the cell surface and incorporated into the S-layer lattice (Messner and Sleytr, 1992; Sára and Sleytr, 2000; Sleytr et al., 2007). This corresponds to up to 20% of the total protein synthesis effort of an organism being devoted to S-layer (glyco)protein production.
With a few exceptions, S-layers are composed of a single (glyco)protein species endowed with the ability to assemble into two-dimensional arrays on the cell surface during all stages of the cellular life cycle. High resolution electron microscopy studies revealed that S-layer lattices can exhibit oblique (p1, p2), square (p4) or hexagonal (p3, p6) symmetry with centre-to-centre spacing of the morphological units of 3 to 35 nm. Depending on the lattice type, the morphological units consist of one, two, three, four and six identical (glyco)protein subunits with molecular masses ranging from 40 000 to 170 000 (Sleytr and Beveridge, 1999; Sleytr et al., 2002). S-layer proteins can undergo diverse co- or post-translational modifications. Examples of covalent modifications include glycosylation, lipid attachment, phosphorylation and methylation (Claus et al., 2002; Schäffer and Messner, 2004; Eichler and Adams, 2005). About 30 years ago, first evidence was provided that S-layer proteins of archaea and bacteria may contain covalently linked carbohydrate chains (Mescher and Strominger, 1976; Sleytr and Thorne, 1976). Indeed, glycosylation is the most frequent modification of S-layer proteins, with the glycosylation degree varying between 1 and 10% (w/w) (Sumper and Wieland, 1995; Messner and Schäffer, 2003; Eichler and Adams, 2005; Messner et al., 2008). Glycosylation is energetically costly as co- or post-translational modification adds significantly to the potential functional spectrum of S-layer proteins (Sumper and Wieland, 1995; Claus et al., 2005; Eichler and Adams, 2005; Messner et al., 2008). Besides Gram-positive bacteria and archaea, for which S-layer glycosylation has been confirmed by various research groups in the past, only recently there were first reports on Gram-negative microorganisms possessing an S-layer glycoprotein layer; these are the pathogenic species Tannerella forsythia (Lee et al., 2006) and Bacteroides distasonis (Fletcher et al., 2007). The relation of S-layer protein glycosylation to pathogenicity is shedding new light in a potential in vivo function of S-layer glycans.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. General features of glycosylated s-layer proteins
3. General features of glycosylated S-layer proteins 3.1. Bacterial S-layer glycoproteins Presently, about 15 different S-layer glycoprotein glycan structures have been fully or at least partially elucidated and according to biochemical evidence, there are currently 30 further indications for S-layer glycoproteins (Figure 7.1). It is evident that prokaryotic Slayer glycoproteins by far exceed the display found with eukaryotic and viral glycoproteins, regarding composition, structure and linkage regions to the polypeptide. Usually, bacterial S-layer glycan chains are long linear or branched homo- or heterosaccharides with 50 to 150 glycoses that constitute about 15 to 50 repeating units. The repeating unit-wise concept of their biosynthesis leads to S-layer glycan heterogeneity, referred to as nanoheterogeneity (Schäffer and Messner, 2004). The monosaccharide constituents of bacterial S-layer glycan chains include a wide range of neutral hexoses, 6-deoxyhexoses and amino sugars. In addition, rare sugars, such as 3-N-acetylquinovosamine (Quip3NAc), 3-N-acetylfucosamine (Fucp3NAc), d-rhamnopyranose (d-Rhap), d-fucopyranose (d-Fucp) or d-glycero-d-manno-heptose, which are otherwise typical constituents of LPS Oantigens (Raetz and Whitfield, 2002), are found. The typical linkages of bacterial S-layer glycans to the protein portion are O-glycosidic linkages to serine, threonine and tyrosine; so far N-glycans have been found only in Archaea. Analysis of the corresponding S-layer protein sequences using PSIPREDView in combination with biochemical data has revealed that S-layer glycans are bound to surface-accessible loops of the protein, with two to four identified glycosylation sites per protein (see Figure 7.1). Bacterial S-layer glycoproteins possess a tripartite structure (Schäffer and Messner, 2004),
111
which compares to LPS O-antigens (Raetz and Whitfield, 2002). In some S-layer glycoproteins, capping of the terminal sugar residue at the non-reducing end of the glycan chain with noncarbohydrate constituents, such as O-methylgroups (2-O-Me, 3-O-Me) or (R)-N-acetylmuramic acid occurs (Schäffer et al., 1999b, 2002; Kählig et al., 2005). It may be speculated that these modifications are involved in glycan chain length termination during S-layer glycan biosynthesis (Raetz and Whitfield, 2002; Clarke et al., 2004).
3.2. Archaeal S-layer glycoproteins S-layers of archaeal organisms are directly exposed to their often extreme natural environments. As a consequence, intrinsic resistances against environmental stresses, such as high salt, acidity and temperature, are characteristic features of archaeal S-layers. The molecular mechanisms for these phenomena are still poorly understood. Archaeal S-layer (glyco)proteins are generally characterized by a predominance of non-polar amino acid residues, but some species contain an increased portion of charged residues (Claus et al., 2002). The S-layer glycoproteins of the hyperthermophiles Methanothermus fervidus and Mt. sociablis seem, however, to be exceptions to the rule, containing more asparagine than aspartate residues (Bröckl et al., 1991). Additional charges can be introduced into these S-layer proteins upon glycosylation (Claus et al., 2002). It has been proposed that an increase of charged residues can confer thermal stability to S-layer (glyco)proteins through enhanced electrostatic interactions (Cambilliau and Claverie, 2000). While most archaeal S-layer proteins seem to be glycosylated, complete S-layer glycan structures were only determined for the S-layer glycoproteins of Halobacterium salinarum (Sumper and Wieland, 1995), Haloferax volcanii (Sumper et al., 1990) and Methanothermus fervidus (Kärcher et al., 1993) (see Figure 7.1). Like eukaryal glycoproteins, archaeal S-layer glycoproteins can undergo
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
112
7. S-layer glycoproteins and secondary wall polymers
Bacterial S-Layer Glycoprotein Glycans Geobacillus stearothermophilus NRS 2004/3a (formerly Bacillus stearothermophilus) 2-OMe-α-L-Rhap-(1→3)-β-L-Rhap-(1→2)-α-L-Rhap-(1→[2)-α-L-Rhap-(1→3)-β-L-Rhap-(1→2)-α-L-Rhap-(1→]n∼15 2)α-L-Rhap-(1→3)-α-L-Rhap-(1→3)-β-D-Galp-(1→O)-Thr590,620 and/or →O)-Ser794 Geobacillus tepidamans GS5-97T α-D-MurNAc-(1→3)-α-L-Rhap-(1→2)-α-D-Fucp-(1→[3)-α-L-Rhap-(1→2)-α-D-Fucp-(1→]n∼10 3)2 α-L-Rhap-(1→3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→3)-β-D-Galp-(1→O)-Ser and/or D-Gal→O-Thr ↑ 1 β-D-GlcNAc Aneurinibacillus thermoaerophilus L420-91T (DSM 10154) and GS4-97 (formerly Bacillus thermoaerophilus) α-D-Fucp3NAc α-D-Fucp3NAc α-D-Fucp3NAc α-D-Fucp3NAc 1 1 1 1 ↑ ↑ ↑ ↑ 2 2 2 2 3-OMe-α-D-Rhap-(1→3)-α-D-Rhap-(1→2)-α-D-Rhap-(1→2)-α-D-Rhap-(1→[3)-α-D-Rhap-(1→3)-α-D-Rhap-(1→2)-α-D-Rhap(1→2)-α-D-Rhap-(1→]n∼15 [3)-α-D-Rhap-(1→]n=1-3 3)-β-D-GalpNAc-(1→O)-Thr67 Aneurinibacillus thermoaerophilus (DSM 10155) (formerly Bacillus thermoaerophilus) [→4)-α- L -Rhap-(1→3)-β- D -glycero- D -manno-Hepp-(1→]n∼18 [3)-α- L -Rhap-(1→]n=0-2 3)-β- D -GalpNAc-(1→O)-Ser69 and/or →O)-Thr471
Paenibacillus alvei (CCM 2051) (formerly Bacillus alvei) α-D-Glcp α-D-Glcp 1 1 ↓ ↓ 6 6 β- D -Galp-(1→4)-β- D -ManpNAc-(1→[3)-β- D -Galp-(1→4)-β- D -ManpNAc-(1→]n∼20 3)α-L-Rhap-(1→3)-α- L-Rhap-(1→3)-α- L -Rhap-(1→3)-β- D -Galp-(1→O)-Tyr 4 ↑ 1 GroA-(2→O)-PO2-(O→4)-β-D -ManpNAc Thermoanaerobacter thermohydrosulfuricus L111-69 and L110-69 (DSM 568) (formerly Clostridium thermohydrosulfuricum) 3-OMe-α- L-Rhap-(1→4)-α- D -Manp-(1→[3)-α- L -Rhap-(1→4)-α- D -Manp-(1→]n∼27 3)α- L-Rhap-(1→3)-α- L-Rhap-(1→3)-α- L -Rhap-(1→3)-β- D -Galp-(1→O)-Tyr Thermoanaerobacter thermohydrosulfuricus S102-70 (formerly Clostridium thermohydrosulfuricum) β- D -Galf-(1→3)-α- D -Galp-(1→2)-α- L-Rhap-(1→3)-α- L -Manp-(1→3)-α- L -Rhap-(1→3)-β- L -Glcp-(1→O)-Tyr
(Continues)
Figure 7.1 Glycan structures of bacterial and archaeal S-layer proteins. Abbreviations: Glcp, glucopyranose; Galf, galactofuranose; Man, mannose; Rha, rhamnose; GlcNAc, N-acetylglucosamine; GalNAc, N-acetylgalactosamine; ManNAc, N-acetylmannosamine; Fuc3NAc, 3-N-acetylfucosamine (3-acetamido-3,6-dideoxygalactose); Qui3NAc, 3-N-acetylquinovosamine (3-acetamido-3,6-dideoxyglucose), d-glycero-d-manno-Hepp, d-glycero-d-manno-heptose; MurNAc, N-acetylmuramic acid; GlcA, glucuronic acid; GalA, galacturonic acid; ManA, mannuronic acids; IdA, iduronic acid; 3-OMe-GalA, 3-O-methylgalacturonic acid; OMe, O-methyl; PO4, phosphate; SO42, sulfate; Asn, asparagine; Thr, threonine; Ser, serine; Tyr, tyrosine; Ala, alanine; X, interchangeable amino acid; n, number of repeats.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
113
3. General features of glycosylated s-layer proteins
Thermoanaerobacter thermohydrosulfuricus L77-66 (DSM 569) and L92-71 (formerly Clostridium thermohydrosulfuricum) O-glycosidic bond via Tyr
[→3)-α-D -GalpNAc-(1→3)-α- D -GalpNAc-(1→]n∼25 4 ↑ 1 α- D -GlcpNAc-(1→2)-β- D -Manp Thermoanaerobacterium thermosaccharolyticum D120-70 (formerly Clostridium thermosaccharolyticum)
β-D-Glcp α-D-Galp β-D-Glcp α-D-Galp 1 1 1 1 ↓ ↓ ↓ ↓ 2 6 2 6 α- L-Rhap-(1→3)-α- D -Manp-(1→4)-β- L -Rhap-(1→3)-α- D -Glcp-(1→[4)-α- L-Rhap-(1→3)-α- D -Manp-(1→4)-β- L-Rhap-(1→3)-α- D -Glcp(1→]n=3-10 4)-α- L-Rhap-(1→3)-α- D -Manp-(1→4)-β- D-Rhap-(1→3)-β- D -Glcp-(1→O)-Tyr 2 6 ↑ ↑ 1 1 β-L-Glcp α-D-Galp Thermoanaerobacterium thermosaccharolyticum E207-71 (Clostridium thermosaccharolyticum) O-glycosidic bond via Tyr
[→4)-β- D -Galp-(1→4)-β -D -Glcp-(1→4)-β - D -Manp-(1→]n~17 3 ↑ 1 β-D -Quip3NAc-(1→6)-β-D -Galf-(1→4)-α- D -Rhap Lactobacillus buchneri 41021/251 α-D -Glcp-(1→6)-[α- D -Glcp-(1→6)-]n=4-6 α- D -Glcp-(1→O)-Ser
Archaeal S-Layer Glycoprotein Glycans Halobacterium halobium R1M1 OSO3-
OSO3-
Ala-NH2
[→4)-GlcNAc-(1→4)-GalA-(1→3)-GalNAc-(1]n=10-15 →N)-Asn 6 3 ↑ ↑ Ala 1 1 3-OMe-GalA Galf Ser
GlcA-(1→4)-GlcA-(1→4)-GlcA-(1→4)-β- D -Glc-(1→N)-Asn 3 3 3 ↑ ↑ ↑ OSO3 OSO3X OSO3
1/3 of GlcA residues can be replaced by IdA
Thr/Ser α-D-Glc-(1→2)-Gal-(1→O)-Thr
(Continues)
Figure 7.1 Continued
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
114
7. S-layer glycoproteins and secondary wall polymers Haloferax volcanii DS2 β- D -Glc-(1→[4)-β- D -Glc-(1→]n=8 4)-β- D -Glc-(1→N)-Asn
Glc-(1→2)-Gal-(1→O)-Thr
Methanothermus fervidus V24S
3-OMe-α-D -Manp-(1→6)-3-OMe-α - D -Manp-(1→[2)-α- D -Manp-(1→]n=3 4)- D -GalNAc-(1→N)-Asn Methanosaeta soehngenii FE (formerly Methanothrix soehngenii)
Oligosaccharide-Rha-(1→N)-Asn
Figure 7.1 Continued
both N- and O-glycosylation (see Figure 7.1). Often, the sugar residues are modified by methylation or sulfation. Summarizing, differences between archaeal and bacterial S-layer glycoproteins are: (i) short versus long glycan chains; (ii) multiple versus few glycosylation sites; (iii) different versus single type of S-layer glycoprotein glycans; and (iv) predominantly N-glycans versus exclusively O-glycans (so far). In addition to S-layer protein glycosylation, glycosylation has also been reported for archaeal flagellins. The Hb. salinarum flagellins contain sulfated N-glycans similar to the glycan moieties found on the S-layer glycoprotein (Wieland et al., 1985). More recently, Methanococcus voltae flagellins have been shown to contain a novel N-linked trisaccharide -[-d-ManpNAcA6Thr-(1→4)--dGlcpNAc3NAcA-(1→3)--d-GlcpNAc]-, with an unusual amide-linked amino acid modification of ManpNAcA (Voisin et al., 2005). Interestingly, the Mc. voltae S-layer glycoprotein also shows this novel trisaccharide structure, suggesting a common glycosylation process for the two Mc. voltae surface proteins. This observation indicates that, in Hb. salinarum and Mc. voltae and presumably
also in other, not yet identified, prokaryotes, common pools of glycan precursors are shared for biosynthesis of cell surface glycoconjugates.
4. Genetics 4.1. Bacterial S-layer glycoproteins S-layer protein glycosylation of the investigated Gram-positive bacteria was found to be encoded by S-layer glycosylation (slg) gene clusters. Currently, most data are available from the organisms G. stearothermophilus NRS 2004/3a (GenBank AF328862), G. tepidamans GS5-97T (AY883421), A. thermoaerophilus strains L420-91T (AY442352) and DSM 10155/G (AF324836). In addition, a partial slg gene cluster sequence is available from T. thermosaccharolyticum E207-71 (AY422724) (Messner et al., 2008). Depending on the complexity of the encoded S-layer glycan, the clusters are 16 to 25 kb in size, corresponding to 16–21 open reading frames, and are transcribed as polycistronic units (Novotny et al., 2004). They code for nucleotide sugar pathway genes that are arranged consecutively, glycosyl transferase genes, glycan processing genes and transporter genes. From the assigned genes, it is
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
115
5. biosynthesis
evident that S-layer protein glycosylation additionally requires the participation of housekeeping genes that map outside the cluster. The comparison of the slg gene clusters of G. stearothermophilus NRS 2004/3a and G. tepidamans GS5-97T, whose S-layer glycans both possess an extended, tripartite structure, revealed that the clusters are organized in a similar way (Zayni et al., 2007). It seems that the central, variable part is responsible for the biosynthesis of individual repeating units and terminating elements of the S-layer glycan, whereas the region with higher homology encodes proteins involved in the assembly of the core region, the transport of the glycan to the cell surface and its ligation to distinct amino acids on the S-layer protein. This resembles the organization of Oantigen gene clusters in Gram-negative organisms, where the variability of O-antigens is considered as a result of recombination events in the central region of the O-antigen gene clusters (Kaplan et al., 2001). A complete comparison of all known slg gene clusters, including the assignment of individual open reading frames and their designation according to the bacterial polysaccharide gene nomenclature, has been published recently (Messner et al., 2008).
4.2. Archaeal S-layer glycoproteins With the availability of complete genome sequences, research now focuses on the functional characterization of genes involved in the glycosylation processes of archaeal S-layer proteins. Most of the molecular understanding of S-layer protein glycosylation in archaeal organisms was obtained for Hf. volcanii during recent years (Abu-Qarn and Eichler, 2006; Abu-Qarn et al., 2007, 2008). In the course of deciphering the Nglycosylation pathway, a number of genes homologous to human and mouse genes have been identified. The encoded proteins are, for instance, possibly responsible for loading activated glucose and mannose residues onto dolichol carriers
in the endoplasmic reticulum (ER) membrane (Burda and Aebi, 1999). Among the annotated proteins are also homologues of Campylobacter jejuni glycosyltransferases involved in protein N-glycosylation (Nothaft et al., 2008). In C. jejuni, the transfer of the completed oligosaccharide structure to selected Asn residues is mediated by PglB (Feldman et al., 2005), the Stt3 homologue of the eukaryal oligosaccharyl transferase (OST) complex (Yan and Lennarz, 2005). In Hf. volcani, Stt3, now renamed AglB (Chaban et al., 2006), is a predicted multi-spanning membrane protein, containing the canonical WWDYG motif (AbuQarn and Eichler, 2006). Involvement of AglB in N-glycosylation was verified by transcription of mRNA and differential expression of the protein in RT-PCR experiments. The aglD gene encodes a glycosyltransferase that is involved in the addition of the terminal hexose residue to a pentasaccharide decorating the Hf. volcanii S-layer protein, at least at sequon Asn13 and Asn83 (Abu-Qarn et al., 2007). The topology of AglD is reminiscent of eukaryal glycosyltransferases responsible for the transfer of mannose or glucose residues from charged dolichol carriers (Burda and Aebi, 1999). Another glycosyltransferase, AglE, was demonstrated to add a so far uncharacterized 190-Da sugar residue to the Hf. volcanii S-layer protein. The topological analysis assigned AglE as an integral membrane protein with the Nterminus and the putative active site located at the cytoplasmic face of the plasma membrane (Abu-Qarn et al., 2008). Together, these findings corroborate the developing picture about the N-glycosylation of the Hf. volcanii S-layer protein in particular, and about N-glycosylation of archaeal proteins in general.
5. Biosynthesis 5.1. Bacterial S-layer glycoproteins Unravelling molecular details about S-layer protein glycosylation is a prerequisite for S-layer
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
116
7. S-layer glycoproteins and secondary wall polymers
protein based carbohydrate engineering, a strategy in which S-layer protein glycosylation and exogenous, functional glycosylation pathways shall converge (Steiner et al., 2008a). S-layer glycoprotein biosynthesis is a very complex process in which the glycosylation event has to be coordinated with the synthesis of the S-layer protein and of the secondary cell wall polymer (SCWP) anchor, its translocation through the cell wall and the incorporation into the existing S-layer lattice. Based on the common principle that sugars are incorporated into growing glycan chains from the respective nucleotide-activated precursors, genes coding for nucleotide sugar pathway enzymes were identified in the different slg gene clusters (Messner et al., 2008). From these data, it is obvious that S-layer protein glycosylation pathways provide a spectrum of enzymes that may be used for carbohydrate engineering. The set-up of functional assays for the initiation enzyme WsaP and for four assigned transferases,
named WsaC through WsaF, encoded by the slg gene cluster of G. stearothermophilus NRS 2004/3a, has allowed drawing a first, full picture of how the S-layer glycan is assembled (Figure 7.2) (Steiner et al., 2007, 2008a). Our current model implicates WsaP in the first step of biosynthesis, whereby galactose is transferred from its nucleotide-activated form (UDP-Gal) to a membrane-associated lipid carrier at the cytoplasmic face of the plasma membrane (Steiner et al., 2007). Chain extension continues by consecutive addition of rhamnose residues from dTDP--l-rhamnose to the nonreducing terminus of the lipid-linked glycan chain by the action of the enzymes WsaC through WsaF, catalysing the formation of the -(1→2)-, -(1→3)and -(1→2)-linkages as present in the S-layer glycan, leading to the core saccharide and repeating unit-like structures (see Figure 7.1). Chain growth is predicted to be terminated by 2-O-methylation of the distal, terminal repeating unit, catalysed by a distinct domain of the multifunctional
Figure 7.2 Schematic representation of the S-layer glycoprotein glycan of G. stearothermophilus NRS 2004/3a (A) and organization of the corresponding S-layer glycosylation gene cluster (B). Gene nomenclature: sgsE, the S-layer structural gene; wsaA, a gene of unknown function; wsaB, oligosaccharyl:protein transferase; wsaC, rhamnosyltransferase; wzm, ABC transporter integral membrane protein; wzt, ATP-binding cassette (ABC) transporter nucleotide-binding protein; wsaE, trifunctional methyl-rhamnosyltransferase; wsaF, rhamnosyltransferase; rmlA; glucose-1-phosphate thymidylyltransferase; rmlC, dTDPdehydrorhamnose 3,5-epimerase; rmlB, dTDP-d-glucose 4,6-dehydratase; rmlD, dTDP-dehydrorhamnose reductase; wsaD, rhamnosyltransferase, wsaP, UDP-galactose-lipid carrier transferase; istA, transposase. Other abbreviations: S, S-layer protein; U, unkown function; L, ligation; E, export; A, assembly; P, sugar precursor biosynthesis, T, transposase. The site of action of the individual enzyme proteins for S-layer glycan biosynthesis is indicated in (A). Adapted, with permission, from Steiner et al. (2008a).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
117
5. biosynthesis
methylrhamnosyltransferase WsaE. The complete glycan chain would then be transported across the membrane by a process involving an ABC transporter and eventually transferred to the S-layer protein by the oligosaccharyl:protein transferase WsaB. With the identification of the initiation enzyme as a UDP-Gal:phosphoryl-polyprenol Gal-1-phosphate transferase and the presence of a dedicated ABC transporter, it is evident that S-layer protein glycosylation utilizes modules from either LPS O-antigen biosynthesis pathways
(Raetz and Whitfield, 2002). As several other slg gene clusters contain an ABC-transporter and numerous glycan chains are modified at the nonreducing end, the model described here for S-layer protein glycosylation might be widely valid.
5.2. Archaeal S-layer glycoproteins Genetic investigations (see Section 3.2) clearly revealed that the AglB, AglD and AglE proteins
(Continues)
Figure 7.3 Schematic presentation of the matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) analysis of the Asn13-containing, Haloferax volcanii S-layer glycoprotein-derived glycopeptide. The MALDI-TOF spectra of (A) the background, (B) the aglB-deleted, (C) the aglD-deleted and (D) the aglE-deleted strains are shown. The components of the glycopeptide-associated sugar residues are: , 162 m/z; , 176 m/z; , 190 m/z. The glycan moieties decorating the peptide peaks are marked on the MALDI-TOF spectra, accordingly. Adapted, with permission, from Abu-Qarn et al. (2007, 2008).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
118
7. S-layer glycoproteins and secondary wall polymers
FIGure 7.3 Continued
of Hf. volcanii (Chaban et al., 2006) are involved in S-layer protein N-glycosylation (Abu-Qarn et al., 2007, 2008). The glycosylation profile of this Slayer protein comprises both N- and O-linked glycan structures (Sumper et al., 1990). Seven proposed N-linked glycans are thought to contain either glucose alone or a mixture of glucose, galactose and idose. Recently, mass spectrometry was employed to provide insight into the composition of the S-layer glycan moieties decorating
amino acids Asn13 and Asn83 of the S-layer in Hf. volcanii deletion mutants (Abu-Qarn et al., 2007, 2008) (Figure 7.3). Deletion of aglB completely eliminated glycosylation at Asn13 (see Figure 7.3B) and Asn83, which confirms that AglB is solely responsible for oligosaccharyl transferase activity and that N-glycosylation is not essential for the organism. The glycan moieties naturally linked to Asn13 and Asn83 contain pentasaccharides consisting of two hexoses, two
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
6. the “non-classical” group of secondary cell wall polymers
hexuronic acids and a 190 m/z subunit, possibly corresponding to a methylated hexuronic acid or a di-methylated hexose (Abu-Qarn et al., 2007, 2008) (see Figure 7.3A). The AglD protein is involved in the addition of the final hexose to the pentasaccharides decorating at least Asn13 (see Figure 7.3C) and Asn83. The S-layer glycoprotein of an aglD-deletion mutant indicated reduced glycosylation and displayed altered protease sensitivity and an increased degree of structural disorder (AbuQarn et al., 2007). The observation that AglB can also transfer truncated glycan structures to the S-layer protein suggests relaxed substrate specificity of the enzyme, as reported for eukaryal OSTs (Munoz et al., 1994), C. jejuni PglB (Glover et al., 2005) and Mc. voltae AglB (Chaban et al., 2006). Although the precise role of AglE in Nglycosylation is still unknown, it is involved in the addition of a 190-Da sugar residue. This modification has been found at position 4 of the pentasaccharide decorating at least two S-layer protein sequons (Abu-Qarn et al., 2007, 2008) (see Figure 7.3D). The AglE protein is a homologue of eukaryal Dpm1, which is responsible for the addition of GDP-mannose to dolichol pyrophosphate to yield phosphodolichol mannose (Burda and Aebi, 1999). It is conceivable that AglE is responsible for loading the 190-Da sugar residue from the Hf. volcanii S-layer glycoprotein pentasaccharide onto a lipid carrier, from where it is then transferred onto the 176-Da sugar residue of the threemembered pentasaccharide precursor via the actions of a distinct transferase (Abu-Qarn et al., 2008), indicating also exocytosolic glycosylation reactions as proposed in Hb. salinarum. Different to aglB and aglD mutants, in aglE-deficient cells, no difference in cell growth, in S-layer glycoprotein release or in proteolytic susceptibility of the S-layer was observed under test conditions. The most pronounced shift in the apparent molecular mass of the Hf. volcanii S-layer glycoprotein and the biggest differences in S-layer architecture and protease susceptibility were observed
119
with the aglD deletion strain, where only the final 162-Da sugar residue of the N-linked pentasaccharide was missing. It can be speculated that this sugar residue plays a critical role in stabilizing the S-layer glycan structure. As in eukarya and bacteria, the N-glycosylation process of proteins in Hf. volcanii, and likely other Archaea, can obviously be divided into two parts: (i) the assembly of a lipid-linked oligosaccharide starting on the cytoplasmic side of the membrane; and (ii) the transfer of the glycan moiety to its target on the external side of the membrane (Sumper and Wieland, 1995). The exact mechanism, however, remains to be elucidated. Aberrant and absent N-glycosylation compromise the ability of Hf. volcanii cells to grow at high salt concentrations. Thus, N-glycosylation can be considered a post-translational modification designed to allow the organism to remain intact in a hypersaline environment (Sumper and Wieland, 1995; Abu-Qarn et al., 2007, 2008).
6. The “non-classical” group of secondary cell wall polymers 6.1. Structure The presence of polysaccharide compounds in the cell wall of bacteria, where they are linked to the peptidoglycan scaffold, has been known since the early days of cell wall research. These mostly anionic polymers have been classified into (i) teichoic acids and (ii) teichuronic acids (Araki and Ito, 1989); both classes together constituting the group of “classical” secondary cell wall polymers, which possess diverse “secondary roles” in cell wall function (Archibald et al., 1993; Navarre and Schneewind, 1999). A third, rather new class of SCWPs comprises compounds that have another, discrete function, which is mediation
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
120
7. S-layer glycoproteins and secondary wall polymers
of the non-covalent attachment of S-layer (glyco)proteins to the bacterial cell wall (Mesnage et al., 2000; Sára, 2001; Cava et al., 2004). This finding, together with their structural features (see below), let us classify these SCWPs as “nonclassical” SCWPs (Schäffer and Messner, 2005) that, per definition, are neither teichoic nor teichuronic acids (Araki and Ito, 1989). While initial investigations on “non-classical” SCWPs were focused on the elucidation of polysac charide structures and on the identification of the linkage to the peptidoglycan layer (Schäffer and Messner, 2005), recent research mainly concerns refinement of the data on the interaction between SCWPs and S-layer (glyco)proteins. In the investigated bacteria of the Bacillaceae family, the “non-classical” SCWPs were found to account for a substantial amount of 7–15% (by weight) of the peptidoglycan layer, which may be taken as an indication for their pivotal role in normal cell function. Interestingly, per microorganism, one distinct type of “non-classical” SCWP is present, making it a strain-specific feature. The linkage of these SCWPs to the peptidoglycan layer has been investigated by nuclear magnetic resonance (NMR) spectroscopy using intact SCWP-peptidoglycan complexes and provided evidence that they are linked to the C-6 atom of N-acetylmuramic acid residues via phosphodiester or pyrophosphate bridges, with about 20–25% of muramyl residues being substituted with SCWP (Schäffer et al., 1999a; Steindl et al., 2002, 2005). The direct association with peptidoglycan corroborates the suitability of “non-classical” SCWPs for their proposed in vivo anchoring function of S-layer (glyco)proteins (Sára, 2001). Comparison of the overall composition of all “non-classical” SCWPs analysed so far revealed some common features: SCWP glycans: (i) are heteropolysaccharides, with constituting glycoses including GlcpNA, ManpNAc, GalpNAc, ManpNAc3NAcA, ManpNAc3NAcNH2, Glcp, and Ribf; (ii) may be anionic or neutral;
(iii) possess possible non-carbohydrate substituents including pyruvate, phosphate or acetate; (iv) are, in most cases, composed of linear or branched repeating units of two to five glycoses; and (v) possess an average molecular mass of 4000–6000 (Table 7.1). Based on their structural motifs, these SCWPs are placed into three groups (Schäffer and Messner, 2005). Group I comprises a [→3)--dManpNAc-(1→4)--d-GlcpNAc-(1→] disaccharide backbone, which may additionally contain pyruvic acid substituents at the ManpNAc residues as shown for Paenibacillus alvei CCM 2051 (Schäffer et al., 2000) and Lysinibacillus sphaericus CCM 2177 (Ilk et al., 1999) or may contain substoichiometric amounts of ribofuranosyl side chains (Altman et al., 1996). Other Geobacillus strains harbouring a tetrasaccharide backbone with the structure [→4)--d-ManpNAc3NAcA-(1→6)--dGlcp-(1→4)--d-ManpNAc3NAcA-(1→3)--dGlcpNAc(1→], in which the 2,3-diacetamido-2, 3-dideoxymannuronic acid may also be modified by amidation, as in the case of G. tepidamans GS5-97T (Steindl et al., 2005), are compiled in group II. One example of an SCWP isolated from Aneurinibacillus thermoaerophilus DSM 10155 was reported with an unusual biantennary structure of defined chain length and has been placed into group III (Steindl et al., 2002). According to this classification scheme, the recently elucidated SCWP of G. stearothermophilus PV72/p2, possessing a [→3)--d-ManpNAcA-(1→4)--d-GlcpN(Ac)0.3(1→6)--d-GlcpNAc-(1→] backbone resembles to some extent group II (Petersen et al., 2008). In this case, however, it has to be considered, that the material used for structure elucidation has been liberated from the cell wall by hydrofluoric acid (HF) treatment, which can induce polysaccharide degradation. Coming back to the in vivo situation of the “non-classical” SCWPs, it is conceivable that glycan chain length variation due to the
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
SCWP Organism structure Geobacillus stearothermophilus PV72/p2
Table 7.1 SCWPs as anchors for S-layer proteins to the bacterial cell walla S-layer protein Charge Negative
Accession no. SbsB (X98095)
References
N-terminus
Ries et al., 1997
3-SLH motifs
Mader et al., 2004 Rünzler et al., 2004 Petersen et al., 2008
Lysinibacillus sphaericus CCM 2177 (3[Pyr-4,6] ~0.5 dMN4dGN) n89
Negative
SbpA (AF211170)
N-terminus 3-SLH motifs
Ilk et al., 1999
Paenibacillus alvei CCM 2051
Negative
SpaA (submitted to GenBank)
Unknown
Schäffer et al., 2000
Negative
Sap (P49051)
N-terminus (proposed)
Mesnage et al., 2000
EA1 (P94217)
3-SLH motifs
Negative
SgsE (AF328864)
N-terminus
Negative
SbsA (X71092)
N-terminus (proposed)
(3[Pyr-4,6]dMN4dGN) n~11 3[Pyr-4,6]dMN4dGNOP Bacillus anthracis Structure unknown; presence of pyruvyl residues Geobacillus stearothermophilus NRS 2004/3a (4DM2,3diNA6dG4dM2,3diNA3dGN) n~6 OP Geobacillus stearothermophilus PV72/p6
no SLH-motifs
Same structure proposed as for G. stearothermophilus NRS 2004/3a Geobacillus stearothermophilus ATCC 12980
Schäffer et al., 1999a, 2002
no SLH-motifs Negative
SbsC (AF055578)
Same structure proposed as for G. stearothermophilus NRS 2004/3a
N-terminus
Jarosch et al., 2001
no SLH-motifs
Ferner-Ortner et al., 2007 Pavkov et al., 2008
Geobacillus tepidamans GS5-97T
Neutral
SgtA (AY883421)
(4dM2,3diNAR6dG4dM2,3diNAR3dGN) n~6 OP Aneurinibacillus thermoaerophilus DSM 10155/G [dGN3dMN4dGalN3dGN3dMN4dGalN3dGN3]
N-terminus (proposed)
Steindl et al., 2005
no SLH-motifs Neutral
SatB (AY395579)
C-terminus (proposed)
6. the “non-classical” group of second cell wall polymers
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
(4[dGN3] ~0.3 dMNA3dGN(Ac) ~0.3 6[(S)Pyr-4, 6-dMN4]dGN) (partial structure)
Site of interaction with SCWP
Steindl et al., 2002
no SLH-motifs
dGN3dMN4dGalN3dGN3dMN4dGalN3dGN4 dMN3dGN3dMN3dGN3dGNOP
121
(Continues)
122
SCWP Organism structure Thermoanaerobacterium thermosaccharolyticum D120-70
S-layer protein Charge
Accession no.
Site of interaction with SCWP
References
Neutral
Unknown
Unknown
Schäffer et al., unpublished
Neutral
Unknown
Unknown
Altman et al., 1996
(3[Ribf 0.5]dMN4dGN) n Thermoanaerobacterium thermosaccharolyticum E207-71 (3[Ribf 0.5]dMN4dGN) n
a
Schäffer et al., unpublished
G, glucose; GN, N-acetylglucosamine; GalN, N-acetylgalactosamine; MN, N-acetylmannosamine; MNA, N-acetylmannosaminuronic acid; M2,3diNA, 2,3-acetamido-2,3-dideoxy-mannuronic acid; M2,3diNAR, 2,3-acetamido-2,3-dideoxy-mannuronic acid with modified carboxyl group; all sugars are in the pyranose form; P, phosphate; Pyr, pyruvic acid; Ribf, ribofuranose; n, number of repeats.
7. S-layer glycoproteins and secondary wall polymers
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
Table 7.1 (Continued)
6. the “non-classical” group of secondary cell wall polymers
repeating unit-wise composition of the glycans may be beneficial for anchoring of the S-layer (glyco)protein by providing more spatial flexibility to the protein during the initial phase of 2D crystallization on the cell surface. In the case of the chemically homogeneous biantennary SCWP of A. thermoaerophilus DSM 10155, doubling of binding motifs may be required to obtain a physiologically relevant binding strength for anchoring the “water-soluble” S-layer protein SatB to the cell wall (Steindl et al., 2002).
6.2. Functions Detailed investigations of the binding mechanism between S-layer (glyco)proteins and SCWPs revealed that, in general, S-layer proteins have two functional regions: a cell-wall-targeting domain which, in most of the organisms investigated thus far, is located at the N-terminus, and a C-terminal self-assembly domain. The existence of an N-terminal cell wall-targeting domain was substantiated by the identification of so called S-layer homology (SLH) motifs, consisting of 50 to 60 amino acids each, which are mostly found in triplicate at the N-terminus of S-layer proteins (Lupas et al., 1994). If present, SLH motifs interact with group I SCWPs carrying pyruvic acid residues (Ries et al., 1997; Lemaire et al., 1998; Ilk et al., 1999; Mesnage et al., 2000; Cava et al., 2004; Mader et al., 2004; Rünzler et al., 2004). Recent data indicated that a highly conserved TRAE motif plays a key role in the binding function of SLH domains (May et al., 2006). For SLH-mediated binding, the construction of knock-out mutants in Bacillus anthracis and Thermus thermophilus demonstrated that the addition of pyruvic acid residues to the SCWP was a necessary modification (Mesnage et al., 2000; Cava et al., 2004). This was also confirmed by surface plasmon resonance (SPR) spectroscopy measurements using the S-layer protein SbsB of Geobacillus stearothermophilus PV72/p2 and the corresponding native and depyruvylated SCWP for interaction studies (Mader et al., 2004). SPR data analysis revealed the presence of at least
123
two binding sites on a single SCWP molecule with an overall Kd of 7.7 107 M (Mader et al., 2004). Contrary to SbsB, in SbpA, the S-layer protein of L. sphaericus CCM 2177, the functional SCWP-binding domain is formed by three SLH-motifs and an additional 58-amino acid SLH-like motif (Huber et al., 2005). A further type of binding mechanism between S-layer (glyco)proteins and SCWPs has been described for the G. stearothermophilus wild-type strains PV72/p6, NRS 2004/3a and ATCC 12980 (Egelseer et al., 1998; Schäffer et al., 1999a; Jarosch et al., 2001). There, non-pyruvylated group II SCWP interacts with a highly conserved Nterminal region of the S-layer protein devoid of SLH motifs (Egelseer et al., 1998; Jarosch et al., 2001). First affinity studies using different N- or C-terminally truncated forms of the S-layer protein SbsC from G. stearothermophilus ATCC 12980 indicated that the N-terminal part comprising aa 31 to 257 is exclusively responsible for cell wall binding (Jarosch et al., 2001). This result is corroborated by the fact that the N-terminus contains a surplus of arginine, lysine and tyrosine residues, which are known to interact with carbohydrates via direct electrostatic interactions and hydrogen bonds. In a very recent study, the first high-resolution structure (2.4 Å resolution) of a bacterial S-layer protein could be elucidated from crystals of the water-soluble, C-terminally truncated form rSbsC31–844 (Pavkov et al., 2008). The crystal structure revealed a novel fold, consisting of six separate domains, which are connected by short flexible linkers. The N-terminal SCWP binding domain, comprising amino acids (aa) 32 to 260, consists of seven -helices organized in three left-handed anti-parallel triple-helical bundles connected by short loops. According to a BLAST search, the N-terminus of SbsC has high similarity not only to S-layer proteins of G. stearothermophilus strains but also to those of Geobacillus kaustophilus and Geobacillus tepidamans GS5-97T (SgtA). The SCWP of G. tepidamans GS5-97T recognized by SgtA differs from that bound by SbsC therein that the carboxyl groups of the ManpNAc3NAcA
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
124
7. S-layer glycoproteins and secondary wall polymers
residues carry modifications that turn the anionic character of this glycan into a neutral one, while that of G. stearothermophilus ATCC 12980 is negatively charged (Schäffer and Messner, 2005). Recently, the basic mechanism for anchoring an S-layer protein devoid of SLH motifs to the rigid cell wall layer was systematically investigated by SPR biosensor technology using the S-layer protein SbsC and the corresponding SCWP of G. stearothermophilus ATCC 12980 as a model system (Ferner-Ortner et al., 2007). The SPR data confirmed that the interaction is highly specific and that the N-terminal region comprising aa 31 to 270 is exclusively responsible for SCWP binding. Analysis of data from the setup, in which SCWP was immobilized on a sensor chip and either rSbsC31–270 or rSbsC31–443 represented the soluble analytes, indicated a binding behaviour with low (Kd 9.32 105 M and 2.95 106 M), medium (Kd 4.8 109 M and 1.22 108 M) and high (Kd 1.94 1012 M and 2.05 1012 M) affinity (Ferner-Ortner et al., 2007). Furthermore, isothermal titration calorimetry (ITC) suggested a strong binding of two S-layer protein molecules to one SCWP molecule with overall binding constants in the range of 106–107 and CD measurements showed that binding of the SCWP dramatically stabilizes the proteins (Pavkov et al., 2008). A cell-wall targeting domain is not necessarily located in the N-terminal region of Slayer proteins. In the S-layer proteins SlpA of Lactobacillus acidophilus ATCC 4356 and CbsA of Lactobacillus crispatus JCM 5810, a cell wallbinding domain has been identified in the Cterminal one third of these S-layer proteins and sequence alignment studies revealed a putative carbohydrate-binding repeat comprising approximately the last 130 C-terminal amino acids, which were suggested to be involved in cell wall binding (Smit et al., 2001). Cell wall anchoring via the C-terminal region seems to be present also in the S-layer proteins of A. thermoaerophilus strains DSM 10155 and L42091T according to sequence alignments. To conclude, the binding strength and specificity between S-layer (glyco)proteins and SCWPs
is of high relevance for generating and maintaining a dynamic protein crystal on a bacterial cell surface during all stages of cell growth and division since it guarantees a defined orientation for incorporated S-layer (glyco)proteins while allowing enough flexibility for recrystallization of Slayer subunits to continuously assume a low free energy arrangement (Sleytr et al., 2005).
7. Outlook Considering that glycans are ubiquitous biomolecules which, in many cases, are key to protein functions, it is evident that they are useful means for addressing various questions in the fields of basic and applied research, relating to the areas of biomimetics, drug targeting, vaccine design or diagnostics. In this context, high-density, periodic and controllable display of glycans, which through random chemical coupling reactions of glycans to various supports cannot be fully accomplished, plays a pivotal role. Exactly for this reason, the Slayer protein self-assembly system offers an attractive solution (Sleytr et al., 2007; Messner et al., 2008). Future research will likely focus on deepening the understanding of the molecular basis of the S-layer protein glycosylation process and of the mode of interaction between S-layer (glyco)proteins and their native anchoring structures to the cell wall, i.e. the “non-classical” SCWPs (Research Focus Box). Optimal strategies will be set up to produce modular S-layer neoglycoproteins by a combined protein/carbohydrate engineering approach that are equipped with functional, tailor-made glycan motifs (Steiner et al., 2008b). Nanometre-controlled glycan display can be envisaged in vivo on selected bacterial species or, by applying a biomimetic approach including “non-classical” SCWPs, on diverse supports. Engineering of such novel, nanopatterned composites by bottom-up strategies using an S-layer based biomolecular construction kit will decisively open up new possibilities in influencing and controlling complex biological systems.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
125
Research Focus Box Deepening the understanding the molecular basis of the S-layer glycosylation process. l Better understanding the mode of interaction between S-layer (glyco)proteins and the anchoring structures to the cell wall, i.e. “nonclassical” secondary cell wall polymers. l
Acknowledgements Financial support came from the Austrian Science Fund, projects P18013-B10 and P20745B11 (to P.M.), projects P19047-B12 and P20605B12 (to C.S.), project P18510-B12 (to E.-M.E.), the Hochschuljubiläumsstiftung der Stadt Wien, project H-1809/2006 (to C.S.) and the US Air Force Office of Scientific Research, project F49620-03-1-0222 (to U.B.S.).
References Abu-Qarn, M., Eichler, J., 2006. Protein N-glycosylation in Archaea: defining Haloferax volcanii genes involved in S-layer glycoprotein glycosylation. Mol. Microbiol. 61, 511–525. Abu-Qarn, M., Yurist-Doutsch, S., Giordano, A., et al., 2007. Haloferax volcanii AglB and AglD are involved in Nglycosylation of the S-layer glycoprotein and proper assembly of the surface layer. J. Mol. Biol. 374, 1224–1236. Abu-Qarn, M., Giordano, A., Battaglia, F., et al., 2008. Identification of AglE, a second glycosyltransferase involved in N-glycosylation of the Haloferax volcanii S-layer glycoprotein. J. Bacteriol. 190, 3140–3146. Altman, E., Schäffer, C., Brisson, J.-R., Messner, P., 1996. Isolation and characterization of an amino sugar-rich glycopeptide from the surface layer glycoprotein of Thermoanaerobacterium thermosaccharolyticum E207-71. Carbohydr. Res. 295, 245–253. Araki, Y., Ito, E., 1989. Linkage units in cell walls of Grampositive bacteria. CRC Crit. Rev. Microbiol. 17, 121–135.
Development of production of modular S-layer (neo)glycoproteins with functional tailor-made glycan motifs. l Development of nanometre-controlled glycan display in vivo and in vitro. l
Archibald, A.R., Hancock, I.C., Harwood, C.R., 1993. Cell wall structure, synthesis and turnover. In: Sonenshein, A., Hoch, J.A., Losick, R. (Eds.), Bacillus subtilis and Other GramPositive Bacteria. ASM Press, Washington, DC, pp. 381–410. Awram, P., Smit, J., 2001. Identification of lipopolysaccharide O antigen synthesis genes required for attachment of the S-layer of Caulobacter crescentus. Microbiology 147, 1451–1460. Baumeister, W., Lembcke, G., 1992. Structural features of archaebacterial cell envelopes. J. Bioenerg. Biomembr. 24, 567–575. Bröckl, G., Behr, M., Fabry, S., et al., 1991. Analysis and nucleotide sequence of the genes encoding the surfacelayer glycoproteins of the hyperthermophilic methanogens Methanothermus fervidus and Methanothermus sociabilis. Eur. J. Biochem. 199, 147–152. Burda, P., Aebi, M., 1999. The dolichol pathway of N-linked glycosylation. Biochim. Biophys. Acta 1426, 239–257. Cambillau, C., Claverie, J.M., 2000. Structural and genomic correlates of hyperthermostability. J. Biol. Chem. 275, 32383–32386. Cava, F., de Pedro, M.A., Schwarz, H., Henne, A., Berenguer, J., 2004. Binding to pyruvylated compounds as an ancestral mechanism to anchor the outer envelope in primitive bacteria. Mol. Microbiol. 52, 677–690. Chaban, B., Voisin, S., Kelly, J., Logan, S.M., Jarrell, K.F., 2006. Identification of genes involved in the biosynthesis and attachment of Methanococcus voltae N-linked glycans: insight into N-linked glycosylation pathways in Archaea. Mol. Microbiol. 61, 259–268. Clarke, B.R., Cuthbertson, L., Whitfield, C., 2004. Nonreducing terminal modifications determine the chain length of polymannose O-antigens of Escherichia coli and couple chain termination to polymer export via an ATP-binding cassette transporter. J. Biol. Chem. 279, 35709–35718.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
126
7. S-layer glycoproteins and secondary wall polymers
Claus, H., Akça, E., Debaerdemaeker, T., Evrard, C., Declercq, J.-P., König, H., 2002. Primary structure of selected archaeal mesophilic and extremely thermophilic outer surface layer proteins. Syst. Appl. Microbiol. 25, 3–12. Claus, H., Akça, E., Debaerdemaeker, T., et al., 2005. Molecular organization of selected prokaryotic S-layer proteins. Can. J. Microbiol. 51, 731–743. Egelseer, E.M., Leitner, K., Jarosch, M., et al., 1998. The Slayer proteins of two Bacillus stearothermophilus wildtype strains are bound via their N-terminal region to a secondary cell wall polymer of identical chemical composition. J. Bacteriol. 180, 1488–1495. Eichler, J., Adams, M.W.W., 2005. Posttranslational protein modification in Archaea. Microbiol. Mol. Biol. Rev. 69, 393–425. Feldman, M.F., Wacker, M., Hernandez, M., et al., 2005. Engineering N-linked protein glycosylation with diverse O-antigen lipopolysaccharide structures in Escherichia coli. Proc. Natl. Acad. Sci. USA 102, 3016–3021. Ferner-Ortner, J., Mader, C., Ilk, N., Sleytr, U.B., Egelseer, E.M., 2007. High-affinity interaction between the Slayer protein SbsC and the secondary cell wall polymer of Geobacillus stearothermophilus ATCC 12980 determined by surface plasmon resonance technology. J. Bacteriol. 189, 7154–7158. Fletcher, C.M., Coyne, M.J., Bentley, D.L., Villa, O.F., Comstock, L.E., 2007. Phase-variable expression of a family of glycoproteins imparts a dynamic surface to a symbiont in its human intestinal ecosystem. Proc. Natl. Acad. Sci. USA 104, 2413–2418. Glover, K.J., Weerapana, E., Numao, S., Imperiali, B., 2005. Chemoenzymatic synthesis of glycopeptides with PglB, a bacterial oligosaccharyl transferase from Campylobacter jejuni. Chem. Biol. 12, 1311–1315. Huber, C., Ilk, N., Rünzler, D., et al., 2005. The three S-layerlike homology motifs of the S-layer protein SbpA of Bacillus sphaericus CCM 2177 are not sufficient for binding to the pyruvylated secondary cell wall polymer. Mol. Microbiol. 55, 197–205. Ilk, N., Kosma, P., Puchberger, M., et al., 1999. Structural and functional analyses of the secondary cell wall polymer of Bacillus sphaericus CCM 2177 that serves as an S-layerspecific anchor. J. Bacteriol. 181, 7643–7646. Jarosch, M., Egelseer, E.M., Huber, C., et al., 2001. Analysis of the structure-function relationship of the S-layer protein SbsC of Bacillus stearothermophilus ATCC 12980 by producing truncated forms. Microbiology 147, 1353–1363. Kählig, H., Kolarich, D., Zayni, S., et al., 2005. N-acetylmuramic acid as capping element of -d-fucose-containing S-layer glycoprotein glycans from Geobacillus tepidamans GS5-97T. J. Biol. Chem. 280, 20292–20299. Kaplan, J.B., Perry, M.B., MacLean, L.L., Furgang, D., Wilson, M.E., Fine, D.H., 2001. Structural and genetic analyses of
O polysaccharide from Actinobacillus actinomycetemcomitans serotype f. Infect. Immun. 69, 5375–5384. Kärcher, U., Schröder, H., Haslinger, E., et al., 1993. Primary structure of the heterosaccharide of the surface glycoprotein of Methanothermus fervidus. J. Biol. Chem. 268, 26821–26826. Lee, S.W., Sabet, M., Um, H.S., Yang, J., Kim, H.C., Zhu, W., 2006. Identification and characterization of the genes encoding a unique surface (S-) layer of Tannerella forsythia. Gene 371, 102–111. Lemaire, M., Miras, I., Gounon, P., Béguin, P., 1998. Identification of a region responsible for binding to the cell wall within the S-layer protein of Clostridium thermocellum. Microbiology 144, 211–217. Lupas, A., Engelhardt, H., Peters, J., Santarius, U., Volker, S., Baumeister, W., 1994. Domain structure of the Acetogenium kivui surface layer revealed by electron crystallography and sequence analysis. J. Bacteriol. 176, 1224–1233. Mader, C., Huber, C., Moll, D., Sleytr, U.B., Sára, M., 2004. Interaction of the crystalline bacterial cell surface layer protein SbsB and the secondary cell wall polymer of Geobacillus stearothermophilus PV72 assessed by realtime surface plasmon resonance biosensor technology. J. Bacteriol. 186, 1758–1768. May, A., Pusztahelyi, T., Hoffmann, N., Fischer, R.J., Bahl, H., 2006. Mutagenesis of conserved charged amino acids in SLH domains of Thermoanaerobacterium thermosulfurigenes EM1 affects attachment to cell wall sacculi. Arch. Microbiol. 185, 263–269. Mescher, M.F, Strominger, J.L., 1976. Purification and characterization of a prokaryotic glucoprotein from the cell envelope of Halobacterium salinarium. J. Biol. Chem. 251, 2005–2014. Mesnage, S., Fontaine, T., Mignot, T., Delepierre, M., Mock, M., Fouet, A., 2000. Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation. EMBO J. 19, 4473–4484. Messner, P., Schäffer, C., 2003. Prokaryotic glycoproteins. In: Herz, W., Falk, H., Kirby, G.W. (Eds.), Progress in the Chemistry of Organic Natural Products, Vol. 85. Springer-Verlag, Wien, pp. 51–124. Messner, P., Sleytr, U.B., 1992. Crystalline bacterial cell-surface layers. Adv. Microb. Physiol. 33, 213–275. Messner, P., Steiner, K., Zarschler, K., Schäffer, C., 2008. Slayer nanoglycobiology of bacteria. Carbohydr. Res. 343, 1934–1951. Munoz, M.D., Hernandez, L.M., Basco, R., Andaluz, E., Larriba, G., 1994. Glycosylation of yeast exoglucanase sequons in alg mutants deficient in the glucosylation steps of the lipid-linked oligosaccharide. Presence of glucotriose unit in Dol-PP-GlcNAc2-Man9Glc3 influences both glycosylation efficiency and selection of N-linked sites. Biochim. Biophys. Acta 1201, 361–366.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
Navarre, W.W., Schneewind, O., 1999. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63, 174–229. Nothaft, H., Amber, S., Aebi, M., Szymanski, C.M., 2008. N-linked protein glycosylation in Campylobacter. In: Nachamkin, I., Szymanski, C.M., Blaser, M.J. (Eds.) Campylobacter, 3ed edn. ASM Press, Washington, DC, pp. 447–469. Novotny, R., Pföstl, A., Messner, P., Schäffer, C., 2004. Genetic organization of chromosomal S-layer glycan biosynthesis loci of Bacillaceae. Glycoconj. J. 20, 435–447. Pavkov, T., Egelseer, E.M., Tesarz, M., Svergun, D.I., Sleytr, U.B., Keller, W., 2008. The structure and binding behavior of the bacterial cell surface layer protein SbsC. Structure 16, 1226–1237. Petersen, B.O., Sára, M., Mader, C., et al., 2008. Structural characterization of the acid-degraded secondary cell wall polymer of Geobacillus stearothermophilus PV72/p2. Carbohydr. Res. 343, 1346–1358. Raetz, C.R.H., Whitfield, C., 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635–700. Ries, W., Hotzy, C., Schocher, I., Sleytr, U.B., Sára, M., 1997. Evidence that the N-terminal part of the S-layer protein from Bacillus stearothermophilus PV72/p2 recognizes a secondary cell wall polymer. J. Bacteriol. 179, 3892–3898. Rünzler, D., Huber, C., Moll, D., Köhler, G., Sára, M., 2004. Biophysical characterization of the entire bacterial surface layer protein SbsB and its two distinct functional domains. J. Biol. Chem. 279, 5207–5215. Sára, M., 2001. Conserved anchoring mechanisms between crystalline cell surface S-layer proteins and secondary cell wall polymers in Gram-positive bacteria. Trends Microbiol. 9, 47–49. Sára, M., Sleytr, U.B., 2000. S-layer proteins. J. Bacteriol. 182, 859–868. Schäffer, C., Messner, P., 2004. Surface-layer glycoproteins: an example for the diversity of bacterial glycosylation with promising impacts on nanobiotechnology. Glycobiology 14, 31R–42R. Schäffer, C., Messner, P., 2005. The structure of secondary cell wall polymers: how Gram-positive bacteria stick their cell walls together. Microbiology 151, 643–651. Schäffer, C., Kählig, H., Christian, R., Schulz, G., Zayni, S., Messner, P., 1999a. The diacetamidodideoxyuronic-acidcontaining glycan chain of Bacillus stearothermophilus NRS 2004/3a represents the secondary cell-wall polymer of wild-type B. stearothermophilus strains. Microbiology 145, 1575–1583. Schäffer, C., Müller, N., Christian, R., Graninger, M., Wugeditsch, T., Scheberl, A., Messner, P., 1999b. Complete glycan structure of the S-layer glycoprotein of Aneurinibacillus thermoaerophilus GS4-97. Glycobiology 9, 407–414.
127
Schäffer, C., Müller, N., Mandal, P.K., Christian, R., Zayni, S., Messner, P., 2000. A pyrophosphate bridge links the pyruvate-containing secondary cell wall polymer of Paenibacillus alvei CCM 2051 to muramic acid. Glycoconj. J. 17, 681–690. Schäffer, C., Wugeditsch, T., Kählig, H., Scheberl, A., Zayni, S., Messner, P., 2002. The surface layer (S-layer) glycoprotein of Geobacillus stearothermophilus NRS 2004/3a. Analysis of its glycosylation. J. Biol. Chem. 277, 6230–6239. Sleytr, U.B., Beveridge, T.J., 1999. Bacterial S-layers. Trends Microbiol. 7, 253–260. Sleytr, U.B., Thorne, K.J.I., 1976. Chemical characterization of the regularly arranged surface layers of Clostridium thermosaccharolyticum and Clostridium thermohydrosulfuricum. J. Bacteriol. 126, 377–383. Sleytr, U.B., Messner, P., Pum, D., Sára, M., 1999. Crystalline bacterial cell surface layers (S-layers): from supramolecular cell structure to biomimetics and nanotechnology. Angew. Chem. Int. Ed. Engl. 38, 1034–1054. Sleytr, U.B., Sára, M., Pum, D., Schuster, B., Messner, P., Schäffer, C., 2002. Self-assembly protein systems: microbial S-layers. In: Steinbüchel, A., Fahnestock, S.R. (Eds.), Biopolymers, Vol. 7: Polyamides and Complex Proteinaceous Matrices I. Wiley-VCH Verlag, Weinheim, pp. 285–338. Sleytr, U.B., Sára, M., Pum, D., Schuster, B., 2005. Crystalline bacterial cell surface layers (S-layers): a versatile selfassembly system. In: Ciferri, A. (Ed.), Supramolecular Polymers, 2ed edn. Taylor & Francis Inc, Boca Raton, pp. 583–612. Sleytr, U.B., Egelseer, E.M., Ilk, N., Pum, D., Schuster, B., 2007. S-Layers as a basic building block in a molecular construction kit. FEBS J. 274, 323–334. Smit, E., Oling, F., Demel, R., Martinez, B., Pouwels, P.H., 2001. The S-layer protein of Lactobacillus acidophilus ATCC 4356: identification and characterisation of domains responsible for S-protein assembly and cell wall binding. J. Mol. Biol. 305, 245–257. Steindl, C., Schäffer, C., Wugeditsch, T., et al., 2002. The first biantennary bacterial secondary cell wall polymer from bacteria and its influence on S-layer glycoprotein assembly. Biochem. J. 368, 483–494. Steindl, C., Schäffer, C., Smrecki, V., Messner, P., Müller, N., 2005. The secondary cell wall polymer of Geobacillus tepidamans GS5-97T: structure of different glycoforms. Carbohydr. Res. 340, 2290–2296. Steiner, K., Novotny, R., Patel, K., et al., 2007. Functional characterization of the initiation enzyme of S-layer glycoprotein glycan biosynthesis in Geobacillus stearothermophilus NRS 2004/3a. J. Bacteriol. 189, 2590–2598. Steiner, K., Novotny, R., Werz, D.B., et al., 2008a. Molecular basis of S-layer glycoprotein glycan biosynthesis in Geobacillus stearothermophilus. J. Biol. Chem. 283, 21120–21133.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
128
7. S-layer glycoproteins and secondary wall polymers
Steiner, K., Hanreich, A., Kainz, B., et al., 2008b. Recombinant glycans on an S-layer self-assembly protein: a new dimension for nanopatterned biomaterials. Small 4, 1728–1740. Sumper, M., Wieland, F.T., 1995. Bacterial glycoproteins. In: Montreuil, J., Vliegenthart, J.F.G., Schachter, H. (Eds.), Glycoproteins. Elsevier Science B.V., Amsterdam, pp. 455–473. Sumper, M., Berg, E., Mengele, R., Strobl, I., 1990. Primary structure and glycosylation of the S-layer protein of Haloferax volcanii. J. Bacteriol. 172, 7111–7118. Voisin, S., Houliston, R.S., Kelly, J., et al., 2005. Identification and characterization of the unique N-linked glycan common to the flagellins and S-layer glycoprotein of Methanococcus voltae. J. Biol. Chem. 280, 16586–16593.
Wieland, F., Paul, G., Sumper, M., 1985. Halobacterial flagellins are sulfated glycoproteins. J. Biol. Chem. 260, 15180–15185. Yan, A., Lennarz, W.J., 2005. Unraveling the mechanism of protein N-glycosylation. J. Biol. Chem. 280, 3121–3124. Zayni, S., Steiner, K., Pföstl, A., et al., 2007. The dTDP-4dehydro-6-deoxyglucose reductase encoding fcd gene is part of the surface layer glycoprotein glycosylation gene cluster of Geobacillus tepidamans GS5-97T. Glycobiology 17, 433–443.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
8 Glycosylation of bacterial and archaeal flagellins Susan M. Logan, Ian C. Schoenhofen and Evelyn C. Soo Summary The biosynthesis, assembly and regulation of the flagellar organelle has been extensively described over many decades and has focused primarily on the peritrichous flagella of Escherichia coli and Salmonella enterica. More recently, the characterization of flagellar systems from other bacterial and archaeal species has revealed distinct differences in flagellar composition and mode of assembly. Glycosylation of the flagellin structural protein has been identified as an important feature of numerous systems and has been shown to play an integral role in flagellar assembly or in virulence of a number of pathogenic species. This chapter focuses on the structural diversity of flagellar glycans, methods for characterization of flagellin glycoproteins and novel glycan biosynthetic pathways. The relevance of the glycosylation process to assembly as well as other novel biological roles is discussed. Keywords: Bacterial flagellin; Archaeal flagellin; Protein glycosylation; O-Linked glycan, N-Linked glycan
1. Introduction Flagellar motility is one of the most extensively studied processes of prokaryotic
Microbial Glycobiology
microbiology (for review see Macnab, 2004). The rich body of work directed towards this nanomachine encompasses many fields of biology including genetics, physiology, bioenergetics and structural biology, and has provided exquisite detail on the structure and function of this unique organelle. In more recent years, the body of work has been expanded to include the field of glycobiology that describes the production of glycosylated flagellins from a diverse range of bacterial and archaeal species. The flagellar glycans produced by these microorganisms are novel and the role of this glycosylation process in both flagellar assembly, as well as in biological interactions, is becoming clearly established. In contrast, the mechanistic basis of the process remains poorly defined.
1.1. Flagellar structures Although the extensively studied peritrichous flagella of Escherichia coli and Salmonella enterica sv. Typhimurium do not appear to produce glycosylated flagellins, glycosylation of flagellins in organisms producing polar flagella appears more commonplace (reviewed in Logan, 2006). Polar flagella are made by many bacteria and can
129
© 2009 2010, Elsevier Inc.
130
8. Glycosylation of flagella
be either simple (i.e. composed of only a single flagellin protein monomer) or complex (i.e. composed of more than one flagellin protein monomer) and are assembled either as a single filament (monotrichous) or in a bundle (multitrichous) at one or both ends of the cell. In some cases, these flagella may be covered with a sheath. Lateral flagella (LAF) are visible as a number of filaments extending at random points on the cell surface, but not from either pole, and are usually comprised of more than one structural protein. The periplasmic flagellum of spirochaetes is attached subterminally to each end of the cell cylinder and the flagella rotate within the periplasmic space conferring a unique form of motility to spirochaete cells (Charon and Goldstein, 2002). Flagellar-based motility is also common to the Archaea, although the flagellar structure produced by these microorganisms is quite distinct to that produced by bacteria. Archaeal flagella are more closely related to bacterial type IV pili in structure and mode of assembly (Thomas et al., 2001; Bardy et al., 2004). The flagellar filament is generally complex in nature and the archaeal flagellin monomers are produced with a leader peptide which is cleaved by a signal peptidase to produce mature flagellin. This protein is then incorporated into the base of the filament which lacks a central channel (Trachtenberg and Cohen-Krausz, 2006). This process is in distinct contrast to the eubacterial system where flagellin is incorporated at the distal end of the growing filament following export through the central lumen (Iino, 1969; Emerson et al., 1970).
1.2. O- versus N-linked glycans Glycans are commonly attached to proteins through either N- or O-linkage. Examination of eubacterial glycosylated flagellins has revealed that, in all examples studied to date, the glycans are attached to the protein via O-linkage to either serine or threonine residues. As is the case for O-glycosylation in eukaryotes, no
c onsensus sequence has been identified for bacterial O-linked glycosylation. However, the sites of glycosylation of bacterial flagellins appear to be restricted to the central variable region of the flagellin protein monomer rather than at the more conserved N- and C-terminals. Elegant X-ray crystallography and electron cryomicroscopy studies have provided a three-dimensional structure of S. enterica sv. Typhimurium flagellin and identified four structural domains, D0, D1, D2 and D3 (Samatey et al., 2000; Yonekura et al., 2003, 2005) (Figure 8.1). Both the N- and C-termini which comprise the D0 and D1 domains are rich in hydrophobic residues and these regions are known to interact hydrophobically with other flagellin subunits in the assembled filament (Yonekura et al., 2005). The D0 and D1 domains are highly conserved among bacteria and are critical for subunit interactions, whereas the central variable regions which comprise the D2 and D3 domains do not appear to be critical to subunit interactions. These domains are surface-exposed in the folded, assembled filament and only limited subunit interaction has been described for the D2 domain of S. enterica sv. Typhimurium. The D2 and D3 domains vary in sequence and length among eubacterial flagellins and are where the sites of glycosylation have been shown to reside (see Figure 8.1). In contrast, the two archaeal flagella studied to date produce flagellins where the glycan is N-glycosidically linked (Wieland et al., 1985; Voisin et al., 2005). Extensive mass spectrometry (MS) characterization of the four flagellin structural proteins from Methanococcus voltae revealed that the glycan was attached through the asparagine (Asn) residue of a typical eukaryotic N-linked sequon (Asn-Xaa-Ser/Thr, where X does not equal proline) rather than via the more recently characterized bacterial N-linked sequon (Asp/Glu-Yaa-Asn-Xaa-Ser/Thr, where X and Y do not equal proline) (Kowarik et al., 2006). In summary, archaeal flagellins show little homology to eubacterial flagellins.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. Flagellar glycan structures
131
Figure 8.1 O-linked sites of flagellar glycan attachment to flagellin monomers. Position and region of various structural domains in S. enterica sv. Typhimurium FliC with alignment of N- (■) and C-terminal regions (■/ ) of glycosylated flagellins from C. jejuni 81–176, H. pylori 1061, L. monocytogenes, P. aeruginosa PAO, P. aeruginosa PAK, and P. syringae pv. tabaci. Precise sites of glycosylation on each flagellin monomer are indicated by vertical lines.
2. Flagellar glycan structures 2.1. Archaea The first structural characterization of a flagellar glycan was completed for the flagellin of Halobacterium halobium (Wieland et al., 1985). This flagellin protein was shown to contain N-glycosidically linked oligosaccharides of sulfated (1→4)-linked glucuronic acid. More recently, the complete structural characterization of each of the four flagellin proteins FlaA, FlaB1, FlaB2 and FlaB3 from M. voltae revealed
a novel trisaccharide of mass 779 attached in N-linkage to a total of 14 sites. The structure of this novel glycan was determined by nuclear magnetic resonance (NMR) spectroscopy and shown to be composed of 2-acetamido-2deoxy-6-N-threonyl-mannopyranosiduronic acid--(1→4)-2,3-dideoxy-2,3-diacetamido-glucopyranosiduronic acid--(1→3)-2-deoxy-2-acetamido-glucopyranosyl (-ManpNAcA6Thr-(1→ 4)--GlcpNAc3NAcA-(1→3)-GlcpNAc) linked to Asn (Voisin et al., 2005). In both of these studies, the same glycan was found to decorate the respective S-layer protein implicating a common N-linked glycosylation pathway for these two major surface structures in Archaea.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
132
8. Glycosylation of flagella
Genetic studies in M. voltae have identified genes involved in the biosynthesis and transfer of the flagellar glycan to the flagellin protein. The aglA gene encodes a glycosyltransferase responsible for attachment of the terminal sugar to the glycan while aglB, which encodes an STT3 oligosaccharyltransferase homologue, is involved in the transfer of the complete glycan to the flagellins and S-layer proteins from a dolichol lipid carrier (Chaban et al., 2006). A third gene from M. voltae, aglH, encodes a protein that displays significant homology to Alg7 from yeast which catalyses the first step in the yeast N-linked glycosylation pathway by performing the enzymatic attachment of N-acetyld-glucosamine (GlcNAc) to a dolichol lipid carrier. Complementation of the alg7 conditional lethal mutation in yeast with the aglH gene provided the first evidence that the function of the M. voltae-encoded protein is an N-acetyl-dglucosamine-1-phosphate transferase (ShamsEldin et al., 2008). Mutational analysis of glycan biosynthetic genes revealed that the glycans played a significant role in the flagellar assembly process. In M. voltae, a mutant strain which was unable to transfer glycan to flagellin protein from the lipid linked carrier was non-motile and non-flagellated, whereas a second mutant strain, in which attachment of the terminal sugar of the glycan was disrupted, was poorly flagellated (Chaban et al., 2006).
2.2. Gram-positive bacteria 2.2.1. Listeria monocytogenes L. monocytogenes produces 4–6 simple, peritrichous flagella when grown at 30°C. Structural characterization revealed that the FlaA structural protein monomer is covalently modified with O-linked -GlcNAc at 3–6 sites per subunit (Schirm et al., 2004b). Modification with GlcNAc by the eukaryotic O-GlcNAc transferase (OGT) is commonly found on many nuclear and cytoplasmic eukaryotic proteins and is critical for a
number of regulatory processes within the cell. In L. monocytogenes, GmaR (lmo0688), which lies close to the flagellin structural gene, is the first flagellin glycosyltransferase and first prokaryotic OGT for which enzymatic activity has been directly demonstrated (Shen et al., 2006). Interestingly, GmaR also has been shown to function as an anti-repressor for MogR (a DNA binding transcriptional repressor) and plays a critical role in transcriptional regulation of flagellar biosynthesis. L. monocytogenes is a facultative intracellular pathogen that downregulates flagellar gene expression upon encountering physiological temperatures (37°C) and, consequently, flagella and related motility are not currently recognized as virulence factors in human infection (Peel et al., 1988). Flagellar motility is known to be critical for biofilm formation by L. monocytogenes and in attachment to environmental surfaces, although glycosylation does not appear to play a role in this process (Lemon et al., 2007). Glycosylation of flagellin is not required for flagellar formation by this bacterium and it remains to be determined what role glycosylation of the flagellin protein plays. 2.2.2. Clostridia spp. Motility is a recognized feature of a number of members of the genus Clostridium including the important human pathogens Clostridium botulinum and Clostridium difficile. Bioinformatic analyses of completed genome sequences of C. botulinum, C. difficile and Clostridium tetani have identified a number of glycan biosynthetic genes within the respective flagellar loci indicating glycosylation is likely to be an integral part of the clostridial motility system. Preliminary evidence for glycosylation of the flagellin protein from Clostridium tyrobutyricum has been presented (Arnold et al., 1998; Bedouet et al., 1998). In the case of Clostridium acetobutylicum flagellin, the glycan was sensitive to neuraminidase treatment indicating a “sialic acid-like” sugar as a glycan component (Lyristis et al., 2000).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. Flagellar glycan structures
2.3. Gram-negative bacteria 2.3.1. Pseudomonas spp. Pseudomonads are ubiquitous environmental organisms and, in some cases, opportunistic pathogens of both humans and plants. Motility has been recognized as critical to the pathogenic process for the human pathogen Pseudomas aeruginosa as well as the plant pathogen Pseudomonas syringae, and both of these organisms produce glycosylated flagella. P. aeruginosa produces a simple polar flagellum and its flagellins are classified as type a or type b based on amino acid sequence, antigenicity and molecular mass. Structural analysis of both type a and b flagellins has shown that novel glycans are attached at two sites in the central surface exposed region of each flagellin monomer (Schirm et al., 2004a; Verma et al., 2006). Flagellin from strain PAK (flagellin type a) is modified with a heterogeneous glycan of up to 11 monosaccharide units with rhamnose (Rha) as the linking sugar. In contrast, the glycan from PAO flagellin (type b) is simpler and appears also to have a deoxyhexose linking sugar. Distal to this monosaccharide is a unique modification of 209 Da, the structure of which has yet to be determined (Verma et al., 2006). A flagellar glycosylation island (GI) has been identified in both strains lying between flgL and fliC. The GI of the PAK strain consists of 14 open-reading frames (ORFs), many of which encode products with similarities to enzymes involved in carbohydrate biosynthesis. Polymorphism in genetic content of this island has been shown among other P. aeruginosa strains producing type a flagellins (Arora et al., 2001, 2004). In contrast, the GI of the PAO strain contains only four ORFs (i.e. PA1088, PA1089, PA1090 and PA1091), which is likely reflective of the simplicity of the glycan found on strains producing type b flagellins (Verma et al., 2006). Both GIs contain a gene encoding a glycosyltransferase (PA1091, orfN), which has been shown to be critical for addition of glycan to the protein (Schirm et al., 2004a; Verma et al.,
133
2006). Mutagenesis has demonstrated that glycosylation is not required for filament assembly or subsequent motility, but has been shown to be important in virulence. In the burned mouse model of infection, genetically defined mutants which produced non-glycosylated yet functional flagella were significantly attenuated (Arora et al., 2005). Additionally, glycosylation of the flagellin protein appears to play a role in the proinflammatory action of P. aeruginosa flagellin (Verma et al., 2005). The flagellins of some plant pathogens including Pseudomonas syringae pv. tabaci, Pseudomonas syringae pv. glycinea and Pseudomonas syringae pv. tomato have also been found to be glycosylated (Taguchi et al., 2006a,b; Takeuchi et al., 2007). The pathovar classification of P. syringae is due to virulence towards different host plant species and flagellin has been shown to be an elicitor of a hypersensitive reaction (HR) towards non-host plants. Glycosylation of flagellin has been shown to induce this HR (Taguchi et al., 2003). A tuft of polar flagella is produced by these organisms and these flagella are composed of a single FliC protein monomer. Six sites of glycosylation were identified in P. syringae pv. tabaci (Taguchi et al., 2006b) and mutation of these sites demonstrated that glycosylation was essential for adhesion, swarming and virulence on host tobacco leaves but was not required for flagellar assembly (Taguchi et al., 2003, 2006b, 2008). Structural analysis of the flagellin from P. syringae pv. tabaci 6605 revealed that the flagellin was glycosylated with a novel trisaccharide consisting of two rhamnosyl (Rha) residues and one modified 4-amino-4,6-dideoxyglucosyl (Qui4N) residue, 4-amino-4,6-dideoxy-3-(hydroxyl-1-oxobutyl)2-Me--d-glucopyranosyl-(-d-Quip4N(3hydroxy-1-oxobutyl)2Me-(1→3)--l-Rhap-(1→ 2)--l-Rhap). In contrast, although the flagellin proteins from the two strains are identical, the trisaccharide isolated from P. syringae pv. glycinea race 4 contained both l-Rha and d-Rha (Takeuchi et al., 2007). It remains to be determined
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
134
8. Glycosylation of flagella
if this change in chirality of the Rha residues contributes to the unique elicitor activity of each flagellin with respect to non-host plants. A P. syringae GI lying between flgL and fliC contains three ORFs; orf1 and orf2 which display significant homology to orfN from the P. aeruginosa GI and orf3 which shares homology to a putative 3-oxoacyl- (acyl carrier protein) synthase of Pseudomonas putida. Deletion of these genes reduced both virulence for respective host plants and HR-inducing activity in both P. syringae pv. tabaci 6605 and P. syringae pv. glycinea strains. Only orf1 and orf2 had a direct effect on flagellar glycosylation (Takeuchi et al., 2003; Ishiga et al., 2005; Taguchi et al., 2006b), while orf3 was shown to be required for the production of acylhomoserine lactones, molecules that are utilized for quorum sensing (Taguchi et al., 2006a). 2.3.2. Campylobacter jejuni/coli Campylobacter spp. produce bipolar, complex flagella composed of two structural proteins, FlaA and FlaB. Motility of campylobacters is essential for colonization of the viscous intestinal mucus in the human host and the flagellin protein is the immunodominant antigen on the cell surface (Black et al., 1988). Extensive genetic and structural studies have characterized the process of flagellar glycosylation in these microorganisms and have shown that it is essential for flagellar assembly, subsequent motility and virulence (Guerry et al., 1996; Linton et al., 2000; Thibault et al., 2001; Logan et al., 2002; Goon et al., 2003). The flagellin structural proteins have been shown to be one of the most heavily glycosylated prokaryotic proteins (see Figure 8.1) with up to 19 sites per monomers. A number of derivatives of the novel “sialic acid-like” nonulosonate sugars, such as pseudaminic acid, i.e. 5,7-diacetamido-3,5,7,9tetradeoxy-l-glycero--l-manno-nonulosonic acid (Pse5Ac7Ac) and legionaminic acid, i.e. 5,7-diacetamido-3,5,7,9-tetradeoxy-d-glycerod-galacto-nonulosonic acid (Leg5Ac7Ac), have
been shown to comprise the glycan modifications. These include the unique acetamidino derivatives 5-acetamidino-7-acetamido-3,5,7,9tetradeoxy-d-glycero-d-galacto-nonulosonic acid (Leg5Am7Ac), 5-E/Z-N-(N-methylacetimidoyl)7-acetamido-3,5,7,9-tetradeoxy-d-glycero-dgalacto-nonulosonic acid (Leg5AmNMe7Ac) and 5-acetamido-7-acetamidino-3,5,7,9-tetradeoxy-lglycero-l-manno-nonulosonic acid (Pse5Ac7Am) (Thibault et al., 2001; Logan et al., 2002; McNally et al., 2006, 2007). Genomic comparisons have revealed that the Campylobacter GI of approximately 50 genes is one of the most variable loci. Within this island are a number of genes that encode proteins with homology to carbohydrate biosynthetic genes, including those similar to sialic acid or N-acetylneuraminic acid (Neu5Ac) biosynthetic enzymes NeuB, NeuC and NeuA. Mutational analysis has revealed a role for many of these genes in motility and additional studies utilizing novel metabolomics approaches and functional studies on recombinant enzymes have defined the precise function of each in nonulosonate sugar biosynthetic pathways (see below). In addition, a unique feature of this GI is the presence of multiple copies of hypothetical genes encoding proteins that belong to the motility accessory family (Maf) of flagellin associated proteins (Karlyshev et al., 2002). The role of these proteins in glycosylation is currently unknown and homologues are found in only a limited number of other bacterial species including Wolinella, Helicobacter and Clostridium. Comparative phylogenomics of C. jejuni isolates has revealed a cluster of six genes within this locus which are a specific marker for a “livestock” clade, although the corresponding structure of the unique glycoform made by these genes remains to be determined (Champion et al., 2005). The flagellar glycans have also been shown to mediate autoagglutination of campylobacter cells (Guerry et al., 2006). This process is recognized to be the preliminary step for many organisms in formation of microcolonies and biofilms and is associated with a
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. Flagellar glycan structures
virulence phenotype of C. jejuni (Misawa and Blaser, 2000; Golden and Acheson, 2002). 2.3.3. Helicobacter pylori This bacterium produces a polar tuft of sheathed, complex flagella at one pole of the cell. Motility is essential for colonization of the mucosal surface of the human stomach prior to development of gastritis and duodenal ulcers (Eaton et al., 1996). The flagellar structural proteins FlaA and FlaB are glycosylated in a similar manner to C. jejuni with Pse5Ac7Ac found at seven sites on FlaA and ten sites on FlaB. As with C. jejuni, glycosylation is essential for filament formation and subsequent motility and so the process offers potential as a therapeutic target. In contrast to C. jejuni/coli, no heterogeneity in glycan composition has been found on H. pylori flagellin which may be due to the presence of a flagellar sheath covering the filament. This observation correlates with the simpler genetic content in H. pylori with respect to flagellar glycan biosynthetic genes (Creuzenet et al., 2000; Josenhans et al., 2002; Schirm et al., 2003; Merkx-Jacques et al., 2004; Schoenhofen et al., 2006a). Helicobacter felis, which is naturally found in the gastric mucosa of cats and dogs, produces bipolar bundles of sheathed flagellar filaments and was the first member of this genus shown to produce a glycosylated flagellin (Josenhans et al., 1999). 2.3.4. Aeromonas spp. These organisms are ubiquitous aquatic bacteria which have been shown to cause disease in fish, amphibians and reptiles; the mesophilic members of this species are significant human pathogens, causing predominantly gastrointestinal infections as well as wound infections and septicaemia. A polar, unsheathed flagellum is expressed in broth cultures (Rabaan et al., 2001) and, when cells are grown on solid media, lateral flagella are produced (Kirov et al., 2002).
135
Polar flagellar glycosylation has been demonstrated in the human pathogens Aeromonas caviae and Aeromonas hydrophila (Rabaan et al., 2001; Schirm et al., 2005) with glycosylation being essential for filament assembly (Gryllos et al., 2001). Characterization by mass spectrometry of the flagellin protein has revealed that six sites on FlaA and seven sites on FlaB carry a novel derivative of a nonulosonic acid sugar of mass 373 Da (Schirm et al., 2005). The lateral flagella of Aeromonas spp. also appear to be glycosylated, although the structure of the glycan on these flagellar filaments is not known (Gavin et al., 2002). 2.3.5. Caulobacter crescentus C. crescentus produces a unipolar, sheathed, complex flagellum in its swarmer cell progeny, as part of a unique developmental life cycle. While the identification of a flagellar glycosylation locus of this organism has been made and shown to contain genes that affect flagellar assembly (Johnson et al., 1983; Leclerc et al., 1998), no structural analysis of the flagellin proteins has been described to date. However, some of the genes identified in the C. crescentus flagellar GI (FlmA, FlmB, FlmC, FlmD and FlmH) have orthologues in GIs of a number of bacterial species which do produce glycosylated flagellins (e.g. C. jejuni, H. pylori and A. caviae). 2.3.6. Spirochaete periplasmic flagella While no detailed structural analysis of any spirochaete flagellar glycan has been completed, a number of studies have provided preliminary evidence for glycosylation of the flagellin structural proteins from Spirochaeta aurantia (Brahamsha and Greenberg, 1988), Serpulina hyodysenteriae (Li et al., 1993), Treponema pallidum (Wyss, 1998) and Borrelia burgdorferi (Ge et al., 1998). While reactivity of B. burgdorferi FlaA protein with the lectins SNA (Sambucus nigra agglutinin) and GNA (Galanthus nivalis
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
136
8. Glycosylation of flagella
agglutinin) indicated a novel complex glycan and sensitivity to N-glycosidase F suggested the glycan was attached in N-linkage, an extensive structural analysis of both FlaA and FlaB proteins from B. burgdorferi B31 has demonstrated that neither protein carries an Nlinked glycan (Sterba et al., 2008).
3. Structural analysis of flagellar glycans The use of mass spectrometry for characterization of flagellin glycan structures has been substantial. Typically, structural analysis begins with accurate mass measurements of the purified intact glycoprotein to determine if the measured mass of the flagellin is consistent with the predicted protein mass and to deduce the mass of the carbohydrate residues. This is then followed by determination of the nature of the carbohydrate modifications and the sites at which the modifications occur. Two approaches have been used to facilitate this work. The first, a “bottom-up” proteomics approach, involves proteolytic digestion of the flagellin glycoprotein followed by separation of peptides by liquid chromatography and collection of peptide fractions at regular intervals for analysis by liquid chromatography-mass spectrometry (LC-MS). Capillary liquid chromatography coupled to nanoelectrospray mass spectrometry (cLC-ESMS) is generally used to obtain the sensitivity that is required for the analysis of the suspected glycopeptides. By performing tandem mass spectrometry (MS-MS) experiments on the multiply-charged ions of the glycopeptides, cleavage of the glycosidic bonds takes place and allows the subsequent detection of characteristic oxonium ions relating to the carbohydrate modifications. The putative structures of the carbohydrate modifications are then deduced through further MS-MS experiments on the oxonium ions.
A second complementary approach, relying upon optimization of collisional activation conditions for specific cleavage of the carbohydrate moieties from the intact glycoprotein, is known as “top-down” mass spectrometry (Fridriksson et al., 2000). Schrim and co-workers have employed this novel approach to characterize flagellar glycans (Schrim et al., 2005; McNally et al., 2007). Typically, low collision energies do not cause significant collision-induced dissociation of the intact multiply-charged protein ions. However, because of the labile nature of the glycosidic bond, it is possible to gradually increase the collision energy and determine the optimal collision voltage at which the carbohydrate residues can be cleaved from the intact glycoprotein, without cleaving the protein backbone itself. The production of second-generation product ions of the intact flagellin multiplycharged ions can be readily achieved to provide structural information on the carbohydrate residues. To identify the location of the carbohydrate modifications on the bacterial flagellin, it is necessary to perform a proteolytic digestion of the flagellin protein followed by base-catalysed hydrolysis of the tryptic peptides to yield modified amino acids of neutral mass which can then be readily identified by a corresponding mass shift in the product ion spectrum of the -eliminated products. For example, in the case of O-linked flagellin glycosylation where the carbohydrate modifications occur at Ser and Thr residues, alkaline hydrolysis would yield modified amino acids of neutral mass 86 and 100 , respectively. The top-down approach offers a rapid and cost-effective alternative to the bottom-up approach for the structural analysis of flagellin glycans, as well as an opportunity for highthroughput application. Nevertheless, to determine the precise structural configuration of the carbohydrate moieties, it is necessary to use NMR spectroscopy. Early investigations of the novel glycans observed on the flagellin of
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Flagellar glycan biosynthetic pathways
C. jejuni 81–176 (Thibault et al., 2001) revealed that it was difficult to obtain sufficient quantities of purified glycopeptide for precise structural characterization of the unique flagellin glycans by NMR analysis. This is in part due to the labile nature of the glycan modifications but also the limitations in current NMR technology. As such, Soo et al. (2004) explored the use of metabolomics as a novel means to further the understanding of Pse5Ac7Ac biosynthesis in C. jejuni 81–176. They observed that intracellular pools of cytidine monophosphate- (CMP-) linked precursors had accumulated in wild-type cells of C. jejuni 81–176. The identification of these novel biosynthetic intermediates within cell lysates of C. jejuni presented an exciting opportunity to use the metabolome as a source for biosynthetic precursors of relevance to the flagellin glycosylation process and to achieve precise structural information on novel flagellin glycans by NMR spectroscopy through their corresponding CMP-linked intermediates. In order to isolate the CMP-linked intermediates from the metabolome, a method employing hydrophilic interaction liquid chromatography and mass spectrometry (HILIC-MS) with precursor ion scanning for fragment ions related to CMP (m/z 322) was developed. These metabolomics studies (McNally et al., 2006, 2007) in combination with NMR spectroscopy have yielded invaluable information on the identity of the biosynthetic CMP-activated precursors. Additionally, they have helped to determine the roles of genes involved in the biosynthesis of sialic-acid like sugars, such as those required for CMP-Pse5Ac7Am biosynthesis in C. jejuni 81–176. Furthermore, they offer an alternate method to the proteomics based bottom-up and top-down approaches for the structural determination of novel flagellar glycans. In contrast to purification of the glycopeptides for NMR analysis, the large-scale purification (1 g per litre of culture) of the CMP-linked intermediates is relatively easy to achieve. The use of this approach has permitted the purification of
137
the CMP-linked precursors, CMP-Pse5Ac7Ac, CMP-Pse5Ac7Am, CMP-Leg5Am7Ac and CMPLeg5AmNMe7Ac from either C. jejuni 81–176 or C. coli VC167. The structures of these metabolites are presented in Figure 8.2.
4. Flagellar glycan biosynthetic pathways The most extensively studied flagellin glycosylation systems are those from the gastrointestinal pathogens, H. pylori and C. jejuni/coli, exemplified by the wealth of detailed structural information summarized in Table 8.1. Since flagellins of Helicobacter and Campylobacter spp. are glycosylated via O-linkage with monosaccharides resembling sialic acid, this section will focus on the biosynthesis of these sialic acid-like molecules. Sialic acids are a family of -keto sugars with a common nine carbon backbone and, by definition, are N- and O-acyl derivatives of 5-amino3,5-dideoxy-d-glycero--d-galacto-nonulosonic acid or neuraminic acid (Neu). These sugars are typically found as the outermost moiety of oligosaccharides on vertebrate glycolipids and glycoproteins and have been shown to mediate a multitude of cell–cell and cell–molecule interactions (Vimr et al., 2004). Importantly, the biosynthesis of sialic acid in prokaryotes requires two enzymes: a UDP-GlcNAc-hydrolysing 2epimerase, NeuC, which produces N-acetyl-dmannosamine, and NeuB which condenses this N-acetylhexoamine with the three-carbon molecule pyruvate, forming the nine-carbon sialic acid, Neu5Ac. Nucleotide activation of Neu5Ac is performed by NeuA resulting in CMPNeu5Ac, which is the required substrate for sialyltransferases that complete the assembly of sialoglycoconjugates. It is only more recently that the biosynthetic steps leading to bacterial sialic acid-like sugars, or 5,7-diacetamido-3,5,7,9-tetradeoxynonulosonate derivatives, have been described.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
138
8. Glycosylation of flagella
Figure 8.2 The structures of CMP-sialic acid-like sugars identified in the metabolome of Campylobacter and characterized by NMR spectroscopy. (A) CMP-pseudaminic acid or CMP-5,7-diacetamido-3,5,7,9-tetradeoxyl-glycero-l-manno-nonulosonic acid and derivatives. (B) CMP-legionaminic acid or CMP-5,7-diacetamido-3,5,7,9-tetradeoxy-d-glycero-d-galacto-nonulosonic acid and derivatives. (C) CMP-sialic acid or CMP-5-acetamido-3,5-dideoxy-d-glycero-dgalacto-nonulosonic acid (CMP-Neu5Ac) is shown for comparison purposes only. Of note, sialic acid and legionaminic acid exhibit the same d-glycero-d-galacto absolute configuration. Known R-groups are shown for both (A) and (B), illustrating the diversity of functional groups observed for each. Confirmation of the - or -linkage of (A) and (B) to flagellin has yet to be determined, although preliminary evidence suggests both are -glycosidically linked.
These sugars appear to be unique to microorganisms and may exhibit configurational differences compared with Neu5Ac (Knirel et al., 2003). Pseudaminic acid, Pse5Ac7Ac, was the first bacterial sialic acid-like sugar identified and was found as a component of P. aeruginosa lipopolysaccharides (Knirel et al., 1984). Leading up to the complete elucidation of the CMP-pseudaminic acid pathway in Helicobacter (Schoenhofen et al., 2006a), a number of studies provided critical initial biosynthetic characterization and are summarized below. First, assuming that the biosynthesis of the bacterial sialic acid-like sugars follows a similar route to that for bacterial Neu5Ac, Pse5Ac7Ac biosynthesis would be expected to involve condensation of a HexNAc derivative with pyruvate. In fact, Chou et al. (2005) demonstrated this was
the case using a C. jejuni NeuB homologue, now designated PseI, a synthetically derived form of 2,4-diacetamido-2,4,6-trideoxy-l-altropyranose, and pyruvate, to chemi-enzymatically synthesize Pse5Ac7Ac. However, it is the HexNAc derivative that largely confers the precise stereochemical and functional nature of the respective nonulosonate the biosynthesis of which was previously ill-defined. Second, characterization of the initial two enzymes was important as there was considerable uncertainty surrounding their functions (Creuzenet et al., 2000; Goon et al., 2003; Creuzenet, 2004; Merkx-Jacques et al., 2004; Obhi and Creuzenet, 2005). Because of its lability and ring flexibility, the product of the initial pathway enzyme, PseB, was overlooked. By accounting for product lability and flexibility,
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
139
4. Flagellar glycan biosynthetic pathways
Table 8.1 Flagellin glycan structures associated with prokaryotic groups Organism
Flagellin glycan structure
Flagella type and glycan linkage
Possible relevance
Gastrointestinal pathogens C. coli
Pse5Ac7Aca Leg5Am7Acb Leg5AmNMe7Acc
Complex O-linkage (Seri/Thrj)
Mimicry with host cell-surface sialic acids Host-pathogen interactions, including adherence and invasion Immune evasion
C. jejuni
Pse5Ac7Ac
Filament assembly
Pse5Ac7Amd H. pylori
Pse5Ac7Ac
Intracellular pathogens L. monocytogenes
GlcNAce
Simple
Mimicry with host intracellular
O-linkage
O-GlcNAcylation
(Ser/Thr)
Immune evasion Modulation of host cell physiology
Plant pathogens P. syringae pv. tabaci pv. glycinea
Qui4N(3-hydroxy-1oxobutyl)2Me-Rha-Rhaf
Simple O-linkage (Ser/Thr)
Host/pathogen interactions influencing host specificity Filament stabilization
Extremophiles H. halobium
Glc-GlcASO4-GlcASO4GlcASO4g
Type IV pilin-like
Protection from harsh environments, in addition to a similarly glycosylated S-layer
M. voltae
ManNAcA6ThrGlcNAc3NAcA-GlcNAch
N-linkage (Asnk)
Filament assembly
a
5,7-Diacetamido-3,5,7,9-tetradeoxy-l-glycero-l-manno-nonulosonic acid; 5-Acetamidino-7-acetamido-3,5,7,9-tetradeoxy-d-glycero-d-galacto-nonulosonic acid; c 5-E/Z-N-(N-methylacetimidoyl)-7-acetamido-3,5,7,9-tetradeoxy-d-glycero-d-galacto-nonulosonic acid; d 5-Acetamido-7-acetamidino-3,5,7,9-tetradeoxy-l-glycero-l-manno-nonulosonic acid; e 2-acetamido-2-deoxy-glucopyranosyl; f 4-amino-4,6-dideoxy-3-(hydroxyl-1-oxobutyl)-2-Me--d-glucopyranosyl--(1→3)-l-rhamnopyranosyl--(1→2)-lrhamnopyranosyl; g Glucopyranosyl-(1→4)-2-O-sulfo-glucopyranosiduronic acid-(1→4)-2-O-sulfo-glucopyranosiduronic acid; h 2-Acetamido-2-deoxy-6-N-threonyl-mannopyranosiduronic acid--(1→4)-2,3-dideoxy-2,3-diacetamidoglucopyranosiduronic acid--(1→3)-2-deoxy-2-acetamido-glucopyranosyl; i Serine; j Threonine; k Asparagine. b
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
140
8. Glycosylation of flagella
the PseB and PseC reaction products were then unequivocally determined (Schoenhofen et al., 2006b), providing a solid foundation for defining the complete CMP-Pse5Ac7Ac pathway. Finally, as with any biosynthetic pathway elucidation, identification of the “catalytic players” or enzymes was critical. This was accomplished by a holistic approach including genomic, metabolomic and functional analyses. Utilizing the knowledge gained from these studies, the elucidation of the CMP-Pse5Ac7Ac pathways of both C. jejuni and H. pylori was completed. This was accomplished by monitoring sequential enzymatic reactions, including their expected co-factors and co-substrates, directly with NMR spectroscopy (Schoenhofen et al., 2006a). Here, the entire CMP-Pse5Ac7Ac pathway, starting from UDP-GlcNAc, was determined and proceeds as indicated in Figure 8.3. In summary, this pathway requires the actions of six biosynthetic enzymes: a C5-epimerase/ C4,6-dehydratase, aminotransferase, N-acetyltransferase, UDP-sugar hydrolase, Pse5Ac7Ac synthase or aldolase and CMP-Pse5Ac7Ac synthetase, designated PseB, PseC, PseH, PseG, PseI and PseF, respectively. Further studies also support these findings, including a detailed comprehensive characterization of PseG function (Liu and Tanner, 2006) as well as a metabolomics study implicating all of these enzymes as necessary for the production of CMP-Pse5Ac7Ac (McNally et al., 2006). Interestingly, the CMPPse5Ac7Ac pathway exhibits feedback regulation involving the initial pathway enzyme PseB and the final pathway product CMP-Pse5Ac7Ac (McNally et al., 2008); CMP-Pse5Ac7Ac was found to be a potent competitive inhibitor of PseB [Ki(app) 8.7 M]. Surprisingly, the regulation of CMP-Pse5Ac7Ac biosynthesis in Campylobacter and Helicobacter more closely resembles that for CMP-Neu5Ac production in eukaryotes, which displays similar feedback regulation (Kornfeld et al., 1964). This is in contrast to CMP-Neu5Ac production in E. coli, which is controlled by an aldolase (Vimr and Troy, 1985).
The biosynthetic pathway of the related nonulosonate, legionaminic acid (Leg5Ac7Ac) would be expected to be similar to that for Neu5Ac since they share the same absolute configuration (see Figure 8.2). As such, the Leg5Ac7Ac NeuClike enzyme would catalyse the conversion of UDP-2,4-diacetamido-2,4,6-trideoxy--d-glucose (UDP-6-deoxy-GlcNAc4NAc → 6-deoxyManNAc4NAc) similar to the conversion performed by the hydrolysing 2-epimerase, NeuC, involved in Neu5Ac biosynthesis (UDP-GlcNAc → ManNAc) (see Figure 8.3). In addition to C. coli, Legionella pneumophila also possesses legionaminic acid and, in fact, this sugar was first identified as a component of L. pneumophila lipopolysaccharides (Knirel et al., 2003). In efforts to reconstitute the CMP-Leg5Ac7Ac pathway from L. pneumophila, Glaze et al. (2008) described its biosynthesis using NeuC-, NeuBand NeuA-like enzymes from L. pneumophila and UDP-2,4-diacetamido-2,4,6-trideoxy--dglucose produced from Campylobacter general protein glycosylation enzymes (PglF, PglE and PglD). Although they reported modest synthesis via this route, the non-requirement for PglE in the production of CMP-Leg5Ac7Ac derivatives from Campylobacter (McNally et al., 2007) casts doubt on the pathway proposed. Further studies will be required to address this incongruence.
5. Conclusions and future perspectives A striking observation is the finding that eubacterial species possessing complex flagella (i.e. more than one flagellin subunit) glycosylate their flagellins with sialic acid-like sugars (see Table 8.1). In addition, it is only in these species that glycosylation has been found to be required for flagellar filament assembly. In contrast, eubacterial species possessing simple flagella (i.e. only one flagellin subunit) do not appear to produce sialic acid-like flagellin
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
5. Conclusions and future perspectives
141
Figure 8.3 Biosynthesis of sialic acid-like sugars. The CMP-pseudaminic acid biosynthetic pathway in H. pylori and C. jejuni (left) versus that proposed for CMP-legionaminic acid in C. coli (right). The enzymes of the CMP-pseudaminic acid pathway in order are: PseB, NADP-dependent dehydratase/epimerase; PseC, pyridoxal phosphate (PLP)-dependent aminotransferase; PseH, N-acetyltransferase; PseG, nucleotide diphosphate (NDP)-sugar hydrolase; PseI, pseudaminic acid synthase; PseF, CMP-pseudaminic acid synthetase. The biosynthetic intermediates are (I) Uridine diphosphate (UDP)-GlcNAc; (II) UDP-2-acetamido-2,6-dideoxy--l-arabino-hexos-4-ulose; (III) UDP-4-amino-4,6-dideoxy--l-AltNAc; (IV) UDP-2,4diacetamido-2,4,6-trideoxy--l-altropyranose; (V) 2,4-diacetamido-2,4,6-trideoxy-l-altropyranose; (VI) pseudaminic acid; (VII) CMP-pseudaminic acid. Pyranose rings are shown as their predominant chair conformation in solution determined from nuclear Overhauser effects (NOEs) and JH,H coupling constants. In addition, this pathway is feedback regulated (dashed line). The CMP-legionaminic acid biosynthetic pathway in C. coli is proposed to include a UDP-2,4-diacetamido2,4,6-trideoxy--d-glucopyranose intermediate; (VIII), possibly produced via the general protein glycosylation enzymes PglF, PglE and PglD. The final putative steps would include NeuC-, NeuB- and NeuA-like enzymes catalysing the formation of 2,4-diacetamido-2,4,6-trideoxy-d-mannopyranose; (IX), legionaminic acid; (X) and CMP-legionaminic acid; (XI), respectively.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
142
8. Glycosylation of flagella
modifications and the alternative glycosylation utilized by these organisms is not required for flagellar filament assembly. Structural comparison of C. jejuni complex filaments, obtained by electron cryomicroscopy reconstruction, with the atomic model for S. enterica sv.Typhimurium simple filaments has indicated that these two filament classes exhibit distinctive topographical features (Galkin et al., 2008). By crosssectional examination, it was shown that C. jejuni flagellar filaments had seven protofilaments surrounding the central lumen, as opposed to eleven protofilaments in the filament from S. enterica sv. Typhimurium. It was suggested that the distinctive morphology of the filament types results from alternative packing of the D1 domains (see Figure 8.1). The D1 domains of C. jejuni and related organisms have diverged from those of S. enterica sv. Typhimurium, such that they no longer contain a Toll-like receptor 5 (TLR5) signalling motif (see Chapter 31) and these changes may cause alterations in the folding of the D1 domain and overall ultrastructure. Despite the differences in subunit packing, the lumen size is comparable between the two types. It is tempting to suggest that the loose packing observed for C. jejuni complex filaments is facilitated by the sialic acid-like sugar modifications, whereby incorporation of these glycosylations has now become obligatory for assembly. Although nonglycosylated simple flagellin of P. syringae still assemble into filaments, their ability to promote motility in highly viscous media is signicantly reduced (Taguchi et al., 2008). Here, glycosylation is thought to stabilize the filament structure since lack of glycosylation results in excess bundling that could impede proper rotation of the filaments. Finally, although the flagellar filaments of Archaea more closely resemble type IV pili in structure and mode of assembly, the stability and assembly of these filaments are also dependent on glycosylation status (Chaban et al., 2006).
Aside from its requirement for filament assem bly and function, flagellin glycosylation has also been suggested to play important roles in adhesion, invasion, immune activation and evasion. For example, autoagglutination is a recognized marker of virulence for bacterial pathogens and is associated with flagellar glycosylation in C. jejuni (Misawa and Blaser, 2000; Golden and Acheson, 2002). Importantly, the composition of glycans present on the filament is critical to this process as evidenced by an autoagglutinationnegative phenotype for filaments containing only Pse5Ac7Ac and lacking Pse5Ac7Am (Guerry et al., 2006). This may result directly from carbohydrate interactions, or indirectly from their ability to introduce subtle filament ultrastructural changes as suggested above. In addition, flagellar glycans of Pseudomonas spp. are important virulence determinants, decreasing host lethality (LD50 values) in certain cases 10 000-fold and have been shown to stimulate inflammation as well as determine host specificity (Takeuchi et al., 2003, 2007; Arora et al., 2005; Verma et al., 2005). Furthermore, the similarity of flagellar glycans from gastrointestinal species to host sialic acids may confer upon these pathogens the ability to interact with specific eukaryotic receptors or lectins, facilitating host–pathogen interactions. Alternatively, these modifications may contribute to immune evasion by mimicking host cell surface composition, thus masking highly immunogenic epitopes. This correlates with the extensive repertoire of nonulosonate derivatives produced by Campylobacter spp., such as Leg5Am7Ac, Leg5AmNMe7Ac, Pse5Ac7Ac and Pse5Ac7Am, possibly enabling continued immune avoidance, whereas H. pylori, which covers its filament with a sheath, only produces Pse5Ac7Ac. Finally, it remains to be established the biological role of the O-GlcNAc modifications found on the flagellins of the intracellular pathogen L. monocytogenes (see Table 8.1), but it cannot be overlooked that
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
the same modification is present on eukaryote nuclear and cytoplasmic proteins where they are vital to proper cellular physiology. As a number of significant human pathogens produce glycosylated flagella essential for virulence, the development of inhibitors targeting flagellin glycosylation has great potential for providing novel antibacterials, especially towards gastrointestinal pathogens where motility is essential for colonization. In closing,
143
it is clear that glycosylation is important for the proper functioning of flagella in the microorganisms listed in Table 8.1. With the continued addition of new examples of organisms possessing flagellar glycans and the structural determination of these glycans, a pattern may emerge to further our understanding of their role in biological- or virulence-associated processes, as well as in the filament asembly process (Research Focus Box).
Research Focus Box
When are eubacterial glycans attached to flagellin monomers and how? l What is the role of glycans in flagella filament assembly, especially for complex flagella? l For complex flagella do “sialic acid-like” sugars influence filament shape and stability? l
Acknowledgements We are grateful to T. Devecseri for help with figure preparation.
References Arnold, F., Bedouet, L., Batina, P., et al., 1998. Biochemical and immunological analyses of the flagellin of Clostridium tyrobutyricum ATCC 25755. Microbiol. Immunol. 42, 23–31. Arora, S.K., Bangera, M., Lory, S., Ramphal, R., 2001. A genomic island in Pseudomonas aeruginosa carries the determinants of flagellin glycosylation. Proc. Natl. Acad. Sci. USA 98, 9342–9347. Arora, S.K., Wolfgang, M.C., Lory, S., Ramphal, R., 2004. Sequence polymorphism in the glycosylation island and
Do the “sialic acid-like” sugars found on flagellins of gastrointestinal pathogens play a role in specific host cell interactions? l What is the role of the GlcNAc modification found of the flagellins of the intracellular pathogen L. monocytogenes? l
flagellins of Pseudomonas aeruginosa. J. Bacteriol. 186, 2115–2122. Arora, S.K., Neely, A.N., Blair, B., Lory, S., Ramphal, R., 2005. Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections. Infect. Immun. 73, 4395–4398. Bardy, S.L., Ng, S.Y., Jarrell, K.F., 2004. Recent advances in the structure and assembly of the archaeal flagellum. J. Mol. Microbiol. Biotechnol. 7, 41–51. Bedouet, L., Arnold, F., Robreau, G., Batina, P., Talbot, F., Binet, A., 1998. Evidence for an heterogeneous glycosylation of the Clostridium tyrobutyricum ATCC 25755 flagellin. Microbios 94, 183–192. Black, R.E., Levine, M.M., Clements, M.L., Hughes, T.P., Blaser, M.J., 1988. Experimental Campylobacter jejuni infection in humans. J. Infect. Dis. 157, 472–479. Brahamsha, B., Greenberg, E.P., 1988. Biochemical and cytological analysis of the complex periplasmic flagella from Spirochaeta aurantia. J. Bacteriol. 170, 4023–4032.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
144
8. Glycosylation of flagella
Chaban, B., Voisin, S., Kelly, J., Logan, S.M., Jarrell, K.F., 2006. Identification of genes involved in the biosynthesis and attachment of Methanococcus voltae N-linked glycans: insight into N-linked glycosylation pathways in Archaea. Mol. Microbiol. 61, 259–268. Champion, O.L., Gaunt, M.W., Gundogdu, O., et al., 2005. Comparative phylogenomics of the food-borne pathogen Campylobacter jejuni reveals genetic markers predictive of infection source. Proc. Natl. Acad. Sci. USA 102, 16043–16048. Charon, N.W., Goldstein, S.F., 2002. Genetics of motility and chemotaxis of a fascinating group of bacteria: the spirochetes. Annu. Rev. Genet. 36, 47–73. Chou, W.K., Dick, S., Wakarchuk, W.W., Tanner, M.E., 2005. Identification and characterization of NeuB3 from Campylobacter jejuni as a pseudaminic acid synthase. J. Biol. Chem. 43, 35922–35928. Creuzenet, C., 2004. Characterization of CJ1293, a new UDPGlcNAc C6 dehydratase from Campylobacter jejuni. FEBS Lett. 559, 136–140. Creuzenet, C., Schur, M.J., Li, J., Wakarchuk, W.W., Lam, J.S., 2000. FlaA1, a new bifunctional UDP-GlcNAc C6 dehydratase/C4 reductase from Helicobacter pylori. J. Biol. Chem. 275, 34873–34880. Eaton, K.A., Suerbaum, S., Josenhans, C., Krakowka, S., 1996. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect. Immun. 64, 2445–2448. Emerson, S.U., Tokuyasu, K., Simon, M.I., 1970. Bacterial flagella: polarity of elongation. Science 169, 190–192. Fridriksson, E.K., Beavil, A., Holowka, D., Gould, H.J., Baird, B., McLafferty, F.W., 2000. Heterogeneous glycosylation of immunoglobulin E constructs characterized by top-down high-resolution 2-D mass spectrometry. Biochemistry 39, 3369–3376. Galkin, V.E., Yu, X., Bielnicki, J., et al., 2008. Divergence of quaternary structures among bacterial flagellar filaments. Science 320, 382–385. Gavin, R., Rabaan, A.A., Merino, S., Tomas, J.M., Gryllos, I., Shaw, J.G., 2002. Lateral flagella of Aeromonas species are essential for epithelial cell adherence and biofilm formation. Mol. Microbiol. 43, 383–397. Ge, Y., Li, C., Corum, L., Slaughter, C.A., Charon, N.W., 1998. Structure and expression of the FlaA periplasmic flagellar protein of Borrelia burgdorferi. J. Bacteriol. 180, 2418–2425. Glaze, P.A., Watson, D.C., Young, N.M., Tanner, M.E., 2008. Biosynthesis of CMP-N,N’-diacetyllegionaminic acid from UDP-N,N’-diacetylbacillosamine in Legionella pneumophila. Biochemistry 47, 3272–3282. Golden, N.J., Acheson, D.W., 2002. Identification of motility and autoagglutination Campylobacter jejuni mutants by random transposon mutagenesis. Infect. Immun. 70, 1761–1771.
Goon, S., Kelly, J.F., Logan, S.M., Ewing, C.P., Guerry, P., 2003. Pseudaminic acid, the major modification on Campylobacter flagellin, is synthesized via the Cj1293 gene. Mol. Microbiol. 50, 659–671. Gryllos, I., Shaw, J.G., Gavin, R., Merino, S., Tomas, J.M., 2001. Role of flm locus in mesophilic Aeromonas species adherence. Infect. Immun. 69, 65–74. Guerry, P., Doig, P., Alm, R.A., Burr, D.H., Kinsella, N., Trust, T.J., 1996. Identification and characterization of genes required for post-translational modification of Campylobacter coli VC167 flagellin. Mol. Microbiol. 19, 369–378. Guerry, P., Ewing, C.P., Schirm, M., et al., 2006. Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol. Microbiol. 60, 299–311. Iino, T., 1969. Polarity of flagellar growth in salmonella. J. Gen. Microbiol. 56, 227–239. Ishiga, Y., Takeuchi, K., Taguchi, F., et al., 2005. Defense responses of Arabidopsis thaliana inoculated with Pseudomonas syringae pv. tabaci wild type and defective mutants for flagellin (fliC) and flagellin glycosylation (orf1). J. Gen. Plant Pathol. 71, 302–307. Johnson, R.C., Ferber, D.M., Ely, B., 1983. Synthesis and assembly of flagellar components by Caulobacter crescentus motility mutants. J. Bacteriol. 154, 1137–1144. Josenhans, C., Ferrero, R.L., Labigne, A., Suerbaum, S., 1999. Cloning and allelic exchange mutagenesis of two flagellin genes of Helicobacter felis. Mol. Microbiol. 33, 350–362. Josenhans, C., Vossebein, L., Friedrich, S., Suerbaum, S., 2002. The neuA/flmD gene cluster of Helicobacter pylori is involved in flagellar biosynthesis and flagellin glycosylation. FEMS Microbiol. Lett. 210, 165–172. Karlyshev, A.V., Linton, D., Gregson, N.A., Wren, B.W., 2002. A novel paralogous gene family involved in phase-variable flagella-mediated motility in Campylobacter jejuni. Microbiology 148, 473–480. Kirov, S.M., Tassell, B.C., Semmler, A.B., O’Donovan, L.A., Rabaan, A.A., Shaw, J.G., 2002. Lateral flagella and swarming motility in Aeromonas species. J. Bacteriol. 184, 547–555. Knirel, Y.A., Vinogradov, E.V., L’vov, V.L., et al., 1984. Sialic acids of a new type from the lipopolysaccharides of Pseudomonas aeruginosa and Shigella boydii. Carbohydr. Res. 133, C5–C8. Knirel, Y.A., Shashkov, A.S., Tsvetkov, Y.E., Jansson, P.E., Zahringer, U., 2003. 5,7-diamino-3,5,7,9-tetradeoxynon2-ulosonic acids in bacterial glycopolymers: chemistry and biochemistry. Adv. Carbohydr. Chem. Biochem. 58, 371–417. Kornfeld, S., Kornfeld, R., Neufeld, E.F., O’Brien, P.J., 1964. The feedback control of sugar nucleotide biosynthesis in liver. Proc. Nat. Acad. Sci. USA 52, 371–379.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
Kowarik, M., Young, N.M., Numao, S., et al., 2006. Definition of the bacterial N-glycosylation site consensus sequence. EMBO J. 25, 1957–1966. Leclerc, G., Wang, S.P., Ely, B., 1998. A new class of Caulobacter crescentus flagellar genes. J. Bacteriol. 180, 5010–5019. Lemon, K.P., Higgins, D.E., Kolter, R., 2007. Flagellar motility is critical for Listeria monocytogenes biofilm formation. J. Bacteriol. 189, 4418–4424. Li, Z., Dumas, F., Dubreuil, D., Jacques, M., 1993. A speciesspecific periplasmic flagellar protein of Serpulina (Treponema) hyodysenteriae. J. Bacteriol. 175, 8000–8007. Linton, D., Karlyshev, A.V., Hitchen, P.G., et al., 2000. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipooligosaccharide. Mol. Microbiol. 35, 1120–1134. Liu, F., Tanner, M.E., 2006. PseG of pseudaminic acid biosynthesis: a UDP-sugar hydrolase as a masked glycosyltransferase. J. Biol. Chem. 281, 20902–20909. Logan, S.M., 2006. Flagellar glycosylation – a new component of the motility repertoire? Microbiology 152, 1249–1262. Logan, S.M., Kelly, J.F., Thibault, P., Ewing, C.P., Guerry, P., 2002. Structural heterogeneity of carbohydrate modifications affects serospecificity of Campylobacter flagellins. Mol. Microbiol. 46, 587–597. Lyristis, M., Boynton, Z.L., Petersen, D., Kan, Z., Bennett, G.N., Rudolph, F.B., 2000. Cloning, sequencing and characterisation of the gene encoding flaC and the posttranslational modification of flagellin from Clostridium acetobutylicum ATCC824. Anaerobe 6, 69–79. Macnab, R.M., 2004. Type III flagellar protein export and flagellar assembly. Biochim. Biophys. Acta 1694, 207–217. McNally, D.J., Hui, J.P., Aubry, A.J., et al., 2006. Functional characterization of the flagellar glycosylation locus in Campylobacter jejuni 81–176 using a focused metabolomics approach. J. Biol. Chem. 281, 18489–18498. McNally, D.J., Aubry, A.J., Hui, J.P., et al., 2007. Targeted metabolomics analysis of Campylobacter coli VC167 reveals legionaminic acid derivatives as novel flagellar glycans. J. Biol. Chem. 282, 14463–14475. McNally, D.J., Schoenhofen, I.C., Houliston, R.S., et al., 2008. CMP-pseudaminic acid is a natural potent inhibitor of PseB, the first enzyme of the pseudaminic acid pathway in Campylobacter jejuni and Helicobacter pylori. Chem. Med. Chem. 3, 55–59. Merkx-Jacques, A., Obhi, R.K., Bethune, G., Creuzenet, C., 2004. The Helicobacter pylori flaA1 and wbpB genes control lipopolysaccharide and flagellum synthesis and function. J. Bacteriol. 186, 2253–2265. Misawa, N., Blaser, M.J., 2000. Detection and characterization of autoagglutination activity by Campylobacter jejuni. Infect. Immun. 68, 6168–6175.
145
Obhi, R.K., Creuzenet, C., 2005. Biochemical characterization of the Campylobacter jejuni Cj1294, a novel UDP-4keto-6-deoxy-GlcNAc aminotransferase that generates UDP-4-amino-4,6-dideoxy-GalNAc. J. Biol. Chem. 280, 20902–20908. Peel, M., Donachie, W., Shaw, A., 1988. Temperaturedependent expression of flagella of Listeria monocytogenes studied by electron microscopy, SDS-PAGE and western blotting. J. Gen. Microbiol. 134, 2171–2178. Rabaan, A.A., Gryllos, I., Tomas, J.M., Shaw, J.G., 2001. Motility and the polar flagellum are required for Aeromonas caviae adherence to HEp-2 cells. Infect. Immun. 69, 4257–4267. Samatey, F.A., Imada, K., Vonderviszt, F., Shirakihara, Y., Namba, K., 2000. Crystallization of the F41 fragment of flagellin and data collection from extremely thin crystals. J. Struct. Biol. 132, 106–111. Schirm, M., Soo, E.C., Aubry, A.J., Austin, J., Thibault, P., Logan, S.M., 2003. Structural, genetic and functional characterization of the flagellin glycosylation process in Helicobacter pylori. Mol. Microbiol. 48, 1579–1592. Schirm, M., Arora, S.K., Verma, A., et al., 2004a. Structural and genetic characterization of glycosylation of type a flagellin in Pseudomonas aeruginosa. J. Bacteriol. 186, 2523–2531. Schirm, M., Kalmokoff, M., Aubry, A., Thibault, P., Sandoz, M., Logan, S.M., 2004b. Flagellin from Listeria monocytogenes is glycosylated with beta-O-linked N-acetylglucosamine. J. Bacteriol. 186, 6721–6727. Schirm, M., Schoenhofen, I.C., Logan, S.M., Waldron, K.C., Thibault, P., 2005. Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins. Anal. Chem. 77, 7774–7782. Schoenhofen, I.C., McNally, D.J., Brisson, J.R., Logan, S.M., 2006a. Elucidation of the CMP-pseudaminic acid pathway in Helicobacter pylori: synthesis from UDPN-acetylglucosamine by a single enzymatic reaction. Glycobiology 16, 8C–14C. Schoenhofen, I.C., McNally, D.J., Vinogradov, E., et al., 2006b. Functional characterisation of dehydratase/ aminotransferase pairs from Helicobacter and Campylobacter: enzymes distinguishing the pseudaminic acid and bacillosamine biosynthetic pathways. J. Biol. Chem. 281, 723–732. Shams-Eldin, H., Chaban, B., Niehus, S., Schwarz, R.T., Jarrell, K.F., 2008. Identification of the archaeal alg7 gene homolog (encoding N-acetylglucosamine-1-phosphate transferase) of the N-linked glycosylation system by cross-domain complementation in Saccharomyces cerevisiae. J. Bacteriol. 190, 2217–2220. Shen, A., Kamp, H.D., Grundling, A., Higgins, D.E., 2006. A bifunctional O-GlcNAc transferase governs flagellar motility through anti-repression. Genes Dev. 20, 3283–3295.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
146
8. Glycosylation of flagella
Soo, E.C., Aubry, A.J., Logan, S.M., et al., 2004. Selective detection and identification of sugar nucleotides by CEelectrospray-MS and its application to bacterial metabolomics. Anal. Chem. 76, 619–626. Sterba, J., Vancova, M., Rudenko, N., et al., 2008. Flagellin and outer surface proteins from Borrelia burgdorferi are not glycosylated. J. Bacteriol. 190, 2619–2623. Taguchi, F., Shimizu, R., Nakajima, R., Toyoda, K., Shiraishi, T., Ichinose, Y., 2003. Differential effects of flagellins from Pseudomonas syringea pvs. tabaci, tomato and glycinea on plant defence response. Plant Physiol. Biochem. 41, 165–174. Taguchi, F., Ogawa, Y., Takeuchi, K., et al., 2006a. A homologue of the 3-oxoacyl-(acyl carrier protein) synthase III gene located in the glycosylation island of Pseudomonas syringae pv. tabaci regulates virulence factors via N-acyl homoserine lactone and fatty acid synthesis. J. Bacteriol. 188, 8376–8384. Taguchi, F., Takeuchi, K., Katoh, E., et al., 2006b. Identification of glycosylation genes and glycosylated amino acids of flagellin in Pseudomonas syringae pv. tabaci. Cell Microbiol. 8, 923–938. Taguchi, F., Shibata, S., Suzuki, T., et al., 2008. Effects of glycosylation on swimming ability and flagellar polymorphic transformation in Pseudomonas syringae pv. tabaci 6605. J. Bacteriol. 190, 764–768. Takeuchi, K., Taguchi, F., Inagaki, Y., Toyoda, K., Shiraishi, T., Ichinose, Y., 2003. Flagellin glycosylation island in Pseudomonas syringea pv. glycinea and its role in host specificity. J. Bacteriol. 185, 6658–6665. Takeuchi, K., Ono, H., Yoshida, M., et al., 2007. Flagellin glycans from two pathovars of Pseudomonas syringae contain rhamnose in d and l configurations in different ratios and modified 4-amino-4,6-dideoxyglucose. J. Bacteriol. 189, 6945–6956. Thibault, P., Logan, S.M., Kelly, J.F., et al., 2001. Identification of the carbohydrate moieties and glycosylation motifs in Campylobacter jejuni flagellin. J. Biol. Chem. 276, 34862–34870.
Thomas, N.A., Bardy, S.L., Jarrell, K.F., 2001. The archaeal flagellum: a different kind of prokaryotic motility structure. FEMS Microbiol. Rev. 25, 147–174. Trachtenberg, S., Cohen-Krausz, S., 2006. The archaeabacterial flagellar filament: a bacterial propeller with a piluslike structure. J. Mol. Microbiol. Biotechnol. 11, 208–220. Verma, A., Arora, S.K., Kuravi, S.K., Ramphal, R., 2005. Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect. Immun. 73, 8237–8246. Verma, A., Schirm, M., Arora, S.K., Thibault, P., Logan, S. M., Ramphal, R., 2006. Glycosylation of b-Type flagellin of Pseudomonas aeruginosa: structural and genetic basis. J. Bacteriol. 188, 4395–4403. Vimr, E.R., Troy, F.A., 1985. Regulation of sialic acid metabolism in Escherichia coli: role of N-acylneuraminate pyruvate-lyase. J. Bacteriol. 164, 854–860. Vimr, E.R., Kalivoda, K.A., Deszo, E.L., Steenbergen, S.M., 2004. Diversity of microbial sialic acid metabolism. Microbiol. Mol. Biol. Rev. 68, 132–153. Voisin, S., Houliston, R.S., Kelly, J., et al., 2005. Identification and characterization of the unique N-linked glycan common to the flagellins and S-layer glycoprotein of Methanococcus voltae. J. Biol. Chem. 280, 16586–16593. Wieland, F., Paul, G., Sumper, M., 1985. Halobacterial flagellins are sulfated glycoproteins. J. Biol. Chem. 260, 15180–15185. Wyss, C., 1998. Flagellins, but not endoflagellar sheath proteins of Treponema pallidum and of pathogen-related oral spirochetes are glycosylated. Infect. Immun. 66, 5751–5754. Yonekura, K., Maki-Yonekura, S., Namba, K., 2003. Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy. Nature 424, 643–650. Yonekura, K., Maki-Yonekura, S., Namba, K., 2005. Building the atomic model for the bacterial flagellar filament by electron cryomicroscopy and image analysis. Structure 13, 407–412.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
9 Glycosylated components of the mycobacterial cell wall: structure and function Delphi Chatterjee and Patrick J. Brennan Summary Pathogenic mycobacteria, such as Mycobacterium tuberculosis and Mycobacterium leprae, the causative agents of tuberculosis and leprosy, are responsible for considerable morbidity and mortality worldwide. The distinctive cell wall (lipo)glycans are centrepiece to the underlying pathology. In addition, a hallmark of chronic mycobacterial infections is the tendency of these pathogens to maintain longterm, asymptomatic infections. The capability of mycobacteria to survive for extended periods in the macrophage has been attributed to components of the cell wall. This structure provides a permeability barrier, shielding the bacterium from degradative forces as well as modulating host immune responses to its own needs and presenting special problems for disease chemotherapy. The cell envelope possesses two major structural components: the plasma membrane and the wall proper. The plasma membrane is characterized by the presence of the phosphatidylinositol mannosides, lipomannan and lipoarabinomannan but, in other respects, appears typical of bacterial membranes. The cell wall however, is highly distinctive characterized by a “core” consisting of covalently linked mycolic acids, the unusual hetero-polysaccaride d-arabinogalactan and peptidoglycan, apparently common to all
Microbial Glycobiology
members of the genus Mycobacterium and related genera, in one form or another. The physical arrangement of the mycolic acids in conjunction with a variety of soluble trehalose-, phthioceroland peptide-containing glycolipids, varying among species and subspecies, generates a distinctive outer membrane, responsible for many of the physiological and pathogenic features of Mycobacterium. Keywords: Mycobacterium spp.; Cell wall; Glycolipids; Glycans; Structure; Functions; Lipoarabinomannan; Lipomannan (LM); Phosphatidylinositol-mannosides; N-glycolyl-muramic acid (MurNGlyc); Arabinoga lactan; Trehalose
1. Characteristic features of Mycobacterium spp. The mycobacteria are a diverse prokaryotic genus containing over 100 members. The majority of these species are non-pathogenic environmental bacteria related to the soil bacteria Streptomyces and Actinomycetes. Among these few species are extremely successful pathogens. These
147
© 2009 2010, Elsevier Inc.
148
9. Mycobacterial cell wall glycans
include Mycobacterium tuberculosis, Mycobacterium leprae and Mycobacterium ulcerans, the respective aetiological agents of tuberculosis, leprosy and Buruli (Bairnsdale) ulcer. Their key to success perhaps lies with their ability to establish residence and proliferate inside the host macrophages despite the anti-mycobacterial properties of these cells. M. tuberculosis is a major human pathogen causing significant human suffering worldwide. As the leading cause of death from a single bacterial infection, it is imperative to understand the biology, physiology and pathogenicity of the organism in order to improve our chance of eradicating the disease. Emergence of new forms of tuberculosis, such as multidrug resistant tuberculosis and extensively-drug resistant tuberculosis, has led to consolidated research on the genome and chemical phenotype of M. tuberculosis towards new drug targets, vaccines and the molecular basis of pathogenesis. M. tuberculosis contains features which most likely contribute to its pathogenicity and potential to establish latent infections. Among these, the lipid and carbohydrate-dominated cell wall plays a critical part in interaction with the host, being the first line of defence against immune attack. In addition, cell wall impermeability contributes to the intrinsic resistance of mycobacteria to many antibiotics. M. leprae, a non-culturable organism is the causative agent of leprosy (Hansen’s disease), a highly variable disease with a spectrum of clinical manifestations that ranges between two polar forms. Leprosy primarily affects superficial tissues, the skin and peripheral nerves, responsible for a peripheral neuropathy with the potential for visible disabilities and the stigma long-associated with leprosy. There are many different classes of nontuberculous mycobacteria widespread in the environment, generally not transmitted from person to person, but responsible for serious opportunistic infections. The usual sources of infection are water, soil and aerosols developed from these sources. The most prominent of these
opportunistic pathogens are members of the Mycobacterium avium complex (MAC), including M. avium, Mycobacterium intracellulare and Mycobacterium scrofulaceum responsible for the majority of bacterial infections in advanced human immunodeficiency virus- (HIV-) acquired immunodeficiency syndrome (AIDS). Mycobacteria also causes devastating diseases in livestock, with Mycobacterium bovis and Mycobacterium paratuberculosis causing bovine tuberculosis in cattle and Johne’s disease in sheep, cattle, goats and deer respectively. Alongside, several of the mycobacterium members of the genus are non-pathogenic, soil dwelling saprophytes, such as Mycobacterium smegmatis and Mycobacterium chelonae. The purpose of this chapter is to familiarize readers with various glycan-containing entities that dominate the mycobacterial cell wall and are implicated in disease processes.
2. The mycobacterial envelope The mycobacterial cell envelope differs significantly from that of the Gram-positive and Gram-negative bacteria for its low permeability and hence resistance to common antibiotics and chemotherapeutic agents. The envelope acts as a permeability barrier to toxic molecules (Brennan and Nikaido, 1995), allows specific interaction with the host during infection and is responsible for the evasion of the host immune responses and pathogenicity (Chatterjee and Khoo, 1998; Briken et al., 2004). Although ostensibly classified as Gram-positive bacteria, the mycobacterial cell wall shares similarities with Gram-negative bacteria. At the electron microscopy level, the mycobacterial cell wall appears to have, beyond the plasma membrane, at least three distinct layers of peptidoglycan (PG), arabinogalactan and an outer, asymmetric lipid bilayer composed of mycolic acids and multiple classes
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. The mycobacterial cell wall skeleton: the mycolylarabinogalactan-PG complex
of phospholipids and glycolipids (Brennan and Nikaido, 1995) (see Chapter 1). Two recent publications (Hoffmann et al., 2008; Zuber et al., 2008) have provided a new perspective on the mycobacterial “outer membrane”. Cryo-electron microscopy of vitreous sections has shown a distinct lipid bilayer structure analogous to that of Gram-negative bacteria, but dominated by the presence of mycolic acids. The PG in covalent linkage to the arabinogalactan, in turn covalently attached to the mycolic acids that dominate the outer membrane, represent the mycobacterial cell wall skeleton (Brennan and Nikaido, 1995; Daffe and Draper, 1998; Brennan and Crick, 2007). Associated with the cell envelope, either the outer or inner membranes, are other important polymers including the lipoarabinomannan (LAM), lipomannan (LM), the phosphatidylinositol-mannosides (PIMs), the trehalose-, and phthiocerolcontaining glycolipids (Daffe and Draper, 1998; Brennan and Crick, 2007) and species-specific surface glycolipids, e.g. the trehalose-containing lipo-oligosaccharides and the glycopeptidolipids (Aspinall et al., 1995; Chatterjee and Khoo, 2001). In non-tuberculosis mycobacteria, such as members of the MAC, these latter glycolipids are the major mycobacterial antigens providing the basis for serovariation.
3. The mycobacterial cell wall skeleton: the mycolylarabinogalactan-PG complex Experimentally, the mycolylarabinogalactanPG (mAGP) complex is the cell wall residue remaining after all other components have been extracted. It is a large polymer consisting of covalently attached PG, the arabinogalactan hetero-polysaccharide and mycolic acids (Figure 9.1) and is regarded as crucial for the viability of the organism and provides many essential
149
enzyme targets for drug development (Brennan and Crick, 2007).
3.1. Peptidoglycan Mycobacteria synthesize a layer of PG that is deposited immediately above the plasma membrane. The mycobacterial PG consists of chains of alternating -(1→4)-linked N-acetyl-dglucosamine (GlcNAc) and N-glycolyl-muramic acid (MurNGlyc) residues which are crosslinked with a tetrapeptide moiety of l-alanyl-disoglutamyl-meso-diaminopimelyl-d-alanine (l-Ala-d-Glu-A2pM-d-Ala). This structure is different to PG found in Gram-negative bacteria as the muramic acid is N-glycolylated, rather than acylated and unusual cross-links occur between two chains of mycobacterial PG (Adam et al., 1969). The overall degree of cross-linking in Mycobacterium spp. is 70–80% (Matsuhashi, 1966) compared to 30–50% in E. coli (Vollmer and Höltje, 2004). About two-thirds of the cross-links are between the carboxyl group of a terminal d-Ala and the amino group of the d-centre of the A2pM residue of another peptide. Approximately one-third of the peptide crossbridges occur between the carboxyl group of the l-centre of one meso-diaminopimelic acid (DAP) residue and the amino group of the d-centre of another DAP to form an l-d cross-link. In M. leprae, the l-Ala is replaced by glycine (Draper et al., 1987) and the muramic acid residues are exclusively N-acetylated (Mahapatra et al., 2008). The non-cross-linked peptide side chains of M. leprae consist of tetra- and tripeptides, some of which contain additional glycine residues. The carbon C-6 of some of the muramic acid residues form phosphodiester bonds to C-1 of -d-GlcNAc which in turn is (1→3)linked to -l-rhamnopyranose (Rhap) providing the “linker unit” between the galactan of arabinogalactan (AG) and PG; theoretically, this is a perfect drug target, in that inhibition of any aspect of its synthesis should disrupt mAGP integrity with untoward consequences
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
150
9. Mycobacterial cell wall glycans
Figure 9.1 Structure of the mycolylarabinogalactan-peptidoglycan (mAGP) complex of the mycobacterial cell wall. The arabinogalactan (AG) contains 32–35 Gal residues in an unbranched, alternating -(1→5) and -(1→6) linkage. Three arabinan chains, each with 22 residues, are linked to the galactan backbone. Compare to the lipoarabinomannan (LAM). Abbreviations: l-Rhap, l-rhamnopyranose; d-GlcNAc, N-acetyl-d-glucosamine; d-GalpNH2, 2-amino-2-deoxy-dgalactopyranose.
of the effects of osmotic pressure on the plasma membrane.
3.2. Arabinogalactan The mAGP complex is dominated by the AG hetero-polysaccharide, constituting about 35% of the cell wall mass. This complex was initially isolated by base solubilization of insoluble cell wall fraction (Misaki et al., 1974) and shown to contain d-arabinofuranosyl (Araf ) and d-galactofuranosyl (Galf ) residues. The present view of the structure of mycobacterial AG is illustrated in Figure 9.1. The polysaccharide is composed of three arabinan chains attached to the homogalactan core
(consisting of 32 d-Galf units) of linear alternating 5- and 6-linked -d-Galf residues. The homoarabinan chains are composed of linear -d-Araf residues with branching produced by 3,5-linked -d-Araf residues units substituted at both positions by -d-Araf residues. Characterization of larger per-O-alkylated oligosaccharides by fast-atom bombardment mass spectrometry (Besra et al., 1995) demonstrated that the arabinan chains are attached to the homogalactan core in a region near the reducing end of the molecule. Galactosamine (2-amino-2-deoxygalactose; GalN) has been reported as a component of mycobacterial envelopes and, interestingly, was found only
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. The soluble cross-species glycoconjugates of the mycobacterial cell wall
in the walls of slow-growing mycobacteria, but not in the rapid-growing species such as that of M. smegmatis. The GalN substituent is attached to an Araf unit of AG and occurs as the free amine rather than the usual N-acetyl compound (Draper et al., 1997). In recent studies (Lee et al., 2006; Bhamidi et al., 2008), an endogenous arabinanase secreted by M. smegmatis was utilized to release large oligoarafuranosides to solubilize the arabinan region of the AG. Using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) with time-of-flight MS/ MS and nuclear magnetic resonance (NMR) spectroscopy, it was demonstrated that succinyl esters are present on 2-position of the inner-branched 1,3,5--d-Araf residues (see Figure 9.1). In addition, an inner arabinan segment of 14 linear -(1→5)-linked Araf residues has been identified. These and earlier results now allow the presentation of a model of the entire primary structure of the mycobacterial mycolyl arabinogalactan highlighted by three arabinan chains of 31 residues each (Lee et al., 2006; Bhamidi et al., 2008). The mycolic acids are located in clusters of four on the terminal [-d-Araf-(1→2)--d-Araf]2-3,5--d-Araf-(1→5)-d-Araf hexa-arabinofuranosides, however, only about two-thirds of these are mycolylated (McNeil et al., 1991).
4. The soluble cross-species glycoconjugates of the mycobacterial cell wall Whereas the mAGP complex is regarded as essential for bacterial survival, and hence various aspects of its synthesis are prime targets for drugs (Brennan and Crick, 2007), the soluble entities of the cell wall are regarded as the effectors of the immune response and disease pathogenesis in such as tuberculosis.
151
4.1. Phosphatidylinositol (PI)-based LAM, LM and PIMs 4.1.1. Lipoarabinomannan Indications of the presence of a polysaccharide predominantly containing d-mannopyranose (Manp) and d-Araf residues existing in both acylated and non-acylated forms were provided almost 70 years ago (Heidelberger, 1939). These polysaccharides were later shown to be ubiquitous in all Mycobacterium spp. and contained an -(1→6)-d-Manp backbone to which was attached an immunodominant -(1→5)-linked d-Araf-containing arabinan (Azuma et al., 1968; Misaki et al., 1977). Our current understanding of the cell wall-associated lipoglycans, LAM and LM stems from Hunter, Brennan and Chatterjee (Hunter et al., 1986; Hunter and Brennan, 1990; Chatterjee et al., 1992a) who have described the isolation of native acylated forms of LAM/LM devoid of proteins and neutral polysaccharides and first reported on the presence of phosphatidylinositol in the lipoglycans, suggesting that LAM/LM are multiglycosylated extensions of the PIMs (Figure 9.2). Using octyl-Sepharose, LAM/LM have been shown to bind to the hydrophobic matrix through their fatty acyl chains in low concentrations of propanol and salt. Additionally, LAM/ LM have been shown to bind to the hydrophobic matrix of octyl-Sepharose through their fatty acyl chains in low concentrations of propanol and salt (Leopold and Fischer, 1993), a property exploited to separate LAM/LM from non-acylated forms or contaminating polysaccharides (Khoo et al., 1996), but allowing separation based on size differences in the glycan moieties and by the number of fatty acids (Leopold and Fischer, 1993). Moreover, arabinan chains of LAMs from all M. tuberculosis strains that were examined, as well as the attenuated M. bovis BCG vaccine strain and M. leprae, the aetiological agent of leprosy, are Manp-capped to varying degree (40–70%). In contrast, the majority of the arabinan termini from the rapidly growing, non-infective M. smegmatis
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
152
9. Mycobacterial cell wall glycans
Figure 9.2 Chemical structures of lipoarabinomannan (LAM), lipomannan (LM), the phosphatidylinositol-mannosides (PIMs) of the cell wall/membrane of M. tuberculosis. The non-reducing termini of LAM and arabinogalactan (AG) are Ara4 and Ara6 as released by Cellulomonas arabinanse. In d-mannopyranose-capped LAM (ManLAM), there are mannose caps, as depicted, attached to the termini of the arabinan. A hallmark of LAM arabinan, as distinct from AG arabinan, is the presence of the linear Ara4.
are uncapped, while a minor portion terminates in inositol-phosphate (Chatterjee et al., 1992b; Prinzis et al., 1993; Khoo et al., 1995b; Gilleron et al., 1997).
Irrespective of the capping functions, the underlying -(1→5)-linked arabinan chains terminate in either one of the two well-defined motifs, namely a branched Ara6 or a linear Ara4 (see Figure 9.2),
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. The soluble cross-species glycoconjugates of the mycobacterial cell wall
the relative proportion of which reflects the amount of -(1→3)-linkages branching off the (1→5)-linked arabinan backbone, prior to termination by -(1→2)-arabinosylation (Chatterjee et al., 1991; Khoo et al., 1995a). Constituent Araf residues in the setting of -(1→5)-elongation, -(1→3)linkages branching off a 3,5-disubstituted-Araf residue and -(1→2)-chain termination is essentially conserved in LAMs from all species. Conventional analytical methods have also led to identification of other structural indices, such as the succinylation (whose exact location remains unresolved) (Delmas et al., 1997; Guerardel et al., 2003) or the presence of -methylthioxylofurnose (Treumann et al., 2002; Turnbull et al., 2004) along with the common presence of varying degree of Manp capping. Two-dimensional gel electrophoresis experiments indicate that isoelectric resolution of LAM into isoforms could be based on arabinan architecture, rather than capping or fatty acyl functions, suggesting that the arabinan exerts significant effect on the isoelectric point of a heterogeneous molecule such as LAM (Torrelles et al., 2004). Biologically, LAM has been included in a general class of bacterial virulence factors named modulins, which operate by inducing host cytokines (Henderson et al., 1996). For example, LAM stimulates macrophages to produce tumour necrosis factor- (TNF-) and the granulocyte-macrophage-colony stimulating factor, interleukin- (IL-) 1, IL-1, IL-6 and IL-10. Moreover, LAM induces several “early genes” involved in the activation of macrophages and stimulates production of nitric oxide, a microbicidal substance, synergistically with interferon- (see Chatterjee and Khoo, 1998; Strohmeier and Fenton, 1999; Briken et al., 2004 and references cited therein). In some of these systems there were intriguing indications that the precise structure of LAM, which differs somewhat between mycobacteria, was important in determining the biological effect. The Manp-capped LAM (ManLAM) produced by M. tuberculosis is generally less effective at
153
stimulating macrophages than the non-capped LAM (AraLAM), which may owe its potency entirely to inositol-phosphate capping (Khoo et al., 1995a; Gilleron et al., 1997). Nevertheless, the activity of bare LAM, i.e. devoid of any capping function on its arabinan, has not been tested against ManLAM, in systems where the latter demonstrates significant activities, to resolve the precise roles of Manp capping. On the other hand, the presence of Manp cap on LAM has been implicated to be essential in mediating the binding to human macrophage Manp receptor (Schlesinger, 1993; Schlesinger et al., 1994, 1996; Taylor et al., 2005), thus presenting an alternative, and probably favourable, mode of phagocytosis of whole bacteria. Interestingly, uptake via the Manp receptors was shown to mediate delivery of internalized LAM to late endosomes for eventual presentation to T-cells by CD1b molecules (Prigozy et al., 1997). The successful isolation of CD1 restricted cytotoxic T-cells from the peripheral blood of patients with tuberculosis (Stenger et al., 1997) that recognize lipoglycan antigens of M. tuberculosis, argues that, as in the case of cutaneous leprosy lesion (Sieling et al., 1995), LAM can be an effective T-cell antigen in host defence and may be targeted as novel vaccine (Jullien et al., 1997). Evidence is emerging that surface mannosylation of M. tuberculosis bacilli is an important host adaptive mechanism for directing phagocytic and post-phagocytic processes within the environment of lung alveoli and mannosylation of the M. tuberculosis surface aids in host cell recognition. The ligand is ManLAM which has been shown to intercalate into the membrane (Ilangumaran et al., 1995) and to traffic within the endomembranes of cells infected with mycobacteria (Beatty et al., 2000). The ManLAM Manp caps also bind to the dendritic cell (DC)-specific intracellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) on DCs (Maeda et al., 2003; Tailleux et al., 2003). Studies show that the Manp receptor and DC-SIGN,
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
154
9. Mycobacterial cell wall glycans
both C-type lectins that recognize M. tuberculosis ManLAM, regulate phagosome trafficking differently. Thus, terminal components of ManLAM are very important in host cell recognition and response. The body of evidence implicating LAM in modulating immune response, such as that manifested by macrophage cytokine induction, is compelling. However, despite many of the structural studies emerging from our laboratory and many others, there had been a general deficit in two areas, namely the structure to function relationship of LAM and the identification of the biosynthetic steps in its formation. The reason is the inherent extreme heterogeneity of LAM and a general lack of functional mutants. With respect to mutants in LAM, major achievements in dissecting biosynthetic steps are discussed in detail in Chapter 21. 4.1.2. Lipomannan Lipomannan is another phosphorylated polysaccharide-associated with the cell envelope and is considered to be the multimannosylated form of PIM which is primarily located in the plasma membrane. In electrophoresis (SDSPAGE), LM migrates as a broad diffuse band around a mass of 16 000 (Hunter et al., 1986). Structurally, LM is composed of two segments, a PI anchor to which is attached an -d-mannan domain (see Figure 9.2); both play a key role in inducing cytokine production by phagocytic cells. The mannan core consists of a linear (1→6)-linked mannan backbone extending from the C-6 of the myo-inositol; the mannan chain is further substituted by -(1→2)-Manp side branches. There are about 20–30 Manp residues in all in M. tuberculosis LM. The LM-like molecules are proinflammatory and often their activities are associated with the degree of glycosylation and acylation on the PI anchor (Gilleron et al., 2006) and the latter is abrogated after deacylation of LM by alkaline treatment (Gibson et al., 2005).
4.1.3. phosphatidylinositol mannosides Among the phospholipids found in Mycobacterium (cardiolipin/diphosphatidylglycerol; phosphatidylethanolamine) (Pangborn and McKinney, 1966), the most unusual and highly characteristic members are PI and its mannosylated forms (Brennan, 1989; Chen et al., 1991). Anderson first isolated a mixture of phospholipids from tubercle bacilli which, upon hydrolysis, yielded glycerophosphoric acid, inositol and Man (Anderson, 1939). The structures of this set of molecules were firmly established almost 25 years later by Lee and Ballou (1964). The PIMs are thought to be localized in both the plasma membrane and the overlying cell envelope (Gaylord and Brennan, 1987; Ortalo-Magné et al., 1996). The PIMs with conserved fatty acid composition substituted with up to six Man residues. M. leprae produces PIM2 as the predominant PIM species (Khoo et al., 1995b), whereas in M. tuberculosis, Mycobacterium phlei, M. bovis both PIM2 and PIM5 (Ballou and Lee, 1964; Lee and Ballou, 1965) are plentiful. M. smegmatis produces PIM2 and PIM6 as most abundant molecules (Chatterjee et al., 1992a; Severn et al., 1998). Structurally, PIM1 has a Manp substituted on the 2-position of the myo-inositol and PIM2 contains a second mannose on C-6 of myo-inositol (Lee and Ballou, 1965). The PIM4-PIM6 contain some -(1→2)-linked Manp and, therefore, differ in structure from the other PIMs (Besra et al., 1997; Khoo et al., 1995b). The extent of acylation of PIM1 and PIM2 varies from the diacyl form consisting of palmitate and tuberculostearic acids to the triacyl and tetracal forms that contain additional palmitate moieties. The first two acyl functions are a part of PI, while the third acyl group is added to O-6 of the first Manp substituted on PI (Brennan and Ballou, 1967, 1968; Khoo et al., 1995b). In the case of the tetra-acylated forms of PIM2 (Ac4PIM2), it has been suggested that there may be acylation of the inositol ring since, logically, the addition
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. The soluble cross-species glycoconjugates of the mycobacterial cell wall
of a fatty acyl group to the second Manp of PIM2 would result in termination of the glycosidic chain, thus preventing synthesis of PIM3PIM6 (Khoo et al., 1995b). Studies have clearly established that the glycerol-phosphate moiety was attached to the l-1 position of the myo-inositol ring and the Manp residues were glycosidically linked to the 2- and the 6-positions of the myo-inositol. Purified PIM species have shown various immunomodulatory activities. They activate macrophages to induce TNF- secretion through Toll-like receptor-2 (TLR-2) (Gilleron et al., 2003) and can induce granuloma formation by recruiting natural killer T-cells (Fischer et al., 2004). The PIMs have been identified as natural antigens of CD1d-restricted or CD1b-restricted T-cells (Fischer et al., 2004; de la Salle et al., 2005). Interestingly, PIMs have been shown to stimulate fusion between phagosomes and early endosomes when presented from the luminal side (in vivo) or the cytosolic side (in vitro). Two models have been proposed as to how PIM could exert this kind of activity, either directly on its target after translocation to the cytosolic side of the membrane, or indirectly by modifying the biophysical properties of the membrane bilayer (Vergne et al., 2004).
4.2. Trehalose-containing lipids 4.2.1. Trehalose mono- and di-mycolates Middlebrook et al. (1959) recognized that virulent tubercle bacilli differed from avirulent and attenuated strains in the unusual growth (serpentine cords) pattern. A search for a marker substance implicated in cord formation and virulence led Bloch (1950) to the trehalose-based lipids, primarily “cord factor”, i.e. trehalose 6,6dimycolate (Figure 9.3). Accurate structures were later developed by Kato and Asselineau (1971). Although there is little evidence that cord factors or sulfolipids contribute to this cord formation, these families of lipids have been implicated in several disease-related events (Goren, 1972).
155
Trehalose [-d-Glc (1↔1)--d-Glc] (see Chapter 11) is ubiquitous among all mycobacterial species and these disaccharides are acylated with long chain fatty acids, e.g. mycolic acids to form trehalose monomycolates (TMM) and trehalose dimycolates (TDM). The structures of cord factors from M. tuberculosis were established through a series of classic studies conducted by Noll et al. (1956) and Goren and Brennan (1979). The heterogeneity of cord factors is associated with mycolic acid composition; symmetrical -, methoxy-methoxy and keto-keto and the asymmetrical combination of -methoxy, methoxy-keto and -keto were all found. M. bovis cord factor lacks the methoxy substituted class. Various biological functions have been attributed to the cord factors (Goren and Brennan, 1979). Most of them seemingly related to the ability of cord factors to induce cytokinemediated events such as systemic toxicity, granulomagenic activity and macrophage released chemotactic factors (Goren and Brennan, 1979; Minnikin, 1982). 4.2.2. Sulfolipids The sulfolipids/sulfatides are also members of the acylated trehalose family. Sulfolipids were originally isolated from M. tuberculosis by Middlebrook et al. (1959) and chemically defined by Goren and Brennan (1979). All of these are tri- or tetra-acylated trehalose-2-sulfate. The acyl functions of the sulfatides may be either palmitate, stearate, phthioceranate or hydroxyphthioceranate (Brennan, 1988) (Figure 9.3). These lipids were originally believed to inhibit phagosome– lysosome fusion (Goren et al., 1976), however, later evidence suggested that sulfatides inhibited phagosome activation (Pabst et al., 1988).
4.3. Phthiocerol-containing glycolipids – the phenolic glycolipids (PGLs) This class of glycolipids was originally described by Smith et al. (1954) in M. bovis and Mycobacterium kansasii, as “mycosides that lack
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
156
9. Mycobacterial cell wall glycans
figure 9.3 Continued
(Continues)
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. The soluble cross-species glycoconjugates of the mycobacterial cell wall
157
Figure 9.3 Structures of some representative glycolipids of the M. tuberculosis cell wall. Trehalose dimycolate (TDM); diacyltrehalose (DAT); triacyltrehalose (TAT); polyacyltrehalose (PAT); trehalose-containing sulfolipid I (SL); phthioceroldimycocerosate (PDIM); phenolic glycolipid (PGL).
amino acids” and were established as glycosides of phenolphthiocerol dimycocerosate (see Figure 9.3). The lipid core is composed of a family of long-chain -diols (C33–C41), esterified by polymethyl-branched (C27–C34) fatty acids (mycocerosic and phthioceranic acids). Later on, these were renamed as phenolic glycolipids after the discovery by Brennan (1988) of the most significant phenolic glycolipid I (PGL-I), a species-specific glycolipid antigen of M. leprae. Until that time, although structurally considered unusual, dominated by the highly unusual secondary alcohol phthiocerol, they had no known immunological and physiological role. The PGLs are present in significant amounts in M. leprae, M. kansasii, a few strains of M. tuberculosis, M. bovis and a few other slow-growing mycobacteria (M. ulcerans, Mycobacterium marinum, Mycobacterium gastri, Mycobacterium microti and Mycobacterium haemophillum). The major chemical differences and immunological distinctiveness of individual PGLs from various
species lies in their variable glycosyl residues (Brennan, 1988) (see Figure 9.3 and Table 9.1). The unique triglycosyl unit of PGL-I of M. leprae contains methylated glucopyranose (Glcp) and Rhap residues in 3,6-di-O-methyl-d-Glcp-(1→4)-2,3-di-O-methyl--l-Rhap-(1→4)-3O-methyl--l-Rhap. In M. kansasii, the phenolic glycolipid comprises a fucopyranose- (Fucp-) containing triglycosyl component 2,6-dideoxy-4O-methyl-Manp-(1→3)-4-O-acetyl-2-O-methylFucp-(1→3)-2,4-di-O-methyl-Rhap. Mycoside B is characteristic of certain bovine strains of M. tuberculosis and M. bovis (Smith et al., 1954; 1960a,b; Noll and Jackim, 1958; Maclennan et al., 1961) and contains but one sugar component, a 2-O-methyl-l-Rhap (Chatterjee et al., 1989). A methoxylated phenolphthiocerol, the socalled “attenuation indicator lipid”, was isolated from some attenuated tubercle bacilli (Goren and Brennan, 1979). In addition, aliphatic (and nonglycosylated) derivatives, diesters of phthiocerols, are produced by several mycobacterial species;
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
158
9. Mycobacterial cell wall glycans
Table 9.1 The phthiocerol-containing phenolphthiocerolglycolipids of some Mycobacterium spp. Mycobacterial species
Structure of carbohydrate domaina
References
M. leprae
3,6-di-O-methyl--d-Glcp-(1→4)-2,3-di-O-methyl--l-Rhap(1→4)-3-O-methyl--l-Rhap
Hunter and Brennan, 1981; Hunter et al., 1983
M. bovis
2-O-methyl-Rhap
Chatterjee et al., 1989
M. tuberculosis
2,3,4 tri-O-methyl--l-Fucp-(1→3)--l-Rhap-(1→3)-2-O-methyl-l-Rhap
Daffe et al., 1991
M. kansasii
2,6-dideoxy-4-O-methyl-Manp-(1→3)-4-O-acetyl-2-O-methylFucp-(1→3)-2,4-di-O-methyl-Rhap
M. marinum
3-O-methyl-Rhap
Dobson et al., 1990
a
Fucp, fucopyranose; Glcp, glucopyranose; Manp, mannopyranose; Rhap, rhamnopyranose.
originally characterized from M. tuberculosis, these compounds are present in all the PGL-containing strains examined so far (Daffe and Laneelle, 1989). Among many strains of M. tuberculosis, the Canetti strains contain a major triglycosyl phenolphthiocerol, the glycosyl portion of which is 2,3,4-tri-O-methyl--l-Fucp-(1→3)--l-Rhap-(1→ 3)-2-O-Me--l-Rhap. The phenolic glycolipids from two strains of M. marinum have been isolated and characterized. The glycolipids from M. marinum MNC 170 were principally glycosides of diacyl C37, C39 and C41 phenolphthiocerols A but, in M. marinum MNC 842, these lipids were accompanied by glycosides of diacyl phenolphthiodiolones A and novel phthiotriols A with the same overall chain lengths. The main acyl components of the phenolic glycolipids from M. marinum MNC 170 were C26 dimethyl and C27 and C29 trimethyl-branched fatty acids but, in the lipids of M. marinum MNC 842, the C27 trimethyl acid was the only principal component. The sugar composition of all these glycolipids had been previously shown to correspond to 3-O-methyl-Rhap. All PGLs are serologically active and they have several biological activities which may be significant in mycobacterial diseases. For instance, M. leprae PGL-I has been shown to play a role in the disease process of leprosy by its ability to
scavenge OH radicals and superoxide anions, thus protecting the bacilli from phagocytic killing. Also, PGL-I has been shown to have a role in the involvement in the invasion of Schwann cells through basal lamina in a laminin-2-dependent pathway (Ng et al., 2000).
5. The species and sub-species specific soluble glycoconjugates of mycobacterial cell walls 5.1. Glycopeptidolipids (GPLs) The most intricate class of glycolipids and the most widely studied of all mycobacterial glycolipids are the GPLs or C mycosides (Brennan, 1988; Aspinall et al., 1995). Smith et al. (1954, 1960a,b) were the first to identify GPLs by infrared spectroscopy of chromatographically fractionated organic solvent extracts from mycobacteria and named them as J substances and then as C-mycosides. In the later part of the 1960s, W.B. Schaefer identified antigens which could be used to serotype isolates of the MAC (Schaefer, 1965) resulting in the recognition of the existence in the environment and in immune compromised patients of at least 31 antigenicallydistinct serotypes/serovariants in the MAC.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
5. The species and sub-species specific soluble glycoconjugates of mycobacterial cell walls
Independently, Marks and co-workers described a number of lipids which gave distinct patterns on thin-layer chromatography and gave a basis for grouping isolates of the MAC (Marks et al., 1970, 1971; Jenkins et al., 1971). Structurally, the GPLs of MAC can be divided into two general classes: the non-polar classes expansively synthesized by all serovariants of MAC, and the polar GPLs, which differ between serovars. The basic structures of the non-polar C-mycosides or GPLs from M. avium, M. intracellulare, M. scrofulaceum and other mycobacteria had been first described by the French workers in the 1960s (Chaput et al., 1961, 1962, 1963; Gastambide-Odier et al., 1965; Vilkas and Lederer, 1968). The three amino acids were established as of the d series, linked by the Nterminal group to 3-hydroxy-C28 fatty acid and by the C-terminal group to an amino alcohol, alaninol. Also, a diacetylated 6-deoxy-l-talose (6-dTal) was glycosidically linked to the hydroxyl group of the d-allo threonine and 2,3,4-tri-O-methyl-l-Rhap to that of alaninol. In the rhamnosyl residue, a 3-O-methyl or 3,4-di-O-methyl group can replace the 2,3,4-tri-O-methyl group. However, it was not until Brennan and Goren (1979) conclusively demonstrated that the Schaefer antigens and Marks-Jenkins lipids were structurally alike and formally renamed these first as peptidolipids and later, more accurately as GPLs. The molecular basis of the serological differences between MAC strains, observed by Schaefer (Schaefer, 1965), was shown due to the unique variable oligosaccharide sequences (Brennan et al., 1981) elaborated on the 6-dTal. Only these polar variable GPLs were able to confer sero-specificity. All GPLs have in common an N-acylated lipopeptide core that bears a rhamnosylated alaninyl C terminus. The chemical difference between the non-polar (nsGPL) and the polar GPLs (ssGPL) lies in the structure of the oligosaccharide attached to the allo-threonine residue (Table 9.2). In non-polar GPLs, this carbohydrate is a 6-deoxytalose residue, whereas in polar GPLs, the 6-deoxytalose residue is further glycosylated with oligosaccharide. Currently, polar GPLs define 28
159
serovars of Mycobacterium simiae, Mycobacterium chelonei and Mycobacterium fortuitum (Brennan, 1988). The polar C-mycoside GPLs provide perfect phenotypic markers of individual serovars and, as polar surface immunogens, can be used in such as enzyme-linked immunosorbent assay to trace infections due to M. avium and M. intracellulare. The modification of MAC GPLs beyond the core non-polar structure led to identification of 31 serotypes using antibodies specific for the different GPLs (for review see Chatterjee and Khoo, 2001). The GPLs of MAC have been associated with the capsular-like matrix surrounding the bacilli, thus forming an electron transparent zone in phaogocytic vesicles (Brennan, 1988). The GPLs have been clearly demonstrated to survive within the intraphagosomal environment where they are resistant to degradation by lysosomal enzymes and inhibit phagosome–lysosome fusion (Frehel and Rastogi, 1989). The function that GPLs play in M. avium pathogenesis is currently unknown, although they are major stimulators of innate immunity through interaction with TLR-2 (Sweet et al., 2008). Certain serotypes have been isolated with high frequency from AIDS patients, i.e. serotypes 1, 4 and 8, but this is probably a reflection of their dominance in the environment, rather than increased virulence. These glycolipids are present in abundant amounts on the cell surface and several lines of evidence indicate that GPLs modulate the surface chemistry of mycobacterial cells. The extent of GPL expression affects the morphology of mycobacterial colonies (Patterson et al., 2000) and mediates the ability of mycobacterial colonies to slide across agar (Martinez et al., 1999; Recht et al., 2000). Both the virulent SmT and avirulent SmO colony forms express GPLs, whereas the rough variants, which have been variously described as virulent (Schaefer et al., 1970) or avirulent (Moehring and Solotorovsky, 1965), are completely devoid of GPLs (Barrow and Brennan, 1982). Furthermore, the SmT variants have been consistently shown to have an increased resistance to antibiotics. Ambiguous results have been obtained using rough morphotypes of M. avium.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
160
9. Mycobacterial cell wall glycans
Table 9.2 Grouping of haptens of the glycopeptidolipids antigens of M. avium complex, based on structural similarities Structure of oligosaccharidea
Serovar number Group 1 2
4-O-Ac-2,3-di-O-Me--l-Fucp-(1→3)--l-Rhap-(1→2)-6-deoxy-l-Tal
4
4-O-Me--l-Rhap-(1→4)-O-Me--l-Fucp-(1→3)--l-Rhap(1→2)-6-deoxy-l-Tal
9
4-O-Ac-2,3-di-O-Me--l-Fucp-(1→4)--d-GlcpA-(1→4)-2,3-di-O-Me--l-Fucp-(1→3)- -l-Rhap(1→2)-6deoxy-l-Tal
14
4-formamido-4,6-dideoxy-2-O-Me-3-C-Me--Manp-(1→3)-2-O-Me--d-Rhap-(1→3)-2-O-Me--l-Fucp(1→3)--l-Rhap(1→2)-6-deoxy-l-Tal
20
2-O-Me--d-Rhap-(1→3)-2-O-Me--l-Fucp-(1→3)--l-Rhap(1→2)-6-deoxy-l-Tal
25
2-O-Me--d-Fucp4NAc-(1→4)--d-GlcpA-(1→4)-2-O-Me--l-Fucp-(1→3)--l-Rhap(1→2)-6-deoxy-l-Tal
26
2,4-di-O-Me--l-Fucp-(1→4)--d-GlcpA-(1→4)-2-O-Me--l-Fucp-(1→3)--l-Rhap(1→2)-6-deoxy-l-Tal
Group 2 12
4-(2-hydroxy)propanamido-4,6-dideoxy-3-O-Me--d-Glcp-(1→3)-4-O-Me--l-Rhap-(1→3)--lRhap-(1→2)-6-deoxy-l-Tal
17
3-(3-hydroxy-2-methyl)butanamido-3,6-dideoxy--d-Glcp-(1→3)-4-O-Me--l-Rhap-(1→3)--l-Rhap(1→2)-6-deoxy-l-Tal
19
3,4-di-O-Me--d-GlcpA-(1→3)-3-C-Me-2,4-di-O-Me--l-Rhap-(1→3)--l-Rhap-(1→2)-6-deoxy-l-Tal
Group 3 8
4,6-O-(1-carboxyethylidene)-3-O-Me--d-Glcp-(1→3)- -l-Rhap(1→2)-6-deoxy-l-Tal
21
4,6-O-(1-carboxyethylidene)- -d-Glcp-(1→3)--l-Rhap-(1→2)-6-deoxy-l-Tal
a
Ac, acetyl group; Fucp, fucopyranose; Glcp, glucopyranose; Manp, mannopyranose; Me, methyl group; Rhap, rhamnopyranose; Tal, talose.
Some rough morphotypes of M. avium have been shown to be avirulent compared to their isogenic SmT isolate, whereas some are of similar virulence. The differences in GPL composition between these Rg and SmT morphotypes have not been defined. Increased permeability of GPL-deficient M. smegmatis to chenodeoxycholate, a negatively charged hydrophobic molecule, often used to study mycobacteria cell wall fluidity (Etienne et al., 2002), has been noted.
5.2. Lipooligosaccharides (LOS) Recognition of this trehalose-based class of glycolipids, LOSs, originated from the works
of Saadat and Ballou (1983) who named these as pyruvylated glycolipids from M. smegmatis. Independently, Brennan et al. (1982) identified serologically active lipid extracts of M. kansasii and M. szulgai and several other mycobacteria that were alkali-labile unlike the lipid extracts from M. avium serocomplex. The basic structure of LOS is a multiply-acylated oligosaccharide comprised of residues of xylose, 3-O-Me-Rhap, Fucp and, in the case of M. kansasii, N-acyl-kansosamine (4-acylamido-4,6-dideoxy-3-C-methyl-2-O-l-Rhamnose) linked to a common core of tetra-Glcp (Table 9.3) (Hunter et al., 1984). Trehalose-containing LOS was also identified in M. malmoense, an organism that has been implicated in pulmonary infection
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
5. The species and sub-species specific soluble glycoconjugates of mycobacterial cell walls
161
Table 9.3 Structure of major trehalose-containing lipo-oligosaccharides of Mycobacterium spp. Structure of oligosaccharidea
Positions of acyl residues
Species
Trivial name
M. smegmatis
(Acidic oligosaccharide A)
4,6-O-(1-carboxyethylidene)-3-O-Me--dGlcp-(1→3)-4,6-O-(1-carboxyethylidene)-d-Glcp-(1→4)--d-Glcp-(1→6)--d-Glcp (1↔1)--d-Glcp
4 and 6-hydroxyls of terminal trehalose
M. smegmatis
(Acidic oligosaccharide B1)
4,6-O-(1-carboxyethylidene)--d-Glcp-(1→4)-d-Glcp-(1→6)--d-Glcp(1↔1)--d-Glcp
NDa
M. smegmatis
(Acidic oligosaccharide B2)
4,6-O-(1-carboxyethylidene)-3-O-Me--dGlcp-(1→3)--d-Glcp-(1→4)--d-Glcp(1→6)--d-Glcp(1↔1)--d-Glcp
ND
M. kansasii
LOS I’
3-O-Me--l-Rhap-(1→3)--d-Glcp-(1→3)-d-Glcp-(1→4)--d-Glcp(1↔1)--d-Glcp
ND
M. kansasii
LOS I
d-Xylp-(1→4)-3-O-Me--l-Rhap-(1→3)-d-Glcp-(1→3)--d-Glcp-(1→4)-d-Glcp(1↔1)--d-Glcp
ND
M. kansasii
LOS II, III
(d-Xylp)2-(1→4)-3-O-Me--l-Rhap(1→3)--d-Glcp-(1→3)--d-Glcp-(1→4)-d-Glcp(1↔1)- -d-Glcp
ND
M. kansasii
LOS IV, V, VI
KanNacyl -(1→3)-Fuc-(1→4)-(d-Xylp)4(1→4)-3-O-Me--l-Rhap-(1→3)--d-Glcp(1→3)--d-Glcp-(1→4)--d-Glcp (1↔1)--d-Glcpb
ND
M. kansasii
LOS VII, VIII
3-, 4-, and 6-hydroxyls of terminal Glcp unit of terminal trehalose
M. malmoense
LOS II
KanNacyl -(1→3)-Fucp-(1→4)-[(d-Xylp)4(1→4)6-3-O-Me--l-Rhap-(1→3)]--d-Glcp(1→3)--d-Glcp-(1→4)--d-Glcp (1↔1)--d-Glcpb -d-Manp-(1→3)--d-Manp-(1→2)--l-Rhap(1→2)-[3-O-Me- l-Rhap)-(1→2)]2--lRhap-(1→3)--d-Glcp-(1↔1)--d-Glcp
3-, 4-, and 6-hydroxyls of terminal Glcp unit of terminal trehalose
Reference Hunter et al., 1983
Hunter et al., 1983, 1984
McNeil et al., 1987
a
Ac, acetyl group; Fucp, fucopyranose; Glcp, glucopyranose; KanNacyl, N-acyl-kansosamine; Manp, mannopyranose; Me, methyl group; Rhap, rhamnopyranose; Tal, talose; Xylf, Xylopyronose.
(McNeil et al., 1987). Variations of LOS include differences in acylation, pyruvylation of some residues and glycosylation patterns. The polar characteristic of these glycolipids, combined with evidence that they are not membrane-bound, suggests that the LOSs may be a major component of the lipid barrier, however, their sporadic presence in only a few strains seems to argue against this. M. leprae, M. tuberculosis and M. avium are all devoid of LOS (Minnikin, 1982).
5.3. Lipid-linked sugar donors Cytoplasmic membranes of all actinomycetes and related bacteria contain small amounts of glycosyl-phosphopolyisoprenols involved in the synthesis of cell wall glycans. Polyprenol mannosyl donor (DPM) was first identified by Takayama et al. (1973) and was determined by Yokoyama and Ballou (1989) to be responsible for -(1→6)-linked manno-oligosaccharide
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
162
9. Mycobacterial cell wall glycans
synthesis in mycobacteria. Synthesis of DPM was shown to be sensitive to amphomycin, which inhibits formation of DPM by preventing the transfer of Manp from guanosine diphosphate- (GDP-) Manp to decaprenylphosphate (Besra et al., 1997). The arabinan portion of LAM and AG is mediated by decaprenylphosphorylAraf (DPA) (Wolucka et al., 1994). The latter is the only known precursor of polymerized Araf residues in mycobacteria (Schultz and Elbein, 1974). Polyprenylphosphoryl sugars are typically synthesized through the transfer of a sugar from a sugar nucleotide precursor, as is for decaprenylphosphoryl-d-Manp and decaprenylphosphoryl-d-Glcp (Takayama and Goldman, 1969, 1970). Interestingly, DPA is synthesized from 5-phosphoribose diphosphate (pRpp) via the pentose-phosphate shunt (Scherman et al., 1995, 1996; Klutts et al., 2002). An unusual mycolic acid-containing phospholipid, the 6-O-mycolyl--d-mannopyranosyl-1-phosphoheptaprenol has been shown to be present in M. smegmatis and M. tuberculosis (Besra et al., 1994). This component was initially identified without mycolic acid substitution and thought to be involved in the transfer of Manp residues to phosphatidyl-mannosides (Lee and Ballou, 1965).
6. Conclusions Mycobacterium spp. are characterized by a cell wall that is extraordinary among prokaryotes in the array of highly complex and unique glycolipids and glycopolymers expressed. The mAGP complex provides the cell wall framework, equivalent in function to the Gram-positive teichoic acid-PG assemblage (see Chapter 1). This is the site of action of existing first-line anti-tuberculosis drugs and of new potential ones. Most distinctive of all features is the peculiar outer membrane, the so-called lipid barrier, constructed in part by the mycolic acids and in part by such compounds as
the trehalose-, phthiocerol-, phosphatidylinositolcontaining lipids/glycoconjugates and, depending on the species, glycopeptidolipids and mycobacterial-specific LOSs. Importantly, the characteristic outer membrane of Mycobacterium determines much of the physiology, pathogenicity, immunoreactivity and chemotherapeutic profile of some of these major bacterial pathogens of our times.
Acknowledgements The authors wish to acknowledge funding from grants and contracts from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
References Adam, A., Petit, J.F., Wietzerbin-Falszpan, J., Sinay, P., Thomas, D.W., Lederer, E., 1969. L’acide N-glycolylmuramique, constituant des parois de Mycobacterium smegmatis: identification par spectrometrie de masse. FEBS Lett. 4, 87–92. Anderson, R.J., 1939. The chemistry of the lipids of the tubercle bacillus and certain other microorganisms. Prog. Chem. Org. Nat. Prod. 3, 145–202. Aspinall, G.O., Chatterjee, D., Brennan, P.J., 1995. The variable surface glycolipids of mycobacteria: structures, synthesis of epitopes, and biological properties. In: Horton, D. (Ed.), Advances in Carbohydrate Chemistry and Biochemistry, vol. 51. Academic Press, Washington DC, pp. 169–242. Azuma, I., Kimura, H., Ninaka, T., Aoki, I., Yamamura, Y., 1968. Chemical and immunological studies on mycobacterial polysaccharides. I. Purification and properties of polysaccharides from human tubercle bacilli. J. Bacteriol. 95, 263–271. Ballou, C.E., Lee, Y.C., 1964. The structure of a myo-inositol mannoside from Mycobacterium tuberculosis glycolipid. Biochemistry 3, 682–685. Barrow, W.W., Brennan, P.J., 1982. Immunogenicity of typespecific C-mycoside glycopeptidolipids of mycobacteria. Infect. Immun. 36, 678–684. Beatty, W.L., Rhoades, E.R., Ullrich, H.J., Chatterjee, D., Heuser, J.E., Russell, D.G., 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1, 235–247. Besra, G.S., Sievert, T., Lee, R.E., Slayden, R.A., Brennan, P.J., Takayama, K., 1994. Identification of the apparent carrier in mycolic acid synthesis. Proc. Natl. Acad. Sci. USA 91, 12735–12739.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Besra, G.S., Khoo, K.-H., McNeil, M.R., Dell, A., Morris, H.R., Brennan, P.J., 1995. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy. Biochemistry 34, 4257–4266. Besra, G.S., Morehouse, C.B., Rittner, C.M., Waechter, C.J., Brennan, P.J., 1997. Biosynthesis of mycobacterial lipoarabinomannan. J. Biol. Chem. 272, 18460–18466. Bhamidi, S., Scherman, M.S., Rithner, C.D., et al., 2008. The identification and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactan. J. Biol. Chem. 283, 12992–13000. Bloch, H., 1950. Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms. J. Exp. Med. 91, 197–218. Brennan, P.J., 1988. Mycobacterium and other actinomycetes. In: Wilkinson, R.C., Wilkinson, S.G. (Eds.) Mycobacterial Lipids, vol. I. Academic Press, London, pp. 203–298. Brennan, P.J., 1989. Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev. Infect. Dis. 11, S420–S430. Brennan, P.J., Ballou, C.E., 1967. Biosynthesis of mannophosphoinositides by Mycobacterium phlei. The family of dimannosylphosphoinositides. J. Biol. Chem. 242, 3046–3056. Brennan, P.J., Ballou, C.E., 1968. Biosynthesis of mannophosphoinositides by Mycobacterium phlei. Enzymatic acylation of the dimannophosphoinositides. J. Biol. Chem. 243, 2975–2984. Brennan, P.J., Crick, D.C., 2007. The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery. Curr. Top. Med. Chem. 7, 475–488. Brennan, P.J., Goren, M.B., 1979. Structural studies on the typespecific antigens and lipids of the Mycobacterium aviumMycobacterium intracellulare Mycobacterium scrofulaceum complex serocomplex. J. Biol. Chem. 254, 4205–4211. Brennan, P.J., Nikaido, H., 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64, 29–63. Brennan, P.J., Heifets, M., Ullom, B.P., 1982. Thin-layer chromatography of lipid antigens as a means of identifying non-tuberculous mycobacteria. J. Clin. Microbiol. 15, 447–455. Brennan, P.J., Mayer, H., Aspinall, G.O., Nam Shin, J.E., 1981. Structures of the glycopeptidolipid antigens from serovars in the Mycobacterium avium/Mycobacterium intracellulare/ Mycobacterium scrofulaceum serocomplex. Eur. J. Biochem. 115, 7–15. Briken, V., Porcelli, S.A., Besra, G.S., Kremer, L., 2004. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53, 391–403.
163
Chaput, M., Michel, G., Lederer, E., 1961. On the mycoside Cm, a new peptido-glycolipid isolated from Mycobacterium marianum. Experientia 17, 107–108. Chaput, M., Michel, G., Lederer, E., 1962. [Structure of mycoside Cm, peptidoglycolipid of Mycobacterium marianum]. Biochim. Biophys. Acta 63, 310–326. Chaput, M., Michel, G., Lederer, E., 1963. [Structure of mycoside C2 of Mycobacterium Avium]. Biochim. Biophys. Acta 78, 329–341. Chatterjee, D., Khoo, K.H., 1998. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8, 113–120. Chatterjee, D., Khoo, K.-H., 2001. The surface glycopeptidolipids of mycobacteria:structures and biological properties. Cell. Mol. Life Sci. 58, 2018–2042. Chatterjee, D., Bozic, C.M., Knisley, C., Cho, S.N., Brennan, P.J., 1989. Phenolic glycolipids of Mycobacterium bovis: new structures and synthesis of a corresponding seroreactive neoglycoprotein. Infect. Immun. 57, 322–330. Chatterjee, D., Bozic, C.M., McNeil, M., Brennan, P.J., 1991. Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem. 266, 9652–9660. Chatterjee, D., Hunter, S.W., McNeil, M., Brennan, P.J., 1992a. Lipoarabinomannan. Multiglycosylated form of the mycobacterial mannosylphophatidylinositols. J. Biol. Chem. 267, 6228–6233. Chatterjee, D., Roberts, A.D., Lowell, K., Brennan, P.J., Orme, I.M., 1992b. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun. 60, 1249–1253. Chen, Q., Brglez, I., Boss, W.F., 1991. Inositol phospholipids as plant second messengers. Symp. Soc. Exp. Biol. 45, 159–175. Daffe, M., Draper, P., 1998. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39, 131–203. Daffe, M., Laneelle, M.A., 1989. Diglycosyl phenol phthiocerol diester of Mycobacterium leprae. Biochim. Biophys. Acta 1002, 333–337. Daffe, M., Cho, S.N., Chatterjee, D., Brennan, P.J., 1991. Chemical synthesis and seroreactivity of a neoantigen containing the oligosaccharide hapten of the Mycobacterium tuberculosis-specific phenolic glycolipid. J. Infect. Dis. 163, 161–168. de la Salle, H., Mariotti, S., Angenieux, C., et al., 2005. Assistance of microbial glycolipid antigen processing by CD1e. Science 310, 1321–1324. Delmas, C., Gilleron, M., Brando, T., et al., 1997. Comparative structural study of the mannosylated-lipoarabinomannans from Mycobacterium bovis BCG vaccine strains: characterization and localization of succinates. Glycobiology 7, 811–817.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
164
9. Mycobacterial cell wall glycans
Dobson, G., Minnikin, D.E., Besra, G.S., Mallet, A.I., Magnusson, M., 1990. Characterisation of phenolic glycolipids from Mycobacterium marinum. Biochim. Biophys. Acta 1042, 176–181. Draper, P., Kandler, O., Darbre, A., 1987. Peptidoglycan and arabinogalactan of Mycobacterium leprae. J. Gen. Microbiol. 133, 1187–1194. Draper, P., Khoo, K.H., Chatterjee, D., Dell, A., Morris, H.R., 1997. Galactosamine in walls of slow-growing mycobacteria. Biochem. J. 327, 519–525. Etienne, G., Villeneuve, C., Billman-Jacobe, H., AstarieDequeker, C., Dupont, M.A., Daffe, M., 2002. The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis. Microbiology 148, 3089–3100. Fischer, K., Scotet, E., Niemeyer, M., et al., 2004. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 101, 10685–10690. Frehel, C., Rastogi, N., 1989. Phagosome-lysosome fusions in macrophages infected by Mycobacterium avium: role of mycosides-C and other cells surface components. Acta Leprol. 7 (Suppl. 1), 173–174. Gastambide-Odier, M., Lederer, E., Sarda, P., 1965. [Structure of the aglycones of mycosides A and B]. Tetrahedron. Lett. 35, 3135–3143. Gaylord, H., Brennan, P.J., 1987. Leprosy and the leprosy bacillus: recent developments in characterization of antigens and immunology of the disease. Annu. Rev. Microbiol. 41, 645–675. Gibson, K.J., Gilleron, M., Constant, P., et al., 2005. A lipomannan variant with strong TLR-2-dependent proinflammatory activity in Saccharothrix aerocolonigenes. J. Biol. Chem. 280, 28347–28356. Gilleron, M., Himoudi, N., Adam, O., et al., 1997. Mycobacterium smegmatis phosphatidylinositols-glyceroarabinomannans. J. Biol. Chem. 272, 117–124. Gilleron, M., Quesniaux, V.F., Puzo, G., 2003. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and Mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J. Biol. Chem. 278, 29880–29889. Gilleron, M., Nigou, J., Nicolle, D., Quesniaux, V., Puzo, G., 2006. The acylation state of mycobacterial lipomannans modulates innate immunity response through Toll-like receptor 2. Chem. Biol. 13, 39–47. Goren, M.B., 1972. Mycobacterial lipids: selected topics. Bacteriol. Rev. 36, 33–64. Goren, M.B., Brennan, P.J., 1979. Mycobacterial lipids: chemistry and biological activities. In: Youmans, G.P. (Ed.), Tuberculosis. W.B. Saunders, Philadelphia, pp. 69–193. Goren, M.B., D’Arcy Hart, P., Young, M.R., Armstrong, J.A., 1976. Prevention of phagosome-lysosome fusion in
cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 73, 2510–2514. Guerardel, Y., Maes, E., Briken, V., et al., 2003. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosisinducing properties. J. Biol. Chem. 278, 36637–36651. Heidelberger, M., 1939. Quantitative absolute methods in the study of antigen-antibody reactions. Bacteriol. Rev. 3, 49–95. Henderson, B., Poole, S., Wilson, M., 1996. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60, 316–341. Hoffmann, C., Leis, A., Niederweis, M., Plitzko, J.M., Engelhardt, H., 2008. Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc. Natl. Acad. Sci. USA 105, 3963–3967. Hunter, S.W., Brennan, P.J., 1981. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J. Bacteriol. 147, 728–735. Hunter, S.W., Brennan, P.J., 1990. Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J. Biol. Chem. 265, 9272–9279. Hunter, S.W., Murphy, R.C., Clay, K., Goren, M.B., Brennan, P.J., 1983. Trehalose-containing lipooligosaccharides. A new class of species-specific antigens from Mycobacterium. J. Biol. Chem. 258, 10481–10487. Hunter, S.W., Fujiwara, T., Murphy, R.C., Brennan, P.J., 1984. N-acylkansosamine. A novel N-acylamino sugar from the trehalose-containing lipooligosaccharide antigens of Mycobacterium kansasii. J. Biol. Chem. 259, 9729–9734. Hunter, S.W., Gaylord, H., Brennan, P.J., 1986. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J. Biol. Chem. 261, 12345–12351. Ilangumaran, S., Arni, S., Poincelet, M., et al., 1995. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J. Immunol. 155, 1334–1342. Jenkins, P.A., Marks, J., Schaefer, W.B., 1971. Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria. Am. Rev. Respir. Dis. 103, 179–187. Jullien, D., Stenger, S., Ernst, W.A., Modlin, R.L., 1997. CD1 presentation of microbial nonpeptide antigens to T cells. J. Clin. Invest. 99, 2071–2074. Kato, M., Asselineau, J., 1971. Chemical structure and biochemical activity of cord factor analogs. 6,6-Dimycoloyl sucrose and methyl 6-mycoloyl-d-glucoside. Eur. J. Biochem. 22, 364–370.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Khoo, K.-H., Dell, A., Morris, H.R., Brennan, P.J., Chatterjee, D., 1995a. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J. Biol. Chem. 270, 12380–12389. Khoo, K.-H., Dell, A., Morris, H.R., Brennan, P.J., Chatterjee, D., 1995b. Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology 5, 117–127. Khoo, K.H., Douglas, E., Azadi, P., et al., 1996. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis – inhibition of arabinan biosynthesis by ethambutol. J. Biol. Chem. 271, 28682–28690. Klutts, J.S., Hatanaka, K., Pan, Y.T., Elbein, A.D., 2002. Biosynthesis of d-arabinose in Mycobacterium smegmatis: specific labeling from d-glucose. Arch. Biochem. Biophys. 398, 229–239. Lee, A., Wu, S.W., Scherman, M.S., et al., 2006. Sequencing of oligoarabinosyl units released from mycobacterial arabinogalactan by endogenous arabinanase: identification of distinctive and novel structural motifs. Biochemistry 45, 15817–15828. Lee, Y.C., Ballou, C.E., 1964. Structural studies on the myoinositol mannosides from the glycolipids of Mycobacterium tuberculosis and Mycobacterium phlei. J. Biol. Chem. 239, 1316–1327. Lee, Y.C., Ballou, C.E., 1965. Complete structures of the glycophospholipids of mycobacteria. Biochemistry 4, 1395–1404. Leopold, K., Fischer, W., 1993. Molecular analysis of the lipoglycans of Mycobacterium tuberculosis. Anal. Biochem. 208, 57–64. Maclennan, A.P., Randall, H.M., Smith, D.W., 1961. The occurence of methyl ethers of rhamose and fucose in specific glycolipids of certain mycobacteria. Biochem. J. 80, 309–318. Maeda, N., Nigou, J., Herrmann, J.L., et al., 2003. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 278, 5513–5516. Mahapatra, S., Crick, D.C., McNeil, M.R., Brennan, P.J., 2008. Unique structural features of the peptidoglycan of Mycobacterium leprae. J. Bacteriol. 190, 655–661. Marks, J., Jenkins, P.A., Schaefer, W.B., 1970. Identification and incidence of a third type of Mycobacterium avium. Am. Rev. Respir. Dis. 102, 499–506. Marks, J., Jenkins, P.A., Schaefer, W.B., 1971. Thin-layer chromatography of mycobacterial lipids as an aid to classification: technical improvements: Mycobacterium avium, M. intracellulare (Battey bacilli). Tubercle 52, 219–225.
165
Martinez, A., Torello, S., Kolter, R., 1999. Sliding motility in mycobacteria. J. Bacteriol. 181, 7331–7338. Matsuhashi, M., 1966. [Biosynthesis in the bacterial cell wall]. Tanpakushitsu Kakusan Koso 11, 875–886. McNeil, M., Tsang, A.Y., McClatchy, J.K., Stewart, C., Jardine, I., Brennan, P.J., 1987. Definition of the surface antigens of Mycobacterium malmoense and use in studying the etiology of a form of mycobacteriosis. J. Bacteriol. 169, 3312–3320. McNeil, M., Daffe, M., Brennan, P.J., 1991. Location of the mycolyl ester substituents in the cell walls of mycobacteria. J. Biol. Chem. 266, 13217–13223. Middlebrook, G., Colemann, C., Schaeffer, W.B., 1959. Sulfolipids from virulent tubercle bacilli. Proc. Natl. Acad. Sci. USA 45, 1801–1804. Minnikin, D.E., 1982. Lipids: complex lipids, their chemistry, biosynthesis and roles. In: Ratledge, C., Stanford, J. (Eds.) The Biology of Mycobacteria, vol. 2. Academic Press, London, pp. 95–184. Misaki, A., Seto, N., Azuma, I., 1974. Structure and immunological properties if d-arabino-d-galactan isolated from cell walls of Mycobacterium species. J. Biochem. 76, 15–27. Misaki, A., Azuma, I., Yamamura, Y., 1977. Structural and immunochemical studies on d-arabino-d-mannans and d-mannans of Mycobacterium tuberculosis and other Mycobacterium species. J. Biochem. 82, 1759–1770. Moehring, J.M., Solotorovsky, M.R., 1965. Relationship of colonial morphology to virulence for chickens of Mycobacterium avium and the nonphotochromogens. Am. Rev. Respir. Dis. 92, 704–713. Ng, V., Zanazzi, G., Timpl, R., et al., 2000. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 103, 511–524. Noll, H., Jackim, E., 1958. The chemistry of the native constituents of the acetone-soluble fat of Mycobacterium tuberculosis (Brevannes). I. Glycerides and phosphoglycolipides. J. Biol. Chem. 232, 903–917. Noll, H., Bloch, H., Asselineau, J., Lederer, E., 1956. The chemical structure of the cord factor of Mycobacterium tuberculosis. Biochim. Biophys. Acta 20, 299–309. Ortalo-Magné, A., Lemassu, A., Lanéelle, M.A., et al., 1996. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 178, 456–461. Pabst, M.J., Gross, J.M., Brozna, J.P., Goren, M.B., 1988. Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J. Immunol. 140, 634–640. Pangborn, M.C., McKinney, J.A., 1966. Purification of serologically active phosphoinositides of Mycobacterium tuberculosis. J. Lipid Res. 7, 627–633. Patterson, J.H., McConville, M.J., Haites, R.E., Coppel, R.L., Billman-Jacobe, H., 2000. Identification of a methyltransferase from Mycobacterium smegmatis involved in glycopeptidolipid synthesis. J. Biol. Chem. 275, 24900–24906.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
166
9. Mycobacterial cell wall glycans
Prigozy, T.I., Sieling, P.A., Clemens, D., et al., 1997. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6, 187–197. Prinzis, S., Chatterjee, D., Brennan, P.J., 1993. Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG. J. Gen. Microbiol. 139, 2649–2658. Recht, J., Martinez, A., Torello, S., Kolter, R., 2000. Genetic analysis of sliding motility in Mycobacterium smegmatis. J. Bacteriol. 182, 4348–4351. Saadat, S., Ballou, C.E., 1983. Pyruvylated glycolipids from Mycobacterium smegmatis. Structures of two oligosaccharide components. J. Biol. Chem. 258, 1813–1818. Schaefer, W.B., 1965. Serologic identification and classification of the atypical mycobacteria by their agglutination. Am. Rev. Respir. Dis. 92, 85–93. Schaefer, W.B., Davis, C.L., Cohn, M.L., 1970. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice. Am. Rev. Respir. Dis. 102, 499–506. Scherman, M., Weston, A., Duncan, K., et al., 1995. The biosynthetic origin of the mycobacterial cell wall arabinosyl residues. J. Bacteriol. 177, 7125–7130. Scherman, M.S., Kalbe-Bournonville, L., Bush, D., Xin, Y., Deng, L., McNeil, M., 1996. Polyprenylphosphate-pentoses in mycobacteria are synthesized from 5-phosphoribose pyrophosphate. J. Biol. Chem. 271, 29652–29658. Schlesinger, L.S., 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150, 2920–2925. Schlesinger, L.S., Hull, S.R., Kaufman, T.M., 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152, 4070–4079. Schlesinger, L.S., Kaufman, T.M., Iyer, S., Hull, S.R., Marchiando, L.K., 1996. Differences in mannose receptormediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J. Immunol. 157, 4568–4575. Schultz, J., Elbein, A.D., 1974. Biosynthesis of mannosyland glucosyl-phosphoryl polyprenols in Mycobacterium smegmatis. Evidence for oligosaccharide-phosphorylpolyprenols. Arch. Biochem. Biophys. 160, 311–322. Severn, W.B., Furneaux, R.H., Falshaw, R., Atkinson, P.H., 1998. Chemical and spectroscopic characterisation of the phosphatidylinositol manno-oligosaccharides from Mycobacterium bovis AN5 and WAg201 and Mycobacterium smegmatis mc2 155. Carbohydr. Res. 308, 397–408. Sieling, P.A., Chatterjee, D., Porcelli, S.A., et al., 1995. CD1restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227–230. Smith, D.W., Harrell, W.K., Randall, H.M., 1954. Correlation of biologic properties of strains of Mycobacterium with
infrared spectrum III, differentiation of bovine and human varieties of M. tuberculosis by means of infrared spectrum. Am. Rev. Tuberc. 69, 505–510. Smith, D.W., Randall, H.M., MacLennan, A.P., Putney, R.K., Rao, S.V., 1960a. Detection of specific lipids in mycobacteria by infrared spectroscopy. J. Bacteriol. 79, 217–229. Smith, D.W., Randall, H.M., MaclLennan, A.P., Lederer, E., 1960b. Mycosides: a new class of type specific glycolipids of mycobacteria. Nature (London) 186, 887–888. Stenger, S., Mazzaccaro, R.J., Uyemura, K., et al., 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276, 1684–1687. Strohmeier, G.R., Fenton, M.J., 1999. Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microb. Infect. 1, 709–717. Sweet, L., Zhang, W., Torres-Fewell, H., Serianni, A., Boggess, W., Schorey, J., 2008. Mycobacterium avium glycopeptidolipids require specific acetylation and methylation patterns for signaling through TLR2. J. Biol. Chem. 283, 33221–33231. Tailleux, L., Schwartz, O., Herrmann, J.L., et al., 2003. DCSIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197, 121–127. Takayama, K., Goldman, D.S., 1969. Pathway for the synthesis of mannophospholipids in Mycobacterium tuberculosis. Biochim. Biophys. Acta 176, 196–198. Takayama, K., Goldman, D.S., 1970. Enzymatic synthesis of mannosyl-1-phosphoryl-decaprenol by a cell-free system of Mycobacterium tuberculosis. J. Biol. Chem. 245, 6251–6257. Takayama, K., Schnoes, H.K., Semmler, E.J., 1973. Characterization of the alkali-stable mannophospholipids of Mycobacterium smegmatis. Biochim. Biophys. Acta 316, 212–221. Taylor, P.R., Gordon, S., Martinez-Pomares, L., 2005. The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol. 26, 104–110. Torrelles, J.B., Khoo, K.H., Sieling, P.A., et al., 2004. Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis. J. Biol. Chem. 279, 41227–41239. Treumann, A., Xidong, F., McDonnell, L., et al., 2002. 5-Methylthiopentose: a new substituent on lipoarabinomannan in Mycobacterium tuberculosis. J. Mol. Biol. 316, 89–100. Turnbull, W.B., Shimizu, K.H., Chatterjee, D., Homans, S.W., Treumann, A., 2004. Identification of the 5-methylthiopentosyl substituent in Mycobacterium tuberculosis lipoarabinomannan. Angew. Chem. Int. Ed. Engl. 43, 3918–3922. Vergne, I., Fratti, R.A., Hill, P.J., Chua, J., Belisle, J., Deretic, V., 2004. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol. Biol. Cell 15, 751–760.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Vilkas, E., Lederer, E., 1968. N-methylation of peptides by the method of Hakomori. Structure of mycoside Cbl. Tetrahedron Lett. 26, 3089–3092. Vollmer, W., Höltje, J.V., 2004. The architecture of the murein (peptidoglycan) in gram-negative bacteria: vertical scaffold or horizontal layer(s)? J. Bacteriol. 186, 5978–5987. Wolucka, B.A., McNeil, M.R., de Hoffmann, E., Chojnacki, T., Brennan, P.J., 1994. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis
167
and its relation to the mode of action of ethambutol on mycobacteria. J. Biol. Chem. 269, 23328–23335. Yokoyama, K., Ballou, C.E., 1989. Synthesis of -1-6 mannooligosaccharide in M. smegmatis. J. Biol. Chem. 264, 21621–21628. Zuber, B., Chami, M., Houssin, C., Dubochet, J., Griffiths, G., Daffé, M., 2008. Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J. Bacteriol. 190, 5672–5680.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
10 Glycoconjugate structure and function in fungal cell walls Marlyn Gonzalez, Piet W. J. de Groot, Frans M. Klis and Peter N. Lipke
Summary Complex cell walls distinguish fungi from animals, and the roles of these walls include osmotic support, selective permeability and interaction with the environment. Fungal walls consist of covalently cross-linked complexes of polysaccharides (usually -glucans and chitin) with glycoproteins. Several different polysaccharides are covalently cross-linked through glycosidic bonds. They are also cross-linked to two types of glycoproteins (CWPs). The Pir-CWPs are multiply cross-linked through ester bonds between deamidated glutamine residues and hydroxyl groups in the major -(1→3)-glucan. The GPIt-CWPs are defined by their linkage through transglycosylation of the truncated glycosylphosphatidylinositol (GPI) glycan to -(1→6)-glucan. These GPIt-CWPs are highly N- and O-mannosylated and may also have ester-glucan cross-links like the Pir-CWPs. GPItCWPs have a common modular structure, with an N-terminal secretion signal, then a well-folded functional enzymatic or ligand binding domain, a middle region of tandem repeats, a C-terminal serineand threonine-rich highly glycosylated “stalk” and
Microbial Glycobiology
a C-terminal GPI addition signal. Their functional regions include enzymes active in cell wall biogenesis and maintenance and nutrient acquisition; transport functions; and cell adhesion proteins that mediate interactions between fungal cells, pathogen and host and in biofilms. Therefore, fungal walls have functions including those assumed by membrane, cytoskeleton and extracellular matrix in other organisms. Keywords: -glucan; Chitin; Glycoprotein; Glyco sylphosphatidylinositol anchor; N-glycosylation; Oglycosylation; Glucan-protein ester
1. Introduction Among the defining characteristics of fungi are cell walls with complex architecture. Fungal walls are substantially thicker than bacterial walls and normally make up 10–30% of the biomass. They are freely permeable to small molecules and so solute transport systems and signalling receptors remain in the membrane,
169
© 2009 2010, Elsevier Inc.
170
10. Glycoconjugates in fungal cell walls
and are homologous to those in other eukaryotes. Walls have obvious functions in osmotic and mechanical support of the cells, which have less extensive cytoskeletons than do motile eukaryotes. Walls are also the site of cell contact with the environment, so the outer surface of the wall is adapted to participate in the cell–cell interactions characteristic of colony and biofilm formation, as well as host–fungal adherence in symbiotic, commensal and pathogenic states. A variety of activities reside in glycoproteins embedded within the walls and linked with fungal wall polysaccharides. Many of these proteins are adhesins; while others cross-link cell wall polysaccharides or are carbohydrate-active enzymes. Such enzymes have functions such as wall biogenesis and turnover, modulation of wall structure in response to stress and to fungal morphogenesis and, conceivably, also in the formation of the extracellular matrix of biofilms. Finally, some cell wall glycoproteins are involved in iron and sterol acquisition or in coping with oxidative stress (Yin et al., 2008). In addition, many, if not all, of the major wall components can elicit immune responses or other host responses as antigens and modulators. Thus, the walls of fungi are complex organelles with extensive cellular, metabolic and environmental functions. This review will briefly discuss the major polysaccharides in fungal walls and, in particular, focus on wall glycoproteins.
followed by the locus name, e.g. CaAls1 is the product of the ALS1 locus in C. albicans. Occasionally, we will also reference studies in other fungal groups. The general observation is that wall glycan structures differ somewhat between fungal organisms, but that the same basic designs are widespread. Indeed, a recent bioinformatics study showed that the sequences of fungal wall glycoproteins differed greatly between Ascomycetes, but that many cell wall biosynthetic enzymes and cellular processes of biosynthesis were highly conserved and ancestral to all of the fungi (Coronado et al., 2007). Similarly, the details of wall polysaccharides and of N- and O-linked protein side-chains differ between ascomycetous fungi, but the general arrangement is likely to be conserved. Breaking fungal cells with glass beads releases a covalently bonded cell wall “ghost” whose shape is maintained and which retains most of its constituents after extraction at 100°C in the presence of sodium dodecyl sulfate (SDS) and reducing agents (Pitarch et al., 2008). Figure 10.1 is a cartoon of the fungal wall structure based mostly on what is known from the ascomycetous yeasts. There is a fibrous and flexible polysaccharide network (structures 1–3), decorated and cross-linked by glycoproteins (structures 4–7). On average, the polysaccharide layer is proximal to the membrane and most glycoproteins are at the exterior surface of the wall. There are minor components, not illustrated or discussed here, including glycolipids and metal ions.
2. Overall structure 3. Wall polysaccharides Our knowledge is based primarily on studies in baker’s yeast, Saccharomyces cerevisiae, and the commensal/opportunistic pathogenic yeast, Candida albicans. Although these yeasts apparently diverged many hundreds of millions of years ago, they both belong to the phylum Ascomycota and their wall structures are similar. Gene products in these two yeasts are referenced by their genus and species initials,
3.1. Fibrous polysaccharides Ninety percent or more of the wall mass is accounted for by polysaccharides and by carbohydrate side-chains of cell wall glycoproteins. In baker’s yeast, about half of this mass is accounted for by the structural polysaccharide -(1→3)-glucan (see Figure 10.1, structure 2).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
171
3. Wall polysaccharides
N N
N
S
S
7
S
S
100–200 nm
6 4
GPIt-CWP
C C 5 4
C
Pir-CWP 1
2 3 Plasma membrane
A GlcNAc Glc Man
P
1 2
β1 4
Chitin
β1 3
β1→3-glucan
3
β1 6 β1 3
β1→6-glucan
β1 6
4
Glu C O O
β1→3-glucan-protein Linkage (Pir-CWP)
Other sugar Phosphodiester Reducing end 5
H AA C N CH2 CH2 P O
6
Ser Thr
7
Asn
Protein
β1→6-glucanprotein linkage (GPIt-CWP)
P
Mannoprotein O-glycans Outer chain
Core
Mannoprotein N-glycans P
P
B
Figure 10.1 Cartoon model of the cell wall of an ascomycetous yeast. (A) Shows the general arrangement, including polysaccharides and glycoproteins. Disulfide cross-links are shown as vertically paired “S”; X designates ester bonds between deamidated Gln residues on CWPs and hydroxyl groups in -(1→3) glucans. (B) A key and sketches of glycan structures. Many linkage details are not shown. Mannosyl linkages are in the -configuration except the left-most mannose in the core of the N-glycan and in some species-specific groups discussed in the text. For details, readers are referred to the text.
-(1→3)-Glucan forms single and triple-stranded helices through regular H bonding between sugars. Because its average degree of polymerization is 1000, and there are a few branches, there develops a network of interacting fibres in the wall. Probably, this network is reinforced by -glucan cross-linking proteins such as the
Pir proteins (see Figure 10.1, structure 4), which will be discussed later. Chitin, an unbranched polymer of -(1→4)-linked N-acetylglucosamine (see Figure 10.1, structure 1), is present in the walls of almost all fungi, at least in some stages of the life cycle and, indeed, chitin is a conserved character in walled cysts of many
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
172
10. Glycoconjugates in fungal cell walls
eukaryote kingdoms (Cavalier-Smith and Chao, 2003). The ratio of chitin to other polysaccharides varies widely between species. Whereas chitin is absent from walls of vegetative cells of Schizosaccharomyces pombe and usually present only in low amounts in the walls of C. albicans and S. cerevisiae, it is, in some fungi, the major cell wall polysaccharide. Chitin forms insoluble ribbons of stacked polysaccharide chains with great tensile strength. In other organisms, cellulose [-(1→4)-glucan], chitosan [-(1→4)polyglucosamine] or -(1→3)-glucan are the major fibrous wall polysaccharides. Each of these can form ribbons or helical structures. Thus, the fibrous polysaccharides constitute a cross-linked framework that gives the wall its insolubility and mechanical strength. A -(1→6)-glucan with -(1→3) branches is a minor but essential component of yeast cell walls (see Figure 10.1, structure 3). This highly branched glucan, which is water-soluble and consists of a few hundred monosaccharide units per molecule, probably does not have a regular secondary structure, but serves as a flexible linking molecule, which is covalently bonded to -(1→3)-glucan chains, chitin chains and glycosylphosphatidylinositol- (GPI-) linked glycoproteins through transglycosylation reactions. These cross-linking reactions apparently take place within the growing wall, so they are exterior to the plasma membrane. Plasma membrane-bound GPI proteins and cell wall resident proteins, such as the family of Gas transglycosylases, ScBgl2, ScCrh1, Scw1 and ScDfg5, have been implicated in these activities, but details are not yet known. The wall polysaccharides elicit responses in host organisms, presumably because they are markers of fungal infections. Thus, chitin and chitosan oligosaccharides are elicitors of plant host defence pathways. Similarly, -(1→3)-glucan binds to the immunomodulatory C-type lectin dectin, leading to proinflammatory reactions aimed at clearing the infection (Dennehy and Brown, 2007; Sun and Zhao, 2007). Recent work
implies that glucan becomes more exposed on cell surfaces as the fungi are damaged, thus contributing to increased inflammation as the infection is contained (Wheeler and Fink, 2006).
3.2. Capsules Capsules are characteristic of the basidiomycete Cryptococcus neoformans and a few other species. C. neoformans capsules consist of long linear chains of -(1→3)-linked mannosyl residues, decorated with highly antigenic 6-Oacetyl groups, as well as -linked glucuronic acid and -linked xylopyranose units. The capsules form a fibrous network that can double or triple the apparent cell diameter and, like bacterial capsules, they render the cells resistant to immune-system surveillance and killing. C. neoformans capsules are released from the cell following treatment with dimethyl sulfoxide. This result implies that they are non-covalently bound to the walls, rather than being part of the cross-linked structure (Cherniak et al., 1998; Frases et al., 2008; Rodrigues et al., 2008; Yoneda and Doering, 2008). A recent report implicates chitinous structures in the wall as anchor sites for the capsule (Rodrigues et al., 2008).
4. Cell wall glycoproteins of ascomycetous fungi The major bioactive components of fungal cell walls are the glycoproteins, which form an exterior layer in the wall and, thus, are the major subject of this chapter. For a recent review of cell wall proteins in Basidiomycetes see Yin et al. (2008). The cell walls of ascomycetous fungi often display an external, fibrillar layer that consists of glycoproteins emanating into the environment (De Groot et al., 2005; Yin et al., 2008). This fibrillar layer is covalently linked to the underlying skeletal polysaccharides that form the internal layer of the wall. The external glycoprotein layer
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Cell wall glycoproteins of ascomycetous fungi
seems to consist largely of individual proteins. However, in some fungi, so-called fimbriae have been described, which are multi-subunit protein complexes that can be released from the wall by shearing forces (Yu et al., 1994). For example, very long appendages can be seen to emerge from C. albicans walls, apparently mediating contact with buccal epithelial cells. Partial purification of these fibrillar structures revealed a 66kDa glycoprotein as its major component. It has been estimated that a haploid cell of baker’s yeast in the exponential phase of growth possesses about two million covalently linked cell wall proteins (CWPs). There are several classes of CWP molecules (Yin et al., 2008): (i)
The GPI-CWPs (see Figure 10.1, structures 5–7) possess a trimmed form of a GPI anchor (GPIt) through which they are covalently bound to the skeletal framework, thereby forming protein–polysaccharide complexes such as CWP-GPIt → -(1→ 6)-glucan → -(1→3)-glucan or CWP-GPIt → -(1→6)-glucan ← chitin (see Figure 10.1, structure 5, where the arrows in the complexes indicate the direction of the glycosidic linkages interconnecting the macromolecules of the complex). This seems to be the main class of covalently linked CWPs. They can be released from the wall by using phosphodiesterases or hydrofluoric acid-pyridine treatment, which cleave the phosphodiester bond in the GPIt structure, or by cell wall hydrolases, e.g. -(1→6)-glucanase, -(1→ 3)-glucanase or chitinase. The mature protein is shorter than the predicted amino acid sequence as it lacks both the Nterminal signal peptide and the C-terminal GPI anchor signal sequence (see Figure 10.1). Both cleavage sites can be reliably predicted using suitable algorithms (De Groot et al., 2005). When by molecular genetic means a C-terminally truncated form of a GPI protein is created without the
(ii)
(iii)
(iv)
(v)
(vi)
173
GPI anchor signal sequence, the resulting protein is generally secreted into the growth medium, thus facilitating its purification. The Pir-CWPs are secreted proteins that possess multiple internal tandem repeats. The repeats are believed to be responsible for cross-linking -(1→3)-glucan chains through an (alkali-sensitive) ester linkage between a specific de-amidated glutamine residue in the repeats and hydroxyl groups of the glucosyl residues (Ecker et al., 2006) (marked by “X” in Figure 10.1, structure 4). Interestingly, CaPir1 is essential for cell viability, emphasizing the role of Pir-CWPs in cell wall integrity. Some GPI-CWPs in S. cerevisiae also possess a Pir-repeat, thus allowing them to act as a cross-linking cell wall protein as well (in Figure 10.1, the left-most GPI-CWP contains both linkages, structures 4 and 5) (Klis et al., 2006). A third group of secretory CWPs, e.g. CaMP65, CaTos1 and ScScw4, ScScw10 and ScTos1, can also be released from hot detergent-extracted cell walls by using mild alkali but they lack the repeats that are characteristic for Pir-CWPs (De Groot et al., 2005). The precise nature of their linkage to the wall is so far unknown. Disulfide-linked secreted CWPs ScAga2, the subunit of the sexual agglutinin of mating type -cells, is involved in recognition of such cells. This subunit is linked through two disulfide bridges to the GPI-CWP ScAga1 (Cappellaro et al., 1994). Conceivably, the fimbriae observed in C. albicans and other fungi are also kept together by disulfide bonds. Secretory CWPs such as ScBgl2 that are non-covalently bound to cell wall polysaccharides, possibly, by the presence of a glycan-binding domain. Some enzymes that hydrolyse nutrients, including phosphatases and glycosidases like invertase are physically entrapped in the periplasmic region and perhaps within
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
174
10. Glycoconjugates in fungal cell walls
the wall matrix. These glycoproteins can be solubilized from walls by heating in SDS sample buffer and are in the soluble fraction after breakage of the walls (Kapteyn et al., 1997). There are also numerous reports in the literature describing the presence of non-covalently bound, non-glycosylated, cytosolic proteins in the fungal cell wall. Unfortunately, these observations are rife with artefacts and possible export mechanisms for such proteins remain unclear (Yin et al., 2008); these observations fall therefore out of the scope of this chapter.
5. Characteristics of fungal cell wall glycoproteins Some important characteristics of the cell wall proteomes of ascomycetous fungi are the following: (i) Many fungi seem to possess a wide arsenal of covalently linked CWPs, as indicated by mass spectrometric and biochemical analysis of the cell wall proteome. For example, the cell walls of S. cerevisiae and C. albicans contain at any time more than 20 different covalently linked CWPs in their walls (Yin et al., 2008). (ii) Some CWPs are among the most abundantly expressed proteins of the cell. (iii) The CWPs often display a modular organization (see Figures 10.1 and 10.2). In GPI-CWPs, the effector domain is generally found in the N-terminal part of the protein, which extends into the medium. This is followed by a serine- (Ser-) and threonine(Thr-) rich region; the C-terminal residue of the mature protein is linked through a GPIremnant to the skeletal framework of the wall. The Ser- and Thr-rich region often contains an internal tandem series of repeats (see Figure 10.2). The multiple
short O-linked carbohydrate side-chains in the Ser- and Thr-rich regions seem to rigidify these protein regions, allowing them to act as a spacer domain (Dranginis et al. 2007). In CWPs that lack a GPI anchor, the effector domain is not necessarily found in the N-terminal domain (Linder and Gustafsson, 2008). (iv) As discussed in the previous section, some CWPs, such as the Pir-CWPs and the GPIprotein ScCwp1, are involved in crosslinking of cell wall polysaccharides. Thus, these CWPs serve covalently to cross-link walls into a single covalent complex that remains intact following boiling in SDS (see Figures 10.1 and 10.3). In agreement with this, both ScCWP1 and ScPIR genes are upregulated in response to cell wall stress. (v) The CWPs also mediate homotypic and heterotypic cell aggregation, endocytosis, (mixed) biofilm formation, coping with oxidative stress and iron and sterol acquisition (De Groot et al., 2005; Dranginis et al., 2007; Yin et al., 2008). (vi) The CWPs as an external layer in the wall also have collective functions (see Figure 10.1). For example, the external glycoprotein layer limits the permeability of the cell wall to macromolecules and, thus, hampers recognition of the internal -glucan layer of the wall by dectins, which are membrane-bound lectin-like receptor proteins belonging to the innate immune system of the host. The extended N-linked protein side-chains found in many CWPs seem to be largely responsible for limiting the permeability of the walls (De Groot et al., 2005). In addition, disulfide links between CWPs may also be involved in limiting the permeability of walls to macromolecules (De Nobel et al., 1990). Both N- and O-linked side-chains of CWPs may contain phosphodiester linkages (see Figure 10.1). At most physiological pHs, these phosphodiester groups are negatively
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
175
5. Characteristics of fungal cell wall glycoproteins
100 ScSag1
Percentage
80 60 Region not present in ScSag1 40 20 0
0
200 Posit
400 ion
600
1000
1200
100 CaAls1
Percentage
80 60 40 20 0
0
200
400
600 Position
800
Figure 10.2 Distribution of Ser and Thr residues in the Ig-like GPIt-CWP adhesins ScSag1 and CaAls1. Note that the Ser and Thr content of the first 300 amino acids, which corresponds to the effector domain, is relatively low. The repeats in the middle part of the CaAls1 protein are clearly recognizable. Upper panel: ScSag1; predicted sequence length, 650 amino acids; predicted secretory signal peptide, 1–19; predicted GPI signal sequence, 628–650; predicted S/T-content, 29.8%. Lower panel: CaAls1; predicted sequence length, 1260 amino acids; predicted secretory signal peptide, 1–17; GPI signal sequence, 1239–1260; predicted S/T-content, 36.8%. There are tandem repeats in the middle of CaAls1 that are not present in ScSag1, which has been split to align the similar regions. A sliding window of 11 amino acids was used.
charged and are thus responsible for the numerous negative charges at the fungal cell surface. Therefore, fungal cell walls act as cation exchangers, thus allowing them to bind positively charged proteins, e.g. proteins released from the cytosol. The change also explains the stainability of many fungi with the positively charged dye Alcian blue (De Groot et al., 2005).
(vii) The CWPs are stable proteins that show only a limited release into the medium (Klis et al., 2006). (viii) The incorporation of specific CWPs in newly formed walls is often temporally and spatially controlled and also strongly depends on environmental conditions as further discussed below (Klis et al., 2006).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
176
10. Glycoconjugates in fungal cell walls A
β1→3-glucan Pir-CWP
c haracteristic of a large number of wall proteins and, in fungi, they are covalently bonded to the wall polysaccharides.
β1→3-glucan β1→3-glucan B
β1→3-glucan GPIt-CWP β1→6-glucan β1→3-glucan
Figure 10.3 Potential cross-linking functions of PirCWPs and hybrid GPI-CWPs. Pir-CWPs possess a number of repeats, allowing them to cross-link multiple -(1→3)glucan chains. This is consistent with their location in the inner part of the cell wall. The ScCwp1 and other GPI-CWPs possess a single Pir repeat, allowing them to cross-link a -(1→6)-glucan to a -(1→3)-glucan. (A) Pir-CWP crosslinks to multiple -(1→3) glucans through tandem repeats. (B) GPIt-CWP cross-linking to -(1→3) glucan through an ester bond and to -(1→6) glucan through the truncated and transglycosylated GPI.
6. The mannoprotein glycans In many mannoproteins, the glycan part outweighs the peptide part by a 10:1 ratio. There are three types of glycosylation known in fungal cell wall proteins: O-glycans (see Figure 10.1, structure 6), N-glycans (structure 7) and GPI anchors (structure 5). Each type of glycosylation shares characteristics of structure and biosynthesis with mammals and other eukaryotes, with some characteristic fungal differences. In most cases, the O-linked glycosyl side-chains consist of manno-oligosaccharides that are occasionally decorated with other sugars, whereas the N-linked side-chains are hypermannosylated, but contain a core structure similar to mammalian N-chains. The core structure is often extended with a very large branched -mannan with an -(1→6)linked backbone that may be decorated with various other sugars as well. GPI anchors are
6.1. O-glycans See Lehle et al. (2006) and Goto (2007) for excellent reviews on this subject. Invariably, proteins that traverse the secretory pathway to the cell surface acquire some or all of the glycan modifications just described. Protein glycosylation is therefore tightly linked to the cell’s secretory pathway. In ascomycetous fungi, secretory proteins that become part of the cell membrane and the cell wall receive their first O-linked mannosyl residue at the endoplasmic reticulum. This first mannose is co- or post-translationally added to the protein, with dolichylphosphatemannose as the sugar donor and protein Omannosyltransferases (PMTs) as the enzymes that catalyse the covalent attachment of the mannose residue to target amino acids. In two independent studies, O-glycosylations in GPICWPs were mapped and shown to be absent from the N-terminal domains of the proteins (Chen et al., 1995; Rauceo et al., 2006). Following addition of the first mannosyl residue at the endoplasmic reticulum (ER), glycoproteins are transported to the Golgi apparatus where O-mannosyltranferases of the MNT family catalyse addition of the second, third and subsequent mannosyl groups in Mn2 dependent reactions that use GDP-Man as the sugar donor (Lehle et al., 2006). These enzymes involved in the elongation of O-linked chains reside in the Golgi apparatus with their large catalytic carboxy-terminal domains luminally oriented. Several MNT mannosyltranferases have been identified that show specificity for the type of linkage they catalyse and for the target protein. For example, three proteins, Ktr1, Ktr3 and Kre2/Mnt1 catalyse the transfer of the second, -(1→2)-linked mannosyl residue and Mnt1 is
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
6. The mannoprotein glycans
also responsible for the attachment of the third, -(1→2)-linked mannose. Finally in S. cerevisiae, the fourth and fifth mannose, both -(1→3)linked, are thought to be transferred by Mnn1, a homolog of Mnt1 that has been reported to participate in both N- and O-glycosylation (Gemmill and Trimble, 1999). That O-glycan extension proceeds in the Golgi apparatus was first demonstrated by the use of several conditional sec mutants in which vesicular transport from the ER to the Golgi apparatus is blocked. For example, in the temperature-sensitive sec18 mutant, 90% of newly formed O-linked saccharides exist as single mannosyl residues at the non-permissive temperature (Ferro-Novick et al., 1984). Protein O-glycosylation in fungi is diverse with respect to sugar components and to the mode of linkage connecting the sugars. In yeasts, such as S. cerevisiae, C. albicans and Pichia pastoris, O-linked glycans consist of mannose residues that are linked through both -(1→2), -(1→3) and -(1→2) linkages. In contrast to Nlinked glycans, which can reach lengths of up to 200 mannose units and be highly branched, O-linked glycans are short (3–7 mannoses) and mostly linear. An exception occurs in S. pombe, in which galactopyranose branches may be added to the mannose chains and contribute to the formation of a mildly branched structure. Similarly branched structures form when phosphorylated mannoses are added to the first or second mannosyl residues and serve as branching points for the addition of new mannoses (see Figure 10.1, structure 6). This type of chain modification may occur in all ascomycetous fungi and impart a negative charge to the cell wall. In filamentous fungi, such as Aspergillus species and Trichoderma reseei, protein O-linked glycans are highly variable in their sugar components and in the linkages connecting them. In addition to mannose, filamentous fungi may also incorporate glucose, galactofuranose and galactopyranose to their O-linked chains
177
and form more highly branched structures than those observed in yeasts. In addition to the (1→2), -(1→3) and -(1→2) linkages common in yeast, sugar residues of O-glycans in filamentous fungi may be linked through -(1→6), -(1→5) (for galactofuranoses) and -(1→6) linkages (Goto, 2007). Such variability in chain structure and sugar components has been proposed to serve as an identifying feature for glycoprotein sorting and specific cellular function. Protein O-linked chains may modulate glycoprotein function by promoting protein stability since these can protect proteins from protease degradation and prevent the formation of protein aggregates. Protein O-mannosylation is vital; complete abolition of this process results in cell death, whereas deficiencies lead to defects in important physiological processes such as cell budding, protein secretion and to activation of the cell wall integrity pathway. The cell wall integrity pathway protects the cell from wall damage caused by environmental stress or genetic defects. In pathogenic fungi, such as the dimorphic C. albicans, defects in O-linked glycosylation lead to reduced growth rates and to the formation of cellular aggregates. Furthermore, O-linked glycosylation mutants of C. albicans exhibit defective hyphal morphogenesis, red uced adherence to epithelial cells and defective biofilm formation. These mutants also show hypersensitivity to commonly used antifungal agents (Willer et al., 2003). Unlike the tripeptide Asn-Xaa-Ser/Thr signal (where Asn, asparagine; Ser, serine; Thr, threonine) for N-linked glycosylation, no consensus has been described for O-linked sugars. Nevertheless, proline (Pro) at position 1 or 3 from a target Ser or Thr appears to favour O-linked glycosylation. Also, in experiments with synthetic acceptor peptides, it was shown that at least a tripeptide is necessary for O-linked glycosylation to proceed and that the process is favoured by increasing the peptide length.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
178
10. Glycoconjugates in fungal cell walls
6.2. N-glycans N-glycans can occur in the N-terminal f unctional domains, the mid-piece tandem repeat regions and the C-terminal Ser- and Thr-rich stalk regions of GPI-CWPs and other classes of CWPs (Dranginis et al., 2007). In structured regions, N-glycans tend to occur in the loop regions in compact protein domains (Grigorescu et al., 2000). Yeast N-glycans are high-mannose structures based on a core structure common with mammalian N-glycans. The core structures are added to the nascent protein in the rough ER. The core Man9Glc3 is trimmed in the ER, then re-elongated in the Golgi apparatus. The mature N-glycan structure is presented in Figure 10.1, structure 7. The outer branch structures are similar to the O-glycans (for reviews, see Dean, 1999; Gemmill and Trimble, 1999). The nonreducing termini of the branches often have species-specific terminal sugars. Some examples include -(1→2)-linked mannose chains in C. albicans or -linked N-acetylglucosamine in Kluyveromyces lactis. Phosphodiesters of mannose are also common in the branches. The N-glycans of wall mannoprotein carry out many functions mentioned above and below. The N-glycans contain many of the phosphodiester groups that give the cell surface its charge and their great size occupies much of the volume of the wall matrix thus restricting wall permeability. Both N- and O-glycosylations contribute to protease resistance of the glycosylated regions (Chen et al., 1995; Klis et al., 2006).
6.3. GPI anchors Mannoproteins with a carboxy-terminal signal peptide for GPI-anchoring receive a GPI anchor in the lumen of the ER (Orlean and Menon, 2007). This step is mediated by a transamidase, which cleaves the protein at about 20–30 amino acids from the C-terminus and adds a pre-assembled glycolipid anchor to the new
c arboxyterminal residue. In the trans-amidase reaction, an amide linkage is formed between the protein and the ethanolamine phosphate of the third mannose residue. The GPI-anchoring ties a protein with its C-terminus to the membrane, allowing it to travel to the cell surface within the lumen of cellular vesicles. The GPI-anchoring of mannoproteins is an essential function in ascomycetous yeasts but not, e.g. in the clinically important, filamentous fungus Aspergillus fumigatus (Li et al., 2007). The preassembled glycolipid anchor consists of a phosphatidylinositol group, a glucosamine residue (GlcN, obtained by deacetylation of GlcNAc) and four or five mannose residues (Figure 10.4). The first three mannose residues each receive an ethanolamine phosphate group, added by three different enzymes of the Mcd4 family. Modification of the GPI anchor has been reported to occur in the Golgi apparatus during the translocation of GPI-proteins to the cell surface. In baker’s yeast, about 50% of the GPI-protein molecules become covalently linked to the cell wall, the remainder being retained at the plasma membrane. Some GPI-proteins are known as typical cell wall resident proteins (e.g. ScCwp1, ScSag1, CaAls1, CaHwp1) and others as abundant plasma membrane proteins (ScEcm33, ScGas1), however, intermediate distributions also occur. The distribution between wall and plasma membrane depends on characteristics of the sequence immediately upstream of the GPI addition site. Consecutive basic residues in this region seem to stimulate plasma membrane retention, however, this may be overridden when they are preceded by stretches of Ser and/or Thr residues. Cleavage of GPI anchors of proteins destined for wall incorporation occurs between the inositol and the first mannose residue (see Figure 10.4). In the same or in a subsequent reaction, the active sugar end of the trimmed anchor is cross-linked to a non-reducing end of -(1→6)-glucan. This positions the protein in the outermost layer of the cell while covalently linking it to the cell wall framework. Which protein or protein complex
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
7. Functions of wall glycoproteins N N
C
β1→6-glucan
C Processing by Dfg5?
P
P
PM
179
heterotypic. Two major classes can be distinguished, the immunoglobulin- (Ig-) like adhesins and the lectin-like adhesins and there are also adhesins such as CaHwp1 and CaEap1 that do not fall into either category. In S. cerevisiae, C. albicans and C. glabrata, many adhesins share a common overall design with an N-terminal, well-folded ligand-binding domain, a Thr-rich midpiece composed of tandem repeats and a Ser- and Thr-rich tail that is probably in an extended conformation with little regular structure (Dranginis et al., 2007; De Groot and Klis, 2008).
GlcN P
PI Man EtN-P
Protein
Glc
Figure 10.4 GPI truncation and transglycosylation of a GPIt-CWP. The carbohydrate active enzyme Dfg5 is believed to be involved in at least the first step. Key: PM, plasma membrane; PI, phosphatidyl inositol; EtNP, ethanolamine phosphate; GlcN, glucosamine; Man, mannose; Glc, glucose. The N- and C-termini of the polypeptide are marked. The presence or absence of the non-reducing-terminal mannose residue has not been established, so it is shown in brackets.
is responsible for anchor cleavage is still uncertain. Interesting candidates are the paralogues Dfg5 and Dcw1, belonging to subfamily 76 according to the carbohydrate-active enzyme classification. Both are plasma membranelocalized GPI proteins and homologues of bacterial endomannosidases. Their coupled deletion leads to synthetic lethality in both S. cerevisiae and C. albicans (Kitagaki et al., 2002).
7. Functions of wall glycoproteins 7.1. Fungal adhesins An important and large group of GPI-CWPs is involved in adhesion, both homotypic and
7.1.1. Ig-like adhesins The Ig-like adhesins are found in S. cerevisiae as mating adhesins (e.g. ScSag1) and in C. albicans the Als (Agglutinin-like sequence) family, which consists of eight members (Dranginis et al., 2007; Hoyer et al., 2008). Figure 10.2A shows a plot of the Ser and Thr content of ScSag1. The mating adhesin ScSag1 has a twodomain structure: the N-terminal half of about 300 amino acids is relatively poor in these two residues and is homologous to the immunoglobulin (Ig) superfamily (Dranginis et al., 2007), whereas the C-terminal half is enriched in Ser and Thr. As illustrated in Figure 10.2B, CaAls1 has a three-domain structure with an N-terminal domain which is also homologous to the immunoglobulin family, a middle part which is enriched in Thr residues and consists of a series of repeats and a third part which is enriched in serine and threonine residues but lacks a regular structure (Hoyer et al., 2008). The number of repeats in the middle part may vary, resulting in considerable allelic variation (Hoyer et al., 2008). Recent modelling work has predicted that the Thr-rich tandem repeats in Als proteins form a string of compact subdomains that have non-specific hydrophobic interactions with a variety of fungal and host protein structures (A. Frank et al., unpublished results). In contrast, the C-terminal Ser- and
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
180
10. Glycoconjugates in fungal cell walls
Thr-rich sequences probably form an extended, unstructured stalk that elevates the interaction domains away from the cell surface. It is tempting to extrapolate these observations to other GPI-CWPs with a similar domain organization and, in particular, to ScMuc1. The number of repeats in the middle part of ScMuc1/Flo11 is correlated with the hydrophobicity of the protein and thus the capacity of the cells to adhere to hydrophobic surfaces, and with homotypic aggregation of the cells, indicating that the middle part of the protein not only contributes to allelic variability but has other important physiological functions as well (Dranginis et al., 2007).
7.1.2. Lectin-like adhesins Lectin-like adhesins are found in S. cerevisiae, where they are involved in flocculation, the Flo (flocculin) family, and in C. glabrata, where they are involved in adhesion to host cells, the Epa (Epithelial adhesion) family. The Ser and Thr distribution plots show that the members of both families consist of an N-terminal effector domain followed by a Ser- and Thr-rich middle part consisting of a variable number of tandem repeats and a Ser- and Thr-rich Cterminal part without a regular structure (De Groot and Klis, 2008). Amazingly, the Epa lectin family in C. glabrata includes 23 members (Zupancic et al., 2008). To study the function of individual adhesins in the absence of their family members, they (or their N-terminal domains) are often heterologously expressed as GPI-CWPs in a non-adhesive strain of S. cerevisiae, where they are incorporated in the cell wall in a similar way as in the donor organism (Rauceo et al., 2006; Dranginis et al., 2007; Hoyer et al., 2007; Zupancic et al., 2008). Domain deletion and domain exchange experiments in this so-called S. cerevisiae surface display model have shown that the N-terminal region of fungal adhesins is
largely responsible for substrate binding. In a seminal paper, Zupancic et al. (2008) combined the S. cerevisiae surface display model with the use of glycan microarrays for determining the glycan specificity of the effector domains of three Epa adhesins of C. glabrata. This allowed them to establish that the PA14 (anthrax Protective Antigen) domain, a short conserved domain within the N-terminal effector region and, in particular, a pentapeptide sequence in a predicted surface loop of the PA14 domain, governs glycan specificity and cell adhesion. All Epa proteins possess a PA14 domain and, except for ScMuc1/Flo11, a similar PA14 domain is present in the N-terminal effector domain of the flocculin family of S. cerevisiae, but is missing from the Ig-like and other adhesins (de Groot and Klis, 2008).
8. Dynamics of the fungal wall proteome The availability of genomic sequences in combination with microarray studies and mass spectrometric approaches has rapidly advanced our knowledge about the dynamics of the cell wall proteomes of ascomycetous fungi. Genomic transcription studies clearly show that the transcript levels of CWP-encoding genes are tightly controlled. This raises the question how well transcript levels and protein levels are correlated. Immunological analysis indicates that transcript levels of CWP-encoding genes tend to be correlated with the corresponding protein levels. As mentioned below, this has also been confirmed by a quantitative mass spectrometric analysis of the cell wall proteome of a wall mutant of S. cerevisiae, suggesting that transcript levels of CWP-encoding genes have predictive value for the corresponding protein levels in the wall (Yin et al., 2008). However, the available evidence is still limited.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
181
9. Conclusions
Both internal and external cues affect the composition of the fungal wall glycoproteome, both quantitatively and qualitatively. Some examples of these are: (i) Phase of the cell cycle. Many CWPencoding genes are only expressed at specific phases of the cell cycle and the corresponding proteins are predominantly found in specific areas of the wall. This has been studied in most detail in the yeast S. cerevisiae (Klis et al., 2006). (ii) Mating pheromones. Not surprisingly, the expression of the mating adhesins is strongly induced in response to the mating pheromone of the opposite mating partner (Dranginis et al., 2007). (iii) Cell wall stress. It is known for S. cerevisiae that, in response to cell wall stress, a specific set of CWP-encoding genes is strongly upregulated and that this response is mediated by the cell wall integrity signalling pathway (Klis et al., 2006). As mentioned above, this group of genes includes the PIR family genes and CWP1, which both encode -glucan-crosslinking CWPs. It has further been established that, in yeast cells deleted for GAS1, a gene that encodes a plasma membrane-bound -(1→3)-transglucosylase, the cell wall integrity pathway is constitutively activated. Quantitative mass spectrometric analysis of the cell wall proteome of such cells indeed revealed considerable changes as predicted by earlier transcript profiling studies (Yin et al., 2008). (iv) Hypoxic conditions. Both in C. albicans and in S. cerevisiae considerable changes in the cell wall proteome occur in response to low levels of oxygen (Klis et al., 2006; Sosinska et al., 2008; Yin et al., 2008). (v) Iron limitation. Iron limitation results in the increased incorporation of
iron-acquisition proteins in the wall of C. albicans and S. cerevisiae (Klis et al., 2006; Sosinska et al., 2008). (vi) Neutral versus acidic pH. Transcript profiling indicates that, both in C. albicans and in S. cerevisiae, the external pH strongly affects the cell wall proteome and this is supported by the available mass spectrometric and immunological evidence (Klis et al., 2006; Sosinska et al., 2008; Yin et al., 2008).
9. Conclusions We have briefly illustrated the structures and the roles for glycoconjugates in fungal cell walls. The overall model is of a covalently cross-linked complex of polysaccharides and glycoproteins. The polysaccharides comprise a fibrous matrix of long H-bonded fibres. Some of the fibres are cross-linked to wall glycoproteins through modified GPI anchors, carboxyl esters and some unknown linkages. Individual glycoprotein molecules can be cross-linked to several polysaccharide chains and they are also cross-linked to each other through disulfide bonds. The matrix also physically entraps some proteins. The wall glycoproteins themselves are highly N- and O-glycosylated and they carry out many cellular activities including adhesion, proteolysis, extracellular metabolism and wall assembly, maintenance and remodelling. Thus, the overall result is that fungal cell walls are covalently cross-linked cell surface complexes of glycoconjugates with a wide variety of functions. This chapter points to several areas where additional research can add to our basic understanding in glycobiology. The areas and questions that are still unclear and potentially will be the focus for future research are listed in the Research Focus Box.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
182
10. Glycoconjugates in fungal cell walls
Research Focus Box
What are the mechanisms of synthesis and assembly of multi-molecular polysaccharide fibrils in fungal cell walls, including -glucans and chitin? l What are the cellular sites and mechanisms of synthesis of the -(1→6)-glucan that crosslinks wall components to each other? l What are the genes encoding the proteins and mechanisms that cross-link cell wall glycoproteins to the polysaccharides? l
Acknowledgements Work at Brooklyn College was supported by NIH SCORE grant S06 GM075158 and work at the Swammerdam Institute for Life Sciences was supported by the EU programme FP72214004, FINSysB.
References Cappellaro, C., Baldermann, C., Rachel, R., Tanner, W., 1994. Mating type-specific cell-cell recognition of Saccharomyces cerevisiae: cell wall attachment and active sites of a- and alpha-agglutinin. EMBO J. 13, 4737–4744. Cavalier-Smith, T., Chao, E.E., 2003. Phylogeny of choanozoa, apusozoa, and other protozoa and early eukaryote megaevolution. J. Mol. Evol. 56, 540–563. Chen, M.H., Shen, Z.M., Bobin, S., Kahn, P.C., Lipke, P.N., 1995. Structure of Saccharomyces cerevisiae alpha-agglutinin. Evidence for a yeast cell wall protein with multiple immunoglobulin-like domains with atypical disulfides. J. Biol. Chem. 270, 26168–26177. Cherniak, R., Valafar, H., Morris, L.C., Valafar, F., 1998. Cryptococcus neoformans chemotyping by quantitative analysis of 1 H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated
Why is O-glycosylation essential in yeast? How do the differing ligand specificities of fungal adhesins and lectins affect hostpathogen interactions? l How and why do fungal cells regulate the incorporation of different glycoproteins into their cell walls? l l
artificial neural network. Clin. Diagn. Lab. Immunol. 5, 146–159. Coronado, J.E., Mneimneh, S., Epstein, S.L., Qiu, W.G., Lipke, P.N., 2007. Conserved processes and lineagespecific proteins in fungal cell wall evolution. Eukaryot. Cell 6, 2269–2277. De Groot, P.W., Klis, F.M., 2008. The conserved PA14 domain of cell wall-associated fungal adhesins governs their glycan-binding specificity. Mol. Microbiol. 68, 535–537. De Groot, P.W., Ram, A.F., Klis, F.M., 2005. Features and functions of covalently linked proteins in fungal cell walls. Fungal Genet. Biol. 42, 657–675. De Nobel, J.G., Klis, F.M., Munnik, T., Priem, J., van den Ende, H., 1990. An assay of relative cell wall porosity in Saccharomyces cerevisiae, Kluyveromyces lactis and Schizosaccharomyces pombe. Yeast 6, 483–490. Dean, N., 1999. Asparagine-linked glycosylation in the yeast Golgi. Biochim. Biophys. Acta 1426, 309–322. Dennehy, K.M., Brown, G.D., 2007. The role of the bglucan receptor Dectin-1 in control of fungal infection. J. Leukoc. Biol. 82, 253–258. Dranginis, A.M., Rauceo, J.M., Coronado, J.E., Lipke, P.N., 2007. A biochemical guide to yeast adhesins: glycoproteins for social and antisocial occasions. Microbiol. Mol. Biol. Rev. 71, 282–294. Ecker, M., Deutzmann, R., Lehle, L., Mrsa, V., Tanner, W., 2006. Pir proteins of Saccharomyces cerevisiae are attached to b-1,3-glucan by a new protein-carbohydrate linkage. J. Biol. Chem. 281, 11523–11529.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
references
Ferro-Novick, S., Novick, P., Field, C., Schekman, R., 1984. Yeast secretory mutants that block the formation of active cell surface enzymes. J. Cell Biol. 98, 35–43. Frases, S., Nimrichter, L., Viana, N.B., Nakouzi, A., Casadevall, A., 2008. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot. Cell 7, 319–327. Gemmill, T.R., Trimble, R.B., 1999. Overview of N- and O-linked oligosaccharide structures found in various yeast species. Biochim. Biophys. Acta 1426, 227–237. Goto, M., 2007. Protein O-glycosylation in fungi: diverse structures and multiple functions. Biosci. Biotechnol. Biochem. 71, 1415–1427. Grigorescu, A., Chen, M.H., Zhao, H., Kahn, P.C., Lipke, P.N., 2000. A CD2-based model of yeast alpha-agglutinin elucidates solution properties and binding characteristics. IUBMB Life 50, 105–113. Hoyer, L.L., Green, C.B., Oh, S.H., Zhao, X., 2008. Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family – a sticky pursuit. Med. Mycol. 46, 1–15. Kapteyn, J.C., Ram, A.F., Groos, E.M., et al., 1997. Altered extent of cross-linking of b1,6-glucosylated mannoproteins to chitin in Saccharomyces cerevisiae mutants with reduced cell wall beta1,3-glucan content. J. Bacteriol. 179, 6279–6284. Kitagaki, H., Wu, H., Shimoi, H., Ito, K., 2002. Two homologous genes, DCW1 (YKL046c) and DFG5, are essential for cell growth and encode glycosylphosphatidylinositol (GPI)-anchored membrane proteins required for cell wall biogenesis in Saccharomyces cerevisiae. Mol. Microbiol. 46, 1011–1022. Klis, F.M., Boorsma, A., De Groot, P.W., 2006. Cell wall construction in Saccharomyces cerevisiae. Yeast 23, 185–202. Lehle, L., Strahl, S., Tanner, W., 2006. Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases. Angew. Chem. Int. Ed. Engl. 45, 6802–6818. Li, H., Zhou, H., Luo, Y., Ouyang, H., Hu, H., Jin, C., 2007. Glycosylphosphatidylinositol (GPI) anchor is required in Aspergillus fumigatus for morphogenesis and virulence. Mol. Microbiol. 64, 1014–1027. Linder, T., Gustafsson, C.M., 2008. Molecular phylogenetics of ascomycotal adhesions – a novel family of putative
183
cell-surface adhesive proteins in fission yeasts. Fungal Genet. Biol. 45, 485–497. Orlean, P., Menon, A.K., 2007. Thematic review series: lipid posttranslational modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids. J. Lipid Res. 48, 993–1011. Pitarch, A., Nombela, C., Gil, C., 2008. Cell wall fractionation for yeast and fungal proteomics. Methods Mol. Biol. 425, 217–239. Rauceo, J.M., De Armond, R., Otoo, H., et al., 2006. Threonine-rich repeats increase fibronectin binding in the Candida albicans adhesin Als5p. Eukaryot. Cell 5, 1664–1673. Rodrigues, M.L., Alvarez, M., Fonseca, F.L., Casadevall, A., 2008. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot. Cell 7, 602–609. Sosinska, G.J., de Groot, P.W., Teixeira de Mattos, M.J., et al., 2008. Hypoxic conditions and iron restriction affect the cell-wall proteome of Candida albicans grown under vagina-simulative conditions. Microbiology 154, 510–520. Sun, L., Zhao, Y., 2007. The biological role of dectin-1 in immune response. Int. Rev. Immunol. 26, 349–364. Wheeler, R.T., Fink, G.R., 2006. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog. 2, e35. Willer, T., Valero, M.C., Tanner, W., Cruces, J., Strahl, S., 2003. O-mannosyl glycans: from yeast to novel associations with human disease. Curr. Opin. Struct. Biol. 13, 621–630. Yin, Q.Y., de Groot, P.W., de Koster, C.G., Klis, F.M., 2008. Mass spectrometry-based proteomics of fungal wall glycoproteins. Trends Microbiol. 16, 20–26. Yoneda, A., Doering, T.L., 2008. Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level. Eukaryot. Cell 7, 546–549. Yu, L., Lee, K.K., Ens, K., et al., 1994. Partial characterization of a Candida albicans fimbrial adhesin. Infect. Immun. 62, 2742–2834. Zupancic, M.L., Frieman, M., Smith, D., Alvarez, R.A., Cummings, R.D., Cormack, B.P., 2008. Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol. Microbiol. 68, 547–559.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
11 Cytoplasmic carbohydrate molecules: trehalose and glycogen Alan D. Elbein
Summary Trehalose and glycogen are two important glucose derivatives long considered to function as storehouses of glucose. However, trehalose is a diverse molecule having a number of other roles including: (i) protecting proteins and membranes against stress; (ii) acting as an allosteric inhibitor of carbohydrate metabolism and a transcriptional regulator; and (iii) serving as an essential component of mycobacterial cell walls and a donor of mycolic acid. Mycobacteria have three different pathways to produce trehalose and mutants missing all these pathways cannot grow without exogenous trehalose. Nevertheless, glycogen is not essential for growth but it does aid microbial survival when carbon and energy sources are absent. Bacterial glycogen is synthesized from adenosine diphosphate- (ADP-) glucose rather than uridine diphosphate- (UDP-) glucose, which is the precursor for animal glycogen synthesis. Furthermore, the bacterial enzyme that synthesizes ADP-glucose is a regulatory enzyme that controls glycogen formation. Activity of this enzyme is increased by glycolytic intermediates, such as pyruvate and fructose-phosphates, and inhibited by adenosine monophosphate (AMP). Thus, when glycolytic intermediates are plentiful, energy is available to synthesize glycogen and ADP-glucose is synthesized. However, when AMP levels are high,
Microbial Glycobiology
there is insufficient energy to produce glycogen and ADP-glucose production is decreased. In mycobacteria, glycogen can be converted to trehalose, probably to increase trehalose levels when they become dangerously low in the cytoplasm. On the other hand, mycobacteria can also convert trehalose to glycogen and this may occur when trehalose levels become dangerously high, since high trehalose levels may be toxic. Keywords: Trehalose; Maltose; Trehalose synthase; Glycogen; Adenosine diphosphate- (ADP-) glucose; Regulation of metabolism; Glycogen-trehalose interconversion; Amylase
1. Introduction The major intracellular sugars found in most, if not all, bacteria are glucose (Glc), trehalose and glycogen. Trehalose [-d-glucopyranosyl -dglucopyranoside or -d-Glcp-(1→1)--d-Glcp] and glycogen are higher homologues of Glc, containing two (trehalose), or many (glycogen), Glc residues glycosidically-linked to each other. Until more recent times, both of these compounds were considered to be produced strictly as storage forms of Glc that the cell could call upon as an immediate source of carbon and/or energy
185
© 2009 2010, Elsevier Inc.
186
11. Trehalose and glycogen
(Elbein, 1974). For example, glycogen follows the three guidelines suggested by Wilkinson (1959) to demonstrate that a compound serves an energystorage function. First, the given compound should accumulate intracellularly during times when the cell has excess energy. Second, the reserve material should be utilized as a source of carbon and energy when the cell no longer has exogenous sources of carbon or energy. Third, the organism should be able to use the reserve material for survival when it is in a non-supportive environment. In many bacteria, glycogen fulfils these requirements, whereas trehalose only fulfils some of these in some organisms and at certain times, but it is more suspect as a reserve than is glycogen. Trehalose can have a number of other important functions in living cells, which will be discussed below, in addition to serving as a reservoir of Glc. In this chapter, the occurrence and distribution, structure, biosynthesis, degradation and biological function(s) of these two very important Glc oligomers will be discussed. For certain microorganisms, such as mycobacteria, some of the trehalose metabolic pathways are apparently closely related and interconnected with the glycogen metabolic pathways; those inter-relations are discussed subsequently.
2. Occurrence, distribution and function of glycogen Glycogen is found in many bacteria and usually accumulates either during the stationary phase or during periods of limited growth, when there is a readily available and sufficient source of energy and carbon to use for producing glycogen. However, some bacteria do synthesize glycogen efficiently, even when undergoing exponential growth (Govons et al., 1973). Glycogen is not an essential component for bacterial growth or survival; deletion mutants in the biosynthetic genes for glycogen synthetic enzymes and, therefore, not able to produce this polymer, grow as well as
the normal, glycogen-producing, parental strains (Dietzler et al., 1974). However, these glycogendeficient mutants have a shorter survival time when placed in media with no exogenous carbon source when compared with glycogen-containing strains. Furthermore, wild-type Escherichia coli, that synthesizes and contains glycogen, does not degrade its RNA or protein when subjected to conditions where a usable carbon source is unavailable due to its glycogen acting as an endogenous energy source (Preiss, 1989). Conversely, a glycogen-deficient mutant releases ammonia under these conditions indicating that protein degradation is occurring and that the bacterium is using its proteins for energy (Preiss, 1989). These data suggest that, under starvation conditions, glycogen serves as the principal energy source when it is available. Another suggested function for glycogen is to provide the energy and carbon required for spore formation (Mackey and Morris, 1971). Various Clostridium spp. accumulate large amounts of glycogen prior to or during the initiation of spore formation and this glycogen is rapidly degraded during spore formation (Mackey and Morris, 1971). On the other hand, glycogen-deficient strains are poor spore formers (Russell, 1992). Glycogen or other similar -(1→4)-glucans have been identified in at least 40 different bacterial species and this polymer is found in Gram-positive and Gram-negative bacteria, as well as in the Archae (Preiss and Romeo, 1989). A number of studies have demonstrated that the series of events leading to glycogen accumulation during the stationary phase begins as a consequence of the depletion of an essential nutrient such as nitrogen or perhaps sulfur and this nutrient deficiency then results in the cessation of growth (Russell, 1992). Since many of these cultures will still have sufficient amounts of energy available, but are unable to grow in the absence of nitrogen, these bacteria store this energy and carbon in the form of glycogen. The results of studies with many different bacteria indicate that the greatest accumulation of
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Biosynthesis of glycogen
glycogen occurs under conditions of limiting amounts of nitrogen (Lowry et al., 1971).
3. Structure of glycogen Bacterial glycogen is similar in terms of its polysaccharide structure to that of mammalian glycogen (Manners, 1971). Thus, glycogen from either source is composed entirely of Glc molecules, most of which are linked in -(1→4)glycosidic bonds. However, this polymer is a highly-branched glucan, with each branch being initiated by a Glc attached in an -(1→6)glucosidic-bond to one of the 4-linked Glc residues (Manners, 1991). Each of these branches then contains a variable number of -(1→4)linked Glc residues. In bacteria, 8–16% of the total glycosidic linkages are -(1→6)-bonds and most of the branches are 6–10 Glc residues in length (Yang et al., 1996) (Figure 11.1). One apparent difference between mammalian glycogen and bacterial glycogen is that, in animal cells, the glycogen molecule is attached to a protein called glycogenin (Krisman and Barengo, 1975). In this glycoprotein, the Glc at the reducing end of the glycogen chain is linked in an O-glycosidic linkage to the hydroxyl group of a tyrosine (Tyr) in the glycogenin. In contrast to animal glycogen, the bacterial glycogen appears to be present as a free polysaccharide without attachment to protein (see Figure 11.1) and glycogenin has not been found naturally occurring in bacteria (Yang et al., 1996).
4. Biosynthesis of glycogen 4.1. Biosynthesis of the glycogen precursor, adenosine diphosphate (ADP)-Glc The precursor for the biosynthesis of glycogen in animal cells is uridine diphosphate-d-Glc
187
(UDP-Glc), whereas the glucosyl donor for formation of bacterial glycogen is ADP-Glc (Preiss and Romeo, 1994). The mammalian glycogen synthase cannot use ADP-Glc as a substitute for UDP-Glc, nor can the bacterial glycogen synthase utilize UDP-Glc. The enzyme that synthesizes ADP-Glc, i.e. ADP-Glc pyrophosphorylase or adenosine triphosphate (ATP):-d-Glc-1-phosphate adenyltransferase, is a key enzyme in glycogen synthesis, since it represents the major regulatory step in the biosynthesis of glycogen (Preiss and Romeo, 1994). This enzyme catalyses the following reaction: ATP -D-Glc-1-phosphate ↔ ADP-Glc PPi (inorganic pyrophosphate) Bacterial ADP-Glc pyrophosphorylases are all allosteric enzymes and regulation of their activity is a major controlling factor in the synthesis and/or accumulation of bacterial glycogen (Preiss, 1984). This regulation in most bacterial species involves the activation or stimulation of the pyrophosphorylase by various glycolytic intermediates and its inhibition by adenosine monophosphate (AMP), ADP or inorganic phosphate. Table 11.1 lists some bacterial ADP-Glc pyrophosphorylases, the activating compounds and the major bacterial pathway of carbon metabolism related to the specific activator of each pyrophosphorylase. In most cases, the synthesis of ADP-Glc is increased by glycolytic intermediates and inhibited by ADP, AMP and inorganic phosphate. High levels of various glycolytic intermediates in the cell are an indication of carbon and/or energy excess (Preiss, 2000). Thus, when cell growth is inhibited as a result of limiting nitrogen in the medium but excess carbon is available, the accumulation of glycolytic intermediates serves as signals for activation of the synthesis of ADP-Glc which serves mainly as a precursor for production of glycogen (Swedes et al., 1975). The activation of
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
188
11. Trehalose and glycogen
Figure 11.1 Generalized structure of bacterial glycogen. (A) A portion of the glycogen molecule is shown to highlight the nature of the glycosidic linkages between individual glucose (Glc) residues. The most common sugar linkage is -(1→4), although each branch is connected by an -(1→6)-glycosidic linkage. (B) The overall structure of bacterial glycogen is depicted by representing each Glc residue by a circle. Open circles, Glc residues in -(1→4)-linkages; closed circles, Glc resdues in -(1→6)-linkages at branch points.
ADP-Glc pyrophosphorylases is likely to be due to increases in the affinity of the enzyme for the substrates ATP and Glc-1-phosphate. As shown in Table 11.1, variation in the specificity of the activator for each of the bacterial ADPGlc pyrophosphorylases correlates with the type
of carbon assimilation pathway occurring in that bacterium. For example, E. coli and Salmonella enterica sv. Typhimurium obtain their energy mostly through glycolysis and the primary activator for their ADP-Glc pyrophosphorylases is fructose-1,6-bisphosphate, with AMP being
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
189
4. Biosynthesis of glycogen
Table 11.1 Activator specificity of various bacterial ADP-Glc pyrophosphorylases Bacterial species Rhodospirillum spp.
Carbon assimilation pathway
Activators Pyruvate
Reductive pyruvate cycle
3-Phosphoglycerate
Photosynthesis (Calvin cycle)
Rhodocyclus purpureus Cyanobacteria Agrobacterium spp.
Entner-Doudoroff cycle
Arthrobacter spp.
Pyruvate, fructose-6-phosphate
Reductive pyruvate cycle
Rhodopseudomonas spp.
Pyruvate, fructose-6-phosphate
Entner-Doudoroff, glycolysis, reductive pyruvate cycle
Mycobacterium smegmatis
Fructose-6-phosphate
Glycolysis
the major inhibitor of the enzyme (Okita et al., 1981). On the other hand, in photosynthetic bacteria, e.g. cyanobacteria, the major activator is 3-phosphoglyceric acid and the major pathway is the Calvin cycle (Levi and Preiss, 1976). A number of ADP-Glc pyrophosphorylases have been purified from various bacteria and, in most cases, the enzyme was found to be a homotetramer composed of a 56 kDa subunit (Preiss et al., 1976). Interestingly, there is a strong and direct correlation between the affinity of ADPGlc pyrophosphorylase for its positive effector and the accumulation of glycogen in the cell. Thus, a number of E. coli mutants have been isolated with variant ADP-Glc pyrophosphorylases having different affinities for the activator fructose-1,6-bisphosphate. Studies with these mutants have shown that the higher the affinity for the activator, the more glycogen accumulated in that mutant (Govons et al., 1973). Chemical modifications with azido-labelled substrates, as well as site-directed mutagenesis studies, have been used to locate the activator binding site, the inhibitor binding site and the substrate binding site in this enzyme. In addition, various mutated ADP-Glc pyrophosphorylase genes (glgC) have been cloned and expressed in various mutants of E. coli and
S. enterica sv. Typhimurium. Analysis of the allosteric properties of these mutant enzymes have provided important and extensive information on structure–function relationships of this enzyme (Preiss and Romeo, 1994).
4.2. Biosynthesis of -(1→4)-linked glucan chain (glycogen precursor) The bacterial glycogen synthases are enzymes that add Glc from ADP-Glc to existing glycogen chains and link these Glc residues in -(1→4)glycosidic bonds (Shen et al., 1964). Thus, this enzyme, by itself, produces a long, linear -(1→ 4)-linked glucan that is unbranched. The bacterial synthases are specific for the glucosyl donor, ADP-Glc (Sigal et al., 1964). In those cases where the enzyme has been examined in more detail, the subunit size of the protein is about 50 kDa and the active enzyme is either a dimer or a tetramer (Fox et al., 1976). The structural gene, glgA, for glycogen synthase, has been cloned from a number of bacteria (i.e. Bacillus stearothermophilus, E. coli, S. enterica sv. Typhimurium, Agrobacterium tumefaciens) and their nucleotide sequences have been determined (Kumar et al., 1986). The E. coli sequence comprises 1431 base pairs (bp) that specify a protein of 477 amino
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
190
11. Trehalose and glycogen
acids with a molecular mass of 52 412. Having this information has allowed site-directed mutagenesis to be undertaken to determine the essential amino acids in the substrate binding sites as well as other functional aspects of the various synthases. For example, studies on substrate binding using a substrate affinity analogue, ADP-pyridoxal, identified Lys15 in the sequence Lys-X-Gly-Gly (where Lys lysine and Gly glycine) as an essential amino acid in binding the substrate ADP-Glc (Tagaya et al., 1985). Site-directed mutagenesis indicated that this Lys is probably involved in binding to the phosphate residue that is adjacent to the glycosidic linkage holding the Glc portion of ADPGlc, but this Lys is not directly involved in the catalytic event. Hence, changing this Lys for a glutamic acid raised the Km for the ADP-Glc substrate 30- to 50-fold (Furukawa et al., 1994). The bacterial glycogen synthase differs from the mammalian enzyme in at least two major aspects. First, the bacterial synthase is not a regulatory protein and does not exist in an active and inactive form, as do the mammalian synthases. Thus, there is no evidence for either phosphorylation or dephosphorylation of the bacterial glycogen synthases, as occurs with the mammalian glycogen synthases (Chock et al., 1980), nor is there any indication of other enzyme catalysed modifications of bacterial glycogen synthases. Second, as mentioned earlier, the bacterial enzyme uses ADP-Glc as the glycosyl donor (Preiss and Greenberg, 1965), whereas the mammalian enzymes all use UDP-Glc (Leloir et al., 1961; Krisman and Barengo, 1975). In one report, the E. coli glycogen synthase showed 1% activity with either UDP-Glc, cytidine diphosphate- (CDP-) Glc or guanosine diphosphate- (GDP-) Glc, as compared to ADPGlc (Holmes and Preiss, 1979). Of note, various -glucans can serve as effective primers for the bacterial glycogen synthase, including glycogen from either animal or bacterial sources, as well as plant amylose or amylopectin (Preiss and Romeo, 1989).
4.3. Branching of the -glucan chain Glycogen synthases are -(1→4)-glucan synthases and, as such, they catalyse the transfer of Glc residues from nucleoside diphosphate glucoses to glucan chains with the formation of -(1→4) glycosidic bonds (Cori and Cori, 1939). However, glycogen is a highly branched polymer and each branch is attached by an -(1→6)glycosidic linkage. Therefore, a branching enzyme is necessary to convert this linear glucan into a highly branched glucan. This branching enzyme cleaves an -(1→4)-glucosidic linkage 6–10 glucose from the non-reducing end of the newly synthesized -(1→4)-glucan and then transfers this oligosaccharide to the main glucan chain and attaches it to the –OH group at position-6 of one of the Glc residues somewhere in the main chain to produce a (1→6)-linked branch. The genes for the branching enzymes of a number of different bacteria have been cloned (Baecker et al., 1986). The E. coli glgB gene contains 2181 bp, specifying a protein of 727 amino acids, with a molecular mass of 84 231. The amino acid sequence of the E. coli branching enzyme has been compared to the amino acid sequences of amylolytic enzymes, e.g. -amylase, pullulanase, glucosyltransferase and cyclodextrin glucanotransferase (Romeo et al., 1988). A marked conservation was noted in the amino acid sequences of the catalytic sites of the four amylolytic enzymes with a sequence in the bacterial branching enzyme, as well as in the branching enzymes from plant and animal sources. It is not surprising that the bacterial branching enzymes show such strong similarity to amylases, since they also catalyse the cleavage of -(1→4)glycosidic bonds (Robyt and French, 1970).
5. Degradation of glycogen A number of enzymes in bacteria exist that can degrade glycogen (MacGregor et al., 2001). For endogenous glycogen to be utilized as an
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
6. Occurrence and distribution of trehalose
energy source, many bacterial species have a glycogen phosphorylase that can catalyse the following reaction:
Glycogen H3 PO 4 ↔ Glc-1-phosphate Glycogen (-1 Glc residue)
This enzyme removes one Glc residue from the non-reducing end of any branch of glycogen, yielding Glc-1-phosphate, in a phosphorolysis reaction using inorganic phosphate rather than ATP as the phosphate donor (Chen and Segal, 1968). Thus, this enzymatic reaction saves the cell one ATP for every Glc released from glycogen. Mammalian glycogen phosphorylases are regulatory enzymes that are activated by phosphorylation, i.e. catalysed by a protein kinase, but the bacterial phosphorylases are not known to be regulatory enzymes (Dietzler and Strominger, 1973). Bacteria also possess various types of amylases, i.e. enzymes that cleave internal -(1→4)glucosidic bonds of glycogen or maltodextrins to produce oligosaccharides (OSs) of various sizes (MacGregor et al., 2001). Exoamylases, or -amylases, catalyse a successive hydrolysis of alternate -(1→4)-linkages with the stepwise release of maltose units whose reducing ends have the -configuration (Henrissat, 1991). Degradation by -amylase starts at the non-reducing end of a glucan chain and ceases when the amylase gets close to the branch, i.e. the -(1→6)-linkage point. On the other hand, endoamylases, or -amylases, cleave internal (1→4)-bonds of linear or branched glucans into smaller OSs and maltose products that possess a new reducing group in the -configuration (Qian et al., 1994). Some amylases are secreted from bacteria to degrade -glucans, e.g. starch and glycogen in the environment, for use by the bacteria as energy sources. Certain amylases are cytoplasmic enzymes that participate in the turnover and utilization by the bacterial cell of its own glycogen for energy requirements
191
(Kiel et al., 1994). Other potential degradative enzymes that can act on glycogen are amyloglucosidases and various -glucosidases that are present in the cytoplasm of various bacterial species (Vikinen and Mantsala, 1989).
6. Occurrence and distribution of trehalose Trehalose is a non-reducing disaccharide in which two Glc residues are linked in a-(1→1)linkage. Although three different anomers are possible, and all three have been synthesized chemically, only the -anomer (Figure 11.2) has been isolated from, and synthesized in, living cells (Elbein, 1974). This naturally occurring disaccharide is widespread throughout the biological community, being found in the cytoplasm of many bacteria, as well as in yeast and fungal species, where it occurs in spores, fruiting bodies and vegetative cells. Spores and macrocysts of Dictyostelium mucoroides have been reported to contain as much as 7% trehalose on a dry-weight basis (Cleeg and Filosa, 1961), while the ascospores of Neurospora tetrasperma have as much as 10% trehalose (Sussman and Lingappa, 1959). This disaccharide also occurs in lichens and algae and is quite prevalent in mushrooms (Lindberg, 1955). Trehalose has also been identified in many lower animals including protozoa, insects, shrimp, nematodes, roundworms, etc. (Becker
Figure 11.2 Structure of ,-trehalose. Although three different isomers of trehalose have been chemically synthesized (,; ,; ,), only the ,-isomer has been found in biological systems.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
192
11. Trehalose and glycogen
et al., 1996). Finally, this sugar also occurs in many different plants (Avonce et al., 2005). In contrast, trehalose is not synthesized or present in mammals, although many mammals, including man, do contain a trehalase that cleaves trehalose into two Glc residues (Ruf et al., 1990). This enzyme is located in the brush border membranes of intestinal epithelial cells and its function is probably to degrade the trehalose that is present in many consumed foods, such as mushrooms.
7. Biosynthesis of trehalose There are at least three different pathways (DeSmet et al., 2000) that can be utilized for the biosynthesis of trehalose in microorganisms (Figure 11.3). In addition, there are several degradative pathways of trehalose metabolism that involve readily reversible reactions that could be utilized, at least in principle, for the biosynthesis of trehalose. These various reactions are discussed below.
7.1. Enzymatic synthesis of trehalose-6phosphate The most widely reported and best studied pathway for the synthesis of trehalose involves two enzymes, named trehalose-phosphate synthase (TPS), also referred to as OtsA in E. coli (Kaasen et al., 1992), and trehalose-phosphate phosphatase (TPP), also referred to as OtsB in E. coli (Kaasen et al., 1994). These two enzymes catalyse the reactions summarized below (and also shown in Figure 11.3):
(i) UDP-Glc Glc-6-phosphate TPS → Trehalose-6-phosphate UDP (ii) Trehalose-6-phosphate TPP → Trehalose Phosphate (inorganic)
The enzyme TPS was first isolated from the yeast Saccharomyces cerevesiae by Cabib and Leloir (1958) and its reaction was demonstrated using cell-free extracts of this yeast. That reaction has subsequently been shown in cell-free extracts prepared from numerous insects and other lower animals, as well as with extracts from Dictyostelium discoideum, plants and a number of different bacterial species (Elbein et al., 2003). On the other hand, purified trehalosephosphate synthase purified from Streptomyces hygroscopicus and several other streptomycetes catalyses a reaction similar to reaction (i) above but, in these cases, the glucosyl donor is GDP-Glc, rather than UDP-Glc (Elbein, 1968). Importantly, in the case of yeast, slime moulds, insects or certain bacterial species, UDP-Glc appears to be the only Glc donor that these TPSs utilize, whereas in streptomycetes, the only Glc donor that has been found active is GDP-Glc (Elbein, 1968). Mycobacterium smegmatis, Mycobacterium tuberculosis and other mycobacteria also contain significant amounts of trehalose which is utilized for a number of different functions (Elbein and Mitchell, 1973; Woodruff et al., 2004). In these microorganisms, TPS can utilize any of the Glc sugar nucleotides, i.e. ADP-Glc, CDP-Glc, GDP-Glc, thymidine diphospate- (TDP-) Glc, UDP-Glc as glucosyl donors for the production of trehalose-phosphate (Lapp et al., 1971). The 58 kDa TPS has been purified to apparent homogeneity from M. smegmatis and the properties of the enzyme were determined, as well as the effects of polyanions on the activity. The protein was also subjected to amino acid sequencing and several peptides were sequenced (Pan et al., 1996). Based on that information, the gene was identified in the M. tuberculosis genome and was cloned and expressed in E. coli as an active enzyme (Pan et al., 2002). This recombinant TPS showed the same broad specificity of glucosyl donor, as substrates for the production of trehalose-phosphate, as the enzyme from M. smegmatis. Hence, the trehalose-phosphate
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
7. Biosynthesis of trehalose
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
Figure 11.3 Pathways of biosynthesis of trehalose in bacteria: (A) TPS/TPP or OtsA/OtsB pathway; (B) TreS pathway; and (C) the TreY/ TreZ pathway.
193
194
11. Trehalose and glycogen
synthases of mycobacteria are similar to the plant sucrose synthase since both transferases have broad specificity for nucleoside diphosphate Glc donors that they utilize as substrates for formation of their disaccharide product. Sucrose synthase can utilize all of the Glc sugar nucleotides for the transfer of Glc to the acceptor fructose to produce sucrose; UDP-Glc, ADPGlc and TDP-Glc are the preferred substrates (Delmer and Albersheim, 1970). This contrasts with most other glycosyltransferases which are quite specific for the sugar being transferred and the purine/pyrimidine base of the nucleotide donor (Coutinho et al., 2003). It can be hypothesized that the broad substrate specificities of bacterial TPS and plant sucrose synthase may reflect the importance to the organism of these disaccharides as storage compounds, stabilizers and structural components. The second enzyme in this biosynthetic pathway, TPP, is a specific phosphatase and organisms that contain TPS also appear to have a TPP that converts the trehalose-phosphate to free trehalose, reaction (ii) above (Matula et al., 1971). Although many non-specific acid and alkaline phosphatases can cleave the phosphate from trehalose-phosphate, the TPPs that have been isolated are highly specific enzymes that will not cleave other sugar phosphates, e.g. Glc1-phosphate or Glc-6-phosphate or even other phosphorylated substrates, i.e. the common phosphatase substrate, p-nitrophenyl-phosphate (Klutts et al., 2003). The gene-encoding TPP is in the same operon as that encoding TPS in E. coli (Horlacher and Boos, 1997), while in S. cerevesiae, TPP is one of the subunits of a multi-enzyme complex that synthesizes trehalose (Bell et al., 1998). The TPP-encoding gene of M. smegmatis has been cloned and the recombinant protein expressed in E. coli as an active enzyme, a 27 kDa protein, which shows an almost absolute requirement for Mg2 ions, but is somewhat active in the presence of Mn2 ions. The enzyme is specific for trehalose-phosphate as substrate and has no activity on any other
sugar-phosphates or any other phosphorylated compounds (Klutts et al., 2003). The TPP of M. tuberculosis has very similar enzymatic properties, i.e. pH optimum, requirement for divalent cations and substrate specificity. However, the M. tuberculosis enzyme is a 45 kDa protein and has less than 25% identity at the amino acid level to the TPP from M. smegmatis (Edavana et al., 2004). In yeast, trehalose-phosphate can apparently serve as a regulator of carbohydrate metabolism by inhibiting the action of hexokinase (Blazquez et al., 1993; Hohmann et al., 1996). It is also a regulator of carbohydrate utilization and growth in Arabidopsis thaliana (Schluepmann et al., 2003). This suggests that the enzyme, TPP, could play an important role in the regulation of Glc metabolism by controlling the level of trehalosephosphate in these cells (Elbein et al., 2003).
7.2. Other pathways for the synthesis of trehalose The TPS/TPP pathway is probably the major route for the production of trehalose in mycobacteria, as well as in most other organisms. However, mycobacteria, corynebacteria, streptomycetes and a number of other microbes have several other alternate pathways that also can produce trehalose (DeSmet et al., 2000; Elbein et al., 2003). In mycobacteria and perhaps other microorganisms, the synthesis and control of the amounts of trehalose and glycogen are closely linked and interrelated and may be coordinately controlled (Pan et al., 2008). This interaction may allow these microorganisms to convert excess trehalose to glycogen when cytoplasmic trehalose levels get “dangerously” high or to use glycogen as a source of trehalose when trehalose levels get “dangerously” low. Studies on a mutant of M. smegmatis that is missing all three synthetic pathways outlined in Figure 11.3 have shown that this mutant cannot grow in any media without exogenous trehalose (Woodruff
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
7. Biosynthesis of trehalose
et al., 2004). Thus, trehalose is essential for the growth of mycobacteria, but high concentrations of trehalose also appear to be toxic to cells. The second trehalose biosynthetic pathway produces this molecule from glycogen or maltooligosaccharides. This pathway involves the action of two enzymes, referred to as TreY and TreZ (see Figure 11.3). The TreY enzyme, maltooligosyltrehalose synthase, catalyses removal of the -(1→4)-Glc at the reducing end of the bacterial glycogen chain and then the re-addition of this Glc to form the “-Glc-(1→1)--Glc” glycosidic bond of trehalose (Maruta et al., 1996a). Thus, TreY basically changes the maltose at the reducing end of the glycogen chain to a trehalose. Subsequently, the second enzyme TreZ, malto-oligosyltrehalose trehalohydrolase, cleaves off the trehalose by hydrolysing the next -(1→4)-bond, thereby yielding one free trehalose and leaving a glycogen missing two Glc residues from its reducing end (Maruta et al., 1996b). This pathway was first described in archaebacteria belonging to the Sulfolobus genus (Maruta et al., 1996b), but has since been found in a number of mycobacteria, as well as in corynebacteria, streptomyces and other bacteria (DeSmet et al., 2000; Elbein et al., 2003). The pathway presumably enables these bacteria to maintain and monitor the level of trehalose in their cytoplasm by degrading glycogen. Nevertheless, nothing is known about the regulation of this pathway, or whether low trehalose levels increase the synthesis or activity of either TreY or TreZ. The third pathway for producing trehalose is from maltose and involves the enzyme, trehalose synthase (TreS). This enzyme is a 68 kDa protein that catalyses the interconversion of maltose and trehalose (Nishimoto et al., 1995). The exact equilibrium of this reaction has been difficult to determine because the Km for each substrate is so high, i.e. 10 mM for maltose, but 90 mM for trehalose (Pan et al., 2004). Despite this, TreS has a greater affinity for maltose as substrate, suggesting that the cellular role of the
195
enzyme is to supply trehalose. The difficulty is that M. smegmatis grows very poorly on maltose and thus this sugar is unlikely to be an exogenous source of trehalose. However, the purified or recombinant TreS protein has been shown to have amylase activity in addition to its maltosetrehalose interconverting activity (Pan et al., 2008). The amylase activity is much lower than the maltose to trehalose activity but, nevertheless, is sufficient to allow the enzyme to cleave malto-oligosaccharides or glycogen to maltose and then convert the maltose to trehalose. In addition, TreS also appears to be involved in the interconversion of trehalose to glycogen. This is based upon studies with a large number of M. smegmatis trehalose-deficient mutants that have been prepared (J.D. Carroll et al., unpublished results): some are single-mutants missing one of the enzymes from the three pathways shown in Figure 11.3; others are double-mutants, missing one enzyme from each of two pathways; and, finally, there are several triple-mutants which cannot synthesize trehalose because they have deletions in all three pathways and are missing either the TPS or TPP of that pathway and the TreY or TreZ of the glycogen pathway. When wild-type M. smegmatis is grown in a mineral salts medium in the presence of high concentrations of trehalose (2% or higher), this organism accumulates very large amounts of glycogen, i.e. 10 to 30-fold increases over the amount of glycogen produced in the absence of trehalose or in other media such as Trypticase Soy broth. Thus, this increase in glycogen does not occur in the presence of high concentrations of other sugars, e.g. Glc or sucrose. Furthermore, any of the above trehalose mutants that still contain TreS, but are missing any other enzymes of the other pathways, still accumulate large amounts of glycogen when grown in the presence of 2% trehalose. In contrast, mutants missing TreS do not accumulate glycogen under these conditions (Pan et al., 2008). These results show that TreS, as well as trehalose, is necessary to convert trehalose to glycogen, but
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
196
11. Trehalose and glycogen
the steps involved in, or the mechanism of this conversion is not known at this time.
7.3. Other possibilities for producing trehalose There are several other pathways in bacteria that are probably degradative in nature, but the reactions are reversible and could, under the right conditions, catalyse the formation of trehalose or a trehalose-derivative. One such pathway is a phosphorolysis pathway catalysed by the enzyme trehalose phosphorylase (Wannet et al., 1998). This enzyme catalyses the following reaction:
metabolism (Blazquez et al., 1993; Muller et al., 1999), the PTS pathway may also be involved in control of Glc metabolism.
8. Functions of trehalose 8.1. Source of energy and carbon
As discussed earlier, trehalose is widespread in nature and trehalose concentrations vary greatly in cells depending on the stage of growth, the nutritional state of the organism and the environmental conditions prevailing at the time of measurement. In a number of instances, it clearly has been implicated as Trehalose H 3 PO 4 ↔ Glc-1-phosphate Glc functioning as an energy source. For example, in insects, trehalose is a major sugar in the This reaction is analogous to other phospho- haemolymph and thorax muscles and is conrylases, e.g. glycogen phosphorylase or maltose sumed during flight (Becker et al., 1996). In funphosphorylase and, in the presence of high lev- gal spores, trehalose hydrolysis is a major event els of Glc-1-phosphate and Glc, it could produce during early germination and trehalose is considered a major source of carbon for synthesis free trehalose. Another reaction that may give rise to treha- of macromolecules as well as providing energy lose involves the phosphotransferase system. For for growth and synthesis (Thevelein, 1984). example, E. coli has two systems for metabolizing trehalose (Boos et al., 1990). Under conditions of 8.2. Protectant of proteins and high osmolarity, trehalose is hydrolysed to Glc by membranes during stress a periplasmic trehalase, encoded by treA, and the Glc is then taken up by the phosphotransferase Trehalose has the capacity to protect proteins system (PTS) as Glc-6-phosphate and used in gly- from denaturation whether occurring as a result colysis (Boos et al., 1990). This periplasmic treha- of heat shock, dehydration, oxidative stress or lase, TreA, is induced by 250 mM NaCl, but not freezing and thawing (Hottinger et al., 1987; by trehalose. On the other hand, at low osmolar- Strom and Kaasen, 1993). The ability of trehalose ity, trehalose is transported via a trehalose-specific to stabilize proteins and membranes is due to its enzyme II of the PTS system, encoded by treB. This structure and stereochemistry (Leopold, 1986). trehalose-6-phosphate produced within the cell is Thus, X-ray crystallization studies have shown then hydrolysed to Glc and Glc-6-phosphate by that trehalose fits well between the polar head trehalose-6-phosphate hydrolase, encoded by treC groups of membrane phospholipids and that (Rimmele and Boos, 1994). Besides the TPS/TPP this interaction results in stabilization (Crowe pathway for synthesis of trehalose-6-phosphate and Crowe, 1988). Also, as in the case of memand then trehalose, the above PTS system is the branes, trehalose interacts well with proteins by only other known mechanism for producing tre- forming hydrogen bonds between its properly halose-6-phosphate. Since trehalose-6-phosphate oriented hydroxyl groups and the polar residues has been implicated as a regulator of carbohydrate of the protein (Crowe et al., 1992). Nevertheless,
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
197
9. Conclusions
it is still unclear why or how this interaction stabilizes proteins. However, it is interesting to note that as a non-reducing disaccharide, trehalose does not cause modification of proteins, as occurs with reducing sugars. That is to say, since trehalose does not have a free aldehyde group, it cannot form a Schiff base with the free amino groups of Lys residues or the N-terminal amino groups of proteins and therefore is not involved in non-enzymic glycation reactions.
8.3. Sensing compound and/or growth regulator In yeast, trehalose-phosphate has been shown to be an allosteric inhibitor of the enzyme hexokinase and is postulated to be a regulator of carbohydrate metabolism (Blazquez et al., 1993). Somewhat similar effects of trehalose or its metabolites have been observed in plants (Muller et al., 1999). For example, insertion of the genes for trehalose synthetic enzymes (TPS and/or TPP) into tobacco plants results in severe growth defects, e.g. dwarfism and aberrant root development (Pilon-Smits et al., 1998). Moreover, in Bacillus spp., there is evidence to indicate that trehalose functions as a transcriptional regulator (Burklen et al., 1998).
8.4. Structural component of the bacterial cell wall In mycobacteria and corynebacteria, trehalose is the basic component of a number of cell wall glycolipids (Brennan and Nikaido, 1995). The best known, and most widely studied, of these trehalose lipids is cord factor, a cell wall lipid of M. tuberculosis (see Chapter 9) which contains the unusual long-chain and branched fatty acids called mycolic acids that are esterified to the –OH groups at position-6 of each Glc (Lederer, 1976). This lipid, called trehalose dimycolate, is considered to be one of the major toxic components of the cell wall and may be the primary reason that
trehalose is essential for these microorganisms (Brennan and Nikaido, 1995). Trehalose monoand dimycolates are also largely responsible for the low permeability of mycobacterial cell walls which confers considerable drug resistance to these organisms (Liu and Nikaido, 1999).
9. Conclusions Trehalose and glycogen are both derivatives of glucose and play important roles in living cells. Glycogen is mainly produced and stored as a glucose reserve when the cell has excess energy and carbon and this glycogen is then converted back to glucose when the cell needs a source of glucose and/or energy. However, glycogen also serves an essential role in providing energy and carbon for spore germination and other energyrequiring activities. Bacterial glycogen differs from animal glycogen in several respects. First, bacterial glycogen is not a glycoprotein, i.e. there is no protein attached to the glycogen. Second, the glucose donor for bacterial glycogen is ADPglucose, rather than UDP-glucose. Third, bacterial glycogen synthesis is regulated by glycolytic intermediates or other metabolites that affect the activity of the allosteric enzyme that produces ADP-glucose, i.e. ADP-glucose pyrophosphorylase. On the other hand, animal glycogen synthesis and degradation is regulated by hormonal action which results in activation of protein kinases that cause the phosphorylation of glycogen synthase and glycogen phosphorylase resulting in increased degradation and decreased synthesis of glycogen. Structurally, trehalose is a much simpler molecule then glycogen but, interestingly, it is physiologically more diverse. It does function as a reservoir of glucose for some organisms and is utilized as an energy source for insect flight muscle and for spore germination in fungi. It is also a very important protectant for cells during times of stress, since it protects proteins and
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
198
11. Trehalose and glycogen
membranes from denaturation and other damage. In many different organisms, synthesis of trehalose is greatly increased when these organisms are subjected to desiccation, heat shock or oxidative stress. Another role of trehalose is as a regulatory molecule. Thus, in yeast and some plants, trehalose-phosphate has been shown to function as a regulator of carbohydrate metabolism and trehalose also appears to function as a transcriptional regulator in Bacillus subtilis. In mycobacteria and related organisms, trehalose is essential for growth and survival and mutants that are unable to synthesize trehalose cannot grow unless exogenous trehalose is added to the media. In these organisms, trehalose may function in some or all of the above capacities, but it also has another very important role as a structural component of the cell wall. In this case, trehalose is acylated with various fatty acids such as mycolic acid to form very hydrophobic glycolipids such as trehalose-dimycolate. These lipids protect the cell from various toxins, such
as antibiotics and other noxious chemicals, by preventing them from penetrating the cell wall. Most organisms that contain trehalose synthesize it from UDP-glucose and glucose-6-phosphate with the intermediate formation of trehalose-6phosphate. But some organisms, such as mycobacteria and corynebacteria, have other pathways that allow them to convert glycogen or glycogen degradation products to trehalose. How these various pathways interact and/or communicate with each other to control trehalose and glycogen levels is not known, but it does represent a very interesting metabolic question. The answer to that question may also disclose new and novel targets for chemoptherapy against important pathogens, such as M. tuberculosis. In conclusion, studies on trehalose and glycogen have provided a wealth of information on synthesis and function of these two important glucose derivatives. Moreover, a number of intriguing and significant questions that need research have been revealed (Research Focus Box).
Research Focus Box
How are the levels of trehalose and glycogen controlled in mycobacteria with three different pathways of synthesis? Are they coordinately controlled? Do they communicate with each other? l What is the mechanism involved in the conversion of trehalose to glycogen in mycobacteria? Is trehalose synthase a regulatory enzyme and, if so, how is it regulated? l Is trehalose synthase a sensor of trehalose levels in the cell? l
Is trehalose metabolism a reasonable target site for chemotherapy against mycobacteria or other microorganisms? If so, how can it be exploited? l Can too much trehalose, or too much glycogen, be a bad thing? l If you could produce the ideal organism, would it synthesize and utilize trehalose? l How? What about glycogen? Would it have the capacity to interconvert glycogen and trehalose? Why? l
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
References Avonce, N., Leyman, B., Thevelein, J.M., Iturriaga, G., 2005. Trehalose metabolism and glucose sensing in plants. Biochem. Soc. Trans. 33, 276–279. Baecker, P.A., Greenberg, E., Preiss, J., 1986. Biosynthesis of bacterial glycogen. Primary structure of Escherichia coli 1,4--d-glucan:1,4-a-d-glucan 6--d-(1,4--d-glucano)transferase as deduced from the nucleotide sequence of the glgB gene. J. Biol. Chem. 268, 8738–8743. Becker, A., Schloeder, P., Steele, J.E., Wegener, G., 1996. The regulation of trehalose metabolism in insects. Experientia 52, 433–439. Bell, W., Sun, W., Hohmann, S., et al., 1998. Composition and functional analysis of the Saccharomyces cerevisiae trehalose synthase complex. J. Biol. Chem. 272, 33311–33319. Blazquez, M.A., Lagunas, R., Gancedo, C., Gancedo, J.M., 1993. Trehalose-6-phosphate, a new regulator of yeast glycolysis that inhibits hexokinase. FEBS Lett. 329, 51–54. Boos, W., Ehmann, U., Forki, W., Klein, M., Rimmele, M., Postma, P., 1990. Trehalose transport and metabolism in Escherichia coli. J. Bacteriol. 172, 3450–3461. Brennan, P.J., Nikaido, H., 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64, 29–63. Burklen, L., Schock, F., Dahl, M.K., 1998. Molecular analysis of the interaction between the Bacillus subtilis trehalose repressor TreR and the tre operator. Molec. Gen. Genet. 260, 48–55. Cabib, E., Leloir, L.F., 1958. The biosynthesis of trehalosephosphate. J. Biol. Chem. 231, 259–275. Chen, G.S., Segal, H., 1968. Escherichia coli polyglucose phosphorylases. Arch. Biochem. Biophys. 127, 164–174. Chock, P.B., Rhee, S.G., Stadtman, E.R., 1980. Interconvertible enzyme cascades in cellular regulation. Annu. Rev. Biochem. 490, 813–843. Cleeg, J.S., Filosa, M.F., 1961. Trehalose in the cellular slime mold, Dictyostelium mucoroides. Nature 192, 1077–1078. Cori, C.F., Cori, G.R., 1939. The activating effect of glycogen on the enzymatic synthesis of glycogen from glucose1-phosphate. J. Biol. Chem. 131, 397–398. Coutinho, P.M., Deleury, E., Davies, G.J., Henrissat, B., 2003. An evolving hierarchical family classification of glycosyltransferases. J. Mol. Biol. 328, 307–317. Crowe, L.M., Crowe, J.H., 1988. Trehalose and dry dipalmitoyl phosphatidylcholine revisited. Biochim. Biophys. Acta 946, 193–201. Crowe, J.H., Hoekstra, F.A., Crowe, L.M., 1992. Anhydrobiosis. Annu. Rev. Physiol. 54, 579–599. Delmer, D.P., Albersheim, P., 1970. The biosynthesis of sucrose and nucleoside diphosphate glucoses in Phaseolus aureus. Plant Physiol. 45, 782–786.
199
DeSmet, K.A.L., Weston, A., Brown, I.N., Young, D.B., Robertson, B.D., 2000. Three pathways for trehalose biosynthesis in mycobacteria. Microbiology 146, 199–208. Dietzler, D.N., Strominger, J.L., 1973. Purification and properties of the adenosine diphosphoglucose:glycogen transglucosylase of Pasteurella pseudotuberculosis. J. Bacteriol. 113, 946–952. Dietzler, D.N., Leckie, M.P., Lais, C.J., Magnani, J.L., 1974. Evidence for the regulation of bacterial glycogen biosynthesis in vivo. Arch. Biochem. Biophys. 162, 602–606. Edavana, V.K., Pastuszak, I., Carroll, J.D., Thampi, P., Abraham, E.C., Elbein, A.D., 2004. Cloning and expression of the trehalose-phosphate phosphatase of Mycobacterium tuberculosis: comparison to the enzyme from Mycobacterium smegmatis. Arch. Biochem. Biophys. 426, 250–257. Elbein, A.D., 1968. Trehalose-phosphate synthesis in Streptomyces hygroscopicus. Purification of GDP-glucose: glucose-6-phosphate 1-glucosyl transferase. J. Bacteriol. 96, 1623–1631. Elbein, A.D., 1974. The metabolism of ,-trehalose. Adv. Carbohydr. Chem. Biochem. 30, 227–256. Elbein, A.D., Mitchell, M., 1973. Levels of glycogen and trehalose in Mycobacterium smegmatis, and the purification and properties of the glycogen synthase. J. Bacteriol. 113, 863–873. Elbein, A.D., Pan, Y.T., Pastuszak, I., Carroll, D., 2003. New insights on trehalose: a multifunctional molecule. Glycobiology 13, 17R–27R. Fox, J., Kawaguchi, K., Greenberg, E., Preiss, J., 1976. Biosynthesis of bacterial glycogen. 13. Purification and properties of the Escherichia coli B ADP glucose: 1,4--Dglucan 4- -glucosyltransferase. Biochemistry 15, 849–857. Furukawa, K., Tagaya, M., Tanaziwa, K., Fukui, T., 1994. Identification of Lys277 at the active site of Escherichia coli glycogen synthase. Application of affinity labeling combined with stie-directed mutagenesis. J. Biol. Chem. 269, 868–871. Govons, S., Gentner, N., Greenberg, E., Preiss, J., 1973. Biosynthesis of bacterial glycogen. XI. Kinetic characterization of an altered ADP-glucose synthase from a “glycogen-excess” mutant of Escherichia coli. J. Biol. Chem. 248, 1731–1740. Henrissat, A., 1991. A classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem. J. 280, 309–316. Hohmann, S., Bell, S., Neves, M.J., Valckx, D., Thevelein, J.M., 1996. Evidence for trehalose-6-phosphate-dependent and -independent mechanisms in control of sugar influx into yeast glycolysis. Mol. Microbiol. 20, 981–991. Holmes, E., Preiss, J., 1979. Characterization of Escherichia coli B glycogen synthase enzymatic reactions and products. Arch. Biochem. Biophys. 196, 436–448.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
200
11. Trehalose and glycogen
Horlacher, R., Boos, W., 1997. Characterization of TreR, the major regulator of the Escherichia coli trehalose system. J. Biol. Chem. 272, 13026–13032. Hottinger, T., Boller, T., Wiemken, A., 1987. Rapid changes of heat and dessication tolerance correlated with changes of trehalose content in Saccharomyces cerevesiae. FEBS Lett. 220, 113–115. Kaasen, I., Falkenberg, P., Sryrvold, O.B., Strom, A.R., 1992. Molecular cloning and physical mapping of the otsBA genes upon exposure, which encode the osmoregulatory trehalose pathway of Escherichia coli: evidence that transcription is activated by katF (AppR). J. Bacteriol. 174, 889–898. Kaasen, I., McDougall, J., Strom, A.R., 1994. Analysis of the otsBA operon for osmoregulatory trehalose synthesis in Escherichia coli and homology of the OtsA and OtsB proteins to the yeast trehalose-6-phosphate synthase/phosphatase complex. Gene 145, 9–15. Kiel, J.A.K., Boels, J.M., Beldman, G., Venema, G., 1994. Glycogen in Bacillus subtilis: molecular characterization of an operon encoding enzymes involved in glycogen biosynthesis and degradation. Mol. Microbiol. 11, 203–218. Klutts, S., Pastuszak, I., Korath-Edavana, V., et al., 2003. Purification, cloning, expression and properties of the mycobacterial trehalose-phosphate phosphatase. J. Biol. Chem. 278, 2093–2100. Krisman, C.R., Barengo, R., 1975. A precursor of glycogen biosynthesis: -1,4-glucan-protein. Eur. J. Biochem. 52, 117–123. Kumar, A., Larsen, E., Preiss, J., 1986. Biosynthesis of bacterial glycogen. Primary structure of Escherichia coli ADP-glucose: -1,4-glucan,4-glucosyltransferase as deduced from the nucleotide sequence of the glgA gene. J. Biol. Chem. 261, 16256–16259. Lapp, D., Patterson, B.W., Elbein, A.D., 1971. Propeties of a trehalose-phosphate synthetase from Mycobacterium smegmatis. J. Biol. Chem. 246, 4567–4579. Lederer, E., 1976. Cord factor and related trehalose esters. Chem. Phys. Lipids 16, 91–106. Leloir, L.F., Rongine deFerrente, M.A., Cardini, C.E., 1961. Starch and oligosaccharide synthesis from uridine diphosphate glucose. J. Biol. Chem. 236, 636–641. Leopold, A.C., 1986. Membranes, Metabolism and Dry Organisms. Cornell University Press, Ithaca. Levi, C., Preiss, J., 1976. Regulatory properties of the ADPglucose pyrophosphorylase of the blue-green bacterium Synechococcus 6301. Plant Physiol. 58, 753–756. Lindberg, B., 1955. Studies on the chemistry of lichens. Investigation of a Dermatocarpon and some Roccella species. Acta Chem. Scand. 9, 917–919. Liu, J., Nikaido, H., 1999. A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acid accumulates meromycolate. Proc. Natl. Acad. Sci. USA 96, 4011–4016.
Lowry, O.H., Carter, J., Ward, J.B., Glaser, L., 1971. The effect of carbon and nitrogen sources on the level of metabolic intermediates in Escherichia coli. J. Biol. Chem. 246, 6511–6521. MacGregor, E.A., Janecek, S., Svensson, B., 2001. Relationship of sequence to specificity in the -amylase family of enzymes. Biochim. Biophys. Acta 1546, 1–20. Mackey, B.M., Morris, J.G., 1971. Ultrastructural changes during sporulation in Clostridium pasteurianum. J. Gen. Microbiol. 63, 13. Manners, D.J. (1971). The structure of glycogen. In: Rose, A.H., Harrison, J.S. (Eds.), The Yeasts, Vol. 2. Academic Press, NewYork, pp. 419–440. Manners, D.J., 1991. Recent developments in our understanding of glycogen structure. Carbohydr. Polym. 16, 37–82. Maruta, K., Hattori, K., Nakada, T., Kubota, M., Sugimoto, T., Kurimoto, M., 1996a. Cloning and sequencing of trehalose biosynthesis genes from Rhizobium sp. M-11. Biosci. Biotechnol. Biochem. 60, 717–720. Maruta, K., Mitsuzumi, H., Nakada, T., et al., 1996b. Cloning and sequencing of a cluster of genes encoding novel enzymes of trehalose biosynthesis from thermophilic archaebacterium Sulfolobus acidocaldarius. Biochim. Biophys. Acta 1291, 177–181. Matula, M., Mitchell, M., Elbein, A.D., 1971. Trehalosephosphate from Mycobacterium smegmatis. J. Bacteriol. 107, 217–223. Muller, J., Wiemken, A., Aeschbacher, R., 1999. Trehalose metabolism in sugar sensing and plant development. Plant Sci. 147, 37–47. Nishimoto, T., Nakano, M., Bnakada, T., et al., 1995. Purification and properties of a novel enzyme, trehalose synthase, from Pimelobacter sp. R48. Biosci. Biotechnol. Biochem. 60, 640–644. Okita, T.W., Rodriguez, R.L., Preiss, J., 1981. Biosynthesis of bacterial glycogen. Cloning of the glycogen biosynthetic enzyme structural genes of Escherichia coli. J. Biol. Chem. 256, 6944–6952. Pan, Y.T., Drake, R.R., Elbein, A.D., 1996. Trehalose-P synthase of Mycobacteria. Its substrate specificity is affected by polyanions. Glycobiology 6, 453–461. Pan, Y.T., Carroll, J.D., Elbein, A.D., 2002. Trehalose-phosphate synthase of Mycobacterium tuberculosis. Cloning, expression and properties of the recombinant enzyme. Eur. J. Biochem. 269, 6091–6100. Pan, Y.T., Edavana, V.K., Jourdian, W.J., et al., 2004. Trehalose synthase of Mycobacterium smegmatis. Purification, cloning, expression and properties of the enzyme. FEBS J. 271, 4259–4269. Pan, Y.T., Carroll, J.D., Asano, N., Pastuszak, I., Korath-Edavana, V., Elbein, A.D., 2008. Trehalose synthase converts glycogen to trehalose. FEBS J. 275, 3408–3420.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Pilon-Smits, E.A.H., Terry, N., Sears, T., et al., 1998. Trehaloseproducing transgenic tobacco plants show improved growth performance under drought stress. J. Plant Physiol. 152, 525–532. Preiss, J., 1984. Bacterial glycogen synthesis and its regulation. Annu. Rev. Microbiol. 38, 419–458. Preiss, J., 1989. Glycogen biosynthesis In: Poindexter, J.S., Ledbetter, E. (Eds.), Bacteria in Nature, Vol. 3. Plenum Press, New York, pp. 189–256. Preiss, J., 2000. Glycogen biosynthesis. In: Lederberg, J., Alexander, M., Bloom, B.R. et al. (Eds.) Encyclopedia of Microbiology, Vol. 2. Academic Press, New York, pp. 541–556. Preiss, J., Greenberg, E., 1965. Biosynthesis of bacterial glycogen. 3. The adenosine diphosphate-glucose: -4glucosyl transferase of Escherichia coli B. Biochemistry 4, 2328–2334. Preiss, J., Romeo, T., 1989. Physiology, biochemistry and genetics of bacterial glycogen synthesis. Adv. Bacter. Physiol. 30, 184–238. Preiss, J., Romeo, T., 1994. Molecular biology and regulatory aspects of glycogen biosynthesis in bacteria. Prog. Nucleic Acid Res. Mol. Biol. 47, 300–329. Preiss, J., Lammel, C., Greenberg, E., 1976. Biosynthesis of bacterial glycogen. Kinetic studies of a glucose-1-P adenylyltrasferase (EC 2.7.7.27) from a glycogen-excess mutant of Escherichia coli B. Arch. Biochem. Biophys. 174, 105–119. Qian, M., Haser, R., Buisson, G., Duee, E., Payan, F., 1994. The active center of a mammalian -amylase. Biochemistry 33, 6284–6294. Rimmele, M., Boos, W., 1994. Trehalose-6- hydrolase of Escherichia coli. J. Bacteriol. 176, 5654–5664. Robyt, J.F., French, D., 1970. Multiple attack and polarity of action of porcine pancreatic -amylase. Arch. Biochem. Biophys. 13, 622–670. Romeo, T., Kumar, A., Preiss, J., 1988. Analysis of the Esherichia coli glycogen gene cluster suggests that catabolic enzymes are encoded among the biosynthetic genes. Gene 70, 363–376. Ruf, J., Wacker, H., James, P., et al., 1990. Rabbit small intestine trehalase. Purification, cDNA cloning, expression, and verification of GPI-anchoring. J. Biol. Chem. 265, 15034–15040. Russell, J.B., 1992. Glucose toxicity and inability of Bacteroides ruminicola to regulate glucose transport and utilization. Appl. Environ. Microbiol. 58, 2040–2045.
201
Schluepmann, H., Pellny, T., van Dijken, A., Smeekens, S., Paul, M., 2003. Trehalose 6-phosphate is indispensable for carbohydrate utilization and growth in Arabidopsis thaliana. Proc. Natl. Acad. Sci. USA, 100, 6849–6854. Shen, L., Ghosh, H.P., Greenberg, E., Preiss, J., 1964. Adenosine diphosphate glucose-glycogen transglucosylase in Arthrobacter sp. NRRL B. Biochim. Biophys. Acta 89, 370–372. Sigal, N., Cattaneo, J., Segal, I.H., 1964. Glycogen accumulation by wild-type and uridine diphosphate glucose pyrophosphorylase-negative strains of Escherichia coli. Arch. Biochem. Biophys. 108, 440–451. Strom, A.R., Kaasen, I., 1993. Trehalose metabolism in Escherichia coli: stress protection and stress regulation of gene expression. Mol. Microbiol. 8, 205–210. Sussman, A.S., Lingappa, B.T., 1959. Role of trehalose in ascospores of Neurospora tetrasperma. Science 130, 1343–1344. Swedes, J.S., Sedo, R.J., Atkinson, D.E., 1975. Relation of growth and protein synthesis to the adenylate energy charge in an adenine-requiring mutant of Escherichia coli. J. Biol. Chem. 250, 6930–6938. Tagaya, M., Nakano, K., Fukui, T., 1985. A new affinity labeling reagent for the active site of glycogen synthase. Uridine diphosphopyridoxal. J. Biol. Chem. 260, 6670–6676. Thevelein, J.M., 1984. Regulation of trehalose metabolism in fungi. Microbiol. Rev. 48, 42–59. Vikinen, M., Mantsala, P., 1989. Microbial amylolytic enzymes. Crit. Rev. Biochem. Mol. Biol. 24, 329–418. Wannet, W.J.B., Op den Camp, H.J.M., Wisselink, H.W., van der Drift, C., Van Griensven, L.J., Vogels, G.D., 1998. Purification and characterization of trehalose phosphorylase from the commercial mushroom Agaricus bisporus. Biochim. Biophys. Acta 1425, 177–188. Wilkinson, J.F., 1959. The problem of energy-storage compounds in bacteria. Exptl. Cell Res. (Suppl. 7), 111–130. Woodruff, P.J., Carlson, B.L., Siridechadilok, B., et al., 2004. Trehalose is required for growth of Mycobacterium smegmatis. J. Biol. Chem. 279, 28835–28843. Yang, H., Liu, M.Y., Romeo, T., 1996. Coordinate genetic regulation of glycogen catabolism and biosynthesis in Escherichia coli via the CsrA gene product. J. Bacteriol. 178, 1012–1017.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
12 Glycosylated compounds of parasitic protozoa Joanne Heng, Thomas Naderer, Stuart A. Ralph and Malcolm J. McConville
Summary Parasitic protists belong to a range of deeply diverging eukaryotic taxa and are the cause of many important diseases in humans. These organisms are capable of surviving in multiple vertebrate and arthropod host environments and, in some cases, as free-living organisms. All parasitic protists express a range of glycoconjugates that form protective protein-rich or carbohydrate-rich surface coats. Protein-rich coats are typically found on developmental stages that inhabit non-hydrolytic niches, such as the bloodstream and non-acidified intracellular vacuoles. These coats are commonly dominated by a limited repertoire of antigenically diverse proteins that are commonly, but not always, glycosylphosphatidylinositol- (GPI-) anchored and modified with N- or O-glycans. Carbohydrate-rich coats are commonly found on developmental stages that dwell within hydrolytic environments, such as vertebrate and arthropod digestive tracts and lysosomal vacuoles. These coats are dominated by GPI-anchored glycoproteins that are heavily modified with N-glycans, O-glycans or phosphoglycans. Free GPI glycolipids (not attached to protein) can also be abundant or dominant components of these coats.
Microbial Glycobiology
Some parasitic protists can also form highly resistant cyst stages encased within polysaccharide-rich cell walls. Considerable progress has been made in defining the structures of the surface and intracellular glycans of the parasitic protists, their biosynthesis and the role that individual components play in parasite infectivity. Keywords: Protozoan parasites; N-glycosylation; Oglycosylation; Glycosylphosphatidylinositol; Phosphoglycosylation
1. Introduction Parasitic protists comprise a highly diverse group of single-celled eukaryotes that are responsible for a range of important human and veterinary diseases (Table 12.1). The major parasite groups belong to the Apicomplexa (Plasmodium, Theileria, Babesia, Toxoplasma and Cryptosporidium spp.), the Kinetoplastida (Trypanosoma and Leishmania spp.), the Amoebozoa (Entamoeba histolytica and Acanthamoeba spp.) and the Metamonada (Giardia and Trichomonas spp.). While organisms
203
© 2009 2010, Elsevier Inc.
204
12. Glycosylated compounds of parasitic protozoa
Table 12.1 Glycan classes synthesized by different parasitic protists O-glycanc
CHO reservee
Oocyst wallf
N-glycana
GPIb
SP
cyto
P-glycansd
Typanosoma brucei
Yes
Yes
No
No
Yes
No
No
Trypanosoma cruzi
Yes
Yes
Yes
No
Yes
?
No
Leishmania spp.
Yes
Yes
No
Yes
Yes
Man
No
Plasmodium spp.
Yes
Yes
No
No
No
?
No
Babesia bovis
Yes
Yes
?
?
No
?
No
Theileria spp
No
Yes
?
?
No
?
No
Toxoplasma gondii
Yes
Yes
No
No
No
G/AP
Yes
Cryptosporidium spp.
Yes
Yes
No
No
No
G/AP
Yes
Trichomonas vaginalis
Yes
No
?
?
Yes
G/AP
Yes
Giardia lamblia
Yes
Yes
Yes
No
No
G/AP
Yes
Yes
Yes
Yes
No
Yes
G/AP
Yes
Parasite Kinetoplastidae
Apicomplexa
Metamonada
Archamoeba Entamoeba histolytica a
N-linked glycans. Glycosylphosphatidylinositols. c O-glycosylation of proteins in the secretory pathway (SP) or cytosol (cyto). d Phosphoglycosylation on proteins or a lipid anchor. e Carbohydrate reserves comprising glycogen/amylopectin-like glucans (G/AP) or mannogen (Man). b
within each clade have shared characteristics, they can also differ markedly from each other with regard to host specificities, tissue tropisms and developmental programmes. For example, the Apicomplexan parasites, Plasmodium, Theileria and Babesia spp. infect blood cells and are transmitted to vertebrates by a hematophagus arthropod definitive host. These parasites target several tissues and differentiate through multiple developmental stages. In contrast, Cryptosporidium parvum has a relatively simple life cycle that involves a single host and invasion of a single cell type, primarily intestinal epithelial cells. Despite their diverse biology, all parasitic protozoa produce complex surface coats that are dominated by glycolipids, glycoproteins
and/or proteo(phospho)glycans. These surface and secreted molecules provide protection from environmental stresses and microbicidal processes and are responsible for mediating essential host–parasite recognition, adhesion and invasion steps. Parasite glycosylation pathways, such as N-glycosylation and glycosylphosphatidylinositol (GPI) biosynthesis are similar to those found in yeast, animals and plants, although significant differences can occur in the substrate specificities and regulatory properties of parasite and mammalian glycosylation enzymes that might be exploitable in developing new anti-parasite therapies. Other parasite glycosylation pathways are entirely novel. For example, the trans-sialytion of O-linked glycans, the phosphoglycosylation
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. The surface coats of parasitic protozoa – an overview
Leishmania insect stage
205
T. brucei bloodstream stage
20 nm
PM
Protein
GPI anchor
GIPL
N-glycans
Phosphoglycans
Figure 12.1 Protein- and carbohydrate-rich coats of parasitic protists. The VSG coat of T. brucei bloodstream forms is the paradigm for a protein-rich surface coat. In contrast, the insect (i.e. promastigote) stages of Leishmania express a carbohydrate-rich surface coat. Both coats are dominated by GPI-anchored macromolecules.
of proteins and glycolipids and the assembly of novel cyst wall polysaccharides and intracellular reserve glycans. The diversity of parasite glycosylation reflects the evolutionary diversity of this group of eukaryotes, the opportunity for lateral gene transfer from prokaryotes and various arthropod and vertebrate hosts and the need to generate compositionally-diverse surface coats at specific stages in their life cycles. In this chapter, we describe the range of glycan structures and pathways that are found in different parasitic protozoa. The reader is also referred to other reviews on this topic for more details (see McConville et al., 2002; Mendonca-Previato et al., 2005; von Itzstein et al., 2008).
2. The surface coats of parasitic protozoa – an overview The surface coats of parasitic protozoa are highly diverse, but can be broadly classified as being protein-rich or carbohydrate-rich
(McConville and Ferguson, 1993) (Figure 12.1). The variant surface glycoprotein (VSG) coat of Trypanosoma brucei bloodstream trypomastigotes (the causative agent of African sleeping sickness) is the prototypic protein-rich surface coat (Mehlert et al., 1998). The bloodstream stages are coated with a monolayer of 106 VSG dimers that effectively shield other surface proteins (transporters, nutrient receptors etc) and membrane components from antibody- and complement-opsonization (see Figure 12.1). The successive expression of structurally-related, but antigenically-distinct VSGs allow these parasites to avoid being cleared by the host antibody responses. All VSGs are GPI-anchored, Nglycosylated glycoproteins (Mehlert et al., 1998). Both modifications are important for maintenance of the VSG surface coat. The use of GPI anchors is likely to facilitate the high-density packing of VSG, as well as the constitutive internalization of immunoglobulin-bound VSG as a mechanism for evading the mammalian immune system (Engstler et al., 2007). The VSG N-glycans may facilitate the folding of diverse VSGs and have important space-filling roles in the surface
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
206
12. Glycosylated compounds of parasitic protozoa
coat (Mehlert et al., 2002). Similar protein-rich coats are assembled by intracellular stages of the Apicomplexan parasites, Plasmodium and Toxoplasma spp. (Boothroyd et al., 1998; Sanders et al., 2005) and the intestinal parasite Giarida lamblia (Nash, 2002). Interestingly, all of these developmental stages occupy relatively non-hydrolytic environments (i.e. bloodstream or non-hydrolytic vacuoles) and/or niches that are directly exposed to the adaptive immune system. A major advantage of the protein-rich coats is that it is possible to generate an almost infinite antigenic diversity, a key strategy used by some of these parasites (i.e. T. brucei, Giardia and Plasmodium falciparum) to avoid being cleared by the immune system (Nash, 2002). In contrast, parasite stages that reside within proteolytically active niches typically express carbohydrate-rich surface coats. The insect (promastigote) stage of Leishmania parasites that proliferate within the digestive tract of the sandfly vector produce the prototypic carbohydrate-rich surface coat. The promastigote surface coat is dominated by lipophosphoglycan (LPG, a GPI-anchored phosphoglycan), free GPI glycolipids and a limited repertoire of GPIanchored glycoproteins (McConville et al., 2002) (see Figure 12.1). These lipoglycoconjugates contain unusual terminal and internal glycosidic linkages that are likely to contribute to the intrinsic resistance of these stages to host hydrolyases. Carbohydrate-rich surface coats are also expressed by the extracellular insect stages of T. brucei and Trypansoma cruzi (Buscaglia et al., 2006), the mammalian stage of Leishmania and T. cruzi (Buscaglia et al., 2006) and the intestinal parasites, E. histolytica and Trichomonas vaginalis (Moody-Haupt et al., 2000; Bastida-Corcuera et al., 2005), all of which reside in highly lytic environments (insect or mammalian digestive tracts, (phago)lysosome of mammalian cells). It is important to note that the composition of these surface coats varies enormously. For example, intracellular amastigote stages of Leishmania,
which reside in the mature phagolysosomes of mammalian macrophages, lack major surface macromolecules, but retain a densely packed layer of endogenously synthesized GPI glycolipids and host-derived glycosphingolipids (McConville and Blackwell, 1991; Schneider et al., 1993; Winter et al., 1994). The uptake and surface expression of host glycolipids may constitute a form of host mimicry and allow this stage to avoid detection by the host immune system. It is also important to note that the same species can express protein-rich and carbohydraterich surface coats on different developmental stages and that the remodelling of these coats can be very rapid as parasites transition from one host environment to another. The following sections describe the assembly of the glycan components of these different surface coats in more detail.
3. Protein-linked and free GPI glycolipids The GPI (or related) glycolipids are a dominant class of glycoconjugates in all parasitic protists. Functionally, GPI glycolipids typically anchor the major surface proteins of these organisms to the plasma membrane and can also be the dominant class of free glycolipids. Most parasitic protists have a canonical GPI pathway that leads to the assembly of protein anchor precursors with the structure EtN-P-Man3GlcN-inositol-phospholipid (where EtN-P, ethanolamine-phosphate; Man, mannose; GlcN, glucosamine), although considerable variation can occur in the nature of the lipid moiety and side chain modifications that are added before or after attachment to protein (Figure 12.2). While Trichomonas spp. lack this pathway (Carlton et al., 2007), pathogenic stages of these parasites synthesize lipoglycoconjugates with a related inositol-lipid anchor.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
207
3. Protein-linked and free GPI glycolipids
Protein
C=O EtN P 6Manα1-2Manα1-6Manα1-4GlcNα1-6Ins-P-lipid R1
R2
R3
R4
Species
R1
R2
T. brucei VSG
-
[α-Gal]1.5
-
diacyl14:0,14:0-Grol
-
2pNAL
acyl18:0
Iyso-acyl18:0-Grol
T. cruzi
α-(1-2)-Man
-
-
alkyl16:0acyl16:0-Grol/
Leishmania
-
-
-
alkyl24:0acyl14:0-Grol
P. falciparum
α-(1-2)-Man
-
acyl18:0,14:0
diacyl-Grol
α-GalNAc1-4 [α-Gal]n
-
diacyl16:0,18:1-Grol
+/-acyl16:0
Iyso-acyl28:0,30:1
procyclin
R3
2
R4
+/-AEP
Lipid
Iyso-alkyl-Grol/ceramide
T. gondii 1E.
histolytica
GPI anchor of the E. histolytica PPG contains a divergent Gal1Man2 GlcN-backbone. The site of side chain attachment to this backbone is unknown. 2AEP, aminoethylphosphonate; pNAL, poly-N-acetyllactosamine 1The
Figure 12.2 Structures of the GPI protein anchors of parasitic protists.
3.1. The GPI protein anchors of kinetoplastid parasites The GPI glycolipids anchor both the dominant surface glycoproteins and a number of other less abundant glycoproteins to the plasma membranes of T. brucei, T. cruzi and Leishmania spp. (McConville and Ferguson, 1993; McConville et al., 2002). Many aspects of GPI biosynthesis were first delineated in T. brucei bloodstream forms because of the high flux through this pathway and the ease of obtaining material for
biochemical studies. The biosynthesis of GPI protein anchors is essential for viability of T. brucei bloodstream stages, although remarkably not for the procyclic insect stages, and compounds that selectively inhibit the T. brucei enzymes have recently been identified (Nagamune et al., 2000; Smith et al., 2004; Stokes et al., 2008). The biosynthesis of the protein anchor precursors in T. brucei bloodstream stages involves the following steps: (i) the addition of N-acetylglucosamine (GlcNAc), transferred from uridine
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
208
(ii) (iii)
(iv) (v) (vi)
12. Glycosylated compounds of parasitic protozoa
diphosphate- (UDP-) GlcNAc, to an endoplasmic reticulum (ER) pool of phosphatidylinositol (PI) that is biosynthetically separate from bulk membrane PI (Martin and Smith, 2006). the de-N-acetylation of GlcNAc-PI to form GlcN-PI. the transfer of GlcN-PI from the cytosolic to the luminal face of the ER and addition of three mannose residues donated from Dol-P-Man. the acylation of the inositol ring and addition of EtN-P. the sequential remodelling of sn-1 and sn-2 fatty acids with myristate. the reversible acylation of the inositol group in mature GPI intermediates, to generate steady state pools of both inositol acylated (glycolipid C) and non-inositol acylated (glycolipid A) GPIs.
However, only glycolipid A is added to VSG and RNAi knock-down of the enzyme that deacylates the inositol headgroup results in reduced expression of VSG (Hong et al., 2006). The transfer of glycolipid A to VSG and other proteins is mediated by the GPI:protein transamidase complex, comprising GPI8 (catalytic subunit), Gaa1p, GPI16 and the kinetoplastid-specific subunits, TTA1 and TTA2 (Nagamune et al., 2003). Finally, the glycan backbone of the VSG anchor can be variably modified with 0–10 -galactose (-Gal) residues in the Golgi apparatus, while the diacylglycerol lipid moiety can be further remodelled with myristate at the plasma membrane (Buxbaum et al., 1996; Roper et al., 2002) (see Figure 12.2). T. brucei procyclic stages have a similar GPI pathway, although they lack the myristoyltransferases that complete the fatty acid remodelling steps and accumulate mature GPI anchor precursors with an inositol-acylated lyso-PI lipid moiety (Mehlert et al., 1998) (see Figure 12.2). These inositol acylated GPIs are attached to the procyclins, a family of surface glycoproteins that contain a
negatively-charged polypeptide backbone. While the procyclins are minimally modified with a single, N-linked glycan, the glycan backbone of the procyclin GPI anchor can be extensively modified with branched poly-N-acetyllactosamine (poly-NAL) side chains (Mehlert et al., 1998). These side chains are added in the Golgi apparatus and can be further elaborated with sialic acid residues when the GPI-anchored procyclins reach the cell surface. The sialylation of poly-NAL chains is catalysed by a surface transsialidase enzyme that transfers sialic acid from host sialylglycoconjugates (Nagamune et al., 2004; Montagna et al., 2006). The polypeptide backbone of the procyclins likely forms a relatively diffuse protein coat, while the sialylated poly-NAL side chains may form a dense glycocalyx over the plasma membrane. Remarkably, T. brucei mutants lacking GPI-anchored procyclins are still able to survive and infect the tsetse fly vector (Nagamune et al., 2000). These mutants appear to compensate for the loss of the procyclin coat by upregulating the expression of free GPI glycolipids that carry the poly-NAL chains (Lillico et al., 2003). Significantly, T. brucei mutants lacking all GPIs (protein-linked and free) are severely impaired in their ability to colonize the tsetse fly (Guther et al., 2006) indicating that the GPI glycocalyx is essential for survival in this host. Unexpectedly, the GPI-negative mutants retain a surface glycocalyx, although the composition of this GPI-free coat remains to be determined (Guther et al., 2006). The cell surfaces of the major T. cruzi developmental stages are dominated by two large superfamilies of GPI-anchored glycoproteins, the trans-sialidase/gp85 glycoproteins and the mucin-like glycoproteins (Buscaglia et al., 2006). Other surface glycoproteins (e.g. IG7, Ssp4) are also GPI anchored. The glycan backbones of these anchors are modified in a stage- and proteinspecific manner with an -(1→2)-linked mannose side chain or the charged group, aminoethylphosphonate (see Figure 12.2). The lipid moieties of these anchors can also vary. While GPI anchor
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. Protein-linked and free GPI glycolipids
precurors generally have alkylacyl- or diacylglycerol lipid moieties, alkylacylglycerol, lysoalkylglycerol or ceramide lipid moieties occur in mature protein-linked GPIs (Lederkremer and Bertello, 2001). These observations suggest ceramide is incorporated into mature GPI precursors or GPI-anchored proteins by lipid remodelling reactions as is proposed to occur in yeast (Heise et al., 1996). The GPI-anchored proteins (e.g. gp63, PSA2) are also abundant on the surface of the promastigote (insect) stages of Leishmania, although the expression of these and other macromolecules is downregulated in the intracellular amastigote stage. Leishmania GPI anchors lack side chain modifications, but may undergo lipid remodelling reactions similar to those that occur in T. brucei (Ralton and McConville, 1998). The GPI-anchored proteins are not essential for promastigote growth in culture or infectivity in the mammalian host (Hilley et al., 2000).
3.2. Non-protein-linked GPIs in kinetoplastid parasites All trypanosomatid parasites synthesize more GPI glycolipids than are required for protein anchoring and free GPIs are the major class of glycolipids in these parasites. In T. brucei bloodstream and procyclic stages, excess GPI glycolipids are transported to the cell surface without additional modifications (Figure 12.3). In T. cruzi and Leishmania, specific pools of GPI precursors appear to be channelled into the synthesis of free GPIs or glycoinsitol-phospholipids (GIPLs) which can be 100-fold more abundant than GPI-anchored proteins (Heise et al., 1996; Ralton and McConville, 1998; McConville et al., 2002; Previato et al., 2004). The major T. cruzi GIPLs retain the Man3GlcN1-inositol-lipid backbone of the protein anchors, but are additionally modified with -(1→2)-linked mannose (Man), galactopyranose or galactofuranose residues (Previato et al., 2004) (see Figure 12.3). In Leishmania,
209
distinct classes of GIPLs are synthesized in a species and stage-specific manner. Type-1 and type-2 GIPLs are structurally related to protein and LPG anchors, respectively, while hybrid type GIPLs have branched glycan stuctures with both protein and LPG anchor motifs (Zawadzki et al., 1998; Mullin et al., 2001) (see Figure 12.3). Despite being the major glycoconjugates on the surface of intracellular amastigote stages, Leishmania mutants lacking GIPLs are viable in culture and remain virulent in susceptible animal models (Zufferey et al., 2003). Leishmania amastigotes are able to scavenge glycosphingolipids from the mammalian host (McConville and Blackwell, 1991; Schneider et al., 1993; Winter et al., 1994) and it is possible that these glycolipids may form an alternative glycocalyx and compensate for the loss of GIPLs in vivo. The insect-dwelling promastigote stages of Leishmania also synthesize a hyperglycosylated GPI, termed lipophosphoglycan (LPG) (McConville et al., 2002). The GPI anchor of LPG contains a divergent glycan core that is subsequently modified with linear chains of -Gal-(1→ 4)--Man-1-PO4 repeating units (see Figure 12.3). These units are assembled by the sequential transfer of Man-1-PO4 from guanosine diphosphate- (GDP-) Man and Gal from UDP-Gal in the Golgi apparatus (Capul et al., 2007b) and can be further elaborated with monosaccharide (Gal, Man or oligosaccharide side chains) in a speciesand growth-dependent manner (McConville et al., 1992). The regulation of LPG elongation and side chain modification appears to be functionally important for parasite development in the sandfly vector. Leishmania major mutants lacking the capacity to synthesize LPG are able to differentiate in the sandfly midgut, but are unable to bind to midgut epithelial cells and are cleared from the gut when the sandfly excretes the remains of the bloodmeal (Sacks et al., 2000). The -Gal side chains on L. major LPG are bound by a lectin on the surface of epithelial cells, promoting parasite binding to the midgut wall (Pimenta et al., 1992; Kamhawi et al., 2004). As promastigotes develop
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
210
12. Glycosylated compounds of parasitic protozoa
T. cruzi
GIPL/LPPG
Galf β1-3Manα1-2Manα1-2Manα1-6Manα1-4GlcNα1-6InsPO3-(ceramide/AAG) lipid Galf β1-3
Leishmania Type-1 GIPL
Manα1-2Manα1-6Manα1-4GlcNα1-6InsPO3-(AAG) lipid
Type-II GIPL
Galα1-6Galα1-3Galf β1-3Manα1-3Manα1-4GlcNα1-6InsPO3-(AAG) lipid
Hybrid GIPL (L. mexicana)
Manα1-2Manα1-6Manα1-4GlcNα1-6InsPO3-(AAG) lipid Manα1-3 Manα1-2Manα1-6Manα1-4GlcNα1-6InsPO3-(diacyl) lipid
Hybrid GIPL (L. panamensis)
Galα1-3Galα1-2Galf β1-3Manα1-3
LPG Manα1-2[Galβ1-4Manα1-PO4]nGalα1-6Galα1-3Galfβ1-3Manα1-3Manα1-4GlcNα1-6InsPO3-(Iyso-AG) lipid
Plasmodium falciparum Merozoite free GPI
Galf β1-3Manα1-2Manα1-2Manα1-6Manα1-4GlcNα1-6InsPO3-(diacyI) lipid
Toxoplasma gondii Tachyzoite free GPI
Manα1-2Manα1-2Manα1-6Manα1-4GlcNα1-6InsPO3-(diacyl) lipid Glcα1-4GalNAcβ1-4
Figure 12.3 Structures of the free GPI glycolipids of parasitic protists.
in the sandfly midgut, structurally-distinct LPG chains are incorporated into the glycocalyx that have side chains capped with arabinopyranose residues (McConville et al., 1992) facilitating
promastigote detachment from the epithelial layer and anterior migration along the digestive tract. The longer LPG chains of these stages may also confer resistance to complement lysis.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. Protein-linked and free GPI glycolipids
Finally, LPG may play a role in establishing promastigote infection in the mammalian host (Spath et al., 2003a). L. major mutants lacking LPG are slow to establish lesions in susceptible animal models, reflecting a high rate of clearance during the early stages of infection and appear to be more susceptible to oxidative stress prior to their differentiation to the obligate intracellular amastigote stage (Spath et al., 2003a; Naderer and McConville, 2008). However, LPG biosynthesis is dramatically decreased in amastigotes stages and L. major mutant strains lacking LPG establish lesions in susceptible mice with the same kinetics as wild-type parasites if the infection is initated with amastigotes. Some other species of Leishmania do not require LPG for either promastigote or amastigote infectivity, possibly reflecting differences in sensitivity to oxidative stress (Ilg, 2000a; Naderer and McConville, 2008).
3.3. The GPI glycolipids of Apicomplexan parasites Biochemical and genomic studies suggest that all studied members of the Apicomplexa have a well-developed GPI biosynthetic pathway (Delorenzi et al., 2002; Templeton et al., 2008). The major mammalian infective-stages of Plasmodium spp. (sporozoites and asexual red blood stages) reside within non-hydrolytic vacuoles and only the transiently-extracellular infective merozoites are coated by GPI-anchored proteins (Gowda et al., 1997; Sanders et al., 2005). At least twelve GPI-anchored proteins, including the dominant merozoite surface protein-1 (MSP1), are expressed by asexual red blood stages of P. falciparum (Sanders et al., 2005). Most of these surface proteins lack other types of glycosylation and the biosynthesis of GPI anchor precursors is the major pathway of glycosylation in these parasite stages (Naik et al., 2000). As in the trypanosomatids, P. falciparum merozoites synthesize a two- to five-fold excess of GPI precursors over that needed for protein anchoring and these
211
excess intermediates are thought to accumulate in the plasma membrane (see Figure 12.3). It has been proposed that GPI-anchored proteins and/ or these free GPI glycolipids have potent immunoregulatory properties and are responsible for inducing many of the symptoms associated with malaria (Naik et al., 2000; Vijaykumar et al., 2001; von Itzstein et al., 2008). The rapidly dividing tachyzoite stage of Toxo plasma gondii also reside within non-hydrolytic vacuoles, although they infect a much wider range of mammalian cells than Plasmodium spp. Like the infective merozoites of Plasmodium spp., T. gondii tachyzoites are coated with GPI-anchored proteins, termed surface antigens (SAG1-4), SACrelated sequences (SRS) and SAG-unrelated proteins (SUSA) (Boothroyd et al., 1998; Pollard et al., 2008). The GPI anchors of these proteins contain single N-acetylgalactosamine (GalNAc) side chain modification (Striepen et al., 1997), while the free GPIs that accumulate on the surface of tachyzoites are modified with -Glc-(1→4)GalNAc (where Glc, glucose; GalNAc, N-acetylgalactosamine) (Striepen et al., 1997) (see Figures 12.2 and 12.3). The glucosylated side chain of the free GPIs is highly immunogenic in humans and appears to be widely distributed across different strains of T. gondii (Striepen et al., 1997). It was originally proposed that the GPI anchors of SAG-1 and other surface proteins were required for surface transport and/or to allow the shedding of antibody-opsonized proteins from the cell surface. However, GPI-anchored proteins have been identified in apical intracellular organelles and a modified SAG-1 containing a polypeptide transmembrane domain was still transported to the cell surface and shed with similar kinetics to the GPI-anchored SAG-1 (Seeber et al., 1998). On the other hand, replacement of the GPI anchor with a transmembrane polypeptide reduced SAG-1 dimerization and the incorporation of this protein into large surface complexes, while also increasing the turnover and degradation of this chimeric protein. The utilization of a GPI-anchor may minimize steric constraints interfering with
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
212
12. Glycosylated compounds of parasitic protozoa
protein–protein interactions and/or increase the lateral mobility of SAG-1 in the parasite plasma membrane (Seeber et al., 1998). The pathways of GPI biosynthesis in P. falciparum and T. gondii have been delineated and share many common characteristics (Gerold et al., 1999; Schmidt et al., 1998; Smith et al., 2007). In particular, acylation of the early-intermediate GlcN-PI appears to be essential for subsequent mannosylation and ethanolamine-phosphate additions. In P. falciparum, the inositol acyl chain is predominantly myristate (Gerold et al., 1999). In both Plasmodium and Toxoplasma, the side chain additions (Man, GalNAc, respectively) are added prior to the attachment of these precursors to protein (Schmidt et al., 1998; Kimmel et al., 2006; Smith et al., 2007). In T. gondii, but not in Plasmodium, the inositol acyl chain is removed prior to GPI attachment to protein (Smith et al., 2007). In contrast to the other Apicomplexan parasites, C. parvum sporozoites have a complex surface coat of mucin-like glycoproteins and abundant GIPLs (Priest et al., 2003, 2006). The latter have a conserved tri-mannose backbone and a heterogeneous diacylglycerol PI lipid moiety (Riggs et al., 1999; Priest et al., 2003). The C. parvum GIPLs are recognized by antibodies in patient’s serum and a monoclonal antibody against these glycolipids neutralizes sporozoite infectivity and reduces C. parvum infection in oocyst-challenged mice (Riggs et al., 1999). While the genome of C. parvum contains most of the expected genes for GPI biosynthesis, it lacks a canonical GlcNAc deacetylase that catalyses the second step in GPI biosynthesis. An unrelated bacterial-type sugar deacetylase is suggested to have replaced this enzyme (Templeton et al., 2008).
3.4. The GPI-anchored proteins in E. histolytica E. histolytica trophozoites are coated with a heavily glycosylated GPI-anchored proteophosphoglycan (PPG, previously referred to as LPG). Trophozoites also express an abundant
surface Gal/GalNAc-binding lectin comprising a type-1 membrane protein (heavy chain) and a GPI-anchored light chain (McCoy et al., 1993; Moody-Haupt et al., 2000; Santi-Rocca et al., 2008). The GPI-anchor of the PPG is highly unusual in containing the glycan backbone sequence -Gal(1→?)--Man-(1→6)--Man-(1→4)-GlcN and long chains of -Gal (see Figure 12.2). The precise point of attachment of these side chains, the linkage between the protein and the GPI and the nature of the lipid moiety have yet to be determined. The nature of the lipid moiety has been established recently as 1-O-[(28:0/30:1)lyso-glycero-3-phosphatidyl-]2-O-(16:0)-Ins (Lotter et al., 2009). Knock-down of genes involved in the de-N-acetylation of GlcNAcPI and addition of the first mannose residue to GlcN-PI result in downregulation of PPG expression, increased sensitivity to complement lysis and decreased capacity for amoebic abscess formation (Vats et al., 2005; Weber et al., 2008), highlighting the importance of these molecules in pathogenesis.
3.5. Synthesis of GPI-related glycoconjugates in Trichomonas T. vaginalis lacks homologues of GPI biosynthetic enzymes and the capacity to synthesize the essential donor, dolichol-P-Man (Samuelson et al., 2005; Carlton et al., 2007) (see Figure 12.3). However, flagellated stages of T. vaginalis produce an abundant LPG that may form a carbohydrate-rich surface coat. The T. vaginalis LPG contains an inositol-phosphoceramide lipid anchor and a complex array of sugars: Glc, Gal, Man, arabinose (Ara), GlcNAc, GalNAc and rhamnose (Rha) (Singh, 1993; Bastida-Corcuera et al., 2005). T. vaginalis mutants expressing truncated LPGs have been isolated after chemical mutagenesis. These mutants are no longer agglutinated by Gal- or GlcNAc-binding lectins and are less adherent and cytotoxic to human vaginal ectocervical cells than wild-type parasites (Bastida-Corcuera et al., 2005).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. N-linked glycans
4. N-linked glycans N-glycans are commonly added to eukaryotic proteins that are destined for the cell surface, secretion or other compartments in the secretory pathway. N-glycan precursors are built up in the ER on a dolichol pyrophosphate (Dol-PP) lipid carrier and then transferred en-bloc to asparagine (Asn) residues within the sequon, Asn-X-Ser/ Thr (where Ser, serine; Thr, threonine), in newly synthesized proteins (Figure 12.4). The en-bloc transfer occurs during or after protein translocation into the ER lumen and is mediated by the oligosaccharyltransferase (OST) which, in fungi and metazoans, comprises a multiprotein complex. Following transfer to protein, N-glycans can be extensively processed by a range of glycosidases and glycosyltransferases in the ER and Golgi apparatus to generate more complex structures. Bioinformatic analysis of recently sequenced parasite genomes suggests that most parasitic protists have the capacity to synthesize dolichollinked oligosaccharides, although these are commonly truncated due to extensive secondary loss of asparagine-linked glycosylation (ALG) genes (Samuelson et al., 2005) (see Figure 12.4). With the exception of the trypanosomes, high mannose or pauci-mannose N-glycans are generally not elaborated to more complex structures.
4.1. N-glycosylation in trypanosomatid parasites The trypanosomatid parasites retain the most complete N-glycosylation pathway, lacking only the Dol-P-Glc-dependent glucosyltransferases (Alg6, 8, 10), Dol-P-Glc synthase and, in the case of Leishmania, one of the Dol-P-Man-dependent mannosyltransferases (Alg 12) (Parodi, 1993; Samuelson et al., 2005). While both T. brucei and T. cruzi have the capacity to synthesize Man9GlcNAc2-PP-Dol, these parasites also transfer shorter Man57GlcNAc2 oligosaccharides to protein (Doyle et al., 1986; Manthri et al., 2008).
213
Man9GlcNAc2 and Man5GlcNAc2 oligosaccha rides are added to Asn residues in VSG in a site-specific manner, possibly by distinct OST complexes (Manthri et al., 2008). Following their addition to protein, the high mannose and paucimannose N-glycans of trypanosomatid parasites are variably modified by the unfolded glycoprotein glucosyltransferase (UGGT), a soluble ER protein that recognizes unfolded glycoproteins (Jones et al., 2005). The UGGT-mediated glucosylation of N-glycans leads to the recruitment of calreticulin, a protein chaperone with a lectin domain that facilitates protein folding. Subsequent removal of the terminal Glc by the ER glucosidase-II can result in the disassembly of this complex and ER export of the folded protein or reglucosylation by UGGT (Jones et al., 2005). The proteins required for this cycle (UGGT, calreticulin and glucosidase II) are present in all the trypanosomatid genomes, suggesting that Nglycosylation in these protists has been retained to engage this protein-folding machinery. In support of this notion, calreticulin has been shown to bind to major lysosomal glycoproteins, while genetic deletion of UGGT or chemical inhibition of glucosidase-II interfere with the lysosomal transport of cysteine proteases in T. cruzi (Conte et al., 2003). Moreover, T. brucei, T. cruzi and L. mexicana mutants lacking components of the calreticulin machinery remain viable in culture, possibly reflecting redundancy in the ER chaperone network, but display a variable capacity to establish infections in the mammalian host (Conte et al., 2003; Jones et al., 2005). In particular, L. mexicana mutants lacking the capacity to synthesize mannosylated N-glycans are viable in culture, but are highly sensitive to elevated temperatures encountered in the mammalian host and are avirulent in animal models (Garami and Ilg, 2001; Ralton et al., 2003). Interestingly, inhibition of core N-glycosylation with tunicamycin (a specific inhibitor of Alg7) often has a more profound effect on the growth and viability of typanosomatid parasites than the mutants mentioned above, suggesting that N-glycosylation
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
214
12. Glycosylated compounds of parasitic protozoa A
AIg7 AIg13 AIg1 AIg2 AIg14
AIg11
Dpm Rft ? AIg5 AIg3
OST STT3
AIg9
AIg6 Alg8 AIg10
AIg12
AIg9
Glc
Phosphate
GlcNAc Dolichol
Man
B Completed genomes Cytosolic - mannose
ER - mannose
ER - Glucose
Others
Alg7
Alg14
Alg13
Alg1
Alg2
Alg11
Rft11
ALg31
Alg9
Alg12
Alg6
Alg8
Alg10
Alg5
Dpm1
STT3
+ +
+
+ +
+
+
+
+
-
-
-
-
-
-
+
+ -
+ +
Kinetoplastidae Trypanosoma brucei Trypanosoma cruzi Leishmania major
+ + +
+ + +
1 1 1
+ + +
+ + +
+ + +
+ + +
+ + +
+ + +
+ + -
-
-
-
-
+ + +
+ + +
Apocomplexa Plasmodium falciparum Plasmodium vivax Babesia bovis Theileria annutata Theleria parve Toxoplasma gondii Cryptosporidium hominus Cryptosporidium parvum
+ + + + + + + +
+ + + + + +
+ + + + + -
+ + +
+ + +
+ +
+ + +
-
-
-
+ + +
+ + +
+ -
+ + +
+ + + + + + + +
+ + + + + +
Archamoebae Entamoeba histolytica
+
+
1
+
+
+
+
-
-
-
-
-
-
-
+
+
Metamonada Giardia lamblia Trichomonas vaginalis
Figure 12.4 Dolichol-linked oligosaccharide biosynthesis in parasitic protists. (A) The pathway of oligosaccharide-PPDol synthesis in yeast and metazoan organisms. (B) Presence of ALG genes in the genomes of parasitic protozoa. Adapted from Samuelson et al. (2005) but with additional genome annotations. The analyses provide strong evidence for extensive secondary loss of ALG genes in different parasitic protozoa. Symbols: 1, Presence; -, absence. 1, Kinetoplastidae and E. histolytica encode alg13 and alg14 fused as a single polypeptide.
may be required for protein folding or function independent of calreticulin binding (Nolan and Farrell, 1985; Kink and Chang, 1987). Long-term treatment of Leishmania parasites with tunicamycin results in loss of viability under culture conditions, as well as the amplification of the
Alg7 gene encoding the GlcNAc-1-P transferase (Kink and Chang, 1987). Similarly, disruption of hexosamine metabolism and N-glycosylation in L. major was lethal even when parasites were cultivated at 27°C (Naderer et al., 2008). These observations suggest that the addition of the minimal
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
215
4. N-linked glycans
Trypanosoma brucei VSG complex N-glycans Galβ1-4GlcNAcβ1-2Manα 1-6 Galβ1-4GlcNAcβ1-6 Galβ1-4GlcNAcβ1-3
Galβ1-4GlcNAcβ1-6
Galβ1-4GlcNAcβ1-2Manα1-3
Manβ1-4GlcNAcβ1-4GlcNAc
Galβ1-4GlcNAcβ1-3
Galα1-3Galβ1-4GlcNAcβ1-6 Galβ1-4GlcNAcβ1-2Manα 1-6 or Galα1-3Galβ1-4GlcNAcβ1-3 Galβ1-4GlcNAcβ1-2Manα1-3 Giant polyNAL
Manβ1-4GlcNAcβ1-4GlcNAc
[Galβ1-4GlcNAcβ1-3]nManα 1-3Manα1-6Manβ1-4GlcNAcβ1-4GlcNAc
Trypanosoma cruzi Mucin O-glycans
Galf β1-2Galf β1-4GlcNAcα1-Thr Galf β1-2Galf β1-4 Galrβ1-3 Galrβ1-6 Galrβ1-2
Toxoplasma gondii Cryptosporidium parvum
GlcNAcα1-Thr
GalNAc-Thr/Ser
Figure 12.5 N- and O-glycosylation in parasitic protists. The trypanosomes (T. brucei and T. cruzi) are the only parasitic protists to synthesize complex N-glycans. The structures of the complex polyNAL N-glycans on T. brucei VSG and the giant polyNAL chains on a flagellar protein are shown. T. cruzi is the only parasitic protist in which complex O-linked glycans have been characterized. Representative O-glycan structures of the major surface mucins are shown. The O-GalNAc has been identified in some Apicomplexan parasites.
N-glycan GlcNAc2-core is essential for Leishmania viability at 27°C, while addition of mannosylated N-glycans are required for viability at elevated temperatures. The high mannose and pauci-mannose Nglycans of all trypanosomatid parasites can be further processed by Golgi -mannosidases. However, only in T. brucei, and to a lesser extent in T. cruzi, are N-glycans converted to more complex structures. In T. brucei bloodstream stages,
Man9GlcNAc2-glycans on VSG are processed to triantennary Man5GlcNAc2, while conventional biantennary Man5GlcNAc2- are first processed to Man3GlcNAc3- before being elaborated with short or long chains of pNAL (Manthri et al., 2008) (Figure 12.5). The pNAL chains on VSG glycans contain two to eight -Gal-(1→ 4)-GlcNAc and -Gal-(1→3)-GlcNAc repeating units and, in some cases, an -Gal-(1→3)-Gal capping unit (see Figure 12.5). However, other
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
216
12. Glycosylated compounds of parasitic protozoa
polypeptides can be modified with larger Nglycan chains. A 50-kDa protein in T. brucei bloodstream forms was found to contain giant pNAL chains (54 repeating units) with a large number of -GlcNAc-(1→6)-Gal inter-repeat linkages (Atrih et al., 2005) (see Figure 12.5). The giant pNAL-containing glycoproteins were localized to the flagellar pocket and intracellular endocytic vacuoles and may form a gel-like matrix in these compartments. Inhibition of Gal metabolism and pNAL synthesis in T. brucei results in disruption of membrane transport and eventual loss of viability, suggesting that Golgi glycosylation is essential for the viability of T. brucei bloodstream forms (Urbaniak et al., 2006). Apart from a potential role in maintaining the permeability barrier properties of the VSG coat, pNAL-N-glycans attached to a number of nutrient receptors in the flagellar pocket are thought to be required for their endocytosis and function (Nolan et al., 1999). The dominant surface glycoproteins of the insect-dwelling T. brucei procyclic stages are exclusively modified with high mannose (triantennary Man59GlcNAc2-) N-linked glycans, indicating that the N-glycosylation machinery of these parasites is regulated in a stagespecific manner. However, disruption of the ALG3 gene in procyclic stages (Manthri et al., 2008), or selection for ConA resistance (Hwa and Khoo, 2000), results in the assembly of complex N-glycans on the procyclins indicating that this developmental stage retains the Golgi enzymes needed to make pNAL chains. A similar situation may occur in some other trypanosomatids. For example, while most cell surface and lysosomal proteins in T. cruzi are modified with high mannose N-glycans (Atwood et al., 2006), biantennary complex and sulfated N-glycans have been identified on the major lysosomal enzyme, cruzipain (Parodi et al., 1995; Barboza et al., 2005). In contrast, there is no evidence that the high mannose N-glycans of Leishmania spp. are elaborated to complex structures in any stage (Ilg et al., 1994; Funk et al., 1997).
4.2. N-glycosylation in the Apicomplexa The secondary loss of ALG genes appears to have been common in the Apicomplexa, as most apicomplexan taxa are predicted to synthesize highly truncated dolichol-linked oligosaccharides (see Figure 12.4). Only T. gondii and Cryptosporidium are predicted to have the capacity to make mannosylated dolichollinked oligosaccharides, while all apicomplexan taxa lack obvious mannosyltransferases for the assembly of Man9GlcNAc2-PP-Dol in the ER lumen (see Figure 12.4). Intriguingly, biochemical analysis of total protein extracts of T. gondii tachyzoite and bradyzoites indicate that many proteins in these stages are modified with both high mannose (Man59GlcNAc2) and pauci-mannose N-glycans (Fauquenoy et al., 2008; Luk et al., 2008). As the T. gondii genome lacks obvious homologues for ALG3, 9 and 12 (see Figure 12.4), other glycosyltransferases may catalyse these reactions. Alternatively, the contamination of parasite extracts with host glycoproteins may account for the presence of high mannose N-glycans. Interestingly, tunicamycin has a delayed effect on T. gondii tachyzoite growth in host cells. Tachyzoites develop normally during the first cycle of intracellular infection following tunicamycin treatment, but are unable to develop normally during second and third rounds of infections in the absence of drugs. A number of other drug treatments induce a similar delayed death phenotype, but the basis of this phenomenon is unknown. Tunicamycin has a similar effect on the intracellular growth of the distantly related apicomplexan parasite, P. falciparum (Naik et al., 2001). Given that the N-glycans of these two parasites differ markedly (see below), a question remains as to whether the effect of tunicamycin on parasite infectivity is due to inhibition of N-glycosylation or other metabolic processes. Plasmodium, Babesia and Theileria are predicted to have lost most of the genes in the N-glycosylation pathway, including all of the ALG genes
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
217
5. O-linked glycans
involved in the assembly of mannosylated dolichol-linked oligosaccharides (see Figure 12.4). While Plasmodium, Babesia and Theileria parva have retained the two enzymes involved in the synthesis of GlcNAc2-PP-Dol, Theileria annulata lacks homologues for Alg13, the catalytic subunit of the second N-acetylglucosaminyltransferase (see Figure 12.3). Intriguingly, Plasmodium and Babesia have the catalytic STT3 component of the OST, suggesting that these parasites transfer GlcNAc2- to protein. The Plasmodium OST may have a refined specificity for these small oligosaccharides, as early studies suggested that conventional dolichol-linked oligosaccharides are not transferred to synthetic peptides in in vitro assays (Dieckmann-Schuppert et al., 1992, 1994). In contrast, no candidates for STT3 could be identified in either of the recently sequenced Theileria genomes, raising the possibility that these parasites may be completely deficient in protein N-glycosylation (see Figure 12.4).
4.3. N-glycosylation in the Metamonada and Archamoebae T. vaginalis and E. histolytica are both predicted to transfer simple Man5GlcNAc2- glycans to proteins (Samuelson et al., 2005) (see Figure 12.4). In E. histolytica, these glycans can be modified with a single terminal Glc residue by the ER UGGT, processed to Man3GlcNAc by a swainsonine-sensitive -mannosidase and further elaborated with short chains of -Gal-(1→ 2)- and -Glc-(1→6)--Gal-(1→2)- (Magnelli et al., 2008). In contrast, the intestinal parasite, G. lamblia lacks all ALG mannosyltransferases, but retains the enzymes needed to make GlcNAcPP-Dol and GlcNAc2-PP-Dol. The synthesis of both these lipid precursors and their transfer to synthetic peptide acceptors has been confirmed using G. lamblia cell extracts (Samuelson et al., 2005). The precise function of these highly truncated N-glycans remains to be determined.
5. O-linked glycans A number of parasite stages are coated by mucin-like glycoproteins that are heavily modified with O-linked glycans. O-Glycosylation in these organisms is initiated by the transfer of -GalNAc (mammalian-like) or -GlcNAc to threonine or serine residues in the polypeptide backbone. There are no examples of O-mannosylation, as occurs in many pathogenic fungi, or of the reversible addition of -GlcNAc to cytoplasmic proteins (O-GlcNAcation), as occurs in metazoans.
5.1. O-glycosylation in the Kinetoplastida The major developmental stages of T. cruzi are coated with a family of mucin-like glycoproteins that are extensively modified with O-linked glycans (Previato et al., 1994; Buscaglia et al., 2004, 2006; Alves and Colli, 2007) (see Figure 12.5). O-glycosylation is initiated with the transfer of GlcNAc to Ser or Thr residues in the polypeptide backbone. The core O-GlcNAc is further extended with 1–5 Gal residues to form short, linear and branched, glycan chains (see Figure 12.5). The terminal -Gal residues in these glycans are the major acceptors for the cell surface transsialidases that transfer sialic acid (1–2 residues per chain) from host glycoconjugates (Schenkman et al., 1993). Other terminal modifications can vary in different strains. For example, all the O-linked Gal residues are in the pyranose configuration in the T. cruzi Y-strain, while in the G-strain some of these residues are in the furanose configuration (Almeida et al., 1994). Moreover, some of the O-glycans on the high molecular mass mucins of T. cruzi amastigote stages are modified with O-glycans that terminate in -Gal-(1→3)--Gal(1→4)-GlcNAc (Almeida et al., 1994). These -Gal epitopes are highly immunogenic to humans and are recognized by lytic antibodies in the serum of acute and chronic Chagasic patients (Almeida et al., 1994). The GlcNAc-transferase that initiates O-glycosylation in T. cruzi is associated with purified
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
218
12. Glycosylated compounds of parasitic protozoa
Golgi membranes, utilizes UDP-GlcNAc as the sugar donor and adds GlcNAc residues to Thr residues in a synthetic dodecapeptide containing the consensus sequence of the T. cruzi MUC gene (Previato et al., 1998). Partial disruption of Gal metabolism in T. cruzi insect-stage epimastigotes by single allele deletion of the gene encoding UDP-Glc-4’-epimerase, that is responsible for converting UDP-Glc to UDP-Gal, causes a severe reduction in mucin O-glycosylation and profound defects in cell morphology (MacRae et al., 2006). It is likely that mucin O-glycosylation is important for the integrity and structure of the surface glycocalyx (Di Noia et al., 1996). The sialylated O-glycans may also protect the mammalian stages of T. cruzi from complement lysis and the parasite’s own haemolysin, prior to invasion of new host cells and escape from host cell lysosomes to the cytosol, respectively (PereiraChioccola et al., 2000). Conventional O-glycosylation has not been detected in T. brucei or Leishmania. However, a cytoplasmic protein in L. major has been reported to have O-glycans containing terminal GlcNAc (Handman et al., 1993). The Leishmania genomes lack candidate genes for reversible cytoplasmic O-GlcNAcation or modification of hydroxyproline (see below) and nothing is known about the enzymology of this reaction.
5.2. O-glycosylation in the Apicomplexa Genomic and biochemical evidence has been obtained for canonical “mammalian-like” Oglycosylation in T. gondii and C. parvum (Winter et al., 2000; Templeton et al., 2008). The abundant GPI-anchored surface glycoproteins of C. parvum sporozoites are modified with single O-linked GalNAc residues linked to Ser and Thr residues (Winter et al., 2000) (see Figure 12.5). Similar modification may occur in T. gondii based on: (i) the presence of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases homologues in the T. gondii genome;
(ii) the expression of these enzymes in tachyzoite and bradyzoite developmental stages; and (iii) the demonstration that these enzymes are functionally active when expressed in Drosophila (Stwora-Wojczyk et al., 2004a,b). However, the endogenous polypeptide substrates for these enzymes have not yet been identified. Early reports suggested that P. falciparum may also O-glycosylate some proteins in vivo (Dayal-Drager et al., 1991). However, analysis of the Plasmodium genomes has failed to reveal candidate glycosyltransferases and subsequent biochemical analyses of in vivo-labelled glycans indicate that O-glycosylation is negligible in intra-erythrocytic stages of P. falciparum (Gowda et al., 1997). A novel pathway of cytoplasmic glycosylation has recently been proposed to occur in T. gondii (West et al., 2004). This pathway was originally identified in the slime mould, Dictyosteleum discoideum, and involves the addition of -GlcNAc to hydroxyproline residues in the cytoplasmic protein, Skp1. Homologues of the Skp1 protein, the prolyl-hydroxylase and the UDP-GlcNAc: hydroxyproline N-acetylglucosaminyltransferase have been identified in the T. gondii genome (West et al., 2006). Moreover, D. discoideum Skp1 is modified with hydroxyproline-linked GlcNAc when incubated with T. gondii lysates (West et al., 2004, 2006). However, the function of T. gondii Skp-1 and this cytoplasmic glycosylation has not been defined.
5.3. O-glycosylation in Metamonada and Archamoebae G. lamblia trophozites produce a protein-rich surface coat dominated by acylated (non-GPI anchored) variant surface proteins (VSPs) and a GPI-anchored invariant surface protein (Das et al., 1991; Nash, 2002). Antigenically distinct VSPs are expressed each time trophozoites re-emerge from the cyst stage, providing a mechanism for
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
6. Phosphoglycosylation
generating new antigenic coats in the same or different hosts (Nash, 2002). The modification of VSP4A1 with short O-linked oligosaccharides containing terminal GlcNAc was demonstrated by compositional analysis and labelling with UDP-[3H]Gal and galactosyltransferase (Papanastasiou et al., 1997). O-glycosylation of the VSP proteins may be common and contribute to the antigenic diversity of these surface coats (Hiltpold et al., 2000). Interestingly, E. histolytica trophozoites also express an abundant type-1 surface membrane protein, termed SREHP (serine rich E. histolytica protein) that is modified with O-GlcNAc (Stanley et al., 1995). Recent studies suggest that SREHP is recognized by host cell receptors and mediates host cell adhesion, independent of the interactions mediated by the abundant surface Gal/GalNAc lectin (Teixeira and Huston, 2008).
6. Phosphoglycosylation The surface proteins of many parasitic protists are modified with glycans that are linked to Ser/Thr residues in the polypeptide backbone via phosphodiester linkages. This novel type of modification, termed phosphoglycosylation, was first detected in D. discoideum, where Ser residues in the lysosomal proteinase-I are modified with -GlcNAc-1-PO4 (Gustafson and Gander, 1984). In parasitic protists, distinct forms of phosphoglycosylation can constitute the major type of protein post-translational modification in the secretory pathway (Haynes, 1998; McConville et al., 2002) (Figure 12.6).
6.1. Phosphoglycosylation in the Kinetoplastida Protein phosphoglycosylation is the most abundant form of protein glycosylation in Leishmania spp. (Ilg, 2000b; McConville et al., 2002). Early immunochemical and biochemical
219
analyses indicated that the secreted acid phosphatases (SAPs) of different Leishmania species were modified with similar phosphoglycans to those found on the LPG (Ilg et al., 1991). Subsequent studies showed that serine residues in the protein backbone of the secreted acid phosphatase (SAP) were modified with Man1-PO4 which was extended with short linear chains of -(1→2)- linked mannose or longer chains of repeating -Gal-(1→4)--Man-1-PO4 phosphodisaccharides (Ilg et al., 1994; Lippert et al., 1999) (see Figure 12.6). The SAPs belong to a heterogeneous family of proteophosphoglycans (PPGs), which include the promastigote filamentous PPG (fPPG), the GPI-anchored cell surface PPG (mPPG) and the non-filamentous amastigote PPG (aPPG) (Ilg, 2000b). The distinct polypeptide backbones of these PPGs contain Ser/Thr-rich or Ser/Proline- (Pro-) rich domains that are extensively modified with phosphoglycan chains (Ilg et al., 1996, 1998). The length and composition of the phosphoglycan chains vary enormously in different PPGs. While the 100-kDa form of L. mexicana SAP is primarily modified with short (1–6 residues long) mannose oligosaccharides, the secreted PPGs of the amastigote stage are elaborated with exceedingly complex branched phosphoglycans (Ilg et al., 1994, 1998) (see Figure 12.6). The assembly of phosphoglycan chains may depend on sequence motifs within the protein carrier, the rate at which these proteins are transported through the secretory pathway and the complement of glycosyltransferases expressed in each species. Protein phosphoglycosylation is essential for Leishmania survival in the sandfly vector. L. major mutants lacking the Golgi GDP-Man transporter (encoded by the LPG2 gene) are deficient in all phosphoglycans and are rapidly cleared from the sandfly midgut with the remains of the blood-meal (Sacks et al., 2000). The clearance of the phosphoglycan-deficent parasites is not due to loss of LPG, as L. major mutants lacking surface LPG are able to survive the first few days in the midgut, although they
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
220
12. Glycosylated compounds of parasitic protozoa
Leishmania spp.
Manα1-2Manα1-2Manα1-PO3-Ser
sAP
[Manα1-2]0-5Manα1-PO4-6Galβ1-4Manα1-PO4-6Galβ1-4Manα1-PO4-Ser
PPG promastigote
Galβ1-4Galβ1-4Manα1-PO4-6Galβ1-4Manα1-PO4-Galβ1-4Manα1-PO4-6Galβ1-4Manα1-PO4-Ser Galβ1-3 Araβ1-2
Manα1-2Manα1-PO4-6Galβ1-4Manα1-PO4-6Galβ1-3 3
PPG amastigote Glcβ1-3
Galβ1-3Galβ1-4Manα1-PO4-6Galβ1-3 Glcβ1-3
Glcβ1-3
Galβ1-4Manα1-PO4-6Galβ1-4Manα1-PO4-6Galβ1-4Manα1-PO4-6Galβ1-4Manα1-PO4-6Galβ1-4Manα1-PO4-Ser Glcβ1-3 Manα1-PO4-6Galβ1-3Glcβ1-3Galβ1-4Manα1-PO4-6Glcβ1-3
Trypanosoma cruzi Manα1-2Manα1-2Manα1-PO3-Ser
NETNES
Galf β1-4Rhaα1-2Fucα1-2/3-Galfβ1-4Xylβ1-4Xyl-PO4-Thr/Ser
gp72
PO4-6Galfβ1-2/3
Trypanosoma congolense GARP
Gal7Man11-PO4-Thr
Entamoeba histolytica PPG
[Glcα1-6]1-20-Glcβ1-6-Galα1-PO3-Ser
Figure 12.6 Phosphoglycosylation in parasitic protists.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
6. Phosphoglycosylation
are eventually cleared due to their inability to bind to midgut epithelial cells (Sacks et al., 2000). These analyses suggest that the secreted proteophosphoglycans protect the newly-transformed promastigotes from complement lysis or other microbicidal processes. Secreted proteophosphoglycans may also promote aggregation of infective metacyclic promastigotes of Leishmania in the fore-gut of the sandfly and facilitate transmission of promastigotes to the mammalian host (Rogers et al., 2004). Conflicting results have been obtained as to whether protein phosphoglycosylation is essential for infectivity in the mammalian host. Initial studies with the L. major LPG2 mutants indicated that phosphoglycosylation was required for initial promastigote survival in macrophages, as well as for growth of the intracellular amastigote stage that perpetuates disease in the mammalian host (Spath et al., 2003b). However, other L. major mutants have since been generated that lack two Golgi UDP-Gal transporter isoforms (LPG4 and LPG5) and are also deficient in protein (and LPG) phosphoglycosylation (Capul et al., 2007b). Unlike the L. major lpg2 mutants, the L. major lpg4/5 mutants are as virulent as wild-type parasites in highly susceptible animal models following their transformation to the amastigote (Capul et al., 2007a). These mutants exhibit a characteristic delay in lesion development because of their deficiency in LPG biosynthesis that is required for promastigote infectivity. Similarly, L. mexicana mutants with deficiencies in Golgi phosphoglycans are as virulent as wild-type parasites (Ilg et al., 2001). Collectively, these analyses suggest phosphoglycosylation is essential for promastigote infectivity in the sandfly vector and important for promastigote transmission to the mammalian host. However, despite the fact that intracellular amastigotes secrete abundant amounts of PPGs, this modification does not appear to be essential for parasite survival in the mammalian host. A number of proteins in the T. cruzi insect (epimastigote and metacyclic trypomastigote) stages have been shown to be phosphoglycosylated.
221
The abundant surface glycoprotein, gp72, is heavily modified with glycans (50% w/w) containing Rha, Xyl, Fuc, Galp, Galf and GlcNAc. These glycans are released by mild acid hydrolysis and are linked to phosphothreonine and some phosphoserine residues in the polypeptide backbone (Haynes, 1998; Ferguson, personal communication). Gp72 homologues in both T. cruzi and T. brucei appear to be required for attachment of the flagellum to the cell body. Interestingly, the T. brucei homologue, Fla-1 is modified with both N-glycans and acid-labile oligosaccharides suggesting that it is phosphoglycosylated (Nozaki et al., 1996). RNAi knockdown of a key enzyme in fucose metabolism in both T. brucei procyclic and bloodstream stages is lethal and, in the case of the former, results in disruption of flagellum adhesion to the cell body (Turnock et al., 2007). These data raise the possibility that fucosylation of Gp72/Fla-1 proteins in both T. cruzi and T. brucei is required for adhesion of the emergent flagellum with the cell body (possibly via a carbohydrate-lectin interaction) and infectivity or survival, respectively. Recent studies have revealed further diversity in the phosphoglycosylation machinery of T. cruzi. The GPI-anchored surface glycoprotein, NETNES, is modified with short chains of -(1→2)-linked Man that are bound via phosphodiester linkage to Ser residues (Macrae et al., 2005) (see Figure 12.6). These structures are identical to those found in Leishmania, suggesting that the GDP-Man:-Man-1-PO4-transferase is likely to be conserved in these trypanosomatids.
6.2. Phosphoglycosylation in E. histolytica Protein phosphoglycosylation has not yet been reported in the Apicomplexa or in the Metamonada. However, the infective trophozoite stage of E. histolytica is coated with an abundant GPI-anchored PPG that is heavily modified with phosphoglycans. The E. histolytica phosphoglycans contain an Gal-1-PO4-Ser linker region
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
222
12. Glycosylated compounds of parasitic protozoa
that is variably modified with linear chains of -(1→6)-linked Glc (Moody-Haupt et al., 2000). Trophozoites of the pathogenic HM-1:IMSS strain synthesize two distinct classes of PPG which have polydisperse molecular masses of 50 000–180 000 (PPG-1) and 35 000–60 000 (PPG2) and are modified with glucan side-chains of different average lengths. In contrast, the non-pathogenic Rahman strain synthesizes one class of PPG which is only elaborated with the short disaccharide side-chain -Glc-(1→6)-Gal (Moody-Haupt et al., 2000). Differences in phosphoglycosylation may thus impact on the density of the surface glycocalyx and/or exposure of other surface molecules and trophozoite virulence. While the transferases responsible for initiating and elongating these phosphoglycans have not been identified yet, a number of UDP-Glc and UDP-Gal transporters have been localized to a putative Golgi fraction in E. histolytica trophozoites, suggesting that these modifications occur following export of the GPI-anchored PPG from the ER (Bredeston et al., 2005).
7. Parasite cyst wall polysaccharides The intestinal parasites G. lamblia and Entamoeba spp. survive adverse environmental conditions by forming cysts that are surrounded by carbohydrate-rich walls (Eichinger, 2001). Encystment is induced in the host intestine by a variety of factors, including nutritional (Glc, cholesterol) shortages, exposure to bile salts and the presence of specific carbohydrate ligands (Eichinger, 2001). The resulting cyst stages are excreted in the faeces and are the primary stage responsible for transmission and persistence in the environment. The fibrillar wall of Giardia cysts contains both protein and polysaccharide (1:2 w/w). The polysaccharide comprises linear polymers of -(1→3)-linked GalNAc that are predicted to form ordered helical structures (Gerwig
et al., 2002). Encystation requires the induction of enzymes involved in de novo hexosamine synthesis, the formation of UDP-GalNAc from UDP-GlcNAc and a novel cyst wall synthase (Jarroll et al., 2001; Karr and Jarroll, 2004). Cyst wall synthesis is also associated with the upregulation of secretory transport and the formation of specialized encystation-specific secretory vesicles (ESVs) that are derived from the Golgi apparatus and contain preformed GalNAc polymers (Lujan et al., 1998). In contrast, the cyst walls of E. histolytica and Entamoeba invadens, contain a mixture of chitin, [-GlcNAc-(1→4)-GlcNAc]n, and chitosan, [-GlcN-(1→4)-GlcN]n, as a major fibrillar component (Das et al., 2006). Cyst wall synthesis requires the induction of two chitin synthases (Campos-Gongora et al., 2004), a family of chitinases (that are presumably involved in remodelling nascent chitin chains) and chitin de-N-acetylases (Campos-Gongora et al., 2004). Chitin polymers are pre-assembled in the Golgi apparatus and deposited at multiple sites over the plasma membrane. Samuelson and colleagues have shown that the expression of an abundant glycoprotein, termed Jacob, is also induced during encystation (Frisardi et al., 2000). They have proposed that Jacob is bound to the plasma membrane of encysting trophozoites by the surface Gal/GalNAc-lectin and directs the deposition of chitin by virtue of containing Cysrich chitin-binding domains (Frisardi et al., 2000). The cysts of Acanthamoeba, another pathogenic amoeba that is more related to slime moulds than Entamoeba, contain cellulose, i.e. polymers of -(1→4)-linked Glc, rather than chitin (LorenzoMorales et al., 2008). Some of the Apicomplexan parasites can also form resistant cyst stages that allow these parasites to persist outside the host. The wall of coccidian oocysts are generally proteinrich and composed of specialized oocyst wall proteins (COWP). Members of the multigene COWP family of Cryptosporidium and T. gondii contain cysteine-rich motifs that may facilitate intra- and inter-molecular cross-linking (Smith
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
223
9. Conclusions
et al., 2005). Similar sequences are absent from the genomes of apicomplexan parasites that lack an environmentally-resistant cyst stage (i.e. Plasmodium, Babesia, Theileria). The oocyst walls of C. parvum may also contain a carbohydrate component, comprising GlcNAc, GalNAc, Man and Gal (Smith et al., 2005). In Eimeria, another coccidian parasite, the predominant cyst wall proteins contain tyrosine-rich domains that are cross-linked by dityrosine bridges to form highly rigid structures (Belli et al., 2003).
8. Intracellular reserve glycans Bioinformatic analyses suggest that many members of the Apicomplexa (T. gondii, C. parvum and Eimeria spp.), the Archamoebae (E. histolytica and Acanthamoeba spp.) and the Metamonada (Trichomonas and Giardia spp.) synthesize intracellular (1→4)-/-(1→6)-glucans that are structurally related to glycogen and/or amylopectin (Wang et al., 1975; Karkhanis et al., 1993; Wu and Muller, 2003; Harris et al., 2004). For example, homologues of glycogen phosphorylases, amylopectin and starch-binding proteins, amylases and debranching enzymes, and an R1 -glucan water dikinase have been identified in C. parvum (Templeton et al., 2008). Glycogen phosphorylase genes have also been identified in Trichomonas, Entamoeba, Acanthamoeba and Giardia. Biochemical analyses have confirmed the presence of amylopectin-like glucans in Eimeria cysts and all stages of T. gondii (Guerardel et al., 2005). The high molecular mass amylopectin fraction of T. gondii forms crystalline inclusions in the cytoplasm that are prominent in slow growing bradyzoites and sporozoite stages. However, amylopectin can also accumulate in intracellular trophozoite stages, during invasion of less permissive host cells, suggesting a possible relationship between amylopectin accumulation and the host nutrient environment (Guerardel
et al., 2005). It is likely that these glucans can be mobilized for glycolysis and/or the synthesis of carbohydrate-rich polymers. Silencing of the Acanthamoeba gene encoding a glycogen phosphorylase prevented the formation of mature cysts, suggesting that the mobilization of these intracellular glucans is needed to sustain high levels of cellulose biosynthesis during cyst formation (Lorenzo-Morales et al., 2008). Some of the trypanosomatid parasites lack obvious reserve polysaccharides. On the other hand, others, including Leishmania, Crithidia and Herpetomonas, synthesize a novel -(1→2)mannan, which we have recently termed mannogen (Gorin et al., 1979; Mendonca-Previato et al., 1979; Ralton et al., 2003). Leishmania mannogen is assembled on a novel -Man-(1→4)-cyclic phosphate primer by the sequential transfer of mannose residues from GDP-Man (Sernee et al., 2006). Mature mannogen lacks phosphate indicating that the phosphate at the reducing end is removed during synthesis (Sernee et al., 2006). The synthesis and degradation of mannogen is highly dynamic and responsive to external carbon source availability indicating a primary reserve function (Ralton et al., 2003). Leishmania mutants lacking mannogen due to global defects in mannose metabolism are very sensitive to elevated temperature and are avirulent in animal models (Ralton et al., 2003), suggesting that mannogen is required for intracellular growth in the sugar-poor environment of mammalian macrophages (Naderer et al., 2006).
9. Conclusions Parasitic protists synthesize a range of glycans and glycoconjugates that are constituents of cell surface coats, cyst walls and intracellular carbohydrate reserves. The glycoconjugates that make up the cell surface coats are highly diverse and, in many cases, have been shown to play important roles in parasite infectivity.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
224
12. Glycosylated compounds of parasitic protozoa
The surface coats of parasitic protists have the following properties: (i) They can be classified as protein-rich or carbohydrate-rich depending on the nature of the major surface macromolecules and/ or surface glycolipids. The development of compositionally different coats is likely to reflect the distinct needs of each parasite stage for antigenic diversity, host cell recognition and protection against host hydrolases (proteases, glycosidases and lipases) within the specific niches that they occupy. (ii) Surface coats with similar physical properties can contain structurally distinct glycoconjugates. For example, the dominant surface glycoconjugates of Leishmania promastigotes (LPG), T. brucei procyclics (procyclins) and E. histolytica (PPG), all have different backbone structures but contribute to the formation of highly polyanionic surface glycocalyxes. (iii) Nearly all the protist surface coats are dominated by GPI-anchored macromolecules or free GPI glycolipids. The use of GPI anchors may facilitate the surface packing of coat components, while also insulating the cytoplasm from external insult. GPI anchors may promote the oligomerization of surface proteins and regulate their secretory or endocytic transport. It is likely that the high demand for GPI precursors led to the evolution of free GPIs as the major glycolipids of these organisms. Trichomonas, the only parasitic protist to lack conventional GPIs, synthesizes a highly abundant surface lipoglycoconjugate that is anchored to the plasma membrane via a related inositollipid moiety. (iv) The carbohydrate-rich surface coats often contain novel glycan modifications. Examples include the sialylation of O-linked glycans and GPI anchors in
T. cruzi and T. brucei, respectively, and the phosphoglycosylation of polypeptides in trypanosomatids and E. histolytica. These modifications contribute to the strong polyanionic characteristics of these coats and their intrinsic resistance to host hydrolyases. (v) With the exception of the trypanosomes, parasitic protists generally have relatively simple N- and O-glycosylation pathways. In the case of N-glycosylation, this reflects extensive secondary loss of ALG genes rather than a primitive state. The high/ pauci-mannose N-glycans may facilitate protein folding via the UGGT-calreticulin chaperone pathway and/or chaperoneindependent pathways. (vi) Finally, the analysis of parasite glycosylation mutants has revealed marked species- and stage-specific differences in the requirement for individual coat components. For example, the synthesis of GPI protein anchor precursors is essential for the viability and virulence of T. brucei bloodstream stage and the asexual red blood cell stages of Plasmodium, but not for the T. brucei procyclic stage or any of the Leishmania developmental stages. These studies highlight potential redundancy in the function of some classes of cell surface glycoconjugates and/or the possibility that some of these molecules are only essential under field conditions that are difficult to replicate in the laboratory. They also suggest that inhibitors of both eukaryoticgeneral and parasite-specific glycosylation pathways may have considerable potential as new therapeutics, but that the requirement for individual glycosylation steps should be validated for all relevant (infective) parasite stages. Areas and questions that will potentially be the topics for future research are listed in the Research Focus Box.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
225
Research Focus Box • Developments in mass spectrometry and glycan profiling can now be used to investigate the stage-specific regulation of individual glycosylation pathways and measure levels of expression of different glycoconjugates in the respective in vivo host systems. • There is a need to develop and refine bioinformatic and biochemical searches for detecting and functionally characterizing glycosylation enzymes in the protozoa. • Targeted gene deletion or knock-down approaches of enzymes involved in glycan synthesis (and catabolism) are needed to establish the physiological roles of
Acknowledgements The work from the authors’ laboratory described in this review was supported by the Australian National Health and Medical Research Council Principal Research Fellow. JH is supported by a Melbourne University Research Scholarship. SR is a University of Melbourne CR Roper Research Fellow. MJM is an NH&MRC Principal Research Fellow.
References Almeida, I.C., Ferguson, M.A., Schenkman, S., Travassos, L.R., 1994. Lytic anti--galactosyl antibodies from patients with chronic Chagas’ disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem. J. 304, 793–802.
glycoconjugates and glycan modifications in parasite biology. • Functional redundancy has complicated studies on the function of parasite glycoconjugates. The generation of parasite mutants that exhibit loss of highly specific, as well as multiple, glycan classes is needed to define levels of redundancy and potential compensatory changes in glycosylation. • Notwithstanding the focused efforts on some parasite glycosylation pathways (i.e. GPI biosynthesis in trypanosomatids), comparatively little is known about the enzymology and regulation of glycosylation pathways and sugar nucleotide biosynthesis in parasitic protozoa.
Alves, M.J., Colli, W., 2007. Trypanosoma cruzi: adhesion to the host cell and intracellular survival. IUBMB Life 59, 274–279. Atrih, A., Richardson, J.M., Prescott, A.R., Ferguson, M.A., 2005. Trypanosoma brucei glycoproteins contain novel giant poly-N-acetyllactosamine carbohydrate chains. J. Biol. Chem. 280, 865–871. Atwood 3rd, J.A., Minning, T., Ludolf, F., et al., 2006. Glycoproteomics of Trypanosoma cruzi trypomastigotes using subcellular fractionation, lectin affinity, and stable isotope labeling. J. Proteome Res. 5, 3376–3384. Barboza, M., Duschak, V.G., Fukuyama, Y., et al., 2005. Structural analysis of the N-glycans of the major cysteine proteinase of Trypanosoma cruzi. Identification of sulfated high-mannose type oligosaccharides. FEBS J. 272, 3803–3815. Bastida-Corcuera, F.D., Okumura, C.Y., Colocoussi, A., Johnson, P.J., 2005. Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells. Eukaryot. Cell 4, 1951–1958. Belli, S.I., Wallach, M.G., Luxford, C., Davies, M.J., Smith, N.C., 2003. Roles of tyrosine-rich precursor glycoproteins and dityrosine- and 3,4-dihydroxyphenylalanine-mediated
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
226
12. Glycosylated compounds of parasitic protozoa
protein cross-linking in development of the oocyst wall in the coccidian parasite Eimeria maxima. Eukaryot. Cell 2, 456–464. Boothroyd, J.C., Hehl, A., Knoll, L.J., Manger, I.D., 1998. The surface of Toxoplasma: more and less. Intl. J. Parasitol. 28, 3–9. Bredeston, L.M., Caffaro, C.E., Samuelson, J., Hirschberg, C.B., 2005. Golgi and endoplasmic reticulum functions take place in different subcellular compartments of Entamoeba histolytica. J. Biol. Chem. 280, 32168–32176. Buscaglia, C.A., Campo, V.A., Di Noia, J.M., et al., 2004. The surface coat of the mammal-dwelling infective trypomastigote stage of Trypanosoma cruzi is formed by highly diverse immunogenic mucins. J. Biol. Chem. 279, 15860–15869. Buscaglia, C.A., Campo, V.A., Frasch, A.C., Di Noia, J.M., 2006. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat. Rev. Microbiol. 4, 229–236. Buxbaum, L.U., Milne, K.G., Werbovetz, K.A., Englund, P.T, 1996. Myristate exchange on the Trypanosoma brucei variant surface glycoprotein. Proc. Natl. Acad. Sci. USA 93, 1178–1183. Campos-Gongora, E., Ebert, F., Willhoeft, U., Said-Fernandez, S., Tannich, E., 2004. Characterization of chitin synthases from Entamoeba. Protist 155, 323–330. Capul, A.A., Barron, T., Dobson, D.E., Turco, S.J., Beverley, S.M., 2007a. Two functionally divergent UDP-Gal nucleotide sugar transporters participate in phosphoglycan synthesis in Leishmania major. J. Biol. Chem. 282, 14006–14017. Capul, A.A., Hickerson, S., Barron, T., Turco, S.J., Beverley, S.M., 2007b. Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major. Infect. Immun. 75, 4629–4637. Carlton, J.M., Hirt, R.P., Silva, J.C., et al., 2007. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315, 207–212. Conte, I., Labriola, C., Cazzulo, J.J., Docampo, R., Parodi, A.J., 2003. The interplay between folding-facilitating mechanisms in Trypanosoma cruzi endoplasmic reticulum. Mol. Biol. Cell 14, 3529–3540. Das, S., Traynor-Kaplan, A., Reiner, D.S., Meng, T.C., Gillin, F.D., 1991. A surface antigen of Giardia lamblia with a glycosylphosphatidylinositol anchor. J. Biol. Chem. 266, 21318–21325. Das, S., Van Dellen, K., Bulik, D., et al., 2006. The cyst wall of Entamoeba invadens contains chitosan (deacetylated chitin). Mol. Biochem. Parasitol. 148, 86–92. Dayal-Drager, R., Hoessli, D.C., Decrind, C., et al., 1991. Presence of O-glycosylated glycoproteins in the Plasmodium falciparum parasite. Carbohydr. Res. 209, C5–C8. Delorenzi, M., Sexton, A., Shams-Eldin, H., Schwarz, R.T., Speed, T., Schofield, L., 2002. Genes for glycosylphosphati-
dylinositol toxin biosynthesis in Plasmodium falciparum. Infect. Immun. 70, 4510–4522. Di Noia, J.M., Pollevick, G.D., Xavier, M.T., et al., 1996. High diversity in mucin genes and mucin molecules in Trypanosoma cruzi. J. Biol. Chem. 271, 32078–32083. Dieckmann-Schuppert, A., Bender, S., Odenthal-Schnittler, M., Bause, E., Schwarz, R.T., 1992. Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur. J. Biochem. 205, 815–825. Dieckmann-Schuppert, A., Bause, E., Schwarz, R.T., 1994. Glycosylation reactions in Plasmodium falciparum, Toxoplasma gondii, and Trypanosoma brucei probed by the use of synthetic peptides. Biochim. Biophys. Acta 1199, 37–44. Doyle, P., de la Canal, L., Engel, J.C., Parodi, A.J., 1986. Characterization of the mechanism of protein glycosylation and the structure of glycoconjugates in tissue culture trypomastigotes and intracellular amastigotes of Trypanosoma cruzi. Mol. Biochem. Parasitol. 21, 93–101. Eichinger, D., 2001. Encystation in parasitic protozoa. Curr. Opin. Microbiol. 4, 421–426. Engstler, M., Pfohl, T., Herminghaus, S., et al., 2007. Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes. Cell 131, 505–515. Fauquenoy, S., Morelle, W., Hovasse, A., et al., 2008. Proteomics and glycomics analyses of N-glycosylated structures involved in Toxoplasma gondii–host cell interactions. Mol. Cell. Proteomics 7, 891–910. Frisardi, M., Ghosh, S.K., Field, J., et al., 2000. The most abundant glycoprotein of amebic cyst walls (Jacob) is a lectin with five Cys-rich, chitin-binding domains. Infect. Immun. 68, 4217–4224. Funk, V.A., Thomas-Oates, J.E., Kielland, S.L., Bates, P.A., Olafson, R.W., 1997. A unique, terminally glucosylated oligosaccharide is a common feature on Leishmania cell surfaces. Mol. Biochem. Parasitol. 84, 33–48. Garami, A., Ilg, T., 2001. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability. EMBO J. 20, 3657–3666. Gerold, P., Jung, N., Azzouz, N., Freiberg, N., Kobe, S., Schwarz, R.T., 1999. Biosynthesis of glycosylphosphatidylinositols of Plasmodium falciparum in a cell-free incubation system: inositol acylation is needed for mannosylation of glycosylphosphatidylinositols. Biochem. J. 344, 731–738. Gerwig, G.J., van Kuik, J.A., Leeflang, B.R., et al., 2002. The Giardia intestinalis filamentous cyst wall contains a novel (1-3)-N-acetyl-d-galactosamine polymer: a structural and conformational study. Glycobiology 12, 499–505. Gorin, P.A., Previato, J.O., Mendonca-Previato, L., Travassos, L.R., 1979. Structure of the d-mannan and d-arabino-dgalactan in Crithidia fasciculata: changes in proportion with age of culture. J. Protozool 26, 473–478.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Gowda, D.C., Gupta, P., Davidson, E.A., 1997. Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage Plasmodium falciparum. J. Biol. Chem. 272, 6428–6439. Guerardel, Y., Leleu, D., Coppin, A., et al., 2005. Amylopectin biogenesis and characterization in the protozoan parasite Toxoplasma gondii, the intracellular development of which is restricted in the HepG2 cell line. Microbes Infect. 7, 41–48. Gustafson, G.L., Gander, J.E., 1984. O -(N-acetyl--glucosamine-1-phosphoryl)serine in proteinase I from Dictyostelium discoideum. Methods Enzymol. 107, 172–183. Guther, M.L., Lee, S., Tetley, L., Acosta-Serrano, A., Ferguson, M.A., 2006. GPI-anchored proteins and free GPI glycolipids of procyclic form Trypanosoma brucei are nonessential for growth, are required for colonization of the tsetse fly, and are not the only components of the surface coat. Mol. Biol. Cell 17, 5265–5274. Handman, E., Barnett, L.D., Osborn, A.H., Goding, J.W., Murray, P.J., 1993. Identification, characterisation and genomic cloning of an O-linked N-acetylglucosaminecontaining cytoplasmic Leishmania glycoprotein. Mol. Biochem. Parasitol. 62, 61–72. Harris, J.R., Adrian, M., Petry, F., 2004. Amylopectin: a major component of the residual body in Cryptosporidium parvum oocysts. Parasitology 128, 269–282. Haynes, P.A., 1998. Phosphoglycosylation: a new structural class of glycosylation? Glycobiology 8, 1–5. Heise, N., Raper, J., Buxbaum, L.U., Peranovich, T.M., de Almeida, M.L., 1996. Identification of complete precursors for the glycosylphosphatidylinositol protein anchors of Trypanosoma cruzi. J. Biol. Chem. 271, 16877–16887. Hilley, J.D., Zawadzki, J.L., McConville, M.J., Coombs, G.H., Mottram, J.C., 2000. Leishmania mexicana mutants lacking glycosylphosphatidylinositol (GPI):protein transamidase provide insights into the biosynthesis and functions of GPI-anchored proteins. Mol. Biol. Cell. 11, 1183–1195. Hiltpold, A., Frey, M., Hulsmeier, A., Kohler, P., 2000. Glycosylation and palmitoylation are common modifications of Giardia variant surface proteins. Mol. Biochem. Parasitol. 109, 61–65. Hong, Y., Nagamune, K., Morita, Y.S., et al., 2006. Removal or maintenance of inositol-linked acyl chain in glycosylphosphatidylinositol is critical in trypanosome life cycle. J. Biol. Chem. 281, 11595–11602. Hwa, K.Y., Khoo, K.H., 2000. Structural analysis of the asparagine-linked glycans from the procyclic Trypanosoma brucei and its glycosylation mutants resistant to concanavalin A killing. Mol. Biochem. Parasitol. 111, 173–184. Ilg, T., 2000a. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana. EMBO J. 19, 1953–1962. Ilg, T., 2000b. Proteophosphoglycans of Leishmania. Parasitol. Today 16, 489–497.
227
Ilg, T., Stierhof, Y.D., Etges, R., Adrian, M., Harbecke, D., Overath, P., 1991. Secreted acid phosphatase of Leishmania mexicana: a filamentous phosphoglycoprotein polymer. Proc. Natl. Acad. Sci. USA 88, 8774–8778. Ilg, T., Overath, P., Ferguson, M.A., Rutherford, T., Campbell, D.G., McConville, M.J., 1994. O- and N-glycosylation of the Leishmania mexicana-secreted acid phosphatase. Characterization of a new class of phosphoserine-linked glycans. J. Biol. Chem. 269, 24073–24081. Ilg, T., Stierhof, Y.D., Craik, D., Simpson, R., Handman, E., Bacic, A., 1996. Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasites. J. Biol. Chem. 271, 21583–21596. Ilg, T., Craik, D., Currie, G., Multhaup, G., Bacic, A., 1998. Stage-specific proteophosphoglycan from Leishmania mexicana amastigotes. Structural characterization of novel mono-, di-, and triphosphorylated phosphodiester-linked oligosaccharides. J. Biol. Chem. 273, 13509–13523. Ilg, T., Demar, M., Harbecke, D., 2001. Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice. J. Biol. Chem. 276, 4988–4997. Jarroll, E.L., Macechko, P.T., Steimle, P.A., et al., 2001. Regulation of carbohydrate metabolism during Giardia encystment. J. Eukaryot. Microbiol. 48, 22–26. Jones, D.C., Mehlert, A., Guther, M.L., Ferguson, M.A., 2005. Deletion of the glucosidase II gene in Trypanosoma brucei reveals novel N-glycosylation mechanisms in the biosynthesis of variant surface glycoprotein. J. Biol. Chem. 280, 35929–35942. Kamhawi, S., Ramalho-Ortigao, M., Pham, V.M., et al., 2004. A role for insect galectins in parasite survival. Cell 119, 329–341. Karkhanis, Y.D., Allocco, J.J., Schmatz, D.M., 1993. Amylopectin synthase of Eimeria tenella: identification and kinetic characterization. J. Eukaryot. Microbiol. 40, 594–598. Karr, C.D., Jarroll, E.L., 2004. Cyst wall synthase: N-acetylgalactosaminyltransferase activity is induced to form the novel N-acetylgalactosamine polysaccharide in the Giardia cyst wall. Microbiology 150, 1237–1243. Kimmel, J., Smith, T.K., Azzouz, N., et al., 2006. Membrane topology and transient acylation of Toxoplasma gondii glycosylphosphatidylinositols. Eukaryot. Cell 5, 1420–1429. Kink, J.A., Chang, K.P., 1987. Tunicamycin-resistant Leishmania mexicana amazonensis: expression of virulence associated with an increased activity of N-acetylglucosaminyltransferase and amplification of its presumptive gene. Proc. Natl. Acad. Sci. USA 84, 1253–1257. Lederkremer, R.M., Bertello, L.E., 2001. Glycoinositolphospholipids, free and as anchors of proteins, in Trypanosoma cruzi. Curr. Pharm. Des. 7, 1165–1179. Lillico, S., Field, M.C., Blundell, P., Coombs, G.H., Mottram, J.C., 2003. Essential roles for GPI-anchored proteins in
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
228
12. Glycosylated compounds of parasitic protozoa
African trypanosomes revealed using mutants deficient in GPI8. Mol. Biol. Cell 14, 1182–1194. Lippert, D.N., Dwyer, D.W., Li, F., Olafson, R.W., 1999. Phosphoglycosylation of a secreted acid phosphatase from Leishmania donovani. Glycobiology 9, 627–636. Lorenzo-Morales, J., Kliescikova, J., Martinez-Carretero, E., et al., 2008. Glycogen phosphorylase in Acanthamoeba spp.: determining the role of the enzyme during the encystment process using RNA interference. Eukaryot. Cell 7, 509–517. Lotter, H., González-Roldán, N., Lindner, B., Winau, F., Isibasi, A., Moreno-Lafont, M., Ulmer, A.J., Holst, O., Tannich, E., Jacobs, T., 2009. Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are creitically important to control amebic liver abscess. PLoS Pathog. 5, e1000434. Lujan, H.D., Mowatt, M.R., Nash, T.E., 1998. The molecular mechanisms of Giardia encystation. Parasitol. Today 14, 446–450. Luk, F.C., Johnson, T.M., Beckers, C.J., 2008. N-linked glycosylation of proteins in the protozoan parasite Toxoplasma gondii. Mol. Biochem. Parasitol. 157, 169–178. Macrae, J.I., Acosta-Serrano, A., Morrice, N.A., Mehlert, A., Ferguson, M.A., 2005. Structural characterization of NETNES, a novel glycoconjugate in Trypanosoma cruzi epimastigotes. J. Biol. Chem. 280, 12201–12211. MacRae, J.I., Obado, S.O., Turnock, D.C., et al., 2006. The suppression of galactose metabolism in Trypanosoma cruzi epimastigotes causes changes in cell surface molecular architecture and cell morphology. Mol. Biochem. Parasitol. 147, 126–136. Magnelli, P., Cipollo, J.F., Ratner, D.M., et al., 2008. Unique ASN-linked oligosaccharides of the human pathogen Entamoeba histolytica. J. Biol. Chem. 283, 18355–18364. Manthri, S., Guther, M.L., Izquierdo, L., Acosta-Serrano, A., Ferguson, M.A., 2008. Deletion of the TbALG3 gene demonstrates site-specific N-glycosylation and N-glycan processing in Trypanosoma brucei. Glycobiology 18, 367–383. Martin, K.L., Smith, T.K., 2006. The glycosylphosphatidylinositol (GPI) biosynthetic pathway of bloodstream-form Trypanosoma brucei is dependent on the de novo synthesis of inositol. Mol. Microbiol. 61, 89–105. McConville, M.J., Blackwell, J.M., 1991. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J. Biol. Chem. 266, 15170–15179. McConville, M.J., Ferguson, M.A., 1993. The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 294, 305–324.
McConville, M.J., Turco, S.J., Ferguson, M.A., Sacks, D.L., 1992. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J. 11, 3593–3600. McConville, M.J., Mullin, K.A., Ilgoutz, S.C., Teasdale, R.D., 2002. Secretory pathway of trypanosomatid parasites. Microbiol. Mol. Biol. Rev. 66, 122–154. McCoy, J.J., Mann, B.J., Vedvick, T.S., Pak, Y., Heimark, D.B., Petri, W.A., 1993. Structural analysis of the light subunit of the Entamoeba histolytica galactose-specific adherence lectin. J. Biol. Chem. 268, 24223–24231. Mehlert, A., Zitzmann, N., Richardson, J.M., Treumann, A., Ferguson, M.A., 1998. The glycosylation of the variant surface glycoproteins and procyclic acidic repetitive proteins of Trypanosoma brucei. Mol. Biochem. Parasitol. 91, 145–152. Mehlert, A., Bond, C.S., Ferguson, M.A., 2002. The glycoforms of a Trypanosoma brucei variant surface glycoprotein and molecular modeling of a glycosylated surface coat. Glycobiology 12, 607–612. Mendonca-Previato, L., Gorin, P.A., Previato, J.O., 1979. Investigations on polysaccharide components of cells of Herpetomonas samuelpessoai grown on various media. Biochemistry 18, 149–154. Mendonca-Previato, L., Todeschini, A.R., Heise, N., Previato, J.O., 2005. Protozoan parasite-specific carbohydrate structures. Curr. Opin. Struct. Biol. 15, 499–505. Montagna, G.N., Donelson, J.E., Frasch, A.C., 2006. Procyclic Trypanosoma brucei expresses separate sialidase and trans-sialidase enzymes on its surface membrane. J. Biol. Chem. 281, 33949–33958. Moody-Haupt, S., Patterson, J.H., Mirelman, D., McConville, M.J., 2000. The major surface antigens of Entamoeba histolytica trophozoites are GPI-anchored proteophosphoglycans. J. Mol.Biol. 297, 409–420. Mullin, K.A., Foth, B.J., Ilgoutz, S.C., et al., 2001. Regulated degradation of an endoplasmic reticulum membrane protein in a tubular lysosome in Leishmania mexicana. Mol. Biol. Cell 12, 2364–2377. Naderer, T., McConville, M.J., 2008. The Leishmaniamacrophage interaction: a metabolic perspective. Cell Microbiol. 10, 301–308. Naderer, T., Ellis, M.A., Sernee, M.F., et al., 2006. Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase. Proc. Natl. Acad. Sci. USA 103, 5502–5507. Naderer, T., Wee, E., McConville, M.J., 2008. Role of hexosamine biosynthesis in Leishmania growth and virulence. Mol. Microbiol. 69, 858–869. Nagamune, K., Nozaki, T., Maeda, Y., et al., 2000. Critical roles of glycosylphosphatidylinositol for Trypano soma brucei. Proc. Natl. Acad. Sci. USA 97, 10336– 10341.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Nagamune, K., Ohishi, K., Ashida, H., et al., 2003. GPI transamidase of Trypanosoma brucei has two previously uncharacterized (trypanosomatid transamidase 1 and 2) and three common subunits. Proc. Natl. Acad. Sci. USA 100, 10682–10687. Nagamune, K., Acosta-Serrano, A., Uemura, H., et al., 2004. Surface sialic acids taken from the host allow trypanosome survival in tsetse fly vectors. J. Exp. Med. 199, 1445–1450. Naik, R.S., Branch, O.H., Woods, A.S., et al., 2000. Glycosy lphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J. Exp. Med. 192, 1563–1576. Naik, R.S., Venkatesan, M., Gowda, D.C., 2001. Plasmodium falciparum: the lethal effects of tunicamycin and mevastatin on the parasite are not mediated by the inhibition of N-linked oligosaccharide biosynthesis. Exp. Parasitol. 98, 110–114. Nash, T.E., 2002. Surface antigenic variation in Giardia lamblia. Mol. Microbiol. 45, 585–590. Nolan, T.J., Farrell, J.P., 1985. Inhibition of in vivo and in vitro infectivity of Leishmania donovani by tunicamycin. Mol. Biochem. Parasitol. 16, 127–135. Nolan, D.P., Geuskens, M., Pays, E., 1999. N-linked glycans containing linear poly-N-acetyllactosamine as sorting signals in endocytosis in Trypanosoma brucei. Curr. Biol. 9, 1169–1172. Nozaki, T., Haynes, P.A., Cross, G.A., 1996. Characterization of the Trypanosoma brucei homologue of a Trypanosoma cruzi flagellum-adhesion glycoprotein. Mol. Biochem. Parasitol. 82, 245–255. Papanastasiou, P., McConville, M.J., Ralton, J., Kohler, P., 1997. The variant-specific surface protein of Giardia, VSP4A1, is a glycosylated and palmitoylated protein. Biochem. J. 322, 49–56. Parodi, A.J., 1993. N-glycosylation in trypanosomatid protozoa. Glycobiology 3, 193–199. Parodi, A.J., Labriola, C., Cazzulo, J.J., 1995. The presence of complex-type oligosaccharides at the C-terminal domain glycosylation site of some molecules of cruzipain. Mol. Biochem. Parasitol. 69, 247–255. Pereira-Chioccola, V.L., Acosta-Serrano, A., Correia de Almeida, I., et al., 2000. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti--galactosyl antibodies. J. Cell Sci. 113, 1299–1307. Pimenta, P.F., Turco, S.J., McConville, M.J., Lawyer, P.G., Perkins, P.V., Sacks, D.L., 1992. Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut. Science 256, 1812–1815. Pollard, A.M., Onatolu, K.N., Hiller, L., Haldar, K., Knoll, L.J., 2008. Highly polymorphic family of glycosylphosphatidylinositol-anchored surface antigens with evidence
229
of developmental regulation in Toxoplasma gondii. Infect. Immun. 76, 103–110. Previato, J.O., Jones, C., Goncalves, L.P., Wait, R., Travassos, L.R., Mendonca-Previato, L., 1994. O-glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosoma cruzi. Biochem. J. 301, 151–159. Previato, J.O., Sola-Penna, M., Agrellos, O.A., et al., 1998. Biosynthesis of O-N-acetylglucosamine-linked glycans in Trypanosoma cruzi. Characterization of the novel uridine diphospho-N-acetylglucosamine:polypeptide Nacetylglucosaminyltransferase-catalyzing formation of N-acetylglucosamine 1→O-threonine. J. Biol. Chem. 273, 14982–14988. Previato, J.O., Wait, R., Jones, C., et al., 2004. Glycoinositol phospholipid from Trypanosoma cruzi: structure, biosynthesis and immunobiology. Adv. Parasitol. 56, 1–41. Priest, J.W., Mehlert, A., Arrowood, M.J., Riggs, M.W., Ferguson, M.A., 2003. Characterization of a low molecular weight glycolipid antigen from Cryptosporidium parvum. J. Biol. Chem. 278, 52212–52222. Priest, J.W., Mehlert, A., Moss, D.M., Arrowood, M.J., Ferguson, M.A., 2006. Characterization of the glycosylphosphatidylinositol anchor of the immunodominant Cryptosporidium parvum 17-kDa antigen. Mol. Biochem. Parasitol. 149, 108–112. Ralton, J.E., McConville, M.J., 1998. Delineation of three pathways of glycosylphosphatidylinositol biosynthesis in Leishmania mexicana. Precursors from different pathways are assembled on distinct pools of phosphatidylinositol and undergo fatty acid remodeling. J. Biol. Chem. 273, 4245–4257. Ralton, J.E., Naderer, T., Piraino, H.L., Bashtannyk, T.A., Callaghan, J.M., McConville, M.J., 2003. Evidence that intracellular 1-2 mannan is a virulence factor in Leishmania parasites. J. Biol. Chem. 278, 40757–40763. Riggs, M.W., McNeil, M.R., Perryman, L.E., Stone, A.L., Scherman, M.S., O’Connor, R.M., 1999. Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a -mannosylated glycolipid. Infect. Immun. 67, 1317–1322. Rogers, M.E., Ilg, T., Nikolaev, A.V., Ferguson, M.A., Bates, P.A., 2004. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 430, 463–467. Roper, J.R., Guther, M.L., Milne, K.G., Ferguson, M.A., 2002. Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei. Proc. Natl. Acad. Sci. USA 99, 5884–5889. Sacks, D.L., Modi, G., Rowton, E., et al., 2000. The role of phosphoglycans in Leishmania-sand fly interactions. Proc. Natl. Acad. Sci. USA 97, 406–411. Samuelson, J., Banerjee, S., Magnelli, P., et al., 2005. The diversity of dolichol-linked precursors to Asn-linked glycans
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
230
12. Glycosylated compounds of parasitic protozoa
likely results from secondary loss of sets of glycosyltransferases. Proc. Natl. Acad. Sci. USA 102, 1548–1553. Sanders, P.R., Gilson, P.R., Cantin, G.T., et al., 2005. Distinct protein classes including novel merozoite surface antigens in raft-like membranes of Plasmodium falciparum. J. Biol. Chem. 280, 40169–40176. Santi-Rocca, J., Weber, C., Guigon, G., Sismeiro, O., Coppee, J.Y., Guillen, N., 2008. The lysine- and glutamic acid-rich protein KERP1 plays a role in Entamoeba histolytica liver abscess pathogenesis. Cell Microbiol. 10, 202–217. Schenkman, S., Ferguson, M.A., Heise, N., de Almeida, M.L., Mortara, R.A., Yoshida, N., 1993. Mucin-like glycoproteins linked to the membrane by glycosylphosphatidylinositol anchor are the major acceptors of sialic acid in a reaction catalyzed by trans-sialidase in metacyclic forms of Trypanosoma cruzi. Mol. Biochem. Parasitol. 59, 293–303. Schmidt, A., Schwarz, R.T., Gerold, P., 1998. Plasmodium falciparum: asexual erythrocytic stages synthesize two structurally distinct free and protein-bound glycosylphosphatidylinositols in a maturation-dependent manner. Exp. Parasitol. 88, 95–102. Schneider, P., Rosat, J.P., Ransijn, A., Ferguson, M.A., McConville, M.J., 1993. Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite Leishmania major. Biochem. J. 295, 555–564. Seeber, F., Dubremetz, J.F., Boothroyd, J.C., 1998. Analysis of Toxoplasma gondii stably transfected with a transmembrane variant of its major surface protein, SAG1. J. Cell Sci. 111, 23–29. Sernee, M.F., Ralton, J.E., Dinev, Z., et al., 2006. Leishmania -1,2-mannan is assembled on a mannose-cyclic phosphate primer. Proc. Natl. Acad. Sci. USA 103, 9458–9463. Singh, B.N., 1993. Lipophosphoglycan-like glycoconjugate of Tritrichomonas foetus and Trichomonas vaginalis. Mol. Biochem. Parasitol. 57, 281–294. Smith, H.V., Nichols, R.A., Grimason, A.M., 2005. Cryptosporidium excystation and invasion: getting to the guts of the matter. Trends Parasitol. 21, 133–142. Smith, T.K., Crossman, A., Brimacombe, J.S., Ferguson, M.A., 2004. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness. EMBO J. 23, 4701–4708. Smith, T.K., Kimmel, J., Azzouz, N., Shams-Eldin, H., Schwarz, R.T., 2007. The role of inositol acylation and inositol deacylation in the Toxoplasma gondii glycosylphosphatidylinositol biosynthetic pathway. J. Biol. Chem. 282, 32032–32042. Spath, G.F., Garraway, L.A., Turco, S.J., Beverley, S.M., 2003a. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. USA 100, 9536–9541. Spath, G.F., Lye, L.F., Segawa, H., Sacks, D.L., Turco, S.J., Beverley, SM., 2003b. Persistence without pathology in
phosphoglycan-deficient Leishmania major. Science 301, 1241–1243. Stanley Jr., S.L., Tian, K., Koester, J.P., Li, E., 1995. The serine-rich Entamoeba histolytica protein is a phosphorylated membrane protein containing O-linked terminal Nacetylglucosamine residues. J. Biol. Chem. 270, 4121–4126. Stokes, M., Guther, M., Turnock, D., et al., 2008. The synthesis of UDP-N-acetylglucosamine is essential for bloodstream form Tryposomma brucei in vitro and in vivo and UDP-N-acetylglucosamine starvation reveals a hierachy in parasite protein glycosylation. J. Biol. Chem. 283, 16147–16161. Striepen, B., Zinecker, C.F., Damm, J.B., et al., 1997. Molecular structure of the “low molecular weight antigen” of Toxoplasma gondii: a glucose 1-4 N-acetylgalactosamine makes free glycosyl-phosphatidylinositols highly immunogenic. J. Mol. Biol. 266, 797–813. Stwora-Wojczyk, M.M., Dzierszinski, F., Roos, D.S., Spitalnik, S.L., Wojczyk, B.S., 2004a. Functional characterization of a novel Toxoplasma gondii glycosyltransferase: UDP-N-acetyl-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase-T3. Arch. Biochem. Biophys. 426, 231–240. Stwora-Wojczyk, M.M., Kissinger, J.C., Spitalnik, S.L., Wojczyk, B.S., 2004b. O-glycosylation in Toxoplasma gondii: identification and analysis of a family of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases. Int. J. Parasitol. 34, 309–322. Teixeira, J.E., Huston, C.D., 2008. Participation of the serinerich Entamoeba histolytica protein in amebic phagocytosis of apoptotic host cells. Infect. Immun. 76, 959–966. Templeton, T.J., Iyer, L.M., Anantharaman, V., et al., 2008. Comparative analysis of Apicomplexa and genomic diversity in eukaryotes. Genome Res. 14, 1686–1695. Turnock, D.C., Izquierdo, L., Ferguson, M.A., 2007. The de novo synthesis of GDP-fucose is essential for flagellar adhesion and cell growth in Trypanosoma brucei. J. Biol. Chem. 282, 28853–28863. Urbaniak, M.D., Turnock, D.C., Ferguson, M.A., 2006. Galactose starvation in a bloodstream form Trypanosoma brucei UDP-glucose 4’-epimerase conditional null mutant. Eukaryot. Cell 5, 1906–1913. Vats, D., Vishwakarma, R.A., Bhattacharya, S., Bhattacharya, A., 2005. Reduction of cell surface glycosylphosphatidylinositol conjugates in Entamoeba histolytica by antisense blocking of E. histolytica GlcNAc-phosphatidylinositol deacetylase expression: effect on cell proliferation, endocytosis, and adhesion to target cells. Infect. Immun. 73, 8381–8392. Vijaykumar, M., Naik, R.S., Gowda, D.C., 2001. Plasmodium falciparum glycosylphosphatidylinositol-induced TNF- secretion by macrophages is mediated without membrane insertion or endocytosis. J. Biol. Chem. 276, 6909–6912.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
von Itzstein, M., Plebanski, M., Cooke, B.M., Coppel, R.L., 2008. Hot, sweet and sticky: the glycobiology of Plasmodium falciparum. Trends Parasitol. 24, 210–218. Wang, C.C., Weppelman, R.M., Lopez-Ramos, B., 1975. Isolation of amylopectin granules and identification of amylopectin phosphorylase in the oocysts of Eimeria tenella. J. Protozool. 22, 560–564. Weber, C., Blazquez, S., Marion, S., et al., 2008. Bioinformatics and functional analysis of an Entamoeba histolytica mannosyltransferase necessary for parasite complement resistance and hepatical Infection. PLoS Negl. Trop. Dis. 2, e165. West, C.M., Van Der Wel, H., Sassi, S., Gaucher, E.A., 2004. Cytoplasmic glycosylation of protein-hydroxyproline and its relationship to other glycosylation pathways. Biochim. Biophys. Acta 1673, 29–44. West, C.M., van der Wel, H., Blader, I.J., 2006. Detection of cytoplasmic glycosylation associated with hydroxyproline. Methods Enzymol. 417, 389–404. Winter, G., Fuchs, M., McConville, M.J., Stierhof, Y.D., Overath, P., 1994. Surface antigens of Leishmania mexicana
231
amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid. J. Cell Sci. 107, 2471–2482. Winter, G., Gooley, A.A., Williams, K.L., Slade, M.B., 2000. Characterization of a major sporozoite surface glycoprotein of Cryptosporidum parvum. Funct. Integr. Genomics. 1, 207–217. Wu, G., Muller, M., 2003. Glycogen phosphorylase sequences from the amitochondriate protests, Trichomonas vaginalis, Mastigamoeba balamuthi, Entamoeba histolytica and Giardia intestinalis. J. Eukaryot. Microbiol. 50, 366–372. Zawadzki, J., Scholz, C., Currie, G., Coombs, G.H., McConville, M.J., 1998. The glycoinositolphospholipids from Leishmania panamensis contain unusual glycan and lipid moieties. J. Mol. Biol. 282, 287–299. Zufferey, R., Allen, S., Barron, T., et al., 2003. Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. J. Biol. Chem. 278, 44708–44718.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
C H A P T E R
13 Analytical approaches towards the structural characterization of microbial wall glycopolymers I. Darren Grice and Jennifer C. Wilson SUMMARY
O-polysaccharide; Lipid A; Capsular polysaccharide; Oligosaccharide
Outlined in this chapter are strategies for the use of the analytical techniques of nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) towards the elucidation of the structures of microbial wall glycans. Specifically, the determination of the structure of capsular polysaccharide, core oligosaccharide or O-antigen utilizing 1D, 1D selective and 2D homonuclear and heteronuclear NMR experiments and database resources is presented. Described is the application of high resolution magic angle spinning techniques for studying glycopolymer structures. MS sample derivatization strategies along with associated gas chromatography-mass spectrometry, sugar, linkage, and absolute configuration analyses are outlined. The use of fast atom bombardment, matrixassisted laser desorption ionization and electrospraymass spectrometry ionization techniques along with their associated mass analysers are presented for characterizing oligosaccharide, lipid A, lipooligosaccharide, lipopolysaccharide and capsular polysaccharide glycan structures. Keywords : Nuclear magnetic resonance (NMR) spectroscopy; Mass spectrometry; Carbohydrates; Glycans; Lipo-oligosaccharide; Lipopolysaccharide;
Microbial Glycobiology
1. INTRODUCTION The surface and cell wall components of microbial species are covered in glycomolecules (polysaccharides, oligosaccharides or the carbohydrate-moiety of a glycoconjugate). These structures play diverse and important roles in host interactions, colonization and virulence (Comstock and Kasper, 2006). Carbohydrates and, in particular, monosaccharides, possess features that result in a high level of structural complexity. Over 100 different monosaccharides have been identified in bacterial polysaccharides (Lindberg, 1998). Monosaccharides also display structural isomerism (e.g. stereoisomers, cyclic, anomeric) and there is a multiplicity of possible linkages between monomeric carbohydrate units and, furthermore, polysaccharides are often branched. Moreover, substitution of the sugar rings with up to 50 various non-sugar functionalities (e.g. acetate, phosphate, etc.)
233
© 2009 2010, Elsevier Inc.
234
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
provides virtually limitless structural variation (Lindberg, 1998). All these factors make the task of assigning a unique structure to a particular microbial isolate challenging. Although surface glycans are found universally, the glycan cell wall components of Gramnegative bacteria will be discussed predominantly herein as examples illustrating the analytical approaches employed in the characterization of glycosylated microbial wall components. The most ubiquitous Gram-negative bacterial cell wall components are lipopolysaccharide (LPS) or lipooligosaccharide (LOS) (Comstock and Kasper, 2006). The LPS molecule contains three distinct regions: lipid A, core oligosaccharide (OS) and O-specific polysaccharide (O-PS) each with integral carbohydrate structures (see Chapters 3 and 4), whereas LOS contains lipid A and core OS (Raetz and Whitfield, 2002). Additionally, capsular polysaccharide (CPS) is a cell-surface glycan (see Chapter 6), both of Gram-positive and -negative bacteria. Although other glycan structures exist on the surface of microbial cell walls, including glycoproteins such as those of the glycosylated pili, e.g. in Pseudomonas aeruginosa (Voisin et al., 2007), Neisseria gonorrhoeae
(Banerjee and Ghosh, 2003; Aas et al., 2007) and Neisseria meningitidis (Banerjee and Ghosh, 2003; Power et al., 2006), or flagella (Logan, 2006), e.g. in Helicobacter pylori (Schirm et al., 2003), Campylobacter jejuni (McNally et al., 2006a; Logan et al., 2008) and P. aeruginosa (Dasgupta et al., 2004), this chapter will focus on strategies for investigating LPS/LOS and CPS structures. Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) have played a pivotal role in elucidating their primary structural features and will be discussed.
2. ISOLATION AND PURIFICATION OF BACTERIAL GLYCAN STRUCTURES Characterization of glycans is dependent on having effective sample preparation prior to analysis (Haslam et al., 2003). Information on the class of structure will determine the strategy employed to isolate the glycan of interest. Figure 13.1 provides some general indications of the pathway often used for isolating glycan
FIGURE 13.1 Strategy for the isolation and purification of Gram-negative cell wall glycans.
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
3. NMR TECHNIQUES EMPLOYED FOR STRUCTURAL CHARACTERIZATION OF GLYCANS
structures. Selected detailed procedures to isolate LPS, LOS, OS, O-PS, CPS and lipid A from a diverse range of bacteria are outlined in Table 13.1. For instance, an aqueous-based isolation of Staphylococcus haemolyticus bacterial cell mass followed by dialysis provided access to CPS (Flahaut et al., 2008). A phenol-chloroformpetroleum ether extraction of Yersinia pestis bacterial cell mass yielded LOS (Hitchen et al., 2002). Ultimately, sample preparation requires a purification step to afford high quality NMR and MS data to make characterization of the samples more straightforward.
3. NMR TECHNIQUES EMPLOYED FOR STRUCTURAL CHARACTERIZATION OF GLYCANS 3.1. Introduction NMR analysis of carbohydrate-containing structures can be challenging, primarily due to spectral overlap; carbohydrate ring protons generally resonate over a relatively small chemical shift range (δ ⫽ 3.0–4.0 ppm). This complication is in addition to the other factors that add complexity to carbohydrate structure already discussed. Microbes add to this inherent complexity by introducing further structural diversity with mechanisms such as phase variation (Comstock and Kasper, 2006). Developments in NMR technology, such as ultra-high magnetic field strengths (Blundell et al., 2006) and cryogenically cooled probeheads (Feng et al., 2002; Martin, 2002; Yamamoto, 2002; Chapdelaine and Cleon, 2003; Voehler et al., 2006) have led to sensitivity increases. The introduction of pulsed field gradients has also led to sensitivity gains because gradient-enhanced spectra are less prone to artefacts, allow better solvent suppression and require shorter phase cycles (Keeler et al., 1994). These advances have all contributed
235
to making NMR analysis of often heterogeneous, small-scale glycan samples feasible. More recently, there has been a number of excellent reviews of the process of NMR determination of polysaccharide structures (Duus et al., 2000; Uhrin and Brisson, 2000; Bubb, 2003; Schweda and Richards, 2003; Hricovini, 2004; Vliegenthart, 2006; Stenutz et al., 2006). For an in-depth coverage of carbohydrate structure determination these reviews and the literature cited therein should be consulted.
3.2. Sample preparation The quantity of sample for NMR analysis is often dictated by practical factors, such as bacterial growth rate, heterogeneity or sample loss in the hydrolysis or purification procedures and, therefore, sometimes, suboptimal amounts of sample are available for analysis. In these cases, it is beneficial to analyse the sample with a cryogenically cooled probe that increases sensitivity by a factor of 3–4. Strategies also exist for examining small volumes of sample, for instance using microprobes (2.5 or 3 mm) or shigemi tubes that allow small volumes of ⬇200 μl to be examined. 3.2.1. Lipid A Lipid A is a membrane-associated molecule with a tendency to aggregate due to its amphipathic nature, contributing to its limited solubility in organic solvents and poor solubility in aqueous media (Raetz and Whitfield, 2002). Purified lipid A is unstable in solution being prone to hydrolysis at the anomeric phosphate under acidic conditions. Chemical modification by methylation, dephosphorylation or deacylation may improve stability (Ribeiro et al., 1999). Solvents previously used for lipid A NMR analysis include: deuterated dimethyl sulfoxide (d6DMSO), deuterated chloroform (CDCl3) or 2:3:1 (v/v) deuterated chloroform-deuterated methanol-deuterium oxide (CDCl3-CD3OD-D2O).
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
LOS
OS OPS
CPS
Lipid A OS O-PS Lipid A
LPS
丣
丣
LOS
OS
丢
丢
LPS
LOS
O-PS
Staphylococcus haemolyticusm
Azospirillum brasilense S17l
Campylobacter jejuni (GBS, MFS assoc.)k
Pseudomonas syringae pv.j
Moraxella catarrhalisi
Agrobacterium tumefaciens A1h
Plesiomonas shigelloides O74:H5g
Helicobacter pylorif
Haemophilus influenzaee
Moraxella bovisd
Pseudomonas aeruginosac
Campylobacter jejunib LOS CPS
Selected representative structural characterization strategies
CPS
Isolation 丣
Hot phenol/H2O PCP
丢
丣
丣
Dialysis 丢
Other
丣
丣 丣
丣
丢 䊊
SEC
丣
䊊
丣
丢 䊊
*
䊊
Chemical manipulations 丢
De-O-acylation De-N-acylation Acid hydrolysis
丢
丣
丣
丣
丣
丢
丣
丢
丢
丣
丢
丣
丣
丣
䊊
䊊
*
䊊
GC-MS: Sugar
䊊
䊊
*
䊊
䊊
GC-MS: Linkage
䊊
*
䊊
䊊
GC-MS: Absolute configuration
䊊
*
䊊
䊊
Permethylation Compositional analysis
䊊
GC-MS: Fatty Acid MALDI-MS TOF
䊊 (Continues)
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
Structure(s) characterized
Yersinia pestisa
Bacterium investigated
236
TABLE 13.1
ESI-MS CE/CE-MS/MS
丢/丢
丢/丢 ⫺/
IT/IT-MS/MS
⫺/
/⫺ 丢
HRFT FT-ICR
䊊
Q-TOF (MS/MS) LD-MS NMR
䊊
䊊
䊊
*
*
䊊
䊊
Symbols: , Capsular polysaccharide (CPS); , lipid A; 丢, lipo-oligosaccharide (LOS); 丣, lipo-polysaccharide (LPS); , oligosaccharide (OS); 䊊, O-specific polysaccharide (O-PS); *, cases where the OS is the full sugar backbone with lipid A fatty acyl moieties stripped from GlcN sugars. Abbreviations: CE, capillary electrophoresis; GBS, Guillain-Barré syndrome; FT-ICR – Fourier transform-ion cyclotron resonance; HRFT, high resolution Fourier transform; IT, ion trap; LD-MS, laser desorption-mass spectrometry; MFS, Miller Fisher syndrome; PCP, phenol-chloroform-petroleum ether; SEC, size exclusion chromatography. a Hitchen et al. (2002); bSzymanski et al. (2003); cBystrova et al. (2004); dWilson et al. (2005); eMikhail et al. (2005); fKhamri et al. (2005); gLukasiewicz et al. (2006); hDe Castro et al. (2006); iWilson et al. (2006); jZdorovenko et al. (2007); kGodschalk et al. (2007); lFedonenko et al. (2008); mFlahaut et al. (2008).
3. NMR TECHNIQUES EMPLOYED FOR STRUCTURAL CHARACTERIZATION OF GLYCANS
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
FAB-MS
237
238
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
Moreover, it has been suggested that addition of deuterated ethylenediaminetetraacetic acid (EDTA) and sodium dodecyl sulfate (SDS) to a sample improves signal resolution markedly. Increasing sample temperature to 60–80°C can also lead to sharper signals and improve resolution (Schweda and Richards, 2003). 3.2.2. OS/CPS/O-PS Most often spectra are acquired in D2O. The sample should be dissolved in 100% D2O under a nitrogen atmosphere, then lyophilized and re-dissolved in 100% D2O (twice). This ensures, that all residual water is removed from the sample so the intensity of the residual 1HO2H signal does not obscure any carbohydrate signals. If it is suspected that a carbohydrate resonance is located beneath the 1HO2H signal, either increasing or decreasing the temperature at which the spectra are acquired will reveal any hidden anomeric signals (Schweda and Richards, 2003).
3.3. One-dimensional (1D) spectra and the structural reporter region Although 1D 1H spectra are easy to acquire, they reveal a surprising amount of information. Visual inspection of a glycan spectrum can immediately provide information regarding the purity, concentration, number of sugar units and the heterogeneity of the sample. For lipid A samples, aggregation state is immediately obvious. In addition, for OS/CPS/O-PS samples, the anomeric configuration of the sugars and whether the sample contains additional noncarbohydrate signals, such as acetate or methyl substituents, can be determined readily from 1D spectra. Samples containing sialic acid or 3deoxy-d-manno-oct-2-ulosonic acid (Kdo) will be immediately obvious as well. This is largely due to the fact that there are two distinct sets of signals that are generally found in glycan
samples. As mentioned previously, the bulk of non-anomeric protons in a carbohydratecontaining sample resonate over a relatively narrow frequency range and constitute one of these groups of signals. Conveniently, however, anomeric proton signals are found outside this region between ⬇4.5 and 5.5 ppm and provide an estimate of the number of sugar units contained within the sample. The integration of the anomeric signals will allow estimation of relative proportions of components in heterogeneous samples. Other signals, such as those arising from the effects of substitution by phosphates, sulfates or acyl groups are also found outside the 3–4 ppm spectral window. In fact, this second group of signals, distinct from the bulk region of the carbohydrate ring protons, gives rise to the so-called “structural reporter-group signals”, a term introduced by Vliegenthart (2006). In the structural reporter approach, the chemical shift and coupling patterns of the structural reporter groups can be exploited to provide structural information by comparison to patterns of chemical shift and coupling constant tabulated for reference compounds, as long as pH, temperature and solvent are carefully calibrated. The chiral carbon next to the ring oxygen that is formed when an aldohexose or ketohexose cyclizes to form a hemiacetal or hemiketal is called the anomeric centre (C-1 in Figure 13.2). The relative orientation of the hydroxyl group that this carbon bears defines which anomer is formed; the α- and β-anomers of glucose are shown in Figure 13.2. Since anomers are diastereomers, they can be readily distinguished from their NMR spectra both with regard to chemical shift (δα ⬎ δβ) and coupling constants. The vicinal coupling constant between H-1 and H-2 if they have an axial-equatorial orientation is 3J1,2 α ⬇3 Hz (α-anomer) and if they have an axial-axial orientation 3J1,2 β ⬇7 Hz (β-anomer). The exceptions are mannose and rhamnose that have an equatorial proton at H-2. Carbon chemical shifts and the 13C-H coupling constants
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
3. NMR TECHNIQUES EMPLOYED FOR STRUCTURAL CHARACTERIZATION OF GLYCANS
FIGURE 13.2
239
The α- and β-anomers of glucose.
are also indicative of anomeric configuration; 1 JC-1H-1⬇170 Hz ⫽ α-anomer and 1JC⫺1H⫺1⬇ 160 Hz ⫽ β-anomer. For sialic acid, which does not have an anomeric proton at C-1, the anomeric configuration can be determined by the H-3eq/H-3ax chemical shift (Wilson et al., 1995).
3.4. 2D homonuclear techniques As previously mentioned, the majority of ring protons from the sugar residues resonate in a relatively narrow spectral region (3.2–4.0 ppm) and, therefore, this region of the 1D spectrum is often severely overlapped for all components of LPS samples, thereby making structural assignment challenging. For this reason, it is necessary to use the 2D homonuclear techniques, such as correlated spectroscopy (COSY) or total correlated spectroscopy (TOCSY) to reduce the overlap by resolving the proton signals over two dimensions. In these experiments, the wellseparated anomeric resonances provide a convenient starting point for the assignment process. A 2D COSY spectrum shows correlations only between directly coupled protons and, therefore, it becomes immediately obvious from inspection of a 2D COSY that the proton attached to the anomeric carbon must correlate with protons in the C-2 position. Problems arise for strongly coupled spins such as H-6 and H6’ from the hydroxymethyl moiety that resonate
close to the spectrum diagonal and for galactopyranoses where the small coupling constant between H-4 and H-5 results in H-4/H-5 correlation being absent. Hence, double quantum filtered COSY (DQF-COSY) or gradient-enhanced COSY (gCOSY) spectra are typically acquired. The other typical “workhorse” homonuclear technique is the 2D TOCSY experiment. In these experiments, magnetization can be transferred through the coupled network of spins that typifies monosaccharides from the anomeric position H-1 around through the ring protons and even beyond in heptoses or octoses via TOCSY transfer. Typically, long mixing times experiments (120–200 ms) should be acquired to ensure maximal TOCSY transfer. Again, the anomeric protons provide a convenient reference point for assignment and examination of 1D slices through a 2D TOCSY spectrum at each of the anomeric chemical shifts yielding data on the individual monosaccharide coupled spin systems. The 2D nuclear Overhauser enhancement spectroscopy (NOESY) spectra provide throughspace information and, in most cases, the glycosidic linkages can be confirmed by observation of a nuclear Overhauser enhancement (NOE) between the anomeric proton of one sugar unit and the aglycone proton of the next sugar in the sequence. Ultimately, this information can be used to establish the order of monosaccharide units in a polysaccharide sequence. Patterns of
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
240
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
NOE data also provide information regarding anomeric configuration, with particular sets of data being observed for different anomeric configurations (Uhrin and Brisson, 2000).
3.5. 2D heteronuclear techniques 1
H detected 1H-13C correlated NMR methods are valuable in structure determination of polysaccharides because they take advantage of the chemical shift dispersion of the 13C nucleus and are more sensitive than 13C direct detection techniques. Spectra can often be acquired on small quantities of sample (⬇100 μg) using gradient-selected sensitivity-enhanced versions of these spectra. The heteronuclear single quantum coherence (HSQC) or hetereonuclear multiple quantum correlation (HMQC) spectra correlates 1-bond 1H to 13C nuclei and is used extensively for LPS and capsular polysaccharide primary structure determination (Duus et al., 2000; Uhrin and Brisson, 2000; Bubb, 2003; Schweda and Richards, 2003; Hricovini, 2004; Vliegenthart, 2006; Stenutz et al., 2006). This experiment is particularly useful for establishing or confirming glycosidic linkage since glycosylation leads to frequency shifts of between 4 and 10 ppm for carbons at the anomeric and linked positions (Bubb, 2003). Two- and threebond correlations can be obtained from heteronuclear multiple bond correlation (HMBC) spectra but have the added advantage of revealing through-bond correlations, such as that through the glycosidic linkage, although they are less sensitive than HSQC spectra and require longer acquisition times. Of particular interest and widespread use is the 2D 1H13 C HSQC-TOCSY spectrum that combines the heteronuclear correlation experiment with the TOCSY experiment providing optimal chemical shift dispersion. Furthermore, edited versions of 1 H-13C HSQC and 1H-13C HSQC-TOCSY experiments (Willker et al., 1993) are useful for discriminating methylene resonances from methyl
or methine resonances and, therefore, aid the investigation of overlap involving hydroxymethyl groups of monosaccharide residues. This is especially important when 13C glycosylation effects shift the hydroxymethyl resonances (C-6 galactose/glucose) into the 66–77 ppm region of the spectrum where the bulk of methine resonances are found. A new heteronuclear experiment (Petersen et al., 2006 and references therein), entitled the heteronuclear 2-bond correlation (H2BC), was introduced that identifies two bond correlations, particularly C-2 to H-1 correlations (compared with HSQC/HMQC 1-bond correlations and HMBC 2- and 3-bond correlations). The utility of this method was illustrated with the full structure determination of the 30 sugarresidue LOS from Francisella victoria. The advantage of this experiment over the conventional HMBC experiment is that it allows ready assignment of 2-bond correlations without complicating 3-bond correlations. Moreover, due to small C-2 to H-1 couplings some of these correlations would be missing in an HMBC spectrum. While this information can also be obtained from an HSQC-TOCSY experiment, the advantage of the H2BC is that it does not contain all the intraring correlations that increase the complexity of HSQC-TOCSY spectra, thus preventing unequivocal assignment of C-2 carbons from this type of spectrum.
3.6. Selective experiments One of the advantages of the anomeric resonances resonating outside the bulk of carbohydrate signals is that their separation can be conveniently exploited by the use of selective NMR experiments. These experiments involve selective excitation over a small frequency range typically using a 90° shaped pulse. There are many shapes of excitation pulses (e.g. Gaussian, q-sneeze) available and the most suitable should produce clean selection of the
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
3. NMR TECHNIQUES EMPLOYED FOR STRUCTURAL CHARACTERIZATION OF GLYCANS
signals of interest. Significant contributions to the arsenal of selective experiments have been provided by Uhrin and co-workers (Uhrinova et al., 1991; Uhrin et al., 1993, 1994; Uhrin, 1997; Uhrin and Brisson, 2000). Typically, a 90° selectiveshaped pulse can be applied to the selective region in which each of the anomeric protons resonate and, in turn, in combination with either COSY, TOCSY and NOESY sequences produce 1D spectra that are quickly acquired and interpreted. For example, St Michael et al. (2004), in elucidating the core OS of Actinobacillus pleuropneumoniae serotypes, used selective 1D TOCSY experiments with mixing times of 150 ms for heptose residues and 90 ms for hexose residues at anomeric resonances to aid the assignment process.
3.7. Application of high resolution magic angle spinning (HR-MAS) to determination of glycopolymer structures The technique of HR-MAS has been used to examine modifications of bacterial CPS on intact C. jejuni bacterial cells (St Michael et al., 2002; McNally et al., 2005, 2006b, 2007; Karlyshev et al., 2005). In these studies, the prevalence of an unusual O-methyl-phosphoramidate [CH3OP(O)(NH2)(OR) or MeOPN] group was investigated. The NMR signals arising from the OCH3 protons of MeOPN, have a distinctive chemical shift and scalar coupling to 31P compared to other CPS signals, making them ideal to monitor the presence or absence of this CPS modification. Spectra of 1H and 1D 1H-31P HSQC HR-MAS NMR were used rapidly to detect MeOPN in microlitre samples of bacterial cells (St Michael et al., 2002; McNally et al., 2005, 2006b, 2007; Karlyshev et al., 2005). A rapid, high throughput HR-MAS NMR screening method was developed to examine animal and human isolates from a range of environmental
241
and clinical settings (McNally et al., 2007). These studies were aimed at determining the abundance of this CPS modification and its potential as a diagnostic marker. Thereby, it was determined that 68% of C. jejuni strains expressed MeOPN and that MeOPN expression was highly prevalent in isolates associated with enteritis (82%) and in isolates from patients with C. jejuni-associated Guillain-Barré (80%) or Miller-Fisher (100%) neurological syndromes.
3.8. Determination of nuclei other than 1H The location of substituents is determined primarily by perturbations to chemical shifts of carbohydrate ring protons, as compared to literature values. Phosphorylation is the most common substitution of polysaccharides and 2D long-range 1H-31P HMQC or HSQC can reveal the position of phosphorylation (Kenne et al., 1988). An example concerns studies on the LOS of Plesiomonas shigelloides (Lukasiewicz et al., 2006), a bacterium associated with waterborne infections, whereby a decasaccharide was isolated by de-N,O-acylation of P. shigelloides O74 LPS (achieved by mild hydrazinolysis followed by KOH treatment). The decasaccharide consisted of the inner core oligosaccharide linked via Kdo to the de-N,O-acylated lipid A (→6)-βd-GlcpN-(1→6)-α-d-GlcpN-1-P), and showed two signals in its 31P spectrum (δ ⫽ 1.58 and 1.76 ppm) typical of phosphate monoesters. The location of these phosphates was determined from a 1H-31P HMBC spectrum. Another illustrative example concerns studies on the structure of mild acid-hydrolysed and de-lipidated P. aeruginosa immunotype 5 LPS (Mikhail et al., 2005). Mild hydrolysis conditions were used to prevent hydrolysis of diphosphate or acyl groups, however, acid hydrolysis of susceptible glycosidic linkages, such as those involving Kdo residues, can still occur. Analysis using MS and NMR of the obtained OSs established
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
242
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
that the core region is highly phosphorylated, with the major species containing two monophosphate groups and one ethanolamine diphosphate (PPEtN) group. In a 1H31P HMQC spectrum, the diphosphate signals correlated with signals for the CH2O of the ethanolamine and H-2 of Hep1. A 1H-31P HMQC-TOCSY experiment confirmed PPEtN attachment at position 2 of the first heptose residue (HepI) of the core. The signals of the monophosphate groups showed correlations to the H-4 of HepI and H-6 of the second heptose (HepII). A third example, concerns the 1D 1H NMR spectrum of OS from Haemophilus influenzae strain Rd that shows a strong methyl signal at ⬇3.24 ppm that is indicative of phosphocholine substitution, the location of which has been determined using 1H-31P HSQC spectra (Schweda et al., 2000).
3.9. Databases of chemical shift information Tabulated chemical shift data for monosaccharides and polysaccharides are an invaluable resource for aiding structural assignment of polysaccharides. Publicly accessible databases have been previously reviewed (Duus et al., 2000). CASPER has been published (Jansson et al., 2006; Loss et al., 2006) with a web interface (http:// www.casper.organ.su.se/casper). This database has been tested extensively and used to simulate 13 C spectra of greater than 200 structures with excellent reliability. Other databases of chemical shift data, include SUGABASE that combines CarbBank and Complex Carbohydrate Structure Data with proton and carbon chemical shifts in a search routine (http://www.boc.chem.uu.nl/sugabase/databases.html), Bacterial Carbohydrate Structure DataBase (http://www.glyco.ac.ru/ bcsdb/start.shtml). Sweetdb, is an initiative of glycosciences.de containing NMR and MS data are also available publicaly (http://www.glycosciences.de/sweetdb/Sweetdatabase).
4. MASS SPECTROMETRY OF GLYCANS 4.1. Introduction Electron-impact ionization MS (EI-MS) was first used in the 1960s to perform structural characterization studies on sugars: permethylated sugars (Kochetkov and Chizhov, 1965); peracetylated sugars (Biemann et al., 1963); and glycosides (de Jongh and Biemann, 1963). Derivatization (e.g. methylation of the labile hydrogens on ⫺OH groups) resulted in an increased volatility of the sample, which allowed the sample to ionize rather than undergo pyrolysis (i.e. decompose due to heat) at the higher temperatures (200–300°C) required for volatization. Trimethylsilane (TMS) has become a common derivatization reagent for analysis by EI-MS and gas chromatography-MS (GC-MS) (de Jongh et al., 1967). Much of this derivatization methodology has remained in current use, with only minor improvements being incorporated (Settineri and Burlingname, 1995). Major advancements in carbohydrate analysis came with development of the soft ionization techniques, fast-atom bombardment mass spectrometry (FAB-MS), liquid-secondary ion mass spectrometry (LSI-MS) and field desorption mass spectrometry (FD-MS). Often FAB-MS gives molecular ions in addition to fragmentation that makes possible the determination of sequence information of glycoconjugates (Reinhold and Carr, 1983). Systematic nomenclature for the fragmentation of glycoconjugates by FAB-MS and collision-induced dissociation (CID) MS/MS was subsequently proposed and reported on by Dell (1987) and Domon and Costello (1988) and are currently in use. In the late 1980s to early 1990s, electrospray ionization mass spectrometry (ES-MS) (Fenn et al., 1989; Smith et al., 1990) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Karas et al., 1987; Hillenkamp et al., 1991) were developed and facilitated analysis at pmol,
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
4. MASS SPECTROMETRY OF GLYCANS
at times fmol, levels (Settineri and Burlingame, 1995). Modern MS-based structural characterization strategies, namely, ES-MS, MALDI-TOF MS, collision-activated dissociation/collision-induced dissociation (CAD/CID) MS and FAB-MS with accompanying derivatization techniques offer speed, high-throughput, precision and high sensitivity (Haslam et al., 2003). Extensive reviews of MS techniques relating to glycans can be found in the literature (Settineri and Burlingame, 1995; Harvey, 2008; Morelle and Michalski, 2005).
4.2. MS structural characterization There is no singular MS strategy that can be applied to characterize the structure of all glycans. In principle, if a researcher has access to suitable MS instrumentation and associated technical and interpretational skills, structural characterization of glycans can be achieved by MS. The fundamental basis of the MS strategy involves the formation of gas-phase molecular and fragment ions from the sample matrix followed by accurate mass measurement. However, the specific sample preparation required to obtain these gas-phase ions is almost exclusively dictated by the ionization method itself (Haslam et al., 2003). Therefore, the choice of ionization method is an integral part of the strategy. Glycans often require chemical manipulations prior to analysis. We briefly outline here some of these manipulations plus some of the accompanying GC-MS analyses. The technique of GC-MS is used routinely for the determination of constituent monosaccharides, linkage analysis and absolute configuration of the sugars.
243
FAB-MS and ES-MS/MS analysis (where MS/ MS refers to successive stages of fragmentation of an isolated precursor). Permethylation replaces the free hydroxy groups (-OH) with methoxyl (-OCH3) groups (Dell, 1987; Dell et al., 1994). Deuteromethyl derivatization can also be carried out, whereby -OCD3 groups replace hydroxyl groups. This gives a characteristic three mass unit shift relative to nondeuterated methyl groups further aiding structural characterization. 4.2.2. Sugar analysis Such analysis provides fundamental information on the constituent monosaccharides and their respective ratios in a glycan sample. The sample is initially chemically hydrolysed into constituent monosaccharides and then commonly converted to volatile alditol acetate or TMS derivatives, that can readily be analysed in high resolution, highly sensitive GC- and EI-MS experiments (Albersheim et al., 1967; de Jongh et al., 1969). The monosaccharides are identified by retention times on the GC column and by comparison to MS spectra of monosaccharide standards. 4.2.3. Linkage analysis This analysis provides information on the glycosidic linkages. The sample is first derivatized to form acid-stable methyl ethers (permethylation), then hydrolysed and readuced to produce monosaccharides with hydroxyl groups at the linkage positions that are then peracetylated (Lindberg and Lönngren, 1978). Derivatized monosaccharides are identified by retention times on the GC column and by comparison to MS spectra of standards (Albersheim et al., 1967).
4.2.1. Permethylation derivatization This increases the lipophilicity of the glycan to aid ionization and facilitates a more consistent fragmentation process via known pathways, which is important particularly for
4.2.4. D and L absolute configuration analysis For this analysis, prior to samples being TMS derivatized, samples are subjected to hydrolysis
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
244
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
with a chiral reagent (e.g. (S)-(⫹)-2-butanolic HCl) and are then re-N-acetylated. Analysis is carried out with the absolute configuration determined by retention time on a GC column and by comparison to MS spectra of standards (Albersheim et al., 1967). Another widely applied protocol has been described by Gerwig et al. (1979). 4.2.5. Chemical hydrolysis This treatment is used to cleave certain glycosidic linkages that are particularly susceptible to hydrolysis with specific reagents. For example, incubation of LPS with sodium acetate buffer (or acetic acid) will cleave the acid-labile ketosidic linkage between the core OS and lipid A (Moran et al., 2002; Mikhail et al., 2005). Incubation of native OS sample with aqueous hydrofluoric acid (HF) will cleave fucose residues or phosphate moieties (Haslam et al., 2000). Treatment with HCl hydrolyses fucose residues from permethylated samples leaving a hydroxyl group. Mild periodate treatment cleaves carboncarbon bonds of sugars if they possess vicinal hydroxyl groups to enable assignment of the linkage position of the reducing end sugar (Haslam et al., 2003). 4.2.6. Exo-glycosidase digestion Such enzymatic digestion is used to assign the anomeric glycan linkage configurations based on the specificity of the utilized enzymes. Some enzymes are even specific for varying linkages in the sugars (i.e. 3-linked as opposed to a 4-linked sugar). The digestion products are then examined by linkage and MS analysis (Settineri and Burlingame, 1994).
4.3. MS techniques The present focus in MS of glycans is on ES and MALDI ionization techniques (Settineri and Burlingame, 1995; Klein, 2005; Didraga et al., 2006; Harvey, 2008), although it is worth
noting that there also exist at least 20 different commercial mass spectrometers. All, however, have three basic components: (i)
an ionization source where sample molecules are given an electrical charge; (ii) a mass analyser where ions are separated on the basis of mass-to-charge ratio; and (iii) a detector where ions are observed and counted. EI-MS and FAB-MS have specific features that make them important in the analysis of glycans. EI is most useful for analysis of highly volatile small molecules, with the EI-MS instrument usually coupled to a GC, e.g. for sugar analysis (de Jongh et al., 1969) and linkage analysis (Bjorndal et al., 1970). Our discussion will subsequently focus on the principal techniques presently used to characterize glycans, namely FAB-MS, MALDI-MS and ES-MS, and the most important analysers associated with these techniques. 4.3.1. FAB-MS FAB-MS (Barber et al., 1981; Dell et al., 1983) is the only soft ionization technique that is capable of providing molecular ions as well as adequate fragmentation ions without employing MS/MS. The FAB experiment itself involves an accelerated beam of atoms (usually xenon) or ions (usually caesium) being fired towards a small metal target from an atom or ion gun. The metal target is mounted on a probe and loaded with a viscous liquid matrix (usually thioglycerol or m-nitrobenzyl alcohol) in which the sample to be analysed is dissolved. When the atom or ion beam collides with the matrix many surface molecules of the sample are ionized and sputtered into the high vacuum and then moved to the detector (Dell, 1987; Dell et al., 2000). Advantages of the technique are that a significant fragmentation is produced along with the molecular ion; positive (usually protonated) and negative (usually deprotonated or with addition
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
4. MASS SPECTROMETRY OF GLYCANS
of Cl⫺) ions can be produced. The method is very effective and sensitive for profiling glycan mixtures, almost as effective as MALDI-TOF, and interpretation of spectra to obtain molecular mass information is uncomplicated, due to singly charged molecular ions that are usually formed. Limitations are those of inferior sensitivity at higher mass ranges compared to MALDI-MS or ES-MS or when non-derivatized or native glycan samples are being analysed. In practical terms, relatively hydrophilic carbohydrates require derivatization to enhance surface activity and spectra are characterized by a high level of chemical noise. 4.3.2. MALDI-MS For MALDI (Karas and Hillenkamp, 1988), the analyte is required to be embedded in a low molecular mass UV-absorbing matrix, normally 2,5-dihydroxybenzoic acid, in vast excess over the glycan sample (Harvey et al., 1996). A laser pulse is fired at the matrix, which absorbs enough energy to transfer some of this to the sample, essentially volatilizing individual isolated monomeric ions. The ions produced are typically analysed by TOF detectors, where ions separate according to their mass/charge ratio, heavier ions drift or move more slowly and lighter ions drift more rapidly towards the detector. In a linear TOF detector, little fragmentation is seen without resorting to analysis of post-source decay ions or additional CAD in the MS/MS mode. Further advances in sensitivity (i.e. order of magnitude) can be achieved by permethylation, usually eliminating the tendency to lose negatively-charged residues when analysis is carried out in the positive ion mode (Haslam et al., 2003). Advantages are that the method is more sensitive than FAB-MS, especially at higher mass range, and there is an uncomplicated interpretation due to singly charged molecular ions usually being formed in the linear mode but, in the CID mode, parent ion selection can be achieved
245
at high-resolution and sensitivity (Harvey et al., 1996). Moreover, the TOF analyser has almost unlimited mass range. Limitations of the technique are that it is not as useful as FAB-MS for profiling small oligosaccharides below m/z 600; the MALDI spectrum is overwhelmed by matrix peaks in this region. Also, there is a lack of sequence-informative fragment ions in the low-mass region without the use of post-source decay or MS/MS inclusion (Haslam et al., 2003) and the difficulty of obtaining protonated ions in MALDI-MS. 4.3.3. ESI-MS In an ES experiment, a solution containing the analyte is introduced into the ES apparatus, by means of loop injection-liquid chromatography (-LC), direct infusion or syringe pump, whereby upon spraying the solution into a high electric field, microdroplets are desolvated to produce gas-phase ions. To cater for small sample quantities, the trend is to use nanoES for higher sensitivity (Wuhrer et al., 2005; Robbe et al., 2006). Numerous separation techniques have been coupled to ES-MS for in-line separation and then characterization of glycans. Li and Richards (2007) reported on the use of capillary electrophoresis ES-MS for the structural characterization of bacterial LPS. Extensive research has been conducted on glycans employing LC in conjunction with ES-MS (Black and Fox, 1996). The ES-MS technique is an ideal method for interfacing to capillary electrophoresis or LC as it is a flow technique that operates at atmospheric pressure. The technique of ESI-MS is favoured over FAB and MALDI for its ease of implementing automated LC-MS/MS and does not require derivatization of samples. Further advantages are sensitivity to pmol, or even fmol, quantities of material (Harvey et al., 1996; Haslam et al., 2003) and ionization is gentle. The limitations are that raw data can be complex, due to characteristic multiple charging in the ES spectra, with very
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
246
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
few fragment ions and little or no sequence information unless MS/MS employed. Although FAB-MS, MALDI-MS and ES-MS do not prerequisitely demand derivatization, more reliable fragmentation can be obtained by functionalizing hydroxyl groups of glycans (e.g. methyl or acetyl derivatives) rather than analysing the native sample. Furthermore, by choosing an appropriate experimental strategy, most structural problems can successfully be addressed using these ionization methods (Dell et al., 2000). 4.3.4. MS/MS and mass analysers A demand for higher sensitivity and more effective MS/MS implementation has led to the development of numerous new mass analysers. Two analysers of principal importance are the ion-trap (IT) and the quadrupoleorthogonal acceleration time-of-flight (Q-TOF) instruments. Both have found application in coupling to ES or nanoES (Sheeley and Reinhold 1998; Weiskopf et al., 1998; Wuhrer et al., 2002; Matamoros, 2007) and MALDI sources (Zehl et al., 2007). Due to the nature of FAB instrumentation, coupling to IT or Q-TOF analysers has not been possible to date (Haslam et al., 2003). The IT instrumentation allows MS/MS due to its unique strength as an ion storage device. The Q-TOF has both quadrupole and TOF analysers arranged orthogonally with a collision cell separating the two. With this configuration, the Q-TOF-MS instrumentation is more powerful than ES-MS and CID MS/MS. These mass analysers produce extensive fragmentation enabling comprehensive characterization abilities. Signal to noise ratios in the MS/MS mode allow sample analysis in the low fmol to amol range (Dell et al., 2000). Fourier-transform-ion cyclotron resonance (FT-ICR) analysers are being used to extend further the capabilities of IT-MS in structural profiling. These instruments offer ultra-high sensitivity and resolution for structural characterization of glycans coupled to ES and MALDI
ionization sources (Park and Lebrilla, 2005; Bereman et al., 2007).
4.4. Structural characterization procedures of selected bacterial glycans classes No singular approach exists for the structural characterization of microbal glycans, however, a generalized approach that offers useful insights is shown in Figure 13.3. Also, an example from the literature of the MS structural characterization of LOS from Yersinia pestis (phoP mutant) will be examined (Figure 13.4). Hitchen et al. (2002) employed the strategy outlined below to characterize the structure of an oligosaccharide and lipid A from Y. pestis. A final structure was deduced by collating partial information from the varying experiments performed. Interpretation of the FAB-MS spectrum of the permethylated phoP mutant OS showed signals at m/z 2108 and 1802 of compositions HexNAcHexHep4KoKdo-ol and HexNAcHexHep4Kdo-ol (where HexNAc, N-acetylhexosamine; Hex, hexose; Hep, heptose; Ko, d-glycero-d-talo-oct-2-ulosonic acid), respectively. An A-type ion at m/z 1004 was attributed to HexNAcHep3⫹ with a signal at m/z 767 attributed to the double cleavage product Hep3 (see Figure 13.4, FAB-MS (OS)). Interpretation of the FAB-MS of lipid A spectrum showed a sodiated molecular ion at m/z 1267, which was attributed to a glucosamine disaccharide backbone substituted with four 3-hydroxytetradecanoic acid, 14:O(3-OH), residues. Signals at m/z 1041 and 815 were assigned to moieties lacking one or two 14:O(3-OH) acyl residues smaller than the m/z 1267. The signal at m/z 1685 arose from the presence of two phosphate groups plus an additional 16:1 acyl residue on the m/z 1267 species [see Figure 13.4, FAB-MS (Lipid A)]. The ESI-CAD MS/MS spectrum of the core OS was carried out on a Q-TOF MS to give an unambiguous sequence and branching pattern
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
4. MASS SPECTROMETRY OF GLYCANS
FIGURE 13.3
247
Overview of characterization strategies for glycans of Gram-negative bacteria.
information for the phoP mutant OS. The principal assignments were an ion at m/z 1065 from the permethylated sample (see Figure 13.4, ESI-CAD MS/MS (OS-A)) being assigned to HexNAcHexHep4KoKdo-ol [M ⫹ 2Na]2⫹ and m/z 1165 from the deuteromethylated sample (see Figure 13.4, ESI-CAD MS/MS (OS-B)) from HexNAcHexHep4KoKdo-ol [M ⫹ 2Na]2⫹. Comparison of the permethylated and deuteromethylated samples revealed the number of hydroxyl groups in the native sample plus
additional more subtle information. Both the [M ⫹ 2Na]2⫹ (i.e. permethylated and deuteromethylated) ions were selected for CAD MS/ MS analysis. Noteworthy product ions were at m/z 361 and 375 (see Figure 13.4, spectrum OSA) and m/z 379 and 396 (see Figure 13.4, spectrum OS-B) and correspond to Ko product ions. Table 13.1 provides some selected, representative glycan structural characterization strategies. Comprehensive details of procedures can be found in the literature cited therein.
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
248
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
FIGURE 13.4 Overview of MS strategies used to define the structures of both the core OS and lipid A of Yersinia pestis LOS. Abbreviations: Glc, glucose; GlcN, glucosamine; GlcNAc, N-acetylglucosamine; Hep, heptose; Kdo, 3-deoxy-d-mannooct-2-ulosonic acid. Adapted, with permission, from Hitchen et al., 2002.
4.5. Databases of mass spectral information A critical key to the structural characterization of complex glycans are the informatics methods for the interpretation of MS and MS fragmentation data. The use and development of tools and databases for the interpretation of these data have increased greatly in recent years (von der Lieth et al., 2006). However, in relation to proteomics and genomics, the field is still regarded as being in its infancy (Packer et al., 2007). Currently, extensive efforts are underway to formulate centralized carbohydrate structure databases with the ultimate goal of a single central database, but obstacles still exist
to achieving that worthwhile goal (Toukach et al., 2007). Nevertheless, there is a range of programs available on the Internet that can be used to interpret MS data originating from glycans. Reviews by von der Lieth et al. (2006) and others (Matthiesen, 2007; Maass et al., 2007; Toukach et al., 2007) provide excellent resources for accessing programs to analyse and interpret MS spectral information.
5. CONCLUSIONS Glycans are structurally complex molecules and, as such, their structural characterization is a challenging task. The precise strategy to be
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
REFERENCES
applied is dictated by the level of information required and the expertise of the research team involved, however, the most comprehensive and informative studies employ aspects of enzymatic, chemical, chromatographic, MS and NMR methods to complete the characterization process. New advances in mass spectrometry and NMR spectroscopy in terms of hardware, software and databases will further accelerate the discovery of novel glycan structures, leading to a greater understanding of the glycopolymers of bacteria.
References Aas, F., Vik, A., Vedde, J., Koomey, M., Egge-Jacobsen, W., 2007. Neisseria gonorrhoeae O-linked pilin glycosylation: functional analyses define both the biosynthetic pathway and glycan structure. Mol. Microbiol. 65, 607–624. Albersheim, P., Nevins, D.J., English, P.D., Karr, A., 1967. Analysis of sugars in plant cell-wall polysaccharides by gas-liquid chromatography. Carbohydr. Res. 5, 340–345. Banerjee, A., Ghosh, S.K., 2003. The role of pilin glycan in Neisserial pathogenesis. Mol. Cell. Biochem. 253, 179–190. Barber, M., Bordoli, R.S., Sedgwick, R.D., Tyler, A.N., 1981. Fast atom bombardment of solids (F.A.B.): a new ion source for mass spectrometry. J. Chem. Soc. Chem. Commun. 7, 325–327. Bereman, M.S., Williams, T.I., Muddiman, D.C., 2007. Carbohydrate analysis by desorption electrospray ionization fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 79, 8812–8815. Biemann, K., DeJongh, D.C., Schnoes, H.K., 1963. Application of mass spectrometry to structure problems. XIII. Acetates of pentoses and hexoses. J. Am. Chem. Soc. 85, 1763–1770. Bjorndal, H., Hellerqvist, C.G., Lindberg, B., Svensson, S., 1970. Gas-liquid chromatography and mass spectrometry in methylation analysis of polysaccharides. Angew. Chem. Int. Ed. Engl. 9, 610–619. Black, G.E., Fox, A., 1996. Liquid chromatography with electrospray ionization tandem mass spectrometry. Profiling carbohydrates in whole bacterial cell hydrolyzates. ACS Symp. Ser. 619, 81–105. Blundell, C.D., Reed, M.A.C., Overduin, M., Almond, A., 2006. NMR spectra of oligosaccharides at ultra-high field (900 MHz) have better resolution than expected due to favorable molecular tumbling. Carbohydr. Res. 341, 1985–1991. Bubb, W.A., 2003. NMR spectroscopy in the study of carbohydrates: characterizing the structural complexity. Concepts Magn. Reson. 19A, 1–19.
249
Bystrova, O.V., Lindner, B., Moll, H., et al., 2004. Full structure of the lipopolysaccharide of Pseudomonas aeruginosa immunotype 5. Biochemistry (Moscow) 69, 170–175. Chapdelaine, G., Cleon, P., 2003. NMR cryogenic probe: a new step to sensitivity. Spectra Anal. 32, 35–38. Comstock, L.E., Kasper, D.L., 2006. Bacterial glycans: key mediators of diverse host immune responses. Cell 126, 847–850. Dasgupta, N., Arora, S.K., Rampal, R., 2004. The flagellar system of Pseudomonas aeruginosa. Pseudomonas 1, 675–698. De Castro, C., Carannante, A., Lanzetta, R., et al., 2006. Structural characterisation of the core oligosaccharides isolated from the lipooligosaccharide fraction of Agrobacterium tumefaciens A1. Chem.-Eur. J. 12, 4668–4674. de Jongh, D.C., Biemann, K., 1963. Application of mass spectrometry to structure problems. XIV. Acetates of partially methylated pentoses and hexoses. J. Am. Chem. Soc. 85, 2289–2294. de Jongh, D.C., Hribar, J.D., Hanessian, S., Woo, P.W.K., 1967. Mass spectrometric studies on aminocyclitol antibiotics. J. Am. Chem. Soc. 89, 3364–3365. de Jongh, D.C., Radford, T., Hribar, J.D., et al., 1969. Analysis of trimethylsilyl derivatives of carbohydrates by gas chromatography and mass spectrometry. J. Am. Chem. Soc. 91, 1728–1740. Dell, A., 1987. F.A.B.-mass spectrometry of carbohydrates. Adv. Carbohydr. Chem. Biochem. 45, 19–72. Dell, A., Morris, H.R., Egge, H., von Nicolai, H., Strecker, G., 1983. Fast-atom-bombardment mass spectrometry for carbohydrate-structure determination. Carbohydr. Res. 115, 41–52. Dell, A., Reason, A.J., Khoo, K.H., Panico, M., McDowell, R. A., Morris, H.R., 1994. Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol. 230, 108–132. Dell, A., Morris, H.R., Easton, R., et al., 2000. Structural analysis of oligosaccharides: FAB-MS, ES-MS and MALDIMS. Carbohydr. Chem. Biol. 2, 915–945. Didraga, M., Barroso, B., Bischoff, R., 2006. Recent developments in proteoglycan purification and analysis. Curr. Pharm. Anal. 2, 323–337. Domon, B., Costello, C.E., 1988. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj. J. 5, 397–409. Duus, J., Gotfredsen, C.H., Bock, K., 2000. Carbohydrate structural determination by NMR spectroscopy: modern methods and limitations. Chem. Rev. 100, 4589–4614. Fedonenko, Y.P., Konnova, O.N., Zdorovenko, E.L., et al., 2008. Structural analysis of the O-polysaccharide from the lipopolysaccharide of Azospirillum brasilense S17. Carbohydr. Res. 343, 810–816. Feng, R., Xie, H., Ren, D.-Z., 2002. Application of cryogenic NMR probes. Bopuxue Zazhi 19, 447–454.
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
250
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
Fenn, J.B., Mann, M., Meng, C.K., Wong, S.F., Whitehouse, C.M., 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science 246, 64–71. Flahaut, S., Vinogradov, E., Kelley, K.A., Brennan, S., Hiramatsu, K., Lee, J.C., 2008. Structural and biological characterization of a capsular polysaccharide produced by Staphylococcus haemolyticus. J. Bacteriol. 190, 1649–1657. Gerwig, G.J., Kamerling, J.P., Vliegenthart, J.F., 1979. Determination of the absolute configuration of monosaccharides in complex carbohydrates by capillary G.L.C. Carbohydr. Res. 88, 10–17. Godschalk, P.C.R., Kuijf, M.L., Li, J., et al., 2007. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect. Immun. 75, 1245–1254. Harvey, D.J., 2008. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update covering the period 2001–2002. Mass Spectrom. Rev. 27, 125–201. Harvey, D.J., Naven, T.J.P., Kuster, B., 1996. Identification of oligosaccharides by matrix-assisted laser desorption ionization and electrospray MS. Biochem. Soc. Trans. 24, 905–912. Haslam, S.M., Coles, G.C., Morris, H.R., Dell, A., 2000. Structural characterization of the N-glycans of Dictyocaulus viviparus: discovery of the Lewisx structure in a nematode. Glycobiology 10, 223–229. Haslam, S.M., Khoo, K.-H., Dell, A., 2003. Sequencing of oligosaccharides and glycoproteins. Carbohydr.-Based Drug Discov. 2, 461–482. Hillenkamp, F., Karas, M., Beavis, R.C., Chait, B.T., 1991. Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Anal. Chem. 63, 1193A–1203A. Hitchen, P.G., Prior, J.L., Oyston, P.C.F., et al., 2002. Structural characterization of lipooligosaccharide (LOS) from Yersinia pestis: regulation of LOS structure by the PhoPQ system. Mol. Microbiol. 44, 1637–1650. Hricovini, M., 2004. Structural aspects of carbohydrates and the relation with their biological properties. Curr. Med. Chem. 11, 2565–2583. Jansson, P.-E., Stenutz, R., Widmalm, G., 2006. Sequence determination of oligosaccharides and regular polysaccharides using NMR spectroscopy and a novel webbased version of the computer program CASPER. Carbohydr. Res. 341, 1003–1010. Karas, M., Hillenkamp, F., 1988. Laser desorption ionization of proteins with molecular masses exceeding 10 000 daltons. Anal. Chem. 60, 2299–2301. Karas, M., Bachmann, D., Bahr, U., Hillenkamp, F., 1987. Matrix-assisted ultraviolet laser desorption of non-volatile compounds. Int. J. Mass Spectrom. Ion Proc. 78, 53–68. Karlyshev, A.V., Champion, O.L., Churcher, C., et al., 2005. Analysis of Campylobacter jejuni capsular loci reveals
multiple mechanisms for the generation of structural diversity and the ability to form complex heptoses. Mol. Microbiol. 55, 90–103. Keeler, J., Clowes, R.T., Davis, A.L., Laue, E.D., 1994. Pulsedfield gradients: theory and practice. Methods Enzymol. 239, 145–207. Kenne, L., Lindberg, B., Schweda, E., Gustafsson, B., Holme, T., 1988. Structural studies of the O-antigen from Vibrio cholerae O:2. Carbohydr. Res. 180, 285–294. Khamri, W., Moran, A.P., Worku, M.L., et al., 2005. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect. Immun. 73, 7677–7686. Klein, M.L., 2005. HPLC and mass spectrometry approaches to protein and carbohydrate characterization. Am. Pharm. Rev. 8, 108, 110–114. Kochetkov, N.K., Chizhov, O.S., 1965. Mass spectrometry of methylated methyl glycosides. Principles and analytical application. Tetrahedron 21, 2029–2047. Li, J., Richards, J.C., 2007. Application of capillary electrophoresis mass spectrometry to the characterization of bacterial lipopolysaccharides. Mass Spectrom. Rev. 26, 35–50. Lindberg, B., 1998. Bacterial polysaccahrides: components. In: Dimitriu, S. (Ed.), Polysaccahrides – Structural Diversity and Functional Versatility. Marcel Dekker Inc., New York, pp. 237–274. Lindberg, B., Lönngren, J., 1978. Methylation analysis of complex carbohydrates: general procedure and application for sequence analysis. Adv. Carbohydr. Chem. Biochem. 33, 295–322. Logan, S., 2006. Flagellar glycosylation: a new component of the motility repertoire? Microbiology 152, 1249–1262. Logan, S., Schoenhofen, I.C., Guerry, P., 2008. O-linked flagellar glycosylation in Campylobacter. In: Nachamkin, I., Szymanski, C.M., Blaser, M.J. (Eds.), Campylobacter, 3rd edn. American Society for Microbiology, Washington DC, pp. 471–481. Loss, A., Stenutz, R., Schwarzer, E., von der Lieth, C.W., 2006. GlyNest and CASPER: two independent approaches to estimate 1H and 13C NMR shifts of glycans available through a common web-interface. Nucl. Acids Res. 34, W733–W737. Lukasiewicz, J., Dzieciatkowska, M., Niedziela, T., et al., 2006. Complete lipopolysaccharide of Plesiomonas shigelloides O74:H5 (strain CNCTC 144/92). 2. Lipid A, its structural variability, the linkage to the core oligosaccharide, and the biological activity of the lipopolysaccharide. Biochemistry 45, 10434–10447. Maass, K., Ranzinger, R., Geyer, H., von der Lieth, C.-W., Geyer, R., 2007. “Glyco-Peakfinder” – de novo composition analysis of glycoconjugates. Proteomics 7, 4435–4444. Martin, G.E., 2002. Cryogenic NMR probes: applications. Encycl. Nucl. Magn. Reson. 9, 33–35.
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
REFERENCES
Matamoros, F.L.E., 2007. Introduction to ion trap mass spectrometry: application to the structural characterization of plant oligosaccharides. Carbohydr. Polym. 68, 797–807. Matthiesen, R., 2007. Useful mass spectrometry programs freely available on the Internet. Methods Mol. Biol. 367, 303–312. McNally, D.J., Jarrell, H.C., Li, J., et al., 2005. The HS:1 serostrain of Campylobacter jejuni has a complex teichoic acidlike capsular polysaccharide with nonstoichiometric fructofuranose branches and O-methyl phosphoramidate groups. FEBS J. 272, 4407–4422. McNally, D.J., Hui, J.P., Aubry, A.J., et al., 2006a. Functional characterization of the flagellar glycosylation locus in Campylobacter jejuni 81–176 using a focused metabolomics approach. J. Biol. Chem. 281, 18489–18498. McNally, D.J., Jarrell, H.C., Khieu, N.H., et al., 2006b. The HS:19 serostrain of Campylobacter jejuni has a hyaluronic acid-type capsular polysaccharide with a nonstoichiometric sorbose branch and O-methyl phosphoramidate group. FEBS J. 273, 3975–3989. McNally, D.J., Lamoureux, M.P., Karlyshev, A.V., et al., 2007. Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. J. Biol. Chem. 282, 28566–28576. Mikhail, I., Yildirim, H.H., Lindahl, E.C.H., Schweda, E.K.H., 2005. Structural characterization of lipid A from nontypeable and type f Haemophilus influenzae: variability of fatty acid substitution. Anal. Biochem. 340, 303–316. Moran, A.P., Knirel, Y.A., Senchenkova, S.Y.N., Widmalm, G., Hynes, S.O., Jansson, P.-E., 2002. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in LewisX and LewisY expression by H. pylori lipopolysaccharides. J. Biol. Chem. 277, 5785–5795. Morelle, W., Michalski, J.-C., 2005. The mass spectrometric analysis of glycoproteins and their glycan structures. Curr. Anal. Chem. 1, 29–57. Niedziela, T., Dag, S., Lukasiewicz, J., et al., 2006. Complete lipopolysaccharide of Plesiomonas shigelloides O74: H5 (strain CNCTC 144/92). 1. Structural analysis of the highly hydrophobic lipopolysaccharide, including the O-antigen, its biological repeating unit, the core oligosaccharide, and the linkage between them. Biochemistry 45, 10422–10433. Packer, N.H., von der Lieth, C.-W., Aoki-Kinoshita, K.F., et al., 2007. Frontiers in glycomics: bioinformatics and biomarkers in disease: an NIH White Paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11–13, 2006). Proteomics 8, 8–20. Park, Y., Lebrilla, C.B., 2005. Application of Fourier transform ion cyclotron resonance mass spectrometry to oligosaccharides. Mass Spectrom. Rev. 24, 232–264.
251
Petersen, B.O., Vinogradov, E., Kay, W., et al., 2006. H2BC: a new technique for NMR analysis of complex carbohydrates. Carbohydr. Res. 341, 550–556. Power, P.M., Seib, K.L., Jennings, M.P., 2006. Pilin glycosylation in Neisseria meningitidis occurs by a similar pathway to wzy-dependent O-antigen biosynthesis in Escherichia coli. Biochem. Biophys. Res. Comm. 347, 904–908. Raetz, C.R.H., Whitfield, C., 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635–700. Reinhold, V.N., Carr, S.A., 1983. New mass-spectral approaches to complex carbohydrate structure. Mass Spectrom. Rev. 2, 153–221. Ribeiro, A.A., Zhou, Z.M., Raetz, C.R.H., 1999. Multidimensional NMR structural analyses of purified Lipid X and Lipid A (endotoxin). Magn. Reson. Chem. 37, 620–630. Robbe, C., Michalski, J.-C., Capon, C., 2006. Structural determination of O-glycans by tandem mass spectrometry. Methods Mol. Biol. 347, 109–123. Schirm, M., Soo, E.C., Aubry, A.J., Austin, J., Thibault, P., Logan, S.M., 2003. Structural, genetic and functional characterization of the flagellin glycosylation process in Helicobacter pylori. Mol. Microbiol. 48, 1579–1592. Schweda, E.K.H., Richards, J.C., 2003. Structural profiling of short-chain lipopolysaccharides from Haemophilus influenzae. Methods Mol. Med. 71, 161–183. Schweda, E.K.H., Brisson, J.R., Alvelius, G., et al., 2000. Characterization of the phosphocholine-substituted oligosaccharide in lipopolysaccharides of type b Haemophilus influenzae. Eur. J. Biochem. 267, 3902–3913. Settineri, C.A., Burlingame, A.L., 1994. Strategies for the characterisation of carbohydrates from glycoproteins by mass spectrometry. In: Crabb, J.W. (Ed.), Techniques in Protein Chemsitry V. Academic Press, Inc., San Diego, pp. 97–104. Settineri, C.A., Burlingame, A.L., 1995. Mass spectrometry of carbohydrates and glycoconjugates. J. Chromatogr. Libr. 58, 447–514. Sheeley, D.M., Reinhold, V.N., 1998. Structural characterization of carbohydrate sequence, linkage, and branching in a quadrupole ion trap mass spectrometer: neutral oligosaccharides and N-linked glycans. Anal. Chem. 70, 3053–3059. Smith, R.D., Loo, J.A., Edmonds, C.G., Barinaga, C.J., Udseth, H.R., 1990. New developments in biochemical mass spectrometry: electrospray ionization. Anal. Chem. 62, 882–899. St Michael, F., Szymanski, C.M., Li, J., et al., 2002. The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168. Eur. J. Biochem. 269, 5119–5136. St Michael, F., Brisson, J.-R., Larocque, S., et al., 2004. Structural analysis of the lipopolysaccharide derived core oligosaccharides of Actinobacillus pleuropneumoniae serotypes 1, 2, 5a and the genome strain 5b. Carbohydr. Res. 339, 1973–1984.
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
252
13. STRUCTURAL STUDIES OF MICROBIAL WALL COMPONENTS
Stenutz, R., Weintraub, A., Widmalm, G., 2006. The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol. Rev. 30, 382–403. Szymanski, C.M., St Michael, F., Jarrell, H.C., et al., 2003. Detection of conserved N-linked glycans and phasevariable lipooligosaccharides and capsules from Campylobacter cells by mass spectrometry and high resolution magic angle spinning NMR spectroscopy. J. Biol. Chem. 278, 24509–24520. Toukach, P., Joshi, H.J., Ranzinger, R., Knirel, Y., von der Lieth, C.-W., 2007. Sharing of worldwide distributed carbohydrate-related digital resources: online connection of the Bacterial Carbohydrate Structure DataBase and GLYCOSCIENCES.de. Nucl. Acids Res. 35, D280–D286. Uhrin, D., 1997. Concatenation of polarization transfer steps in 1D homonuclear chemical shift correlated experiments. Application to oligo- and polysaccharides. Anal. Spectrosc. Libr. 8, 51, 53–89. Uhrin, D., Brisson, J.-R., 2000. Structure determination of microbial polysaccharides by high resolution NMR spectroscopy. NMR Microbiol., 165–190. Uhrin, D., Brisson, J.R., Bundle, D.R., 1993. Pseudo-3D NMR spectroscopy: application to oligo- and polysaccharides. J. Biomol. NMR 3, 367–373. Uhrin, D., Brisson, J.-R., Kogan, G., Jennings, H.J., 1994. 1D analogs of 3D NOESY-TOCSY and 4D TOCSY-NOESYTOCSY. Application to polysaccharides. J. Magn. Reson. Ser. B 104, 289–293. Uhrinova, S., Uhrin, D., Liptaj, T., Batta, G., 1991. Detection of long-range couplings in oligomers and evaluation of coupling constants in polymers. Application of the 1D COSY technique. Magn. Reson. Chem. 29, 22–28. Vliegenthart, J.F.G., 2006. Introduction to NMR spectroscopy of carbohydrates. ACS Symp. Ser. 930, 1–19. Voehler, M.W., Collier, G., Young, J.K., Stone, M.P., Germann, M.W., 2006. Performance of cryogenic probes as a function of ionic strength and sample tube geometry. J. Magn. Reson. 183, 102–109. Voisin, S., Kus, J.V., Houliston, S., St-Michael, F., Watson, D., Cvitkovitch, D.G., Kelly, J., Brisson, J.R., Burrows, L.L., 2007. Glycosylation of Pseudomonas aeruginosa strain Pa5196 type IV pilins with mycobacterium-like α-1,5-linked D-Araf oligosaccharides. J. Bacteriol. 189, 151–159.
von der Lieth, C.-W., Luetteke, T., Frank, M., 2006. The role of informatics in glycobiology research with special emphasis on automatic interpretation of MS spectra. Biochim. Biophys. Acta 1760, 568–577. Weiskopf, A.S., Vouros, P., Harvey, D.J., 1998. Electrospray ionization-ion trap mass spectrometry for structural analysis of complex N-linked glycoprotein oligosaccharides. Anal. Chem. 70, 4441–4447. Willker, W., Leibfritz, D., Kerssebaum, R., Bermel, W., 1993. Gradient selection in inverse heteronuclear correlation spectroscopy. Magn. Reson. Chem. 31, 287–292. Wilson, J.C., Angus, D.I., von Itzstein, M., 1995. 1H NMR evidence that Salmonella typhimurium sialidase hydrolyzes sialosides with overall retention of configuration. J. Am. Chem. Soc. 117, 4214–4217. Wilson, J.C., Hitchen, P.G., Frank, M., et al., 2005. Identification of a capsular polysaccharide from Moraxella bovis. Carbohydr. Res. 340, 765–769. Wilson, J.C., Collins, P.M., Klipic, Z., Grice, I.D., Peak, I. R., 2006. Identification of a novel glycosyltransferase involved in LOS biosynthesis of Moraxella catarrhalis. Carbohydr. Res. 341, 2600–2606. Wuhrer, M., Kantelhardt, S.R., Dennis, R.D., Doenhoff, M.J., Lochnit, G., Geyer, R., 2002. Characterization of glycosphingolipids from Schistosoma mansoni eggs carrying Fuc(α 1-3)GalNAc-, GalNAc(β 1-4)[Fuc(α 1-3)]GlcNAcand Gal(β 1-4)[Fuc(α 1-3)]GlcNAc- (Lewis X) terminal structures. Eur. J. Biochem. 269, 481–493. Wuhrer, M., Deelder, A.M., Hokke, C.H., 2005. Protein glycosylation analysis by liquid chromatography-mass spectrometry. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 825, 124–133. Yamamoto, A., 2002. Nuclear magnetic resonance spectroscopy: the recent developments of hardware: the current status of cryogenic probe. Bunseki 12, 320–321. Zdorovenko, G.M., Zdorovenko, E.L., Varbanets, L.D., 2007. Composition, structure, and biological properties of lipopolysaccharides from different strains of Pseudomonas syringae pv. atrofaciens. Microbiology 76, 683–697. Zehl, M., Pittenauer, E., Jirovetz, L., et al., 2007. Multistage and tandem mass spectrometry of glycosylated triterpenoid saponins isolated from Bacopa monnieri. Comparison of the information content provided by different techniques. Anal. Chem. 79, 8214–8221.
I. MICROBIAL GLYCOLIPIDS, GLYCOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
14 Single-molecule characterization of microbial polysaccharides Marit Sletmoen1, Dionne C.G. Klein1 and Bjørn T. Stokke Summary
1. Introduction
Single-molecule techniques have paved the way for a more detailed molecular understanding of various biological functions of single molecules. The impact of single-molecule approaches has been particularly large for studies of cellular functions, e.g. related to replication and the function of motor proteins, and there is emerging evidence that this strategy also will provide important information on microbial polysaccharides. Single-molecule characterization of the mechanical responses of microbial polysaccharides has revealed reduced entropy associated with low-force stretching to “fingerprints” reflecting the deformation of the constituting carbohydrates and their linkage pattern. Molecular interactions and structure rearrangements are readily determined within the sub-nanonewton and nanometre range. The molecular understanding of the role of polysaccharides in various biological processes, e.g. recognition and cell adhesion, is expected to gain momentum by further application of single-molecule techniques.
Single-molecule techniques that have emerged over the past 20 years have provided new and important molecular insight into the function of biological macromolecules. Important examples include macromolecular behaviour involved in e.g. cellular transport (Svoboda et al., 1993), generation of adenosine triphosphate (ATP) (Yasuda et al., 2001) and DNA transcription, recombination and replication (Bustamante et al., 2003; van Oijen, 2007). This approach allows insight into the distribution of molecular properties and is complementary to most classical characterization techniques that reveal average properties of the molecular ensembles studied. The additional information obtained from single-molecule studies opens up a new level of understanding of complex systems since distributions of a given property, derived from the collection of individual observations using a single-molecule approach, may reveal deviating subpopulations and their properties. The importance of building knowledge at the single-molecule level within molecular biology is
Keywords: Single-molecule; Atomic force microscopy; Fluorescence spectroscopy; Force spectroscopy; Molecular recognition 1
Footnote: These authors contributed equally to this work.
Microbial Glycobiology
253
© 2009 2010, Elsevier Inc.
254
14. Single-molecule studies of polysaccharides
nowadays well accepted. Two important examples are single-enzyme kinetics that permit a statistical description of binding trajectories and transition states (Schenter et al., 1999) and understanding the mechanisms influencing the target localization speed of many gene-regulating proteins which exceed that set by the bimolecular collision limit imposed by the diffusion of the compounds (Stanford et al., 2000; Gowers et al., 2005). In general, although single-molecule studies are not as widely applied to microbial polysaccharides (PSs) as within other areas of molecular biology, there is an increasing literature documenting their potential for use on microbial PSs and which clearly shows that the novelty of the available information is important also for these materials. Additionally, the more abundant literature on single-molecule studies of other biological macromolecules may serve as an inspiration for the application of the techniques to microbial PSs. Single-molecule properties are accessible using experimental set-ups such as atomic force microscopy, optical or magnetic tweezers, fluorescence resonance energy transfer and fluorescence
Figure 14.1 Examples of single-molecule techniques applicable for studying microbial PSs: (A) atomic force microscopy (AFM); (B) optical and magnetic tweezers; (C) fluorescence resonance energy transfer (FRET); (D) fluorescence correlation spectroscopy (FCS).
c orrelation spectroscopy (Figure 14.1) or others. Though the studies require properly extracted and further prepared samples of molecules, they support the determination of microbial PS chain trajectories, force-elongation profiles, interaction strengths with their specific receptors, co-localization or proximity and co-migration with other molecular components. Examples of the application of these techniques to the field of microbial PSs are discussed in this chapter.
2. Atomic force microscopy and its application to microbial PSs In an atomic force microscope (AFM) (Binnig et al., 1986), a sharp tip at the end of a miniature cantilever is scanned over a surface using a piezoelectrical scanner, while a laser records the deflection of the cantilever. In the contact mode, the deflection of the cantilever is kept constant. In the oscillating mode, either with the tip intermittently touching the surface for a fraction of the oscillation cycle or oscillating within the attractive force field of the surface, the cantilever is driven close to its resonance frequency and the amplitude of the response of the cantilever is kept constant while scanning the surface. Tapping mode is preferred for imaging of biological samples, as the applied lateral forces are minimized. An AFM enables studies of microbial cell surfaces and their PSs under physiological conditions with nanometre resolution, combined with elasticity and molecular interaction studies (Gaboriaud and Dufrêne, 2007). The samples need to be attached to a surface for the AFM imaging. The resolution depends on the radius of curvature of the scanning tip and the imaging conditions; these may be as good as a lateral resolution of 1 nm and a vertical resolution of 0.1 nm under optimal conditions. Because an AFM can be used in liquid medium, it offers the possibility of studying the
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
3. Measurements of mechanical properties of single PSs
function (e.g. adhesion and specific interaction) of biomolecules together with their structure under near physiological conditions. The imaging capabilities of an AFM are to some extent similar to that achievable using electron microscopy, but the strength within the AFM sets it apart because it can be operated under conditions closer to physiological ones. Figure 14.2 shows a tapping mode AFM image depicting the biological precursor PSs of alginate as they are being converted to alginate by the action of enzymes (Sletmoen et al., 2004). These enzymes are identified as the higher globular domains in the image. This image illustrates the resolution that can be obtained when viewing single PS strands using an AFM. In (dynamic) force spectroscopy, the determination of the deflection of the cantilever, while performing approach–retract cycles at the same lateral position, yields information about the interaction force between the tip and surface with pico-newton sensitivity. In this way, elasticity, adhesion and molecular interactions can be measured at the single-molecule level. Thus, atomic force microscopy has been applied to study the topography and elastic properties as well as molecular interactions of microbial cell surfaces (Gaboriaud and Dufrêne, 2007).
Figure 14.2 Tapping mode AFM height topograph of mannuronan, the biological precursor PSs of alginate, as such molecules are being converted to alginate by the action of the C-5-mannuronan epimerase, AlgE4. The enzymes are identified as the higher globular domains in the image. (See colour plates section.)
255
3. Measurements of mechanical properties of single PSs Generally, PSs possess both mechanical and biochemical functions and PSs excreted by microorganisms influence the viscosity of the microenvironment surrounding the cell. The macroscopic properties of such PSs depend on the primary chemical composition, structure and conformation of the molecules, as well as their interactions at the single-molecule level. Additionally, PSs play key roles in protein sorting, cell–cell communication, cell adhesion and molecular recognition in the immune system. Researchers have more recently become aware of a coupling between the mechanical forces exerted on biopolymers and their biochemical function (Bustamante et al., 2004). This has led biochemists to apply external forces to these processes in an attempt to alter the extent, or even the fate, of these reactions and, thus, reveal their underlying molecular mechanisms. Measurements of the mechanical properties of single biopolymers can be performed using ultrasensitive force probes, e.g. an AFM or optical or magnetic tweezers. When using these techniques, the applied forces and molecular extensions typically range from tens to hundreds of piconewtons (pN) and a few to tens of nanometres, respectively. While most nano-mechanical probing techniques support the determination of force-elongation profiles, magnetic tweezers can also be used to probe torsional properties of extended biopolymers. The force–extension relationships of PSs are most often obtained by stretching single molecules that have been adsorbed between a substrate and the cantilever tip (Rief et al., 1997, 1998; Li et al., 1998, 1999; Marszalek et al., 1998, 1999). The gradual extension of the molecules is obtained by continuously increasing the tip-surface separation controlled by the z-piezo of the AFM-scanner and carried out in the aqueous or other relevant solution.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
256
14. Single-molecule studies of polysaccharides
Knowledge obtained of the viscoelastic properties of PS at the single-molecule level are considered essential in order to understand their properties and functions in living systems (Kawakami et al., 2004). The elastic response of pyranose rings of PSs that are involved in loadbearing structures, or that experience mechanical forces in other contexts, is one important aspect of this. Single-molecule techniques have afforded new information concerning how sugar rings respond to these stresses (Marszalek et al., 2001). Most of the studies presented in the following text include investigations of the properties of microbial PSs, but data obtained on other PSs are also included because they serve as model compounds. Polysaccharide force–extension relations are characterized by an elastic retracting force at low forces that arises from the reduction of chain conformational entropy as the molecules approach their contour length (Marszalek et al., 2001). At a certain degree of extension, an enthalpic contribution to the molecular elasticity becomes dominant, resulting in a more abrupt increase in force with further increase in tip-surface separation distance. Generic models of polymer elasticity, e.g. the freely jointed or the worm-like chain model, work to a certain point for several PSs (Marszalek et al., 2001). Force-induced mechanical deformation, and even transitions of the monosaccharides, leaves characteristic fingerprints in the force–extension curves when the forces are increased. The transitions may involve a change of the pyranose ring from the chair to the boat-like or inverted chair conformation. Such a conformational change increases the displacement between consecutive glycosidic oxygen atoms (Rief et al., 1997; Marszalek et al., 1998). The force drives these new conformations by reducing the activation energy of conformations that are not populated at 20–22°C (Bell, 1978; Evans and Ritchie, 1997; Rief et al., 1998). By controlling the applied force, the probability for a certain transition to occur is increased or decreased. In the
force–extension curve this is observed as a plateau region (Figure 14.3). Once all the monomer units have gone through the conformational transition, a deformation of the pyranose rings and bending of the covalent bonds in the linkages between the pyranose rings can give rise to a further increase in the length of the molecule. Examination of a family of force–extension curves can reveal contour lengths of PS segments stretched by the AFM that vary over a wide range, because the AFM tip picks molecules randomly with respect to their ends. Nevertheless, general features related to the deformation of the constituting monosaccharides and their linkage geometry is clearly discernible. Cellulose, polymeric -(1→4)-d-glucose, displays a force–extension behaviour conforming to a purely entropic polymer model (Marszalek et al., 2001). The force–elongation relationships for other PSs display pronounced deviations from the entropic elasticity that is visible as sudden changes in the curvature of their force– extension curves (see Figure 14.3). Amylose, -(1→4)-d-glucan and dextran, -(1→4)-dglucan, show a single transition that occurs at 280 and 850 pN, respectively. This transition involves a transition of the pyranose ring from a chair-to-boat conformation, a conformational change which provides a 20% increase in chain length due to an increase in distance between glycosidic oxygen atoms (Marszalek et al., 1998; Rief et al., 1998). The spectrum obtained for pullulan is a combination of the spectra of amylose and dextran, in agreement with its structural composition. The two transitions in pectin, -(1→4)-d-galacturonan, at 300 and 900 pN has been explained by a force-induced two-step chair inversion transition in the -dgalactopyranuronic acid ring, which increases the separation of the O-1 to O-4 oxygen atoms by 20% (Marszalek et al., 1998). In the experiments described above, single PSs are stretched at a constant rate, while the resulting force changes over wide ranges. Since monosaccharide rings undergo force-dependent
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
257
3. Measurements of mechanical properties of single PSs
2500
Force (pN)
2000
4
O
1
1500
O
1000 500 amylose: α-(1
0
4)-D-glucose
2500
Force (pN)
2000
O
6
1500 1
1000
O
500 dextran: α-(1
0 O
6)-D-glucose
4
2500 1 Force (pN)
2000
O
4 1
1500
6
O
1000 500
1 O
0
pullulan: α-(1 α-(1
2500
4)-D-glucose- α-(1
6)-D-glucose
O
2000 Force (pN)
4)-D-glucose-
1500
4
1000
1 O
500 pectin: α-(1
0
4)-D-galacturonic acid
2500
Force (pN)
2000 1500 O
4
O
1000 1 500 cellulose: β-(1
0 0.6
0.7
0.8
0.9
4)-D-glucose
1.0
Normalized extension
Figure 14.3 Force–extension relationships of single PSs obtained by stretching the molecules between a substrate and an AFM cantilever. The monomer and the type of glycosidic linkages in the PS for which the force–extension curves were obtained are displayed on the left. All force–extension curves, except that of cellulose, display marked deviations from the purely entropic elasticity. Reproduced, with permission, from Marszalek et al. (2001).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
258
14. Single-molecule studies of polysaccharides
transitions, this approach (where the force is a variable) introduces an undesirable level of complexity in the results (Marszalek et al., 2002). No analytical model allowing the analysis of the observed chair-to-boat transition has been developed for a controlled extension due to the associated difficulties. An alternative approach of controlling the force applied to the molecule, therefore, has been suggested, potentially yielding results set apart from that obtained using the constant extension approach (e.g. Oberhauser et al., 2001). Force-ramp AFM captures the ring transitions under conditions where the entropic elasticity of the molecule is separated from its conformational transitions. This approach enables a quantitative analysis of the data with a twostate model that directly provides the physicochemical characteristics of the ring transitions, e.g. the width of the energy barrier, the relative energy of the conformers and their enthalpic elasticity (Marszalek et al., 2002). The variance in length of a single PS can be used to establish a thermodynamic equilibrium and to detect conformational changes and underlying dynamics not directly observable with other methods. In constant-velocity experiments, the length variance is calculated from the fluctuations in the measured force in the subsequent stretching of a molecule. This force variance is converted into the variance in the length of the molecule using the spring constant of the cantilever. A further analysis of the variance in the transition region between the chair and the boat conformation has revealed the existence of an intermediate state approximately half-way between the chair and the boat conformation (Lee et al., 2004). These results are interpreted by the aid of single-molecule dynamics (SMD) simulations. The additional degree of freedom associated with the C-5–C-6 bond of (1→6)-linked PSs has been shown to increase the complexity of the mechanical behaviour of these polymers (Lee et al., 2004). Subsequent simulations revealed that the plateau in the force–extension curve observed in experiments can be explained by a transition
of the glucopyranose rings in the dextran monomers from the chair (4C1) to the inverted chair (1C4) conformation (Neelov et al., 2006). Such experiments provide the free energy difference and distance between states. However, unlike the observation of hopping between folded and unfolded states of an RNA hairpin (Liphardt et al., 2001), the dynamics of the pyranose conformational transition cannot at present be probed, since each monomeric hopping processes is too small (1 Å) and too fast for the stretching experiments to probe. In many of the above-mentioned studies, a constant loading rate has been applied to the molecules, supporting the determination of the elastic response of the molecules. However, most biomolecular interactions exhibit elastic and viscous forces (Kawakami et al., 2004), which should be analysed independently to allow a deeper understanding of their contribution to dynamic biological processes. The viscoelastic responses of single biomolecules can be determined by force spectroscopy in an AFM by sinusoidally varying the cantilever position with the molecule extended between the tip and the surface. Monitoring the amplitude and phase response of the cantilever allows conservative (elastic) and dissipative (viscous) interactions to be distinguished. For example, Kawakami et al. (2004) determined the viscoelastic behaviour of single dextran molecules from the frequency power spectral density (PSD) of the Brownian oscillations when the molecule was clamped at a given tension between the cantilever and the substrate (Kawakami et al., 2004). Importantly, the system under investigation is close to equilibrium throughout the measurement and measurement relies on the thermally induced molecular dynamics that are inherent to biological functions. Later studies showed that single-molecule viscoelastic data can also be directly extracted from the thermally driven cantilever motion during conventional force–extension measurements (Bippes et al., 2006). The results obtained using
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Atomic force microscopy as a tool to investigate function of microbial PSs
this approach showed good agreement with those extracted from the PSD and were acquired with a time resolution of one order of magnitude faster than the approaches based on the analysis of the PSD of the cantilever motion. The dynamics of the transition from chair-toboat conformation cannot be probed due to the small size of each hopping process and its high speed. It has, however, been argued that the determination of local dissipation would give access to finer-scale conformational dynamics (Khatri et al., 2007). This is in analogy to the macroscopic rheology of complex fluids where dissipative mechanical spectra reflect dynamics of various structural and topological transitions. The observations presented in some of the papers cited above (Kawakami et al., 2004; Bippes et al., 2006; Khatri et al., 2007) have revealed that the measured frictions are, in the dissipative part of the spectra, many orders of magnitude larger than solvent friction. These observations suggest an internal source of dissipation. In the case of dextran, the effective friction to elongation exhibits a minimum at a force that coincides with the plateau in the force–extension trace (Humphris et al., 2000, 2002; Kawakami et al., 2004). These observations indicate that the internal friction arises through a process related to the local internal conformational transitions in the chain (Khatri et al., 2007).
4. Atomic force microscopy as a tool to investigate function of microbial PSs Molecular recognition is important in cell adhesion and aggregation. Also, in pathogenesis, molecular recognition plays a key function, as the first steps in the infectious process are caused by interaction of microbial molecules with receptors on the host cell surface (Gaboriaud and Dufrêne, 2007). The technique of atomic force microscopy offers the possibility to study single
259
molecules, molecular complexes and the surfaces of whole cells under physiological conditions at nanoscale resolution (Müller and Engel, 1999). In addition, specific interactions between molecules can be measured directly, which makes it possible to study the function of certain biomolecules (e.g. adhesion) and relate this to topographical features (Dupres et al., 2005). Examples of both AFM imaging and interaction studies on various microbial species and their PSs are outlined below. In force spectroscopy measurement in an AFM, a ligand tethered to the AFM tip is allowed to interact with receptors on a surface allowing determination of ligand–receptor interactions at the single-molecule level. Building a molecular understanding of such interactions can be accomplished by varying the ligand or introducing a mutation of the molecules used in the force-spectroscopic approach (Hinterdorfer and Dufrêne, 2006). Control measurements verifying the specificity can be achieved, e.g. by adding free ligand to the AFM fluid cell, which strongly reduces the frequency of specific interaction events (Sletmoen et al., 2004). Also, molecular linkers are used to couple ligands to AFM tips and/or receptors to samples (Hinterdorfer and Dufrêne, 2006). These linkers reduce non-specific interaction and make it possible for the ligand to orient itself such that it can access the receptor-binding pocket. Measured interactions range from 20 to 400 pN depending on the type of interaction (e.g. Butt et al., 2005; Samori, 2006). In force-volume imaging, spatially-resolved interaction maps are determined recording force–distance curves at multiple lateral positions. Molecular recognition imaging employs molecular recognition during imaging and is a fast technique with highresolution (Raab et al., 1999). The application of atomic force microscopy for structural imaging, chemical imaging, e.g. as applied to measure hydrophobic forces, and molecular recognition imaging as part of nanoscale microbe analysis has been reviewed by
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
260
14. Single-molecule studies of polysaccharides
Dufrêne (2008). Various microbes can be imaged under physiological conditions using this microscopy with emphasis on the effects of drugs on cell surface ultrastructure. For example, major ultrastructural changes on mycobacterial cells upon treatment with four different drugs have been reported and these changes reflect inhibition of synthesis of major cell wall constituents, i.e. arabinans (Dufrêne, 2008). Analyses with an atomic force microscope have a high impact on our understanding of the structure–function relationship of microbial surfaces and new applications can be developed for atomic force microscopy in medicine and biotechnology (Dufrêne, 2004). Images, obtained using AFM analysis, of bacteria mutants possessing different, or even lacking, extracellular PSs show clear differences in topology (Figure 14.4). The strength of adhesion caused by fibril material has been determined by force spectroscopy and the role of extracellular PSs in cellular cohesion
and the social behaviour of Myxococcus xanthus has been demonstrated (Pelling et al., 2005). With respect to fungi, Dague et al. (2008) followed the structural changes of Aspergillus fumigatus that occur during germination and recorded a change from nanofibrillar structures on the cells into an amorphous layer (Figure 14.5). Adhesion force measurements revealed a transition from hydrophobic to hydrophilic surface properties corresponding to the structural changes. In vivo cell–cell interactions have been investigated at the single-molecule level, e.g. cells of Dictyostelium discoideum are engaged in development of a multicellular organism, in which the glycoprotein csA plays a central role in cell–cell adhesion (Benoit et al., 2000). For investigation, one D. discoideum cell was picked up with a tipless AFM cantilever that was coated with a lectin binding the cell, contact between the cell on the cantilever and one of the cells in the Petri dish was established and then the cantilever retracted
G 8
Force (nN)
4
0
-4
-8
0
1000
2000
Displacement (nm)
Figure 14.4 Atomic force microscopy deflection-mode images of large social groups and individual M. xanthus cells in air (A–F) and force–displacement curves (G). Individual cells of M. xanthus mutants (Scale bar, 2 m): (A) wild-type showing polar pili; (B) wild-type displaying slime-like substances (*) and extruding blebs (arrow); (C) a pilA mutant showing the absence of pili at the cell pole; (D) a dif mutant showing the presence of long pili that bend toward the cell body; (E) a stk mutant displaying an excess of extracellular substances in the form of filaments with diameters from 15 to 65 nm; (F) an LPS O-antigen mutant. (G) Force curves measured on living wild-type (curve i), stk (curve ii) and glutaraldehyde-fixed wild-type M. xanthus (curve iii) cells (the curves are shifted 4nN for clarity). Reproduced, with permission, from Pelling et al. (2005).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Atomic force microscopy as a tool to investigate function of microbial PSs
261
Figure 14.5 Real-time imaging of cell surface dynamics. A series of high-resolution AFM deflection images recorded on a single A. fumigatus cell during germination. Within less than 3 h, the crystalline rodlet layer changed to a layer of amorphous material, presumably reflecting inner cell wall PSs. Reproduced, with permission, from Dague et al. (2008).
while monitoring the adhesion forces. The forces that are required to break the adhesion between the two cells were 23 pN and multiples of this value (Benoit et al., 2000). This indicates that a single molecular species is involved in most of the adhesive interaction between D. discoideum cells. Control measurements were performed on genetically modified cells, in which the csA gene was selectively inactivated and dissociation was highly reduced for these cells. The value of 23 pN is lower than for most antibody–antigen or lectin–sugar interactions; the force measured for the adhesive interaction between a single mannose molecule and the lectin concanavalin A was 479 pN (Ratto et al., 2004). This can explain why motile cells of D. discoideum can still glide against each other as they become part of the multicellular structure. Bacterial lipopolysaccharides (LPSs) (see Chapters 1 and 3) can cause septic shock, a life-threatening complication (Waage et al., 1989). The LPS-binding protein (LBP) binds
LPS transferring it to CD14 and LBP and CD14, together with TLR-4 and MD-2, are involved in the immune response related to septic shock (see Chapter 31). The His-tagged LBP that had been attached to AFM tips and exposed to LPS from Salmonella enterica sv. Minnesota, with varying saccharide lengths, was absorbed onto the LBPfunctionalized tips (Kim et al., 2007). The interaction between the LBP-LPS-modified AFM tips and model lipid bilayers containing CD14 was studied. Longer LPS saccharide regions resulted in higher interaction forces. Above a certain concentration, the polycationic, antimicrobial peptide polymyxin B inhibited the specific binding interaction between LBP-LPS and CD 14 molecules (Kim et al., 2007). The interaction between AFM tips coated with organic macromolecules and strains of the Gram-negative bacterium Pseudomonas aeruginosa have been measured (Abu-Lail et al., 2007). Two strains, deviating in their ability to express PSs, were covalently bound to different glass
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
262
14. Single-molecule studies of polysaccharides
slides. Separate AFM cantilevers with 1 m silica spheres were coated with either poly(methacrylic acid) or one of two different humic acids. Different adhesion forces between the various organic macromolecular probes and bacterial strains were observed and suggested to be caused by electrostatic interactions, cell softness, LPS heterogeneity and hydrophobicity (Abu-Lail et al., 2007). Nanoscale investigations of the adhesive properties of the terrestrial algae Prasiola linearis using an AFM have revealed that extracellular polymeric substances contain both PSs and a small amount of protein (Mostaert et al., 2006). Using atomic force microscopy pulling techniques, it was concluded that amyloid protein structures are important for the strength of this EPS. The use of AFM in studies of interactions of bacterial biofilms with different surfaces has been overviewed by Beech et al. (2002). Both the bacterial cells and the exopolymers, extracellular polymeric substances (EPSs) (see Chapter 37) of the biofilms have been clearly resolved and
applied in the study of adhesion and cellular properties of biofilms. The EPSs produced by diatoms, which are an important component of marine biofilms, consist of PSs, proteins and glycoproteins (Arce et al., 2004). Although it is not known which of these molecules are crucial in the attachment of diatoms to surfaces and to each other, atomic force microscopy studies have contributed to understanding the interaction forces between EPSs and surfaces and the distribution of different types of EPS on the diatom surface. Arce et al. (2004) attached a single diatom cell to the end of a tipless cantilever and measured the interaction with two different surfaces, intersleek and mica. They found that the interaction forces depend more strongly on the cell used than on the growth stage of the cell, were similar for the two surfaces examined, and concluded that macromolecular specificity of diatom EPSs play a pivotal role in adhesion. Secretion of mucilage from diatom pores was vizualized for the first time by Higgins et al. (2002) (Figure 14.6). In order to make imaging of the pores possible,
Figure 14.6 The AFM contact mode images of a living diatom secreting mucilage from its pores (A) and a subsequent scan showing an increase in mucilage secretion (B). Scale bars, 1 m. Reproduced, with permission, from Higgins et al. (2002).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
4. Atomic force microscopy as a tool to investigate function of microbial PSs
the EPS layer was gently removed by the scanning AFM tip. Two types of mucilage with distinct adhesive properties were distinguished, with measured adhesive forces of 4 nN (girdle region) and 2 nN (valve region). This study illustrates the possibility of using atomic force microscopy to study topography and related function of microbial structures. Single adhesins can be mapped on living bacteria (Dupres et al., 2005), as shown in Figure
263
14.7. Living Mycobacterium bovis BCG cells were immobilized on a membrane and an AFM tip functionalized with heparin was used to record force–distance curves in a grid pattern across the cell surface. The lateral resolution was 20 nm. The recorded forces were in the range of single-molecule interactions. Interestingly, the distribution of the adhesins was not homogeneous, but localized to nano-domains that may have very specific biological functions.
Figure 14.7 Single-molecular adhesion events on living mycobacteria. (A) Nanoscale mapping recorded with a heparin AFM tip. Notice that the adhesion is concentrated in a nanodomain. (B) Corresponding histogram from 1024 force curves of adhesion forces. The first peak (53 pN) reflects the detection of single monomers, whereas the second peak (110 pN) may correspond to single dimers or two monomers. Reproduced, with permission, from Hinterdorfer and Dufrêne (2006) and Dupres et al. (2005).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
264
14. Single-molecule studies of polysaccharides
5. Single-molecule studies of microbial PSs using optical techniques In fluorescence resonance energy transfer (FRET), the molecules of interest are labelled with a donor and an acceptor chromophore. Energy transfer from the donor to the acceptor results in a FRET signal. This signal is highly distance-dependent and the FRET technique can be applied as a “molecular ruler”. Moreover, FRET can be implemented to provide either ensemble average properties or single-pair FRET (spFRET) (Weiss, 2000). The ensemble FRET approach is implemented in highly sensitive and specific assays and sensors. Single-pair FRET is realized by intramolecular labelling, thus the intermolecular dynamics of single molecules are accessible, e.g. enzyme structural changes during catalysis. Alternatively, intermolecular labelling makes it possible to follow enzyme– substrate association/dissociation at the singlemolecule level. As an example, see Ditzler et al. (2007) for a review on single-molecule RNA enzymology. Proteolytic enzymes can be investigated in continous assays by using internally quenched peptide substrates, i.e. fluorescently labelled substrates that mimic the target of the enzyme (Warfield et al., 2006). In addition to this donor group, a second fluorophore attached to these substrates makes up the acceptor. When an enzyme cleaves the peptide chain that holds together donor and acceptor, the distance is increased and the FRET effect is very much reduced with an associated decrease in FRET and an increase in donor fluorescence. This is a sensitive assay for enzyme activity and a low concentration of substrate is sufficient. For exmple, Warfield et al. (2006) have developed internally quenched peptide substrates for FRET assays of lysostaphin, an antibiotic for Staphylococcus aureus; the substrates are based
on the target for lysostaphin, the bacterial penta-glycine cross-bridge. Sub-micromolar detection of LPS has been accomplished within a FRET-based sensor (Voss et al., 2007). A peptide corresponding to the amino acids in the LPS-binding domain of CD14 was used which was labelled with a fluorescent donor and acceptor. The change in FRET efficiency upon interaction with LPS was used as the detection signal. The sensor was claimed to yield an increase in sensitivity of three orders of magnitude compared to previous LPS sensors and able to detect LPS in the presence of up to 50% fetal calf serum, which is important for application of the sensor to clinical samples. See also Lager et al. (2006) and Ha et al. (2007) for other applications. Jones et al. (1999) developed a model that describes an amphiphatic molecule with its lipophilic region integrated into a detergent micelle and its hydrophilic region, containing the donor, extending outward. Experimental verification was achieved with LPS from different bacterial strains, which resulted in differences in measured donor to micelle separation caused by differing lengths of various O-specific PS chains. Thus, this system offers the possibility of studying the molecular conformation of reconstituted lipophilic molecules such as LPS. Fluorescence correlation spectroscopy (FCS) is a highly sensitive optical technique to determine diffusion constants, sizes of molecules and complexes, molecular interactions and fast internal dynamics. In addition to studies of fluorescentlylabelled molecules in solution and unlabelled or differently labelled interacting molecules, trafficking of biomolecules in living cells can also be determined (Schwille and Haustein, 2002). A confocal laser scanning microscope equipped with a highly sensitive photodetector is used and measurements are performed in the confocal volume, 1 femtolitre (smaller than an Escherichia coli cell). Concentrations of fluorescent molecules used are in the nM range, such that on average one (or very few) single-molecule is
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
265
6. Conclusions
present in the detection volume. Fluctuations in fluorescence intensity are recorded and, from the auto-correlation or cross-correlation function, the local concentration of fluorescentlylabelled molecules and mobility coefficient can be derived. Very short data acquisition times are involved in this technique (Schwille and Haustein, 2002). Examples of the applications of FCS in microbial PS include reports on transport properties of schizophyllan and succinoglycan. The dynamic properties of schizophyllan in a dilute environment as determined by FCS were used as a basis to derive molecular parameters, e.g. as chain length and stiffness (Leng et al., 2001). The diffusion coefficient of succinoglycan, as measured by FCS, was found to decrease with decreasing pH, at constant ionic strength (Duval et al., 2006). The effective hydrodynamic radius increased from 10.3 nm at high pH to 14.5 nm at low pH. This increase is likely due to aggregation following a decrease in molecular charge. Masuda et al. (2005) developed a special FCS technique, where the size of the effective confocal volume was varied, that enables monitoring of the spatio-temporal dependence of the diffusion coefficient. This so-called sampling-volume-controlled (SVC)-FCS makes it possible directly to observe anomalous subdiffusion (ASD) in non-homogeneous media, in this case hyaluronan aqueous solutions. It was shown that moderate ASD may occur even in the presence of a small amount of hyaluronan in extracellular matrices. The diffusion of bacteriophages in the Stenotrophonas maltophilia biofilm and the influence of EPS on this diffusion and reactivity were studied using two-photon excitation- (TPE-) FCS (Lacroix-Gueu et al., 2005). With TPE, photobleaching was reduced and, by using infra-red wavelengths, deeper specimen penetration was achieved. Moreover, the bacteriophages were found to penetrate the EPS matrix of the biofilm and, in this way, use the protective effect of the biofilm toward antimicrobials.
6. Conclusions Single-molecule techniques applied to microbial PSs have proven capable of providing novel information necessary for the understanding of structure–function relationships of this class of molecule. In particular, the possibility of determining these properties under mechanical tension provides important insights into molecular behaviour that is not readily accessible by combined classical approaches. Nevertheless, single-molecule studies of microbial PSs is probably awaiting a richer future than seen in past years due to the potential migration of single-molecule techniques, which have already been established in other fields, to applications with microbial PSs (Research Focus Box). This is the case for techniques such as optical tweezers or optical traps (Ashkin, 1992, 1997) that provide a unique means of manipulating and controlling biological objects and for magnetic tweezers that are capable of inducing mechanical torsion on single molecules. When using optical tweezers, force is sensed by the displacement of a microsphere trapped in a narrowly focused beam of laser light. While the AFM allows measurement of forces in the range of 5–103 pN, optical tweezers allow reliable determination of forces ranging from 0.1 to 100 pN (Neuman et al., 2007). Interesting studies have been conducted in which adhesive forces between individual bacterial surfaces and protein-coated surfaces have been reported (Simpson et al., 2003; Castelain et al., 2007) but, to our knowledge, optical or magnetic tweezers have not yet been used to investigate single PS molecules. The present lack of examples of published optical tweezers-based single-molecule studies investigating PSs may reflect practical challenges faced when developing this field. The use of optical tweezers for the study of PSs requires further development of suitable attachment methods for the PSs onto the colloidal probes,
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
266
14. Single-molecule studies of polysaccharides
Research Focus Box • Sample preparation standarization is required from extraction of microbial samples to preparation for single-molecule studies, including, e.g immobilization strategies. • Microbial PS standards for single-molecule studies are needed. • Extension of the accessible force range and measurement capabilities with the application
including methods that allow specific attachment of the end of the molecule. The use of molecular linkers, as developed for AFM singlemolecule stretching and interaction studies, may find use also in optical tweezer studies. Despite the practical challenges faced, the potential of this technique in revealing insights into the involvement of PSs in intra- and intermolecular interactions should inspire the future use of this technique in PS research.
Acknowledgements D.C.G.K. acknowledges support from the Norwegian Research Council, Grant number 170521/V40.
References Abu-Lail, L.I., Liu, Y., Atabek, A., Camesano, T.A., 2007. Quantifying the adhesion and interaction forces between Pseudomonas aeruginosa and natural organic matter. Environ. Sci. Tech. 41, 8031–8037. Arce, F.T., Avci, R., Beech, I.B., Cooksey, K.E., WigglesworthCooksey, B., 2004. A live bioprobe for studying diatomsurface interactions. Biophys. J. 87, 4284–4297. Ashkin, A., 1992. Forces of a single-beam gradient laser trap on a dielectric sphere in the ray optics regime. Biophys. J. 61, 569–582.
of additional single-molecule techniques to microbial polysaccharides. • Automation and high-throughput data analysis would be advantageous. • Developments towards single-molecule studies with additional molecules present, i.e. steps that would aid in vivo applications.
Ashkin, A., 1997. Optical trapping and manipulation of neutral particles using lasers. Proc. Natl. Acad. Sci. USA 94, 4853–4860. Beech, I.B., Smith, J.R., Steele, A.A., Penegar, I., Campbell, S.A., 2002. The use of atomic force microscopy for studying interactions of bacterial biofilms with surfaces. Colloids Surf. B, Biointerf. 23, 231–247. Bell, G.I., 1978. Models for the specific adhesion of cells to cells. A theoretical framework for adhesion mediated by reversible bonds between cell surface molecules. Science 200, 618–627. Benoit, M., Gabriel, D., Gerisch, G., Gaub, H.E., 2000. Discrete interactions in cell adhesion measured by single-molecule force spectroscopy. Nat. Cell Biol. 2, 313–317. Binnig, G., Quate, C.F., Gerber, C., 1986. Atomic force microscope. Phys. Rev. Lett. 56, 930–933. Bippes, C.A., Humphris, A.D.L., Stark, M., Müller, D.J., Janovjak, H., 2006. Direct measurement of single-molecule visco-elasticity in atomic force microscope force-extension experiments. Eur. Biophys. J. 35, 287–292. Bustamante, C., Bryant, Z., Smith, S.B., 2003. Ten years of tension: single-molecule DNA mechanics. Nature 421, 423–427. Bustamante, C., Chemla, Y.R., Forde, N.R., Izhaky, D., 2004. Mechanical processes in biochemistry. Annu. Rev. Biochem. 73, 705–748. Butt, H.-J., Cappella, B., Kappl, M., 2005. Force measurements with the atomic force microscope: Technique, interpretation and applications. Surf. Sci. Rep. 59, 1–152. Castelain, M., Pignon, F., Piau, J.M., Magnin, A., MercierBonin, M., Schmitz, P., 2007. Removal forces and adhesion properties of Saccharomyces cerevisiae on glass substrates probed by optical tweezer. J. Chem. Phys. 127, 135104–135114.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Dague, E., Alsteens, D., Latgé, J-P., Dufrêne, Y.F., 2008. High-resolution cell surface dynamics of germinating Aspergillus fumigatus conidia. Biophys. J. 94, 656–660. Ditzler, M.A., Aleman, E.A., Rueda, D., Walter, N.G., 2007. Single molecule RNA enzymology. Biopolymers 87, 302–316. Dufrêne, Y.F., 2004. Using nanotechniques to explore microbial surfaces. Nat. Rev. Microbiol. 2, 451–460. Dufrêne, Y.F., 2008. AFM for nanoscale microbe analysis. Analyst 133, 297–301. Dupres, V., Menozzi, F.D., Locht, C., et al., 2005. Nanoscale mapping and functional analysis of individual adhesins on living bacteria. Nat. Methods 2, 515–520. Duval, J.F.L., Slaveykova, V.I., Hosse, M., Buffle, J., Wilkinson, K.J., 2006. Electrohydrodynamic properties of succinoglycan as probed by fluorescence correlation spectroscopy, potentiometric titration and capillary electrophoresis. Biomacromolecules 7, 2818–2826. Evans, E., Ritchie, K., 1997. Dynamic strength of molecular adhesion bonds. Biophys. J. 72, 1541–1555. Gaboriaud, F., Dufrêne, Y.F., 2007. Atomic force microscopy of microbial cells: application to nanomechanical properties, surface forces and molecular recognition forces. Colloids Surf. B Biointerfaces 54, 10–19. Gowers, D.M., Wilson, G.G., Halford, S.E., 2005. Measurement of the contributions of 1D and 3D pathways to the translocation of a protein along DNA. Proc. Natl. Acad. Sci. USA 102, 15883–15888. Ha, J-S., Song, J.J., Lee, Y-M., et al., 2007. Design and application of highly responsive fluorescence resonance energy transfer biosensors for detection of sugar in living Saccharomyces cerevisiae cells. Appl. Environ. Microbiol. 73, 7408–7414. Higgins, M.J., Crawford, S.A., Mulvaney, P., Wetherbee, R., 2002. Characterization of the adesive mucilages secreted by live diatom cells using atomic force microscopy. Protist 153, 25–38. Hinterdorfer, P., Dufrêne, Y.F., 2006. Detection and localization of single molecular recognition events using atomic force microscopy. Nat. Methods 3, 347–355. Humphris, A.D.L., Tamayo, J., Miles, M.J., 2000. Active quality factor control in liquids for force spectroscopy. Langmuir 16, 7891–7894. Humphris, A.D.L., Antognozzi, M., McMaster, T.J., Miles, M.J., 2002. Transverse dynamic force spectroscopy: a novel approach to determining the complex stiffness of a single molecule. Langmuir 18, 1729–1733. Jones, G.M., Wofsy, C., Aurell, C., Sklar, L.A., 1999. Analysis of vertical fluorescence resonance energy transfer from the surface of a small-diameter sphere. Biophys. J. 76, 517–527. Kawakami, M., Byrne, K., Khatri, B.S., McLeish, T.C.B., Radford, S.E., Smith, D.A., 2004. Viscoelastic properties
267
of single polysaccharide molecules determined by analysis of thermally driven oscillations of an atomic force microscope cantilever. Langmuir 20, 9299–9303. Khatri, B.S., Kawakami, M., Byrne, K., Smith, D.A., McLeish, T.C.B., 2007. Entropy and barrier-controlled fluctuations determine conformational viscoelasticity of single biomolecules. Biophys. J. 92, 1825–1835. Kim, J.S., Jang, S., Kim, U., Cho, K., 2007. AFM studies of inhibition effect in binding of antimicrobial peptide and immune proteins. Langmuir 23, 10438–10440. Lacroix-Gueu, P., Briandet, R., Lévêque-Fort, S., BellonFontaine, M-N., Fontaine-Aupart, M-P., 2005. In situ measurements of viral particles diffusion inside mucoid biofilms. C. R. Biol. 328, 1065–1072. Lager, I., Looger, L.L., Hilpert, M., Lalonde, S., Frommer, W.B., 2006. Conversion of a putative Agrobacterium sugarbinding protein into a FRET sensor with high selectivity for sucrose. J. Biol. Chem. 13, 30875–30883. Lee, G., Nowak, W., Jaroniec, J., Zhang, Q., Marszalek, P.E., 2004. Molecular dynamics simulations of forced conformational transitions in 1,6-linked polysaccharides. Biophys. J. 87, 1456–1465. Leng, X., Starchev, K., Buffle, J., 2001. Applications of fluorescence correlation spectroscopy: measurement of sizemass relationship of native and denatured schizophyllan. Biopolymers 59, 290–299. Li, H., Rief, M., Oesterhelt, F., Gaub, H.E., 1998. Singlemolecule force spectroscopy on xanthan by AFM. Adv. Mater. 3, 316–319. Li, H., Rief, M., Oesterhelt, F., Gaub, H.E., Zhang, X., Shen, J., 1999. Single-molecule force spectroscopy on polysaccharides by AFM-nanomechanical fingerprint of ˜ -(1,4)linked-polysaccharides. Chem. Phys. Lett. 305, 197–201. Liphardt, J., Onoa, B., Smith, S.B., Tinoco, I., Bustamante, C., 2001. Reversible unfolding of single RNA molecules by mechanical force. Science 292, 733–737. Marszalek, P.E., Oberhauser, A.F., Pang, Y-P., Fernandez, J.M., 1998. Polysaccharide elasticity governed by chairboat transitions of the glucopyranose ring. Nature 396, 661–664. Marszalek, P.E., Pang, Y-P., Li, H., Yazal, J.E., Oberhauser, A.F., Fernandez, J.M., 1999. Atomic levers control pyranose ring conformations. Proc. Natl. Acad. Sci. USA 96, 7894–7898. Marszalek, P.E., Li, H., Fernandez, J.M., 2001. Fingerprinting polysaccharides with single-molecule atomic force microscopy. Nat. Biotechnol. 19, 258–262. Marszalek, P.E., Li, H., Oberhauser, A.F., Fernandez, J.M., 2002. Chair-boat transitions in single polysaccharide molecules observed with force-ramp AFM. Proc. Natl. Acad. Sci. USA 99, 4278–4283. Masuda, A., Ushida, K., Okamoto, T., 2005. New fluorescence correlation spectroscopy enabling direct observation of
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
268
14. Single-molecule studies of polysaccharides
spatiotemporal dependence of diffusion constants as an evidence of anomalous transport in extracellular matrices. Biophys. J. 88, 3584–3591. Mostaert, A., Higgins, M.J., Fukuma, T., Rindi, F., Jarvis, S.P., 2006. Nanoscale mechanical characterisation of amyloid fibrils discovered in a natural adhesive. J. Biol. Physics. 32, 393–401. Müller, D.J., Engel, A., 1999. pH and voltage induced structural changes of porin OmpF explains channel closure. J. Mol. Biol. 285, 1347–1351. Neelov, I.M., Adolf, D.B., McLeish, T.C.B, Paci, E., 2006. Molecular dynamics simulation of dextran extension by constant force in single molecule AFM. Biophys. J. 91, 3579–3588. Neuman, K.C., Lionnet, T., Allemand, J-F., 2007. Singlemolecule micromanipulation techniques. Annu. Rev. Mat. Sci. 37, 33–67. Oberhauser, A.F., Hansma, P.K., Carrion-Vazquez, M., Fernandez, J.M., 2001. Stepwise unfolding of titin under force-clamp atomic force microscopy. Proc. Natl. Acad. Sci. USA 98, 468–472. Pelling, A.E., Li, Y., Shi, W., Gimzewski, J.K., 2005. Nanoscale visualization and characterization of Myxococcus xanthus cells with atomic force microscopy. Proc. Natl. Acad. Sci. USA 102, 6484–6489. Raab, A., Han, W., Badt, D., et al., 1999. Antibody recognition imaging by force microscopy. Nat. Biotechn. 17, 902–905. Ratto, T.V., Langry, K.C., Rudd, R.E., Balhorn, R.L., Allen, M.J., McElfresh, M.W., 2004. Force spectroscopy of the doubletethered concanavalin-A mannose bond. Biophys. J. 86, 2430–2437. Rief, M., Oesterhelt, F., Heymann, B., Gaub, H.E., 1997. Single molecule force spectroscopy on polysaccharides by atomic force microscopy. Science 275, 1295–1297. Rief, M., Fernandez, J.M., Gaub, H.E., 1998. Elastically coupled two-level systems as a model for biopolymer extensibility. Phys. Rev. Lett. 81, 4764–4767. Samori, P. (Ed.)., 2006. Scanning Probe Microscopies Beyond Imaging. Manipulation of Molecules and Nanostructures. Wiley-VCH Verlag, Weinheim.
Schenter, G.K., Lu, H.P., Xie, X.S., 1999. Statistical analyses and theoretical models of single-molecule enzymatic dynamics. J. Phys. Chem. A. 103, 10477–10488. Schwille, P., Haustein, E., 2002. Fluorescence correlation spectroscopy: a tutorial for the biophysics textbook online. http://www.biophysics.org/education/resources.htm. Simpson, K.H., Bowden, G., Höök, M., Anvari, B., 2003. Measurement of adhesive forces between individual Staphylococcus aureus MSCRAMMs and protein-coated surfaces by use of optical tweezers. J. Bacteriol. 185, 2031–2035. Sletmoen, M., Skjåk-Bræk, G., Stokke, B.T., 2004. Singlemolecular pair unbinding studies of mannuronan C-5 epimerase AlgE4 and its polymer substrate. Biomacro molecules 5, 1288–1295. Stanford, N.P., Szczelkun, M.D., Marko, J.F., Halford, S.E., 2000. One- and three-dimensional pathways for proteins to reach specific DNA sites. EMBO J. 19, 6546–6557. Svoboda, K., Schmidt, C.F., Schnapp, B.J., Block, S.M., 1993. Direct observation of kinesin stepping by optical trapping interferometry. Nature 365, 721–727. van Oijen, A.M., 2007. Single-molecule studies of complex systems: the replisome. Mol. Biosyst. 3, 117–125. Voss, S., Fisher, R., Jung, G., Wiesmüller, K-H., Brock, R., 2007. A fluorescence-based synthetic LPS sensor. J. Am. Chem. Soc. 129, 554–561. Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., Espevik, T., 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169, 333–338. Warfield, R., Bardelang, P., Saunders, H., et al., 2006. Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus. Org. Biomol. Chem. 4, 3626–3638. Weiss, S., 2000. Measuring conformational dynamics of biomolecules by single molecule fluorescence spectroscopy. Nat. Struct. Biol. 7, 724–729. Yasuda, R., Noji, H., Yoshida, M., Kinosita, K., Itoh, H., 2001. Resolution of distinct rotational substeps by submillisecond kinetic analysis of F-1-ATPase. Nature 410, 898–904.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
15 Viral surface glycoproteins in carbohydrate recognition: structure and modelling Jeffrey C. Dyason and Mark von Itzstein
Summary
1. Introduction
The importance of carbohydrate-recognizing viral surface glycoproteins in a range of clinically important viral infections has been identified and a number of these proteins have been investigated as possible drug discovery targets. As a part of these investigations several of these proteins have had their three-dimensional structures determined by either nuclear magnetic resonance spectroscopic or X-ray crystallographic methods. This structural information has provided an excellent basis for structure-assisted inhibitor design using computational chemistry methods. This chapter describes some of the most significant developments in the field of structure-based investigations of viral surface-resident carbohydrate-recognizing proteins. Specifically, an overview of these carbohydrate-recognizing proteins from four important human viruses, including influenza, dengue, rotavirus and parainfluenza, and associated structural investigations will be presented.
For viruses to be able to replicate, they need to be able to adhere, then bind and invade and, finally, to escape from a susceptible host cell. Animal host cell surfaces are highly decorated by a range of glycan structures that are made up of both charged and neutral carbohydrates (Gagneux and Varki, 1999). These carbohydrates are involved in a range of different functions, including cell protection, a host of recognition events and cell–cell communication (Gagneux and Varki, 1999). As a consequence of this elaborate host cell surface carbohydrate display, viruses have had to develop a variety of strategies that can deal with this protective barrier to enable successful viral propagation. In fact, many viruses actively use these carbohydrates in the recognition and invasion process of their life cycle. Understanding the structure of these viral surface proteins is vital not only to help understand their function but also to enable the design of new drugs capable of mitigating the effects caused during infection.
Keywords: Virus; Carbohydrate; Molecular modelling; Influenza; Dengue virus; Rotavirus; Parainfluenza
Microbial Glycobiology
269
© 2009 2010, Elsevier Inc.
270
15. Viral surface proteins as drug discovery targets
2. Influenza Virus Influenza virus has been an affliction of mankind for centuries, with several major pandemics being reported, including the Spanish Flu which, at the end of World War I (1918– 1919), killed an estimated 40 million people (Taubenberger et al., 2001). More recently, the emergence of the highly pathogenic avian influenza virus strain, H5N1, although not easily transmissible between humans, has a reported mortality rate in man of over 50% (WHO, 2008). Influenza virus contains a single-stranded segmented RNA genome and is a member of the orthomyxoviridae family that is further subdivided into three distinct types, influenza virus A, B and C (van Regenmortel et al., 2000). Of most concern to the human population are types A and B, with type A the most likely to cause pandemics (Luscher-Mattli, 2000). Both types A and B have two surface-based carbohydrate recognizing proteins involved in the infectious cycle of the virus, namely haemagglutinin (HA), which has a lectin and fusion function and sialidase (also known as neuraminidase, NA) which has a glycohydrolase function. Type C has only one major carbohydrate recognizing protein and that is haemagglutinin-esterasefusion protein (HEF), which combines the roles of the HA and NA of influenza A and B (Herrler et al., 1988). Currently, the major way of combating influenza virus A and B infection is via an annual vaccine injection, however, this is not foolproof and generally provides no protection against new strains of influenza virus, like that which may arise from the avian H5N1 strains. Also available are several drugs, the most successful of which are the NA inhibitors (von Itzstein, 2007), Relenza® and Tamiflu® (see below). However, mutant influenza strains resistant to Tamiflu® have been recently detected that potentially limit the available armament and clearly necessitates the ongoing search for new treatments
(von Itzstein, 2007). While influenza virus C is not common, it can cause respiratory tract infections generally in young children, however, in some cases, this may lead to more severe infections such as bronchiolitis and pneumonia (Wagaman et al., 1989; Crescenzo-Chaigne and van der Werf, 2007). There is currently no vaccine or specific drug treatment for influenza C.
2.1. Haemagglutinin as a drug discovery target Influenza virus HA is a homo-trimeric glycosylated protein located on the surface of the virion (Figure 15.1) and is responsible for the initial
Figure 15.1 The secondary structure of an influenza virus haemagglutinin trimer is shown with a translucent surface. The surface is coloured by electrostatic potential with red denoting areas of negative charge while blue denotes areas of positive charge. (See colour plates section.)
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. Influenza Virus
attachment of the virion to the host cell surface, by recognition of terminal sialic acid moieties. A change in conformation of the protein is then responsible for the initiation of fusion with the cell membrane. The first structure of influenza virus A HA was published in 1981 (Wilson et al., 1981). Since that time, over 70 structures of various influenza virus HAs have been deposited in the Research Collabatory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB) (Berman et al., 2000). During the 1980s and early 1990s, there were a number of attempts at using the available crystal structures of influenza virus HA to design small molecule HA binders that would hopefully inhibit the replication of influenza virus. A number of excellent reviews have appeared that detail these attempts (LuscherMattli, 2000; Matrosovich and Klenk, 2003). However, it was realized that the low affinity of the sialic acid binding site would not produce the tight binding inhibitor required for a drug, leading to the design and synthesis of multivalent and polymeric inhibitors. These inhibitors have, however, not produced a suitable drug candidate, although work is still being undertaken (Ogata et al., 2007; Marra et al., 2008). A recent study by Nandi (2008) described an in silico search of a small subset in the ZINC database (Irwin and Shoichet, 2005) and led to the suggestion of some possible small molecule inhibitors of HA binding, although biological evaluation of these compounds is not yet reported. Avian influenza virus HA preferentially recognizes terminal -(2→3)-linked sialic acid containing glycoconjugates, whereas humanadapted influenza virus HA preferentially recognizes terminal -(2→6)-linked sialic acid glycoconjugates. More recently, the crystal structures of HAs from the virus responsible for the 1918–1919 pandemic (Gamblin et al., 2004) and from the highly pathogenic avian influenza H5N1 strain (Stevens et al., 2006) have been elucidated. Knowledge of these structures has led to a greater understanding of the sialic acid
271
specificity of these strains and it appears as if only a few amino acid mutations are needed to enable the avian influenza virus HA to switch its specificity and recognize human receptors (Stevens et al., 2006; Yamada et al., 2006). Recent reports that influenza virus may recognize receptors other than the accepted -(2→6)linked sialic acids observed in the human lower respiratory tract (Rapoport et al., 2006; Nicholls et al., 2007), has inspired studies that may more completely characterize novel asialoglycan recognition by HA. For example, the von Itzstein group described a nuclear magnetic resonance (NMR) spectroscopy-based study that enables the interrogation of H5 (from H5N1), as a surface protein of virus-like particles, with novel inhibitors and potential novel glycan structures (Haselhorst et al., 2008).
2.2. Sialidase as a drug discovery target The NA of influenza virus A and B has been the major focus in the development of drugs to combat influenza infection with two drugs already available on the market, namely the structure-based designed zanamivir (Relenza®, GlaxoSmithKline) and oseltamivir (Tamiflu®, Roche). The development of these drugs has been adequately reviewed elsewhere (Laver, 2006; von Itzstein, 2007, 2008). Influenza virus NA is a receptor-destroying enzyme which cleaves the HA receptor, sialic acid, from a range of sialyloligosaccharides allowing newly formed viral progeny to escape the surface of infected cells and go on to infect more cells. Influenza virus NA is a glycosylated homotetramer which is tethered to the virus surface by a long protein stalk at its C terminal (Figure 15.2). The first structure of influenza virus NA was published in 1983 (Colman et al., 1983; Varghese et al., 1983) and there exists nearly 100 structures in the current PDB, including a number of mutant proteins as well as a number of inhibitor-enzyme complexes.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
272
15. Viral surface proteins as drug discovery targets
Figure 15.3 Superimposition of two complexed N9 Figure 15.2 The influenza virus sialidase tetramer is shown with a translucent surface, coloured by electrostatic potential overlaying the monomer secondary structure. Each monomer has six four-stranded anti-parallel -sheets arranged as if on the blades of a propeller. (See colour plates section.)
The inhibitor-enzyme complexes in particular allow further study to understand the interactions involved and the design of new inhibitors to combat the existence of mutated influenza viruses that are less susceptible to the existing drugs, particularly Tamiflu®. This wealth of structural information has facilitated the use of structure-based drug design techniques, such as docking, molecular mechanics/PoissonBoltzmann surface area (MM/PBSA) simulations, comparative molecular field analysis (CoMFA), etc., in providing not only an explanation of how inhibitors bind to the influenza virus NAs but also in the design of new inhibitors. A selection of publications gives an overview of the use of these techniques (Stoll et al., 2003; Masukawa et al., 2003; Armstrong et al., 2006; Platis et al., 2006; Zhang et al., 2006; Abu Hammad et al., 2007).
sialidase structures of influenza virus showing the induced fit of Glu276 when oseltamivir carboxylate (orange carbon atoms) is bound, compared with Neu5Ac2en (green carbon atoms). (See colour plates section.)
One aspect that is not handled consistently in many of these studies is the ability of the protein to undergo induced-fit when the glycerol side chain of the sialic acid-based inhibitor zanamivir is replaced with a hydrophobic group, e.g. the active form of oseltamivir, oseltamivir carboxylate (Figure 15.3). In this example, to accommodate the hydrophobic group of oseltamivir carboxylate, glutamic acid residue 276 (Glu276) flips to form an internal interaction with arginine 224 (Arg224) that results in a hydrophobic pocket where, previously, there was a negatively-charged hydrogen bonding group. Such induced-fit phenomena are not easily predicted or indeed adequately handled by theoretical models. Relying on this induced fit, as oseltamivir carboxylate does, also makes it a “hot-spot” for the virus to generate mutants that render the drug less able to inhibit the receptor-destroying enzyme function of the NA. This outcome has already been observed in a histidine-tyrosine (His274Tyr) N1 mutant where oseltamivir carboxylate is 265-fold less potent
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
2. Influenza Virus
273
et al., 2001; Mishin et al., 2005), although some strain variability has been observed. A complication with the current avian H5N1 strain (an example of a group 1 NA) induced disease is that in humans it manifests differently to the normally observed human influenza disease resulting in a higher mortality. In fact, the H5N1 strain appears to have more in common with the Spanish flu strain of 1918–1919 (H1N1) where healthier individuals appear to be more susceptible than the usual influenza target population of the old, young and immunocompromised. It has been proposed that this is a direct consequence of these pandemic or pandemic-like viruses’ ability to cause an immune event referred to as a cytokine storm (Peiris et al., 2007).
Figure 15.4 Crystal structures of the influenza virus N8 sialidase. The surface and the magenta coloured 150 loop are from a structure of the uncomplexed protein while the Neu5Ac2en and green-coloured 150 loop are from a structure where Neu5Ac2en was soaked into the protein crystals. The surface is coloured by electrostatic potential. (See colour plates section.)
compared to zanamivir which is only a factor of 2 less potent (Collins et al., 2008). One of the most interesting advances to come from recent NA structure determination and analysis is the existence of two distinct groups of influenza virus NAs, group 1 and 2 (Russell et al., 2006). The main difference between the groups appears to be a very flexible active site loop that includes one of the main catalytic residues, aspartic acid 151 (Asp151). The group 1 NAs consisting of N1, N4, N5 and N8 subtypes have the very flexible 150-loop which opens up a large new pocket in the active site in their uncomplexed form, whereas the group 2 NAs consisting of N2, N3, N6, N7 and N9 show no movement of this 150-loop (Figure 15.4). While the current commercially available NA-targeting drugs have all been designed against the group 2 NAs, they generally appear to be equally effective against the group 1 NAs (Govorkova
2.3. Haemagglutinin esterase fusion protein The HEF of influenza virus C is structurally very similar to HA found on the surface of influenza virus A and B, in that it is a homotrimeric glycosylated surface protein. The major differences are in: (i) the receptor that is recognized, sialic acidcontaining glycoconjugates are recognized by HA while 9-O-acetylated sialic acidglycoconjugates are recognized by HEF; and (ii) the fact that HEF contains both a lectin function as well as a receptor-destroying enzyme, in contrast to influenza virus A and B that have two distinct proteins for these functions. The receptor-destroying enzyme of HEF is an esterase and cleaves an O-acetate group from the 9’-position of sialic acids. The crystal structure of HEF was published in 1998 (Rosenthal et al., 1998) with the receptor-destroying enzyme active site being very similar in nature to a serine esterase and being completely separate to the receptor-binding site. Modelling experiments using a forced glycosidic angle torsion search have helped explain NMR results obtained
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
274
15. Viral surface proteins as drug discovery targets
recently within the von Itzstein group (Mayr et al., 2008) for both HEF and bovine coronavirus esterase. This led to the understanding of the essential pharmacophoric groups required for binding to the receptor-destroying enzyme active site and the knowledge that the aglycon group does not appear to be involved in substrate binding to this site. Similar haemagglutinin esterases (30% homology) have also been identified in corona and toroviruses (de Groot, 2006) and, although these viruses are not closely related to influenza virus C, an understanding of the structure and function of the haemagglutinin esterase will provide more information on the mechanism of cell recognition and entry.
2.4. Future directions Influenza virus is very adaptable, with resistant mutants already appearing for at least one of the commercially available NA inhibitors. The ongoing structural and computational studies on the surface-resident carbohydrate recognizing proteins will help not only to identify new and potent drugs but also to understand more fully the mechanism of action of these proteins. This is especially of interest to the group 1 NAs including the current avian influenza (H5N1), where a flexible loop in the active site provides antiinfluenza drug designers with another target to improve the potency of existing drugs and the chance to develop new group 1-specific drugs.
3. Parainfluenza The paramyxoviridae family includes as members the human parainfluenza viruses, Newcastle disease virus and the measles and mumps viruses (Lamb et al., 1996). Of particular interest are human parainfluenza viruses and Newcastle disease virus, both of which have a surface-resident carbohydrate recognizing protein known as haemagglutinin-neuramindase (HN) which
is involved in both cellular recognition and as a receptor-destroying enzyme (Lamb et al., 1996). There are four human parainfluenza viruses (hPIV) strains identified, hPIV-1, hPIV-2, hPIV3 and hPIV-4, all of which cause respiratory tract symptoms, e.g. coughing and wheezing, predominantly in infants. The human parainfluenza viruses are considered the second most important cause of lower respiratory tract disease in young children, behind respiratory syncytial virus (Henrickson, 2003). Strains hPIV-1 and hPIV-2 are commonly associated with the respiratory tract disease croup, while hPIV-3 can cause bronchiolitis and pneumonia and hPIV-4 is rarely detected (Henrickson, 2003). Newcastle disease virus is also known as avian paramyxovirus 1 and has a devastating effect on the poultry industry worldwide (Seal et al., 2000).
3.1. Haemagglutinin-neuraminidase as a drug discovery target Similar to the HEF of influenza virus C, HN includes both a recognition element for terminal sialic acids as well as a receptor-destroying (sialidase/neuraminidase) function to facilitate virion budding. The first crystal structures of a HN from Newcastle disease virus were published in 2000 (Crennell et al., 2000), showing it to be very similar to the influenza virus NA in its overall shape and active site configuration, however, the active site appeared to be more flexible, probably allowing it to function as both a sialic acid-recognizing lectin and a NA. A more recent Newcastle disease virus HN structure (Zaitsev et al., 2004) has revealed the presence of a second sialic acid binding site which is proposed to be involved in the fusion process but not in the initial recognition of sialic acids. At that time, these Newcastle disease virus HN structures were the only available structures for structurebased drug design of inhibitors against human parainfluenza viruses and led to two reports of designed inhibitors for this enzyme system
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
275
4. Dengue virus
(Alymova et al., 2004; Tindal et al., 2007). These studies made use of the 2-deoxy-2,3-didehydroN-acetylneuraminic acid (Neu5Ac2en) template which was also the precursor of the influenza virus NA inhibitor Relenza® and both also targeted a large cavity around the O-4 binding region of the Neu5Ac2en template. The best of these inhibitors led to micromolar inhibition of the NA function of the most serious of the human parainfluenza viruses (i.e. hPIV-3). A crystal structure has been reported for one of these designed inhibitors (Ryan et al., 2006) in complex with Newcastle disease virus HN and demonstrates that the ligand is bound into the active site in the predicted manner (Figure 15.5). More recently, several crystal structures of the HN from hPIV-3 have been published (Lawrence et al., 2004), although, to the best of our knowledge, no structure-based drug design studies have been reported. Furthermore, crystal structures of the HN from PIV5, formerly
known as simian virus 5, have been published (Yuan et al., 2005) and reveal an overall architecture that appears to be similar to those of Newcasle disease virus and hPIV-3.
3.2. Future directions In addition to providing drug design opportunities, these HN structures, along with structures of the fusion (F) protein, provide more information on the mechanism of cell entry by this family of viruses. This will lead to a greater understanding of how these viruses propagate, making it easier to combat their spread. The original structure-based drug design studies for an anti-human parainfluenza virus drug were based on the available Newcastle disease virus HN structures, more detailed design work can now be undertaken using the hPIV-3 structures. Also, there are a number of non-sialic acid based templates that have been used in the development of influenza virus NA (e.g. cyclohexene, cyclopentane and pyrrolidine), these alternative templates could be used in the structure-based drug design process to extend the range of compounds as potential HN inhibitors.
4. Dengue virus
Figure 15.5 Crystal structure of 4-O-benzyl-Neu5Ac2en soaked into the haemagglutinin-neuraminidase of Newcastle disease virus, showing the large pocket targeted by the benzyl group of the designed inhibitor. (See colour plates section.)
The flaviviruses are members of the Flaviviridae family and are transmitted to humans by either mosquito or tick bites (Solomon and Mallewa, 2001). Flavivrus infection can lead to a number of severe and debilitating symptoms, e.g. fever-arthralgia-rash, viral haemorrhagic fever and neurological disease (Solomon and Mallewa, 2001). The mosquito-borne viruses include Dengue virus (DENV), of which there are four strains (DENV1, DENV2, DENV3 and DENV4), yellow fever virus, West Nile virus and Japanese encephalitis virus, while the tick-borne viruses include tick-borne encephalitis virus, Langat virus and Omsk haemorrhagic fever virus.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
276
15. Viral surface proteins as drug discovery targets
4.1. E-Glycoprotein and E-glycoproteindomain 3 The surface of flavivirus is predominantly covered by E-glycoprotein (EGP) which forms dimers that are tethered to the surface by a stalk region. The EGP-associated glycan of the virus has been shown to be important for DENV infection through its interaction with dendritic cell-specific ICAM-3-grabbing nonintegrin, DC-SIGN (Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003) (see Chapter 34). This interaction and its involvement in the life cycle have been recently reviewed (Perera et al., 2008). Of note, EGP is the major site of host cell receptor binding and of host-mediated antibody neutralization. Both the mosquito and tickborne virus EGPs share significant sequence and structural homology. The crystal structures of EGP from several sources show that it is comprised of three distinct domains (Figure 15.6); namely DENV2 (Modis et al., 2003; Zhang et al., 2004), DENV3 (Modis et al., 2005) and tickborne encephalitis virus (Rey et al., 1995). After binding and during the fusion process, the EGP dimers dissociate and reform as trimers; the structures of this trimeric fusion state are also available, i.e. DENV2 (Modis et al., 2004),
tick-borne encephalitis virus (Bressanelli et al., 2004) and West Nile virus (Nybakken et al., 2006). Of these three domains, it has been found that Domain 3 (D3) is mostly responsible for the virus binding to target host cells (Crill and Roehring, 2001). Also, D3 by itself has been shown to block virus binding. In addition to the crystal structures mentioned above, there have been structures of the D3 sub-unit from DENV2 (Huang et al., 2008), DENV4 (Volk et al., 2007), West Nile virus (Volk et al., 2004), Japanese encephalitis virus (Wu et al., 2003), Langat virus (Wu et al., 2003) and haemorrhagic fever virus (Volk et al., 2006) determined by NMR spectroscopic techniques. While the receptor for EGP has not been definitively established, previous studies have identified the glycosaminoglycan, heparan sulfate and a range of protein species as proposed mammalian cell surface receptors (Clyde et al., 2006). A recent work (Aoki et al., 2006) has shown that there is an association between DENV and the mammalian cell surface glycolipid, paragloboside. This suggests that EGP and, in particular D3, are carbohydrate-recognizing proteins with small variations in sequence between the members of this family leading to differing cell receptors.
Figure 15.6 Crystal structure of the E-glycoprotein dimer of dengue virus. The red-coloured ribbon is Domain 1, the yellow-coloured ribbon is Domain 2, while the blue-coloured ribbon is Domain 3. The surface is coloured by electrostatic potential. (See colour plates section.)
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
277
5. Rotavirus
The available D3 structures from different flaviviruses also allows us to come to a greater understanding of how various neutralizing antibodies bind to D3 and EGP (Wu et al., 2003; Nybakken et al., 2005; Kaufmann et al., 2006; Gromowski and Barrett, 2007) and facilitate the design of possible therapeutics capable of halting the spread of these arthropod-borne viruses (Figure 15.7).
4.2. Future directions Access to the available structures and molecular modelling techniques, for example blind autodocking (Hetenyi and van der Spoel, 2002) and saturation transfer difference (STD-) NMR spectroscopic techniques (Mayer and Meyer,
2001; Haselhorst et al., 2007a,b) in combination with glycan array studies (Day et al., 2007), will provide exciting opportunities for the identification of not only the host cell based glycan receptor but also characterization of the binding site on D3. This information combined with structurebased drug design techniques can then be applied to search for a possible inhibitor of the initial recognition and binding events involved in cellular invasion by these arthropod-borne viruses. As presented in the influenza virus HA example above, small molecule-based inhibitors may not bind with sufficient affinity to produce an entity capable of preventing virus replication, however, multivalent inhibitors may provide valuable alternatives.
5. Rotavirus
Figure 15.7 Superimposition of the available flavivirus Domain 3 structures. Green, DENV2; red, DENV3; blue, Japenese encephalitis virus; cyan, Langat virus; magenta, Omsk haemorrhagic fever virus; yellow, tickborne encephalitis virus; and brown, West Nile virus. The surface represents the remaining portion of the EGP dimer and is coloured by electrostatic potential. A major difference can be seen in loop 1 for tick-borne encephalitis virus, Omsk haemorrhagic fever virus and Langat virus which bulges out because there is a 4 residue deletion in the loop 2 portions of these proteins. (See colour plates section.)
Rotavirus is a member of the Reoviridae family and is the most frequent causative agent of severe diarrhoea in young children accounting for 25–55% of all hospital admissions for diarrhoea and 600 000 deaths every year (Glass et al., 2006). While advances in the development of vaccines have been made (Heyse et al., 2008) for the human population, questions about safety and efficacy still remain (Franco and Greenberg, 2001). Furthermore, rotavirus also impacts on productivity in the livestock industry (Yu et al., 2008) and therefore further work is needed to better understand the rotavirus lifecycle and carbohydrate involvement for drug and new vaccine development opportunities.
5.1. VP8* The rotavirus virion surface spike protein VP4 is responsible for receptor binding and cell penetration (Ludert et al., 1996; Zarate et al., 2000; Arias et al., 2002). The protein VP4 is cleaved by trypsin into the N-terminal VP8*
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
278
15. Viral surface proteins as drug discovery targets
fragment which has been shown to be responsible for haemagglutination and the VP5* fragment which is believed to be involved in cellular fusion (Fiore et al., 1991; Ciarlet et al., 2002; Graham et al., 2003). There has been some controversy over the absolute requirement of sialic acid in the initial binding of VP8* of the virus to the cell surface (Delorme et al., 2001; Ciarlet et al., 2002; Isa et al., 2006). Currently, rotavirus strains are classified as either sialidase-sensitive, i.e. they no longer infect sialidase-treated cells inferring a sialic acid dependence of infection, or sialidaseinsensitive as they infect cells regardless of sialidase treatment, thereby suggesting sialic acid independence of infection. To examine carbohydrate recognition further, the first structures (NMR and X-ray) of a VP8* from a Rhesus rotavirus strain (sialidasesensitive) was published in 2002 (Dormitzer et al., 2002). Subsequently, the crystal structures of a number of native and site-directed mutant Rhesus rotavirus VP8* proteins have been reported (Kraschnefski et al., 2009). The only other VP8* structure from a sialidase-sensitive strain that has been published is from the porcine CRW-8 strain (Blanchard et al., 2007). All of the crystal structures of the above VP8* proteins have included the ligand Neu5Ac2Me (Figure 15.8). The binding site shows that the sugar ring is positioned between two tyrosine (Tyr) residues, while the carboxylic acid moiety of the sialic acid forms hydrogen bonds with a serine (Ser) residue and finally an arginine (Arg) residue forms hydrogen bonds to the glycerol side chain of the sialic acid. This sialic acid binding motif is different to that seen in influenza virus haemagglutinin and sialidase, but it has been reported in several sialyl-Lewis X recognizing bacterial toxins (Baker et al., 2007). Further to these structural investigations, and more relevant to human rotavirus infection, two structures of VP8* proteins from the sialidaseinsensitive human strains Wa (Kraschnefski
Figure 15.8 Crystal structure of Neu5Ac2Me (cyancoloured carbons) bound to the VP8* protein of rotavirus strain CRW-8. Hydrogen bonds to the serine (Ser) and arginine (Arg) are shown with magenta-coloured dotted lines while the two tyrosine (Tyr) residues which help position the sugar ring are also shown. (See colour plates section.)
et al., 2005; Blanchard et al., 2007) and DS-1 (Monnier et al., 2006) have been determined. Finally, a recent publication (Yu et al., 2008) has described the crystallization and preliminary X-ray diffraction analysis of VP8* protein from the sialidase-sensitive bovine rotavirus strain NCDV. Molecular modelling and STD NMR experiments within our group (Haselhorst et al., 2007a) have shown a very good correlation between the binding of a number of sialic acid derivatives to Rhesus rotavirus VP8* and the degree to which these compounds can inhibit rotavirus infection of cells. Also, information obtained on the binding epitope of sialic acid disaccharides showed that the penultimate sugar residue does not interact with the protein, but remains predominantly solvated. This is in very good agreement with molecular dynamics calculations that showed that this sugar (galactose) was unable to adopt a conformation where it is in close proximity to the surface (Haselhorst et al., 2007a).
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
279
Research Focus Box • Identification of next generation influenza virus sialidase inhibitors is required to replace existing drugs as resistance develops. • Understanding the carbohydrate recognition processes involved in dengue virus and rotavirus infection is necessary to enable the
5.2. Future directions The knowledge of the binding site and ligand for the VP8* protein from human rotavirus strains provides exciting opportunities for the design of inhibitors to prevent virus entry and infection. For example, the use of computational chemistry methods in exploring the available structural data in combination with other techniques, such as NMR spectroscopy, will be invaluable in advancing the role of carbohydrates in the rotavirus lifecycle.
6. Conclusions A large number of clinically important viruses utilize carbohydrate viral surface protein interactions to propagate infection and disease. The identification and structural characterization of the proteins and glycans essential in these recognition phenomena opens up new avenues for both drug discovery and vaccine development. While only a limited number of viral surface protein structures have been determined, already structure-based drug design techniques have afforded new classes of drugs. Although significant advances have been made in targeting virus surface glycoproteins for the
development of useful chemotherapeutic agents. • A systematic investigation of host–virus carbohydrate recognition phenomena would greatly enhance the field.
discovery of drugs, there remains an urgent need for further investigations (Research Focus Box). The science of glycovirology is still in its infancy but shows great promise for the delivery of new weapons against pathogens that have very few drug treatments available.
References Abu Hammad, A.M., Afifi, F.U., Taha, M.O., 2007. Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions. J. Mol. Graph. Model. 26, 443–456. Alymova, I.V., Taylor, G., Takimoto, T., et al., 2004. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob. Agents Chemother. 48, 1495–1502. Aoki, C., Hidari, K.I., Itonori, S., et al., 2006. Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2. J. Biochem. 139, 607–614. Arias, C.F., Isa, P., Guerrero, C.A., et al., 2002. Molecular biology of rotavirus cell entry. Arch. Med. Res. 33, 356–361. Armstrong, K.A., Tidor, B., Cheng, A.C., 2006. Optimal charges in lead progression: a structure-based neuraminidase case study. J. Med. Chem. 49, 2470–2477. Baker, H.M., Basu, I., Chung, M.C., Caradoc-Davies, T., Fraser, J.D., Baker, E.N., 2007. Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J. Mol. Biol. 374, 1298–1308.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
280
15. Viral surface proteins as drug discovery targets
Berman, H.M., Westbrook, J., Feng, Z., et al., 2000. The Protein Data Bank. Nucleic Acids Res. 28, 235–242. Blanchard, H., Yu, X., Coulson, B.S., von Itzstein, M., 2007. Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*). J. Mol. Biol. 367, 1215–1226. Bressanelli, S., Stiasny, K., Allison, S.L., et al., 2004. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23, 728–738. Ciarlet, M., Ludert, J.E., Iturriza-Gomara, M., et al., 2002. Initial interaction of rotavirus strains with Nacetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J. Virol. 76, 4087–4095. Clyde, K., Kyle, J.L., Harris, E., 2006. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J. Virol. 80, 11418–11431. Collins, P.J., Haire, L.F., Lin, Y.P., et al., 2008. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 453, 1258–1261. Colman, P.M., Varghese, J.N., Laver, W.G., 1983. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303, 41–44. Crennell, S., Takimoto, T., Portner, A., Taylor, G., 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7, 1068–1074. Crescenzo-Chaigne, B., van der Werf, S., 2007. Rescue of influenza C virus from recombinant DNA. J. Virol. 81, 11282–11289. Crill, W.D., Roehrig, J.T., 2001. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 7769–7773. Day, C., Tiralongo, J., Hartnell, R.D., von Itzstein, M., Wilson, J.C., Korolik, V., 2007. Optimisation of glycan and small molecule arrays for analysis of Campylobacter chemotaxis and adherence. Zoonoses Pub. Health 54 (Suppl. 1), 99. de Groot, R.J., 2006. Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses. Glycoconj. J. 23, 59–72. Delorme, C., Brussow, H., Sidoti, J., et al., 2001. Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J. Virol. 75, 2276–2287. Dormitzer, P.R., Sun, Z.Y., Wagner, G., Harrison, S.C., 2002. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 21, 885–897. Fiore, L., Greenberg, H.B., Mackow, E.R., 1991. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181, 553–563.
Franco, M.A., Greenberg, H.B., 2001. Challenges for rotavirus vaccines. Virology 281, 153–155. Gagneux, P., Varki, A., 1999. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9, 747–755. Gamblin, S.J., Haire, L.F., Russell, R.J., et al., 2004. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303, 1838–1842. Glass, R.I., Parashar, U.D., Bresee, J.S., et al., 2006. Rotavirus vaccines: current prospects and future challenges. Lancet 368, 323–332. Govorkova, E.A., Leneva, I.A., Goloubeva, O.G., Bush, K., Webster, R.G., 2001. Comparison of efficacies of RWJ270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob. Agents Chemother. 45, 2723–2732. Graham, K.L., Halasz, P., Tan, Y., et al., 2003. Integrin-using rotaviruses bind 21 integrin 2 I domain via VP4 DGE sequence and recognize X2 and V3 by using VP7 during cell entry. J. Virol. 77, 9969–9978. Gromowski, G.D., Barrett, A.D., 2007. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366, 349–360. Haselhorst, T., Blanchard, H., Frank, M., et al., 2007a. STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core. Glycobiology 17, 68–81. Haselhorst, T., Munster-Kuhnel, A.K., Oschlies, M., Tiralongo, J., Gerardy-Schahn, R., von Itzstein, M., 2007b. Direct detection of ligand binding to Sepharose-immobilised protein using saturation transfer double difference (STDD) NMR spectroscopy. Biochem. Biophys. Res. Commun. 359, 866–870. Haselhorst, T., Garcia, J.M., Islam, T., et al., 2008. Avian influenza H5-containing virus-like particles (VLPs): host-cell receptor specificity by STD NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 47, 1910–1912. Henrickson, K.J., 2003. Parainfluenza viruses. Clin. Microbiol. Rev. 16, 242–264. Herrler, G., Durkop, I., Becht, H., Klenk, H.D., 1988. The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. J. Gen. Virol. 69, 839–846. Hetenyi, C., van der Spoel, D., 2002. Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci. 11, 1729–1737. Heyse, J.F., Kuter, B.J., Dallas, M.J., Heaton, P., 2008. Evaluating the safety of a rotavirus vaccine: the REST of the story. Clin. Trials 5, 131–139. Huang, K.C., Lee, M.C., Wu, C.W., Huang, K.J., Lei, H.Y., Cheng, J.W., 2008. Solution structure and neutralizing
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
antibody binding studies of domain III of the dengue-2 virus envelope protein. Proteins 70, 1116–1119. Irwin, J.J., Shoichet, B.K., 2005. ZINC – a free database of commercially available compounds for virtual screening. J. Chem. Infect. Model. 45, 177–182. Isa, P., Arias, C.F., Lopez, S., 2006. Role of sialic acids in rotavirus infection. Glycoconj. J. 23, 27–37. Kaufmann, B., Nybakken, G.E., Chipman, P.R., et al., 2006. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proc. Natl. Acad. Sci. USA 103, 12400–12404. Kraschnefski, M.J., Scott, S.A., Holloway, G., Coulson, B.S., von Itzstein, M., Blanchard, H., 2005. Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8* carbohydrate-binding protein of the human rotavirus strain Wa. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61, 989–993. Kraschnefski, M.J., Bugarcic, A., Fleming, F., et al., 2009. Effects on sialic acid recognition of amino acid mutations in the carbohydrate-binding cleft of the rotavirus spike protein. Glycobiology 19, 194–200. Lamb, R.A., Kolakofsky, D., 1996. Paramyxoviridae: the viruses and their replication. In: Fields, B.N., Knipe, D.M., Howley, P.M. (Eds.), Fundamental Virology. Lippincott-Raven, Philadelphia, pp. 577–604. Laver, W., 2006. Antiviral drugs for influenza: Tamiflu® past, present and future. Future Virol. 1, 577–586. Lawrence, M.C., Borg, N.A., Streltsov, V.A., et al., 2004. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol 335, 1343–1357. Ludert, J.E., Feng, N., Yu, J.H., Broome, R.L., Hoshino, Y., Greenberg, H.B., 1996. Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J. Virol. 70, 487–493. Luscher-Mattli, M., 2000. Influenza chemotherapy: a review of the present state of art and of new drugs in development. Arch. Virol. 145, 2233–2248. Marra, A., Moni, L., Pazzi, D., Corallini, A., Bridi, D., Dondoni, A., 2008. Synthesis of sialoclusters appended to calix[4]arene platforms via multiple azide-alkyne cycloaddition. New inhibitors of hemagglutination and cytopathic effect mediated by BK and influenza A viruses. Org. Biomol. Chem. 6, 1396–1409. Masukawa, K.M., Kollman, P.A., Kuntz, I.D., 2003. Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations. J. Med. Chem. 46, 5628–5637. Matrosovich, M., Klenk, H.D., 2003. Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Rev. Med. Virol. 13, 85–97. Mayer, M., Meyer, B., 2001. Group epitope mapping by saturation transfer difference NMR to identify segments of a
281
ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123, 6108–6117. Mayr, J., Haselhorst, T., Langereis, M.A., et al., 2008. Influenza C virus and bovine coronavirus esterase reveal a similar catalytic mechanism: new insights for drug discovery. Glycoconj. J. 25, 393–399. Mishin, V.P., Hayden, F.G., Gubareva, L.V., 2005. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob. Agents Chemother. 49, 4515–4520. Modis, Y., Ogata, S., Clements, D., Harrison, S.C., 2003. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 100, 6986–6991. Modis, Y., Ogata, S., Clements, D., Harrison, S.C., 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313–319. Modis, Y., Ogata, S., Clements, D., Harrison, S.C., 2005. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 79, 1223–1231. Monnier, N., Higo-Moriguchi, K., Sun, Z.Y., Prasad, B.V., Taniguchi, K., Dormitzer, P.R., 2006. High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J. Virol. 80, 1513–1523. Nandi, T., 2008. Proposed lead molecules against hemagglutinin of avian influenza virus (H5N1). Bioinformation 2, 240–244. Navarro-Sanchez, E., Altmeyer, R., Amara, A., et al., 2003. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 4, 723–728. Nicholls, J.M., Chan, M.C., Chan, W.Y., et al., 2007. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 13, 147–149. Nybakken, G.E., Oliphant, T., Johnson, S., Burke, S., Diamond, M.S., Fremont, D.H., 2005. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437, 764–769. Nybakken, G.E., Nelson, C.A., Chen, B.R., Diamond, M.S., Fremont, D.H., 2006. Crystal structure of the West Nile virus envelope glycoprotein. J. Virol. 80, 11467–11474. Ogata, M., Murata, T., Murakami, K., et al., 2007. Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses. Bioorg. Med. Chem. 15, 1383–1393. Peiris, J.S., de Jong, M.D., Guan, Y., 2007. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev. 20, 243–267.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
282
15. Viral surface proteins as drug discovery targets
Perera, R., Khaliq, M., Kuhn, R.J., 2008. Closing the door on flaviviruses: entry as a target for antiviral drug design. Antiviral Res. 80, 11–22. Platis, D., Smith, B.J., Huyton, T., Labrou, N.E., 2006. Structure-guided design of a novel class of benzylsulfonate inhibitors for influenza virus neuraminidase. Biochem. J. 399, 215–223. Rapoport, E.M., Mochalova, L.V., Gabius, H.J., Romanova, J., Bovin, N.V., 2006. Search for additional influenza virus to cell interactions. Glycoconj. J. 23, 115–125. Rey, F.A., Heinz, F.X., Mandl, C., Kunz, C., Harrison, S.C., 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375, 291–298. Rosenthal, P.B., Zhang, X., Formanowski, F., et al., 1998. Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature 396, 92–96. Russell, R.J., Haire, L.F., Stevens, D.J., et al., 2006. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443, 45–49. Ryan, C., Zaitsev, V., Tindal, D.J., et al., 2006. Structural analysis of a designed inhibitor complexed with the hemagglutininneuraminidase of Newcastle disease virus. Glycoconj. J. 23, 135–141. Seal, B.S., King, D.J., Sellers, H.S., 2000. The avian response to Newcastle disease virus. Dev. Comp. Immunol. 24, 257–268. Solomon, T., Mallewa, M., 2001. Dengue and other emerging flaviviruses. J. Infect 42, 104–115. Stevens, J., Blixt, O., Tumpey, T.M., Taubenberger, J.K., Paulson, J.C., Wilson, I.A., 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312, 404–410. Stoll, V., Stewart, K.D., Maring, C.J., et al., 2003. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series. Biochemistry 42, 718–727. Tassaneetrithep, B., Burgess, T.H., Granelli-Piperno, A., et al., 2003. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823–829. Taubenberger, J.K., Reid, A.H., Janczewski, T.A., Fanning, T.G., 2001. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos. Trans. Roy. Soc. Lond., Sect. B, Biol. Sci. 356, 1829–1839. Tindal, D.J., Dyason, J.C., Thomson, R.J., et al., 2007. Synthesis and evaluation of 4-O-alkylated 2-deoxy2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity. Bioorg. Med. Chem. Lett. 17, 1655–1658.
van Regenmortel, M.H.V., Fauquet, C.M., Bishop, D.H.L. et al., (Eds.), 2000. Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego. Varghese, J.N., Laver, W.G., Colman, P.M., 1983. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution. Nature 303, 35–40. Volk, D.E., Beasley, D.W., Kallick, D.A., Holbrook, M.R., Barrett, A.D., Gorenstein, D.G., 2004. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J. Biol. Chem. 279, 38755–38761. Volk, D.E., Chavez, L., Beasley, D.W., Barrett, A.D., Holbrook, M.R., Gorenstein, D.G., 2006. Structure of the envelope protein domain III of Omsk hemorrhagic fever virus. Virology 351, 188–195. Volk, D.E., Lee, Y.C., Li, X., et al., 2007. Solution structure of the envelope protein domain III of dengue-4 virus. Virology 364, 147–154. von Itzstein, M., 2007. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug Discov. 6, 967–974. von Itzstein, M., 2008. Avian influenza virus, a very sticky situation. Curr. Opin. Chem. Biol. 12, 102–108. Wagaman, P.C., Spence, H.A., O’Callaghan, R.J., 1989. Detection of influenza C virus by using an in situ esterase assay. J. Clin. Microbiol. 27, 832–836. WHO. (2008). World Health Organization – Avian Influenza. http://www.who.int/csr/disease/avian_influenza/ en/index.html. Wilson, I.A., Skehel, J.J., Wiley, D.C., 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289, 366–373. Wu, K.P., Wu, C.W., Tsao, Y.P., et al., 2003. Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J. Biol. Chem. 278, 46007–46013. Yamada, S., Suzuki, Y., Suzuki, T., et al., 2006. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444, 378–382. Yu, X., Guillon, A., Szyczew, A.J., et al., 2008. Crystallization and preliminary X-ray diffraction analysis of the carbohydraterecognizing domain (VP8*) of bovine rotavirus straon NCDV. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. F64, 509–511. Yuan, P., Thompson, T.B., Wurzburg, B.A., Paterson, R.G., Lamb, R.A., Jardetzky, T.S., 2005. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13, 803–815.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
References
Zaitsev, V., von Itzstein, M., Groves, D., et al., 2004. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J. Virol. 78, 3733–3741. Zarate, S., Espinosa, R., Romero, P., Mendez, E., Arias, C.F., Lopez, S., 2000. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J. Virol. 74, 593–599.
283
Zhang, J., Yu, K., Zhu, W., Jiang, H., 2006. Neuraminidase pharmacophore model derived from diverse classes of inhibitors. Bioorg. Med. Chem. Lett. 16, 3009–3014. Zhang, Y., Zhang, W., Ogata, S., et al., 2004. Conformational changes of the flavivirus E glycoprotein. Structure 12, 1607–1618.
I. MICROBIAL GLYCOLIPIDS, GLYcOPROTEINS AND GLYCOPOLYMERS
c h a p t e r
19 Biosynthesis of cell wall teichoic acid polymers Mark P. Pereira and Eric D. Brown
Summary
and insertion of teichoic acid in the bacterial cell wall are summarized.
Wall teichoic acids are phosphate-rich polymers that are part of the complex meshwork that makes up the Gram-positive cell wall. These polymers are essential to the proper rod-shaped morphology of Bacillus subtilis and have been shown to be an important virulence determinant in the opportunistic pathogen Staphylococcus aureus. Although the biosynthesis of the teichoic acid polymer has been the subject of decades of investigation, only through recent advances in the development of chemical tools necessary for functional assays has the model of teichoic acid biosynthesis in B. subtilis and S. aureus been solidified. Here, we discuss the use of these tools to characterize the enzymes involved in the membrane-localized steps of biosynthesis through both in vitro reconstitution of entire biosynthetic pathways, as well as careful mechanistic studies of each reaction. Mechanistic and structural studies aimed at understanding the biosynthesis of soluble precursors necessary for each step are also outlined. In addition, we discuss recent work on understanding the enzymatic polymerization of glycerol-phosphate and ribitol-phosphate in terms of catalytic mechanism and processivity. Finally, the current challenges and unknowns in the biosynthesis
Keywords: Teichoic acid; Bacterial cell wall; Anionic poly mer; Gram-positive bacteria; Poly(glycerol-phosphate)
Microbial Glycobiology
1. Introduction In the model Gram-positive organism Bacillus subtilis, the vegetative cell wall is primarily made up of a thick peptidoglycan layer, proteins and covalently associated anionic polymers. The major anionic polymer is a phosphate-rich molecule termed wall teichoic acid (WTA) that can account for more than 50% of the cell wall dry weight (Hancock, 1997). These molecules are typically phosphodiester-linked polyol-phosphate repeats that are coupled to peptidoglycan via a conserved linkage unit. The structure of WTA can vary depending on organism or particular strain. B. subtilis 168 has a glycerol-phosphate polymer, while both Staphylococcus aureus and B. subtilis strain W23 have a ribitol-phosphate polymer. A comparison
337
© 2009 2010, Elsevier Inc.
338
19. Biosynthesis of Cell Wall Teichoic Acid Polymers
of the chemical structures of these molecules is depicted in Figure 19.1. (See Chapter 5 for an introductory review to these molecules.) Although peptidoglycan is known to function in cell shape determination and to provide rigidity and stability to resist osmotic pressure, to date, the function of teichoic acid cannot be linked to any one specific process (Bhavsar and Brown, 2006). It has long been suggested that WTA plays a role in providing bacteriophage attachment sites (Young, 1967; Yasbin et al., 1976), regulating autolysins in cell wall turnover and remodelling (Herbold and Glaser, 1975) or simply as a reserve for excess phosphate (Grant, 1979). Recently, WTA has also been linked to cell shape by suggestions that it adds considerable rigidity to the cell wall (Matias and Beveridge, 2005). This idea is supported by a loss of rod shape in B. subtilis mutants that lack WTA (D’Elia et al., 2006b). A possible clinical
r elevance of WTA has also begun to emerge with the discovery that this polymer is an important factor in biofilm formation (Gross et al., 2001) and virulence of S. aureus (Weidenmaier et al., 2004). In this chapter, we focus on recent advances in the study of the biosynthesis of the most common and studied teichoic acid polymers, the major WTAs from B. subtilis and S. aureus. This in-depth review details synthesis of the required nucleotide-activated precursors as well as our emerging understanding of priming and polymerization of teichoic acid polymers. We discuss how the availability of active recombinant proteins and soluble substrate analogues has facilitated some exciting advances in our knowledge of teichoic acid biosynthesis. We also discuss the outstanding questions and hurdles that currently preclude a complete understanding of WTA biosynthesis.
Figure 19.1 Chemical structure of common wall teichoic acid polymers. Wall teichoic acid from B. subtilis 168 has a glycerol-phosphate repeating unit, while both S. aureus and B. subtilis W23 have a repeating unit of ribitol-phosphate. Each of the polyol-phosphate polymers are linked to the C-6 of muramic acid in cell wall peptidoglycan via a conserved disaccharide linkage unit. Abbreviations: d-Ala, d-alanine; d-Glc, d-glucose; GlcNAc, N-acetyl-d-glucosamine.
II. synthesis of microbial glycosylated components
3. Biosynthesis of WTA precursors
2. Model of teichoic acid biosynthesis Until recently, much of our comprehension of teichoic biosynthesis has come from vintage biochemical studies done decades ago using impure cellular lysates and exhaustive chemical analysis of the Gram-positive cell walls. With the discovery and identification of the genes involved in WTA biosynthesis, tagABDEFGHO in B. subtilis 168 and tarABDFGHIJKLO in B. subtilis W23 and S. aureus (Mauël et al., 1991; Lazarevic et al., 2002; Qian et al., 2006), new and better informed models of teichoic acid biosynthesis began to emerge. Indeed, the availability of temperature-sensitive mutations in some of the tag genes led to putative functional assignments (Pooley et al., 1991, 1992). Bioinformatic studies analysing sequence homology between the tag genes of B. subtilis 168 and the ribitol-phosphate tar genes of B. subtilis W23 and S. aureus aided in the functional predictions for genes linked to ribitol-phosphate teichoic acid biosynthesis (Lazarevic et al., 2002; Qian et al., 2006). Figure 19.2 outlines the current model for poly(glycerol-phosphate) WTA biosynthesis in the organism B. subtilis 168. In addition to the polymer shown in Figure 19.1, two additional anionic polymers can be present in the B. subtilis cell wall: a minor teichoic acid polymer [poly(glucopyranosyl-Nacetylgalactosamine-1-phosphate)] and the phosphate starvation induced polymer teichuronic acid [poly(glucuronyl-N-acetylgalactosamine)]. Comparatively little is known about the assembly of these polymers. It is believed that enzymes encoded in the gga locus catalyse the synthesis of minor teichoic acid using nucleotide-activated precursors in a similar manner to teichoic acid (Estrela et al., 1991). Likewise, the products tua gene cluster have been implicated in the synthesis of teichuronic acid, an anionic polymer devoid of phosphate in B. subtilis in phosphate limiting conditions (Ellwood and Tempest, 1972). Dispensability studies suggest although these
339
polymers may be present in the cell wall, they cannot functionally replace teichoic acid in either phosphate limiting (Bhavsar et al., 2004) or phosphate replete conditions (Bhavsar et al., 2001).
3. Biosynthesis of WTA precursors The nucleotide precursors involved in polymer biosynthesis were discovered before the polymer itself was known. In the mid 20th century, Baddiley and co-workers described the presence of the cytidine-containing compounds cytidine diphosphate- (CDP-) glycerol and CDP-ribitol in the cell (Baddiley et al., 1956). It was further discovered that the formation of teichoic acid is dependent on the concurrent synthesis of these and other nucleotide-activated precursors as substrates for glycosyl transfer. Due to the soluble nature of enzymes involved in precursor synthesis and the availability of functional assays, the study of activated precursor biosynthesis is by far the most advanced area of teichoic acid research.
3.1. Linkage unit precursors According to the biosynthetic model of teichoic acid, synthesis begins with the sequential addition of N-acetylglucosamine-1-phosphate (GlcNAc-1P) and N-acetylmannosamine (ManNAc) to the lipid carrier undecaprenyl-phosphate, forming Lipid and Lipid, respectively. Each of these additions is dependent on the activated precursor uridine diphosphate- (UDP-) N-acetylglucosamine (UDP-GlcNAc) formed in two successive reactions by the bifunctional enzyme, GlmU. Careful enzymological studies have revealed that the substrate glucosamine-1-phoshate is acetylated with the co-factor acetyl-co-enzyme A prior to activation by uridine triphosphate (UTP) without channelling of intermediates between the active
II. synthesis of microbial glycosylated components
340 19. Biosynthesis of Cell Wall Teichoic Acid Polymers
II. synthesis of microbial glycosylated components
Figure 19.2 Model of teichoic acid biosynthesis in B. subtilis 168. Assembly of teichoic acid is accomplished on a membrane-bound undecaprenylphosphate. A linkage unit comprised of N-acetyl-d-glucosamine-1-phosphate (GlcNAc-1-P) and N-acetyl-d-mannosamine (ManNAc) is added to the intracellular face by the concerted action of TagO and TagA. The enzymes TagB and TagF have primase and polymerase activities, respectively. The TagB enzyme adds the first glycerol-phosphate and subsequently TagF polymerizes poly(glycerol-phosphate) to form the membrane-bound product Lipidf.n. Glucosylation of the polymer is thought to be catalysed by the TagE enzyme and export by TagGH is believed to occur before attachment to peptidoglycan by an unknown transferase. It is also believed that d-alanylation of the polymer occurs extracytoplasmically; for an excellent review on alanylation of these polymers, see Neuhaus and Baddiley (2003). Abbreviations: AcCoA, acetyl-co-enzyme A; CoA, co-enzyme A; d-Ala, d-alanine; d-Glc, d-glucose; GlcN-1-P, d-glucosamine-1-phospahte; Glycerol-P, glycerol phosphate; CDP-Gro, cytidine diphosphate-glycerol; CTP, cytidine triphosphate; UMP, uridine monophosphate; UDP, uridine diphosphate; UDP-Glc, UDP-glucose; UDP-GlcNAc, UDP-N-acetyl-d-glucosamine; UTP, uridine triphosphate; PPi, inorganic pyrophosphate.
3. Biosynthesis of WTA precursors
sites (Gehring et al., 1996). Although little work has been done on the B. subtilis orthologue, considerable structural and mechanistic data are available for the Escherichia coli and Streptococcus pneumoniae enzymes (Sulzenbacher et al., 2001; Olsen et al., 2007). As UDP-GlcNAc is a precursor for a variety of extracellular carbohydrates, including teichoic acid and peptidoglycan, GlmU is arguably a reasonable target for antibacterial drug discovery. Indeed, the left-handed -helix fold of the acetyltransferase domain is unique to prokaryotic UDPGlcNAc synthases (Olsen and Roderick, 2001). The activated precursor for the addition of the second sugar, UDP-N-acetylmannosamine (UDP-ManNAc), is an epimer at the 2 position of UDP-GlcNAc. Through a thermosensitive mutation in the gene mnaA, Soldo et al. (2002b) assigned this locus to the UDP-GlcNAc 2-epimerase activity. The mechanism of epimerization is believed to progress through anti-elimination of UDP and the subsequent syn-addition of UDP and 2-acetamidoglucal intermediates to form UDP-ManNAc (Tanner, 2002). A recent structure of the Bacillus anthracis MnaA orthologue reveals an allosteric interaction of UDP-GlcNAc that controls solvent accessibility to the active site (Velloso et al., 2008). The interaction was shown to be necessary in maintaining the enzyme in an active conformation (Velloso et al., 2008), thus potentially modulating the flux of this important precursor between peptidoglycan and teichoic acid biosynthesis. This notion is supported by the maintenance of a 12:1 ratio of UDP-GlcNAc to UDP-ManNAc at equilibrium by MnaA accounting for a higher need of UDP-GlcNAc for murein synthesis (Soldo et al., 2002b).
3.2. Teichoic acid polymer precursors The activation of glycerol-3-phosphate with cytidine triphosphate (CTP), to form CDPglycerol and pyrophosphate, is necessary for WTA synthesis in both B. subtilis and S. aureus strains. The tagD locus was originally linked to
341
CDP-glycerol synthesis when it was determined that a mutation in this gene diminished glycerol incorporation into both teichoic acid and cellular CDP-glycerol levels when cells were grown at a non-permissive temperature. Mutations at other loci (tagB and tagF) also decreased glycerol incorporation into teichoic acids, however, CDP-glycerol concentrations were increased. From this the authors suggested that tagD encoded the glycerol-3-phosphate cytidylyltransferase (Pooley et al., 1991). Both the TagD enzyme of B. subtilis 168 and the S. aureus orthologue TarD have been the subject of extensive structural and biochemical study. Although each of these enzymes catalyses the synthesis of CDP-glycerol from the same substrates, the kinetic characterization of the purified enzymes show significant mechanistic differences. Steady state kinetic analyses of these enzymes indicated that both follow a sequential reaction mechanism that requires the formation of a ternary complex of enzyme and substrates for catalysis. Nevertheless, these enzymes differed in other respects. Using product inhibition studies, Park et al. (1993) described a mechanism where a particular order of substrate binding or product release was not a prerequisite for TagD catalysis while, curiously, Badurina et al. (2003) showed that the S. aureus orthologue TarD catalyses cytidylyl-transfer by an ordered mechanism. The kinetic constants for these reactions were also markedly different. The Michaelis constants for the TagD enzyme were also reported to be 100-fold higher than that of the TarD enzyme (Park et al., 1993; Badurina et al., 2003). This discrepancy may be due to the negative cooperativity in substrate binding observed only for the TagD enzyme (Park et al., 1993; Sanker et al., 2001). The X-ray crystallographic structural analyses of TagD bound with the substrate CTP or the product CDP-glycerol have described the amino acids potentially involved in substrate binding (Weber et al., 1999; Pattridge et al., 2003). These structural analyses along with site-directed
II. synthesis of microbial glycosylated components
342
19. Biosynthesis of Cell Wall Teichoic Acid Polymers
mutagenesis indicated two motifs, HXGH and RTXGISTT, as having a role in catalysis. The motif HXGH is believed to bind CTP (Weber et al., 1999) and stabilize a putative pentacoordinate transition state (Park et al., 1997); the motif also places TagD as a member of a nucleotidyl-transferase superfamily including class I aminoacyl-tRNA synthetases, pantothenate synthases and CTP:choline-phosphate cytidylyltransferases (Weber et al., 1999). As the TarD and TagD enzymes share these motifs and a high level of amino acid sequence identity (69%), the observed mechanistic and kinetic differences remain a curiosity. Nevertheless, Badurina et al. (2003) have demonstrated that tarD can functionally replace tagD in vivo by complementing a tagD null. Comparatively less is known about the synthesis of CDP-ribitol than the analogous CDPglycerol synthase reaction. The proteins TarI and TarJ were predicted to be involved in this reaction based on their similarities to enzymes involved in Gram-negative capsule synthesis (Lazarevic et al., 2002). Akin to the bifunctional Haemophilis influenzae enzyme Bcs1, CDPribitol synthesis in S. aureus and B. subtilis W23 occurs in a two-step reaction where d-ribulose5-phosphate is reduced using nicotinamide adenine dinucleotide phosphate (NADPH) prior to cytidylyl-transfer from CTP (Zolli et al., 2001; Pereira and Brown, 2004). Interestingly, co-expression of tarI and tarJ open reading frames resulted in association of the gene products allowing for co-purification of the enzymes (Pereira and Brown, 2004). It was further determined that TarI and TarJ formed a stable hetero-tetramer, i.e. TarIJ, to catalyse efficiently the two reactions. Steady state kinetic analysis and product inhibition studies indicated ordered mechanisms for both the reductase activity and the cytidylyltransferase activity. In each case, the co-factor bound first and exited last from the active site (Pereira and Brown, 2004). Unlike TagD and TarD, currently no structural information is available for the enzyme complex.
4. Studying membrane activities In studying teichoic acid biosynthesis, our understanding of biochemical activities that are membrane-localized has lagged significantly behind that of soluble precursor synthesis. Historically, membrane-localized activities had to be assayed using crude or partially purified fractions as a source of enzymes and insoluble membrane fractions as a source of substrates. An in vitro assay, using recombinant teichoic acid biosynthetic proteins, partially solved this problem by defining the enzyme variable (Schertzer and Brown, 2003), however, by using membranes as a source of acceptors, the chemical composition of substrates had not been clearly defined. Soluble undecaprenyl analogues have emerged in the last five years as a very important tool in the study of enzymes that act upon membrane-embedded substrates. Such analogues have been created to study the substrate specificity of peptidoglycan glycosyltransferase MurG (Cudic et al., 2001; Liu et al., 2003) and transglycosylase PBP1A (Ye et al., 2001; Barrett et al., 2007), as well as lipopolysaccharide synthesizing enzymes (Montoya-Peleaz et al., 2005). Recently, the Walker group has addressed the lack of available tools for teichoic acid research through the synthesis of soluble analogues of membrane-bound teichoic acid intermediates. In the TagO product Lipid, the C-55 undecaprenyl group has been replaced with that of either a C-13 saturated hydrocarbon moiety (Ginsberg et al., 2006) or a C-15 farnesyl moiety (Zhang et al., 2006; Brown et al., 2008). Steady state kinetic analysis of the farnesyl substitution with the TagA enzyme (Zhang et al., 2006) and the C-13 substitution with the TagF enzyme (Pereira et al., 2008a) allowed for the determination of specificity constants that support the suitability of these analogues for enzymatic study. Interestingly, Pereira et al. (2008a) reported a 100fold increase in TagF turnover when a soluble
II. synthesis of microbial glycosylated components
5. Linkage unit glycosyltransferases
analogue was used in place of inverted membrane vesicles, highlighting the success of these molecules as tools for teichoic acid study. The seminal research utilizing these analogues for in vitro pathway reconstitution and mechanistic study is outlined in the text. The use of soluble acceptor molecules will perhaps revolutionize the study of teichoic biosynthetic enzymes as the mechanistic details of these enzymes are only beginning to appear in the literature. Note that we have proposed here a new naming scheme to differentiate the teichoic acid undecaprenyllinked intermediates from those involved in peptidoglycan and Gram-negative outer membrane biogenesis. To simplify, the designation of each intermediate corresponds with the enzyme to which it interacts: Lipid (TagA), Lipid (TagB) and Lipidf (TagF) (see Figure 19.2).
5. Linkage unit glycosyltransferases 5.1. TagO-UDP-GlcNAc–undecaprenylphosphate GlcNAc-1-P transferase The first step in teichoic acid synthesis is the addition of GlcNAc-1-P from UDPGlcNAc to the membrane-localized substrate undecaprenyl-phosphate. To date, this activity has been poorly characterized biochemically. Much evidence on the role of this reaction in teichoic acid biosynthesis comes from observations that radiolabelled UDP-GlcNAc is incorporated into a substrate for further catalysis by the teichoic acid polymerases (Yokoyama et al., 1989). Homology to the MraY glycosyltransferase involved in peptidoglycan biosynthesis led to the assertion by Soldo et al. (2002a) that the transmembrane enzyme TagO is involved in this first step. It was through gene deletion studies that the role of TagO was solidified. Soldo et al. (2002a) first observed an impact on phosphate and glycerol-phosphate incorporation
343
into the B. subtilis cell wall in cells depleted of TagO while peptidoglycan synthesis was unaffected, supporting a role in teichoic acid biosynthesis. It was subsequently discovered that an uncomplemented tagO null could be made abolishing teichoic acid synthesis (Weidenmaier et al., 2004; D’Elia et al., 2006a) and resulting in a loss of rod-shaped morphology (D’Elia et al., 2006b). From a comprehensive deletion study of teichoic acid biosynthetic genes in S. aureus, D’Elia et al., (2006a) discovered that genes linked to late stage synthesis became non-essential in a tagO null. That a deletion in tagO would have such a profound impact on the dispensability of the late genes was remarkable and further supported a role of TagO in the first step of teichoic acid biosynthesis. Much of what is known for the mechanism of catalysis of TagO is from bioinformatic comparison to other members in its family of GlcNAc-1-phosphate transferases (MraY, WecA, and WbpL). Each of these enzymes differs in their carbohydrate specificity which is determined by C-terminal carbohydrate recognition domains on a cytoplasmic loop (Anderson et al., 2000). It is believed that these prenylphosphate glycosyltransferases operate via a double displacement mechanism where an Asp residue acts as an active site nucleophile cleaving the pyrophosphate bond in UDP-GlcNAc to form an acyl-enzyme intermediate before transfer to undecaprenyl-phosphate. For an in-depth review see Price and Momany (2005).
5.2. TagA-UDP-ManNAc–Lipid ManNAc transferase The synthesis of a soluble analogue of the TagO product (Lipid) through the substitution of insoluble 55-carbon undecaprenyl moiety with a soluble saturated 13-carbon moiety allowed for the characterization of the mechanism and products of the TagA reaction. Ginsberg et al. (2006) showed that the TagA enzyme was
II. synthesis of microbial glycosylated components
344
19. Biosynthesis of Cell Wall Teichoic Acid Polymers
able to catalyse the transfer of ManNAc to the soluble Lipid analogue to form Lipid. This product was further confirmed to be suitable for catalysis by the enzyme TagB. Zhang et al. (2006) continued this work in a study investigating the lipid preference and steady-state kinetic mechanism of the enzyme. While it was established that TagA was sensitive to lipid length and hydrophobicity, it was found that the enzyme was not sensitive to lipid structure. The level of branching, bond saturation or double bond geometry did not greatly affect the substrate specificity constant. As membranes were not present in the reaction, these studies also established that, although the TagA protein and the undecaprenyl-linked substrate are membrane-localized (Leaver et al., 1981), biological membranes are not required for the enzymatic activity. The use of the soluble Lipid and Lipid analogues for steady-state kinetic analysis allowed for the determination of the kinetic mechanism of TagA. In an ordered mechanism where UDPManNAc binds the active site first and UDP is the last product to exit, the product Lipid was found to form dead-end complexes with both the apo and the UDP-ManNAc-bound form of the enzyme (Zhang et al., 2006). The TagA enzyme belongs to a family of glycosyltransferases that are for the most part uncharacterized. The purification and mechanistic characterization of this enzyme will surely aid in a structural biological effort to study this class of enzymes.
6. Teichoic acid polymer biosynthesis Much like the study of the teichoic acid linkage unit glycosyltransferases, biochemical study of the enzymes involved in the polyol-phosphate polymer formation has been hampered due to a lack of chemically defined substrates. Only
until very recently, poly(glycerol-phosphate) and poly(ribitol-phosphate) activities were studied using crude preparations of insoluble materials (Burger and Glaser, 1964; Mauck and Glaser, 1972a). However, with the genetic association of the tagF allele to poly(glycerol-phosphate) polymerase activity and the tagB allele to glycerol-phosphate primase activity (Pooley et al., 1991, 1992), biochemical characterization of these activities became a possibility. Through the use of an in vitro membrane-pelleting assay, developed by Schertzer and co-workers, it was demonstrated that pure recombinant TagB and TagF could catalyse the addition of glycerolphosphate to a membrane-linked acceptor molecule using the activated precursor CDP-glycerol (Schertzer and Brown, 2003; Bhavsar et al., 2005). Analytical characterization of the reaction products indicated that the TagF enzyme did in fact catalyse the formation of a polymer of glycerol-phosphate while TagB added only a single glycerol-phosphate (Schertzer and Brown, 2003; Bhavsar et al., 2005).
6.1. Primase-polymerase model of teichoic acid biosynthesis While the membrane pelleting assays supported the model that tagB would encode a primase and tagF a polymerase, these activities were unambiguously defined with the use of soluble substrate analogues. It was confirmed that the TagB enzyme catalyses the addition of one glycerol-phosphate to the product of the TagA reaction (Ginsberg et al., 2006). Using the products of both the TagA (Lipid) and TagB (Lipidφ.1) reaction, it was determined that TagF would only catalyse glycerol-phosphate transfer to a lipid-linked substrate that had already been “primed” with a single polyol-phosphate unit (Pereira et al., 2008a). Chemical logic supports the notion that a separate enzyme activity would be necessary for the addition of the first glycerol-phosphate due to the differences in
II. synthesis of microbial glycosylated components
6. Teichoic acid polymer biosynthesis
active site architecture necessary to accommodate the ManNAc for catalysis. The necessity of a priming reaction for TagF polymerization is consistent with the genetic indispensability of the tagB gene (Bhavsar et al., 2004). Interestingly, the poly(ribitol-phosphate) polymerase of S. aureus, TarL, does not require a separate enzyme for the addition of the first ribitol-phosphate residue and subsequent polymerization (Brown et al., 2008). This result is not entirely surprising since the ribitol-phosphate polymer is built on an oligomer of glycerol-phosphate (see Figure 19.1) that potentially could be accommodated in the TarL active site in place of ribitol-phosphate. Perhaps most interesting is that dispensability studies suggest the B. subtilis W23 orthologue of TarL cannot use an “unprimed” substrate (Meredith et al., 2008; Pereira et al., 2008b). As it is possible for S. aureus TarL to catalyse addition to the terminal hydroxyl of both glycerolphosphate and ribitol-phosphate, careful steadystate analysis to determine specificity constants for lipid-linked substrates that are “primed” and “unprimed” with ribitol-phosphate are needed to understand how the relaxed specificity necessary for accepting two chemically distinct substrates for ribitol-phosphate transfer affects enzyme catalysis.
6.2. Mechanism of catalysis Although the demonstration of in vitro biochemical activity for these enzymes using pure recombinant proteins and chemically defined substrates has proven to be a landmark stepping stone in WTA biosynthesis, much still remains to be learned about these enzymes. A lack of homology to characterized enzymes and an absence of structural information for these macromolecules remain an obstacle to deeper understanding of their structure and function. Site-directed mutagenesis studies of the TagF and TagB enzymes aimed at understanding the mechanism of catalysis has implicated two
345
conserved histidine residues that were shown to be essential for in vivo and in vitro function (Bhavsar et al., 2005; Schertzer et al., 2005). High levels of sequence similarity in the C-terminus among polyol-phosphate transferases and identification of conserved residues that affected catalysis in both TagB and TagF is highly suggestive that these enzymes operate via a conserved mechanism (Figure 19.3A). From pH dependence of TagF activity, Schertzer et al. (2005) suggested that a histidine may be acting as an active site base, however, further study is needed to confirm this model. Histidine could also reasonably function as a nucleophile in catalysis (Figure 19.3B). In the absence of structural data for any member of this enzymatic class, further kinetic analysis into the steadystate kinetic mechanism is required for the understanding of how this enzyme catalyses the formation of phosphodiester linkages. The construction of a defined length polymer by the TagF enzyme is particularly curious. In vivo isolated teichoic acid and polymers synthesized on membrane vesicles have both been estimated at lengths between 30 and 60 units (Pollack and Neuhaus, 1994; Schertzer and Brown, 2003). In contrast, in vitro polymer synthesis using a soluble analogue of Lipid φ.1 has produced mixed results. In a study by Brown et al. (2008) of the poly(ribitol-phosphate) polymerase of S. aureus, TarL, the polymeric product formed was approximately 30 units. Varying the ratios of CDP-ribitol to soluble acceptor could not modulate this length, suggestive of a processive assembly of defined length polymer. In contrast, Pereira et al. (2008a) showed that B. subtilis 168 TagF poly(glycerol-phosphate) polymerase formed a polymer with lengths determined by the ratio of the provided substrates. This study suggested that TagF’s substrate Kms (2.6 M for Lipid φ.1 and 152 M for CDP-glycerol) might dictate polymer length through the availability of substrates and further indicated that TagF may have a distributive polymerase activity. Figure 19.3C describes processive and distributive polymerization. It is
II. synthesis of microbial glycosylated components
A
His
His TagF_B. subtilis 168 TagF_S. epidermidis TarL_B. subtilis W23 TarL_S. aureus TarK_S. aureus TarK_B. subtilis W23 TarF_B. subtilis W23 TarB_B. subtilis W23 TagB_B. subtilis 168 TarB_S. aureus TarF_S. aureus
B
C
Figure 19.3 Mechanism of poly(glycerol-phosphate) and poly(ribitol-phosphate) polymerization. (A) Alignment schematic of proteins involved in teichoic acid polyol-phosphate transfer. Highest levels of identity (yellow) and similarity (black) among the amino acid sequences are present in the C-terminal region. Highlighted are the conserved histidines Schertzer et al. (2005) implicated in TagF and TagB activity. One point of curiosity is the function of the extensive N-terminal region of TagF that is not homologous to any other sequenced protein. (B) Two potential catalytic mechanisms for glycerolphosphate transfer are shown schematically. It is hypothesized that a histidine residue may function to deprotonate the terminal hydroxyl of the growing polymer for nucleophilic attack on the -phosphate of cytidine diphosphate- (CDP-) glycerol. It is also conceivable that the histidine directly acts as a nucleophile forming a phosphor-histidine intermediate with glycerol-phosphate from CDP-glycerol to promote catalysis through a ping-pong mechanism. (C) The factors regulating polymer length are currently unknown. It is conceivable that the level of processivity of a polymerase may determine the length of polymer that is formed. A processive polymerase will remain associated with the growing polymer through the addition of many units in a single binding event, while a distributive polymerase dissociates and re-associates to the polymer repeatedly adding only as few as one unit in each binding event. Preliminary data studying the processivity of two teichoic acid polymerases provided differing models of elongation. The TarL enzyme from S. aureus was suggested to be processive (Brown et al., 2008), while the TagF enzyme from B. subtilis did not appear to maintain association with the growing polymer during catalysis (Pereira et al., 2008a). (See colour plates section.)
347
8. conclusions
conceivable that the TarL and TagF enzymes work through different mechanisms, however, sequence conservation of this enzyme class would appear to predict otherwise. Further investigations into the mechanism of length regulation and processivity are clearly necessary.
7. Outstanding issues 7.1. Export and assembly of WTA To date, biochemical studies have focused on intracellular steps for teichoic acid biosynthesis. Relatively little is known about polymer export, even less is known about the attachment of teichoic acid to the C-6 of muramic acid in peptidoglycan. In the two final steps following polymerization, the entire prenyl-linked polymer is hypothesized to be flipped to the outer face of the cell membrane by the TagGH enzymes. These enzymes are proposed to carry out the polysaccharide transport role because of their homology to other ATP-binding cassette (ABC) polysaccharide transporters (Lazarevic and Karamata, 1995). Indeed, depletion of TagGH in B. subtilis 168 yielded a phenotype that was consistent with depletion of other late acting B. subtilis Tag proteins (Lazarevic and Karamata, 1995). It has also been demonstrated that a deletion in tarG in S. aureus, while deleterious in a wild-type background, was dispensable in a tarO null, consistent with characteristic genetic interactions that have been observed between late acting genes and the first step in teichoic acid synthesis. The identity of the enzyme catalysing the covalent attachment of teichoic acid to peptidoglycan has remained elusive. This activity is thought to occur on the extracytoplasmic face of the cell membrane in chorus with peptidoglycan strand synthesis (Mauck and Glaser, 1972b). Recent advances in the synthesis of lipid-linked teichoic acid in vitro will surely aid in the molecular characterization of the putative transporter TagGH and in the discovery of the enzyme(s) involved in transfer to peptidoglycan.
7.2. Localization of enzymes and formation of biosynthetic complex The localization of WTA biosynthetic enzymes may provide clues to the molecular details of teichoic acid incorporation into the Gram-positive cell wall. Similar to the proposed notion of a murein biosynthetic complex, the formation of a complex of WTA biosynthetic enzymes is a possibility. This idea is not a new one as Leaver et al. (1981) described the co-fractionation of detergent solubilized enzymes involved in linkage unit synthesis during sucrose density centrifugation. Interestingly, these enzymes also fractionated with prenyl-phosphate containing molecules that could subsequently be used for poly(glycerol) polymerization. Recently, it was discovered that disruption of the amphipathic helix in the membrane targeting domain of TagB, while abolishing function, did not affect the membrane localization of the enzyme (Bhavsar et al., 2007). Cellular localization of green fluorescent protein-tagged enzymes revealed that the teichoic acid machinery showed a similar helical localization pattern (Formstone et al., 2008) to that of nascent peptidoglycan (Daniel and Errington, 2003). Indeed, two hybrid studies revealed a complex network of interactions between WTA machinery and shape determinants MreC and MreD. As it has been reported that teichoic acid incorporation into the cell wall occurs with non-cross-linked peptidoglycan (Mauck and Glaser, 1972b), it may be surmised that synthesis and export of WTA is mediated within a large multienzyme complex associated with the peptidoglycan synthesis.
8. Conclusions Our understanding of WTA synthesis has developed considerably in recent years. With the in vitro reconstitution of teichoic acid biosynthetic pathways in both B. subtilis and S. aureus, functional roles for many of the gene
II. synthesis of microbial glycosylated components
348
19. Biosynthesis of Cell Wall Teichoic Acid Polymers
products are now emerging. Additionally, the development of assays using chemically defined substrate analogues provides new opportunities for careful kinetic and mechanistic study of teichoic acid biosynthetic enzymes. Early work on mechanism has revealed some surprising
and fascinating results, particularly around priming and polymerization steps, that will surely be subject of further and on-going study. Further areas that will potentially be the topics for future research are listed in the Research Focus Box.
Research Focus Box The determination of the additional protein factors necessary for export and cell wall attachment is essential to understanding the complete pathway of teichoic acid biosynthesis. l Further study of polyol-phosphate transferases is required to allow l
Acknowledgements Work in our laboratory has been supported by the Canadian Institutes of Health Research Grant MOP-15496. E.D. Brown holds a Canada Research Chair and M.P. Pereira holds a Canadian Institutes of Health Research Canada Graduate Scholarship.
References Anderson, M.S., Eveland, S.S., Price, N.P., 2000. Conserved cytoplasmic motifs that distinguish sub-groups of the polyprenol phosphate: N-acetylhexosamine-1-phosphate transferase family. FEMS Microbiol. Lett. 191, 169–175. Baddiley, J., Buchanan, J.G., Carss, B., Mathias, A.P., 1956. Cytidine diphosphate ribitol from Lactobacillus arabinosus. J. Chem. Soc. 64, 4583–4588. Badurina, D.S., Zolli-Juran, M., Brown, E.D., 2003. CTP: glycerol 3-phosphate cytidylyltransferase (TarD) from Staphylococcus aureus catalyzes the cytidylyl transfer via an ordered Bi-Bi reaction mechanism with micromolar Km values. Biochim. Biophys. Acta 1646, 196–206.
understanding of both the chemical mechanism of this family of enzymes and the factors governing polymer length. l Biochemical study is needed to determine the possible coordination of teichoic acid and peptidoglycan biosynthesis in a biosynthetic complex.
Barrett, D., Wang, T.S., Yuan, Y., Zhang, Y., Kahne, D., Walker, S., 2007. Analysis of glycan polymers produced by peptidoglycan glycosyltransferases. J. Biol. Chem. 282, 31964–31971. Bhavsar, A.P., Brown, E.D., 2006. Cell wall assembly in Bacillus subtilis: how spirals and spaces challenge paradigms. Mol. Microbiol. 60, 1077–1090. Bhavsar, A.P., Beveridge, T.J., Brown, E.D., 2001. Precise deletion of tagD and controlled depletion of its product, glycerol 3-phosphate cytidylyltransferase, leads to irregular morphology and lysis of Bacillus subtilis grown at physiological temperature. J. Bacteriol. 183, 6688–6693. Bhavsar, A.P., Erdman, L.K., Schertzer, J.W., Brown, E.D., 2004. Teichoic acid is an essential polymer in Bacillus subtilis that is functionally distinct from teichuronic acid. J. Bacteriol. 186, 7865–7873. Bhavsar, A., Truant, R., Brown, E., 2005. The TagB protein in Bacillus subtilis 168 is an intracellular peripheral membrane protein that can incorporate glycerol phosphate onto a membrane-bound acceptor in vitro. J. Biol. Chem. 280, 36691–36700. Bhavsar, A.P., D’Elia, M.A., Sahakian, T.D., Brown, E.D., 2007. The amino terminus of Bacillus subtilis TagB possesses separable localization and functional properties. J. Bacteriol. 189, 6816–6823.
II. synthesis of microbial glycosylated components
References
Brown, S., Zhang, Y.H., Walker, S., 2008. A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps. Chem. Biol. 15, 12–21. Burger, M., Glaser, L., 1964. The synthesis of teichoic acids. I. Polyglycerolphosphate. J. Biol. Chem. 239, 3168–3177. Cudic, P., Behenna, D.C., Yu, M.K., Kruger, R.G., Szewczuk, L.M., McCafferty, D.G., 2001. Synthesis of P(1)-CitronellylP(2)- -d-pyranosyl pyrophosphates as potential substrates for the E. coli undecaprenyl-pyrophosphoryl-N-acetylglucoseaminyl transferase MurG. Bioorg. Med. Chem. Lett. 11, 3107–3110. D’Elia, M.A., Pereira, M.P., Chung, Y.S., et al., 2006a. Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J. Bacteriol. 188, 4183–4189. D’Elia, M.A., Millar, K.E., Bevridge, T.J., Brown, E.D., 2006b. Wall teichoic acid polymers are dispensable for cell viability in Bacillus subtilis. J. Bacteriol. 188, 8313–8316. Daniel, R.A., Errington, J., 2003. Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell. Cell 113, 767–776. Ellwood, D.C., Tempest, D.W., 1972. Influence of culture pH on the content and composition of teichoic acids in the walls of Bacillus subtilis. J. Gen. Microbiol. 73, 395–402. Estrela, A.I., Pooley, H.M., de Lencastre, H., Karamata, D., 1991. Genetic and biochemical characterization of Bacillus subtilis 168 mutants specifically blocked in the synthesis of the teichoic acid poly(3-O--d-glucopyranosylN-acetylgalactosamine 1-phosphate): gneA, a new locus, is associated with UDP-N-acetylglucosamine 4-epimerase activity. J. Gen. Microbiol. 137, 943–950. Formstone, A., Carballido-Lopez, R., Noirot, P., Errington, J., Scheffers, D.J., 2008. Localization and interactions of teichoic acid synthetic enzymes in Bacillus subtilis. J. Bacteriol. 190, 1812–1821. Gehring, A.M., Lees, W.J., Mindiola, D.J., Walsh, C.T., Brown, E.D., 1996. Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional GlmU protein of Escherichia coli. Biochemistry 35, 579–585. Ginsberg, C., Zhang, Y.H., Yuan, Y., Walker, S., 2006. In vitro reconstitution of two essential steps in wall teichoic acid biosynthesis. ACS Chem. Biol. 1, 25–28. Grant, W.D., 1979. Cell wall teichoic acid as a reserve phosphate source in Bacillus subtilis. J. Bacteriol. 137, 35–43. Gross, M., Cramton, S.E., Gotz, F., Peschel, A., 2001. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect. Immun. 69, 3423–3426. Hancock, I.C., 1997. Bacterial cell surface carbohydrates: structure and assembly. Biochem. Soc. Trans. 25, 183–187.
349
Herbold, D.R., Glaser, L., 1975. Interaction of Nacetylmuramic acid L-alanine amidase with cell wall polymers. J. Biol. Chem. 250, 7231–7238. Lazarevic, V., Karamata, D., 1995. The tagGH operon of Bacillus subtilis 168 encodes a two-component ABC transporter involved in the metabolism of two wall teichoic acids. Mol. Microbiol. 16, 345–355. Lazarevic, V., Abellan, F., Möller, S., Karamata, D., Mauël, C., 2002. Comparison of ribitol and glycerol teichoic acid genes in Bacillus subtilis W23 and 168: identical function, similar divergent organization, but different regulation. Microbiology 148, 815–824. Leaver, J., Hancock, I.C., Baddiley, J., 1981. Fractionation studies of the enzyme complex involved in teichoic acid synthesis. J. Bacteriol. 146, 847–852. Liu, H., Ritter, T.K., Sadamoto, R., Sears, P.S., Wu, M., Wong, C.H., 2003. Acceptor specificity and inhibition of the bacterial cell-wall glycosyltransferase MurG. Chem. Bio. Chem. 4, 603–609. Matias, V.R., Beveridge, T.J., 2005. Cryo-electron microscopy reveals native polymeric cell wall structure in Bacillus subtilis 168 and the existence of a periplasmic space. Mol. Microbiol. 56, 240–251. Mauck, J., Glaser, L., 1972a. An acceptor-dependent polyglycerolphosphate polymerase. Proc. Natl. Acad. Sci. USA 69, 2386–2390. Mauck, J., Glaser, L., 1972b. On the mode of in vivo assembly of the cell wall of Bacillus subtilis. J. Biol. Chem. 247, 1180–1187. Mauël, C., Young, M., Karamata, D., 1991. Genes concerned with synthesis of poly(glycerol phosphate), the essential teichoic acid in Bacillus subtilis strain 168, are organized in two divergent transcription units. J. Gen. Microbiol. 137, 929–941. Meredith, T.C., Swoboda, J.G., Walker, S., 2008. Late-stage polyribitol phosphate wall teichoic acid biosynthesis in Staphylococcus aureus. J. Bacteriol. 190, 3046–3056. Montoya-Peleaz, P.J., Riley, J.G., Szarek, W.A., Valvano, M.A., Schutzbach, J.S., Brockhausen, I., 2005. Identification of a UDP-Gal: GlcNAc-R galactosyltransferase activity in Escherichia coli VW187. Bioorg. Med. Chem. Lett. 15, 1205–1211. Neuhaus, F.C., Baddiley, J., 2003. A continuum of anionic charge: structures and functions of d-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67, 686–723. Olsen, L.R., Roderick, S.L., 2001. Structure of the Escherichia coli GlmU pyrophosphorylase and acetyltransferase active sites. Biochemistry 40, 1913–1921. Olsen, L.R., Vetting, M.W., Roderick, S.L., 2007. Structure of the E. coli bifunctional GlmU acetyltransferase active site with substrates and products. Protein Sci. 16, 1230–1235. Park, Y.S., Sweitzer, T.D., Dixon, J.E., Kent, C., 1993. Expression, purification, and characterization of CTP:
II. synthesis of microbial glycosylated components
350
19. Biosynthesis of Cell Wall Teichoic Acid Polymers
glycerol-3-phosphate cytidylyltransferase from Bacillus subtilis. J. Biol. Chem. 268, 16648–16654. Park, Y.S., Gee, P., Sanker, S., Schurter, E.J., Zuiderweg, E.R., Kent, C., 1997. Identification of functional conserved residues of CTP: glycerol-3-phosphate cytidylyltransferase. Role of histidines in the conserved HXGH in catalysis. J. Biol. Chem. 272, 15161–15166. Pattridge, K.A., Weber, C.H., Friesen, J.A., Sanker, S., Kent, C., Ludwig, M.L., 2003. Glycerol-3-phosphate cytidylyltransferase. Structural changes induced by binding of CDP-glycerol and the role of lysine residues in catalysis. J. Biol. Chem. 278, 51863–51871. Pereira, M.P., Brown, E.D., 2004. Bifunctional catalysis by CDP-ribitol synthase: convergent recruitment of reductase and cytidylyltransferase activities in Haemophilus influenzae and Staphylococcus aureus. Biochemistry 43, 11802–11812. Pereira, M.P., Schertzer, J.W., D’Elia, M.A., et al., 2008a. The wall teichoic acid polymerase TagF efficiently synthesizes poly(glycerol phosphate) on the TagB product lipid III. Chem. Bio. Chem. 9, 1385–1390. Pereira, M.P., D’Elia, M.A., Troczynska, J., Brown, E.D., 2008b. Duplication of teichoic acid biosynthetic genes in Staphylococcus aureus leads to functionally redundant poly(Ribitol Phosphate) polymerases. J. Bacteriol. 190, 5642–5649. Pollack, J., Neuhaus, F., 1994. Changes in wall teichoic acid during the rod-sphere transition of Bacillus subtilis 168. J. Bacteriol. 176, 7252–7259. Pooley, H.M., Abellan, F.X., Karamata, D., 1991. A conditional-lethal mutant of Bacillus subtilis 168 with a thermosensitive glycerol-3-phosphate cytidylyltransferase, an enzyme specific for the synthesis of the major wall teichoic acid. J. Gen. Microbiol. 137, 921–928. Pooley, H.M., Abellan, F.X., Karamata, D., 1992. CDPglycerol: poly(glycerophosphate) glycerophosphotransferase, which is involved in the synthesis of the major wall teichoic acid in Bacillus subtilis 168, is encoded by tagF (rodC). J. Bacteriol. 174, 646–649. Price, NP., Momany, F.A., 2005. Modeling bacterial UDPHexNAc: polyprenol-P HexNAc-1-P transferases. Glycobiology 15, 29R–42R. Qian, Z., Yin, Y., Zhang, Y., Lu, L., Li, Y., Jiang, Y., 2006. Genomic characterization of ribitol teichoic acid synthesis in Staphylococcus aureus: genes, genomic organization and gene duplication. BMC Genomics 7, 74. Sanker, S., Campbell, H.A., Kent, C., 2001. Negative cooperativity of substrate binding but not enzyme activity in wild-type and mutant forms of CTP: glycerol-3-phosphate cytidylyltransferase. J. Biol. Chem. 276, 37922–37928. Schertzer, J.W., Brown, E.D., 2003. Purified, recombinant TagF protein from Bacillus subtilis 168 catalyzes the polymerization of glycerol phosphate onto a membrane acceptor in vitro. J. Biol. Chem. 278, 18002–18007.
Schertzer, J.W., Bhavsar, A.P., Brown, E.D., 2005. Two conserved histidine residues are critical to the function of the TagF-like family of enzymes. J. Biol. Chem. 280, 36683–36690. Soldo, B., Lazarevic, V., Karamata, D., 2002a. tagO is involved in the synthesis of all anionic cell-wall polymers in Bacillus subtilis 168. Microbiology 148, 2079–2087. Soldo, B., Lazarevic, V., Pooley, H.M., Karamata, D., 2002b. Characterization of a Bacillus subtilis thermosensitive teichoic acid-deficient mutant: gene mnaA (yvyH) encodes the UDP-N-acetylglucosamine 2-epimerase. J. Bacteriol. 184, 4316–4320. Sulzenbacher, G., Gal, L., Peneff, C., Fassy, F., Bourne, Y., 2001. Crystal structure of Streptococcus pneumoniae Nacetylglucosamine-1-phosphate uridyltransferase bound to acetyl-coenzyme A reveals a novel active site architecture. J. Biol. Chem. 276, 11844–11851. Tanner, M.E., 2002. Understanding nature’s strategies for enzyme-catalyzed racemization and epimerization. Acc. Chem. Res. 35, 237–246. Velloso, L.M., Bhaskaran, S.S., Schuch, R., Fischetti, V.A., Stebbins, C.E., 2008. A structural basis for the allosteric regulation of non-hydrolysing UDP-GlcNAc 2epimerases. EMBO Rep. 9, 199–205. Weber, C.H., Park, Y.S., Sanker, S., Kent, C., Ludwig, M.L., 1999. A prototypical cytidylyltransferase: CTP: glycerol-3phosphate cytidylyltransferase from Bacillus subtilis. Structure 7, 1113–1124. Weidenmaier, C., Kokai-Kun, J.F., Kristian, S.A., et al., 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10, 243–245. Yasbin, R.E., Maino, V.C., Young, F.E., 1976. Bacteriophage resistance in Bacillus subtilis 168, W23, and interstrain transformants. J. Bacteriol. 125, 1120–1126. Ye, X.Y., Lo, M.C., Brunner, L., Walker, D., Kahne, D., Walker, S., 2001. Better substrates for bacterial transglycosylases. J. Am. Chem. Soc. 123, 3155–3156. Yokoyama, K., Mizuguchi, H., Araki, Y., Kaya, S., Ito, E., 1989. Biosynthesis of linkage units for teichoic acids in Gram-positive bacteria: distribution of related enzymes and their specificities for UDP-sugars and lipid-linked intermediates. J. Bacteriol. 171, 940–946. Young, F.E., 1967. Requirement of glucosylated teichoic acid for adsorption of phage in Bacillus subtilis 168. Proc. Natl. Acad. Sci. USA 58, 2377–2384. Zhang, Y.H., Ginsberg, C., Yuan, Y., Walker, S., 2006. Acceptor substrate selectivity and kinetic mechanism of Bacillus subtilis TagA. Biochemistry 45, 10895–10904. Zolli, M., Kobric, D.J., Brown, E.D., 2001. Reduction precedes cytidylyl transfer without substrate channeling in distinct active sites of the bifunctional CDP-ribitol synthase from Haemophilus influenzae. Biochemistry 40, 5041–5048.
II. synthesis of microbial glycosylated components
P a r t
II
Synthesis of microbial glycosylated components A. Biosynthesis and biosynthetic processes
c h a p t e r
16 Biosynthesis of bacterial peptidoglycan Jean van Heijenoort Summary
Mur synthetases; MraY transferase; MurG transferase; Penicillin-binding proteins
Bacterial peptidoglycan has been extensively investigated owing to its importance as an essential cell wall structural component. Its biosynthesis is a two-stage process, which is the target of well-known antibiotics and which is closely correlated with cellular morphogenesis. First, the monomer unit is assembled by a sequence of reactions in the cytoplasm and at the inner side of the cytoplasmic membrane leading to the lipid II intermediate. The second stage involves extracytoplasmic polymerization reactions catalysed by glycosyltransferases and transpeptidases using lipid II as substrate after its translocation through the membrane. The different steps of the pathway are described, as well as their variations, their in vivo functioning and their inhibition by antibiotics. The areas calling for more thorough investigation concern the peptidoglycan-synthesizing complexes functioning in coordination with cell growth and cell division, the role played by peptidoglycan hydrolases and the examination of yet unexplored structural modifications of peptidoglycan. The need to understand better the mechanisms of resistance to antibiotics and to use specific peptidoglycan targets for the search of novel antibacterials also fully warrants the continued study of peptidoglycan biosyntheis. Keywords: Uridine diphosphate- (UDP-) N-acetylglucosamine; UDP-N-acetylmuramic acid; UDP-Nacetylmuramic acid-peptides; Lipid intermediates;
Microbial Glycobiology
1. Introduction Over the past fifty years, bacterial peptidoglycan has been extensively investigated owing to its importance as an essential structural cell wall component (see Chapter 2), to its involvement in cellular morphogenesis (Scheffers and Pinho, 2005; Vicente et al., 2006; den Blaauwen et al., 2008; Zapun et al., 2008a) and to the fact that steps of its biosynthesis are specifically inhibited by well-known antibiotics and are potential targets for the search for novel antibacterials (Gale et al., 1981; Green, 2002; Kotnik et al., 2007; Barreteau et al., 2008). The various steps of the biosynthesis were studied in different species and a two-stage pathway valid for most eubacteria emerged (Rogers et al., 1980; Ward, 1984). First, the peptidoglycan monomer unit is assembled in the final form of a lipid intermediate by enzymes located in the cytoplasm or at the inner side of the cytoplasmic membrane (Bugg and Walsh, 1992; van Heijenoort, 2001b, 2007; Barreteau et al., 2008; Bouhss et al., 2008). The second stage involves extracytoplasmic polymerization reactions using as substrate the lipid intermediate after its translocation through
287
© 2009 2010, Elsevier Inc.
288
16. Biosynthesis of peptidoglycan
the membrane. Two major types of membranebound activities are involved in polymerization: glycosyltransferases which catalyse the formation of the linear glycan chains (Goffin and Ghuysen, 1998; van Heijenoort, 2001a, 2007) and transpeptidases which catalyse the cross-linking between the peptide subunits of the new chains and the binding to the pre-existing cell wall (Goffin and Ghuysen, 2002; Macheboeuf et al., 2006; Sauvage et al., 2008; Zapun et al., 2008b).
Fructose-6-P L-glutamine
GlmS Glucosamine-6-P GlmM Glucosamine-1-P
Acetyl-CoA
GlmU N-acetylglucosamine-1-P
UTP
GlmU
2. Assembly of the monomer unit
UDP-GlcNAc PEP
MurA UDP-GlcNAc-enolpyruvate
The monomer unit is assembled by a linear sequence of reactions extending from d-fructose6-phosphate to the final lipid intermediate (Figure 16.1). The pathway was established by characterizing its precursors and developing a specific enzymatic assay for each step. The genes involved in the process were identified, mapped in a few regions of the bacterial chromosome, cloned, sequenced and most shown to be essential. Their products were over-produced, characterized and many crystallized. This in turn enabled structural and mechanistic studies. The literature on the pathway has been reviewed in detail (Rogers et al., 1980; Ward, 1984; Bugg and Walsh, 1992; van Heijenoort, 2001b; Barreteau et al., 2008; Bouhss et al., 2008). For convenience, the successive formations (see Figure 16.1) of uridine diphosphate- (UDP-) N-acetylglucosamine (GlcNAc), UDP-N-acetylmuramic acid (UDPMurNAc), UDP-MurNAc-peptides and lipids intermediates will be considered.
2.1. Formation of UDP-GlcNAc In eubacteria, UDP-GlcNAc is used not only for peptidoglycan synthesis, but also for that of other cell wall polymers (see Chapters 17 to 22). Its synthesis from d-fructose-6-phosphate (Figure 16.2) requires four steps (Dobrogosz, 1968;
NADPH
MurB UDP-MurNAc MurC
L-Ala
UDP-MurNAc-L-Ala MurD
D-Glu
UDP-MurNAc-dipeptide MurE
A2pm or L-Lys UDP-MurNAc-tripeptide
MurF
D-Ala-D-Ala
UDP-MurNAc-pentapeptide MraY
Undecapreny1-P Lipid I
MurG
UDP-GlcNAc Lipid II Peptidoglycan
Figure 16.1 Stepwise assembly of the peptidoglycan monomer unit. Abbreviations: A2pm, diaminopimelic acid; acetyl-CoA, acetyl co-enzyme A; d-, l-Ala, d-, l-alanine; dGlu, d-glutamic acid; l-Lys, l-lysine; NADPH, nicotinamide adenine dinucleotide phosphate; PEP, phosphoenolpyruvate; undecaprenyl-P, undecaprenyl-phosphate; UDP, uridine diphosphate; UDP-GlcNAc, UDP-N-acetylglucosamine; UDP-MurNAc, UDP-N-acetylmuramic acid; UTP, uridine diphosphate. Reproduced, with permission, from van Heijenoort (2007).
II. Synthesis of microbial glycosylated components
2. Assembly of the monomer unit
Fructose-6-P Gln
GlmS
Glu Glucosamine-6-P
GlmM Glucosamine-1-P Acetyl-CoA
GlmU
GlmU
CoA N-acetylglucosamine-1-p UTP PPi UDP-N-acetylglucosamine
Peptidoglycan
Other cell wall polymers
Figure 16.2 Biosynthesis of UDP-N-acetylglucosamine in bacteria. Abbreviations: acetyl-CoA, acetyl co-enzyme A; CoA, co-enzyme A; gln, glutamine; glu, glutamic acid; PPi, inorganic pyrophosphate; UDP, uridine diphosphate; UTP, uridine diphosphate.
White, 1968). First, the glmS gene product converts d-fructose-6-phosphate to d-glucosamine6-phosphate. The N-terminal domain of GlmS catalyses hydrolysis of l-glutamine to l-glutamate and ammonia, whereas the C-terminal domain utilizes released ammonia to form dglucosamine-6-phosphate. The 3D-structures of the two domains were determined and catalytic mechanisms proposed (Durand et al., 2008 and references therein). In the second step (see Figure 16.2), the interconversion of dglucosamine-6-phosphate and d-glucosamine1-phosphate is catalysed by phosphoglucosamine mutase GlmM (Mengin-Lecreulx and van Heijenoort, 1996). The mutase was shown to be active only after phosphorylation of a specific serine and catalysis proceeds according to a ping-pong bi-bi mechanism involving d-glucosamine-1,6-diphosphate as intermediate (Jolly et al., 1999).
289
The last two steps concern the acetylation and uridylation reactions (see Figure 16.2) carried out by the bifunctional glmU gene product (Mengin-Lecreulx and van Heijenoort, 1994). The C-terminal domain of GlmU catalyses acetylation of d-glucosamine-1-phosphate, whereas the N-terminal domain catalyses uridylation of the formed N-acetylglucosamine-1-phosphate to yield UDP-GlcNAc (Mengin-Lecreulx and van Heijenoort, 1994; Gehring et al., 1996). The two domains are functionally independent and each one is essential. Crystal structure determinations revealed that the two domains are connected by a long -helical arm and that three GlmU molecules form a homotrimeric arrangement (Mochalkin et al., 2007 and references therein).
2.2. Formation of UDP-MurNAc The formation of UDP-MurNAc (see Figure 16.1) is a two-step process. First, the addition of enolpyruvate from phosphoenolpyruvate to position-3 of N-acetylglucosamine in UDPGlcNAc is catalysed by transferase MurA to yield UDP-GlcNAc-enolpyruvate. In the second step, the reduction of the enolpyruvate moiety to d-lactoyl is catalysed by reductase MurB to yield UDP-MurNAc. In general, Gram-negative bacteria have only one murA gene, whereas lowG C Gram-positive bacteria have two. The MurA and MurB enzymes were purified from various organisms and their 3D structures determined (van Heijenoort, 2001b; Barreteau et al., 2008 and references therein). The reaction pathway of MurA was studied using rapid kinetics, phosphoenolpyruvate (PEP) analogues and site-directed mutagenesis (Skarzynski et al., 1998 and references therein). An addition–elimination mechanism was proposed and proceeds through a tetrahedral intermediate (Figure 16.3). The ketal adduct formed between the two substrates is non-covalently bound to the enzyme and the stereochemical course of the enzymatic enolpyruvyl transfer was
II. Synthesis of microbial glycosylated components
290
16. Biosynthesis of peptidoglycan
OO
OH
O-
O
P
HO HO +
O
OH OH
HNAc O
HO O
P
O
O
O-
PEP
UDP-GlcNAc
O-
O-
O
Uridine
O
OH O
P O
P
O
HO
OH OH
O O
HNAc O
H3C
O
P
O-
HO P
O
O
Uridine
O
Phospholactoyl-UDP-GlcNAc
Pi OH O HO
OH OH
O HNAc O O-
O
P O
HO O
P
O
Uridine
O
UDP-GlcNAc-enolpyruivate
Figure 16.3 MurA-catalysed formation of UDP-N-acetylglucosamine-enolpyruvate. Abbreviations: PEP, phosphoenolpyruvate; Pi, inorganic phosphate; UDP, uridine diphosphate; UDP-GlcNAc, UDP-N-acetylglucosamine.
determined. Structural studies with Escherichia coli MurA revealed that it can assume three conformational states corresponding to different stages of the catalytic process. Reductase MurB from E. coli is a flavoprotein and its mechanism (Figure 16.4) involves two half-reactions (Benson et al., 1997 and references therein). First, tightly bound flavine adenine
dinucleotide (FAD) is reduced by the twoelectron transfer from nicotinamide adenine dinucleotide phosphate (NADPH) (see Figure 16.4A). Second (see Figure 16.4B), the two-electron transfer from E-FADH2 to the C-3 of the enol ether of UDP-GlcNAc-enolpyruvate is followed by the delivery at C-2 of a proton from the active-site serine of MurB.
II. Synthesis of microbial glycosylated components
291
2. Assembly of the monomer unit
A
NADPH
+
NADP + E-FADH2
E-FAD
OH
B
O HO
OH OH
O
E-FADH2 +
HNAc O O
O
HO O
P
O
P
O
Uridine
O
UDP-GlcNAc-enolpyruvate OH O CH3
HO
OH OH
O HNAc O
O-
O
UDP-MurNAc
P O
HO O
+ P
O
E-FAD Uridine
O
Figure 16.4 MurB-catalysed reduction of UDP-N-acetylglucosamine-enolpyruvate to UDP-N-acetylmuramic acid. Abbreviations: FAD, flavine adenine dinucleotide (oxidized form); FADH2, flavine adenine dinucleotide (reduced form); NAD, nicotinamide adenine dinucleotide; NADPH, nicotinamide adenine dinucleotide phosphate (reduced form); UDP, uridine diphosphate; UDP-GlcNAc, UDP-N-acetylglucosamine; UDP-MurNAc, UDP-N-acetylmuramic acid.
2.3. Formation of the UDP-MurNAcpeptide precursors The formation of the UDP-MurNAc-peptide precursors proceeds (see Figure 16.1) by the stepwise addition of l-alanine (less frequently glycine), d-glutamic acid, a diamino acid (usually l-lysine or diaminopimelic acid, less frequently another diamino acid or homoserine) and d-alanyl-d-alanine (less frequently dalanyl-d-lactate or d-alanyl-d-serine) onto the dlactoyl group of UDP-MurNAc (van Heijenoort, 2001b; Smith, 2006; Barreteau et al., 2008 and references therein). At each step a specific cytoplasmic enzyme, designated as Mur synthetase, catalyses the formation of an amide or peptide
bond with concomitant cleavage of adenosine triphosphate (ATP) into adenosine diphosphate (ADP) and inorganic phosphate (Figure 16.5). The isolation of conditional-lethal mutants, characterized by a cell-lysis phenotype, was developed in different organisms. In E. coli, the Mur synthetase genes (murC, murD, murE, and murF) are unique, essential and are located in the dcw cluster containing both peptidoglycan synthesis and cell division genes. Cognate mur gene sequences from a wide variety of bacterial genera are now known, many of them also belonging to a division-cell wall cluster. Although the Mur synthetases have limited overall sequence identity, several specific motifs with high identity reveal the existence of common invariants.
II. Synthesis of microbial glycosylated components
292
16. Biosynthesis of peptidoglycan
MurC
UDP-MurNAc + L-Ala + ATP
MurD
UDP-MurNAc-L-Ala + D-Glu + ATP UDP-MurNAc-L-Ala-D-Glu + ADP + Pi
MurE
UDP-MurNAc-L-Ala-D-Glu + L-Lys (or A2pm) + ATP UDP-MurNAc-tripeptide + ADP + Pi
MurF
UDP-MurNAc-tripeptide + D-Ala-D-Ala + ATP UDP-MurNAc-pentapeptide + ADP + Pi
ATP
UDP-MurNAc-L-Ala + ADP + Pi
ADP
O
R'-NH2
O
R
R
–
O
O
=
PO3
Acyl phosphate –
O R
O
O
=
PO3
NH2+
R
+
Pi
NHR'
R' Tetrahedral intermediate
Figure 16.5 Stepwise assembly of the peptide subunit and reaction mechanism of the Mur synthetases, where R UDP-MurNAc or UDP-MurNAc-peptide and R’ amino acid or dipeptide. Abbreviations: A2pm, diaminopimelic acid; ADP, adenosine diphosphate; ATP, adenosine triphospahte; l-Ala, l-alanine; d-Glu, d-glutamic acid; l-lys, l-lysine; Pi, inorganic phosphate; UDP-MurNAc, UDP-N-acetylmuramic acid.
The structures of the four Mur synthetases were found to share the same three-domain topology with an N-terminal domain responsible for binding the UDP-MurNAc-peptide, a central ATP-binding domain and a C-terminal domain associated with binding the incoming amino acid or dipeptide. Domains 2 and 3 have conserved topology whereas that of the Nterminal domain differs from one synthetase to another. The Mur synthetases have also a similar active site architecture lying at the junction of the three structural domains and comprising specific binding pockets for the three substrates distributed around the catalytic centre.
The Mur synthetases all operate by a similar catalytic mechanism (see Figure 16.5) entailing the carboxy activation of a C-terminal amino acid residue of the nucleotide substrate to an acyl phosphate intermediate followed by the nucleophilic attack by the amino group of the condensing amino acid or dipeptide, with the elimination of phosphate and subsequent amide or peptide bond formation. The reversible formation of the acyl phosphate intermediate was substantiated and the possible presence of a tetrahedral transition state following the acyl phosphate was suggested. Being closely structurally and functionally related proteins,
II. Synthesis of microbial glycosylated components
293
2. Assembly of the monomer unit
the Mur synthetases thus appear as a welldefined subfamily of the ATP-dependent ligases (Smith, 2006).
2.4. Lipid intermediates in the biosynthesis of peptidoglycan The study of cell-free peptidoglycansynthesizing systems using UDP-GlcNAc, radiolabelled UDP-MurNAc-pentapeptide and particulate preparations from Staphylococcus
aureus and Micrococcus luteus led to the discovery of lipid intermediates I and II and to the determination of their respective role in the pathway (Chatterjee and Park, 1964; Meadow et al., 1964; Anderson et al., 1965). The first membrane step involves the transfer of the phospho-MurNAc-pentapeptide moiety of UDP-MurNAc-pentapeptide to undecaprenyl phosphate to yield lipid I and uridine monophosphate (UMP) (Figure 16.6). Thereafter, N-acetylglucosamine is added onto lipid I to yield lipid II. The structures of lipids I and II
OH HO
O O O
L-Ala
OH HNAc OH O O O P P O O
8
γ-D-Glu A2pm
LIPID I
D-Ala D-Ala OH
HNAc HO HO
O O
O O O
OH L-Ala
OH HNAc OH O O O P P O O
8
γ-D-Glu A2pm
LIPID II
D-Ala D-Ala
Periplasm
Translocation
Membrane MraY P + UDP-MurNAc
P
P
pep UMP
P MurNAc + pep
MurG
UDP-GlcNAc
P MurNAc-GlcNAc UDP
pep
Cytoplasm
Lipid I
Lipid II
Figure 16.6 Structure of lipids I and II, and their synthesis by transferases MraY and MurG. Pep pentapeptide. Abbreviations: UDP, uridine diphosphate; UDP-GlcNAc, UDP-N-acetylglucosamine; UDP-MurNAc, UDP-N-acetylmuramic acid; UMP, uridine monophosphate. Reproduced, with permission, from van Heijenoort (2007).
II. Synthesis of microbial glycosylated components
294
16. Biosynthesis of peptidoglycan
(see Figure 16.6) were established after isolation from cell-free systems (Higashi et al., 1967). Subsequently, they were characterized from various organisms. Their low pool levels, their limited accumulation in cell-free systems and the tedious work of their isolation restricted for decades their availability for the study of the membrane steps of the pathway. These difficulties have now been overcome by their chemical or enzymatic synthesis (Welzel, 2005; van Heijenoort, 2007; Bouhss et al., 2008 and references therein).
2.5. Biosynthesis of lipid I by transferase MraY The formation of lipid I is catalysed by integral membrane protein MraY which is essential and unique (Ikeda et al., 1991; Boyle and Donachie, 1998). A common 2D membrane topology model was established for the E. coli and S. aureus MraYs (Bouhss et al., 1999), which has ten transmembrane segments, five cytoplasmic domains and six periplasmic domains including the N- and C-terminal ends. The cytoplasmic domains are involved in substrate recognition and catalysis, thereby indicating that lipid I is formed at the inside surface of the membrane (Bouhss et al., 1999; Price and Momany, 2005). The MraY enzyme belongs to the UDP-d-Nacetylhexosamine: polyprenol phosphate d-Nacetylhexosamine-1-P transferase family (Price and Momany, 2005). A multistep catalytic mechanism (Figure 16.7) was proposed (Neuhaus, 1971; Ikeda et al., 1991; Lloyd et al., 2004; Price and Momany, 2005). The MraY reaction is fully reversible and takes place with conservation of the -anomeric configuration of the MurNAc residue. In most eubacteria, undecaprenyl phosphate is assumed to be the substrate of MraY. However, the recent structural analysis of lipids I and II from Mycobacterium smegmatis demonstrated the predominant presence of decaprenol
(Mahapatra et al., 2005). Purification of MraY from Bacillus subtilis (Bouhss et al., 2004) has not yet led to its crystallization.
2.6. Biosynthesis of lipid II by transferase MurG The transfer of N-acetylglucosamine from UDP-GlcNAc onto the C4 hydroxyl of the MurNAc unit of lipid I is catalysed by transferase MurG (Mengin-Lecreulx et al., 1991). The formation of the -(1→4)-linkage is accompanied by inversion of the anomeric configuration of N-acetylglucosamine (Figure 16.8). The MurG protein belongs to the GT-B glycosyltransferase (GT) superfamily (Ünligil and Rini, 2000). It is unique and essential. Mainly MurG from E. coli has been studied (van Heijenoort, 2001a, 2007; Bouhss et al., 2008 and references therein) and shown to be associated with the inner side of the cytoplasmic membrane, thereby establishing that the entire peptidoglycan monomer unit is assembled inside the cell prior to translocation across the membrane. Thus, MurG is a key enzyme at the junction between the two stages of peptidoglycan synthesis. The crystal structure of MurG consists of two domains separated by a deep cleft (Ha et al., 2000). The binding site for UDP-GlcNAc was proposed to be in the C-terminal domain and that for lipid I in the N-terminal domain in which a hydrophobic patch surrounded by basic residues could be the site of interaction with the negatively charged membrane. Sequence comparison of various orthologues confirmed the extrinsic and cationic characters of MurG and its functioning as a moderately hydrophobic peripheral protein. Detailed enzymatic studies were carried out with lipid I analogues. The partial reversibility of the reaction was established, the specificities of the acceptor and donor sites were investigated and an ordered bi-bi mechanism was demonstrated.
II. Synthesis of microbial glycosylated components
295
2. Assembly of the monomer unit
OH O
HO
OH
O R
O
Asp
MraY
MraY
Asp
NHAc
O
P
O
+
Uridine phosphate OH
O R
P
O
MraY
O
+
O
HO
O
UDP-MurNAC-pentapeptide
Mg
MraY intermediate
OH
Asp
NHAc
Uridine
O
Asp
MraY
O
OH
O
O
HO
O NHAc MraY
+
Asp O
Undecaprenyl phosphate
OH
O
OH
R
OH
OH
MraY intermediate
HO
P
R
NHAc
O MraY
P
O
Asp
O
P P
O
OH
HO
O
C55
O
OH
OH O
HO O
OH
R
NHAc LIPID I
O
O
P P
O
HO
O
C55
O
OH
Figure 16.7 Multistep MraY-catalysed formation of lipid I. Abbreviations: Asp, aspartic acid; UDP, uridine diphosphate; UDP-MurNAc, UDP-N-acetylmuramic acid. Reproduced, with permission, from van Heijenoort (2007).
2.7. Side pathways Besides the UDP-MurNAc-peptide and lipid intermediate precursors, the functioning of the pathway is dependent on a number of other substrates (see Figure 16.1). Some, like acetyl co-enzyme
A (acetyl-CoA), uridine triphosphate (UTP), PEP, ATP, l-alanine, l-lysine and diaminopimelic acid, are involved in various metabolic reactions. Other ones, like d-alanine, d-glutamic acid, dipeptide d-alanyl-X, undecaprenyl phosphate, are more
II. Synthesis of microbial glycosylated components
296
16. Biosynthesis of peptidoglycan
OH
OH O
O
HO
HO
HO
RO
OH
NHAc O UDP-GlcNAc donor
O
P
OH
LIPID I acceptor
H NHAc O
+
P
OH O
O
O
P
Undecaprenyl
O
O O
P
OH MurG
Uridine
OH
OH
O
O HO
O
H
RO
HO
+
OH
NHAc LIPID II
NHAc O
P O
Uridine diphosphate OH
O
P
O
Undecaprenyl
O
Figure 16.8 MurG-catalysed formation of lipid II. Abbreviations: UDP, uridine diphosphate; UDP-GlcNAc, UDP-Nacetyl-glucosamine. Reproduced, with permission, from van Heijenoort (2007).
specific of the biosynthesis of peptidoglycan or other cell wall polymers and their formation has been reviewed in detail (van Heijenoort, 2001b; Barreteau et al., 2008; Bouhss et al., 2008).
3. Translocation of the monomer unit Prior to its use as substrate in extracytoplasmic polymerization, lipid II is translocated through the hydrophobic environment of the cytoplasmic membrane (van Heijenoort, 2001a, 2007; Bouhss et al., 2008 and references therein). Considering its low pool level, its translocation must be a fast and unidirectional process in order to sustain a steady peptidoglycan
synthesis in growing cells. More than four decades after its discovery, the mechanism of its translocation remains unknown. Fluorescence spectrometry experiments carried out in lipid vesicles with a fluorescent lipid II analogue showed that there was no spontaneous move of the lipid intermediate across the bilayer (van Dam et al., 2007). Nevertheless, translocation was observed when E. coli inner membrane vesicles were used, revealing that an intact translocation machinery was present and likely composed of membrane proteins. Additional experiments indicated that lipid II translocation was perhaps coupled to ongoing transglycosylation. Earlier results had suggested that translocation of lipid II was dependent on phospholipid synthesis and was likely to be more than just a flip-flop mechanism (Ehlert
II. Synthesis of microbial glycosylated components
297
4. Polymerization of the monomer unit
and Höltje, 1996). Interestingly, protein-mediated mechanisms were reported for the transfer of enterobacterial common antigen and O-antigen units across the membrane (van Heijenoort, 2007; Bouhss et al., 2008 and references therein).
by inversion of the -anomeric configuration of the MurNAc residue and thus leads to linear chains containing exclusively -(1→4)-linkages (van Heijenoort, 2001a and references therein). In several cases, it was established that the reaction takes place at the reducing end of the growing chain which is transferred as the donor substrate to the C4 hydroxyl of the GlcNAc unit of lipid II acting as the acceptor substrate (van Heijenoort, 2001a; Perlstein et al., 2007 and references therein). The GTs responsible for the polymerization reaction come in two forms (Goffin and Ghuysen, 1998; van Heijenoort, 2001a, 2007 and references therein), namely as an N-terminal module in bifunctional class A penicillinbinding proteins (PBPs), which also contain a C-terminal transpeptidase (TP) module, and as monofunctional glycosyltransferases. They
4. Polymerization of the monomer unit 4.1. Glycan chain formation by transglycosylation Peptidoglycan glycan chains are assembled by polymerization of the GlcNAc--(1→ 4)-MurNAc-disaccharide-peptide unit of lipid II with formation of -(1→4)-linkages (Figure 16.9). The transglycosylation reaction is accompanied
Acceptor
OH
OH O
O GT
H
O
O NHAc
OH O
Lipid II
Donor
H
RO
HO
OH
NHAc O P
O O
O
O
O RO
HO NHAc Extending glycan chain
OH
O NHAc O GT-O-H P O
OH
P O
OH
Undecaprenyl
O O Periplasm
OH
P O
Undecaprenyl Membrane
Figure 16.9 Mechanism of transglycosylation with chain elongation at the reducing end. R d-lactoyl-peptide. Abbreviation: GT, glycosyltransferase. Reproduced, with permission, from van Heijenoort (2007).
II. Synthesis of microbial glycosylated components
298
16. Biosynthesis of peptidoglycan
show high sequence similarity, belong to the GT51 family in the sequence-based classification of GTs and possess five conserved motifs (Goffin and Ghuysen, 1998; Coutinho et al., 2003). Presently, more than 15 GTs have been purified and most assayed for their activity with lipid II or analogues as substrate (van Heijenoort, 2007; Sauvage et al., 2008 and references therein). Analysis of the reaction products formed by purified PBP1b from E. coli revealed an average glycan chain length of over 25 disaccharide units and almost 50% of cross-linked peptides (Bertsche et al., 2005). The recent resolution of the crystal structures of PBP2 from S. aureus (Lovering et al., 2007) and of the GT domain of Aquifex aeolicus (Yuan et al., 2007) opens the
way to more systematic studies of the GT catalytic site and reaction mechanism. PBP2a from S. aureus has a bi-lobal fold with the GT and TP domains separated by a short -rich linker region (Lovering et al., 2007).
4.2. Cross-bridge formation by transpeptidation The cross-linking between the peptide subunits of the glycan chains is essential for the formation of the 3D structure of peptidoglycan (see Chapter 2). It involves two types of transpeptidation reactions (Goffin and Ghuysen, 2002). Type (4→3) or dd-transpeptidation (Figure 16.10) is the main one and entails the formation of a
Donor ---GlcNAc-MurNAc---
---GlcNAc-MurNAc---
---GlcNAc-MurNAc---
L-Ala
L-Ala
L-Ala
D-iGlu
D-iGlu
D-iGlu
m-A2pm
m-A2pm
m-A2pm
D-Ala
D-Ala
PBP-Ser-OH
D-Ala
PBP-Ser-O
CO H2N
D-Ala D-Ala
m-A2pm
D-Ala
D-Ala
CO
D-Ala
NH
m-A2pm
D-IGlu L-Ala
---GlcNAc-MurNAc---
D-IGlu L-Ala
---GlcNAc-MurNAc---
Acceptor
Figure 16.10 Cross-linking by dd-transpeptidation between donor and acceptor peptide subunits. Abbreviations: A2pm, diaminopimelic acid; d-, l-Ala, d-, l-alanine; d-Glu, d-glutamic acid; d-iGlu, d-isoglutamic acid; GlcNAc, N-acetylglucosamine; MurNAc, N-acetylmuramic acid; PBP, penicillin-binding protein; ser, serine. Reproduced, with permission, from Zapun et al. 2008b. Penicillin-binding proteins and -lactam resistance. FEMS Microbiol. Rev. 32, 361–385.
II. Synthesis of microbial glycosylated components
6. In vivo functioning of the monomer unit assembly
peptide bond between the carboxyl group of the d-alanine in position-4 of a donor peptide subunit and the N amino group of l-lysine or diaminopimelic acid in position-3 of an acceptor peptide subunit, concomitantly with the release of the donor C-terminal d-alanine. The dd-transpeptidases responsible for this reaction belong to the PBP family. The PBPs are acyltransferases specifically inhibited by the covalent binding of -lactam antibiotics to their active site (Goffin and Ghuysen, 2002; Macheboeuf et al., 2006; Sauvage et al., 2008; Zapun et al., 2008b). They come in two forms: as C-terminal modules in class A PBPs in association with an N-terminal GT module or without it as in class B PBPs. Furthermore, they are bound to the cytoplasmic membrane with the bulk of the polypeptide chain exposed to the outside. Like all PBPs, dd-transpeptidases have the three conserved motifs of the SXXK serine enzyme superfamily. In the known 3D structures of TP domains, the three motifs are close to each other near the boundary of the catalytic centre. The active site serine of the SXXK motif is the catalytic nucleophile giving rise to an acyl-enzyme intermediate with the donor peptide subunit prior to the formation of the cross-linking with the acceptor subunit (see Figure 16.10). Type (3→3) or ld-transpeptidation functions in parallel with dd-transpeptidation in a number of organisms (Goffin and Ghuysen, 2002). This entails the formation of a peptide bond between the carboxyl of l-lysine or diaminopimelic acid in position-3 of a donor tetrapeptide subunit and the side chain amino group of the diamino acid in position-3 of the acceptor peptide subunit, concomitantly with the release of the donor C-terminal d-alanine. With the exception of carbapenems, ld-transpeptidases are insensitive to -lactams. Present in many organisms, they play a critical role in the mechanisms of resistance to antibiotics (Mainardi et al., 2008) and in the covalent binding of proteins to peptidoglycan (Dramsi et al., 2008).
299
5. Variations in peptidoglycan biosynthesis Modifications of the basic structure of peptidoglycan are encountered in most eubacteria (see Chapter 2; Vollmer, 2008; Vollmer et al., 2008). Moreover, variations in a given bacterium are observed under many circumstances (growth phase, growth conditions, antibiotic treatments, mutations, etc.). The physiological significance of many structural modifications is yet poorly understood. They are introduced either on the precursors of the monomer unit or during and after the polymerization reactions. They imply a certain variability of the specificities of the enzymes of the pathway or the presence of additional activities. Since the enzymatic specificities are not quite the same from one step to another, any change at a given step must be accepted by the following ones. Therefore, the cumulative effect of the different specificities along the pathway determines the extent of flexibility of peptidoglycan biosynthesis and that of its structural variability. It should be noted that the reactions responsible of modifications are not necessarily complete. Consequently, the presence of homologous precursors can lead to the functioning in parallel of more than one pathway (van Heijenoort, 2001b, 2007; Barreteau et al., 2008 and references therein). It should also be stressed that certain mechanisms of resistance to -lactam and glycopeptide antibiotics imply modifications in the biosynthesis of peptidoglycan (Mainardi, 2008; Zapun et al., 2008b).
6. In vivo functioning of the monomer unit assembly The mechanisms regulating the expression of the genes of the pathway have been studied to a limited extent. The expression of the murC, murD, murE, murF, murG and mraY genes of
II. Synthesis of microbial glycosylated components
300
16. Biosynthesis of peptidoglycan
the E. coli dcw cluster was shown to be mainly dependent on one promoter, namely Pmra (Mengin-Lecreulx et al., 1998). More recently, different riboregulatory mechanisms were described in B. subtilis and E. coli for the control of the expression of the glmS gene responsible for the synthesis of d-glucosamine-6-phosphate (Winkler et al., 2004; Urban et al., 2007). By comparing precursor pool levels, specific enzyme activities and rates of peptidoglycan synthesis, an overall view of the in vivo functioning of the E. coli pathway was established (reviewed in van Heijenoort, 2001b). Many enzymes were found to be more or less constitutive, their specific activity varying little with growth rate and only to a certain extent with growth phase. The specific activities are in excess or at least adjusted to the requirements of fast-growing cells. Possible control mechanisms by feed-back inhibition involving specific cell effectors were proposed for different steps. Furthermore, the functioning of the pathway from UDP-GlcNAc to UDP-MurNAc-pentapeptide (see Figure 16.1) was shown to depend on the rate of synthesis of UDP-GlcNAc. The formation of lipid I is limited by the pool of undecaprenyl phosphate and the reversibility of the MraY reaction (see Figure 16.6). During growth of many organisms, a turnover of peptidoglycan with release of soluble fragments into the medium is observed. However, in some Gram-negative bacteria, the turnover is accompanied by a recycling process whereby released fragments are incorporated back into the cell and reused in the assembly of the monomer unit (Park and Ueharan, 2008 and references therein).
7. In vivo functioning of the polymerization process The correlation between the transglycosylation and transpeptidation reactions was investigated with numerous organisms and cell-free
systems (Rogers et al., 1980; Ward, 1984; van Heijenoort, 2001a and references therein). In growing cells, they are tightly coupled in agreement with the bifunctionality of the class A PBPs. However, transglycosylation can proceed independently from transpeptidation as exemplified for instance by the formation of soluble material after inhibition of transpeptidation by -lactams. This clearly suggests that transpeptidation is necessary for the attachment of new material to pre-existing peptidoglycan. No transpeptidation was observed when transglycosylation was specifically inhibited by moenomycin (van Heijenoort, 2001a and references therein) or when GT-inactivated PBP1a from E. coli was used in a polymerization assay with lipid II (Born et al., 2006). Peptidoglycan being an essential continuous structural component of the cell envelope, the incorporation of new material is necessarily closely correlated with the complex machineries of cell growth and cell division and thus involves both spatial and temporal constraints. The localization of incorporation was analysed by various labelling and microscopy approaches (den Blaauwen et al., 2008; Zapun et al., 2008a and references therein). The results are consistent with the presence of different peptidoglycan-synthesizing systems. In rod-shaped organisms, one is associated with cell elongation whereas another one is involved in cell septation (den Blaauwen et al., 2008). In cocci, most material is incorporated during septation, but additional systems were proposed to account for preseptal, peripheral and thickening processes (Zapun et al., 2008a). A major difficulty with the study of the peptidoglycan-synthesizing complexes is the presence in many organisms of a multiplicity of peptidoglycan GT and TP activities (Goffin and Ghuysen, 1998, 2002). Efforts are made to specify with which system each activity is associated and several models of their in vivo functioning have been proposed (Scheffers and Pinho, 2005; Sauvage et al., 2008; Zapun et al., 2008a and references therein).
II. Synthesis of microbial glycosylated components
Acknowledgement
8. Inhibition of peptidoglycan biosynthesis An historically important aspect of peptidoglycan biosynthesis is its specific inhibition by antibiotics, some of which are well-known drugs in clinical use (-lactams, glycopeptides, fosfomycin, bacitracin, etc.) or in use as animal growth promoters (moenomycin, etc.). The elucidation of the mechanisms of action of these drugs and that of numerous other synthesized inhibitors often paralleled the study of individual steps of the pathway. Inhibitors for practically every step have now been described and they act by targeting an enzyme or a precursor. Non-covalent binding with an enzyme was observed with many steps of the assembly of the monomer unit (Dini, 2005; Barreteau et al., 2008; Bouhss et al., 2008 and references therein) and also with inhibition of GT activities by moenomycin (Welzel, 2005 and references therein). Covalent binding to an enzyme with formation of stable intermediates is exemplified with fosfomycin and d-cycloserine (Gale et al., 1981; Barreteau et al., 2008) and, most of all, with -lactams acting as suicide substrates of the PBPs (Goffin and Ghuysen, 2002; Macheboeuf et al., 2006; Sauvage et al., 2008; Zapun et al., 2008b). The formation of non-covalent complexes between certain antibiotics (glycopeptides, lantibiotics, ramoplanin and others) and lipid II or nascent peptidoglycan interferes with the polymerization reactions (Kahne et al., 2005; Walker et al., 2005; Chatterjee et al., 2005; Mainardi et al., 2008 and references therein). The cellular effect of a peptidoglycan inhibitor is dependent on target accessibility. By their size and/or polar structure, many potent inhibitors of isolated enzymes cannot penetrate the cytoplasmic membrane. The efficiency of fosfomycin and d-cycloserine is due to the use of endogeneous transport systems (Gale et al., 1981). The extracytoplasmic location of the GT and TP activities, as well as that of lipid II or nascent peptidoglycan,
301
explains in part their efficient use as targets. In growing cells, the inhibition of a specific step of the pathway will bring about an accumulation of the upstream precursors and a decrease of the downstream precursor pools with arrest of the polymeriztion reactions. This in turn leads to bacteriostasis or to a bactericidal effect often accompanied with morphological changes and cell lysis.
9. Concluding remarks Although many aspects of peptidoglycan biosynthesis have been studied, important areas call for more thorough investigations. Understanding the organization of the peptidoglycansynthesizing complexes and their functioning in coordination with cell growth and cell division is undoubtedly the most challenging problem and will need many years of sustained efforts. Closely related with this aspect is the presence in most organisms of numerous specific peptidoglycan hydrolases. They have only been studied in some cases and more systematic work is required for determining the roles they play. Furthermore, the genetics, biochemistry and physiological meaning of many structural modifications of peptidoglycan (amidation, methylation, phosphorylation, etc.) remain unexplored. Finally, various mechanisms of resistance to antibiotics involve modifications in peptidoglycan synthesis, several of which are not yet clearly understood. The need to overcome resistance mechanisms and to use specific targets for the search of novel antibacterials also fully warrants the continued study of peptidoglycan biosynthesis.
Acknowledgements This work was supported by grant UMR8619 from the Centre National de la Recherche Scientifique.
II. Synthesis of microbial glycosylated components
302
16. Biosynthesis of peptidoglycan
References Anderson, J.S., Matsuhashi, M., Haskin, M.A., Strominger, J.L., 1965. Lipid-phosphoacetylmuramyl-pentapeptide and lipid-phosphodisaccharide-pentapeptide: presumed membrane transport intermediates in cell wall synthesis. Proc. Natl. Acad. Sci. USA 53, 881–889. Barreteau, H., Kovacˇ, A., Boniface, A., Sova, M., Gobec, S., Blanot, D., 2008. Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 168–207. Benson, T.E., Walsh, C.T., Massey, V., 1997. Kinetic characterization of wild-type and S229A mutant MurB: evidence for the role of Ser 229 as general acid. Biochemistry 36, 796–805. Bertsche, U., Breukink, E., Kast, T., Vollmer, W., 2005. In vitro murein (peptidoglycan) synthesis by dimers of the bifunctional transglycosylase-transpeptidase PBP1B from Escherichia coli. J. Biol. Chem. 280, 38096–38101. Born, P., Breukink, E., Vollmer, W., 2006. In vitro synthesis of cross-linked murein and its attachment to sacculi by PBP1A from Escherichia coli. J. Biol. Chem. 281, 26985–26993. Bouhss, A., Mengin-Lecreulx, D., Le Beller, D., van Heijenoort, J., 1999. Topological analysis of the MraY protein catalysing the first membrane step of peptidoglycan synthesis. Mol. Microbiol. 34, 576–585. Bouhss, A., Crouvoisier, M., Blanot, D., Mengin-Lecreulx, D., 2004. Purification and characterization of the bacterial MraY translocase catalyzing the first membrane step of peptidoglycan synthesis. J. Biol. Chem. 279, 29974–29980. Bouhss, A., Trunkfield, A.E., Bugg, T.D.H., Mengin-Lecreulx, D., 2008. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Micriob. Rev. 32, 208–233. Boyle, D.S., Donachie, W.D., 1998. mraY is an essential gene for cell growth in Escherichia coli. J. Bacteriol. 180, 6429–6432. Bugg, T.D.H., Walsh, C.T., 1992. Intracellular steps of bacterial cell wall peptidoglycan synthesis: enzymology, antibiotics and antibiotic resistance. Nat. Prod. Rep. 9, 199–215. Chatterjee, A.N., Park, J.T., 1964. Biosynthesis of cell wall mucopeptide by a particulate fraction from Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 51, 9–16. Chatterjee, C., Paul, M., Xie, L., van der Donk, W.A., 2005. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105, 633–683. Coutinho, P.M., Deleury, E., Davies, G.J., Henrissat, B., 2003. An evolving hierarchical family classification of glycosyltransferases. J. Mol. Biol. 328, 307–317. den Blaauwen, T., de Pedro, M.A, Nguyen-Distèche, M., Ayala, J.A., 2008. Morphogenesis of rod-shaped sacculi. FEMS Microbiol. Rev. 32, 321–344.
Dini, C., 2005. MraY inhibitors as novel antibacterial agents. Curr. Top. Med. Chem. 5, 1221–1236. Dobrogosz, W.J., 1968. Effect of amino sugars on catabolite repression in Escherichia coli. J. Bacteriol. 95, 578–584. Dramsi, S., Magnet, S., Davison, S., Arthur, M., 2008. Covalent attachment of proteins to peptidoglycan. FEMS Microbiol. Rev. 32, 307–320. Durand, P., Golinelli-Pimpaneau, B., Mouilleron, S., Badet, B., Badet-Denisot, M.-A., 2008. Highlights of glucosamine6P synthase catalysis. Arch. Biochem. Biophys. 474, 302–317. Ehlert, K., Höltje, J.-V., 1996. Role of precursor translocation in coordination of murein and phospholipid synthesis in Escherichia coli. J. Bacteriol. 178, 6766–6771. Gale, E.F., Cundiffe, E., Reynolds, P.E., Richmond, M.H., Warning, M.J., 1981. The Molecular Basis of Antibiotic Action. John Wiley and Sons, London. Gehring, A.M., Lees, W.J., Mindiola, D.J., Walsh, C.T., Brown, E.D., 1996. Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional GlmU protein of Escherichia coli. Biochemistry 35, 579–585. Goffin, C., Ghuysen, J.-M., 1998. Multimodular penicillinbinding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62, 1079–1093. Goffin, C., Ghuysen, J.-M., 2002. Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent. Microbiol. Mol. Biol. Rev. 66, 702–738. Green, D.W., 2002. The bacterial cell wall as a source of antibacterial targets. Expert Opin. Ther. Targets 6, 1–19. Ha, S., Walker, D., Shi, Y., Walker, S., 2000. The 1.9 Å crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis. Protein Sci. 9, 1045–1052. Higashi, Y., Strominger, J.L., Sweeley, C.C., 1967. Structure of a lipid intermediate in cell wall peptidoglycan synthesis: a derivative of a C55 isoprenoid alcohol. Proc. Natl. Acad. Sci. USA 57, 1878–1884. Ikeda, M., Wachi, M., Jung, H.K., Ishino, F., Matsuhashi, M., 1991. The Escherichia coli mraY gene encoding UDP-Nacetylmuramoyl-pentapeptide: undecaprenyl-phosphate phospho-N-acetylmuramoyl-pentapeptide transferase. J. Bacteriol. 173, 1021–1026. Jolly, L., Ferrari, P., Blanot, D., van Heijenoort, J., Fassy, F., Mengin-Lecreulx, D., 1999. Reaction mechanism of phosphoglucosamine mutase from Escherichia coli. Eur. J. Biochem. 262, 202–210. Kahne, D., Leimkuhler, C., Lu, W., Walsh, C., 2005. Glycopeptide and lipoglycopeptide antibiotics. Chem. Rev. 105, 425–448.
II. Synthesis of microbial glycosylated components
References
Kotnik, M., Anderluh, P.S., Prezelj, A., 2007. Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis. Curr. Pharma. Design 13, 2283–2309. Lloyd, A.J., Brandish, P.E., Gilbey, A.M., Bugg, T.D.H., 2004. Phospho-N-acetyl-muramyl-pentapeptide translocase from Escherichia coli: catalytic role of conserved aspartic acid residues. J. Bacteriol. 186, 1747–1757. Lovering, A.L., de Castro, L.H., Lim, D., Strynadka, N.C.J., 2007. Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis. Science 315, 1402–1405. Macheboeuf, P., Contreras-Martel, C., Job, V., Dideberg, O., Dessen, A., 2006. Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol. Rev. 30, 673–691. Mahapatra, S., Yagi, T., Belisle, J.T., et al., 2005. Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate. J. Bacteriol. 187, 2747–2757. Mainardi, J.-L., Villet, R., Bugg, T.D., Mayer, C., Arthur, M., 2008. Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria. FEMS Microbiol. Rev. 32, 386–408. Meadow, P.M., Anderson, J.S., Strominger, J.L., 1964. Enzymatic polymerization of UDP-acetylmuramyl.lala.d-glu.l-lys.d-ala.d-ala and UDP-acetylglucosamine by a particulate enzyme from Staphylococcus aureus and its inhibition by antibiotics. Biochem. Biophys. Res. Commun. 14, 382–387. Mengin-Lecreulx, D., van Heijenoort, J., 1994. Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-Nacetylglucosamine synthesis. J. Bacteriol. 176, 5788–5795. Mengin-Lecreulx, D., van Heijenoort, J., 1996. Characterization of the essential gene glmM encoding phosphoglucosamine mutase in Escherichia coli. J. Biol. Chem. 271, 32–39. Mengin-Lecreulx, D., Texier, L., Rouseau, M., van Heijenoort, J., 1991. The murG gene of Escherichia coli codes for the UDP-N-acetylglucosamine: N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase involved in the membrane steps of peptidoglycan synthesis. J. Bacteriol. 173, 4625–4636. Mengin-Lecreulx, D., Ayala, J., Bouhss, A., van Heijenoort, J., Parquet, C., Hara, H., 1998. Contribution of the Pmra promoter to expression of genes in the Escherichia coli mra cluster of cell envelope biosynthesis and cell division genes. J. Bacteriol. 180, 4406–4412. Mochalkin, I., Lightle, S., Zhu, Y., et al., 2007. Characterization of substrate binding and catalysis in the potential
303
antibacterial target N-acetylglucosamine-1-phosphate uridyltransferase (GlmU). Protein Sci. 16, 2657–2666. Neuhaus, F.C., 1971. Initial translocation reaction in the biosynthesis of peptidoglycan by bacterial membranes. Acc. Chem. Res. 4, 297–303. Park, J.T., Uehara, T., 2008. How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbial. Mol. Biol. Rev. 72, 211–227. Perlstein, D.L., Zhang, Y., Wang, T.-S., Kahne, D.E., Walker, S., 2007. The direction of glycan chain elongation by peptidoglycan glycosyltransferases. J. Amer. Chem. Soc. 129, 12674–12675. Price, N.P., Momany, F.A., 2005. Modeling bacterial UDP-HexNAc:polyprenol-P HexNAc-1-P transferases. Glycobiology 15, 29R–42R. Rogers, H.J., Perkins, H.R., Ward, J.B., 1980. Microbial Cell Walls and Membranes. Chapman & Hall Ltd., London. Sauvage, E., Kerff, F., Terrak, M., Ayala, J.A., Charlier, P., 2008. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 234–258. Scheffers, D.-J., Pinho, M.G., 2005. Bacterial cell wall synthesis: new insights from localization studies. Microbiol. Mol. Biol. Rev. 69, 585–607. Skarzynski, T., Kim, D.H., Lees, W.J., Walsh, C.T., Duncan, K., 1998. Stereochemical course of enzymatic enolpyruvyl transfer and catalytic conformation of the active site revealed by the crystal structure of the fluorinated analogue of the reaction tetrahedral intermediate bound to the active site of the C115A mutant of MurA. Biochemistry 37, 2572–2577. Smith, C.A., 2006. Structure, function and dynamics in the mur family of bacterial cell wall ligases. J. Mol. Biol. 362, 640–655. Ünligil, U.M., Rini, J.M., 2000. Glycosyltransferase structure and mechanism. Curr. Opin. Struct. Biol. 10, 510–517. Urban, J.H., Papenfort, K., Thomsen, J., Schmitz, R.A., Vogel, J., 2007. A conserved small RNA promotes discoordinate expression of the glmUS operon mRNA to activate GlmS synthesis. J. Mol. Biol. 373, 521–528. van Dam, V., Sijbrandi, R., Kol, M., Swiezewska, E., de Kruijff, B., Breukink, E., 2007. Transmembrane transport of peptidoglycan precursors across model and bacterial membranes. Mol. Microbiol. 64, 1105–1114. van Heijenoort, J., 2001a. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 11, 25R–36R. van Heijenoort, J., 2001b. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat. Prod. Rep. 18, 503–519. van Heijenoort, J., 2007. Lipid intermediates in the biosynthesis of bacterial peptidoglycan. Microbiol. Mol. Biol. Rev. 71, 620–635.
II. Synthesis of microbial glycosylated components
304
16. Biosynthesis of peptidoglycan
Vicente, M., Rico, A.L., Martinez-Arteaga, R., Mingorance, J., 2006. Septum enlightenment: assembly of bacterial division proteins. J. Bacteriol. 188, 19–27. Vollmer, W., 2008. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol. Rev. 32, 287–306. Vollmer, W., Blanot, D., de Pedro, M.A., 2008. Peptidoglycan structure and architecture. FEMS Microbiol. Rev. 32, 149–167. Walker, S., Chen, L., Hu, Y., Rew, Y., Shin, D., Boger, D.L., 2005. Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity. Chem. Rev. 105, 449–475. Ward, J.B., 1984. Biosynthesis of peptidoglycan: points of attack by wall inhibitors. Pharmac. Ther. 25, 327–369. Welzel, P., 2005. Syntheses around the transglycosylation step in peptidoglycan biosynthesis. Chem. Rev. 105, 4610–4660.
Winkler, W.C., Nahvi, A., Roth, A., Collins, J.A., Breaker, R.R., 2004. Control of gene expression by a natural metabolite-responsive ribozyme. Nature 428, 281–286. White, R.J., 1968. Control of amino sugar metabolism in Escherichia coli and isolation of mutants unable to degrade amino sugars. Biochem. J. 106, 847–858. Yuan, Y., Barrett, D., Zhang, Y., Kahne, D., Sliz, P., Walker, S., 2007. Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis. Proc. Natl. Acad. Sci. USA 104, 5348–5353. Zapun, A., Vernet, T., Pinho, M.G., 2008a. The different shapes of cocci. FEMS Microbiol. Rev. 32, 345–360. Zapun, A., Contreras-Martel, C., Vernet, T., 2008b. Penicillinbinding proteins and -lactam resistance. FEMS Microbiol. Rev. 32, 361–385.
II. Synthesis of microbial glycosylated components
c h a p t e r
17 Biosynthesis and membrane assembly of lipid A M. Stephen Trent
Summary
1. Introduction
Lipopolysaccharide is the major surface molecule of most Gram-negative bacteria and is a potent stimulator of the innate immune response. The lipid anchor of lipopolysaccharide, known as lipid A, is a unique glucosamine-based saccharolipid that forms the outer monolayer of the outer membrane. Lipid A is synthesized on the cytoplasmic side of the inner membrane by nine constitutive enzymes that are highly conserved among diverse Gram-negative bacterial species. Once the lipid anchor is assembled, it is substituted with an oligosaccharide core and transported across the inner membrane by MsbA, a conserved ATP-binding cassette (ABC) transporter. The oligosaccharide can then be extended further by the addition of the O-specific polysaccharide. Recently, several proteins involved in the transport of nascent lipopolysaccharide to the outer membrane were identified. Although the synthesis of lipid A is a highly conserved process, Gram-negative bacteria have evolved mechanisms to modify the structure of lipid A during transit to the bacterial surface. Lipid A modifications are variable from organism to organism, are often regulated and play an important role in pathogenesis.
Gram-negative bacteria are further guarded from their environment by an asymmetric outer membrane that encapsulates their peptidoglycan layer. The outer membrane consists of phospholipids, lipopolysaccharides (LPS) and proteins (Figure 17.1). The inner leaflet of the outer membrane is composed of phospholipids, whereas the outer leaflet is composed primarily of LPS (Kamio and Nikaido, 1976), a conserved microbial component that is a potent stimulator of the innate immune response (Galanos et al., 1985; Kotani et al., 1985; Raetz and Whitfield, 2002). In Enterobacteriaceae, LPS is anchored within the outer membrane by a glucosamine-based saccharolipid termed lipid A. The oligosaccharide (OS) core and O-specific polysaccharide (O-PS) of LPS are linked to the lipid moiety via an eight-carbon sugar called 3-deoxy-d-manno-oct2-ulosonic acid (Kdo). Notably, it is the lipid A domain of LPS that is detected by the Toll-like receptor- (TLR-) 4/MD2 receptor of the mammalian innate immune system (Galanos et al., 1984; Hoshino et al., 1999; Aderem and Ulevitch, 2000) (see Chapter 31). Herein, we will discuss the biosynthesis of the Kdo2-lipid A region of LPS
Keywords: Lipopolysaccharide; Lipid A; Outer membrane; Lpx; MsbA
Microbial Glycobiology
305
© 2009 2010, Elsevier Inc.
306
17. Biosynthesis and membrane assembly of lipid A
Environment
LPS Kdo Lipid A
β-barrel (porin)
OM
β-barrel
Phospholipid
Lipoprotein
Periplasm
Undecaprenyl phosphate sugar
Phospholipid
TM
IM TM α-Helical protein
Cytoplasm
O HO
O
OH
O O
O
NH2
P O O
O
HO P O OH O O O
O O
O
O NH O O
HO O O HO
O NH O
O O P OH OH
HO
O O PO 8
Phosphatidylethanolamine
Lipid A
X
OH
Undecaprenyl phosphate sugar
Figure 17.1 Schematic of the Gram-negative cell envelope typified by E. coli. Unlike Gram-positive organisms, Gramnegative bacteria are further guarded from their environment by an asymmetric outer membrane (OM), interspersed with proteins (top panel). The inner leaflet is composed of glycerophospholipids (PL) whereas the outer leaflet of the outer membrane is composed almost exclusively of lipopolysaccharide (LPS). Lipid A serves as the hydrophobic anchor of LPS and the Kdo (3-deoxy-d-manno-oct-2-ulosonic acid) residues serve as a bridge to the remaining saccharide moiety. The chemical structures of lipid A, phosphatidylethanolamine and undecaprenyl-phosphate are shown (bottom panel). Undecaprenyl phosphate is an essential carrier lipid required for the synthesis of various bacterial polymers.
and also describe how the molecule is modified and assembled into the outer membrane.
2. The constitutive lipid a biosynthetic pathway In Escherichia coli, nine enzymatic steps are required to produce Kdo2-lipid A, a bis-phosphorylated dissacharide of glucosmaine that is
hexa-acylated and glycoslyated with two Kdo residues (Figure 17.2). Most Gram-negative bacteria have the ability to synthesize a lipid similar to that of E. coli Kdo2-lipid A via a highly conserved pathway referred to as the Raetz pathway (named after Christian R. H. Raetz). However, examination of the lipid A structures from various organisms shows an impressive amount of diversity (Trent et al., 2006; Raetz et al., 2007). These differences arise from the action of
II. synthesis of microbial glycosylated components
2. The constitutive lipid a biosynthetic pathway
307
Figure 17.2 The constitutive biosynthetic pathway of the Kdo2-lipid A domain of LPS. The structures shown are for the
biosynthesis of Kdo2-lipid A in E. coli K-12 and S. enterica sv. Typhimurium. The names of the major intermediates are indicated and the nine enzymes are listed below reaction arrows. Acyl-acyl carrier protein serves as the obligate acyl donor for the various acyltransferases. The pathway is also referred to as the Raetz pathway, named after its discoverer Christian R.H. Raetz.
latent modification enzymes that together make up the variable component of lipid A biosynthesis and which is discussed later in the chapter. E. coli LpxA catalyses the first step of the constitutive pathway transferring a 3-hydroxytetradecanoic acid (-hydroxymyristate ) [14:0(3-OH)] chain to uridine diphosphate- (UDP-) Nacetylglucosamine (UDP-GlcNAc) (Galloway and Raetz, 1990), a precursor of both peptidoglycan and lipid A. The second and first committed step of the pathway is catalysed by the zinc metalloenzyme LpxC (Young et al., 1995; Jackman et al., 1999). The enzyme LpxC catalyses the irreversible hydrolysis of the amide linkage at position-2 of the backbone glucosamine by removing an
acetyl group. Also, LpxC is highly conserved in all Gram-negative bacteria and, since the enzyme has no homology to mammalian deacetylases or amidases, it has been an attractive target for the development of novel antibacterial compounds (Kline et al., 2002; McClerren et al., 2005). Once deacetylated, a second 14:0(3-OH) chain is added by LpxD to form UDP-2,3diacylglucosamine (Kelly et al., 1993). Both LpxA and LpxD utilize acyl-acyl carrier protein (ACP) as the obligate acyl donor (Galloway and Raetz, 1990; Kelly et al., 1993). Unlike acyltransferases involved in phospholipid biosynthesis, these enzymes usually have a high degree of specificity for their acyl donor with regards to fatty acyl
II. synthesis of microbial glycosylated components
308
17. Biosynthesis and membrane assembly of lipid A
chain length and extent of saturation. Detailed biochemical investigations of LpxA, including a crystal structure with bound lipid product (Williams and Raetz, 2007), support a precise “hydrocarbon ruler” contributing to the extraordinary chain length selectivity of these enzymes. The fourth step of Kdo2-lipid A biosynthesis is cleavage of the pyrophosphate linkage of UDP-2,3-diacylglucosamine by LpxH to form uridine monophosphate (UMP) and 2,3diacylglucosamine 1-phosphate (lipid X) (Babinski et al., 2002) (see Figure 17.2). Next, LpxB condenses one molecule of UDP-2,3-diacylglucoasmine with one molecule of lipid X and releases UDP resulting in the formation of the characteristic -(1→6)-glycosidic linkage present in lipid A molecules (Crowell et al., 1986). The early steps of the pathway occur in the cytoplasm, however, both LpxB and LpxH are peripherally associated with the inner membrane. The final steps of the constitutive pathway are catalysed by four integral membrane proteins: LpxK, KdtA (WaaA), LpxL (HtrB) and LpxM (MsbB). Since these reactions all require cytolosic factors (see Figure 17.2), the active sites of these enzymes are presumably in the cytoplasm. A specific kinase, LpxK, catalyses the phosphorylation of the 4-OH group of the tetraacyldisaccharide-1-phosphate intermediate thereby producing lipid IVA, a key lipid A precursor (Garrett et al., 1997). In E. coli, this is followed by the transfer of two Kdo residues onto position6 of the dissacharide backbone. The reaction is catalysed by the bifunctional glycosyltransferase KdtA (WaaA) and utilizes CMP-Kdo as the nucleotide sugar donor (Clementz and Raetz, 1991). Addition of Kdo to the lipid anchor represents the first step of core biosynthesis as Kdo is present in nearly all Gram-negative bacteria. Interestingly, the number of Kdo residues transferred by KdtA differs in various bacterial species. For example, the Kdo transferase of Haemophilus influenzae (White et al., 1997) transfers a single Kdo residue, whereas KdtA of Chlamydia and Chlamydophila spp. can transfer
three or even four residues to the dissacharide backbone (Brabetz et al., 2000). Remarkably, comparison of the secondary structure of the Kdo transferases (Raetz and Whitfield, 2002) gives no clues as to the number of glycosidic linkages that can be generated by these enzymes. The final steps of the E. coli biosynthetic pathway involve the addition of two secondary acyl chains by LpxL and LpxM. The protein LpxL (HtrB) transfers a dodecanoic acid (laurate) (12:0) to the 2-position (Clementz et al., 1996) and LpxM (MsbB) a tetradecanoic acid (myristate) (14:0) to the 3-position (Clementz et al., 1997). These enzymes utilize acyl-ACPs as their substrate and function only after the addition of the Kdo residues. Like the early acyltransferases (LpxA and LpxD), LpxL and LpxM are very selective for a specific acyl chain length and degree of saturation (Clementz et al., 1996, 1997; VorachekWarren et al., 2002). In some bacteria, a third acyl transferase, termed LpxP, is expressed during cold shock and replaces the function of LpxL in the constitutive pathway (Carty et al., 1999). The LpxP protein incorporates a 9-hexadecenoic acid (palmitoleate) (16:1) chain which is thought to aid in adjusting the fluidity of the outer membrane when shifted to lower growth temperatures. Finally, it is important to note that not all Gram-negative bacteria contain two late acyltransferases. For example, Chlamydia trachomatis contains a single LpxL orthologue and produces a lipid A with a single secondary acyl chain at the 2-position (Rund et al., 1999). Interestingly, some Gram-negative organisms, like Campylobacter jejuni, synthesize a lipid A bearing two secondary acyl chains (Moran et al., 1991), but contain a single late acyltransferase orthologue. The differences in the acyl chain specificity and number of late acyltransferases contributes greatly to the diversity of lipid A structures found in Gramnegative bacteria. Since the secondary acyl chains of lipid A are critical for the endotoxicity of the molecule (Golenbock et al., 1991; Somerville et al., 1996; Nichols et al., 1997) these differences are also of significant biological importance.
II. synthesis of microbial glycosylated components
4. Modification of the kdo-lipid a domain of LPS
3. Transport Both the lipid A domain and core OS, including the Kdo residues, are assembled on the cytoplasmic side of the inner membrane. Once translocated across the inner membrane, the Ospecific polysaccharide (O-PS) is ligated to the core-lipid A moiety completing LPS assembly (Figure 17.3). Nascent LPS must then be shuttled across the periplasm and eventually translocated to the outer leaflet of the outer membrane where it resides as a major surface molecule. Although progress has been made towards identifying the molecular machinery required for transport of LPS to the bacterial cell surface (Bos et al., 2007), this process is not fully understood. Transport of the core-lipid A across the inner membrane is mediated by a highly conserved ATP-binding cassette (ABC) transporter, called MsbA (Doerrler et al., 2001) (see Figure 17.3). In E. coli, MsbA is essential for growth and inactivation of the transporter in temperaturesensitive mutants results in the accumulation of lipid A and glycerophospholipids in the inner membrane (Doerrler et al., 2001). Further supporting the role of MsbA as a LPS flippase is the observation that loss of MsbA function results in the loss of lipid A modifications known to occur on the periplasmic face of the inner membrane (Doerrler et al., 2004). Unlike E. coli, Neisseria meningitidis is not dependent upon LPS synthesis for growth (Steeghs et al., 1998). Loss of MsbA-dependent transport in this bacterial species does not result in cell death or the loss of outer membrane biogenesis (Tefsen et al., 2005). For this reason, it remains unclear if MsbA plays a direct role in the flip-flop of glycerophospholipids. Recent work has identified several proteins involved in the periplasmic transport of LPS, including the periplasmic protein LptA, and a complex of proteins composed of LptBFG that function together as an ABC protein complex. The LptBFG complex is thought to extract LPS
309
from the inner membrane en route to the outer membrane. The bitopic inner membrane protein LptC is also required for removal of LPS from the inner membrane (Sperandeo et al., 2007, 2008; Tran et al., 2008) (see Figure 17.3). Since LptA is a soluble protein, it may function as a chaperone shuttling LPS across the periplasm where it is transferred to the LptDE complex (Figure 17.3). Indeed, E. coli LptA has been shown directly to bind the lipid A portion of LPS (Tran et al., 2008). The outer membrane protein LptD (formerly termed Imp) and the lipoprotein LptE (formerly termed RlpB) are thought to function together to flip nascent LPS within the outer membrane to the bacterial cell surface (Braun and Silhavy, 2002; Bos et al., 2004; Wu et al., 2006). Depletion of any single LPS transport (Lpt) protein in E. coli results in the accumulation of abnormal membrane structures resulting in cell death.
4. Modification of the kdo-lipid a domain of LPS Following the conserved pathway, the Kdolipid A domain of LPS can be modified by latent enzymes that make up the variable component of lipid A biosynthesis (Trent et al., 2006). In most cases, these modifications occur at the periplasmic face of the inner membrane or in the outer membrane, separating the constitutive and variable pathways. How these modifications are regulated and the number and type of modifications vary for each bacterial species contributing towards the diversity of microbial cell surfaces (Trent et al., 2006; Raetz et al., 2007). For this section, we will focus primarily on the lipid A modifications known to occur in E. coli and Salmonella enterica sv. Typhimurium. Modification to the disaccharide backbone of lipid A centres on the removal or decoration of the lipid A phosphate groups. The lipid A disaccharide of E. coli K-12 typically contains a monophosphate group at positions 1 and 4, however,
II. synthesis of microbial glycosylated components
310
17. Biosynthesis and membrane assembly of lipid A
Figure 17.3 Possible model for the transport of LPS through the bacterial cell envelope. Core-lipid A is synthesized on the cytoplasmic side of the inner membrane (IM) and transported over the inner membrane by the ABC transporter, MsbA (Doerrler et al., 2004). The O-PS is assembled separately (not shown) from core-lipid A and is transferred to the core-lipid A domain within the periplasm (Raetz and Whitfield, 2002). How LPS is transported to the cell surface remains unclear, but several essential proteins involved in this process have been identified. The ABC transporter comprised of LptBFG along with LptC and the periplasmic protein LptA participate in transport of LPS from the periplasmic side of the inner membrane to the inner leaflet of the outer membrane (Sperandeo et al., 2007, 2008; Ruiz et al., 2008; Tran et al., 2008). The proteins LptDE are required to transfer LPS to the cell surface (Bos et al., 2004; Wu et al., 2005), perhaps by acting as a flippase complex. It is very likely that additional unidentified protein components are involved in this process.
approximately 20–30% of the lipid A contains an unsubstituted diphosphate group at the 1-position (Raetz and Whitfield, 2002). E. coli LpxT phosphorylates the 1-position of Kdo2lipid A (Figure 17.4) forming a 1-diphosphate lipid A species (Touze et al., 2008). The reaction occurs on the periplasmic side of the inner membrane and undecaprenyl pyrophosphate (C55-PP) serves as the phosphate donor releasing undecaprenyl-P (C55-P). In this way, LpxT
also contributes to the total cellular pool of C55-P. The latter is an essential carrier lipid (see Figure 17.1) required for the synthesis of various bacterial polymers (Bouhss et al., 2008), such as peptidoglycan and the O-antigen domain of LPS. Two additional enzymes, ArnT and EptA, modify the phosphate groups of E. coli and S. enterica lipid A catalysing the addition of aminecontaining residues. The protein ArnT transfers
II. synthesis of microbial glycosylated components
4. Modification of the kdo-lipid a domain of LPS
311
Figure 17.4 Comparison of the modified and unmodified forms of Kdo2-lipid A. The structure on the left shows the
unmodified Kdo2-lipid A of E. coli K-12 or S. typhimurium that is hexa-acylated containing monophosphate groups at positions-1 and -4. An additional phosphate group may also be present during growth in nutrient rich broth forming a diphosphate at the 1-position (Touze et al., 2008). The PagL and PagP modifications are regulated by the PhoP/PhoQ system (Guo et al., 1998; Trent et al., 2001a) whereas modifications requiring the enzymes ArnT (Trent et al., 2001b) and EptA (Trent and Raetz, 2002) are regulated by the transcription factor PmrA. Removal of the 3-acyloxyacyl linked fatty acyl chains by LpxR and addition of phosphoethanolamine by EptB to the outer Kdo sugar require the presence of Ca2 in the growth medium (Reynolds et al., 2005, 2006). The proteins LpxO, LpxR and PagL are not present in E. coli K-12 (Gibbons et al., 2000; Trent et al., 2001a; Reynolds et al., 2006). However, a homologue of LpxR can be found in some pathogenic strains of E. coli.
the sugar, 4-amino-4-deoxy-l-arabinopyranose (l-Arap4N) (Trent et al., 2001b) and EptA serves as a phosphoethanolamine transferase (Trent and Raetz, 2002; Lee et al., 2004). Expression of ArnT and EptA is under the control of the transcription factor PmrA that is induced during growth under conditions of low pH and high Fe3 concentration (Groisman et al., 1997; Wosten et al., 2000). Attachment of these positively charged residues to lipid A can provide resistance to some cationic antimicrobial peptides including polymyxin B (Helander et al., 1994; Nummila et al., 1995; Gunn et al., 1998; Cox et al., 2003; Tzeng et al., 2005). It is important to note that formation of the 1-diphosphate species by the action of LpxT does not occur under growth conditions that promote the
addition of l-Arap4N and phosphoethanolamine (Guo et al., 1997; Zhou et al., 1999, 2001). Like LpxT, both ArnT and EptA contain multiple transmembrane domains and modify lipid A on the outer surface of the inner membrane (Doerrler et al., 2004). ArnT utilizes the sugar donor undecaprenyl-phosphate--l-Arap4N (Trent et al., 2001c) that is first synthesized within the cytoplasm and transported across the inner membrane (Raetz et al., 2007). The l-Arap4N residue is transferred primarily to the 4-phosphate group of E. coli and S. enterica sv. Typhimurium lipid A (Trent et al., 2001b). In pathogens lacking the phosphoethanolamine modification, e.g. Yersinia pestis and Pseudomonas aeruginosa, l-Arap4N can be found attached to both phosphate groups
II. synthesis of microbial glycosylated components
312
17. Biosynthesis and membrane assembly of lipid A
(Trent et al., 2006) (Figure 17.5). Interestingly, most Gram-negative bacteria produce either phosphoethanolamine-modified or l-Arap4Nmodified lipid A, whereas E. coli and S. enterica sv. Typhimurium contain both residues (see Figures 17.4 and 17.5). In different organisms, lArap4N addition to lipid A has been correlated with increased resistance to cationic antimicrobial peptides and l-Arap4N-deficient mutants of S. enterica sv. Typhimurium show reduced virulence (Gunn et al., 1998; McCoy et al., 2001; Moskowitz et al., 2004; Winfield et al., 2005). The addition of phosphoethanolamine groups to lipid A occurs in a large number of pathogenic bacteria. Phosphatidylethanolamine (see Figure 17.1) serves as the phosphoethanolamine donor
substrate (Trent et al., 2001c; Trent and Raetz, 2002). In E. coli and S. enterica, EptA adds phosphoethanolamine predominantly to the 1-phosphate group (Zhou et al., 2000). S. enterica eptA mutants show only slight increases in susceptiblity to polymyxin B suggesting that phosphoethanolamine addition is not critical for resistance to cationic antimicrobial peptides (Lee et al., 2004). On the other hand, loss of phosphoethanolamine addition in N. meningitidis (Tzeng et al., 2005) or C. jejuni (T.W. Cullen and M.S. Trent, unpublished results) leads to significant polymxyin sensitivity. Both N. meningitidis and C. jejuni lack the enzymatic machinery to produce l-Arap4N-modified lipid A and these bacteria modify both lipid A phosphate groups with
Figure 17.5 Chemical structures of the Kdo-lipid A domain found in the LPS of selected pathogenic bacteria. Partial covalent modifications are indicated with dashed bonds and the length of each fatty acyl chain is indicated by the enclosed circles. Note that the dissacharide of C. jejuni lipid A contains a diamino-sugar resulting in three acyl chains in an amide linkage (Moran et al., 1991). The biochemical origin of the diamino-sugar precedes the constitutive lipid A pathway with the conversion of UDP-GlcNAc to its diamino-anolog, that can be acylated by LpxA (Sweet et al., 2004a,b).
II. synthesis of microbial glycosylated components
4. Modification of the kdo-lipid a domain of LPS
phosphoethanolamine. Further investigation will be required to determine the roles of phosphoethanolamine modification in cationic antimicrobial peptide resistance and pathogenesis. Several enzymes that alter the acylation pattern of the lipid A moiety of LPS have also been described. A small outer membrane enzyme, PagP, transfers a hexadecanoic acid (palmitate) (16:0) chain to the 2-position of E. coli or S. enterica lipid A (Guo et al., 1998; Bishop et al., 2000) (see Figure 17.4). Addition of a palmitate to lipid A increases resistance to certain cationic antimicrobial peptides, presumably by increasing the packing of the fatty acyl chains in the outer membrane. The active site of PagP faces the exterior and the enzyme utilizes phospholipids (e.g. phosphatidylethanolamine) as palmitoyl donors (Hwang et al., 2002). Since phospholipids are typically not present on the outer surface, PagP activity is thought to be regulated by the migration of phospholipids into the outer leaflet. Expression of pagP is under the control of the PhoP/PhoQ two-component regulatory system which is activated during exposure of the bacterium to cationic antimicrobial peptides or during Mg2 limitation (Guo et al., 1997; Bader et al., 2005). In the case of S. enterica, the PhoP/PhoQ system is activated following phagocytosis by macrophages alerting the bacterium to its presence inside the phagolysosome (Alpuche Aranda et al., 1992). Homologues of PagP can be found in several pathogenic bacteria including Shigella flexneri, Legionella pneumophila and species of Bordetella and Yersinia. Two additional outer membrane enzymes, PagL and LpxR, also modify the lipid moiety of LPS by removing specific fatty acyl chains (see Figure 17.4). Though PagL is a PhoP-activated lipase and removes the 14:0(3-OH) chain at position-3 (Trent et al., 2001a), LpxR removes the intact 3-acyloxyacyl moiety of the lipid A domain (Reynolds et al., 2006). Moreover, LpxR is not dependent on PhoP activation, but does require the divalent cation Ca2 for enzymatic activity. Interestingly, both PagL and LpxR remain inactive
313
within the S. enterica outer membrane, unless over-expressed, suggesting the presence of endogenous inhibitors. Although the function of these enzymes is unknown, reduction in the number of acyl chains reduces the endotoxicity of LPS. Therefore, activation of PagL and/or LpxR within the outer membrane may function to aid in evading the innate immune response. Finally, in some bacterial species, the inner membrane enzyme LpxO may hydroxylate the secondary linked acyl chains of lipid A (Gibbons et al., 2000, 2008). In S. enterica, LpxO hydroxylates the 3-secondary tetradecanoic acid (myristate) (14:0) in the presence of oxygen, using Fe2 and -ketoglutarate as co-factors. The reaction occurs on the cytoplasmic side of the inner membrane and is not under the control of the PhoP/PhoQ system. Orthologues of LpxO, LpxR, and PagL are present in several Gram-negative bacteria; however, these enzymes are not found in E. coli K-12. The core region of LPS, including the Kdo residues, is also subject to structural modification. For example, E. coli and S. enterica grown in the presence of 5 mM Ca2 modify the outer Kdo residue of their LPS with a phosphoethanolamine residue (Kanipes et al., 2001) (see Figure 17.4). The protein EptB, a homologue of EptA, catalyses the transfer of phosphoethanolamine to Kdo from phosphatidylethanolamine releasing diacylglycerol. Loss of EptB function in deep-rough mutants of E. coli results in hypersensitivity to Ca2 suggesting that EptB plays a role in maintaining outer membrane stability under certain conditions (Reynolds et al., 2005). Of note, EptB is not regulated by PmrA, but is under the control of the E transcription factor (Figueroa-Bossi et al., 2006). As described earlier, some organisms express a mono-functional Kdo transferase (KdtA). Typically, bacteria having a single Kdo residue in their inner core, such as H. influenzae (Helander et al., 1988; Phillips et al., 1992), Vibrio cholerae (Chatterjee and Chaudhuri, 2003) and Bordetella pertussis (Caroff et al., 2001), phosphorylate their Kdo at the same position where the outer Kdo
II. synthesis of microbial glycosylated components
314
17. Biosynthesis and membrane assembly of lipid A
residue is normally present. Phosphorylation of Kdo takes place in the cytoplasm, does not appear to be regulated and is catalysed by a specific ATP-dependent kinase, called KdkA (White et al., 1999). The inner core region of Helicobacter pylori also has a single Kdo residue, however, the Kdo transferase of this bacterium is bifunctional. Interestingly, following transport of the core-lipid A across the H. pylori inner membrane, a Kdo hydrolase removes the outer Kdo residue (Stead et al., 2005). A putative Kdo-trimming enzyme has also been reported in membrane of Francisella novicida (Wang et al., 2004). The level of structural diversity found in the Kdo-lipid A domain of LPS is quite remarkable, allowing Gram-negative bacteria to express numerous chemical subtypes of lipid A on their surface. Although not discussed here, other modification enzymes include phosphatases that remove the 1 and 4 phosphate groups (Tran et al., 2004; Wang et al., 2004, 2006) and methyl transferases that use S-adenosylmethionine to methylate the 1-phosphate group (Boon Hinckley et al., 2005). As the lipid A structure of more Gram-negative organisms is investigated, it is likely that additional lipid A modification systems will be discovered.
5. Conclusions In 1979, the laboratory of Christian R. H. Raetz reported the discovery of lipid X, a key precursor in the lipid A biosynthetic pathway (Nishijima et al., 1981). From this initial finding evolved the elucidation of the constitutive biosynthetic pathway of Kdo2-lipid A (see Figure 17.2) representing a major achievement in understanding the biogenesis of the bacterial cell envelope. More recently, progress has also been made towards understanding the transport of LPS and the major proteins involved in this process have likely been identified. One of the major challenges remaining in this area is the development of reconstituted in vitro systems allowing the biochemical characterization of these proteins. Finally, many of the molecular mechanisms involved in the modification of the Kdo-lipid A domain of LPS have been elucidated. However, since these modification systems are highly variable from organism to organism, more investigation is required to determine the specific role these modifications play in the maintenance of the outer membrane and in pathogenesis (Research Focus Box).
Research Focus Box What regulatory mechanisms are involved in maintaining the perfect balance that leads to the asymmetrical nature of the Gramnegative outer membrane? Little is known about the regulation of lipid A biosynthesis within the bacterial cell and whether its synthesis is coordinated with that of glycerophospholipids.
l
N. meningitidis is not dependent upon LPS synthesis for growth. Is this true for other Gram-negative organisms? l Can lipid A modification systems be exploited for our benefit? Lipid A modification systems have the potential to be critical in the development of new adjuvants, LPS antagonists for treatment of sepsis and for engineering whole cell vaccines. l
II. synthesis of microbial glycosylated components
References
Acknowledgements M.S. Trent is supported by National Institutes of Health Grants AI064184 and AI076322.
References Aderem, A., Ulevitch, R.J., 2000. Toll-like receptors in the induction of the innate immune response. Nature 406, 782–787. Alpuche Aranda, C.M., Swanson, J.A., Loomis, W.P., Miller, S.I., 1992. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc. Natl. Acad. Sci. USA 89, 10079–10083. Babinski, K.J., Ribeiro, A.A., Raetz, C.R., 2002. The Escherichia coli gene encoding the UDP-2,3-diacylglucosamine pyrophosphatase of lipid A biosynthesis. J. Biol. Chem. 277, 25937–25946. Bader, M.W., Sanowar, S., Daley, M.E., et al., 2005. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122, 461–472. Bishop, R.E., Gibbons, H.S., Guina, T., Trent, M.S., Miller, S.I., Raetz, C.R., 2000. Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J. 19, 5071–5080. Boon Hinckley, M., Reynolds, C.M., Ribeiro, A.A., et al., 2005. A Leptospira interrogans enzyme with similarity to yeast Ste14p that methylates the 1-phosphate group of lipid A. J. Biol. Chem. 280, 30214–30224. Bos, M.P., Tefsen, B., Geurtsen, J., Tommassen, J., 2004. Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface. Proc. Natl. Acad. Sci. USA 101, 9417–9422. Bos, M.P., Robert, V., Tommassen, J., 2007. Biogenesis of the gram-negative bacterial outer membrane. Annu. Rev. Microbiol. 61, 191–214. Bouhss, A., Trunkfield, A.E., Bugg, T.D., Mengin-Lecreulx, D., 2008. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol. Rev. 32, 208–233. Brabetz, W., Lindner, B., Brade, H., 2000. Comparative analyses of secondary gene products of 3-deoxy-d-mannooct-2-ulosonic acid transferases from Chlamydiaceae in Escherichia coli K-12. Eur. J. Biochem. 267, 5458–5465. Braun, M., Silhavy, T.J., 2002. Imp/OstA is required for cell envelope biogenesis in Escherichia coli. Mol. Microbiol. 45, 1289–1302. Caroff, M., Aussel, L., Zarrouk, H., et al., 2001. Structural variability and originality of the Bordetella endotoxins. J. Endotoxin Res. 7, 63–68. Carty, S.M., Sreekumar, K.R., Raetz, C.R., 1999. Effect of cold shock on lipid A biosynthesis in Escherichia coli. Induction At 12 degrees C of an acyltransferase specific
315
for palmitoleoyl-acyl carrier protein. J. Biol. Chem. 274, 9677–9685. Chatterjee, S.N., Chaudhuri, K., 2003. Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Biochim. Biophys. Acta 1639, 65–79. Clementz, T., Raetz, C.R., 1991. A gene coding for 3-deoxy-dmanno-octulosonic-acid transferase in Escherichia coli. Identification, mapping, cloning, and sequencing. J. Biol. Chem. 266, 9687–9696. Clementz, T., Bednarski, J.J., Raetz, C.R., 1996. Function of the htrB high temperature requirement gene of Escherchia coli in the acylation of lipid A: HtrB catalyzed incorporation of laurate. J. Biol. Chem. 271, 12095–12102. Clementz, T., Zhou, Z., Raetz, C.R., 1997. Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J. Biol. Chem. 272, 10353–10360. Cox, A.D., Wright, J.C., Li, J., Hood, D.W., Moxon, E.R., Richards, J.C., 2003. Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide. J. Bacteriol. 185, 3270–3277. Crowell, D.N., Anderson, M.S., Raetz, C.R., 1986. Molecular cloning of the genes for lipid A disaccharide synthase and UDP-N-acetylglucosamine acyltransferase in Escherichia coli. J. Bacteriol. 168, 152–159. Doerrler, W.T., Reedy, M.C., Raetz, C.R., 2001. An Escherichia coli mutant defective in lipid export. J. Biol. Chem. 276, 11461–11464. Doerrler, W.T., Gibbons, H.S., Raetz, C.R., 2004. MsbAdependent translocation of lipids across the inner membrane of Escherichia coli. J. Biol. Chem. 279, 45102–45109. Figueroa-Bossi, N., Lemire, S., Maloriol, D., Balbontin, R., Casadesus, J., Bossi, L., 2006. Loss of Hfq activates the E-dependent envelope stress response in Salmonella enterica. Mol. Microbiol. 62, 838–852. Galanos, C., Lehmann, V., Lüderitz, O., et al., 1984. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur. J. Biochem. 140, 221–227. Galanos, C., Lüderitz, O., Rietschel, E.T., et al., 1985. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148, 1–5. Galloway, S.M., Raetz, C.R., 1990. A mutant of Escherichia coli defective in the first step of endotoxin biosynthesis. J. Biol. Chem. 265, 6394–6402. Garrett, T.A., Kadrmas, J.L., Raetz, C.R., 1997. Identification of the gene encoding the Escherichia coli lipid A 4-kinase. Facile phosphorylation of endotoxin analogs with recombinant LpxK. J. Biol. Chem. 272, 21855–21864.
II. synthesis of microbial glycosylated components
316
17. Biosynthesis and membrane assembly of lipid A
Gibbons, H.S., Lin, S., Cotter, R.J., Raetz, C.R., 2000. Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2/-ketoglutarate-dependent dioxygenase homologue. J. Biol. Chem. 275, 32940–32949. Gibbons, H.S., Reynolds, C.M., Guan, Z., Raetz, C.R., 2008. An inner membrane dioxygenase that generates the 2-hydroxymyristate moiety of Salmonella lipid A. Biochemistry 47, 2814–2825. Golenbock, D.T., Hampton, R.Y., Qureshi, N., Takayama, K., Raetz, C.R., 1991. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266, 19490–19498. Groisman, E.A., Kayser, J., Soncini, F.C., 1997. Regulation of polymyxin resistance and adaptation to low-Mg2 environments. J. Bacteriol. 179, 7040–7045. Gunn, J.S., Lim, K.B., Krueger, J., et al., 1998. PmrA-PmrBregulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 27, 1171–1182. Guo, L., Lim, K.B., Gunn, J.S., et al., 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276, 250–253. Guo, L., Lim, K.B., Poduje, C.M., et al., 1998. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95, 189–198. Helander, I.M., Lindner, B., Brade, H., et al., 1988. Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd/b. Description of a novel deeprough chemotype. Eur. J. Biochem. 177, 483–492. Helander, I.M., Kilpelainen, I., Vaara, M., 1994. Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study. Mol. Microbiol. 11, 481–487. Hoshino, K., Takeuchi, O., Kawai, T., et al., 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749–3752. Hwang, P.M., Choy, W.Y., Lo, E.I., et al., 2002. Solution structure and dynamics of the outer membrane enzyme PagP by NMR. Proc. Natl. Acad. Sci. USA 99, 13560–13565. Jackman, J.E., Raetz, C.R., Fierke, C.A., 1999. UDP-3-O-(R3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme. Biochemistry 38, 1902–1911. Kamio, Y., Nikaido, H., 1976. Outer membrane of Salmonella typhimurium: accessibility of phospholipid head groups to phospholipase c and cyanogen bromide activated dextran in the external medium. Biochemistry 15, 2561–2570. Kanipes, M.I., Lin, S., Cotter, R.J., Raetz, C.R., 2001. Ca2induced phosphoethanolamine transfer to the outer 3-deoxy-d-manno-octulosonic acid moiety of Escherichia
coli lipopolysaccharide. A novel membrane enzyme dependent upon phosphatidylethanolamine. J. Biol. Chem. 276, 1156–1163. Kelly, T.M., Stachula, S.A., Raetz, C.R., Anderson, M.S., 1993. The firA gene of Escherichia coli encodes UDP-3-O-(R-3hydroxymyristoyl)-glucosamine N-acyltransferase. The third step of endotoxin biosynthesis. J. Biol. Chem. 268, 19866–19874. Kline, T., Andersen, N.H., Harwood, E.A., et al., 2002. Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC. J. Med. Chem. 45, 3112–3129. Kotani, S., Takada, H., Tsujimoto, M., et al., 1985. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli Re-mutant. Infect. Immun. 49, 225–237. Lee, H., Hsu, F.F., Turk, J., Groisman, E.A., 2004. The PmrAregulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J. Bacteriol. 186, 4124–4133. McClerren, A.L., Endsley, S., Bowman, J.L., et al., 2005. A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin. Biochemistry 44, 16574–16583. McCoy, A.J., Liu, H., Falla, T.J., Gunn, J.S., 2001. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides. Antimicrob. Agents Chemother. 45, 2030–2037. Moran, A.P., Zahringer, U., Seydel, U., Scholz, D., Stutz, P., Rietschel, E.T., 1991. Structural analysis of the lipid A component of Campylobacter jejuni CCUG 10936 (serotype O:2) lipopolysaccharide. Description of a lipid A containing a hybrid backbone of 2-amino-2-deoxy-dglucose and 2,3-diamino-2,3-dideoxy-d-glucose. Eur. J. Biochem. 198, 459–469. Moskowitz, S.M., Ernst, R.K., Miller, S.I., 2004. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186, 575–579. Nichols, W.A., Raetz, C.R.H., Clementz, T., et al., 1997. htrB of Haemophilus influenzae: determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity. J. Endotoxin Res. 4, 163–172. Nishijima, M., Bulawa, C.E., Raetz, C.R., 1981. Two interacting mutations causing temperature-sensitive phosphatidylglycerol synthesis in Escherichia coli membranes. J. Bacteriol. 145, 113–121. Nummila, K., Kilpeläinen, I., Zähringer, U., Vaara, M., Helander, I.M., 1995. Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol. Microbiol. 16, 271–278.
II. synthesis of microbial glycosylated components
References
Phillips, N.J., Apicella, M.A., Griffiss, J.M., Gibson, B.W., 1992. Structural characterization of the cell surface lipooligosaccharides from a nontypable strain of Haemophilus influenzae. Biochemistry 31, 4515–4526. Raetz, C.R., Whitfield, C., 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635–700. Raetz, C.R., Reynolds, C.M., Trent, M.S., Bishop, R.E., 2007. Lipid A modification systems in Gram-negative bacteria. Annu. Rev. Biochem. 76, 295–329. Reynolds, C.M., Kalb, S.R., Cotter, R.J., Raetz, C.R., 2005. A phosphoethanolamine transferase specific for the outer 3-deoxy-d-manno-octulosonic acid residue of Escherichia coli lipopolysaccharide. Identification of the eptB gene and Ca2 hypersensitivity of an eptB deletion mutant. J. Biol. Chem. 280, 21202–21211. Reynolds, C.M., Ribeiro, A.A., McGrath, S.C., Cotter, R.J., Raetz, C.R., Trent, M.S., 2006. An outer membrane enzyme encoded by Salmonella typhimurium lpxR that removes the 3-acyloxyacyl moiety of lipid A. J. Biol. Chem. 281, 21974–21987. Ruiz, N., Gronenberg, L.S., Kahne, D., Silhavy, T.J., 2008. Identification of two inner-membrane proteins required for the transport of lipopolysaccharide to the outer membrane of Escherichia coli. Proc. Natl. Acad. Sci. USA 105, 5537–5542. Rund, S., Lindner, B., Brade, H., Holst, O., 1999. Structural analysis of the lipopolysaccharide from Chlamydia trachomatis serotype L2. J. Biol. Chem. 274, 16819–16824. Somerville Jr, J.E., Cassiano, L., Bainbridge, B., Cunningham, M.D., Darveau, R.P., 1996. A nove